data_1yju_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yju _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 108.862 -1.695 . . . . 1.87 108.862 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.14 147.54 5.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.06 -1.089 . . . . 3.28 108.06 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.5 tp -150.64 82.92 1.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.509 -0.552 . . . . 3.19 109.509 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -77.92 100.73 6.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 110.035 -0.357 . . . . 3.49 110.035 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.78 118.21 27.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.04 -1.467 . . . . 3.81 107.04 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.77 119.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 105.498 -2.038 . . . . 2.93 105.498 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.67 93.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 125.513 1.525 . . . . 3.11 107.967 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -78.47 112.36 15.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.009 -1.478 . . . . 7.46 107.009 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.64 -136.76 7.82 Favored Glycine 0 N--CA 1.434 -1.479 1 N-CA-C 101.994 -4.442 . . . . 3.54 101.994 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.63 173.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.874 0.87 . . . . 2.21 112.683 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -154.03 -81.03 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.954 1.302 . . . . 3.85 108.674 -167.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -172.13 131.37 0.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 125.361 1.464 . . . . 6.15 107.957 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 48.45 -146.12 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.558 -0.734 . . . . 2.8 109.21 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.1 p 51.61 -86.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.907 1.447 . . . . 1.56 114.907 161.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.5 p -45.31 -41.7 9.03 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.214 -0.929 . . . . 3.66 111.53 166.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.03 -72.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.3 1.44 . . . . 1.87 110.064 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -25.82 66.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.806 -0.616 . . . . 1.75 111.241 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -53.21 -57.52 10.22 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.527 -0.916 . . . . 5.61 108.527 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.69 -60.12 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.908 -0.775 . . . . 1.88 108.908 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -54.16 -57.03 12.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.85 0.357 . . . . 3.27 111.373 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -57.0 -47.58 80.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.433 0.693 . . . . 1.9 110.07 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -60.03 -65.23 0.71 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.931 -0.396 . . . . 1.45 109.931 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.75 -29.43 69.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.006 -1.078 . . . . 3.91 111.217 -166.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -55.82 -20.38 15.0 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.163 -0.961 . . . . 2.22 112.348 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -30.64 69.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.808 -1.183 . . . . 7.51 112.417 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' A' ' 31' ' ' GLY . 52.1 m-70 -70.07 116.04 9.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.209 -1.034 . . . . 2.36 108.209 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 32.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.418 -0.802 . . . . 9.14 113.082 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' HIS . . . -126.08 -8.53 5.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.037 1.78 . . . . 0.89 111.82 166.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.02 118.64 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 105.974 -1.861 . . . . 3.46 105.974 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.83 -37.75 18.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.222 -0.659 . . . . 2.74 109.222 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.4 162.12 40.86 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.052 0.387 . . . . 4.32 110.866 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.91 96.08 2.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.433 1.893 . . . . 2.57 108.957 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 m -99.73 99.78 10.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.719 1.608 . . . . 2.91 107.545 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.96 92.53 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 122.819 1.295 . . . . 3.16 109.286 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.72 82.22 3.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.484 -1.302 . . . . 2.36 107.484 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -37.5 -44.07 0.63 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.248 1.819 . . . . 3.91 110.378 163.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.4 -32.93 28.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.121 . . . . 2.14 113.067 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -120.95 20.45 11.57 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.416 1.086 . . . . 3.99 110.296 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 34.59 56.66 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.368 1.867 . . . . 2.23 111.523 -170.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -140.69 125.58 18.23 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.968 0.359 . . . . 2.65 111.968 -167.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.74 98.99 8.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.245 -1.391 . . . . 1.62 107.245 165.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -77.25 96.29 4.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 104.787 -2.301 . . . . 1.36 104.787 159.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.67 150.0 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.249 -1.342 . . . . 2.34 107.996 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.14 133.74 55.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.427 -2.064 . . . . 4.02 105.427 166.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -156.26 161.82 40.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.176 -1.416 . . . . 3.91 107.176 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.18 140.99 22.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 4.15 107.088 161.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.45 -22.58 28.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.399 2.066 . . . . 1.71 111.628 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.648 0.779 . . . . 4.06 111.169 -172.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.98 -11.29 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.647 0.379 . . . . 3.29 111.957 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.88 130.99 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.315 -0.624 . . . . 2.39 109.315 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.01 154.08 47.68 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.177 -1.569 . . . . 1.89 109.177 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.04 -40.52 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.585 1.523 . . . . 0.91 109.34 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.09 -38.26 79.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.381 -0.342 . . . . 9.45 111.202 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -53.0 47.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.154 1.382 . . . . 3.51 109.745 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.35 -51.87 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.031 -0.986 . . . . 1.92 109.04 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.46 -52.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.695 -0.669 . . . . 2.28 111.446 -177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -48.06 -49.41 31.57 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.935 1.294 . . . . 3.82 109.496 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -63.37 -47.44 82.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.98 -0.555 . . . . 1.95 109.642 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.79 -58.81 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 121.471 -0.768 . . . . 2.16 111.29 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.68 -49.04 76.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.692 -0.855 . . . . 2.73 108.692 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.7 t -48.37 -50.32 31.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.238 1.015 . . . . 1.42 111.712 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.13 -42.76 86.53 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.168 1.173 . . . . 2.62 114.168 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.89 -2.92 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 N-CA-C 119.127 2.411 . . . . 1.38 119.127 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -142.27 177.64 8.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.963 1.881 . . . . 3.17 111.846 -144.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -110.62 140.3 45.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.184 -1.784 . . . . 5.18 106.184 150.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.0 116.15 16.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.861 0.864 . . . . 2.25 110.827 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -122.55 116.99 24.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.394 1.078 . . . . 2.23 111.417 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.88 72.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.93 1.692 . . . . 3.09 112.407 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 123.818 0.847 . . . . 2.32 110.443 169.173 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.601 0 N-CA-C 109.255 -1.538 . . . . 2.05 109.255 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.4 151.96 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.229 -0.656 . . . . 3.37 109.229 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.8 tp -152.37 111.07 3.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.271 -1.011 . . . . 2.94 108.271 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -106.49 117.53 34.28 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.096 0.474 . . . . 2.86 111.693 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.6 mt -106.78 129.91 54.57 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.81 -1.182 . . . . 3.98 107.81 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.74 101.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.18 -1.415 . . . . 3.36 107.18 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.91 78.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.578 -1.638 . . . . 2.86 106.578 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -77.68 116.06 17.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 6.32 107.458 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.39 -11.71 3.25 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.504 1.049 . . . . 1.45 112.631 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.0 mtp -63.76 149.55 46.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.053 0.926 . . . . 2.46 109.922 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.4 17.72 0.34 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.795 0.665 . . . . 2.43 112.795 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -171.39 152.09 3.22 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.787 1.176 . . . . 2.91 110.786 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.14 -35.97 3.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.295 1.838 . . . . 1.77 112.739 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -59.18 -69.64 0.19 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.8 111.798 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.2 m -40.35 -45.73 2.21 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.908 1.283 . . . . 1.77 110.414 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 t -53.32 -73.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 123.842 0.714 . . . . 1.82 111.108 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -21.51 64.33 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.706 -0.621 . . . . 1.43 112.13 -166.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -55.8 -47.31 77.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.364 1.066 . . . . 4.68 109.362 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.56 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.453 -0.943 . . . . 1.79 108.453 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -49.94 -60.6 2.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.539 0.736 . . . . 3.19 110.428 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 t -52.39 -44.49 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.726 0.81 . . . . 1.62 110.989 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -61.51 -62.79 1.57 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.107 0.412 . . . . 1.61 110.494 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.38 -33.35 75.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.241 -0.912 . . . . 2.72 111.434 -166.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.1 p -60.02 -11.99 7.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.449 -0.782 . . . . 3.31 112.649 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -62.65 -39.51 94.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.008 0.822 . . . . 5.4 110.908 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -70.71 125.85 27.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.047 -1.094 . . . . 2.37 108.047 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -75.76 48.86 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.899 0.879 . . . . 8.06 110.334 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.86 -39.67 0.15 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 126.516 2.008 . . . . 1.31 110.566 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mp -79.26 119.75 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.43 -1.693 . . . . 3.72 106.43 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.96 -26.11 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.456 0.702 . . . . 3.1 110.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -155.3 155.11 33.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.959 -0.756 . . . . 3.62 108.959 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -149.75 131.6 15.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.409 -1.33 . . . . 1.97 107.409 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -142.28 118.87 11.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.055 -1.091 . . . . 2.69 108.055 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p -99.76 97.87 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.265 1.031 . . . . 2.87 110.938 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 97.82 11.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.687 -0.856 . . . . 1.78 108.687 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -49.99 -34.12 20.03 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.88 0.872 . . . . 3.98 111.684 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.96 60.64 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.742 0.817 . . . . 2.24 111.66 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -119.37 11.67 12.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.086 1.354 . . . . 2.32 109.763 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 m120 37.71 38.73 0.17 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.722 2.009 . . . . 2.21 111.95 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.58 133.52 54.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 121.681 -0.637 . . . . 1.82 109.594 -168.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 101.46 13.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.335 -1.728 . . . . 1.67 106.335 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -76.67 92.62 3.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.684 -2.339 . . . . 1.35 104.684 166.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.74 150.54 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.822 -1.548 . . . . 2.37 106.822 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -126.17 142.48 51.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.794 -1.558 . . . . 3.87 106.794 155.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.42 175.57 13.81 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.196 0.999 . . . . 3.13 108.996 -170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.98 125.78 26.55 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 108.671 -0.863 . . . . 3.53 108.671 171.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.26 61.06 6.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.364 3.376 . . . . 2.21 111.509 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -168.07 -43.22 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.894 1.678 . . . . 3.57 110.119 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.3 pt -73.26 -30.18 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.748 -0.834 . . . . 3.49 108.748 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -153.49 149.14 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.515 -0.92 . . . . 2.37 108.515 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 167.25 31.74 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 110.62 -0.992 . . . . 1.92 110.62 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.58 -46.22 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.499 2.133 . . . . 0.81 110.756 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -45.72 -40.8 9.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.872 1.269 . . . . 9.19 111.105 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -57.5 12.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.447 1.899 . . . . 3.39 107.969 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mt -63.3 -48.82 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.579 -0.737 . . . . 2.1 109.575 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.8 -60.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.931 0.893 . . . . 2.65 109.139 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -57.83 -42.44 84.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.701 1.2 . . . . 6.41 109.738 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 m -61.3 -47.13 87.37 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.468 -0.493 . . . . 1.76 110.564 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.16 -45.05 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 1.76 111.065 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -57.27 -52.95 63.25 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.103 0.561 . . . . 3.04 109.728 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -54.75 -42.22 71.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.818 1.247 . . . . 1.29 111.146 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.82 -55.49 19.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.0 0.818 . . . . 2.56 111.106 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.28 -42.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.65 1.02 . . . . 1.45 115.65 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.68 140.98 52.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 117.754 0.777 . . . . 3.34 112.194 -137.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.82 79.76 4.29 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.247 0.546 . . . . 3.34 110.316 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.91 141.16 44.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.571 -0.706 . . . . 2.08 110.284 -165.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -156.41 128.38 7.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.173 -0.955 . . . . 2.79 111.209 -167.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.9 116.96 2.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.174 1.39 . . . . 3.37 110.931 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.222 -0.358 0 C-N-CA 124.565 1.146 . . . . 2.71 109.051 168.577 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 2.35 111.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.74 92.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.321 1.058 . . . . 3.06 108.508 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.8 tp -95.31 101.19 12.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.032 1.733 . . . . 3.01 106.961 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -95.42 120.41 35.61 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.514 -1.291 . . . . 2.81 107.514 156.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 148.51 25.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.73 1.269 . . . . 3.71 108.255 158.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.89 143.54 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.534 -2.025 . . . . 2.93 105.534 160.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.21 127.56 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.556 1.542 . . . . 3.77 108.308 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -118.24 155.41 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.391 0.677 . . . . 7.35 110.021 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.89 -31.88 6.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.278 1.418 . . . . 1.54 110.582 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mtp -51.12 130.52 26.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.556 0.742 . . . . 2.07 110.273 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -154.03 17.38 0.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.246 -0.407 . . . . 2.38 112.087 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -169.36 151.17 4.45 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.143 0.883 . . . . 2.43 109.378 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.46 -37.73 12.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.798 1.639 . . . . 1.7 112.013 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.6 p -57.92 -71.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.99 0.916 . . . . 0.85 111.67 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.8 m -40.32 -44.07 1.86 Allowed 'General case' 0 C--N 1.338 0.109 0 C-N-CA 125.096 1.358 . . . . 2.1 111.012 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.84 -73.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 123.703 0.627 . . . . 1.94 111.041 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -20.31 66.08 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.567 -0.708 . . . . 1.56 112.206 -168.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.33 -42.53 82.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.865 0.866 . . . . 3.88 109.729 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.5 mt -62.17 -57.26 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.501 -0.926 . . . . 1.64 108.501 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.32 -57.95 8.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.968 0.907 . . . . 3.4 109.866 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -52.29 -54.36 32.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.033 0.933 . . . . 1.58 110.442 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -59.03 -40.08 83.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.888 -0.577 . . . . 1.58 112.092 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -73.67 -36.82 65.37 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.331 0.969 . . . . 2.73 112.512 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 m -70.81 70.39 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.034 0.921 . . . . 2.51 110.357 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HZ3' ' CD2' ' A' ' 29' ' ' HIS . 1.5 pptp? -174.0 -23.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.687 2.795 . . . . 6.72 112.394 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.414 ' CD2' ' HZ3' ' A' ' 28' ' ' LYS . 11.3 m-70 -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.249 1.386 . . . . 2.53 111.189 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 67.84 -3.85 1.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.603 2.361 . . . . 6.74 113.67 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.83 -28.87 40.6 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.412 -1.075 . . . . 0.91 110.412 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.88 129.48 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.259 0.624 . . . . 3.77 109.397 171.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.19 -42.74 12.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.291 1.036 . . . . 2.41 109.294 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.337 -0.246 . . . . 3.08 110.337 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -137.67 130.77 30.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.666 1.586 . . . . 1.99 107.006 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -134.4 103.61 5.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.976 -1.49 . . . . 2.26 106.976 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.334 2.8 p -89.73 88.25 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 123.461 1.601 . . . . 2.85 110.231 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.1 84.81 4.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.305 -1.316 . . . . 2.26 107.839 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.53 -36.56 4.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.725 1.61 . . . . 4.24 111.147 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.85 -33.45 23.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.394 0.678 . . . . 2.08 111.936 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -113.83 4.51 15.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.043 1.737 . . . . 3.69 110.967 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 44.23 52.63 7.04 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.23 1.012 . . . . 2.12 110.3 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -139.81 142.66 36.66 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 122.721 0.408 . . . . 2.52 110.696 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.34 101.19 10.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.698 -1.223 . . . . 1.69 107.698 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -78.27 104.89 9.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.115 -2.18 . . . . 0.99 105.115 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.67 121.72 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.743 -1.577 . . . . 1.95 106.743 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -102.22 123.8 46.69 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.443 -1.688 . . . . 3.39 106.443 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.33 152.62 32.33 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.364 0.666 . . . . 3.87 109.478 -171.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -95.67 108.4 39.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 107.647 -1.242 . . . . 3.84 107.647 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.97 -46.72 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.213 1.942 . . . . 2.5 112.587 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.2 -32.13 15.62 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.989 1.107 . . . . 3.88 113.989 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 pt -96.05 7.47 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 118.521 0.6 . . . . 3.45 112.467 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.72 -55.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.098 0.863 . . . . 3.23 111.69 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.46 143.3 5.25 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.827 1.68 . . . . 1.94 110.266 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -57.94 -39.58 85.16 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.819 2.346 . . . . 0.93 110.603 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -29.23 -50.88 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.006 2.122 . . . . 11.82 113.218 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -71.62 -49.71 37.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.5 1.12 . . . . 4.17 109.767 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.0 mt -58.71 -54.07 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.703 -0.68 . . . . 1.95 109.362 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -53.88 -54.68 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.461 -0.57 . . . . 3.23 109.461 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -53.33 -45.12 68.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.882 0.473 . . . . 6.63 110.351 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -59.8 -52.55 64.98 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.104 0.411 . . . . 1.72 110.415 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.6 mt -51.78 -58.66 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 2.06 109.361 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -52.07 -57.67 8.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.627 0.727 . . . . 3.43 109.805 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -58.66 -26.11 63.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.322 1.449 . . . . 1.28 113.371 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.27 -76.9 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.592 1.542 . . . . 2.93 110.968 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.6 31.91 0.43 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.775 -1.014 . . . . 1.42 112.989 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -132.68 173.48 11.3 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.368 1.084 . . . . 3.29 112.571 -165.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.58 155.8 34.27 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 105.65 -1.981 . . . . 3.81 105.65 157.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.75 166.36 33.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.01 0.823 . . . . 2.2 112.371 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.88 132.04 10.05 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.561 1.144 . . . . 2.9 110.571 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.11 125.98 21.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.721 1.209 . . . . 3.8 110.309 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 124.825 1.25 . . . . 2.1 111.949 173.847 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.051 0 CA-C-O 122.091 0.828 . . . . 1.66 113.003 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.16 145.31 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.328 -1.101 . . . . 3.11 109.059 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -147.85 119.94 8.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.35 -2.093 . . . . 2.95 105.35 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.98 113.05 22.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.61 -1.626 . . . . 2.49 106.61 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -110.91 131.85 54.7 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.415 -1.328 . . . . 4.38 107.415 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -75.88 126.32 36.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 105.032 -2.211 . . . . 2.81 105.032 154.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -119.34 108.73 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.334 -1.728 . . . . 3.24 106.334 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -79.84 98.77 7.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.767 . . . . 5.72 108.93 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 -105.23 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.23 -2.348 . . . . 3.54 107.23 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.5 mtp 57.49 35.25 25.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.629 0.772 . . . . 3.29 112.1 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -74.58 121.22 21.24 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.731 -0.606 . . . . 3.08 110.043 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t 68.46 152.53 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.77 1.628 . . . . 3.2 113.239 169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.25 72.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.158 1.783 . . . . 3.39 110.566 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 p -178.8 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.672 1.189 . . . . 1.92 109.466 -160.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.7 m -73.15 -51.1 19.15 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.922 -0.77 . . . . 1.88 108.922 159.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -42.7 -73.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.476 1.911 . . . . 2.06 111.58 -175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -25.73 68.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.089 -0.382 . . . . 1.72 111.903 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -67.41 -49.43 63.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.154 0.981 . . . . 5.38 108.925 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -53.34 -62.3 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 108.207 -1.035 . . . . 1.82 108.207 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -53.42 -57.1 11.82 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.366 0.267 . . . . 3.08 110.713 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -49.71 -50.88 42.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.854 -0.594 . . . . 1.6 110.331 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 t -55.53 -50.59 69.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.347 0.521 . . . . 1.59 110.801 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 mt -67.83 -38.22 82.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.59 -1.644 . . . . 2.9 110.557 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.8 m -59.95 -10.23 3.88 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.667 -0.646 . . . . 2.97 112.591 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -62.77 -40.83 98.52 Favored 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.718 -1.238 . . . . 5.85 109.83 168.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -72.38 135.35 45.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.777 -1.194 . . . . 2.66 107.777 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.48 -0.74 55.82 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.868 -0.52 . . . . 7.03 110.961 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.62 -15.07 64.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.402 0.525 . . . . 0.89 113.306 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.7 tt -88.82 124.46 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.028 -1.101 . . . . 4.03 108.028 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.7 mt -82.23 -40.26 21.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.047 0.939 . . . . 2.48 109.5 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -155.21 148.62 25.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 110.127 -0.323 . . . . 3.17 110.127 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.4 t -132.9 138.98 47.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.963 1.305 . . . . 1.99 107.703 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 m -143.92 102.38 3.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.004 -1.11 . . . . 2.37 108.004 164.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.327 1.2 p -88.76 80.88 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 123.708 1.718 . . . . 2.58 108.809 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 90.4 4.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.93 1.692 . . . . 1.96 110.158 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pp -54.53 -29.9 52.1 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.571 1.148 . . . . 4.18 112.427 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.9 26.04 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.156 0.582 . . . . 1.8 111.43 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 p -114.63 9.25 16.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.354 1.462 . . . . 3.41 111.658 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.97 45.0 3.18 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.254 1.422 . . . . 2.15 111.247 -171.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -133.26 136.49 45.57 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 122.73 0.412 . . . . 2.02 111.734 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.63 109.19 20.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.565 1.146 . . . . 1.78 108.247 164.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -78.58 114.18 17.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.846 -2.279 . . . . 0.89 104.846 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.12 107.19 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.337 -1.357 . . . . 2.23 107.337 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -87.31 105.3 17.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.672 -1.603 . . . . 4.25 106.672 163.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.26 175.22 6.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.529 1.932 . . . . 3.08 106.293 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.35 130.77 23.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.239 -0.652 . . . . 3.71 109.239 166.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -57.52 -35.12 98.89 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.681 2.254 . . . . 1.83 110.938 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.2 -6.56 24.12 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.5 0.926 . . . . 4.4 113.5 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 pt -120.97 -31.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.421 0 CA-C-N 119.703 1.138 . . . . 4.04 113.047 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 tt -152.04 144.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 119.783 1.174 . . . . 2.44 108.781 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.67 159.78 51.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.788 -1.325 . . . . 1.87 109.788 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.8 -48.29 1.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.958 1.772 . . . . 0.83 109.274 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.443 HH22 ' CD ' ' A' ' 63' ' ' GLU . 41.7 tpt85 -55.7 -34.8 65.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.821 0.849 . . . . 9.0 111.744 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -61.04 2.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.696 2.399 . . . . 3.45 108.807 174.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.05 -43.68 81.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.493 0.717 . . . . 2.03 110.139 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.28 -43.23 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.749 -0.643 . . . . 3.26 110.749 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -54.51 -45.26 73.26 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.248 0.931 . . . . 3.54 110.409 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.5 m -55.31 -53.39 56.68 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.531 0.605 . . . . 1.9 110.559 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.17 -53.93 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.461 0.704 . . . . 3.19 111.335 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.443 ' CD ' HH22 ' A' ' 56' ' ' ARG . 39.8 mt-10 -54.11 -57.48 10.93 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.458 1.103 . . . . 3.19 109.807 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.5 t -52.66 -49.75 64.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.545 1.538 . . . . 1.89 111.071 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.18 -54.56 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.099 0.409 . . . . 4.17 110.96 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.87 -42.44 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.782 -1.199 . . . . 1.59 115.42 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.68 141.47 47.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.031 -0.668 . . . . 3.32 111.517 -133.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -78.24 123.43 26.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.225 -1.398 . . . . 3.44 107.225 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.18 159.0 15.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 2.41 110.757 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 m -151.35 114.51 4.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.272 1.029 . . . . 2.27 108.348 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.73 127.13 29.85 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.654 -0.869 . . . . 4.12 108.654 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 123.398 0.679 . . . . 1.99 110.949 177.62 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 109.642 -1.383 . . . . 1.95 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.62 145.41 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 118.524 1.162 . . . . 3.44 108.864 169.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.43 91.09 2.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.903 -1.517 . . . . 3.64 106.903 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.32 105.65 17.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.109 -0.7 . . . . 2.95 109.109 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.29 147.88 33.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.806 0.692 . . . . 2.96 109.48 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.45 133.44 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.832 -1.914 . . . . 2.93 105.832 161.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.35 137.1 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 125.123 1.369 . . . . 3.57 107.808 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -140.04 153.28 46.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.776 0.831 . . . . 8.77 109.862 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.8 -43.85 1.67 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.829 -1.308 . . . . 1.69 109.829 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -48.43 114.35 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.318 1.447 . . . . 2.84 114.103 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 p -97.48 115.93 28.73 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.133 1.373 . . . . 4.37 110.397 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.7 m 69.73 176.88 0.27 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.157 0.979 . . . . 3.29 113.31 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.18 -37.96 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.543 2.337 . . . . 1.93 112.523 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 p -64.51 -56.96 10.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.802 0.667 . . . . 1.11 112.802 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 119.966 -1.709 . . . . 1.73 108.542 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.93 -66.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.623 0.769 . . . . 1.83 110.776 172.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.258 0.1 OUTLIER -68.89 -26.04 64.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 121.795 -0.565 . . . . 1.42 111.285 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -59.77 -53.76 54.24 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 4.48 109.116 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.29 -60.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.727 -0.842 . . . . 1.79 108.727 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -55.18 -52.95 61.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.012 0.195 . . . . 3.16 110.743 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 t -57.73 -43.05 85.04 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.438 0.695 . . . . 1.55 111.603 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -62.22 -48.26 80.78 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.278 0.561 . . . . 1.54 109.919 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.06 -37.84 75.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.779 -0.629 . . . . 3.39 111.047 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.9 m -71.09 61.73 0.29 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 120.643 1.565 . . . . 2.44 111.334 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -148.98 -69.98 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.556 1.942 . . . . 4.85 109.252 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.51 111.98 2.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 3.32 111.653 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -77.99 47.08 0.62 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.817 1.784 . . . . 6.6 115.817 -152.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.84 2.87 5.26 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.992 0.815 . . . . 1.14 113.058 164.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.0 115.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.101 1.761 . . . . 3.74 107.049 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.9 mt -85.7 -43.69 13.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.827 0.851 . . . . 2.55 110.555 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -145.32 146.91 31.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.839 -0.43 . . . . 3.66 109.839 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.8 p -134.68 134.81 41.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.435 1.494 . . . . 3.32 107.397 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -151.06 104.66 3.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.966 -1.494 . . . . 2.37 106.966 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.33 3.4 p -92.89 88.7 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.445 1.593 . . . . 2.85 110.562 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.28 80.41 4.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.514 -1.221 . . . . 2.4 108.459 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.1 tt -42.38 -38.93 2.01 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.68 1.992 . . . . 2.78 111.226 166.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.17 -35.01 47.62 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.666 0.786 . . . . 2.22 112.065 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 p -108.64 8.52 27.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.466 1.506 . . . . 3.5 111.015 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.6 45.44 5.73 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.595 1.558 . . . . 2.17 110.392 -171.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -133.24 137.92 46.29 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.045 0.538 . . . . 2.02 110.239 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.34 107.85 20.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.469 -1.308 . . . . 1.73 107.469 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -84.03 97.4 9.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.966 -2.235 . . . . 0.92 104.966 162.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.84 154.38 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.512 -1.662 . . . . 3.11 106.512 162.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -128.55 145.01 51.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.57 -1.27 . . . . 3.88 107.57 159.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -160.18 172.43 17.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.492 0.717 . . . . 3.12 111.448 -165.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -105.93 100.17 26.57 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.155 1.382 . . . . 3.91 109.935 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -72.76 67.56 3.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.989 3.126 . . . . 2.35 112.298 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -166.34 -47.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.813 1.245 . . . . 3.75 110.343 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.17 -17.28 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 123.74 0.816 . . . . 3.42 110.462 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 tt -148.56 154.72 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.472 -2.048 . . . . 2.35 105.472 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.8 167.8 25.84 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.51 -1.436 . . . . 2.02 109.51 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.09 -39.83 76.1 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.664 1.576 . . . . 0.87 109.064 165.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -44.65 -52.36 8.28 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.261 1.424 . . . . 8.52 112.178 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -52.36 64.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.543 1.065 . . . . 2.82 110.321 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.83 -56.14 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.068 -0.715 . . . . 2.32 109.068 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.87 -56.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 122.805 0.442 . . . . 2.71 109.851 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -52.73 -49.53 65.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.165 1.386 . . . . 6.52 110.078 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.1 m -58.69 -45.77 88.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.112 -0.329 . . . . 1.63 110.112 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.6 -65.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.777 -0.453 . . . . 2.14 109.777 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.28 -46.87 72.82 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.419 -0.513 . . . . 2.92 110.393 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -60.61 -20.3 60.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.134 -1.412 . . . . 1.23 113.688 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.64 -73.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.162 1.801 . . . . 2.64 109.655 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.56 29.21 0.39 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.723 -1.043 . . . . 1.33 113.23 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.31 172.42 8.66 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 118.763 1.281 . . . . 3.29 113.362 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -103.88 146.39 28.72 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.203 -2.147 . . . . 4.25 105.203 158.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.6 137.94 20.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.833 0.853 . . . . 2.04 111.162 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 m -157.07 111.73 2.75 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.084 -1.01 . . . . 2.59 112.593 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -39.22 128.48 1.75 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.407 1.483 . . . . 4.51 110.583 165.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.454 -0.233 0 C-N-CA 124.589 1.156 . . . . 2.16 109.1 169.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 110.876 -0.89 . . . . 3.3 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.41 141.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 126.702 2.001 . . . . 2.73 106.385 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.0 tp -153.87 113.86 3.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.407 1.483 . . . . 3.34 107.037 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.87 121.23 37.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 2.15 108.209 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 145.45 50.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.343 0.52 . . . . 3.89 111.875 170.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.89 136.73 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.062 -1.459 . . . . 3.02 107.062 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.72 95.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 127.019 2.128 . . . . 3.05 106.006 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -79.57 126.11 30.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.51 -0.876 . . . . 5.92 108.848 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.46 8.99 4.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.202 1.382 . . . . 1.58 113.555 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.0 mtp -78.6 117.21 19.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.437 1.118 . . . . 2.54 108.268 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -143.73 16.39 1.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.146 0.795 . . . . 2.32 113.146 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -169.26 141.32 2.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.23 0.923 . . . . 3.37 109.453 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.03 -39.67 0.91 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.485 1.914 . . . . 1.79 113.63 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -59.52 -75.56 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.816 0.846 . . . . 1.26 111.847 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -46.97 -36.78 8.12 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 125.636 1.575 . . . . 2.1 111.521 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.21 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.872 0.869 . . . . 2.18 109.123 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.256 0.3 OUTLIER -64.73 -15.96 62.25 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.656 -0.653 . . . . 2.12 112.742 -166.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -57.44 -40.43 78.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.42 1.088 . . . . 3.77 108.698 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.43 -63.78 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.292 -1.003 . . . . 1.8 108.292 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -58.35 6.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.495 0.318 . . . . 3.06 110.648 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 t -50.97 -47.32 61.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.127 0.971 . . . . 1.58 111.201 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -62.23 -57.44 11.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.823 -0.548 . . . . 1.46 109.654 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.43 -39.69 70.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.406 0.682 . . . . 3.39 111.497 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -48.46 -35.81 13.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.345 -0.847 . . . . 2.79 112.136 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 1.29 2.03 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.115 -0.991 . . . . 7.45 113.316 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.437 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 10.7 m170 -83.71 -19.85 34.5 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.134 -1.604 . . . . 2.4 110.738 171.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 65.92 -3.02 0.81 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.723 1.609 . . . . 7.64 115.236 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.79 15.79 51.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.28 0.945 . . . . 1.04 111.833 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -113.19 142.02 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.955 -1.498 . . . . 3.34 106.955 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.73 -40.57 9.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.581 0.752 . . . . 3.75 109.466 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -155.14 156.3 35.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.369 0.531 . . . . 3.47 110.691 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 m -137.29 116.58 12.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.54 -2.022 . . . . 3.32 105.54 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.62 99.6 7.65 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.253 -1.388 . . . . 2.45 107.253 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.285 0.6 OUTLIER -94.38 91.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 123.107 1.432 . . . . 2.64 110.484 -173.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.15 91.79 7.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.678 1.591 . . . . 2.06 111.23 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -44.55 -42.27 7.13 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.4 1.88 . . . . 2.69 112.521 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.28 -35.16 59.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.585 0.754 . . . . 2.34 111.463 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -107.5 3.67 25.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.397 1.479 . . . . 3.64 110.955 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.35 59.13 1.21 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.487 1.915 . . . . 2.86 109.832 -166.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 140.66 37.01 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.083 0.553 . . . . 2.03 111.013 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.47 113.83 26.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 1.73 108.384 165.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.59 99.33 8.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.621 -1.992 . . . . 1.17 105.621 158.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.75 141.8 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.377 -1.342 . . . . 2.21 107.377 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -125.19 116.34 21.86 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.231 -1.766 . . . . 4.54 106.231 165.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.09 165.0 37.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.591 1.157 . . . . 2.99 109.401 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.23 137.74 27.62 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.844 -1.169 . . . . 4.32 107.844 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.49 -40.44 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.165 1.91 . . . . 2.46 112.262 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.09 -31.69 23.23 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.336 0.516 . . . . 3.58 111.373 -164.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -56.4 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.402 -0.592 . . . . 4.96 109.402 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.73 -41.92 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.673 -0.24 . . . . 3.11 110.944 -163.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.73 115.44 0.09 OUTLIER Glycine 0 CA--C 1.534 1.253 0 N-CA-C 109.423 -1.471 . . . . 1.89 109.423 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.72 -33.19 79.26 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 CA-C-N 120.306 2.053 . . . . 1.06 112.44 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -47.55 -43.14 24.85 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.968 0.729 . . . . 7.97 112.968 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -58.67 -55.19 38.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.078 0.942 . . . . 4.1 109.903 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.1 mt -50.96 -52.92 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.822 -0.626 . . . . 2.37 110.671 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.39 -48.24 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-O 118.64 -0.695 . . . . 2.95 110.117 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -51.09 -48.69 61.61 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.619 -0.511 . . . . 3.73 109.619 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.437 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 99.2 m -61.37 -48.13 82.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 118.513 -1.275 . . . . 2.27 109.907 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.9 mt -54.35 -57.05 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 119.388 -0.339 . . . . 2.18 111.167 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.25 -46.1 88.43 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.503 0.592 . . . . 4.67 110.414 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -66.79 -15.97 63.95 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.718 -1.135 . . . . 1.32 112.517 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.81 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.461 1.482 . . . . 2.69 110.496 162.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.96 36.2 0.5 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.017 -0.88 . . . . 1.47 113.548 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -132.81 175.09 9.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.352 1.076 . . . . 3.15 111.265 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -129.74 121.98 27.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.001 -1.111 . . . . 3.36 108.001 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.13 163.46 13.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.454 0.701 . . . . 2.26 111.934 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -155.98 123.99 5.7 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.601 1.56 . . . . 2.11 108.53 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.87 138.27 58.4 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.815 0.734 . . . . 3.56 109.963 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 123.182 0.593 . . . . 2.08 111.443 177.128 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 N-CA-C 108.392 -1.883 . . . . 1.94 108.392 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.72 138.4 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.294 -0.533 . . . . 3.06 110.008 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -142.43 88.43 2.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.256 1.822 . . . . 3.1 107.541 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -82.57 121.28 26.6 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.873 -1.528 . . . . 2.25 106.873 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -128.71 137.71 51.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.179 -0.325 . . . . 2.9 110.238 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.45 145.81 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.711 -1.218 . . . . 2.97 107.711 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.26 155.19 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.472 -1.677 . . . . 2.82 106.472 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -126.31 132.68 51.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.393 -1.336 . . . . 5.54 107.393 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.25 23.81 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.288 1.423 . . . . 1.83 112.201 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mtp -72.37 78.0 1.02 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.259 1.029 . . . . 2.33 109.189 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 t -97.26 -3.48 40.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.791 0.836 . . . . 2.28 112.813 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -163.41 144.65 9.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.591 1.087 . . . . 2.63 110.795 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.05 -37.43 0.16 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 127.88 2.472 . . . . 1.66 113.37 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -52.46 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.198 0.999 . . . . 0.87 112.339 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.8 m -43.04 -49.51 6.11 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 126.504 1.921 . . . . 2.0 110.191 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.4 t -45.82 -69.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 125.432 1.493 . . . . 2.01 110.554 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.281 0.3 OUTLIER -70.21 -17.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.428 -0.509 . . . . 2.12 111.638 -175.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -70.24 -42.32 72.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.301 -1.0 . . . . 5.55 108.301 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -51.2 -61.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.92 -0.77 . . . . 1.73 108.92 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -58.8 -54.32 48.45 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.809 -0.557 . . . . 2.72 112.103 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.4 t -54.4 -30.99 53.98 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.831 0.852 . . . . 1.76 111.483 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 t -71.03 -69.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.497 -0.752 . . . . 1.48 110.275 167.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -50.85 -47.31 60.36 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.26 1.424 . . . . 3.66 113.462 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.7 p -46.08 -34.19 3.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.682 0.793 . . . . 3.32 111.83 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -64.09 -21.79 66.67 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.706 1.203 . . . . 6.96 111.788 -175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -64.21 -29.75 70.84 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.472 0.578 . . . . 2.22 110.384 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 67.68 -1.95 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.137 1.775 . . . . 5.78 114.771 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.01 32.64 5.74 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.885 1.22 . . . . 0.94 110.785 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mt -138.37 126.65 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.099 -1.815 . . . . 3.2 106.099 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.52 -37.66 13.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 123.64 0.588 . . . . 2.77 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -144.76 148.56 34.25 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.161 -1.051 . . . . 4.3 108.161 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -157.07 68.17 0.55 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.132 -1.062 . . . . 2.02 108.132 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 m -84.9 108.69 17.67 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.053 -0.351 . . . . 2.69 110.053 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.21 112.87 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.983 -0.747 . . . . 3.64 108.983 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.41 98.5 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.657 0.783 . . . . 2.05 110.429 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -38.75 -47.48 1.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.126 1.77 . . . . 2.73 112.148 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.12 66.55 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.493 1.117 . . . . 2.18 111.79 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -117.09 10.63 13.96 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.723 1.209 . . . . 2.71 109.943 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.32 59.59 0.27 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.438 2.295 . . . . 2.8 112.305 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.12 152.78 37.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.559 0.744 . . . . 1.91 109.76 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.52 118.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.994 1.318 . . . . 1.84 108.101 164.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -81.1 96.52 7.2 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 105.251 -2.129 . . . . 0.91 105.251 163.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.83 141.21 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.837 -1.542 . . . . 1.91 106.837 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -122.87 121.83 37.15 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.53 -2.396 . . . . 3.42 104.53 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -137.78 169.27 18.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.776 0.716 . . . . 3.47 112.293 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -108.01 99.88 33.21 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.651 0.78 . . . . 4.66 109.237 -171.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.67 48.16 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.114 2.542 . . . . 2.45 112.835 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -137.12 17.96 2.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.048 1.339 . . . . 5.04 110.323 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.11 -56.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 124.422 1.089 . . . . 5.63 108.576 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.67 142.65 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.154 -1.425 . . . . 2.78 107.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.0 151.24 20.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.657 -1.377 . . . . 2.2 109.657 160.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.79 -38.58 29.79 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.957 1.771 . . . . 0.87 110.605 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -50.02 -44.52 51.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.433 0.693 . . . . 8.44 111.303 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -53.47 37.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.5 1.12 . . . . 3.34 108.881 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.67 -54.49 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.993 -0.549 . . . . 1.97 109.784 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.91 -52.69 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.449 -0.575 . . . . 2.38 109.449 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -56.21 -47.2 78.86 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.76 0.824 . . . . 6.32 110.263 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.3 m -58.37 -46.08 87.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.235 0.471 . . . . 1.94 110.437 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 54.6 mt -54.3 -64.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.131 -0.692 . . . . 1.9 109.131 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -55.0 -47.82 74.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.948 0.404 . . . . 4.25 110.197 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -58.47 -20.3 44.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.116 -1.421 . . . . 1.33 113.825 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.25 -76.4 0.09 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-N 121.189 1.813 . . . . 2.75 109.439 167.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.72 35.56 0.46 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.522 -1.154 . . . . 1.39 113.281 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -129.81 175.15 9.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 1.365 . . . . 3.16 112.749 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.33 145.62 44.97 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 104.483 -2.414 . . . . 3.29 104.483 161.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.49 162.62 35.03 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.786 1.176 . . . . 1.96 112.503 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 t -155.84 112.86 3.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.623 0.769 . . . . 2.34 108.949 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.82 126.22 26.91 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.411 0.551 . . . . 3.66 109.962 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 109.052 -0.721 . . . . 2.18 109.052 -176.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 N-CA-C 106.318 -2.713 . . . . 2.44 106.318 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.93 80.44 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.632 -1.247 . . . . 3.15 107.632 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.1 78.58 4.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.772 -1.566 . . . . 3.24 106.772 172.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.28 121.73 24.8 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.385 -2.08 . . . . 2.42 105.385 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.57 145.46 51.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.248 -0.649 . . . . 3.01 109.248 174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.23 136.88 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.154 -1.795 . . . . 3.19 106.154 165.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.17 157.09 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 107.148 -1.427 . . . . 3.5 107.148 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -146.37 149.42 33.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.409 -0.589 . . . . 6.98 109.409 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.85 -13.89 31.96 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.144 1.354 . . . . 1.65 111.547 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.8 mtm -66.9 113.79 5.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.496 1.148 . . . . 2.02 110.064 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -82.1 -50.96 8.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.531 1.133 . . . . 4.44 110.471 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -169.67 172.28 6.95 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.395 1.078 . . . . 3.27 110.076 -160.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.85 -47.67 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.089 2.956 . . . . 1.59 114.906 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p -67.89 -47.61 68.38 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.861 -0.525 . . . . 1.23 112.108 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.8 m -70.65 -35.35 72.84 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.347 -0.983 . . . . 2.42 108.347 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.34 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 124.633 1.173 . . . . 2.23 109.729 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.275 0.3 OUTLIER -71.02 -16.64 62.63 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -165.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -45.34 -47.54 13.31 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 108.858 -0.793 . . . . 4.83 108.858 165.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.38 -65.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.085 -0.709 . . . . 1.78 109.085 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -55.18 -48.14 74.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 123.133 0.27 . . . . 4.38 111.056 -166.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.7 t -54.32 -60.27 3.57 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.486 -0.931 . . . . 1.48 108.486 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 t -51.91 -42.59 62.89 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.904 0.481 . . . . 1.45 111.698 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 mt -71.9 -53.82 11.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.635 -0.826 . . . . 2.53 111.94 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.0 m -49.23 -33.36 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.729 -1.232 . . . . 2.62 111.902 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -51.93 -32.79 34.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.222 1.193 . . . . 6.74 114.222 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -55.0 -29.75 57.93 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.756 0.707 . . . . 2.37 111.013 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 73.01 -1.04 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.054 1.742 . . . . 6.05 112.001 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.02 -42.43 5.97 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 110.604 -0.998 . . . . 1.95 110.604 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.52 125.9 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.102 -1.444 . . . . 4.01 107.102 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.88 -38.71 32.07 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.771 0.828 . . . . 3.94 109.96 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.74 154.88 37.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.376 -0.601 . . . . 3.31 109.376 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 t -155.19 63.64 0.63 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.241 0.543 . . . . 2.08 112.144 -164.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 99.75 7.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.96 0.504 . . . . 2.29 109.845 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 0.8 OUTLIER -89.04 93.68 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 122.477 1.132 . . . . 2.56 110.269 172.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.8 96.55 9.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.365 1.466 . . . . 1.84 109.9 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.0 tp -51.08 -39.25 55.64 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.164 1.786 . . . . 3.41 112.555 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.82 73.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.257 0.551 . . . . 1.91 110.674 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -81.05 -22.81 39.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.482 1.113 . . . . 3.16 111.231 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.53 55.8 4.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.773 1.629 . . . . 2.97 107.991 -168.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.57 144.33 46.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.896 -1.047 . . . . 1.9 108.611 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.74 27.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.588 1.155 . . . . 1.61 108.778 171.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -87.98 91.41 8.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.947 -1.872 . . . . 0.96 105.947 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.51 125.69 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.731 -1.211 . . . . 2.76 107.731 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -96.76 110.45 22.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.85 -1.537 . . . . 4.57 106.85 162.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -125.64 158.36 34.93 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.919 0.888 . . . . 3.23 108.812 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -97.97 113.21 63.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.841 1.256 . . . . 4.11 108.43 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.44 70.0 4.94 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.999 3.133 . . . . 2.89 110.915 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -163.13 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.333 1.453 . . . . 3.78 109.56 -173.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.94 -33.88 5.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 122.749 0.419 . . . . 3.96 111.332 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 tt -132.66 149.14 31.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.556 -0.905 . . . . 2.46 108.556 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.69 160.02 23.27 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.427 -1.069 . . . . 1.81 110.427 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -41.39 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.43 2.087 . . . . 1.01 110.483 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -57.18 -35.44 69.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 119.299 -0.382 . . . . 9.12 111.236 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -56.58 20.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.0 2.52 . . . . 3.87 109.143 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.98 -50.38 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.931 -0.766 . . . . 1.68 108.931 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.05 -47.24 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 118.772 -0.632 . . . . 2.45 110.538 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -52.77 -48.58 66.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.366 1.067 . . . . 3.96 109.191 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.4 m -60.25 -49.95 75.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.158 -0.682 . . . . 1.89 109.158 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.91 -62.44 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.527 0.731 . . . . 1.81 110.865 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.08 -49.22 72.23 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.315 -0.624 . . . . 2.89 109.315 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.1 t -51.14 -44.7 61.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.045 0.938 . . . . 1.28 112.546 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.78 -52.41 65.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.904 1.229 . . . . 2.62 113.302 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.61 10.53 0.12 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.281 -1.288 . . . . 1.46 116.056 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -139.04 176.14 8.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.346 1.573 . . . . 3.18 112.89 -148.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 151.87 37.57 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.534 -2.025 . . . . 3.18 105.534 154.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 157.04 43.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.967 0.507 . . . . 1.9 111.545 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -147.54 115.55 6.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.587 1.555 . . . . 2.92 108.69 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.31 134.39 50.26 Favored 'General case' 0 N--CA 1.458 -0.034 0 C-N-CA 122.637 0.375 . . . . 3.66 111.801 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.534 0.337 0 C-N-CA 123.847 0.859 . . . . 2.39 110.08 -179.132 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.044 0 N-CA-C 110.392 -1.083 . . . . 2.69 110.392 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.25 143.46 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.689 1.196 . . . . 3.26 109.179 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 tt -147.76 115.42 6.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.62 1.568 . . . . 4.08 107.204 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.74 124.41 49.52 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.144 -0.688 . . . . 2.32 109.144 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.8 mt -102.82 142.41 34.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.355 -1.72 . . . . 3.43 106.355 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -75.71 138.99 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.387 -2.079 . . . . 3.33 105.387 148.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 131.39 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.597 1.559 . . . . 3.17 108.015 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -126.3 144.56 50.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.776 1.231 . . . . 5.93 108.263 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.09 -31.77 6.32 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.849 1.214 . . . . 1.67 110.186 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtm -58.75 141.96 51.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.518 -0.549 . . . . 2.62 109.518 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -152.62 10.99 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.8 0.667 . . . . 2.36 112.8 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -171.18 152.1 3.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 2.6 109.17 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.31 -43.11 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.301 1.84 . . . . 1.56 112.276 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 p -44.3 -66.9 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.479 1.512 . . . . 0.79 113.096 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.8 m -47.51 -48.38 27.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.628 1.171 . . . . 2.09 109.488 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.35 -67.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.158 -0.928 . . . . 2.11 111.101 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -27.13 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.233 -0.917 . . . . 1.73 111.632 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -53.39 -49.1 67.94 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.234 0.614 . . . . 4.02 109.838 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -54.47 -65.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.088 -0.708 . . . . 1.83 109.088 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.1 -61.6 1.81 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.404 1.082 . . . . 2.76 110.916 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -48.95 -45.99 42.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.057 1.343 . . . . 1.55 110.574 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 t -62.25 -65.91 0.62 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.817 -0.611 . . . . 1.81 110.701 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.54 -35.09 76.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.503 1.047 . . . . 3.12 111.806 -163.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.4 m -46.65 -31.6 2.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.842 -0.536 . . . . 3.41 112.119 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -34.14 23.26 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.353 0.871 . . . . 5.3 113.353 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -61.07 -41.4 96.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.038 0.381 . . . . 2.54 110.329 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.84 -2.23 2.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.657 2.383 . . . . 6.85 113.329 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.28 -31.96 36.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.598 -1.001 . . . . 1.16 110.598 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.11 106.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.204 -2.147 . . . . 3.87 105.204 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.7 mt -79.94 -33.3 39.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.995 0.518 . . . . 3.24 109.92 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -147.35 156.47 42.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.539 -0.541 . . . . 3.62 109.539 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.86 134.74 17.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.866 -1.531 . . . . 1.97 106.866 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -144.21 116.16 8.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.389 -1.338 . . . . 3.05 107.389 164.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.15 111.4 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.573 0.701 . . . . 2.75 110.376 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.44 104.35 12.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.982 0.913 . . . . 2.23 109.659 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -44.88 -37.09 3.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.609 1.163 . . . . 3.89 111.346 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.08 -30.75 16.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.796 0.838 . . . . 1.98 112.056 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -127.92 17.4 6.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.385 1.074 . . . . 2.62 109.77 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 31.51 47.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.778 2.031 . . . . 2.13 112.672 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.76 143.6 47.22 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.854 0.462 . . . . 2.2 111.346 -170.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.28 98.49 8.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.575 1.95 . . . . 1.6 107.786 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -79.15 104.06 9.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.376 -2.083 . . . . 1.11 105.376 167.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.28 136.63 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.307 -1.738 . . . . 2.15 106.307 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -107.46 114.47 28.5 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.719 -1.586 . . . . 3.97 106.719 160.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -129.2 175.69 8.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.13 -2.544 . . . . 3.09 104.13 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.39 132.28 24.17 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 107.746 -1.205 . . . . 3.69 107.746 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.98 59.87 5.28 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 125.058 3.839 . . . . 2.79 110.883 -173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -155.64 -54.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 128.428 2.691 . . . . 3.38 107.264 -168.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -88.45 -25.4 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.349 1.059 . . . . 3.77 110.407 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.55 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.425 -0.954 . . . . 2.86 108.425 170.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.35 164.76 30.91 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 111.001 -0.839 . . . . 1.53 111.001 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.67 -45.19 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.916 2.41 . . . . 1.23 110.866 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.2 -42.63 69.95 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 122.995 0.518 . . . . 9.29 110.587 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -56.28 9.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.732 1.613 . . . . 3.98 109.37 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mt -59.19 -49.71 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.999 0.519 . . . . 2.32 109.602 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -53.78 -52.63 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.793 -0.447 . . . . 2.51 109.793 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -50.92 -51.29 53.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.973 0.509 . . . . 4.49 109.816 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -57.64 -53.37 58.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.226 -0.59 . . . . 1.9 110.262 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.0 mt -53.73 -59.92 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 124.196 0.999 . . . . 2.1 110.466 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.53 -50.46 73.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.224 -0.658 . . . . 4.56 109.224 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -48.69 -46.13 40.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 1.95 112.016 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.66 -56.54 19.15 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.255 0.934 . . . . 2.76 113.425 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 10.98 0.12 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.953 -1.471 . . . . 1.39 116.655 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.46 176.02 9.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.851 1.825 . . . . 3.22 112.655 -153.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -120.12 158.48 26.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.756 -1.572 . . . . 3.69 106.756 156.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.01 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.04 0.936 . . . . 2.06 112.482 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -157.56 111.45 2.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.072 1.349 . . . . 4.12 109.781 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 84.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.614 1.097 . . . . 3.47 108.809 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 124.439 1.096 . . . . 3.21 113.53 -176.153 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 N-CA-C 111.473 -0.651 . . . . 2.61 111.473 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.97 91.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.345 -0.983 . . . . 4.23 108.345 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -108.34 111.46 23.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 4.02 107.838 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -83.41 135.21 34.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.952 -1.129 . . . . 2.77 107.952 164.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.33 130.25 54.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.396 -1.335 . . . . 3.83 107.396 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.83 129.51 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 107.807 -1.183 . . . . 4.25 107.807 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.37 151.55 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 125.083 1.353 . . . . 2.95 109.189 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -129.5 144.23 51.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.437 -0.949 . . . . 6.8 108.437 163.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.58 3.11 35.02 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.5 1.524 . . . . 1.93 112.333 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 82.6 mtp -66.94 158.0 31.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.647 -0.914 . . . . 2.3 110.886 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 t -164.67 128.46 2.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.415 1.086 . . . . 3.32 108.556 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.3 m 62.41 177.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.54 1.536 . . . . 2.93 112.949 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.29 -27.67 56.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.869 -1.059 . . . . 2.02 111.461 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -56.61 -70.39 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.285 1.434 . . . . 0.78 113.648 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.5 m -49.46 -42.19 42.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.457 -0.777 . . . . 2.41 109.707 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 t -51.53 -71.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.407 0.683 . . . . 1.9 111.625 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 -29.29 69.1 Favored 'General case' 0 C--N 1.34 0.163 0 O-C-N 121.513 -0.742 . . . . 1.82 111.007 -173.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -55.03 -56.42 20.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.35 -0.611 . . . . 5.18 109.35 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.52 -54.2 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.631 -0.507 . . . . 2.03 109.631 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.5 -54.81 19.41 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.888 0.375 . . . . 3.11 110.99 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -52.92 -56.74 13.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.121 0.968 . . . . 2.27 110.381 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -50.25 -56.35 11.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.735 1.214 . . . . 2.69 109.919 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.87 -45.62 64.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.41 -0.516 . . . . 3.7 111.599 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.4 m -52.12 -36.16 50.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.097 0.862 . . . . 2.25 111.02 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.87 -26.13 23.23 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.12 1.156 . . . . 5.34 114.12 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.25 -29.26 70.62 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.219 1.372 . . . . 2.23 111.093 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 72.04 -3.59 2.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 6.96 113.03 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.59 -30.77 38.92 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.321 -1.112 . . . . 1.03 110.321 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.75 116.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.222 -1.399 . . . . 3.85 107.222 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -79.01 -33.9 44.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.157 0.583 . . . . 2.55 109.452 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.08 146.54 24.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.226 -0.657 . . . . 3.11 109.226 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.5 t -139.82 130.89 26.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.294 -1.743 . . . . 2.56 106.294 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -145.36 116.81 8.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.586 -0.894 . . . . 2.81 108.586 167.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.54 85.41 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.935 -1.135 . . . . 3.34 107.935 -166.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 93.46 8.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.66 -0.867 . . . . 2.12 108.66 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.1 tt -44.69 -39.83 5.43 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.715 1.206 . . . . 2.85 111.826 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.93 -30.08 22.92 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.857 0.863 . . . . 2.29 112.438 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -123.35 14.8 9.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.275 1.43 . . . . 2.68 110.175 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 m120 30.56 53.32 0.15 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 127.376 2.271 . . . . 2.31 112.829 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.83 140.25 46.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.221 0.608 . . . . 2.38 109.437 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.34 101.48 10.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.169 1.788 . . . . 1.86 107.032 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -77.82 107.08 10.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.287 -1.746 . . . . 1.15 106.287 170.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -112.7 118.95 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.021 -1.474 . . . . 2.01 107.021 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -96.12 119.15 34.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.9 -1.519 . . . . 4.06 106.9 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -158.57 127.42 5.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.449 0.3 . . . . 4.11 110.744 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.11 128.11 91.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.382 -0.97 . . . . 3.38 108.382 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.88 -50.5 5.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.251 1.967 . . . . 2.44 111.71 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.15 -21.9 36.23 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.721 1.378 . . . . 3.23 114.721 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.35 -1.89 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.041 0.837 . . . . 3.12 112.104 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.82 -47.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.322 0.965 . . . . 2.95 113.594 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 148.64 8.46 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.446 1.022 . . . . 1.99 112.1 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.05 -47.52 17.47 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.251 2.634 . . . . 1.21 111.402 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.407 HH21 ' N ' ' A' ' 60' ' ' HIS . 7.8 tpm_? -47.81 -43.87 28.19 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.148 0.979 . . . . 8.73 111.843 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.89 -53.88 51.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.868 0.867 . . . . 3.92 110.987 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.26 -52.86 53.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.43 -0.581 . . . . 1.78 109.43 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -57.48 -47.38 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.033 -0.728 . . . . 2.73 109.033 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.407 ' N ' HH21 ' A' ' 56' ' ' ARG . 52.4 t-80 -59.09 -41.91 89.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.693 0.797 . . . . 6.16 110.126 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.9 m -63.0 -45.76 90.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.102 -0.333 . . . . 2.0 110.102 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.31 -49.94 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.327 0.651 . . . . 1.97 110.824 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -49.95 -59.19 4.11 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.108 0.963 . . . . 2.99 109.749 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -52.92 -48.55 67.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.753 1.621 . . . . 1.9 111.189 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.21 -55.42 35.2 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.939 -0.476 . . . . 2.59 110.976 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.84 -40.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.663 1.025 . . . . 1.67 115.663 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -122.95 132.53 54.2 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.326 0.563 . . . . 3.28 110.874 -133.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.44 133.12 37.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.02 -1.845 . . . . 4.24 106.02 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.74 145.33 30.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.058 -0.401 . . . . 2.25 110.372 -172.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -135.89 110.7 8.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.424 1.09 . . . . 3.73 109.576 -170.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.95 116.56 1.11 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.215 0.606 . . . . 3.25 109.918 164.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.796 -1.187 . . . . 3.85 107.796 178.424 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 N-CA-C 109.2 -1.56 . . . . 1.79 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.12 146.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 121.657 -0.908 . . . . 3.21 109.95 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.05 116.45 22.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.471 2.308 . . . . 3.74 105.497 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.11 107.26 12.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.385 -0.969 . . . . 2.53 108.385 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -119.62 143.79 47.48 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 125.128 1.518 . . . . 3.03 109.423 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.31 136.72 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.891 -1.892 . . . . 3.4 105.891 162.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.38 122.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.015 1.726 . . . . 3.36 106.905 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -104.35 150.53 24.41 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.082 0.953 . . . . 6.38 110.912 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 -49.58 4.14 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 107.978 -2.049 . . . . 1.83 107.978 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -27.53 112.44 0.06 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.844 2.458 . . . . 3.28 112.312 163.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -157.56 160.52 38.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.443 0.697 . . . . 3.14 109.572 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.3 m 63.68 155.84 0.06 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.356 1.862 . . . . 2.59 113.106 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.98 -36.24 2.39 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.64 1.576 . . . . 2.26 111.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.53 -48.26 79.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.712 2.005 . . . . 1.15 114.127 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.2 -43.76 64.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.339 -1.356 . . . . 1.9 107.339 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.59 -64.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.465 1.106 . . . . 2.51 111.785 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -31.05 68.56 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.869 -0.519 . . . . 2.11 111.446 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.8 -55.92 26.72 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.339 -0.985 . . . . 5.43 108.339 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.18 -61.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.454 -0.573 . . . . 1.83 109.454 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.33 -44.24 92.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.905 -0.718 . . . . 4.95 111.168 -165.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -64.21 -47.35 80.08 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.674 -0.862 . . . . 1.67 108.674 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 t -56.88 -42.78 80.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.835 -0.602 . . . . 1.97 110.949 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.05 -64.47 0.93 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 119.373 0.988 . . . . 2.7 112.026 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.9 m -44.01 -34.48 1.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.763 1.225 . . . . 2.5 114.014 -162.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.28 -29.76 0.15 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.221 1.563 . . . . 7.17 115.221 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -55.82 -40.65 73.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.314 0.961 . . . . 2.25 111.102 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp-105 70.52 -1.67 2.46 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.717 2.007 . . . . 6.88 112.666 -167.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.09 -32.41 35.81 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 1.1 110.51 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.13 118.13 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.286 -1.746 . . . . 3.66 106.286 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.4 mt -81.42 -33.39 32.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.203 1.001 . . . . 2.38 110.427 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -150.55 133.97 16.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.988 -1.486 . . . . 3.75 106.988 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.0 t -133.74 62.51 1.65 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.776 0.83 . . . . 2.12 110.253 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 95.54 8.02 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.648 -0.706 . . . . 2.86 109.674 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.27 85.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.6 1.19 . . . . 3.64 107.823 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 80.22 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.05 1.34 . . . . 2.31 108.334 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -38.99 -43.8 1.01 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.67 2.388 . . . . 3.26 111.152 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.54 -33.51 45.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.645 0.778 . . . . 2.2 111.834 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 p -112.33 8.26 19.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.558 1.543 . . . . 3.04 111.513 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.26 45.92 5.14 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.274 1.43 . . . . 2.08 110.761 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -134.24 144.77 48.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.488 0.715 . . . . 1.9 110.594 -171.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.88 105.47 17.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.144 -1.428 . . . . 1.66 107.144 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -83.96 100.41 11.02 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.901 -1.889 . . . . 0.88 105.901 165.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.5 mt -112.07 108.35 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 124.786 1.234 . . . . 2.2 107.716 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.7 115.23 19.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.033 -1.469 . . . . 3.04 107.033 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -144.52 162.58 36.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.46 -2.052 . . . . 2.97 105.46 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.99 139.42 32.49 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 107.004 -1.48 . . . . 4.51 107.004 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.56 69.06 5.26 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.351 3.368 . . . . 2.49 111.481 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -165.28 -46.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.561 1.544 . . . . 4.27 110.216 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -81.68 -25.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 4.23 109.668 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -158.33 157.11 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.4 164.49 26.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.728 -0.949 . . . . 1.65 110.728 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.86 -47.49 1.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.996 2.464 . . . . 0.95 110.802 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -61.87 -34.09 75.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.211 -0.306 . . . . 8.25 111.211 -175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -57.31 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.495 1.518 . . . . 3.69 108.586 173.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.49 -51.73 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.263 -0.88 . . . . 2.22 109.451 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.5 mt -52.39 -56.84 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.472 0.309 . . . . 2.47 110.206 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -49.39 -48.81 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.479 0.712 . . . . 3.94 109.819 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.6 m -60.12 -52.23 66.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 119.9 -0.72 . . . . 1.94 110.121 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.68 -57.43 5.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 124.036 0.934 . . . . 1.89 110.468 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.66 -52.23 66.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.441 -0.577 . . . . 4.74 109.441 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -51.19 -40.91 59.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.974 0.909 . . . . 1.39 111.895 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.63 -48.68 80.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.713 1.142 . . . . 2.65 113.367 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.28 -1.47 0.06 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 118.371 2.108 . . . . 1.03 118.371 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -138.57 176.64 8.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.788 1.794 . . . . 3.42 113.432 -145.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.58 139.1 53.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.851 -1.907 . . . . 3.35 105.851 167.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.16 161.0 22.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.202 1.001 . . . . 2.13 112.459 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.7 m -157.05 116.2 3.36 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.493 -1.241 . . . . 2.0 110.059 171.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 mt -49.99 140.8 11.7 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.782 1.174 . . . . 4.28 109.18 164.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 124.827 1.251 . . . . 3.08 110.611 177.71 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 111.209 -0.756 . . . . 2.1 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.13 140.4 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.653 -1.24 . . . . 3.5 107.653 159.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 tp -137.35 91.68 2.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.428 -1.323 . . . . 3.1 107.428 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.99 116.62 26.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.677 -1.601 . . . . 2.55 106.677 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.91 140.7 52.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.2 -0.312 . . . . 4.12 110.518 174.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.68 139.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.829 -1.545 . . . . 2.86 106.829 167.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.82 150.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 123.898 0.879 . . . . 3.69 108.76 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -146.53 168.0 22.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 5.72 108.791 -170.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.4 -55.79 3.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.716 -1.754 . . . . 1.62 108.716 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 ptm -60.48 138.93 57.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.466 -0.431 . . . . 2.86 110.767 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -159.07 19.84 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.444 -0.343 . . . . 2.55 111.863 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.6 p -173.33 159.35 3.75 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.907 0.776 . . . . 3.73 110.219 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.72 -41.07 55.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.975 1.71 . . . . 2.08 113.149 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.2 p -63.22 -67.08 0.45 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.137 0.575 . . . . 1.07 111.342 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -43.73 -42.25 5.32 Favored 'General case' 0 N--CA 1.461 0.075 0 O-C-N 121.389 -0.819 . . . . 2.38 110.759 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.07 -73.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 123.205 0.602 . . . . 2.02 111.011 173.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -21.04 66.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.521 -0.737 . . . . 1.31 111.921 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -58.12 -47.71 82.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.001 0.92 . . . . 4.89 110.03 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.7 mt -59.9 -54.25 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.701 -0.852 . . . . 1.82 108.701 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -54.0 -59.82 4.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.641 0.588 . . . . 2.95 109.57 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.3 t -51.37 -49.15 62.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.086 1.354 . . . . 1.48 111.135 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -58.33 -51.11 71.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 1.63 110.386 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.01 -36.54 84.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 118.705 -1.198 . . . . 2.96 110.158 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.8 m -63.85 7.32 0.12 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.119 -0.988 . . . . 3.17 113.306 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.81 -46.72 43.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.42 -1.425 . . . . 5.17 110.296 157.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.467 0.707 . . . . 2.63 110.613 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -0.52 11.86 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.507 -0.746 . . . . 8.99 112.292 170.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.72 -15.25 61.85 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.031 0.378 . . . . 1.02 112.319 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -94.0 142.8 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.484 -1.302 . . . . 4.08 107.484 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.27 -45.75 4.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.321 1.048 . . . . 4.25 110.025 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.13 153.98 49.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.291 1.036 . . . . 3.49 108.829 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 p -156.02 59.63 0.59 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.435 0.694 . . . . 3.24 111.463 -170.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 m -87.06 104.63 16.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.509 -0.758 . . . . 2.71 111.429 -175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.303 2.7 p -92.68 92.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 122.655 1.217 . . . . 3.06 111.654 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.68 90.66 7.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.785 -1.191 . . . . 2.03 107.785 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tt -44.15 -37.35 3.07 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.55 1.14 . . . . 2.72 111.453 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.14 22.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.906 0.882 . . . . 1.98 112.247 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -120.8 15.44 11.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.012 1.325 . . . . 2.49 110.41 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.15 50.6 0.72 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.548 1.939 . . . . 2.01 111.733 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.75 143.6 35.04 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.222 0.609 . . . . 1.88 109.372 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.84 118.74 36.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.972 -1.122 . . . . 1.62 107.972 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -87.33 95.58 10.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.844 -2.28 . . . . 1.24 104.844 162.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.1 mt -93.48 140.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.848 -1.538 . . . . 2.08 106.848 169.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -118.68 136.86 53.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.94 -1.874 . . . . 4.78 105.94 161.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.62 173.7 15.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.964 1.306 . . . . 2.94 108.126 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -113.29 117.48 45.34 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.62 -1.252 . . . . 3.91 107.62 164.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.26 -40.11 83.82 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.456 1.437 . . . . 2.2 111.945 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -67.64 -12.62 60.86 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.709 0.686 . . . . 4.97 112.663 -167.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 pt -117.97 6.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 123.928 0.891 . . . . 3.31 112.946 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.37 -42.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.474 0.916 . . . . 2.69 113.474 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.49 159.29 5.55 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.201 -0.76 . . . . 2.29 111.201 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.31 -34.54 66.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.526 2.151 . . . . 0.83 110.837 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.11 -46.13 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.534 0.938 . . . . 7.83 113.534 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.45 -35.29 70.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.2 0.909 . . . . 4.11 112.182 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mt -58.19 -47.11 88.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.834 -0.802 . . . . 1.82 108.834 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.83 -48.5 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 118.147 -0.93 . . . . 2.9 109.985 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -47.07 -49.46 21.58 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.957 0.799 . . . . 4.24 109.523 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.0 m -59.21 -55.78 30.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.338 -0.545 . . . . 2.36 110.017 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -63.52 -45.5 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 122.537 0.335 . . . . 2.0 110.702 -170.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.92 -54.64 39.06 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.974 0.509 . . . . 3.12 110.315 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -64.88 -20.7 66.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.829 -1.081 . . . . 1.17 112.416 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.16 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 119.849 1.204 . . . . 2.72 109.05 160.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 18.0 0.24 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.152 -1.36 . . . . 1.32 115.111 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.15 122.9 40.26 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.95 1.875 . . . . 3.29 112.683 -157.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.76 86.84 4.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.889 -0.782 . . . . 3.41 108.889 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.11 163.11 26.92 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.13 -0.981 . . . . 2.08 110.709 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.0 m -154.68 104.53 2.54 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.738 -0.838 . . . . 2.31 108.738 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 126.42 27.3 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 122.86 0.464 . . . . 3.11 111.443 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.341 0.218 0 CA-C-O 121.541 0.686 . . . . 2.24 110.853 -173.713 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 111.35 -0.7 . . . . 3.59 111.35 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.83 117.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.58 -1.267 . . . . 4.21 107.58 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.12 135.63 14.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.909 0.861 . . . . 3.96 111.026 164.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.39 117.36 33.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.75 1.22 . . . . 2.43 109.766 -170.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.95 126.43 46.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.966 -1.494 . . . . 4.08 106.966 172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.46 137.97 21.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.001 -2.222 . . . . 3.56 105.001 160.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.25 107.47 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.306 -1.368 . . . . 2.79 107.306 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -102.25 115.1 29.85 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.965 -1.124 . . . . 6.58 107.965 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.65 -45.18 0.99 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.978 -1.649 . . . . 1.51 108.978 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -55.69 137.2 49.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.909 0.483 . . . . 2.7 110.224 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -165.97 12.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 2.94 112.766 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -170.74 144.41 2.29 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 117.908 -1.044 . . . . 2.66 108.355 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.81 -50.49 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.621 2.369 . . . . 2.23 113.437 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -57.12 -47.7 80.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.797 1.239 . . . . 1.13 114.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.38 -49.63 32.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.388 1.075 . . . . 2.13 108.171 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -43.23 -64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.335 1.854 . . . . 1.95 110.487 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -9.54 55.09 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 120.348 -0.541 . . . . 1.68 111.554 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -47.49 59.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.48 -1.387 . . . . 5.82 107.96 -172.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.28 -57.28 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.836 -1.074 . . . . 1.87 108.345 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -70.32 0.09 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.234 0.614 . . . . 4.3 111.968 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -47.85 -47.13 31.68 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.611 0.641 . . . . 3.48 111.881 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -59.56 -65.68 0.63 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.853 -0.425 . . . . 1.82 109.853 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.04 -34.66 70.33 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.436 0.562 . . . . 2.73 111.318 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -55.3 -25.32 33.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.298 0.481 . . . . 2.63 112.298 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -18.94 64.35 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.663 1.119 . . . . 6.62 112.654 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -84.88 119.97 25.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.54 -1.282 . . . . 2.37 107.54 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -69.07 -0.82 6.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.088 -1.008 . . . . 7.27 113.704 -172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.48 -20.98 61.0 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.523 -0.736 . . . . 1.07 113.595 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.99 138.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 117.818 0.809 . . . . 4.72 110.486 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -100.62 -42.61 6.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.836 1.655 . . . . 2.43 110.196 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -148.36 149.99 32.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.445 -0.576 . . . . 3.71 109.445 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 t -141.75 74.22 1.44 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.857 0.837 . . . . 2.63 110.332 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -85.4 82.92 8.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.216 0.606 . . . . 3.47 109.957 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.07 126.34 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 112.594 0.591 . . . . 3.0 112.594 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.35 104.22 7.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.337 1.455 . . . . 1.98 108.684 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.48 -30.02 38.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.314 0.645 . . . . 3.86 111.321 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.68 50.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.923 0.889 . . . . 2.26 111.61 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -122.08 14.2 10.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 2.51 110.027 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 34.19 55.14 0.62 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.457 1.903 . . . . 2.29 111.713 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.59 143.34 25.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.088 -0.383 . . . . 2.43 110.241 -172.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 112.31 24.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.608 1.963 . . . . 1.88 108.747 165.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.55 95.6 5.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 104.627 -2.36 . . . . 1.24 104.627 160.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 mt -91.27 142.31 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 106.288 -1.745 . . . . 2.13 106.288 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -119.26 111.51 18.31 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.868 -2.271 . . . . 3.82 104.868 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -152.5 155.62 37.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.246 1.019 . . . . 4.8 108.674 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.21 100.17 7.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 123.873 0.733 . . . . 3.22 109.458 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 -42.05 71.76 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.826 2.351 . . . . 2.37 111.427 -172.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -20.34 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.871 2.468 . . . . 4.49 114.385 166.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 pt -112.56 16.1 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.074 0.95 . . . . 3.24 113.112 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 tt -160.53 -46.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.961 0.801 . . . . 2.95 112.203 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.27 157.27 8.42 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.551 1.072 . . . . 2.02 111.43 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.59 -45.32 26.37 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.622 2.214 . . . . 1.24 110.474 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.99 -55.49 6.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.75 1.22 . . . . 9.78 112.762 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -56.53 -48.36 77.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.004 0.907 . . . . 3.97 111.056 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.51 -51.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.642 -0.708 . . . . 1.59 109.317 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -49.43 -60.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 C-N-CA 123.16 0.584 . . . . 2.84 109.428 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -45.51 -49.0 14.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.538 0.735 . . . . 3.55 109.707 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.1 m -63.15 -48.52 78.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.021 -0.672 . . . . 1.76 110.741 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.6 mt -52.19 -64.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.322 0.649 . . . . 2.06 109.841 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -47.67 84.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.135 -0.626 . . . . 2.81 109.718 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -61.44 -19.56 62.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.128 -1.415 . . . . 1.53 113.583 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.08 -70.04 0.26 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 121.296 1.862 . . . . 2.76 109.654 166.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.55 24.82 0.27 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.862 -1.521 . . . . 1.34 115.877 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.71 173.79 10.01 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.089 1.944 . . . . 3.26 113.431 -164.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.74 152.61 20.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.234 -2.135 . . . . 3.61 105.234 154.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.8 162.47 41.24 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.202 0.91 . . . . 2.1 111.449 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.19 141.8 17.78 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.253 0.221 . . . . 2.81 111.571 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.81 70.32 3.26 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.368 1.067 . . . . 3.87 111.211 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 123.976 0.91 . . . . 3.02 110.807 171.72 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 109.103 -1.599 . . . . 1.98 109.103 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.8 152.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 125.407 1.483 . . . . 3.04 107.621 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -141.77 109.92 5.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.979 -1.489 . . . . 3.77 106.979 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -122.03 112.33 18.12 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.433 0.693 . . . . 2.52 110.745 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.44 142.38 51.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.856 1.347 . . . . 3.48 110.031 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.33 138.1 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.369 -1.715 . . . . 2.96 106.369 166.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.9 152.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.144 -1.058 . . . . 3.16 108.144 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -138.01 131.16 30.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.798 0.839 . . . . 7.15 109.031 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 9.49 85.04 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.813 -0.915 . . . . 1.84 110.813 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -102.25 126.37 49.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.149 1.779 . . . . 3.29 106.798 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 t -158.7 155.61 28.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.483 0.583 . . . . 3.13 109.884 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m 66.0 164.1 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.962 1.705 . . . . 3.82 112.763 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -43.92 49.02 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.924 -1.035 . . . . 2.22 110.891 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 p -43.33 -74.23 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.173 1.789 . . . . 1.0 114.12 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -49.92 -44.24 50.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.486 0.714 . . . . 2.39 109.528 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.35 -66.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.16 0.584 . . . . 2.36 111.952 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -68.08 -28.48 67.4 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.263 -0.898 . . . . 2.65 110.688 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -57.65 -52.86 63.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.612 0.642 . . . . 4.84 109.782 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -54.45 -61.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.783 -0.821 . . . . 1.77 108.783 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.77 -55.09 33.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.302 0.241 . . . . 2.81 111.077 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 t -54.11 -34.74 61.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.317 1.047 . . . . 1.99 111.313 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -69.37 -65.86 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.048 0.84 . . . . 1.87 109.894 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.98 -44.74 71.05 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.253 1.021 . . . . 3.55 112.091 -170.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.6 p -54.55 -25.42 25.8 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.92 -0.487 . . . . 3.3 112.097 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.85 -20.29 63.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.604 0.762 . . . . 6.08 111.698 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -64.25 -38.37 90.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.901 -0.778 . . . . 2.31 108.901 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 70.25 -2.33 2.16 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.282 2.233 . . . . 6.18 113.127 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.91 37.87 3.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.291 -1.123 . . . . 0.97 110.291 167.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.54 139.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.524 -2.028 . . . . 3.31 105.524 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.88 -40.17 9.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.006 0.523 . . . . 3.8 110.379 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -155.02 164.13 39.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.369 0.531 . . . . 3.79 111.344 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -153.56 125.09 7.62 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.753 2.421 . . . . 3.26 106.669 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -132.11 106.67 8.14 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.278 -1.749 . . . . 2.44 106.278 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -88.18 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.453 -1.314 . . . . 3.15 107.453 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.88 89.44 5.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.244 -1.021 . . . . 1.93 108.244 -171.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.32 -42.99 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.588 1.955 . . . . 2.9 111.012 165.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.07 62.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.646 1.178 . . . . 2.03 112.39 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -116.43 17.97 15.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.614 1.565 . . . . 2.53 109.246 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 19.42 59.59 0.02 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.489 2.716 . . . . 3.06 113.422 -164.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.9 144.89 39.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.034 0.534 . . . . 1.76 109.748 -174.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.2 106.85 18.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.796 -1.187 . . . . 1.7 107.796 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.37 100.72 12.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.712 -1.958 . . . . 0.93 105.712 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.72 146.09 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.791 -1.559 . . . . 3.26 106.791 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -122.17 133.74 54.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.239 -2.134 . . . . 3.38 105.239 165.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.15 169.16 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.615 0.366 . . . . 4.56 110.299 -160.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.21 139.46 24.2 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.052 -1.832 . . . . 4.12 106.052 159.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.35 -34.75 1.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.146 1.898 . . . . 2.57 113.138 -175.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.65 -28.46 15.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.357 0.981 . . . . 3.41 112.348 -163.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.54 -24.62 29.47 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 118.998 0.817 . . . . 3.0 110.638 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 tt -121.61 -44.18 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.517 0.562 . . . . 2.88 112.517 -169.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 120.08 0.24 Allowed Glycine 0 CA--C 1.534 1.224 0 N-CA-C 109.16 -1.576 . . . . 2.31 109.16 -168.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.7 -38.05 94.75 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 120.673 2.237 . . . . 1.73 111.138 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -23.26 63.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.157 1.169 . . . . 10.06 114.157 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.57 -51.93 67.71 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.91 1.232 . . . . 3.53 109.451 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -56.47 -49.31 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.538 -0.744 . . . . 1.83 110.071 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.6 -59.44 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.232 0.924 . . . . 2.57 110.164 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -49.14 -50.04 39.33 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.837 0.855 . . . . 4.45 109.344 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.8 m -57.51 -52.06 66.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.181 -0.463 . . . . 1.63 110.231 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.29 -57.25 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 119.23 -0.414 . . . . 1.96 110.574 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.83 -51.02 71.52 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.725 -0.79 . . . . 3.38 110.019 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -57.81 -35.99 71.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.226 1.01 . . . . 2.73 111.241 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mp -52.12 -68.61 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.518 0.599 . . . . 3.4 111.518 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.75 14.99 0.18 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.187 -1.341 . . . . 1.1 115.571 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -133.82 175.04 9.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.413 1.607 . . . . 3.3 113.869 -156.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.23 152.61 22.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.367 -2.086 . . . . 4.01 105.367 155.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.09 139.91 23.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.023 1.329 . . . . 1.86 109.567 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 m -155.41 110.44 2.99 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.25 -0.906 . . . . 2.09 111.101 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.23 139.98 7.91 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.139 -1.059 . . . . 4.15 108.139 166.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 123.128 0.571 . . . . 2.64 109.961 179.566 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.871 0 N-CA-C 108.294 -1.922 . . . . 2.07 108.294 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.56 129.84 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.5 -1.296 . . . . 4.26 107.5 170.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -113.26 128.23 56.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.628 -1.99 . . . . 3.1 105.628 166.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -121.17 104.08 9.49 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.287 -0.634 . . . . 2.42 109.287 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.35 129.76 36.53 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.757 -1.571 . . . . 3.68 106.757 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.4 131.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.423 -2.066 . . . . 2.8 105.423 155.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -108.1 150.44 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.161 -1.792 . . . . 2.89 106.161 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -135.38 125.27 25.67 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.05 -0.722 . . . . 5.6 109.05 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.47 -13.97 5.87 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.294 1.426 . . . . 1.73 112.517 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.1 ptp -65.74 149.4 50.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.54 1.17 . . . . 3.63 110.26 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -163.17 139.6 7.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.659 -1.608 . . . . 3.1 106.659 168.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.8 t 73.46 142.01 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.681 1.592 . . . . 3.56 112.582 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.12 -36.2 0.29 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.911 2.085 . . . . 2.14 113.166 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -56.55 -77.08 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.192 0.997 . . . . 1.21 112.805 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -55.11 -33.68 63.05 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 124.076 0.95 . . . . 2.72 110.531 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -52.69 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 O-C-N 123.662 0.601 . . . . 2.36 109.497 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.302 0.3 OUTLIER -66.98 -16.51 64.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.855 -0.528 . . . . 2.01 112.01 -168.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -55.94 -44.14 78.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.957 -1.127 . . . . 5.21 107.957 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.6 -63.86 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.246 -1.02 . . . . 1.82 108.246 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -60.18 -50.88 71.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.313 0.486 . . . . 2.9 112.313 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.3 t -50.24 -52.22 37.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.888 0.875 . . . . 1.7 109.548 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -56.77 -54.73 42.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.942 0.337 . . . . 1.59 110.897 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.17 -34.4 77.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 118.871 -1.132 . . . . 2.88 111.211 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 m -61.25 -10.73 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.977 -1.077 . . . . 2.3 112.28 173.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -75.86 -20.52 58.03 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 120.924 -1.11 . . . . 5.57 112.197 172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.56 -169.12 0.39 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.987 -1.116 . . . . 2.76 107.987 167.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -126.87 -0.84 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.411 -0.806 . . . . 6.88 112.347 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.03 -19.96 22.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.214 0.461 . . . . 0.89 113.023 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mp -79.9 113.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.984 -1.487 . . . . 3.93 106.984 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -79.73 -36.51 37.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.817 1.247 . . . . 2.47 110.202 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -154.91 150.6 27.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.44 -1.319 . . . . 3.87 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -155.65 86.92 1.07 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.983 -0.376 . . . . 2.02 109.983 -164.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.7 m -112.77 107.14 15.67 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.472 0.709 . . . . 2.57 109.933 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.19 90.2 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 122.813 1.292 . . . . 2.79 110.232 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 92.6 8.22 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.414 -0.958 . . . . 1.82 108.414 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -40.58 -39.87 1.14 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.552 1.541 . . . . 2.98 112.395 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.1 61.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.628 0.771 . . . . 1.73 111.872 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -116.1 11.09 15.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.588 1.555 . . . . 2.44 110.047 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.32 39.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.812 2.445 . . . . 3.3 112.917 -173.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 141.09 52.35 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.49 0.716 . . . . 2.04 110.251 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.72 96.57 7.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.784 1.634 . . . . 1.62 108.415 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -77.17 101.29 6.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.762 -1.94 . . . . 0.96 105.762 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.6 mt -109.92 112.49 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 125.215 1.406 . . . . 1.96 107.512 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.74 124.85 34.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.694 -1.595 . . . . 3.15 106.694 169.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.21 177.5 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.925 -1.509 . . . . 3.66 106.925 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.98 137.02 28.65 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.342 0.974 . . . . 3.94 109.277 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.24 67.74 5.17 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.012 3.808 . . . . 2.64 110.703 -173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -172.97 -45.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.013 1.725 . . . . 3.63 109.298 -171.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -85.3 -28.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.617 0.767 . . . . 4.26 109.676 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.8 tt -158.08 156.22 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.09 -1.078 . . . . 2.63 108.09 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.43 163.01 27.25 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.624 -0.991 . . . . 1.69 110.624 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.09 -45.52 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.699 2.266 . . . . 0.89 110.819 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.4 HH21 ' CD2' ' A' ' 60' ' ' HIS . 27.4 tpt180 -61.19 -30.75 70.61 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.952 -0.468 . . . . 9.0 110.896 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -57.47 11.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.838 1.655 . . . . 3.67 109.072 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -56.61 -49.86 76.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.09 -0.707 . . . . 2.05 109.09 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.15 -48.33 84.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.994 -0.527 . . . . 2.46 110.782 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.4 ' CD2' HH21 ' A' ' 56' ' ' ARG . 14.1 m170 -53.11 -43.99 67.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.689 0.796 . . . . 3.96 109.069 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 m -62.59 -42.98 99.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.838 -0.745 . . . . 1.86 110.158 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.47 -46.35 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.224 -0.922 . . . . 2.07 111.787 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.05 -55.13 22.59 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.019 0.928 . . . . 3.16 108.918 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t -53.25 -51.19 63.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.145 1.378 . . . . 1.32 111.276 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.55 -44.42 96.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.51 -0.744 . . . . 2.92 112.263 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.29 -46.63 0.02 OUTLIER Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.844 -0.693 . . . . 1.86 114.751 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -125.75 142.8 51.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.432 -0.907 . . . . 3.33 113.031 -126.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.47 80.67 4.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.315 -0.624 . . . . 3.75 109.315 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.92 158.61 30.59 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.424 -0.797 . . . . 1.84 110.764 -171.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -155.21 117.45 4.19 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.866 -1.146 . . . . 2.3 111.235 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.26 121.04 11.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.465 1.106 . . . . 3.69 111.006 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 125.131 1.372 . . . . 3.24 109.855 173.525 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.958 0 N-CA-C 108.078 -2.009 . . . . 2.07 108.078 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.2 79.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 123.019 1.39 . . . . 3.53 108.122 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 tp -80.16 79.74 6.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 123.113 1.435 . . . . 3.31 107.175 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.9 122.68 25.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.579 -2.1 . . . . 2.59 105.784 164.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.01 139.72 43.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.428 -0.582 . . . . 2.83 109.428 172.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.07 111.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.116 -1.809 . . . . 3.3 106.116 169.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.49 164.51 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.527 -2.027 . . . . 2.62 105.527 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -138.22 130.99 29.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.118 -0.989 . . . . 6.53 108.805 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.82 5.65 17.79 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.852 1.215 . . . . 1.6 112.377 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 mtp -75.2 87.37 2.46 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.834 1.317 . . . . 2.56 108.07 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -83.27 -30.13 27.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.859 0.864 . . . . 2.99 111.995 -173.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.3 t -153.76 152.41 30.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.521 -0.737 . . . . 2.62 110.451 -168.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.09 -46.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.976 2.51 . . . . 2.02 113.732 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.0 p -39.95 -60.87 0.94 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.95 113.712 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -59.61 -43.49 93.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.774 1.23 . . . . 1.9 108.06 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -52.92 -70.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.185 -0.916 . . . . 2.39 110.418 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -28.94 68.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.501 -0.75 . . . . 1.62 110.706 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -55.02 -54.77 38.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.388 -0.815 . . . . 5.29 109.926 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mt -56.06 -54.08 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 119.475 1.034 . . . . 1.87 110.625 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -54.86 -51.22 66.62 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.311 -0.556 . . . . 3.26 109.773 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -56.35 -44.62 80.27 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.481 0.712 . . . . 1.94 111.757 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -64.96 -39.91 94.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.561 1.144 . . . . 3.67 111.809 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.71 -45.67 50.78 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.969 -0.693 . . . . 3.17 111.45 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -68.25 72.47 0.2 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.303 1.041 . . . . 2.6 110.75 -174.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -34.96 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.74 2.416 . . . . 7.18 110.639 -169.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -53.72 -70.09 0.1 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 119.684 1.129 . . . . 2.95 112.536 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 131.97 -4.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.01 3.724 . . . . 6.53 113.611 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.34 18.39 33.11 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.643 1.11 . . . . 1.09 112.466 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.18 121.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.799 1.639 . . . . 5.0 107.932 -175.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.8 mt -95.09 -38.04 10.81 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.089 0.555 . . . . 2.35 110.113 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -156.07 157.51 36.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.397 -1.335 . . . . 3.51 107.397 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.23 58.93 0.65 Allowed 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.218 0.607 . . . . 3.25 110.24 -163.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -79.19 104.1 9.58 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.361 -0.607 . . . . 2.11 109.361 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.58 95.43 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.381 1.086 . . . . 2.5 110.165 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.17 95.11 10.05 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.902 -1.124 . . . . 2.04 109.331 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 tt -42.79 -38.93 2.29 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.778 1.631 . . . . 2.63 112.36 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.55 61.31 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 124.59 1.156 . . . . 1.76 111.529 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.8 t -116.48 14.74 15.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.227 1.411 . . . . 2.62 109.545 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.27 52.02 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.716 2.406 . . . . 2.88 111.41 -169.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.455 -0.778 . . . . 2.55 110.503 -171.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 109.79 22.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.53 1.532 . . . . 1.84 107.872 171.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -82.82 93.07 7.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.574 -1.639 . . . . 0.88 106.574 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.7 mt -103.97 110.42 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.344 1.068 . . . . 2.17 109.754 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -78.06 71.93 4.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.521 -1.659 . . . . 3.71 106.521 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.46 162.36 27.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.992 -0.549 . . . . 3.08 109.606 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -116.27 105.32 50.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.833 -0.803 . . . . 3.08 108.833 167.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.51 -32.73 83.74 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.67 2.247 . . . . 1.75 113.365 -168.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.18 -30.24 59.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.38 0.536 . . . . 3.86 112.26 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.89 -3.0 9.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 113.503 0.927 . . . . 3.44 113.503 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 tt -157.57 131.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.246 -1.39 . . . . 2.3 107.246 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.44 155.0 46.57 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.347 -1.901 . . . . 2.03 108.347 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -59.29 -40.17 70.97 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.795 -1.271 . . . . 0.84 108.795 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -44.92 26.79 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.507 1.123 . . . . 10.74 112.526 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.57 -54.89 41.77 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.275 0.943 . . . . 2.96 109.597 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.32 -47.65 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.357 -0.838 . . . . 1.67 110.006 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.77 -52.26 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.239 -0.652 . . . . 2.7 109.239 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -54.73 -47.38 73.86 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.374 -0.346 . . . . 3.54 110.517 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -51.21 -54.62 23.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.137 0.88 . . . . 2.23 110.401 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -57.69 -58.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 119.213 -0.422 . . . . 3.03 110.222 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -63.94 -44.39 93.0 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.158 -1.017 . . . . 4.2 111.18 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.9 t -62.84 -20.29 64.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 117.768 -1.111 . . . . 1.17 112.609 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.86 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.212 1.369 . . . . 3.05 109.89 165.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.36 25.05 0.32 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.606 -1.108 . . . . 1.19 114.126 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.23 172.56 7.5 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.85 1.325 . . . . 3.2 113.235 -165.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -95.55 161.4 14.07 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.33 -1.73 . . . . 4.95 106.33 156.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.26 94.9 2.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.861 0.864 . . . . 2.06 112.297 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -87.69 119.67 28.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.602 0.761 . . . . 2.39 109.788 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -63.66 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.125 0.875 . . . . 4.07 110.702 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 124.485 1.114 . . . . 3.06 109.515 173.642 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 CA-C-O 122.361 0.978 . . . . 2.02 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.26 147.86 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 106.447 -1.686 . . . . 3.31 106.447 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 tp -142.36 136.4 29.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.516 -2.031 . . . . 2.97 105.516 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -115.07 145.32 42.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.407 -0.96 . . . . 2.34 108.407 156.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -133.15 146.03 51.2 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 124.668 1.23 . . . . 3.32 107.837 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.18 131.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.535 -1.654 . . . . 3.48 106.535 160.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.54 157.27 3.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 106.153 -1.795 . . . . 3.21 106.153 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -139.07 132.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.273 -1.01 . . . . 5.83 108.273 163.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.35 10.06 12.25 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.663 1.601 . . . . 1.92 112.761 -173.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.5 mtt -62.69 150.46 40.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.034 1.417 . . . . 2.46 109.48 167.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -154.41 86.92 1.16 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.469 0.652 . . . . 3.18 109.937 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.5 t 73.62 90.32 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.086 1.354 . . . . 3.37 112.916 165.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.11 -124.3 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.786 -1.102 . . . . 2.86 108.174 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.5 p 49.47 -81.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.779 2.032 . . . . 1.57 114.165 163.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -46.35 -43.75 16.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.608 0.763 . . . . 2.7 109.747 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.0 t -48.46 -74.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.52 1.128 . . . . 2.08 111.197 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -30.13 69.7 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 122.069 -0.395 . . . . 1.94 111.475 -172.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -51.54 -56.04 15.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.248 -0.649 . . . . 5.16 109.248 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.09 -60.19 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.325 -0.62 . . . . 1.72 109.325 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -49.88 -55.73 13.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.236 0.614 . . . . 3.04 111.142 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.2 t -54.26 -59.77 4.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.456 1.102 . . . . 1.46 109.45 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -52.08 -49.97 62.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.687 0.279 . . . . 1.42 110.939 -174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.9 -49.7 69.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.111 0.411 . . . . 2.67 112.111 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.261 4.5 t -60.6 -25.09 65.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 118.549 -1.26 . . . . 3.86 111.541 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -55.35 -25.65 36.28 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.189 0.811 . . . . 4.72 113.189 173.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -54.92 -31.44 60.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.018 0.827 . . . . 2.39 111.286 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -3.66 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.088 1.755 . . . . 9.28 111.811 -162.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.8 -35.81 15.2 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.553 -1.019 . . . . 1.5 110.553 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 97.89 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.694 -1.595 . . . . 3.84 106.694 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.11 -24.22 43.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.357 -0.838 . . . . 3.34 110.124 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -155.78 153.74 30.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.971 -0.752 . . . . 4.01 108.971 169.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.7 113.49 5.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.783 2.033 . . . . 3.19 107.311 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -119.4 104.77 10.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.425 -1.324 . . . . 2.41 107.425 165.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.34 78.38 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.754 1.264 . . . . 3.26 107.657 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.93 88.84 5.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.954 -1.021 . . . . 1.95 108.502 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.7 tt -38.67 -39.66 0.52 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.06 1.744 . . . . 2.92 112.413 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -36.41 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.454 1.102 . . . . 2.05 112.084 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 t -111.72 11.61 21.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.642 1.577 . . . . 2.4 109.934 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.35 41.28 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.234 2.614 . . . . 3.05 113.399 -170.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.95 45.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.8 0.84 . . . . 2.05 109.422 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.12 111.45 24.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.854 -1.906 . . . . 1.67 105.854 170.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -82.34 114.28 20.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.408 -2.071 . . . . 0.98 105.408 163.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -121.87 109.08 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 125.002 1.321 . . . . 2.07 107.483 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -79.45 72.38 6.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.856 -1.535 . . . . 3.77 106.856 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 176.36 9.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.298 1.039 . . . . 4.38 108.618 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.86 130.16 8.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 118.387 0.54 . . . . 3.66 110.196 160.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -51.88 -34.98 57.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.283 2.656 . . . . 1.72 113.589 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.95 -22.6 66.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.075 0.852 . . . . 4.69 112.999 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 pt -110.89 -22.52 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 119.122 0.873 . . . . 3.8 110.486 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -162.53 130.17 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.978 -1.119 . . . . 3.83 107.978 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.76 170.51 48.08 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.974 -0.851 . . . . 1.72 110.974 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.26 -57.06 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.104 1.869 . . . . 1.33 110.689 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.33 -26.79 68.63 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.847 -0.533 . . . . 9.93 111.743 -173.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -51.55 63.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.981 1.312 . . . . 4.56 110.159 173.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.9 -53.0 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.23 -0.919 . . . . 1.92 109.694 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -55.46 -50.73 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.405 -0.591 . . . . 2.82 109.405 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -49.47 -46.12 47.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.79 0.836 . . . . 4.72 110.396 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -58.23 -50.2 74.4 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.586 -0.524 . . . . 2.11 109.586 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.8 -54.82 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.971 0.509 . . . . 2.15 110.838 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -55.39 -53.42 56.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.243 -0.651 . . . . 4.57 109.243 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -48.4 -47.71 37.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.97 1.308 . . . . 1.15 111.676 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.66 -48.57 79.12 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.372 0.987 . . . . 2.82 113.478 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 0.11 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 118.293 2.077 . . . . 1.19 118.293 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -138.97 177.47 7.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.814 1.807 . . . . 3.25 112.617 -144.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -104.0 158.68 16.25 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.093 -1.447 . . . . 2.94 107.093 145.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.88 154.13 37.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.559 0.695 . . . . 2.21 110.905 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.0 m -156.13 103.79 2.22 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.419 -0.8 . . . . 2.3 110.438 -164.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.94 134.41 16.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.474 1.109 . . . . 3.97 111.94 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 124.976 1.311 . . . . 2.5 109.099 178.834 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 105.564 -3.014 . . . . 1.98 105.564 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 m -136.51 146.32 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.211 1.006 . . . . 4.06 110.131 -170.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 tp -155.23 153.37 30.55 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.041 -1.466 . . . . 3.59 107.041 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -115.4 148.52 39.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.858 -0.793 . . . . 2.93 108.858 165.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.0 mt -121.85 128.82 52.06 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.063 -1.829 . . . . 3.91 106.063 165.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.6 142.1 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.465 -2.42 . . . . 2.84 104.465 161.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.38 120.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 124.616 1.166 . . . . 3.25 108.575 -171.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 131.53 53.88 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.085 0.954 . . . . 8.41 110.986 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.22 -19.28 5.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.965 1.745 . . . . 1.86 109.938 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 mtm -63.32 163.75 10.08 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.204 -0.586 . . . . 2.63 110.531 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -150.47 -44.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.618 0.367 . . . . 2.63 111.455 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.3 m -139.36 169.44 17.75 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.78 -0.575 . . . . 3.63 109.697 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.31 -36.86 1.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.938 2.095 . . . . 2.25 113.272 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -48.26 -44.09 33.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.268 1.827 . . . . 0.99 113.786 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.8 m -70.56 -46.92 62.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.166 -1.42 . . . . 1.92 107.166 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.07 -63.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.336 . . . . 3.01 111.001 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -26.53 64.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.496 -0.752 . . . . 1.67 111.703 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.78 -54.68 39.0 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.727 -0.842 . . . . 5.42 108.727 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -53.88 -60.34 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.591 -0.522 . . . . 2.06 109.591 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -53.22 -52.94 57.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.529 0.331 . . . . 3.28 111.31 -171.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -58.76 -54.6 45.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.94 0.496 . . . . 1.48 110.217 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 t -55.31 -38.92 69.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.37 0.668 . . . . 1.51 111.864 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.1 mt -75.21 -54.65 6.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 113.595 0.961 . . . . 2.68 113.595 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -54.58 -35.96 63.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.349 -0.844 . . . . 2.85 110.931 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -25.16 9.98 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.338 1.236 . . . . 4.46 114.338 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.673 1.124 . . . . 2.22 111.095 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 77.85 -3.73 2.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.698 2.399 . . . . 7.39 113.898 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -23.84 16.3 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.848 -0.901 . . . . 1.12 110.848 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.41 105.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.728 -1.953 . . . . 4.02 105.728 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.66 -30.51 41.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.227 1.011 . . . . 2.41 109.434 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.08 139.99 18.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.473 -0.936 . . . . 3.51 108.473 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -133.06 119.19 19.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.579 -2.008 . . . . 2.22 105.579 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -125.74 106.96 10.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.784 -1.561 . . . . 2.59 106.784 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.24 87.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.297 1.046 . . . . 3.33 108.878 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.2 86.23 5.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.017 -1.475 . . . . 1.79 107.017 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -40.91 -38.71 1.0 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.826 1.651 . . . . 3.47 111.201 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.53 -36.17 43.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.592 1.157 . . . . 1.65 112.726 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -113.95 13.22 18.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.353 1.461 . . . . 2.33 110.049 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 40.52 41.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.39 1.876 . . . . 2.03 112.057 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 143.45 50.83 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.143 0.577 . . . . 1.95 110.368 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.71 108.28 19.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.447 -2.057 . . . . 1.69 105.447 170.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -78.59 115.8 18.54 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.651 -1.981 . . . . 1.52 105.651 165.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -120.07 114.7 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.083 -1.08 . . . . 2.4 108.083 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -100.07 115.4 29.69 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.633 -1.617 . . . . 4.13 106.633 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.13 145.98 22.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.797 1.239 . . . . 3.04 108.503 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -85.91 137.03 35.78 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 119.054 0.843 . . . . 4.4 109.577 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.34 -31.69 13.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.186 1.924 . . . . 2.55 111.765 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.52 46.86 0.99 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.774 1.23 . . . . 5.03 112.538 -169.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -50.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 128.295 2.638 . . . . 5.44 106.028 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.4 -89.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.887 1.275 . . . . 2.98 107.61 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.5 139.01 9.97 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.492 -1.443 . . . . 2.06 109.492 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.7 -37.27 94.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.421 2.747 . . . . 0.87 112.812 -164.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -35.98 -49.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.83 112.825 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -68.22 -46.15 71.37 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.018 -0.734 . . . . 3.02 109.018 -171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 mt -60.47 -47.35 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.499 -0.773 . . . . 1.69 109.219 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.38 -57.4 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.306 0.642 . . . . 2.98 109.494 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -52.81 -45.82 67.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.655 0.382 . . . . 3.64 110.09 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.8 m -59.48 -54.75 43.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.841 -0.429 . . . . 1.74 109.841 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.1 mt -51.76 -55.45 9.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.593 1.157 . . . . 2.09 110.754 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.35 -57.84 10.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.407 -0.59 . . . . 3.07 109.407 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.3 t -52.94 -37.48 61.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.1 1.36 . . . . 1.31 111.598 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.35 -54.71 28.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.51 0.724 . . . . 3.48 112.632 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.27 -8.36 0.04 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 117.539 1.776 . . . . 1.23 117.539 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.76 176.2 8.67 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.41 1.605 . . . . 3.18 112.475 -142.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -124.54 152.61 43.25 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.922 -2.251 . . . . 3.15 104.922 161.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.61 164.84 30.47 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.015 0.746 . . . . 1.82 113.015 -168.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -153.81 138.88 17.32 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 122.978 0.511 . . . . 3.26 111.379 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.58 66.74 1.45 Allowed 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.547 1.539 . . . . 4.09 110.71 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.392 -0.595 . . . . 2.48 109.392 165.526 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.569 0 N-CA-C 109.378 -1.489 . . . . 1.89 109.378 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.08 142.28 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.608 0.704 . . . . 3.9 109.782 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.2 83.63 1.84 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.768 -1.567 . . . . 3.91 106.768 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.4 116.54 27.67 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.891 -1.504 . . . . 2.31 107.148 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.34 142.22 51.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.746 0.248 . . . . 2.94 110.677 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.88 145.21 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.36 -1.348 . . . . 2.86 107.36 166.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.7 161.62 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.6 1.56 . . . . 2.96 107.441 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.09 140.1 30.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.874 -0.787 . . . . 9.17 108.874 160.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.67 -34.15 3.54 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.0 -1.24 . . . . 1.53 110.0 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.1 mtp -56.18 115.46 2.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.41 -0.464 . . . . 2.13 109.832 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -125.65 -20.49 4.68 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.946 0.899 . . . . 3.06 111.98 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.5 t -153.92 151.59 29.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.052 -1.03 . . . . 2.81 109.707 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -30.99 -45.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.562 2.345 . . . . 1.67 113.526 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 p -39.96 -58.62 1.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.508 1.523 . . . . 0.86 113.733 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.3 -46.99 87.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.241 -1.392 . . . . 2.01 107.241 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -51.16 -66.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.473 -1.24 . . . . 2.06 110.404 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -27.33 64.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.887 -0.725 . . . . 1.62 111.193 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.74 -53.49 57.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.624 0.647 . . . . 5.31 110.259 172.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.14 -60.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -54.63 -51.02 66.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.543 -0.299 . . . . 3.25 110.939 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.5 t -60.23 -42.82 96.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.522 0.729 . . . . 1.88 111.237 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 t -65.88 -36.78 84.35 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.827 -0.546 . . . . 1.63 111.102 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.18 -52.64 13.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.266 -0.574 . . . . 2.97 111.85 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 m -67.09 76.46 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.228 1.011 . . . . 2.51 110.683 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.45 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.458 2.703 . . . . 4.57 110.518 -171.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -56.33 -30.26 62.35 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.576 1.08 . . . . 2.77 113.296 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 37.97 2.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.245 1.018 . . . . 8.74 110.251 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.33 -2.01 0.73 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 121.573 -0.705 . . . . 0.99 112.897 165.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.05 127.4 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.776 -1.564 . . . . 3.76 106.776 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.78 -43.35 18.47 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.981 1.312 . . . . 2.89 109.417 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -152.11 155.25 37.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 110.203 -0.295 . . . . 3.3 110.203 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.47 136.85 35.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.731 1.612 . . . . 3.13 107.004 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -151.52 87.92 1.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.229 -1.397 . . . . 3.49 107.229 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.27 0.3 OUTLIER -92.52 92.08 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.714 1.245 . . . . 2.61 109.958 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.64 92.98 9.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.177 -0.952 . . . . 1.74 108.986 -170.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.05 -42.37 2.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.302 1.441 . . . . 2.96 111.701 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.25 -33.54 42.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.435 1.094 . . . . 1.63 112.46 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -117.78 14.43 14.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.887 1.275 . . . . 2.58 110.364 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 30.26 53.97 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.686 2.394 . . . . 3.0 112.363 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 150.22 46.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.733 0.813 . . . . 2.07 109.175 -174.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.67 27.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.572 1.149 . . . . 1.87 107.965 168.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -81.22 99.18 8.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 104.337 -2.468 . . . . 0.87 104.337 154.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.54 147.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.49 -1.67 . . . . 2.01 106.49 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -124.58 130.93 53.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.352 -2.092 . . . . 4.18 105.352 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -146.41 173.13 12.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 119.095 0.861 . . . . 3.28 111.365 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -107.77 94.12 11.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.112 0.965 . . . . 4.33 109.587 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 63.25 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.659 3.573 . . . . 2.58 111.851 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -155.09 -54.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 128.702 2.801 . . . . 3.74 106.692 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.4 pt -99.82 -13.41 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 124.843 1.257 . . . . 3.3 111.849 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -151.55 142.34 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.638 -1.616 . . . . 2.25 106.638 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.39 168.48 40.36 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.977 -0.849 . . . . 2.06 110.977 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.83 -47.49 1.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.563 2.176 . . . . 0.85 110.779 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -24.73 66.81 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.992 -0.442 . . . . 9.06 110.534 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -56.15 25.28 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.893 -1.754 . . . . 3.34 109.27 172.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.49 -55.12 21.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 108.869 -0.789 . . . . 2.59 108.869 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -58.05 -44.7 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.43 -0.35 . . . . 2.5 110.105 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.5 -37.26 83.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.906 1.282 . . . . 6.24 109.999 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -58.53 -51.83 68.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.751 -0.833 . . . . 1.61 108.751 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.98 -52.61 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 119.206 -0.426 . . . . 1.87 111.006 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -47.07 -52.2 15.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.156 0.983 . . . . 3.12 109.911 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.4 t -70.43 -9.71 57.17 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.754 1.622 . . . . 1.33 113.683 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.48 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.197 -1.409 . . . . 4.03 107.197 159.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.59 37.43 0.51 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.909 -0.94 . . . . 1.31 112.343 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -136.29 124.69 23.39 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.222 1.011 . . . . 3.27 110.266 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.75 -1.204 . . . . 4.63 107.75 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.31 163.1 40.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.918 -0.488 . . . . 2.12 111.462 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -145.62 126.69 14.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.607 1.163 . . . . 3.22 108.983 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.85 119.78 11.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.649 1.179 . . . . 4.52 108.314 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.47 0.527 0 CA-C-N 118.83 0.741 . . . . 2.16 111.782 -178.156 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.894 0 N-CA-C 111.04 -0.824 . . . . 1.7 111.04 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -103.97 126.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-N 117.634 0.717 . . . . 3.78 109.573 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 95.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.476 1.132 . . . . 5.0 108.873 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 5.0 tp10 -78.51 122.64 26.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.612 -1.255 . . . . 2.44 107.612 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.43 145.54 48.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.994 -0.373 . . . . 2.63 109.994 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.98 142.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.069 -1.826 . . . . 2.99 106.069 164.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.06 95.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 125.246 1.418 . . . . 3.35 108.618 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -97.47 143.5 28.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.523 0.729 . . . . 7.01 111.149 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.81 -36.38 3.0 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.627 1.108 . . . . 1.64 110.806 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -64.51 153.43 39.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.133 0.492 . . . . 2.77 112.171 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -153.58 149.5 27.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 170.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m 70.43 151.39 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.468 1.507 . . . . 3.2 112.486 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.5 -35.37 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.515 1.926 . . . . 2.15 112.559 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 -65.48 0.57 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.251 1.42 . . . . 1.36 112.649 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -68.91 -40.42 79.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.462 -1.31 . . . . 2.29 107.462 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.7 t -42.92 -68.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 113.98 -1.464 . . . . 2.17 110.238 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.304 0.4 OUTLIER -69.62 -20.06 63.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.704 -0.798 . . . . 2.37 110.995 -175.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.53 -42.21 87.58 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.113 -0.992 . . . . 3.73 108.992 -174.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -53.54 -66.53 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.816 -0.809 . . . . 1.97 108.816 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.24 -56.17 20.98 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.035 0.534 . . . . 3.14 111.962 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -53.43 -36.49 61.6 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.512 1.125 . . . . 1.84 111.174 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -70.22 -62.08 1.53 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.502 -0.749 . . . . 1.46 110.357 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -46.29 66.5 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.699 0.8 . . . . 3.46 111.961 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 p -50.85 -33.43 23.78 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.779 0.432 . . . . 3.81 111.129 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -64.26 -18.5 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.847 0.684 . . . . 5.3 112.847 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.434 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 12.2 m170 -60.48 -28.63 68.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 2.46 110.456 173.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 74.83 -1.85 2.98 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.311 1.844 . . . . 7.45 112.285 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 24.96 25.35 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.377 -0.689 . . . . 1.2 111.377 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mm -121.04 144.92 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.171 -1.789 . . . . 3.42 106.171 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.13 -45.86 7.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.832 -0.803 . . . . 4.23 108.832 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -155.55 153.4 30.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.375 0.534 . . . . 3.69 109.939 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.0 m -135.02 113.1 11.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 104.986 -2.227 . . . . 3.36 104.986 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.41 96.09 5.81 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.162 -1.051 . . . . 2.62 108.162 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.03 95.12 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.445 0.64 . . . . 3.09 109.667 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.71 91.72 6.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.372 -0.83 . . . . 1.75 110.185 -168.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -37.3 -50.87 1.04 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 2.88 112.819 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.52 31.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 2.44 112.528 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.7 t -105.93 -15.54 14.89 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.829 1.252 . . . . 2.66 110.729 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.72 41.52 14.86 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.837 0.855 . . . . 2.69 109.425 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -120.53 147.57 44.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.66 1.184 . . . . 2.23 108.794 176.007 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.1 114.18 27.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.859 -1.534 . . . . 1.55 106.859 162.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -78.2 94.37 4.75 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.144 -2.169 . . . . 0.9 105.144 167.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 mt -98.74 111.92 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.708 -0.849 . . . . 2.52 108.708 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.15 115.59 26.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.323 -1.732 . . . . 3.77 106.323 159.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.62 140.19 28.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.979 1.312 . . . . 3.9 107.792 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -87.37 114.16 57.41 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.381 -0.97 . . . . 3.72 108.381 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.12 -48.78 15.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.17 1.913 . . . . 2.16 113.194 -172.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.59 -21.42 60.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.804 1.039 . . . . 3.31 113.804 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -97.18 -4.54 9.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 119.728 1.149 . . . . 3.35 112.7 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.05 -46.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.454 1.279 . . . . 2.69 114.454 -175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.84 155.65 2.36 Favored Glycine 0 CA--C 1.541 1.674 0 O-C-N 121.609 -0.682 . . . . 2.23 112.889 -171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 -51.58 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.25 2.634 . . . . 1.57 112.252 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -47.9 -44.6 29.77 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.679 0.791 . . . . 8.24 112.187 -170.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -52.35 -56.13 16.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.023 0.929 . . . . 3.96 110.859 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.17 -48.87 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 O-C-N 121.814 -0.554 . . . . 1.97 110.547 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mm -51.81 -51.34 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 119.014 -0.517 . . . . 3.04 110.27 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -50.51 -54.45 22.28 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 122.968 0.507 . . . . 3.56 109.896 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.434 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 50.0 m -56.41 -47.29 79.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.255 -0.978 . . . . 2.13 110.733 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 -54.8 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 118.534 0.606 . . . . 2.34 111.949 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -67.01 -43.63 82.4 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.582 -0.447 . . . . 4.99 110.678 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 t -57.9 -40.7 80.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.51 0.724 . . . . 1.53 110.978 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.13 -59.97 4.5 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.389 0.995 . . . . 2.49 110.736 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.57 -40.45 0.02 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 115.762 1.065 . . . . 1.46 115.762 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -112.33 139.72 47.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.948 -0.737 . . . . 3.18 111.549 -135.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.02 133.0 36.11 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 106.48 -1.674 . . . . 3.18 106.48 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.18 31.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.044 0.384 . . . . 1.91 111.477 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.48 145.55 25.28 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 109.447 -0.575 . . . . 2.37 109.447 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.15 130.3 35.13 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.927 -0.768 . . . . 3.39 108.927 -174.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.536 0.415 0 C-N-CA 123.257 0.623 . . . . 2.06 112.19 -178.381 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 N-CA-C 111.679 -0.568 . . . . 1.67 111.679 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.21 138.31 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.208 -1.172 . . . . 2.94 109.302 172.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.23 88.1 2.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.601 -1.629 . . . . 3.17 106.601 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -79.65 123.3 27.52 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.372 -1.714 . . . . 2.25 106.372 171.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.12 133.41 46.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.84 0.291 . . . . 3.1 110.336 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.3 145.71 9.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.57 -0.9 . . . . 3.98 108.57 172.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.4 122.0 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.211 1.004 . . . . 2.87 110.117 -169.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.48 132.96 51.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.139 -0.689 . . . . 5.7 109.139 170.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.61 -25.67 5.87 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.995 2.236 . . . . 1.86 109.149 178.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 mtp -57.2 107.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.53 0.732 . . . . 2.58 109.889 164.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -139.99 9.36 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.913 1.285 . . . . 2.44 112.588 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -172.53 147.58 1.88 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.521 1.055 . . . . 2.78 109.92 -173.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.73 -38.02 1.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.339 1.856 . . . . 1.81 113.176 178.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 p -60.58 -77.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.863 0.865 . . . . 0.85 112.04 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 p -48.59 -29.88 4.75 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.071 1.348 . . . . 3.32 112.122 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.98 -72.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 2.02 109.867 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 0.3 OUTLIER -68.62 -12.74 61.73 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.015 -1.053 . . . . 1.54 112.942 -171.367 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -52.7 -42.86 65.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.237 -1.023 . . . . 5.06 108.237 172.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.92 -60.83 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.478 1.511 . . . . 1.68 109.666 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.23 -48.32 82.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.944 -0.391 . . . . 4.78 109.944 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.31 -48.69 80.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.458 -0.942 . . . . 1.68 108.458 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -51.01 -57.29 9.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.667 1.122 . . . . 1.5 111.01 176.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.25 -38.83 75.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.006 -1.078 . . . . 2.66 111.451 -169.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -55.07 -15.65 2.29 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.985 -1.072 . . . . 2.92 113.078 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -66.42 -37.24 84.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.369 -0.832 . . . . 6.06 110.766 173.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -69.56 124.94 25.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.716 -1.216 . . . . 2.15 107.716 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.61 47.32 0.83 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.161 -0.962 . . . . 8.71 109.943 172.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.88 -17.21 0.83 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.305 1.907 . . . . 1.12 111.998 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.1 tt -105.54 138.19 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.114 -1.069 . . . . 3.7 108.114 176.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -86.06 -49.38 7.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.531 1.133 . . . . 2.77 109.803 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -152.79 162.54 41.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.717 0.407 . . . . 4.4 110.304 -176.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.58 89.5 1.56 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.219 1.008 . . . . 2.16 109.973 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.94 90.05 8.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.071 -0.714 . . . . 2.47 109.071 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -85.94 98.42 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.559 1.144 . . . . 3.52 109.304 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.73 92.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.377 0.671 . . . . 1.97 109.849 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -36.89 -44.19 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.707 2.003 . . . . 2.68 110.869 165.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.17 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.008 0.923 . . . . 1.97 112.461 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.46 14.97 10.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.077 1.351 . . . . 2.57 109.983 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 34.92 55.39 0.74 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.763 2.025 . . . . 2.17 111.876 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.01 153.54 36.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.63 -0.878 . . . . 1.87 108.63 -173.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.01 127.49 54.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.637 0.586 . . . . 2.27 109.977 163.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -86.01 91.4 8.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.02 105.706 170.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.23 137.84 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.124 -1.436 . . . . 2.79 107.124 172.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -115.31 119.05 34.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.365 -2.087 . . . . 3.01 105.365 163.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 178.85 7.39 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 127.213 2.205 . . . . 2.94 106.096 -176.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -132.23 132.63 23.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.95 . . . . 3.67 110.386 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.71 64.09 7.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.918 3.745 . . . . 2.35 112.161 -167.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -166.74 -45.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.738 1.215 . . . . 3.75 110.239 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.77 -27.11 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.184 -0.673 . . . . 3.49 109.184 174.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -154.89 150.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.771 -1.196 . . . . 2.62 107.771 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.86 166.06 33.73 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.338 -1.105 . . . . 1.68 110.338 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.47 -48.57 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.373 2.049 . . . . 1.09 110.479 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.407 HH21 ' CD2' ' A' ' 60' ' ' HIS . 25.4 tpt180 -56.96 -27.42 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.924 0.489 . . . . 9.07 111.274 -177.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -55.59 31.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.299 1.839 . . . . 3.7 109.078 175.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt -56.23 -47.21 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.62 -0.882 . . . . 1.75 108.62 174.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mm -55.84 -50.97 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 119.28 -0.391 . . . . 3.21 111.0 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.407 ' CD2' HH21 ' A' ' 56' ' ' ARG . 17.2 m170 -54.36 -46.51 73.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.162 0.985 . . . . 3.97 109.302 178.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 m -58.05 -50.08 74.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.84 109.609 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.93 -51.9 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.15 -0.969 . . . . 2.04 111.782 178.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -50.86 -56.68 11.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.438 1.095 . . . . 3.13 109.241 175.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.3 t -52.34 -51.46 58.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.741 1.616 . . . . 1.88 111.365 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.49 -41.21 89.25 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.45 -0.781 . . . . 4.09 111.85 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.27 -50.52 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.328 -0.939 . . . . 1.5 114.624 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.58 144.99 38.61 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 118.973 -1.091 . . . . 3.23 113.806 -128.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.1 59.4 3.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.345 -0.613 . . . . 4.28 109.345 -176.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.82 168.47 19.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.689 0.626 . . . . 2.52 112.689 -166.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.06 132.01 10.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.819 -0.808 . . . . 2.47 108.819 173.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 130.73 47.88 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.864 -0.791 . . . . 3.25 108.864 167.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 108.322 -0.992 . . . . 3.56 108.322 177.23 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 CA-C-O 121.803 0.669 . . . . 1.95 111.794 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.24 149.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.987 -0.713 . . . . 3.14 110.071 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 tp -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.433 1.893 . . . . 3.42 106.346 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -128.81 157.37 41.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.05 -1.092 . . . . 2.62 108.05 163.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.69 142.92 49.94 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.358 1.036 . . . . 3.93 108.997 162.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.8 t -76.84 128.92 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.797 -1.927 . . . . 2.94 105.797 165.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.93 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.375 -1.343 . . . . 3.02 107.375 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.97 142.72 45.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.09 -1.448 . . . . 5.62 107.09 166.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.2 -47.63 1.34 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.726 -0.95 . . . . 1.49 110.726 167.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.82 143.57 54.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.229 -0.656 . . . . 3.32 109.229 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.62 -66.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.289 -0.257 . . . . 3.92 110.969 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -64.14 148.06 50.83 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.642 -0.661 . . . . 3.13 110.983 -171.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.35 -47.11 0.29 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.278 1.831 . . . . 2.05 112.507 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.2 p -60.08 -37.59 80.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.556 1.543 . . . . 1.29 113.64 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.65 -46.98 28.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.612 -1.305 . . . . 2.19 109.756 172.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.87 -67.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.292 1.037 . . . . 2.03 111.157 177.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -27.1 64.33 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.792 -0.568 . . . . 1.38 111.161 -173.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.06 -53.2 60.04 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.18 -0.914 . . . . 5.45 108.994 175.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.82 -55.68 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.423 1.01 . . . . 1.85 109.862 174.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -51.67 -59.26 4.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.275 -0.269 . . . . 3.16 110.275 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -53.82 -43.37 69.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 2.03 111.812 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -60.07 -50.42 73.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.28 1.032 . . . . 2.54 109.181 -176.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.42 -37.27 71.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.078 -0.649 . . . . 3.36 112.097 179.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -53.57 -23.99 12.4 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.029 -1.044 . . . . 2.64 113.458 177.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -60.21 -31.35 70.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.759 1.163 . . . . 7.67 112.18 174.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -70.52 148.52 48.14 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.867 0.758 . . . . 2.25 109.05 -175.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -105.25 37.77 2.11 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.788 -0.57 . . . . 7.46 111.905 -171.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.03 24.56 0.61 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.12 -0.392 . . . . 1.41 112.12 170.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -114.01 134.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.107 -1.812 . . . . 3.8 106.107 168.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.25 -40.11 10.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 2.68 109.069 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.53 136.89 14.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.201 -0.296 . . . . 3.32 110.201 178.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.91 132.61 56.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.962 -2.607 . . . . 2.34 103.962 164.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.6 t -138.22 138.17 38.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 117.977 -1.489 . . . . 3.84 109.096 146.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.286 6.7 p -106.03 94.32 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 122.638 1.209 . . . . 3.12 110.512 -174.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.23 88.62 6.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.495 -0.928 . . . . 1.67 108.495 -168.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tt -30.67 -50.02 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.048 2.139 . . . . 3.12 111.996 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.74 -32.56 52.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.19 0.996 . . . . 2.05 112.754 -175.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -118.93 15.24 13.37 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.7 1.6 . . . . 2.49 110.212 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 16.89 58.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.968 2.907 . . . . 3.31 114.597 -167.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 148.65 52.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.523 -0.917 . . . . 1.79 108.523 178.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.88 111.59 23.94 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.167 -2.16 . . . . 1.57 105.167 169.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -79.6 120.58 24.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.577 -1.638 . . . . 0.95 106.577 167.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mt -125.6 97.28 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 O-C-N 124.592 1.183 . . . . 2.1 107.882 -171.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -80.53 120.89 25.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.779 -1.563 . . . . 3.34 106.779 166.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.18 164.29 15.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.819 -1.549 . . . . 4.05 106.819 -165.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.06 132.54 24.4 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 108.245 -1.02 . . . . 4.03 108.245 172.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.65 -52.74 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.992 2.462 . . . . 2.42 112.466 -160.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.83 -32.84 46.56 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.252 0.834 . . . . 3.13 113.252 -172.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 pt -88.49 5.51 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.322 0.86 . . . . 3.88 113.322 -177.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.39 -52.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.531 1.06 . . . . 3.35 111.584 -172.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.48 114.0 0.37 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 108.97 -1.652 . . . . 1.87 108.97 -171.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -56.9 -31.77 90.27 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 119.991 1.896 . . . . 1.06 111.204 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -54.16 -36.79 63.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.956 -0.545 . . . . 7.8 112.034 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -67.16 -47.0 72.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.396 0.998 . . . . 4.2 110.352 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 mt -54.92 -51.83 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.653 -0.654 . . . . 1.78 110.601 170.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.35 -52.87 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 119.007 -0.52 . . . . 2.62 110.125 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -46.32 -47.95 18.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.305 1.042 . . . . 3.56 109.25 174.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.0 m -62.86 -49.53 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.107 -0.637 . . . . 1.68 110.663 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.58 -51.12 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.414 0.686 . . . . 1.79 111.162 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.65 -40.18 76.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.867 0.303 . . . . 3.13 111.634 179.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -65.35 -23.17 66.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 117.507 -1.235 . . . . 1.24 112.524 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.84 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.52 1.509 . . . . 2.65 109.407 165.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.99 19.04 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.319 -1.267 . . . . 1.32 114.943 174.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -136.1 116.35 13.52 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.367 1.584 . . . . 3.34 110.251 -163.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 154.46 37.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 117.109 -1.836 . . . . 4.26 107.568 177.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.11 164.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.797 0.839 . . . . 1.99 110.53 -173.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.9 m -148.63 92.91 2.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.472 -0.936 . . . . 2.23 108.472 171.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -55.11 126.47 24.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.855 0.862 . . . . 3.78 110.963 174.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 124.393 1.077 . . . . 2.55 109.088 -172.995 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.618 0 N-CA-C 107.165 -2.374 . . . . 1.84 107.165 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.4 139.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.708 -0.849 . . . . 4.21 108.708 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.32 87.67 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.333 -1.728 . . . . 2.92 106.333 167.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.1 134.06 36.74 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 118.156 -1.417 . . . . 2.57 108.27 167.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 146.88 46.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 124.23 0.956 . . . . 3.87 108.716 164.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.14 135.51 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.662 -1.977 . . . . 2.85 105.662 169.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.8 135.38 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.541 1.536 . . . . 4.04 108.258 -177.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -145.64 136.03 24.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.861 -2.274 . . . . 5.92 104.861 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.75 -53.82 0.65 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.74 -1.744 . . . . 1.64 108.74 -171.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 ptm -65.5 149.71 49.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.395 -0.474 . . . . 2.73 110.623 173.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.13 -1.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.633 0.975 . . . . 2.64 113.633 -168.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -169.21 157.53 7.71 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.021 1.282 . . . . 3.19 109.848 -166.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.55 -50.46 1.13 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.183 2.193 . . . . 2.26 113.267 -174.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -33.45 75.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.063 1.345 . . . . 1.59 113.056 -176.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.9 m -72.56 -53.92 10.61 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.377 -1.342 . . . . 1.94 107.377 168.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -43.99 -64.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.637 1.575 . . . . 2.11 111.689 -173.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -16.21 64.14 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.038 -0.414 . . . . 1.85 111.749 -173.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.5 98.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.668 -0.864 . . . . 5.68 108.668 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -60.49 -58.63 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.169 -1.049 . . . . 2.0 108.169 -178.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -53.73 -56.28 18.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.092 0.557 . . . . 3.15 110.803 178.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -49.52 -45.03 46.79 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.569 0.748 . . . . 1.38 111.235 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.7 t -63.14 -61.04 2.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.445 0.698 . . . . 1.49 110.774 175.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.96 -39.49 94.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.009 -1.076 . . . . 2.8 111.405 -168.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 m -53.4 -16.92 1.57 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.202 0.815 . . . . 2.69 113.202 176.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -61.72 -42.82 99.46 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.036 -1.04 . . . . 5.69 111.212 171.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.46 135.63 39.39 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.285 -0.635 . . . . 2.45 109.285 -176.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -78.97 -1.53 35.81 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.718 -0.613 . . . . 7.21 112.639 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.94 -19.21 56.55 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.381 0.537 . . . . 0.9 112.664 -178.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.1 tt -93.81 137.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.913 -0.773 . . . . 3.72 108.913 175.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.27 -38.36 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.428 1.491 . . . . 2.32 110.087 -174.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -140.16 149.78 43.4 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.919 -0.771 . . . . 4.04 108.919 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 t -153.99 119.12 5.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 106.593 -1.632 . . . . 2.17 106.593 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -145.85 111.21 5.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.062 -0.718 . . . . 2.8 109.062 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.88 108.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.586 0.708 . . . . 2.98 111.321 -175.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.33 101.7 10.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.004 0.922 . . . . 1.9 109.472 -170.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -43.08 -38.92 2.53 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.706 1.202 . . . . 3.38 111.222 168.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.53 -29.18 23.92 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.914 0.886 . . . . 2.14 112.065 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -128.06 16.03 6.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.49 1.116 . . . . 2.4 109.9 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 35.06 47.23 0.26 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.309 1.843 . . . . 2.57 112.569 -174.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.27 145.71 41.63 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.75 -0.594 . . . . 1.95 110.457 -171.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.96 106.88 17.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.711 -1.589 . . . . 1.68 106.711 172.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -79.44 98.63 6.86 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.43 -1.693 . . . . 1.07 106.43 168.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.45 140.74 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.897 -1.89 . . . . 2.73 105.897 164.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.13 132.21 55.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.452 -1.314 . . . . 3.36 107.452 156.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -148.92 169.12 21.27 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.943 0.897 . . . . 3.29 109.5 -172.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.68 111.33 55.34 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.666 -0.683 . . . . 3.7 109.34 174.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.12 52.05 3.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.048 3.165 . . . . 2.3 112.362 -176.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -139.78 -64.57 0.48 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.467 1.507 . . . . 4.13 107.294 178.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.28 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.118 0.967 . . . . 5.1 111.364 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 142.84 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.851 -1.537 . . . . 2.69 106.851 176.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.05 159.29 35.66 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.045 -1.222 . . . . 2.03 110.045 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.69 -47.31 11.49 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.825 1.683 . . . . 0.98 110.054 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -48.43 -42.33 31.93 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 122.999 0.52 . . . . 7.61 111.952 178.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -51.71 54.56 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.414 1.486 . . . . 3.47 109.723 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mt -60.88 -52.23 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.427 -0.806 . . . . 1.78 109.364 175.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.77 -54.13 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 118.602 0.637 . . . . 3.08 110.411 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -47.67 -53.2 15.64 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.581 1.553 . . . . 3.87 109.789 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.1 m -56.35 -51.33 68.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.456 . . . . 1.84 109.855 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.5 -53.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 O-C-N 121.993 -0.442 . . . . 2.03 110.742 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.9 -47.63 84.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.963 0.802 . . . . 3.89 110.195 -178.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -68.94 -9.86 54.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.928 -1.035 . . . . 1.32 113.023 -175.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.01 -78.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.253 1.388 . . . . 3.67 108.396 158.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.19 26.89 0.32 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.61 -1.106 . . . . 1.05 114.55 171.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -125.36 172.76 9.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.061 1.43 . . . . 3.16 113.36 -160.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 70.38 0.82 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.342 1.068 . . . . 3.81 108.666 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.41 144.51 35.8 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.329 -0.857 . . . . 1.95 111.274 -165.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -151.29 110.09 3.85 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.166 -0.959 . . . . 2.52 113.089 -172.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 76.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.475 2.31 . . . . 3.45 115.189 -175.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.221 -0.428 0 C-N-CA 124.241 1.016 . . . . 2.11 112.331 168.544 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.556 0 N-CA-C 106.148 -2.781 . . . . 1.92 106.148 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.43 137.34 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.655 1.228 . . . . 3.4 109.598 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.36 79.47 1.61 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.88 1.324 . . . . 2.98 107.935 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.37 102.06 8.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.012 -1.477 . . . . 2.79 107.012 168.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.31 141.28 47.21 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.698 0.399 . . . . 3.02 109.951 176.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.38 140.86 16.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.986 -1.486 . . . . 2.86 106.986 172.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -117.46 107.46 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.433 -1.321 . . . . 2.64 107.433 174.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -78.19 137.91 38.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.114 -1.439 . . . . 6.3 107.114 170.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.08 -41.44 2.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 123.965 0.793 . . . . 1.57 111.415 161.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -58.61 143.05 47.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.574 -0.368 . . . . 2.96 111.632 -178.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -145.85 142.0 28.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.44 1.096 . . . . 3.0 110.543 177.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.9 m 69.68 164.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.096 1.758 . . . . 3.92 114.186 167.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.61 -35.51 2.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.67 1.988 . . . . 1.84 112.194 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -55.63 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.169 0.988 . . . . 1.0 112.268 173.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -54.37 -37.62 65.19 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 120.831 -1.168 . . . . 2.06 109.623 -177.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -49.21 -65.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.893 0.477 . . . . 2.01 111.157 172.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.274 0.2 OUTLIER -68.12 -22.42 64.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.759 -0.588 . . . . 1.59 111.486 -175.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -60.28 -56.24 23.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.095 -1.076 . . . . 4.19 108.095 174.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.8 mt -57.62 -58.61 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.693 -0.854 . . . . 1.69 108.693 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.86 -56.47 21.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.369 0.531 . . . . 3.12 111.643 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -59.28 -38.86 81.18 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.742 -0.598 . . . . 1.71 111.243 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -65.28 -61.39 2.15 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.829 -0.545 . . . . 1.77 110.543 175.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.27 -31.61 72.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.429 -0.794 . . . . 3.77 111.963 -169.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.4 -10.49 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.666 1.121 . . . . 3.44 113.514 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -69.13 -21.2 64.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.435 1.016 . . . . 6.35 112.212 170.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -69.53 115.59 8.96 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.613 0.765 . . . . 2.35 109.362 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -78.57 46.26 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.41 -0.806 . . . . 7.96 112.659 -174.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.05 24.6 0.1 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.271 1.415 . . . . 1.42 110.785 170.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.14 122.11 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.416 -1.698 . . . . 3.41 106.416 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.9 mt -85.18 -38.54 18.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.735 0.814 . . . . 3.04 109.204 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -155.17 156.33 35.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.377 -1.342 . . . . 3.93 107.377 -176.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.2 t -146.67 59.75 1.2 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.03 -1.1 . . . . 2.55 108.03 178.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.38 94.28 3.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.356 -0.979 . . . . 3.49 108.356 -163.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.346 2.6 p -90.06 83.95 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 123.579 1.657 . . . . 2.67 111.242 -169.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.94 87.06 4.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.68 -1.145 . . . . 1.72 108.772 -178.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -40.34 -44.02 1.87 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.297 1.439 . . . . 3.57 110.632 162.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.03 -37.03 0.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.815 1.646 . . . . 2.27 113.556 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -132.43 26.0 4.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.114 1.366 . . . . 3.83 109.688 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 29.92 52.8 0.11 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.36 2.664 . . . . 2.09 112.571 -175.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 154.53 42.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.602 0.593 . . . . 4.29 112.602 -178.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.1 106.72 17.37 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.232 1.813 . . . . 1.66 109.508 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -78.78 83.09 4.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.517 -1.661 . . . . 1.63 106.517 167.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.06 145.48 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.522 -1.288 . . . . 2.66 107.522 173.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.4 134.85 50.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.299 -2.482 . . . . 3.82 104.299 161.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.88 172.28 17.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.773 0.715 . . . . 2.96 109.803 -168.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.74 81.78 1.23 Allowed Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.24 1.416 . . . . 4.48 107.952 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.72 -35.48 47.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.302 2.668 . . . . 1.67 112.733 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.95 -20.47 6.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.125 1.157 . . . . 4.35 114.125 176.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.9 pt -120.43 -57.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 119.621 1.101 . . . . 3.35 111.702 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tp -87.46 -36.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.007 -0.368 . . . . 3.26 110.007 -161.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.53 149.94 3.18 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.49 -0.644 . . . . 2.36 111.49 -177.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.52 -41.16 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.242 1.961 . . . . 0.89 110.33 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -54.61 -37.65 65.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.965 0.906 . . . . 7.55 111.148 -176.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -57.81 11.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.79 0.436 . . . . 3.68 110.821 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -54.42 -45.32 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 2.48 110.02 176.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -56.32 -51.59 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.626 -0.671 . . . . 2.39 111.322 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -49.39 -47.12 47.98 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.512 0.725 . . . . 3.66 109.279 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -49.68 76.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 119.681 -0.807 . . . . 2.4 109.645 -177.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.12 -50.32 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.545 0.338 . . . . 1.83 111.561 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.9 -46.63 83.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.405 -0.518 . . . . 4.13 111.042 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.6 t -57.55 -44.63 85.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.557 0.743 . . . . 1.81 111.232 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.8 -54.4 46.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.376 -0.828 . . . . 2.6 110.738 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.55 -42.13 0.02 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.859 1.104 . . . . 1.52 115.859 -178.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.79 134.47 55.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.376 -0.821 . . . . 3.22 111.138 -131.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.24 104.31 6.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.6 1.546 . . . . 4.6 108.715 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.98 154.34 29.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.921 0.889 . . . . 2.04 110.331 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -152.87 103.93 2.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 2.3 109.52 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -66.62 71.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.14 1.376 . . . . 3.59 112.643 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 123.996 0.918 . . . . 2.45 111.082 176.089 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 N-CA-C 109.46 -1.456 . . . . 2.05 109.46 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.33 129.35 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.236 -0.653 . . . . 2.85 109.236 -174.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -140.51 101.04 4.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.918 0.866 . . . . 4.13 109.105 -169.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.41 106.15 18.14 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.019 -1.104 . . . . 2.15 108.019 178.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.93 139.49 48.53 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.303 0.501 . . . . 3.06 110.343 170.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.15 143.77 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.125 -1.435 . . . . 2.66 107.125 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.75 156.02 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.33 -1.359 . . . . 2.92 107.33 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -138.34 122.23 17.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.405 1.082 . . . . 9.1 108.218 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.5 -45.79 1.13 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.925 -1.27 . . . . 1.54 109.925 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -56.0 140.4 43.43 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.851 -0.426 . . . . 2.73 109.851 170.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -166.32 22.79 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.83 0.308 . . . . 2.73 111.83 -172.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -169.33 147.2 3.64 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.11 0.868 . . . . 2.69 109.377 -174.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.0 0.38 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.017 2.127 . . . . 1.91 113.167 175.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 p -54.5 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.846 0.858 . . . . 0.92 111.659 172.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -41.32 -47.37 3.47 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 125.5 1.52 . . . . 2.17 110.834 176.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 t -46.63 -66.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.603 1.161 . . . . 1.72 110.933 173.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.318 0.3 OUTLIER -69.82 -17.61 63.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 119.692 -0.803 . . . . 1.83 111.302 -176.087 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -69.11 -45.02 71.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.31 -0.996 . . . . 3.98 108.31 -176.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.4 mt -53.7 -69.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.702 -0.851 . . . . 1.68 108.702 175.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.54 -59.08 3.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.522 0.729 . . . . 3.7 112.548 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -54.88 -41.76 71.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.232 0.613 . . . . 1.77 110.37 -177.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -61.4 -61.07 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.095 -0.378 . . . . 1.64 110.96 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.35 -35.63 79.72 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 118.627 -1.229 . . . . 2.72 111.406 -169.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -57.89 -13.98 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.109 0.411 . . . . 2.46 112.109 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -61.99 -40.68 96.46 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.093 -1.005 . . . . 5.11 111.15 169.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -67.78 122.44 18.11 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.454 -0.573 . . . . 2.17 109.454 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.68 48.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.173 -0.954 . . . . 7.13 111.095 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.94 0.1 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.08 1.324 . . . . 1.05 111.524 -178.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.37 142.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.052 -0.721 . . . . 3.66 109.052 173.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.96 -34.14 9.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.814 1.246 . . . . 2.61 110.461 -176.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -154.65 155.26 34.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.154 -0.684 . . . . 4.02 109.154 -175.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.7 t -155.76 80.08 1.01 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.73 0.812 . . . . 2.25 110.569 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -86.21 97.18 10.22 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.466 -0.771 . . . . 2.4 110.321 172.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -85.08 80.23 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.77 1.628 . . . . 3.2 108.651 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.18 93.92 9.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.856 -0.794 . . . . 1.69 108.856 -174.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -46.8 -35.49 6.32 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.448 1.099 . . . . 2.78 111.862 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.53 -30.39 41.41 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.567 0.747 . . . . 1.78 111.878 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -121.1 13.35 11.25 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.524 1.53 . . . . 2.42 109.782 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.04 33.19 6.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.167 2.187 . . . . 2.54 112.979 176.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.01 147.47 46.27 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.353 0.661 . . . . 1.89 111.57 -161.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.88 108.69 20.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.818 1.647 . . . . 1.66 108.657 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.96 87.41 4.78 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.804 -2.295 . . . . 1.05 104.804 162.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.8 mt -79.67 150.28 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.896 -1.52 . . . . 2.45 106.896 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -126.65 122.55 35.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 104.824 -2.287 . . . . 3.47 104.824 156.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -145.6 128.87 16.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 107.341 -1.355 . . . . 3.97 107.341 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.3 121.61 75.31 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 106.942 -1.503 . . . . 3.59 106.942 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.93 -46.63 18.59 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.378 2.052 . . . . 2.08 112.799 -165.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -56.94 -8.86 0.69 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.964 1.706 . . . . 3.61 115.249 -166.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 pt -115.17 -10.18 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.415 1.086 . . . . 3.15 113.65 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.89 -42.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.736 1.153 . . . . 2.92 113.097 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.91 153.44 5.33 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.6 -1.0 . . . . 2.15 110.6 -174.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.59 -35.48 17.03 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.261 1.974 . . . . 1.09 110.652 -174.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 -37.28 61.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.358 0.663 . . . . 7.99 112.291 -172.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.11 -58.09 9.72 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.227 0.467 . . . . 4.36 110.024 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mp -51.29 -49.71 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.287 -0.635 . . . . 2.65 109.287 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.83 -54.16 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.971 -0.537 . . . . 3.03 110.783 179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -48.84 -52.07 26.18 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.498 0.719 . . . . 3.82 109.844 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -56.07 -51.57 67.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 122.123 -0.361 . . . . 1.94 110.487 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.0 mt -55.74 -47.73 78.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.748 -0.595 . . . . 1.98 111.877 -176.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.343 0.519 . . . . 4.9 111.477 176.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -66.85 -15.62 63.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.243 -0.884 . . . . 1.54 112.466 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.33 -89.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.602 -1.258 . . . . 4.03 107.602 155.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.49 20.23 0.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.898 -1.501 . . . . 1.36 114.8 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -123.76 139.05 54.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.957 1.878 . . . . 3.25 113.121 -160.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -77.33 139.59 39.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.049 -1.463 . . . . 4.28 107.049 171.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.02 146.58 43.95 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.509 1.124 . . . . 2.19 109.357 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -153.06 112.25 3.81 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 121.673 -0.642 . . . . 2.21 110.575 176.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.06 121.36 7.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.847 0.859 . . . . 3.76 109.347 173.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 CA--C 1.529 0.17 0 C-N-CA 123.293 0.637 . . . . 2.24 110.287 172.879 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 109.609 -1.396 . . . . 2.91 109.609 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.18 147.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.134 1.373 . . . . 3.63 109.994 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.31 103.77 3.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 4.13 108.6 175.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.97 117.8 31.97 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.025 -0.989 . . . . 2.22 108.47 178.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.58 142.12 50.46 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.515 0.598 . . . . 2.95 110.851 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.71 134.84 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 107.033 -1.469 . . . . 3.08 107.033 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.61 119.87 60.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.839 1.256 . . . . 2.68 107.687 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -87.14 62.8 7.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.125 0.57 . . . . 6.77 110.484 -164.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.54 -104.63 0.2 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.69 -0.964 . . . . 3.57 110.69 174.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mtm 57.66 65.53 1.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.419 1.087 . . . . 2.53 111.873 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 p -65.97 -23.81 66.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.356 1.243 . . . . 4.13 114.356 -168.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.3 t -166.66 155.48 10.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.786 0.721 . . . . 2.56 109.143 -165.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.64 -39.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.659 2.384 . . . . 1.69 113.301 172.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 p -52.98 -76.08 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.603 1.161 . . . . 0.88 112.726 169.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.2 m -46.97 -41.03 15.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.165 1.786 . . . . 2.28 111.124 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.1 t -51.72 -73.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.931 0.893 . . . . 2.14 110.01 168.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.301 0.3 OUTLIER -67.31 -14.86 63.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.388 0.613 . . . . 1.81 112.275 -167.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.05 -42.15 93.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.032 -1.042 . . . . 5.62 108.494 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.46 -65.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.712 -0.847 . . . . 1.61 108.712 -175.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -66.16 0.45 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.107 0.963 . . . . 3.82 112.234 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -47.55 -45.28 26.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.591 0.756 . . . . 1.46 111.068 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 t -60.95 -62.56 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.224 0.466 . . . . 1.82 111.12 175.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.59 -31.5 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.122 0.874 . . . . 2.9 111.163 -171.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 m -54.31 -19.54 5.56 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.116 -0.99 . . . . 2.79 112.646 176.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -37.97 77.4 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.711 -1.243 . . . . 6.76 112.59 170.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.86 165.09 16.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 2.76 109.992 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.92 42.13 3.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.758 0.823 . . . . 8.52 110.032 169.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.84 18.4 3.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.222 -1.151 . . . . 1.13 110.222 164.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.71 148.93 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.807 -2.294 . . . . 4.82 104.807 167.154 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.34 -37.12 5.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.784 1.233 . . . . 2.94 110.276 -174.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -157.63 162.4 38.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.675 -0.861 . . . . 3.97 108.675 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -143.37 73.85 1.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.194 0.997 . . . . 3.07 110.779 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.85 83.6 5.75 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.161 -0.681 . . . . 2.75 109.161 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.4 103.43 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.522 0.677 . . . . 2.72 110.503 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.71 100.16 9.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.383 1.073 . . . . 1.73 108.906 -172.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -38.18 4.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.254 1.422 . . . . 3.15 110.575 170.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.85 39.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.394 1.078 . . . . 1.7 112.262 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.24 16.0 10.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.641 1.177 . . . . 2.32 109.688 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.08 43.51 1.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.212 2.205 . . . . 2.09 112.512 -178.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.17 144.34 34.74 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 122.149 -0.345 . . . . 2.0 110.826 -166.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.65 108.13 20.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.443 1.497 . . . . 1.58 108.556 168.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.79 83.44 7.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.354 -2.091 . . . . 0.86 105.354 157.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.8 mt -83.06 153.29 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.32 -1.733 . . . . 2.1 106.32 170.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -121.76 141.98 50.65 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.876 -1.898 . . . . 4.83 105.876 166.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.09 165.5 24.6 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 118.742 0.701 . . . . 3.1 112.186 -163.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.74 97.46 44.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 123.986 0.804 . . . . 4.2 110.736 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.72 -21.05 72.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.839 2.359 . . . . 1.73 114.641 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.44 -31.18 14.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.973 0.806 . . . . 4.11 111.875 168.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -66.86 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 123.229 0.611 . . . . 5.77 110.208 175.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.29 116.02 41.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.333 -0.988 . . . . 2.69 108.333 -166.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.16 161.91 38.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.378 -1.489 . . . . 1.83 109.378 -176.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -54.03 -37.88 86.68 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.856 1.704 . . . . 1.17 109.485 171.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 57' ' ' ASP . 12.8 ptt180 -35.96 -53.39 0.76 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 11.63 112.05 168.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 56' ' ' ARG . 64.6 m-20 -71.52 -52.02 20.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.709 -1.589 . . . . 2.96 106.709 -164.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -56.08 -52.37 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.384 -1.28 . . . . 2.13 109.406 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -53.38 -56.59 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.042 0.537 . . . . 2.55 109.683 179.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -56.93 -38.1 72.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.206 0.457 . . . . 4.2 110.247 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.7 m -65.08 -46.89 79.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.259 0.481 . . . . 1.87 110.609 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.78 -46.43 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.294 1.038 . . . . 1.76 110.431 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.28 -55.65 28.96 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 123.575 0.75 . . . . 2.94 109.672 173.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -51.85 -46.6 64.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.636 1.174 . . . . 1.75 111.357 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.79 -45.24 79.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.219 -0.926 . . . . 2.77 112.107 177.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.86 -46.46 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.999 0.76 . . . . 1.49 114.999 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -129.13 134.78 48.2 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 120.482 -0.487 . . . . 3.16 112.011 -135.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.46 154.94 32.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.731 -1.211 . . . . 3.27 107.731 168.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.29 165.08 28.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.907 0.483 . . . . 2.16 110.962 -166.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 m -132.58 112.09 11.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.571 1.549 . . . . 3.5 107.949 177.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 tp -73.1 78.59 1.23 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.796 1.238 . . . . 4.08 108.698 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.536 0.404 0 CA-C-N 115.583 -0.735 . . . . 2.01 111.377 178.523 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.094 0 N-CA-C 110.385 -1.086 . . . . 2.14 110.385 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.89 132.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.188 -1.412 . . . . 3.14 107.188 163.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.85 124.42 44.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 103.771 -2.677 . . . . 4.49 103.771 169.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.4 127.03 40.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.096 -1.816 . . . . 2.46 106.096 -179.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.94 144.97 35.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.283 -0.266 . . . . 2.9 110.283 -172.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.84 139.29 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.212 -1.403 . . . . 3.12 107.212 168.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.98 99.49 6.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 126.235 1.814 . . . . 3.12 108.031 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -84.86 140.9 30.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.464 1.106 . . . . 6.29 108.061 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.92 -11.63 34.65 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.328 0.966 . . . . 1.65 112.818 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.72 146.89 53.33 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.292 1.046 . . . . 2.78 111.295 177.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -162.04 143.47 10.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.875 -1.898 . . . . 2.97 105.875 166.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.4 t 69.64 145.58 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.351 1.46 . . . . 3.18 113.147 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.19 -32.32 0.47 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.248 1.819 . . . . 1.8 113.176 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 p -51.66 -81.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.724 1.209 . . . . 1.01 112.936 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.5 m -45.7 -43.67 12.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.835 1.254 . . . . 2.17 110.68 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.1 -65.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.444 1.098 . . . . 2.32 110.976 174.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.293 0.3 OUTLIER -68.91 -20.21 64.23 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.549 0.69 . . . . 1.93 111.003 -176.559 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.03 -40.46 97.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.92 -1.113 . . . . 5.06 109.023 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.7 -67.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.933 0.893 . . . . 1.88 109.096 176.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.99 -64.17 0.87 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.942 0.497 . . . . 3.48 111.64 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -48.48 -47.56 38.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.933 0.893 . . . . 3.89 111.935 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 t -67.82 -39.94 83.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 O-C-N 121.336 -0.852 . . . . 1.55 112.285 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.97 -37.57 69.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.672 1.124 . . . . 2.83 110.937 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -68.87 73.13 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.17 1.388 . . . . 2.55 110.091 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 129.36 3.064 . . . . 6.57 109.648 -172.396 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -54.17 -40.79 67.82 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 119.114 0.87 . . . . 2.59 112.282 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 77.91 -5.17 2.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.674 2.389 . . . . 8.39 111.338 -163.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.53 47.09 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 121.304 -0.873 . . . . 1.66 111.456 176.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.28 133.93 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.114 1.366 . . . . 4.65 107.894 173.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -102.16 -31.89 10.37 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.413 1.085 . . . . 2.64 110.731 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -155.1 153.61 31.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.821 -0.609 . . . . 3.35 109.715 174.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -150.02 96.17 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.272 1.029 . . . . 2.03 110.846 -171.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.9 104.39 16.28 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.141 -0.689 . . . . 2.67 109.141 171.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.6 82.45 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.996 0.918 . . . . 3.51 108.85 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 90.21 6.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.071 -1.085 . . . . 1.86 108.071 -176.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -47.56 -32.68 5.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.773 0.829 . . . . 2.78 111.304 169.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.75 -32.57 31.18 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.941 0.896 . . . . 2.03 111.876 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -122.53 18.05 10.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.405 1.482 . . . . 2.49 109.68 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 m120 36.83 45.16 0.4 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.965 2.106 . . . . 2.65 112.916 -175.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.28 143.99 42.45 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.493 0.588 . . . . 2.59 111.82 -174.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.11 112.91 24.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.427 1.491 . . . . 1.64 108.131 168.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -86.23 105.68 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.475 -1.676 . . . . 1.04 106.475 164.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.72 103.62 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.586 1.554 . . . . 2.09 108.338 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.34 83.66 4.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.57 -1.641 . . . . 4.24 106.57 172.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 165.0 14.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.287 1.035 . . . . 3.1 112.3 177.233 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.97 101.12 39.59 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.394 1.078 . . . . 3.78 110.195 174.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 60.62 6.88 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.489 3.46 . . . . 2.31 113.796 -166.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -157.23 -40.07 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.657 0.783 . . . . 4.17 111.42 167.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.06 -13.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.208 0.603 . . . . 3.05 110.249 174.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -149.48 144.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 108.071 -1.085 . . . . 2.31 108.071 175.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.4 148.75 20.8 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 108.317 -1.913 . . . . 2.18 108.317 170.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.46 -42.93 56.19 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.466 1.444 . . . . 0.89 109.702 178.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.59 -42.28 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.173 1.389 . . . . 8.55 113.218 168.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.26 -41.6 76.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.262 0.937 . . . . 3.32 109.597 -175.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 mt -63.59 -49.27 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.422 -0.955 . . . . 1.58 108.422 176.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -50.0 -56.85 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.879 -0.415 . . . . 2.83 109.879 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -51.49 -51.66 53.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.073 0.549 . . . . 3.93 110.114 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.6 m -58.97 -52.57 65.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.625 -0.43 . . . . 1.89 110.056 -176.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.83 -60.55 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.862 0.865 . . . . 1.89 110.024 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.4 -45.06 80.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.802 -0.444 . . . . 3.87 109.802 -176.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -62.97 -9.17 8.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.227 -1.368 . . . . 1.12 114.278 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.76 -87.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 121.359 1.89 . . . . 3.87 107.808 155.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.13 42.49 0.47 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.833 -0.982 . . . . 1.22 112.307 174.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.4 170.83 11.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.327 1.064 . . . . 3.27 112.912 -171.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -117.42 122.47 43.89 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 104.684 -2.339 . . . . 3.45 104.684 167.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.79 154.82 26.74 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.732 0.813 . . . . 2.11 111.073 -171.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.4 m -156.24 121.46 4.76 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.455 -0.778 . . . . 2.18 110.363 172.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.44 128.62 38.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 4.74 110.149 173.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 125.547 1.539 . . . . 2.37 109.528 178.407 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 CA-C-O 118.327 -1.263 . . . . 3.48 115.069 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.67 100.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 120.169 1.985 . . . . 3.22 110.975 176.101 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -104.17 101.45 11.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.825 2.05 . . . . 3.73 107.288 174.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -97.51 107.15 19.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.97 -0.752 . . . . 2.44 108.97 172.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -99.94 148.25 24.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 124.14 0.9 . . . . 3.3 108.952 166.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.15 145.73 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.161 -1.792 . . . . 2.78 106.161 158.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.05 139.23 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.746 1.218 . . . . 3.5 108.766 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -133.56 153.58 51.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.766 0.826 . . . . 7.72 111.023 -178.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.03 -21.0 28.0 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.862 1.22 . . . . 1.95 110.965 -174.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.5 mtm -66.75 150.55 48.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.156 -0.614 . . . . 2.14 109.681 174.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t -151.35 10.81 0.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.105 0.78 . . . . 2.44 113.105 177.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.5 t -171.87 151.56 2.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.544 1.066 . . . . 2.85 109.528 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.28 -31.94 0.71 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.696 1.998 . . . . 2.1 113.012 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -53.3 -67.5 0.25 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.377 1.071 . . . . 0.74 113.145 170.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.5 m -43.15 -50.96 6.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.217 1.407 . . . . 1.94 108.346 176.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 t -50.02 -66.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.743 -1.117 . . . . 2.21 111.551 177.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.327 0.1 OUTLIER -65.83 -28.98 69.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.683 -0.407 . . . . 1.34 111.112 -171.404 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.07 -52.29 56.57 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.32 1.448 . . . . 3.86 108.281 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -51.76 -65.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.092 -1.077 . . . . 1.98 108.092 171.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.44 -42.07 88.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.91 -0.586 . . . . 2.96 110.759 -158.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -59.54 -45.66 91.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.739 0.815 . . . . 1.73 110.39 173.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -59.5 -49.67 76.87 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.761 -0.459 . . . . 1.31 109.761 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.07 -45.23 75.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.751 -0.593 . . . . 3.4 110.985 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -61.55 -7.03 2.81 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.395 1.257 . . . . 3.54 114.395 179.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -66.63 -31.94 72.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.492 1.042 . . . . 5.03 110.654 169.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.452 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 11.6 m170 -64.74 121.5 14.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.627 0.771 . . . . 2.65 109.168 -176.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.06 46.05 0.78 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.445 0.906 . . . . 6.5 113.445 -165.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.62 20.38 0.13 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.469 1.033 . . . . 1.99 111.335 166.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.68 140.18 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.093 -1.077 . . . . 3.37 108.093 174.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.3 mt -109.28 -35.9 6.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.366 1.066 . . . . 2.73 111.433 -173.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -155.46 158.42 38.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.462 1.028 . . . . 3.49 109.854 -177.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 p -155.91 140.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.742 2.417 . . . . 3.14 105.467 -177.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -156.45 90.59 1.18 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.362 -1.718 . . . . 2.45 106.362 170.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.48 76.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.603 -1.258 . . . . 3.22 107.603 -172.14 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.86 93.24 4.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.572 -0.705 . . . . 2.1 109.133 -171.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tt -42.98 -37.17 1.79 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.252 1.421 . . . . 3.22 111.566 168.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.23 -32.91 39.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 2.24 112.452 178.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -116.05 12.23 15.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.255 1.422 . . . . 2.66 110.125 178.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 40.44 37.74 0.49 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.823 2.049 . . . . 2.14 112.141 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 154.89 45.54 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.489 0.716 . . . . 2.51 109.762 -169.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.68 112.12 11.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.413 -1.328 . . . . 1.8 107.413 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -92.08 96.94 10.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.899 2.479 . . . . 1.4 104.602 170.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.79 135.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 104.707 -2.331 . . . . 2.98 104.707 172.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.1 127.88 54.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.501 -1.666 . . . . 4.19 106.501 168.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -165.35 168.47 16.78 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.111 0.965 . . . . 4.49 109.74 -173.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -92.13 119.05 68.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.412 1.07 . . . . 4.0 108.905 171.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.62 -32.51 93.43 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.543 1.495 . . . . 2.15 113.039 176.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -84.88 49.88 1.81 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.901 1.228 . . . . 5.55 111.843 -165.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.97 -47.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 127.395 2.278 . . . . 5.12 107.83 178.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -53.62 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.308 1.043 . . . . 3.48 109.595 -173.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.06 145.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.717 -0.614 . . . . 2.18 111.7 -166.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -52.5 -39.63 74.03 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.514 2.143 . . . . 1.17 111.354 178.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -37.95 -48.76 1.2 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.435 1.494 . . . . 8.89 112.697 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.57 -50.24 59.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.864 0.84 . . . . 3.69 109.506 -172.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.3 -52.58 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.598 -0.689 . . . . 2.28 110.896 175.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.86 -50.8 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.946 -0.761 . . . . 3.04 108.946 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -55.37 -47.04 76.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.008 0.523 . . . . 6.56 110.373 -179.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.452 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 99.1 m -60.08 -48.4 81.89 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.856 0.753 . . . . 2.09 110.936 176.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.7 -51.69 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.865 0.757 . . . . 2.09 110.837 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.95 -55.5 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.119 0.968 . . . . 2.86 109.943 177.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -57.09 -34.95 68.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.751 1.22 . . . . 1.27 111.597 -177.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.67 -58.1 4.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.529 0.604 . . . . 3.44 110.275 172.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 -41.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.826 1.09 . . . . 1.57 115.826 -176.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -117.25 142.69 46.74 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 117.421 0.61 . . . . 3.32 111.65 -135.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.8 150.49 30.71 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.838 -1.542 . . . . 3.69 106.838 173.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.41 164.61 35.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.235 0.471 . . . . 2.02 111.994 -176.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.7 m -158.2 132.04 7.85 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 118.282 -0.866 . . . . 1.93 110.624 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.49 128.68 37.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.893 1.224 . . . . 3.67 108.777 172.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.465 0.284 0 C-N-CA 123.442 0.697 . . . . 3.05 111.967 177.343 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 111.796 -0.521 . . . . 2.13 111.796 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.42 128.9 74.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.089 0.956 . . . . 4.56 110.727 -175.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.25 120.3 28.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.108 1.363 . . . . 5.66 108.076 173.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.83 107.89 19.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.185 -1.043 . . . . 2.41 108.185 177.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -117.78 148.55 41.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.036 0.534 . . . . 3.08 110.998 -174.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.7 151.2 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.884 0.873 . . . . 3.1 108.971 173.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.72 86.76 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.981 1.312 . . . . 3.28 109.339 174.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 107.48 18.78 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.664 -0.648 . . . . 7.52 110.416 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.62 -20.77 0.39 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.357 0.98 . . . . 1.54 112.133 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.7 mtm -62.5 169.7 2.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.176 0.988 . . . . 2.16 111.79 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 t -158.9 -44.66 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.519 0.727 . . . . 2.57 110.856 -177.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.9 m -138.44 164.3 29.71 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.189 0.449 . . . . 3.02 110.665 -168.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -38.64 3.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.48 1.912 . . . . 2.19 112.464 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.8 p -52.68 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.782 1.233 . . . . 1.0 112.265 170.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.4 m -42.69 -41.97 3.33 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.638 1.175 . . . . 2.28 111.43 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.22 -72.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.024 0.53 . . . . 2.02 111.121 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -17.88 65.08 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.465 -0.772 . . . . 1.36 112.334 -170.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -54.99 -46.4 75.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.859 0.864 . . . . 4.27 109.36 173.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.08 -60.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.895 -1.15 . . . . 1.82 107.895 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -50.84 -58.17 6.62 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.794 0.438 . . . . 2.97 110.654 178.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -56.2 -33.69 65.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.473 0.709 . . . . 1.87 111.908 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -70.62 -64.46 0.89 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.581 0.628 . . . . 1.93 110.609 172.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.12 -32.89 74.82 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.052 -1.03 . . . . 3.18 111.583 -167.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -56.93 -16.45 6.88 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 3.11 112.701 175.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -63.08 -35.8 81.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.398 -0.814 . . . . 5.88 111.126 171.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -72.98 109.7 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.53 -0.915 . . . . 2.58 108.53 177.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -65.87 -3.74 5.62 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.928 -1.107 . . . . 7.98 110.898 167.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.73 -25.37 71.69 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.623 1.106 . . . . 1.39 112.833 166.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 pp -99.84 156.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 119.142 1.471 . . . . 4.28 110.519 175.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.22 -38.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.557 1.543 . . . . 2.43 110.046 -177.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -155.65 157.06 36.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.651 0.659 . . . . 3.75 109.409 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -140.64 131.78 26.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.073 -1.454 . . . . 2.08 107.073 170.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.45 98.31 3.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.344 1.458 . . . . 2.82 107.651 -177.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.33 106.55 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.334 0.654 . . . . 2.99 111.761 -174.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.13 97.67 8.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.545 -0.722 . . . . 2.1 109.223 -174.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -48.98 -40.2 29.62 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.19 0.996 . . . . 2.81 111.597 175.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.55 -32.95 1.02 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.384 1.074 . . . . 1.89 113.226 175.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -125.82 13.76 7.98 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.084 0.953 . . . . 2.28 111.154 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 34.52 49.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.776 . . . . 2.03 112.277 -172.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 139.71 53.59 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.164 0.585 . . . . 3.93 109.856 -179.001 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.96 112.17 24.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.223 1.409 . . . . 1.75 107.738 162.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -79.18 102.16 8.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.281 -2.488 . . . . 1.57 104.281 160.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.0 mt -106.76 124.73 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.336 -1.728 . . . . 2.07 106.336 174.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -97.48 114.74 26.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.219 -2.141 . . . . 4.59 105.219 166.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.66 151.62 29.0 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.76 -1.941 . . . . 4.41 105.76 -178.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.62 129.43 23.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.409 0.443 . . . . 3.83 110.883 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -56.94 -35.31 98.6 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.898 2.399 . . . . 1.73 111.737 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.64 -25.87 65.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.13 0.789 . . . . 3.71 113.13 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.9 pt -106.86 -26.96 3.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 118.965 0.802 . . . . 3.83 112.161 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -152.93 131.97 3.12 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 CA-C-N 119.246 0.93 . . . . 2.78 109.584 172.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.71 166.75 53.4 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.473 -0.651 . . . . 1.7 111.473 -177.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.02 -55.54 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.86 2.374 . . . . 1.36 110.586 177.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -56.97 -32.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 122.391 -0.193 . . . . 8.59 111.03 -174.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -56.88 13.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.659 1.584 . . . . 4.02 109.184 175.049 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.66 -50.33 68.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.059 -0.719 . . . . 3.1 109.059 176.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.2 -46.97 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.007 -0.542 . . . . 3.18 110.524 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -52.71 -51.73 59.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.984 0.811 . . . . 3.64 109.714 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -52.33 -58.39 6.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.466 0.575 . . . . 1.85 110.302 175.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.3 -55.78 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.043 0.537 . . . . 1.94 111.179 -172.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -53.67 -45.6 70.33 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.709 0.804 . . . . 4.19 109.635 176.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -66.98 -9.88 43.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.617 -1.182 . . . . 1.31 113.392 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.96 -100.99 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.276 1.398 . . . . 3.72 107.85 156.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.86 38.92 0.5 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.243 0.929 . . . . 1.64 112.871 177.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -130.81 122.71 27.61 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.311 1.056 . . . . 3.27 109.336 -171.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -79.91 133.61 36.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.971 -1.863 . . . . 3.01 105.971 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.28 161.15 30.88 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 113.791 1.034 . . . . 1.9 113.791 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -158.22 137.71 11.87 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.912 1.285 . . . . 1.91 108.572 177.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -82.43 48.22 1.26 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.747 1.612 . . . . 4.28 111.232 -175.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 117.209 2.3 . . . . 2.68 117.209 -160.65 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.427 -1.207 . . . . 2.65 115.292 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 p -156.63 127.7 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 120.371 2.086 . . . . 2.68 110.29 172.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.48 108.97 6.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.787 -1.19 . . . . 4.62 107.787 172.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.35 119.44 28.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.434 -1.321 . . . . 2.26 107.434 169.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -119.69 140.49 50.58 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.707 1.139 . . . . 3.82 110.494 170.046 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.81 119.87 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.718 -1.216 . . . . 2.61 107.718 173.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.54 94.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.569 1.148 . . . . 3.65 108.37 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -78.45 86.16 4.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.937 -1.505 . . . . 8.29 106.937 176.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.12 -138.25 5.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 103.48 -3.848 . . . . 3.38 103.48 175.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 mtm 65.78 166.97 0.19 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.951 1.3 . . . . 2.24 111.62 -170.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.6 p -147.21 -83.41 0.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.993 0.517 . . . . 4.34 110.134 -176.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t -146.29 103.46 3.71 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.595 0.758 . . . . 3.52 110.389 -166.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 45.33 -129.98 1.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.458 -0.941 . . . . 2.77 108.458 -169.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.1 p 43.53 -87.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.463 1.905 . . . . 1.48 113.962 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -39.83 -43.75 1.51 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.087 1.755 . . . . 1.83 110.391 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -44.42 -67.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 2.12 110.649 172.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.326 0.4 OUTLIER -71.78 -21.6 61.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 119.797 -0.761 . . . . 1.41 112.512 -177.525 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.56 -45.32 92.17 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.362 -1.347 . . . . 5.03 107.362 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.43 -69.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.62 -0.718 . . . . 1.81 109.085 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -56.6 -48.14 78.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.774 0.261 . . . . 4.77 111.589 -165.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -70.45 -20.77 62.87 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.23 0.612 . . . . 1.59 110.485 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.7 t -66.85 -62.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.33 -1.481 . . . . 1.91 109.036 162.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.66 -50.58 35.18 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 113.62 0.97 . . . . 2.96 113.62 -162.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -44.15 -28.26 0.48 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.015 1.326 . . . . 3.6 113.58 -167.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -63.17 -40.48 97.67 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.192 2.597 . . . . 4.86 112.944 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -62.2 129.06 39.02 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.254 -1.017 . . . . 2.41 108.254 172.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.88 -3.47 3.44 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.795 1.405 . . . . 11.87 114.795 -166.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.16 -14.13 56.49 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 119.546 -0.585 . . . . 1.36 112.214 -178.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mm -88.91 104.86 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.037 -1.098 . . . . 3.54 108.037 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.0 mt -78.99 -38.96 35.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.004 -0.739 . . . . 2.73 109.004 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -155.31 145.68 21.95 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.599 -0.889 . . . . 3.72 108.599 176.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.75 105.99 6.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.307 -1.368 . . . . 2.53 107.307 175.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 t -120.94 103.6 9.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.963 -1.125 . . . . 2.35 107.963 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.04 127.78 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.072 0.549 . . . . 2.94 110.481 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.03 108.94 11.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.035 0.934 . . . . 2.37 110.247 -170.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.81 -41.51 5.06 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.933 1.293 . . . . 3.61 111.08 168.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.77 14.36 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 124.109 0.964 . . . . 1.69 112.475 -175.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -130.07 14.28 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.212 1.005 . . . . 2.53 110.006 -177.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 m120 29.97 53.55 0.13 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 126.169 1.788 . . . . 2.29 111.831 -169.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.29 141.17 37.76 Favored 'General case' 0 N--CA 1.461 0.085 0 O-C-N 121.577 -0.702 . . . . 1.83 110.712 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.19 112.61 24.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.753 1.621 . . . . 1.61 108.424 168.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -79.91 104.0 10.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.055 -1.832 . . . . 0.96 106.055 162.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.41 113.0 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.482 -0.933 . . . . 2.16 108.482 175.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -84.1 107.38 16.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 105.699 -1.963 . . . . 3.85 105.699 164.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -147.2 167.48 24.09 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.67 -1.604 . . . . 3.93 106.67 174.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.35 136.65 27.34 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.757 1.021 . . . . 4.37 113.757 174.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.34 48.59 2.93 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.506 3.471 . . . . 2.06 113.023 -165.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -155.85 -47.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.004 1.322 . . . . 3.11 109.464 -173.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 pt -67.75 -32.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.228 -1.027 . . . . 4.03 108.228 166.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.31 17.6 tt -131.67 -91.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 123.735 0.647 . . . . 2.4 112.579 170.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.67 152.78 6.49 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.536 -1.426 . . . . 2.47 109.536 -168.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.71 -57.17 0.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.197 1.931 . . . . 1.29 109.033 172.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptt85 -29.28 -55.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.223 2.209 . . . . 11.29 113.22 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.23 -51.06 65.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.552 -0.907 . . . . 2.85 108.552 -171.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.81 -49.95 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.536 -0.542 . . . . 1.88 109.536 177.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.1 mm -50.28 -57.99 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 119.09 -0.481 . . . . 2.79 109.795 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -51.46 -46.31 63.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.055 0.542 . . . . 3.75 110.258 177.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -57.57 -47.9 80.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.388 -0.339 . . . . 1.72 110.986 178.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.0 -50.6 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.278 0.945 . . . . 3.11 110.989 -177.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -50.28 73.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.337 0.517 . . . . 2.95 110.243 176.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -52.0 -42.0 62.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.526 0.73 . . . . 1.43 111.132 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.74 -49.29 48.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.305 -0.872 . . . . 2.81 111.687 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.9 -44.22 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 116.001 1.16 . . . . 1.37 116.001 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.87 156.8 39.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.813 0.672 . . . . 3.19 112.813 -135.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.21 139.71 39.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.651 -1.611 . . . . 5.65 106.651 171.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.85 70.59 1.21 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.401 1.48 . . . . 2.54 110.1 -166.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -84.99 100.32 11.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.425 0.631 . . . . 2.27 109.629 -170.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.33 73.88 0.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.68 1.592 . . . . 3.52 112.651 -178.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.541 0.6 0 C-N-CA 125.086 1.354 . . . . 2.25 111.682 167.082 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 109.728 -0.471 . . . . 12.27 109.728 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.03 37.73 86.63 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.282 0.468 . . . . 5.78 112.06 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.84 -52.14 9.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.165 0.986 . . . . 6.22 110.061 -163.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.45 113.31 0.3 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.862 -1.695 . . . . 1.87 108.862 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.14 147.54 5.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.06 -1.089 . . . . 3.28 108.06 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.5 tp -150.64 82.92 1.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.509 -0.552 . . . . 3.19 109.509 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -77.92 100.73 6.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 110.035 -0.357 . . . . 3.49 110.035 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.78 118.21 27.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.04 -1.467 . . . . 3.81 107.04 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.77 119.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 105.498 -2.038 . . . . 2.93 105.498 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.67 93.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 125.513 1.525 . . . . 3.11 107.967 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -78.47 112.36 15.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.009 -1.478 . . . . 7.46 107.009 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.64 -136.76 7.82 Favored Glycine 0 N--CA 1.434 -1.479 1 N-CA-C 101.994 -4.442 . . . . 3.54 101.994 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.63 173.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.874 0.87 . . . . 2.21 112.683 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -154.03 -81.03 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.954 1.302 . . . . 3.85 108.674 -167.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -172.13 131.37 0.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 125.361 1.464 . . . . 6.15 107.957 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 48.45 -146.12 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.558 -0.734 . . . . 2.8 109.21 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.1 p 51.61 -86.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.907 1.447 . . . . 1.56 114.907 161.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.5 p -45.31 -41.7 9.03 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.214 -0.929 . . . . 3.66 111.53 166.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.03 -72.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.3 1.44 . . . . 1.87 110.064 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -25.82 66.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.806 -0.616 . . . . 1.75 111.241 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -53.21 -57.52 10.22 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.527 -0.916 . . . . 5.61 108.527 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.69 -60.12 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.908 -0.775 . . . . 1.88 108.908 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -54.16 -57.03 12.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.85 0.357 . . . . 3.27 111.373 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -57.0 -47.58 80.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.433 0.693 . . . . 1.9 110.07 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -60.03 -65.23 0.71 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.931 -0.396 . . . . 1.45 109.931 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.75 -29.43 69.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.006 -1.078 . . . . 3.91 111.217 -166.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -55.82 -20.38 15.0 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.163 -0.961 . . . . 2.22 112.348 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -30.64 69.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.808 -1.183 . . . . 7.51 112.417 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' A' ' 31' ' ' GLY . 52.1 m-70 -70.07 116.04 9.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.209 -1.034 . . . . 2.36 108.209 175.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 32.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.418 -0.802 . . . . 9.14 113.082 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' HIS . . . -126.08 -8.53 5.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.037 1.78 . . . . 0.89 111.82 166.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.02 118.64 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 105.974 -1.861 . . . . 3.46 105.974 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.83 -37.75 18.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.222 -0.659 . . . . 2.74 109.222 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.4 162.12 40.86 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.052 0.387 . . . . 4.32 110.866 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.91 96.08 2.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.433 1.893 . . . . 2.57 108.957 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 m -99.73 99.78 10.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.719 1.608 . . . . 2.91 107.545 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.96 92.53 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 122.819 1.295 . . . . 3.16 109.286 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.72 82.22 3.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.484 -1.302 . . . . 2.36 107.484 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -37.5 -44.07 0.63 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.248 1.819 . . . . 3.91 110.378 163.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.4 -32.93 28.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.121 . . . . 2.14 113.067 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -120.95 20.45 11.57 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.416 1.086 . . . . 3.99 110.296 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 34.59 56.66 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.368 1.867 . . . . 2.23 111.523 -170.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -140.69 125.58 18.23 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.968 0.359 . . . . 2.65 111.968 -167.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.74 98.99 8.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.245 -1.391 . . . . 1.62 107.245 165.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -77.25 96.29 4.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 104.787 -2.301 . . . . 1.36 104.787 159.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.67 150.0 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.249 -1.342 . . . . 2.34 107.996 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.14 133.74 55.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.427 -2.064 . . . . 4.02 105.427 166.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -156.26 161.82 40.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.176 -1.416 . . . . 3.91 107.176 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.18 140.99 22.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 4.15 107.088 161.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.45 -22.58 28.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.399 2.066 . . . . 1.71 111.628 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.648 0.779 . . . . 4.06 111.169 -172.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.98 -11.29 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.647 0.379 . . . . 3.29 111.957 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.88 130.99 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.315 -0.624 . . . . 2.39 109.315 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.01 154.08 47.68 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.177 -1.569 . . . . 1.89 109.177 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.04 -40.52 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.585 1.523 . . . . 0.91 109.34 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.09 -38.26 79.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.381 -0.342 . . . . 9.45 111.202 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -53.0 47.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.154 1.382 . . . . 3.51 109.745 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.35 -51.87 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.031 -0.986 . . . . 1.92 109.04 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.46 -52.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.695 -0.669 . . . . 2.28 111.446 -177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -48.06 -49.41 31.57 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.935 1.294 . . . . 3.82 109.496 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -63.37 -47.44 82.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.98 -0.555 . . . . 1.95 109.642 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.79 -58.81 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 121.471 -0.768 . . . . 2.16 111.29 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.68 -49.04 76.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.692 -0.855 . . . . 2.73 108.692 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.7 t -48.37 -50.32 31.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.238 1.015 . . . . 1.42 111.712 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.13 -42.76 86.53 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.168 1.173 . . . . 2.62 114.168 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.89 -2.92 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 N-CA-C 119.127 2.411 . . . . 1.38 119.127 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -142.27 177.64 8.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.963 1.881 . . . . 3.17 111.846 -144.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -110.62 140.3 45.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.184 -1.784 . . . . 5.18 106.184 150.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.0 116.15 16.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.861 0.864 . . . . 2.25 110.827 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -122.55 116.99 24.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.394 1.078 . . . . 2.23 111.417 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.88 72.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.93 1.692 . . . . 3.09 112.407 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m -55.39 -40.76 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.818 0.847 . . . . 2.32 110.443 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt 65.34 101.72 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.72 1.208 . . . . 5.53 110.602 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.319 4.7 tp 31.55 63.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.936 2.494 . . . . 6.0 113.989 -161.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 . . . . . 0 C--O 1.255 1.394 0 N-CA-C 101.169 -3.641 . . . . 10.45 101.169 133.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 105.726 -1.953 . . . . 8.77 105.726 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.75 -174.48 7.79 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 108.875 -1.69 . . . . 5.62 108.875 138.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.02 59.61 4.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.331 1.453 . . . . 5.25 110.253 -170.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.79 139.23 22.61 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.255 -1.538 . . . . 2.05 109.255 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.4 151.96 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.229 -0.656 . . . . 3.37 109.229 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.8 tp -152.37 111.07 3.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.271 -1.011 . . . . 2.94 108.271 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -106.49 117.53 34.28 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.096 0.474 . . . . 2.86 111.693 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.6 mt -106.78 129.91 54.57 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.81 -1.182 . . . . 3.98 107.81 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.74 101.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.18 -1.415 . . . . 3.36 107.18 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.91 78.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.578 -1.638 . . . . 2.86 106.578 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -77.68 116.06 17.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 6.32 107.458 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.39 -11.71 3.25 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.504 1.049 . . . . 1.45 112.631 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.0 mtp -63.76 149.55 46.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.053 0.926 . . . . 2.46 109.922 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.4 17.72 0.34 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.795 0.665 . . . . 2.43 112.795 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -171.39 152.09 3.22 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.787 1.176 . . . . 2.91 110.786 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.14 -35.97 3.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.295 1.838 . . . . 1.77 112.739 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -59.18 -69.64 0.19 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.8 111.798 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.2 m -40.35 -45.73 2.21 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.908 1.283 . . . . 1.77 110.414 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 t -53.32 -73.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 123.842 0.714 . . . . 1.82 111.108 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -21.51 64.33 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.706 -0.621 . . . . 1.43 112.13 -166.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -55.8 -47.31 77.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.364 1.066 . . . . 4.68 109.362 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.56 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.453 -0.943 . . . . 1.79 108.453 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -49.94 -60.6 2.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.539 0.736 . . . . 3.19 110.428 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 t -52.39 -44.49 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.726 0.81 . . . . 1.62 110.989 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -61.51 -62.79 1.57 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.107 0.412 . . . . 1.61 110.494 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.38 -33.35 75.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.241 -0.912 . . . . 2.72 111.434 -166.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.1 p -60.02 -11.99 7.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.449 -0.782 . . . . 3.31 112.649 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -62.65 -39.51 94.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.008 0.822 . . . . 5.4 110.908 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -70.71 125.85 27.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.047 -1.094 . . . . 2.37 108.047 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -75.76 48.86 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.899 0.879 . . . . 8.06 110.334 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.86 -39.67 0.15 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 126.516 2.008 . . . . 1.31 110.566 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mp -79.26 119.75 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.43 -1.693 . . . . 3.72 106.43 176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.96 -26.11 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.456 0.702 . . . . 3.1 110.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -155.3 155.11 33.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.959 -0.756 . . . . 3.62 108.959 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -149.75 131.6 15.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.409 -1.33 . . . . 1.97 107.409 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -142.28 118.87 11.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.055 -1.091 . . . . 2.69 108.055 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p -99.76 97.87 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.265 1.031 . . . . 2.87 110.938 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 97.82 11.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.687 -0.856 . . . . 1.78 108.687 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -49.99 -34.12 20.03 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.88 0.872 . . . . 3.98 111.684 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.96 60.64 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.742 0.817 . . . . 2.24 111.66 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -119.37 11.67 12.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.086 1.354 . . . . 2.32 109.763 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 m120 37.71 38.73 0.17 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.722 2.009 . . . . 2.21 111.95 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.58 133.52 54.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 121.681 -0.637 . . . . 1.82 109.594 -168.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 101.46 13.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.335 -1.728 . . . . 1.67 106.335 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -76.67 92.62 3.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.684 -2.339 . . . . 1.35 104.684 166.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.74 150.54 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.822 -1.548 . . . . 2.37 106.822 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -126.17 142.48 51.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.794 -1.558 . . . . 3.87 106.794 155.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.42 175.57 13.81 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.196 0.999 . . . . 3.13 108.996 -170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.98 125.78 26.55 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 108.671 -0.863 . . . . 3.53 108.671 171.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.26 61.06 6.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.364 3.376 . . . . 2.21 111.509 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -168.07 -43.22 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.894 1.678 . . . . 3.57 110.119 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.3 pt -73.26 -30.18 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.748 -0.834 . . . . 3.49 108.748 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -153.49 149.14 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.515 -0.92 . . . . 2.37 108.515 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 167.25 31.74 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 110.62 -0.992 . . . . 1.92 110.62 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.58 -46.22 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.499 2.133 . . . . 0.81 110.756 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -45.72 -40.8 9.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.872 1.269 . . . . 9.19 111.105 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -57.5 12.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.447 1.899 . . . . 3.39 107.969 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mt -63.3 -48.82 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.579 -0.737 . . . . 2.1 109.575 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.8 -60.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.931 0.893 . . . . 2.65 109.139 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -57.83 -42.44 84.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.701 1.2 . . . . 6.41 109.738 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 m -61.3 -47.13 87.37 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.468 -0.493 . . . . 1.76 110.564 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.16 -45.05 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 1.76 111.065 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -57.27 -52.95 63.25 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.103 0.561 . . . . 3.04 109.728 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -54.75 -42.22 71.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.818 1.247 . . . . 1.29 111.146 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.82 -55.49 19.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.0 0.818 . . . . 2.56 111.106 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.28 -42.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.65 1.02 . . . . 1.45 115.65 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.68 140.98 52.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 117.754 0.777 . . . . 3.34 112.194 -137.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.82 79.76 4.29 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.247 0.546 . . . . 3.34 110.316 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.91 141.16 44.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.571 -0.706 . . . . 2.08 110.284 -165.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -156.41 128.38 7.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.173 -0.955 . . . . 2.79 111.209 -167.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.9 116.96 2.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.174 1.39 . . . . 3.37 110.931 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.21 98.08 5.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 124.565 1.146 . . . . 2.71 109.051 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.06 54.5 0.67 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 6.03 111.014 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.14 52.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.124 0.97 . . . . 8.07 111.804 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 116.265 -1.826 . . . . 8.58 107.362 175.033 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.009 -1.848 . . . . 8.86 106.009 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.98 16.1 63.62 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.387 -0.674 . . . . 4.62 112.979 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -12.35 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.77 2.828 . . . . 4.63 116.967 -170.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 38.65 71.12 0.25 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.419 1.485 . . . . 2.35 111.372 -165.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.74 92.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.321 1.058 . . . . 3.06 108.508 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.8 tp -95.31 101.19 12.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.032 1.733 . . . . 3.01 106.961 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -95.42 120.41 35.61 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.514 -1.291 . . . . 2.81 107.514 156.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 148.51 25.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.73 1.269 . . . . 3.71 108.255 158.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.89 143.54 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.534 -2.025 . . . . 2.93 105.534 160.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.21 127.56 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.556 1.542 . . . . 3.77 108.308 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -118.24 155.41 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.391 0.677 . . . . 7.35 110.021 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.89 -31.88 6.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.278 1.418 . . . . 1.54 110.582 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mtp -51.12 130.52 26.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.556 0.742 . . . . 2.07 110.273 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -154.03 17.38 0.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.246 -0.407 . . . . 2.38 112.087 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -169.36 151.17 4.45 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.143 0.883 . . . . 2.43 109.378 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.46 -37.73 12.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.798 1.639 . . . . 1.7 112.013 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.6 p -57.92 -71.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.99 0.916 . . . . 0.85 111.67 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.8 m -40.32 -44.07 1.86 Allowed 'General case' 0 C--N 1.338 0.109 0 C-N-CA 125.096 1.358 . . . . 2.1 111.012 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.84 -73.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 123.703 0.627 . . . . 1.94 111.041 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -20.31 66.08 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.567 -0.708 . . . . 1.56 112.206 -168.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.33 -42.53 82.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.865 0.866 . . . . 3.88 109.729 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.5 mt -62.17 -57.26 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.501 -0.926 . . . . 1.64 108.501 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.32 -57.95 8.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.968 0.907 . . . . 3.4 109.866 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -52.29 -54.36 32.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.033 0.933 . . . . 1.58 110.442 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -59.03 -40.08 83.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.888 -0.577 . . . . 1.58 112.092 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -73.67 -36.82 65.37 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.331 0.969 . . . . 2.73 112.512 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 m -70.81 70.39 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.034 0.921 . . . . 2.51 110.357 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HZ3' ' CD2' ' A' ' 29' ' ' HIS . 1.5 pptp? -174.0 -23.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.687 2.795 . . . . 6.72 112.394 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.414 ' CD2' ' HZ3' ' A' ' 28' ' ' LYS . 11.3 m-70 -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.249 1.386 . . . . 2.53 111.189 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 67.84 -3.85 1.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.603 2.361 . . . . 6.74 113.67 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.83 -28.87 40.6 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.412 -1.075 . . . . 0.91 110.412 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.88 129.48 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.259 0.624 . . . . 3.77 109.397 171.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.19 -42.74 12.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.291 1.036 . . . . 2.41 109.294 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.337 -0.246 . . . . 3.08 110.337 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -137.67 130.77 30.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.666 1.586 . . . . 1.99 107.006 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -134.4 103.61 5.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.976 -1.49 . . . . 2.26 106.976 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.334 2.8 p -89.73 88.25 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 123.461 1.601 . . . . 2.85 110.231 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.1 84.81 4.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.305 -1.316 . . . . 2.26 107.839 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.53 -36.56 4.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.725 1.61 . . . . 4.24 111.147 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.85 -33.45 23.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.394 0.678 . . . . 2.08 111.936 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -113.83 4.51 15.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.043 1.737 . . . . 3.69 110.967 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 44.23 52.63 7.04 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.23 1.012 . . . . 2.12 110.3 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -139.81 142.66 36.66 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 122.721 0.408 . . . . 2.52 110.696 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.34 101.19 10.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.698 -1.223 . . . . 1.69 107.698 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -78.27 104.89 9.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.115 -2.18 . . . . 0.99 105.115 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.67 121.72 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.743 -1.577 . . . . 1.95 106.743 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -102.22 123.8 46.69 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.443 -1.688 . . . . 3.39 106.443 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.33 152.62 32.33 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.364 0.666 . . . . 3.87 109.478 -171.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -95.67 108.4 39.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 107.647 -1.242 . . . . 3.84 107.647 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.97 -46.72 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.213 1.942 . . . . 2.5 112.587 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.2 -32.13 15.62 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.989 1.107 . . . . 3.88 113.989 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 pt -96.05 7.47 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 118.521 0.6 . . . . 3.45 112.467 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.72 -55.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.098 0.863 . . . . 3.23 111.69 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.46 143.3 5.25 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.827 1.68 . . . . 1.94 110.266 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -57.94 -39.58 85.16 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.819 2.346 . . . . 0.93 110.603 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -29.23 -50.88 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.006 2.122 . . . . 11.82 113.218 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -71.62 -49.71 37.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.5 1.12 . . . . 4.17 109.767 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.0 mt -58.71 -54.07 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.703 -0.68 . . . . 1.95 109.362 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -53.88 -54.68 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.461 -0.57 . . . . 3.23 109.461 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -53.33 -45.12 68.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.882 0.473 . . . . 6.63 110.351 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -59.8 -52.55 64.98 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.104 0.411 . . . . 1.72 110.415 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.6 mt -51.78 -58.66 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 2.06 109.361 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -52.07 -57.67 8.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.627 0.727 . . . . 3.43 109.805 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -58.66 -26.11 63.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.322 1.449 . . . . 1.28 113.371 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.27 -76.9 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.592 1.542 . . . . 2.93 110.968 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.6 31.91 0.43 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.775 -1.014 . . . . 1.42 112.989 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -132.68 173.48 11.3 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.368 1.084 . . . . 3.29 112.571 -165.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.58 155.8 34.27 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 105.65 -1.981 . . . . 3.81 105.65 157.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.75 166.36 33.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.01 0.823 . . . . 2.2 112.371 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.88 132.04 10.05 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.561 1.144 . . . . 2.9 110.571 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.11 125.98 21.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.721 1.209 . . . . 3.8 110.309 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.98 -47.18 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.825 1.25 . . . . 2.1 111.949 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.5 mttm 55.87 92.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.286 1.034 . . . . 6.89 112.289 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.1 mm 75.72 52.97 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.393 1.477 . . . . 6.75 109.711 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--O 1.252 1.23 0 N-CA-C 101.757 -3.423 . . . . 12.22 101.757 151.17 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 105.504 -2.035 . . . . 10.84 105.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 -149.18 35.08 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.086 -1.606 . . . . 5.28 109.086 -167.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -141.67 92.59 2.47 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 5.74 107.86 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.18 165.66 12.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.385 0.993 . . . . 1.66 113.003 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.16 145.31 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.328 -1.101 . . . . 3.11 109.059 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -147.85 119.94 8.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.35 -2.093 . . . . 2.95 105.35 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.98 113.05 22.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.61 -1.626 . . . . 2.49 106.61 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -110.91 131.85 54.7 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.415 -1.328 . . . . 4.38 107.415 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -75.88 126.32 36.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 105.032 -2.211 . . . . 2.81 105.032 154.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -119.34 108.73 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.334 -1.728 . . . . 3.24 106.334 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -79.84 98.77 7.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.767 . . . . 5.72 108.93 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 -105.23 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.23 -2.348 . . . . 3.54 107.23 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.5 mtp 57.49 35.25 25.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.629 0.772 . . . . 3.29 112.1 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -74.58 121.22 21.24 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.731 -0.606 . . . . 3.08 110.043 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t 68.46 152.53 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.77 1.628 . . . . 3.2 113.239 169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.25 72.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.158 1.783 . . . . 3.39 110.566 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 p -178.8 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.672 1.189 . . . . 1.92 109.466 -160.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.7 m -73.15 -51.1 19.15 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.922 -0.77 . . . . 1.88 108.922 159.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -42.7 -73.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.476 1.911 . . . . 2.06 111.58 -175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -25.73 68.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.089 -0.382 . . . . 1.72 111.903 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -67.41 -49.43 63.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.154 0.981 . . . . 5.38 108.925 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -53.34 -62.3 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 108.207 -1.035 . . . . 1.82 108.207 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -53.42 -57.1 11.82 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.366 0.267 . . . . 3.08 110.713 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -49.71 -50.88 42.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.854 -0.594 . . . . 1.6 110.331 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 t -55.53 -50.59 69.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.347 0.521 . . . . 1.59 110.801 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 mt -67.83 -38.22 82.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.59 -1.644 . . . . 2.9 110.557 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.8 m -59.95 -10.23 3.88 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.667 -0.646 . . . . 2.97 112.591 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -62.77 -40.83 98.52 Favored 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.718 -1.238 . . . . 5.85 109.83 168.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -72.38 135.35 45.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.777 -1.194 . . . . 2.66 107.777 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.48 -0.74 55.82 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.868 -0.52 . . . . 7.03 110.961 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.62 -15.07 64.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.402 0.525 . . . . 0.89 113.306 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.7 tt -88.82 124.46 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.028 -1.101 . . . . 4.03 108.028 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.7 mt -82.23 -40.26 21.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.047 0.939 . . . . 2.48 109.5 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -155.21 148.62 25.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 110.127 -0.323 . . . . 3.17 110.127 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.4 t -132.9 138.98 47.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.963 1.305 . . . . 1.99 107.703 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 m -143.92 102.38 3.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.004 -1.11 . . . . 2.37 108.004 164.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.327 1.2 p -88.76 80.88 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 123.708 1.718 . . . . 2.58 108.809 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 90.4 4.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.93 1.692 . . . . 1.96 110.158 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pp -54.53 -29.9 52.1 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.571 1.148 . . . . 4.18 112.427 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.9 26.04 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.156 0.582 . . . . 1.8 111.43 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 p -114.63 9.25 16.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.354 1.462 . . . . 3.41 111.658 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.97 45.0 3.18 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.254 1.422 . . . . 2.15 111.247 -171.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -133.26 136.49 45.57 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 122.73 0.412 . . . . 2.02 111.734 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.63 109.19 20.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.565 1.146 . . . . 1.78 108.247 164.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -78.58 114.18 17.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.846 -2.279 . . . . 0.89 104.846 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.12 107.19 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.337 -1.357 . . . . 2.23 107.337 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -87.31 105.3 17.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.672 -1.603 . . . . 4.25 106.672 163.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.26 175.22 6.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.529 1.932 . . . . 3.08 106.293 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.35 130.77 23.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.239 -0.652 . . . . 3.71 109.239 166.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -57.52 -35.12 98.89 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.681 2.254 . . . . 1.83 110.938 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.2 -6.56 24.12 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.5 0.926 . . . . 4.4 113.5 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 pt -120.97 -31.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.421 0 CA-C-N 119.703 1.138 . . . . 4.04 113.047 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 tt -152.04 144.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 119.783 1.174 . . . . 2.44 108.781 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.67 159.78 51.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.788 -1.325 . . . . 1.87 109.788 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.8 -48.29 1.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.958 1.772 . . . . 0.83 109.274 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.443 HH22 ' CD ' ' A' ' 63' ' ' GLU . 41.7 tpt85 -55.7 -34.8 65.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.821 0.849 . . . . 9.0 111.744 -174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -61.04 2.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.696 2.399 . . . . 3.45 108.807 174.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.05 -43.68 81.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.493 0.717 . . . . 2.03 110.139 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.28 -43.23 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.749 -0.643 . . . . 3.26 110.749 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -54.51 -45.26 73.26 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.248 0.931 . . . . 3.54 110.409 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.5 m -55.31 -53.39 56.68 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.531 0.605 . . . . 1.9 110.559 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.17 -53.93 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.461 0.704 . . . . 3.19 111.335 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.443 ' CD ' HH22 ' A' ' 56' ' ' ARG . 39.8 mt-10 -54.11 -57.48 10.93 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.458 1.103 . . . . 3.19 109.807 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.5 t -52.66 -49.75 64.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.545 1.538 . . . . 1.89 111.071 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.18 -54.56 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.099 0.409 . . . . 4.17 110.96 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.87 -42.44 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.782 -1.199 . . . . 1.59 115.42 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.68 141.47 47.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.031 -0.668 . . . . 3.32 111.517 -133.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -78.24 123.43 26.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.225 -1.398 . . . . 3.44 107.225 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.18 159.0 15.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 2.41 110.757 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 m -151.35 114.51 4.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.272 1.029 . . . . 2.27 108.348 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.73 127.13 29.85 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.654 -0.869 . . . . 4.12 108.654 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.74 131.82 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.398 0.679 . . . . 1.99 110.949 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -72.47 81.99 1.07 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.859 0.464 . . . . 6.36 109.759 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -27.94 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.849 -0.614 . . . . 5.69 110.323 163.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.972 2.109 . . . . 8.27 111.704 177.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 106.078 -1.823 . . . . 16.11 106.078 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.11 -66.66 1.83 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.923 -2.071 . . . . 6.2 107.923 -156.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 7.9 p-10 -70.71 171.37 10.57 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.809 -0.441 . . . . 5.25 109.809 162.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.0 111.93 4.25 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.642 -1.383 . . . . 1.95 109.642 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.62 145.41 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 118.524 1.162 . . . . 3.44 108.864 169.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.43 91.09 2.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.903 -1.517 . . . . 3.64 106.903 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.32 105.65 17.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.109 -0.7 . . . . 2.95 109.109 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.29 147.88 33.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.806 0.692 . . . . 2.96 109.48 173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.45 133.44 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.832 -1.914 . . . . 2.93 105.832 161.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.35 137.1 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 125.123 1.369 . . . . 3.57 107.808 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -140.04 153.28 46.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.776 0.831 . . . . 8.77 109.862 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.8 -43.85 1.67 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.829 -1.308 . . . . 1.69 109.829 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -48.43 114.35 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.318 1.447 . . . . 2.84 114.103 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 p -97.48 115.93 28.73 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.133 1.373 . . . . 4.37 110.397 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.7 m 69.73 176.88 0.27 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.157 0.979 . . . . 3.29 113.31 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.18 -37.96 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.543 2.337 . . . . 1.93 112.523 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 p -64.51 -56.96 10.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.802 0.667 . . . . 1.11 112.802 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 119.966 -1.709 . . . . 1.73 108.542 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.93 -66.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.623 0.769 . . . . 1.83 110.776 172.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.258 0.1 OUTLIER -68.89 -26.04 64.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 121.795 -0.565 . . . . 1.42 111.285 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -59.77 -53.76 54.24 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 4.48 109.116 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.29 -60.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.727 -0.842 . . . . 1.79 108.727 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -55.18 -52.95 61.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.012 0.195 . . . . 3.16 110.743 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 t -57.73 -43.05 85.04 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.438 0.695 . . . . 1.55 111.603 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -62.22 -48.26 80.78 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.278 0.561 . . . . 1.54 109.919 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 mp -70.06 -37.84 75.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.779 -0.629 . . . . 3.39 111.047 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.9 m -71.09 61.73 0.29 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 120.643 1.565 . . . . 2.44 111.334 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -148.98 -69.98 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.556 1.942 . . . . 4.85 109.252 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.51 111.98 2.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 3.32 111.653 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -77.99 47.08 0.62 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.817 1.784 . . . . 6.6 115.817 -152.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.84 2.87 5.26 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.992 0.815 . . . . 1.14 113.058 164.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.0 115.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.101 1.761 . . . . 3.74 107.049 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.9 mt -85.7 -43.69 13.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.827 0.851 . . . . 2.55 110.555 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -145.32 146.91 31.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.839 -0.43 . . . . 3.66 109.839 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.8 p -134.68 134.81 41.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.435 1.494 . . . . 3.32 107.397 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -151.06 104.66 3.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.966 -1.494 . . . . 2.37 106.966 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.33 3.4 p -92.89 88.7 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.445 1.593 . . . . 2.85 110.562 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.28 80.41 4.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.514 -1.221 . . . . 2.4 108.459 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.1 tt -42.38 -38.93 2.01 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.68 1.992 . . . . 2.78 111.226 166.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.17 -35.01 47.62 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.666 0.786 . . . . 2.22 112.065 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 p -108.64 8.52 27.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.466 1.506 . . . . 3.5 111.015 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.6 45.44 5.73 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.595 1.558 . . . . 2.17 110.392 -171.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -133.24 137.92 46.29 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.045 0.538 . . . . 2.02 110.239 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.34 107.85 20.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.469 -1.308 . . . . 1.73 107.469 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -84.03 97.4 9.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.966 -2.235 . . . . 0.92 104.966 162.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.84 154.38 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.512 -1.662 . . . . 3.11 106.512 162.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 5.2 mtmp? -128.55 145.01 51.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.57 -1.27 . . . . 3.88 107.57 159.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -160.18 172.43 17.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.492 0.717 . . . . 3.12 111.448 -165.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -105.93 100.17 26.57 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.155 1.382 . . . . 3.91 109.935 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -72.76 67.56 3.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.989 3.126 . . . . 2.35 112.298 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -166.34 -47.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.813 1.245 . . . . 3.75 110.343 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.17 -17.28 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 123.74 0.816 . . . . 3.42 110.462 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 tt -148.56 154.72 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.472 -2.048 . . . . 2.35 105.472 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.8 167.8 25.84 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.51 -1.436 . . . . 2.02 109.51 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.09 -39.83 76.1 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.664 1.576 . . . . 0.87 109.064 165.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -44.65 -52.36 8.28 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.261 1.424 . . . . 8.52 112.178 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -52.36 64.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.543 1.065 . . . . 2.82 110.321 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.83 -56.14 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.068 -0.715 . . . . 2.32 109.068 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.87 -56.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 122.805 0.442 . . . . 2.71 109.851 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -52.73 -49.53 65.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.165 1.386 . . . . 6.52 110.078 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.1 m -58.69 -45.77 88.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.112 -0.329 . . . . 1.63 110.112 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.6 -65.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.777 -0.453 . . . . 2.14 109.777 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.28 -46.87 72.82 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.419 -0.513 . . . . 2.92 110.393 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -60.61 -20.3 60.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.134 -1.412 . . . . 1.23 113.688 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.64 -73.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.162 1.801 . . . . 2.64 109.655 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.56 29.21 0.39 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.723 -1.043 . . . . 1.33 113.23 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.31 172.42 8.66 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 118.763 1.281 . . . . 3.29 113.362 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -103.88 146.39 28.72 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.203 -2.147 . . . . 4.25 105.203 158.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.6 137.94 20.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.833 0.853 . . . . 2.04 111.162 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 m -157.07 111.73 2.75 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.084 -1.01 . . . . 2.59 112.593 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -39.22 128.48 1.75 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.407 1.483 . . . . 4.51 110.583 165.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m -127.72 142.76 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.589 1.156 . . . . 2.16 109.1 169.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -74.86 85.46 2.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.582 -1.266 . . . . 6.34 107.582 158.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.33 151.42 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.422 -1.325 . . . . 7.1 107.422 155.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 C--O 1.255 1.377 0 N-CA-C 105.25 -2.13 . . . . 8.87 105.25 173.052 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 106.752 -1.573 . . . . 9.49 106.752 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.31 -135.23 48.0 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 105.412 -3.075 . . . . 7.57 105.412 -130.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.56 -110.12 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.379 1.09 . . . . 9.54 108.812 161.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.15 -12.32 31.98 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.876 -0.89 . . . . 3.3 110.876 -162.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.41 141.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 126.702 2.001 . . . . 2.73 106.385 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.0 tp -153.87 113.86 3.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.407 1.483 . . . . 3.34 107.037 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.87 121.23 37.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 2.15 108.209 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 145.45 50.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.343 0.52 . . . . 3.89 111.875 170.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.89 136.73 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.062 -1.459 . . . . 3.02 107.062 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.72 95.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 127.019 2.128 . . . . 3.05 106.006 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -79.57 126.11 30.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.51 -0.876 . . . . 5.92 108.848 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.46 8.99 4.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.202 1.382 . . . . 1.58 113.555 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 36.0 mtp -78.6 117.21 19.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.437 1.118 . . . . 2.54 108.268 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -143.73 16.39 1.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.146 0.795 . . . . 2.32 113.146 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -169.26 141.32 2.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.23 0.923 . . . . 3.37 109.453 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.03 -39.67 0.91 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.485 1.914 . . . . 1.79 113.63 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -59.52 -75.56 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.816 0.846 . . . . 1.26 111.847 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -46.97 -36.78 8.12 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 125.636 1.575 . . . . 2.1 111.521 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.21 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.872 0.869 . . . . 2.18 109.123 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.256 0.3 OUTLIER -64.73 -15.96 62.25 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.656 -0.653 . . . . 2.12 112.742 -166.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -57.44 -40.43 78.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.42 1.088 . . . . 3.77 108.698 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.43 -63.78 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.292 -1.003 . . . . 1.8 108.292 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -58.35 6.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.495 0.318 . . . . 3.06 110.648 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 t -50.97 -47.32 61.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.127 0.971 . . . . 1.58 111.201 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -62.23 -57.44 11.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.823 -0.548 . . . . 1.46 109.654 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.43 -39.69 70.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.406 0.682 . . . . 3.39 111.497 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -48.46 -35.81 13.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.345 -0.847 . . . . 2.79 112.136 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 1.29 2.03 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.115 -0.991 . . . . 7.45 113.316 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.437 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 10.7 m170 -83.71 -19.85 34.5 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.134 -1.604 . . . . 2.4 110.738 171.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 65.92 -3.02 0.81 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.723 1.609 . . . . 7.64 115.236 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.79 15.79 51.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.28 0.945 . . . . 1.04 111.833 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -113.19 142.02 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.955 -1.498 . . . . 3.34 106.955 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.73 -40.57 9.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.581 0.752 . . . . 3.75 109.466 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -155.14 156.3 35.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.369 0.531 . . . . 3.47 110.691 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 m -137.29 116.58 12.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.54 -2.022 . . . . 3.32 105.54 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.62 99.6 7.65 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.253 -1.388 . . . . 2.45 107.253 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.285 0.6 OUTLIER -94.38 91.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 123.107 1.432 . . . . 2.64 110.484 -173.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.15 91.79 7.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.678 1.591 . . . . 2.06 111.23 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -44.55 -42.27 7.13 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.4 1.88 . . . . 2.69 112.521 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.28 -35.16 59.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.585 0.754 . . . . 2.34 111.463 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -107.5 3.67 25.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.397 1.479 . . . . 3.64 110.955 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.35 59.13 1.21 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.487 1.915 . . . . 2.86 109.832 -166.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 140.66 37.01 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.083 0.553 . . . . 2.03 111.013 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.47 113.83 26.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 1.73 108.384 165.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.59 99.33 8.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.621 -1.992 . . . . 1.17 105.621 158.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.75 141.8 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.377 -1.342 . . . . 2.21 107.377 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -125.19 116.34 21.86 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.231 -1.766 . . . . 4.54 106.231 165.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.09 165.0 37.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.591 1.157 . . . . 2.99 109.401 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.23 137.74 27.62 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.844 -1.169 . . . . 4.32 107.844 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.49 -40.44 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.165 1.91 . . . . 2.46 112.262 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.09 -31.69 23.23 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.336 0.516 . . . . 3.58 111.373 -164.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -56.4 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.402 -0.592 . . . . 4.96 109.402 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.73 -41.92 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.673 -0.24 . . . . 3.11 110.944 -163.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.73 115.44 0.09 OUTLIER Glycine 0 CA--C 1.534 1.253 0 N-CA-C 109.423 -1.471 . . . . 1.89 109.423 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.72 -33.19 79.26 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 CA-C-N 120.306 2.053 . . . . 1.06 112.44 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -47.55 -43.14 24.85 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.968 0.729 . . . . 7.97 112.968 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -58.67 -55.19 38.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.078 0.942 . . . . 4.1 109.903 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.1 mt -50.96 -52.92 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.822 -0.626 . . . . 2.37 110.671 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.39 -48.24 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-O 118.64 -0.695 . . . . 2.95 110.117 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -51.09 -48.69 61.61 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.619 -0.511 . . . . 3.73 109.619 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.437 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 99.2 m -61.37 -48.13 82.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 118.513 -1.275 . . . . 2.27 109.907 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.9 mt -54.35 -57.05 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 119.388 -0.339 . . . . 2.18 111.167 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.25 -46.1 88.43 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.503 0.592 . . . . 4.67 110.414 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -66.79 -15.97 63.95 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.718 -1.135 . . . . 1.32 112.517 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.81 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.461 1.482 . . . . 2.69 110.496 162.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.96 36.2 0.5 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.017 -0.88 . . . . 1.47 113.548 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -132.81 175.09 9.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.352 1.076 . . . . 3.15 111.265 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -129.74 121.98 27.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.001 -1.111 . . . . 3.36 108.001 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.13 163.46 13.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.454 0.701 . . . . 2.26 111.934 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -155.98 123.99 5.7 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.601 1.56 . . . . 2.11 108.53 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.87 138.27 58.4 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.815 0.734 . . . . 3.56 109.963 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.6 -34.01 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.182 0.593 . . . . 2.08 111.443 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttm 42.54 61.43 2.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.733 2.013 . . . . 7.47 113.332 172.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 pt -73.91 68.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.426 0.691 . . . . 6.39 110.291 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.409 1.884 . . . . 9.21 108.114 178.253 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 105.146 -2.168 . . . . 11.35 105.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 54.84 -150.08 19.08 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 117.28 -2.39 . . . . 6.8 107.851 -129.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 178.14 0.21 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.342 1.857 . . . . 5.41 112.345 -176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.22 77.18 0.72 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.392 -1.883 . . . . 1.94 108.392 162.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.72 138.4 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.294 -0.533 . . . . 3.06 110.008 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -142.43 88.43 2.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.256 1.822 . . . . 3.1 107.541 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -82.57 121.28 26.6 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.873 -1.528 . . . . 2.25 106.873 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -128.71 137.71 51.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.179 -0.325 . . . . 2.9 110.238 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.45 145.81 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.711 -1.218 . . . . 2.97 107.711 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.26 155.19 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.472 -1.677 . . . . 2.82 106.472 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -126.31 132.68 51.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.393 -1.336 . . . . 5.54 107.393 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.25 23.81 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.288 1.423 . . . . 1.83 112.201 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mtp -72.37 78.0 1.02 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.259 1.029 . . . . 2.33 109.189 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 t -97.26 -3.48 40.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.791 0.836 . . . . 2.28 112.813 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -163.41 144.65 9.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.591 1.087 . . . . 2.63 110.795 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.05 -37.43 0.16 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 127.88 2.472 . . . . 1.66 113.37 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -52.46 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.198 0.999 . . . . 0.87 112.339 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.8 m -43.04 -49.51 6.11 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 126.504 1.921 . . . . 2.0 110.191 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.4 t -45.82 -69.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 125.432 1.493 . . . . 2.01 110.554 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.281 0.3 OUTLIER -70.21 -17.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.428 -0.509 . . . . 2.12 111.638 -175.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -70.24 -42.32 72.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.301 -1.0 . . . . 5.55 108.301 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -51.2 -61.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.92 -0.77 . . . . 1.73 108.92 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -58.8 -54.32 48.45 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.809 -0.557 . . . . 2.72 112.103 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.4 t -54.4 -30.99 53.98 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.831 0.852 . . . . 1.76 111.483 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 t -71.03 -69.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.497 -0.752 . . . . 1.48 110.275 167.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -50.85 -47.31 60.36 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.26 1.424 . . . . 3.66 113.462 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.7 p -46.08 -34.19 3.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.682 0.793 . . . . 3.32 111.83 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -64.09 -21.79 66.67 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.706 1.203 . . . . 6.96 111.788 -175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -64.21 -29.75 70.84 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.472 0.578 . . . . 2.22 110.384 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 67.68 -1.95 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.137 1.775 . . . . 5.78 114.771 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.01 32.64 5.74 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.885 1.22 . . . . 0.94 110.785 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mt -138.37 126.65 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.099 -1.815 . . . . 3.2 106.099 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.52 -37.66 13.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 123.64 0.588 . . . . 2.77 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -144.76 148.56 34.25 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.161 -1.051 . . . . 4.3 108.161 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -157.07 68.17 0.55 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.132 -1.062 . . . . 2.02 108.132 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 m -84.9 108.69 17.67 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.053 -0.351 . . . . 2.69 110.053 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.21 112.87 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.983 -0.747 . . . . 3.64 108.983 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.41 98.5 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.657 0.783 . . . . 2.05 110.429 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -38.75 -47.48 1.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.126 1.77 . . . . 2.73 112.148 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.12 66.55 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.493 1.117 . . . . 2.18 111.79 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -117.09 10.63 13.96 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.723 1.209 . . . . 2.71 109.943 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.32 59.59 0.27 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.438 2.295 . . . . 2.8 112.305 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.12 152.78 37.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.559 0.744 . . . . 1.91 109.76 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.52 118.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.994 1.318 . . . . 1.84 108.101 164.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -81.1 96.52 7.2 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 105.251 -2.129 . . . . 0.91 105.251 163.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.83 141.21 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.837 -1.542 . . . . 1.91 106.837 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -122.87 121.83 37.15 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.53 -2.396 . . . . 3.42 104.53 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -137.78 169.27 18.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.776 0.716 . . . . 3.47 112.293 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -108.01 99.88 33.21 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.651 0.78 . . . . 4.66 109.237 -171.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.67 48.16 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.114 2.542 . . . . 2.45 112.835 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -137.12 17.96 2.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.048 1.339 . . . . 5.04 110.323 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.11 -56.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 124.422 1.089 . . . . 5.63 108.576 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.67 142.65 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.154 -1.425 . . . . 2.78 107.154 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.0 151.24 20.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.657 -1.377 . . . . 2.2 109.657 160.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.79 -38.58 29.79 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.957 1.771 . . . . 0.87 110.605 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -50.02 -44.52 51.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.433 0.693 . . . . 8.44 111.303 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -53.47 37.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.5 1.12 . . . . 3.34 108.881 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.67 -54.49 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.993 -0.549 . . . . 1.97 109.784 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.91 -52.69 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.449 -0.575 . . . . 2.38 109.449 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -56.21 -47.2 78.86 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.76 0.824 . . . . 6.32 110.263 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.3 m -58.37 -46.08 87.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.235 0.471 . . . . 1.94 110.437 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 54.6 mt -54.3 -64.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.131 -0.692 . . . . 1.9 109.131 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -55.0 -47.82 74.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.948 0.404 . . . . 4.25 110.197 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -58.47 -20.3 44.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.116 -1.421 . . . . 1.33 113.825 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.25 -76.4 0.09 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-N 121.189 1.813 . . . . 2.75 109.439 167.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.72 35.56 0.46 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.522 -1.154 . . . . 1.39 113.281 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -129.81 175.15 9.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 1.365 . . . . 3.16 112.749 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.33 145.62 44.97 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 104.483 -2.414 . . . . 3.29 104.483 161.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.49 162.62 35.03 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.786 1.176 . . . . 1.96 112.503 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 t -155.84 112.86 3.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.623 0.769 . . . . 2.34 108.949 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.82 126.22 26.91 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.411 0.551 . . . . 3.66 109.962 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.94 118.65 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.052 -0.721 . . . . 2.18 109.052 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -76.06 70.75 2.77 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.558 0.743 . . . . 6.52 109.179 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.35 -44.03 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.969 0.908 . . . . 5.51 113.167 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.196 0 C-N-CA 123.583 0.753 . . . . 7.99 110.286 -162.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.087 -0.338 . . . . 14.77 110.087 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.92 160.49 52.8 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.113 -1.195 . . . . 6.99 110.113 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.57 177.27 4.79 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.162 -1.051 . . . . 4.78 108.162 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.03 78.71 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 106.318 -2.713 . . . . 2.44 106.318 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.93 80.44 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.632 -1.247 . . . . 3.15 107.632 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.1 78.58 4.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.772 -1.566 . . . . 3.24 106.772 172.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.28 121.73 24.8 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.385 -2.08 . . . . 2.42 105.385 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -131.57 145.46 51.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.248 -0.649 . . . . 3.01 109.248 174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.23 136.88 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.154 -1.795 . . . . 3.19 106.154 165.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.17 157.09 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 107.148 -1.427 . . . . 3.5 107.148 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -146.37 149.42 33.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.409 -0.589 . . . . 6.98 109.409 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.85 -13.89 31.96 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.144 1.354 . . . . 1.65 111.547 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.8 mtm -66.9 113.79 5.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.496 1.148 . . . . 2.02 110.064 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -82.1 -50.96 8.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.531 1.133 . . . . 4.44 110.471 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -169.67 172.28 6.95 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.395 1.078 . . . . 3.27 110.076 -160.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.85 -47.67 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.089 2.956 . . . . 1.59 114.906 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p -67.89 -47.61 68.38 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.861 -0.525 . . . . 1.23 112.108 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.8 m -70.65 -35.35 72.84 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.347 -0.983 . . . . 2.42 108.347 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.34 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 124.633 1.173 . . . . 2.23 109.729 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.275 0.3 OUTLIER -71.02 -16.64 62.63 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.671 0.989 . . . . 1.52 113.671 -165.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -45.34 -47.54 13.31 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 108.858 -0.793 . . . . 4.83 108.858 165.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.38 -65.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.085 -0.709 . . . . 1.78 109.085 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -55.18 -48.14 74.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 123.133 0.27 . . . . 4.38 111.056 -166.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.7 t -54.32 -60.27 3.57 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.486 -0.931 . . . . 1.48 108.486 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 t -51.91 -42.59 62.89 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.904 0.481 . . . . 1.45 111.698 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 mt -71.9 -53.82 11.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.635 -0.826 . . . . 2.53 111.94 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.0 m -49.23 -33.36 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.729 -1.232 . . . . 2.62 111.902 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -51.93 -32.79 34.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.222 1.193 . . . . 6.74 114.222 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -55.0 -29.75 57.93 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.756 0.707 . . . . 2.37 111.013 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 73.01 -1.04 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.054 1.742 . . . . 6.05 112.001 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.02 -42.43 5.97 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 110.604 -0.998 . . . . 1.95 110.604 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.52 125.9 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.102 -1.444 . . . . 4.01 107.102 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.88 -38.71 32.07 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.771 0.828 . . . . 3.94 109.96 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.74 154.88 37.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.376 -0.601 . . . . 3.31 109.376 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 t -155.19 63.64 0.63 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.241 0.543 . . . . 2.08 112.144 -164.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 99.75 7.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.96 0.504 . . . . 2.29 109.845 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.295 0.8 OUTLIER -89.04 93.68 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 122.477 1.132 . . . . 2.56 110.269 172.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.8 96.55 9.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.365 1.466 . . . . 1.84 109.9 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.0 tp -51.08 -39.25 55.64 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.164 1.786 . . . . 3.41 112.555 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.82 73.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.257 0.551 . . . . 1.91 110.674 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -81.05 -22.81 39.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.482 1.113 . . . . 3.16 111.231 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.53 55.8 4.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.773 1.629 . . . . 2.97 107.991 -168.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.57 144.33 46.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.896 -1.047 . . . . 1.9 108.611 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.63 113.74 27.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.588 1.155 . . . . 1.61 108.778 171.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -87.98 91.41 8.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.947 -1.872 . . . . 0.96 105.947 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.51 125.69 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.731 -1.211 . . . . 2.76 107.731 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -96.76 110.45 22.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.85 -1.537 . . . . 4.57 106.85 162.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -125.64 158.36 34.93 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.919 0.888 . . . . 3.23 108.812 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -97.97 113.21 63.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.841 1.256 . . . . 4.11 108.43 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.44 70.0 4.94 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.999 3.133 . . . . 2.89 110.915 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -163.13 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.333 1.453 . . . . 3.78 109.56 -173.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.94 -33.88 5.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 122.749 0.419 . . . . 3.96 111.332 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 tt -132.66 149.14 31.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.556 -0.905 . . . . 2.46 108.556 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.69 160.02 23.27 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.427 -1.069 . . . . 1.81 110.427 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -41.39 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.43 2.087 . . . . 1.01 110.483 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -57.18 -35.44 69.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 119.299 -0.382 . . . . 9.12 111.236 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -56.58 20.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.0 2.52 . . . . 3.87 109.143 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.98 -50.38 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.931 -0.766 . . . . 1.68 108.931 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.05 -47.24 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 118.772 -0.632 . . . . 2.45 110.538 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -52.77 -48.58 66.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.366 1.067 . . . . 3.96 109.191 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.4 m -60.25 -49.95 75.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.158 -0.682 . . . . 1.89 109.158 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.91 -62.44 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.527 0.731 . . . . 1.81 110.865 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.08 -49.22 72.23 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.315 -0.624 . . . . 2.89 109.315 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.1 t -51.14 -44.7 61.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.045 0.938 . . . . 1.28 112.546 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.78 -52.41 65.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.904 1.229 . . . . 2.62 113.302 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.61 10.53 0.12 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.281 -1.288 . . . . 1.46 116.056 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -139.04 176.14 8.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.346 1.573 . . . . 3.18 112.89 -148.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 151.87 37.57 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.534 -2.025 . . . . 3.18 105.534 154.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 157.04 43.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.967 0.507 . . . . 1.9 111.545 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -147.54 115.55 6.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.587 1.555 . . . . 2.92 108.69 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.31 134.39 50.26 Favored 'General case' 0 N--CA 1.458 -0.034 0 C-N-CA 122.637 0.375 . . . . 3.66 111.801 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.82 -42.56 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.847 0.859 . . . . 2.39 110.08 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.69 64.09 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.215 -1.402 . . . . 5.18 107.215 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 mp 64.48 -74.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.549 1.54 . . . . 5.72 108.087 -164.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 131.685 3.994 . . . . 10.42 105.503 169.176 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 105.803 -1.925 . . . . 9.75 105.803 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.51 115.88 0.96 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.334 -1.506 . . . . 6.52 109.334 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.42 92.11 0.13 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.427 1.091 . . . . 8.71 110.451 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.95 58.6 3.53 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.392 -1.083 . . . . 2.69 110.392 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.25 143.46 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.689 1.196 . . . . 3.26 109.179 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 tt -147.76 115.42 6.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.62 1.568 . . . . 4.08 107.204 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.74 124.41 49.52 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.144 -0.688 . . . . 2.32 109.144 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.8 mt -102.82 142.41 34.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.355 -1.72 . . . . 3.43 106.355 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -75.71 138.99 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.387 -2.079 . . . . 3.33 105.387 148.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 131.39 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.597 1.559 . . . . 3.17 108.015 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -126.3 144.56 50.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.776 1.231 . . . . 5.93 108.263 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.09 -31.77 6.32 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.849 1.214 . . . . 1.67 110.186 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtm -58.75 141.96 51.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.518 -0.549 . . . . 2.62 109.518 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -152.62 10.99 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.8 0.667 . . . . 2.36 112.8 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -171.18 152.1 3.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 2.6 109.17 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.31 -43.11 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.301 1.84 . . . . 1.56 112.276 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 p -44.3 -66.9 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.479 1.512 . . . . 0.79 113.096 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.8 m -47.51 -48.38 27.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.628 1.171 . . . . 2.09 109.488 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.35 -67.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.158 -0.928 . . . . 2.11 111.101 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -27.13 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.233 -0.917 . . . . 1.73 111.632 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -53.39 -49.1 67.94 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.234 0.614 . . . . 4.02 109.838 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -54.47 -65.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.088 -0.708 . . . . 1.83 109.088 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.1 -61.6 1.81 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.404 1.082 . . . . 2.76 110.916 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -48.95 -45.99 42.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.057 1.343 . . . . 1.55 110.574 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 t -62.25 -65.91 0.62 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.817 -0.611 . . . . 1.81 110.701 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.54 -35.09 76.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.503 1.047 . . . . 3.12 111.806 -163.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.4 m -46.65 -31.6 2.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.842 -0.536 . . . . 3.41 112.119 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -34.14 23.26 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.353 0.871 . . . . 5.3 113.353 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -61.07 -41.4 96.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.038 0.381 . . . . 2.54 110.329 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.84 -2.23 2.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.657 2.383 . . . . 6.85 113.329 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.28 -31.96 36.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.598 -1.001 . . . . 1.16 110.598 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.11 106.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.204 -2.147 . . . . 3.87 105.204 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.7 mt -79.94 -33.3 39.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.995 0.518 . . . . 3.24 109.92 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -147.35 156.47 42.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.539 -0.541 . . . . 3.62 109.539 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.86 134.74 17.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.866 -1.531 . . . . 1.97 106.866 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -144.21 116.16 8.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.389 -1.338 . . . . 3.05 107.389 164.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.15 111.4 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.573 0.701 . . . . 2.75 110.376 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.44 104.35 12.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.982 0.913 . . . . 2.23 109.659 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -44.88 -37.09 3.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.609 1.163 . . . . 3.89 111.346 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.08 -30.75 16.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.796 0.838 . . . . 1.98 112.056 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -127.92 17.4 6.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.385 1.074 . . . . 2.62 109.77 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 31.51 47.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.778 2.031 . . . . 2.13 112.672 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.76 143.6 47.22 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.854 0.462 . . . . 2.2 111.346 -170.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.28 98.49 8.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.575 1.95 . . . . 1.6 107.786 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -79.15 104.06 9.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.376 -2.083 . . . . 1.11 105.376 167.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.28 136.63 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.307 -1.738 . . . . 2.15 106.307 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -107.46 114.47 28.5 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.719 -1.586 . . . . 3.97 106.719 160.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -129.2 175.69 8.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.13 -2.544 . . . . 3.09 104.13 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.39 132.28 24.17 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 107.746 -1.205 . . . . 3.69 107.746 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.98 59.87 5.28 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 125.058 3.839 . . . . 2.79 110.883 -173.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -155.64 -54.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 128.428 2.691 . . . . 3.38 107.264 -168.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -88.45 -25.4 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.349 1.059 . . . . 3.77 110.407 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.55 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.425 -0.954 . . . . 2.86 108.425 170.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.35 164.76 30.91 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 111.001 -0.839 . . . . 1.53 111.001 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.67 -45.19 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.916 2.41 . . . . 1.23 110.866 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.2 -42.63 69.95 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 122.995 0.518 . . . . 9.29 110.587 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -56.28 9.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.732 1.613 . . . . 3.98 109.37 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mt -59.19 -49.71 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.999 0.519 . . . . 2.32 109.602 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -53.78 -52.63 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.793 -0.447 . . . . 2.51 109.793 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -50.92 -51.29 53.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.973 0.509 . . . . 4.49 109.816 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -57.64 -53.37 58.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.226 -0.59 . . . . 1.9 110.262 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.0 mt -53.73 -59.92 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 124.196 0.999 . . . . 2.1 110.466 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.53 -50.46 73.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.224 -0.658 . . . . 4.56 109.224 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -48.69 -46.13 40.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 1.95 112.016 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.66 -56.54 19.15 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.255 0.934 . . . . 2.76 113.425 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 10.98 0.12 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.953 -1.471 . . . . 1.39 116.655 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.46 176.02 9.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.851 1.825 . . . . 3.22 112.655 -153.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -120.12 158.48 26.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.756 -1.572 . . . . 3.69 106.756 156.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.01 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.04 0.936 . . . . 2.06 112.482 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -157.56 111.45 2.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.072 1.349 . . . . 4.12 109.781 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 84.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.614 1.097 . . . . 3.47 108.809 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m -61.4 -20.62 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.439 1.096 . . . . 3.21 113.53 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.45 -118.41 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.857 -1.164 . . . . 6.61 107.857 164.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.279 21.1 pt 40.45 27.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.012 1.725 . . . . 9.14 114.638 -167.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.252 1.224 1 N-CA-C 99.689 -4.189 . . . . 11.86 99.689 156.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.482 ' H3 ' ' CG ' ' A' ' 3' ' ' ASP . 63.5 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 109.135 -0.691 . . . . 10.43 109.135 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.12 -82.46 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 105.036 -3.226 . . . . 5.0 105.036 -171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.482 ' CG ' ' H3 ' ' A' ' 1' ' ' MET . 10.0 m-20 75.85 -50.86 0.62 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.2 1.8 . . . . 5.62 114.254 149.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.84 49.86 67.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.332 0.968 . . . . 2.61 111.473 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.97 91.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.345 -0.983 . . . . 4.23 108.345 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -108.34 111.46 23.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 4.02 107.838 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -83.41 135.21 34.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.952 -1.129 . . . . 2.77 107.952 164.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.33 130.25 54.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.396 -1.335 . . . . 3.83 107.396 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.83 129.51 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 107.807 -1.183 . . . . 4.25 107.807 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.37 151.55 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 125.083 1.353 . . . . 2.95 109.189 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -129.5 144.23 51.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.437 -0.949 . . . . 6.8 108.437 163.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.58 3.11 35.02 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.5 1.524 . . . . 1.93 112.333 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 82.6 mtp -66.94 158.0 31.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.647 -0.914 . . . . 2.3 110.886 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 t -164.67 128.46 2.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.415 1.086 . . . . 3.32 108.556 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.3 m 62.41 177.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.54 1.536 . . . . 2.93 112.949 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.29 -27.67 56.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.869 -1.059 . . . . 2.02 111.461 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -56.61 -70.39 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.285 1.434 . . . . 0.78 113.648 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.5 m -49.46 -42.19 42.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.457 -0.777 . . . . 2.41 109.707 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 t -51.53 -71.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.407 0.683 . . . . 1.9 111.625 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 -29.29 69.1 Favored 'General case' 0 C--N 1.34 0.163 0 O-C-N 121.513 -0.742 . . . . 1.82 111.007 -173.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -55.03 -56.42 20.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.35 -0.611 . . . . 5.18 109.35 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.52 -54.2 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.631 -0.507 . . . . 2.03 109.631 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.5 -54.81 19.41 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.888 0.375 . . . . 3.11 110.99 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -52.92 -56.74 13.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.121 0.968 . . . . 2.27 110.381 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -50.25 -56.35 11.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.735 1.214 . . . . 2.69 109.919 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.87 -45.62 64.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.41 -0.516 . . . . 3.7 111.599 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.4 m -52.12 -36.16 50.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.097 0.862 . . . . 2.25 111.02 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.87 -26.13 23.23 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.12 1.156 . . . . 5.34 114.12 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.25 -29.26 70.62 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.219 1.372 . . . . 2.23 111.093 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 72.04 -3.59 2.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 6.96 113.03 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.59 -30.77 38.92 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.321 -1.112 . . . . 1.03 110.321 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.75 116.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.222 -1.399 . . . . 3.85 107.222 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -79.01 -33.9 44.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.157 0.583 . . . . 2.55 109.452 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.08 146.54 24.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.226 -0.657 . . . . 3.11 109.226 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.5 t -139.82 130.89 26.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.294 -1.743 . . . . 2.56 106.294 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -145.36 116.81 8.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.586 -0.894 . . . . 2.81 108.586 167.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.54 85.41 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.935 -1.135 . . . . 3.34 107.935 -166.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 93.46 8.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.66 -0.867 . . . . 2.12 108.66 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.1 tt -44.69 -39.83 5.43 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.715 1.206 . . . . 2.85 111.826 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.93 -30.08 22.92 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.857 0.863 . . . . 2.29 112.438 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -123.35 14.8 9.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.275 1.43 . . . . 2.68 110.175 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 m120 30.56 53.32 0.15 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 127.376 2.271 . . . . 2.31 112.829 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.83 140.25 46.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.221 0.608 . . . . 2.38 109.437 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.34 101.48 10.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.169 1.788 . . . . 1.86 107.032 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -77.82 107.08 10.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.287 -1.746 . . . . 1.15 106.287 170.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -112.7 118.95 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.021 -1.474 . . . . 2.01 107.021 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -96.12 119.15 34.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.9 -1.519 . . . . 4.06 106.9 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -158.57 127.42 5.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.449 0.3 . . . . 4.11 110.744 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.11 128.11 91.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.382 -0.97 . . . . 3.38 108.382 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.88 -50.5 5.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.251 1.967 . . . . 2.44 111.71 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.15 -21.9 36.23 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.721 1.378 . . . . 3.23 114.721 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.35 -1.89 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.041 0.837 . . . . 3.12 112.104 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.82 -47.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.322 0.965 . . . . 2.95 113.594 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 148.64 8.46 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.446 1.022 . . . . 1.99 112.1 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.05 -47.52 17.47 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.251 2.634 . . . . 1.21 111.402 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.407 HH21 ' N ' ' A' ' 60' ' ' HIS . 7.8 tpm_? -47.81 -43.87 28.19 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.148 0.979 . . . . 8.73 111.843 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.89 -53.88 51.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.868 0.867 . . . . 3.92 110.987 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.26 -52.86 53.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.43 -0.581 . . . . 1.78 109.43 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -57.48 -47.38 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.033 -0.728 . . . . 2.73 109.033 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.407 ' N ' HH21 ' A' ' 56' ' ' ARG . 52.4 t-80 -59.09 -41.91 89.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.693 0.797 . . . . 6.16 110.126 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.9 m -63.0 -45.76 90.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.102 -0.333 . . . . 2.0 110.102 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.31 -49.94 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.327 0.651 . . . . 1.97 110.824 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -49.95 -59.19 4.11 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.108 0.963 . . . . 2.99 109.749 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -52.92 -48.55 67.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.753 1.621 . . . . 1.9 111.189 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.21 -55.42 35.2 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.939 -0.476 . . . . 2.59 110.976 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.84 -40.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.663 1.025 . . . . 1.67 115.663 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -122.95 132.53 54.2 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.326 0.563 . . . . 3.28 110.874 -133.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.44 133.12 37.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.02 -1.845 . . . . 4.24 106.02 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.74 145.33 30.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.058 -0.401 . . . . 2.25 110.372 -172.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -135.89 110.7 8.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.424 1.09 . . . . 3.73 109.576 -170.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.95 116.56 1.11 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.215 0.606 . . . . 3.25 109.918 164.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 m -66.92 152.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.796 -1.187 . . . . 3.85 107.796 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -102.26 84.91 2.55 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 108.394 -0.965 . . . . 9.5 108.394 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.3 pt -75.78 -46.78 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.923 -0.769 . . . . 5.49 108.923 162.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 116.422 -1.751 . . . . 9.43 111.057 -177.571 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 106.99 -1.485 . . . . 8.73 106.99 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.98 -166.6 6.25 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 107.51 -2.236 . . . . 5.01 107.51 -140.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.14 98.51 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.593 1.157 . . . . 5.53 113.347 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.82 160.19 34.29 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 109.2 -1.56 . . . . 1.79 109.2 156.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.12 146.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 121.657 -0.908 . . . . 3.21 109.95 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.05 116.45 22.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.471 2.308 . . . . 3.74 105.497 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.11 107.26 12.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.385 -0.969 . . . . 2.53 108.385 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -119.62 143.79 47.48 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 125.128 1.518 . . . . 3.03 109.423 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.31 136.72 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.891 -1.892 . . . . 3.4 105.891 162.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.38 122.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.015 1.726 . . . . 3.36 106.905 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -104.35 150.53 24.41 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.082 0.953 . . . . 6.38 110.912 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 -49.58 4.14 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 107.978 -2.049 . . . . 1.83 107.978 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -27.53 112.44 0.06 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.844 2.458 . . . . 3.28 112.312 163.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -157.56 160.52 38.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.443 0.697 . . . . 3.14 109.572 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.3 m 63.68 155.84 0.06 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.356 1.862 . . . . 2.59 113.106 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.98 -36.24 2.39 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.64 1.576 . . . . 2.26 111.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.53 -48.26 79.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.712 2.005 . . . . 1.15 114.127 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.2 -43.76 64.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.339 -1.356 . . . . 1.9 107.339 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.59 -64.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.465 1.106 . . . . 2.51 111.785 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -31.05 68.56 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.869 -0.519 . . . . 2.11 111.446 -174.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.8 -55.92 26.72 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.339 -0.985 . . . . 5.43 108.339 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.18 -61.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.454 -0.573 . . . . 1.83 109.454 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.33 -44.24 92.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.905 -0.718 . . . . 4.95 111.168 -165.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -64.21 -47.35 80.08 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.674 -0.862 . . . . 1.67 108.674 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 t -56.88 -42.78 80.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.835 -0.602 . . . . 1.97 110.949 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.05 -64.47 0.93 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 119.373 0.988 . . . . 2.7 112.026 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.9 m -44.01 -34.48 1.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.763 1.225 . . . . 2.5 114.014 -162.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.28 -29.76 0.15 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.221 1.563 . . . . 7.17 115.221 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -55.82 -40.65 73.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.314 0.961 . . . . 2.25 111.102 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp-105 70.52 -1.67 2.46 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.717 2.007 . . . . 6.88 112.666 -167.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.09 -32.41 35.81 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 1.1 110.51 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.13 118.13 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.286 -1.746 . . . . 3.66 106.286 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.4 mt -81.42 -33.39 32.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.203 1.001 . . . . 2.38 110.427 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -150.55 133.97 16.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.988 -1.486 . . . . 3.75 106.988 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.0 t -133.74 62.51 1.65 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.776 0.83 . . . . 2.12 110.253 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 95.54 8.02 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.648 -0.706 . . . . 2.86 109.674 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.27 85.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.6 1.19 . . . . 3.64 107.823 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 80.22 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.05 1.34 . . . . 2.31 108.334 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -38.99 -43.8 1.01 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.67 2.388 . . . . 3.26 111.152 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.54 -33.51 45.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.645 0.778 . . . . 2.2 111.834 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 p -112.33 8.26 19.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.558 1.543 . . . . 3.04 111.513 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.26 45.92 5.14 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.274 1.43 . . . . 2.08 110.761 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -134.24 144.77 48.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.488 0.715 . . . . 1.9 110.594 -171.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.88 105.47 17.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.144 -1.428 . . . . 1.66 107.144 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -83.96 100.41 11.02 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.901 -1.889 . . . . 0.88 105.901 165.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.5 mt -112.07 108.35 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 124.786 1.234 . . . . 2.2 107.716 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.7 115.23 19.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.033 -1.469 . . . . 3.04 107.033 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -144.52 162.58 36.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.46 -2.052 . . . . 2.97 105.46 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.99 139.42 32.49 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 107.004 -1.48 . . . . 4.51 107.004 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.56 69.06 5.26 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.351 3.368 . . . . 2.49 111.481 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -165.28 -46.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.561 1.544 . . . . 4.27 110.216 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -81.68 -25.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 4.23 109.668 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -158.33 157.11 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.4 164.49 26.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.728 -0.949 . . . . 1.65 110.728 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.86 -47.49 1.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.996 2.464 . . . . 0.95 110.802 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -61.87 -34.09 75.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.211 -0.306 . . . . 8.25 111.211 -175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -57.31 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.495 1.518 . . . . 3.69 108.586 173.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.49 -51.73 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.263 -0.88 . . . . 2.22 109.451 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.5 mt -52.39 -56.84 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.472 0.309 . . . . 2.47 110.206 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -49.39 -48.81 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.479 0.712 . . . . 3.94 109.819 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.6 m -60.12 -52.23 66.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 119.9 -0.72 . . . . 1.94 110.121 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.68 -57.43 5.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 124.036 0.934 . . . . 1.89 110.468 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.66 -52.23 66.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.441 -0.577 . . . . 4.74 109.441 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -51.19 -40.91 59.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.974 0.909 . . . . 1.39 111.895 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.63 -48.68 80.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.713 1.142 . . . . 2.65 113.367 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.28 -1.47 0.06 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 118.371 2.108 . . . . 1.03 118.371 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -138.57 176.64 8.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.788 1.794 . . . . 3.42 113.432 -145.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.58 139.1 53.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.851 -1.907 . . . . 3.35 105.851 167.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.16 161.0 22.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.202 1.001 . . . . 2.13 112.459 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.7 m -157.05 116.2 3.36 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.493 -1.241 . . . . 2.0 110.059 171.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 mt -49.99 140.8 11.7 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.782 1.174 . . . . 4.28 109.18 164.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.83 40.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.827 1.251 . . . . 3.08 110.611 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 -64.7 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.913 0.885 . . . . 7.08 109.165 -173.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.15 63.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 105.956 -1.868 . . . . 9.76 105.956 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 117.751 -1.119 . . . . 11.98 108.937 -152.623 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 108.883 -0.784 . . . . 8.43 108.883 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.99 41.25 44.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.619 0.628 . . . . 6.49 111.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.09 154.64 37.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.276 0.63 . . . . 5.63 110.657 -162.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.66 76.12 0.84 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.209 -0.756 . . . . 2.1 111.209 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.13 140.4 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.653 -1.24 . . . . 3.5 107.653 159.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 tp -137.35 91.68 2.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.428 -1.323 . . . . 3.1 107.428 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.99 116.62 26.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.677 -1.601 . . . . 2.55 106.677 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.91 140.7 52.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.2 -0.312 . . . . 4.12 110.518 174.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.68 139.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.829 -1.545 . . . . 2.86 106.829 167.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.82 150.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 123.898 0.879 . . . . 3.69 108.76 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -146.53 168.0 22.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 5.72 108.791 -170.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.4 -55.79 3.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.716 -1.754 . . . . 1.62 108.716 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 ptm -60.48 138.93 57.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.466 -0.431 . . . . 2.86 110.767 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -159.07 19.84 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.444 -0.343 . . . . 2.55 111.863 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.6 p -173.33 159.35 3.75 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.907 0.776 . . . . 3.73 110.219 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.72 -41.07 55.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.975 1.71 . . . . 2.08 113.149 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.2 p -63.22 -67.08 0.45 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.137 0.575 . . . . 1.07 111.342 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -43.73 -42.25 5.32 Favored 'General case' 0 N--CA 1.461 0.075 0 O-C-N 121.389 -0.819 . . . . 2.38 110.759 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.07 -73.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 123.205 0.602 . . . . 2.02 111.011 173.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -21.04 66.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.521 -0.737 . . . . 1.31 111.921 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -58.12 -47.71 82.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.001 0.92 . . . . 4.89 110.03 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.7 mt -59.9 -54.25 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.701 -0.852 . . . . 1.82 108.701 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -54.0 -59.82 4.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.641 0.588 . . . . 2.95 109.57 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.3 t -51.37 -49.15 62.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.086 1.354 . . . . 1.48 111.135 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -58.33 -51.11 71.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 1.63 110.386 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.01 -36.54 84.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 118.705 -1.198 . . . . 2.96 110.158 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.8 m -63.85 7.32 0.12 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.119 -0.988 . . . . 3.17 113.306 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.81 -46.72 43.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.42 -1.425 . . . . 5.17 110.296 157.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.467 0.707 . . . . 2.63 110.613 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -0.52 11.86 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.507 -0.746 . . . . 8.99 112.292 170.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.72 -15.25 61.85 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.031 0.378 . . . . 1.02 112.319 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -94.0 142.8 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.484 -1.302 . . . . 4.08 107.484 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.27 -45.75 4.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.321 1.048 . . . . 4.25 110.025 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.13 153.98 49.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.291 1.036 . . . . 3.49 108.829 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 p -156.02 59.63 0.59 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.435 0.694 . . . . 3.24 111.463 -170.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 m -87.06 104.63 16.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.509 -0.758 . . . . 2.71 111.429 -175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.303 2.7 p -92.68 92.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 122.655 1.217 . . . . 3.06 111.654 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.68 90.66 7.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.785 -1.191 . . . . 2.03 107.785 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tt -44.15 -37.35 3.07 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.55 1.14 . . . . 2.72 111.453 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.14 22.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.906 0.882 . . . . 1.98 112.247 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -120.8 15.44 11.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.012 1.325 . . . . 2.49 110.41 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.15 50.6 0.72 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.548 1.939 . . . . 2.01 111.733 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.75 143.6 35.04 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.222 0.609 . . . . 1.88 109.372 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.84 118.74 36.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.972 -1.122 . . . . 1.62 107.972 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -87.33 95.58 10.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.844 -2.28 . . . . 1.24 104.844 162.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.1 mt -93.48 140.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.848 -1.538 . . . . 2.08 106.848 169.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -118.68 136.86 53.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.94 -1.874 . . . . 4.78 105.94 161.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.62 173.7 15.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.964 1.306 . . . . 2.94 108.126 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -113.29 117.48 45.34 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.62 -1.252 . . . . 3.91 107.62 164.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.26 -40.11 83.82 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.456 1.437 . . . . 2.2 111.945 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -67.64 -12.62 60.86 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.709 0.686 . . . . 4.97 112.663 -167.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 pt -117.97 6.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 123.928 0.891 . . . . 3.31 112.946 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.37 -42.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.474 0.916 . . . . 2.69 113.474 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.49 159.29 5.55 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.201 -0.76 . . . . 2.29 111.201 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.31 -34.54 66.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.526 2.151 . . . . 0.83 110.837 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.11 -46.13 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.534 0.938 . . . . 7.83 113.534 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.45 -35.29 70.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.2 0.909 . . . . 4.11 112.182 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mt -58.19 -47.11 88.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.834 -0.802 . . . . 1.82 108.834 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.83 -48.5 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 118.147 -0.93 . . . . 2.9 109.985 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -47.07 -49.46 21.58 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.957 0.799 . . . . 4.24 109.523 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.0 m -59.21 -55.78 30.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.338 -0.545 . . . . 2.36 110.017 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -63.52 -45.5 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 122.537 0.335 . . . . 2.0 110.702 -170.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.92 -54.64 39.06 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.974 0.509 . . . . 3.12 110.315 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -64.88 -20.7 66.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.829 -1.081 . . . . 1.17 112.416 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.16 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 119.849 1.204 . . . . 2.72 109.05 160.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 18.0 0.24 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.152 -1.36 . . . . 1.32 115.111 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.15 122.9 40.26 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.95 1.875 . . . . 3.29 112.683 -157.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.76 86.84 4.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.889 -0.782 . . . . 3.41 108.889 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.11 163.11 26.92 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.13 -0.981 . . . . 2.08 110.709 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.0 m -154.68 104.53 2.54 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.738 -0.838 . . . . 2.31 108.738 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 126.42 27.3 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 122.86 0.464 . . . . 3.11 111.443 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 m -101.8 113.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.541 0.686 . . . . 2.24 110.853 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 75' ' ' GLU . 22.3 mmmt -69.97 75.98 0.48 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.573 0.749 . . . . 6.41 109.526 169.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.2 mt -72.95 90.71 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.665 -1.235 . . . . 5.76 107.665 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 73' ' ' LYS . 92.0 mt-10 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.986 2.114 . . . . 8.7 105.324 173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.807 -0.072 . . . . 13.67 110.807 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.1 -75.75 0.47 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.988 0.804 . . . . 7.33 111.114 175.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 66.83 -62.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.108 2.163 . . . . 7.96 112.283 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.11 44.09 55.01 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 123.946 0.784 . . . . 3.59 111.35 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.83 117.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.58 -1.267 . . . . 4.21 107.58 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.12 135.63 14.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.909 0.861 . . . . 3.96 111.026 164.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.39 117.36 33.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.75 1.22 . . . . 2.43 109.766 -170.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.95 126.43 46.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.966 -1.494 . . . . 4.08 106.966 172.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.46 137.97 21.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.001 -2.222 . . . . 3.56 105.001 160.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.25 107.47 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.306 -1.368 . . . . 2.79 107.306 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -102.25 115.1 29.85 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.965 -1.124 . . . . 6.58 107.965 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.65 -45.18 0.99 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.978 -1.649 . . . . 1.51 108.978 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -55.69 137.2 49.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.909 0.483 . . . . 2.7 110.224 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -165.97 12.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 2.94 112.766 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -170.74 144.41 2.29 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 117.908 -1.044 . . . . 2.66 108.355 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.81 -50.49 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.621 2.369 . . . . 2.23 113.437 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -57.12 -47.7 80.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.797 1.239 . . . . 1.13 114.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.38 -49.63 32.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.388 1.075 . . . . 2.13 108.171 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -43.23 -64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.335 1.854 . . . . 1.95 110.487 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -9.54 55.09 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 120.348 -0.541 . . . . 1.68 111.554 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -47.49 59.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.48 -1.387 . . . . 5.82 107.96 -172.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.28 -57.28 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.836 -1.074 . . . . 1.87 108.345 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -70.32 0.09 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.234 0.614 . . . . 4.3 111.968 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -47.85 -47.13 31.68 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.611 0.641 . . . . 3.48 111.881 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -59.56 -65.68 0.63 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.853 -0.425 . . . . 1.82 109.853 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.04 -34.66 70.33 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.436 0.562 . . . . 2.73 111.318 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -55.3 -25.32 33.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.298 0.481 . . . . 2.63 112.298 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -18.94 64.35 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.663 1.119 . . . . 6.62 112.654 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -84.88 119.97 25.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.54 -1.282 . . . . 2.37 107.54 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -69.07 -0.82 6.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.088 -1.008 . . . . 7.27 113.704 -172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.48 -20.98 61.0 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.523 -0.736 . . . . 1.07 113.595 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.99 138.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 117.818 0.809 . . . . 4.72 110.486 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -100.62 -42.61 6.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.836 1.655 . . . . 2.43 110.196 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -148.36 149.99 32.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.445 -0.576 . . . . 3.71 109.445 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 t -141.75 74.22 1.44 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.857 0.837 . . . . 2.63 110.332 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -85.4 82.92 8.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.216 0.606 . . . . 3.47 109.957 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.07 126.34 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 112.594 0.591 . . . . 3.0 112.594 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.35 104.22 7.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.337 1.455 . . . . 1.98 108.684 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.48 -30.02 38.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.314 0.645 . . . . 3.86 111.321 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.68 50.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.923 0.889 . . . . 2.26 111.61 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -122.08 14.2 10.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 2.51 110.027 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 34.19 55.14 0.62 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.457 1.903 . . . . 2.29 111.713 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.59 143.34 25.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.088 -0.383 . . . . 2.43 110.241 -172.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 112.31 24.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.608 1.963 . . . . 1.88 108.747 165.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.55 95.6 5.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 104.627 -2.36 . . . . 1.24 104.627 160.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 mt -91.27 142.31 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 106.288 -1.745 . . . . 2.13 106.288 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -119.26 111.51 18.31 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.868 -2.271 . . . . 3.82 104.868 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -152.5 155.62 37.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.246 1.019 . . . . 4.8 108.674 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.21 100.17 7.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 123.873 0.733 . . . . 3.22 109.458 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 -42.05 71.76 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.826 2.351 . . . . 2.37 111.427 -172.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -20.34 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.871 2.468 . . . . 4.49 114.385 166.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 pt -112.56 16.1 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.074 0.95 . . . . 3.24 113.112 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 tt -160.53 -46.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.961 0.801 . . . . 2.95 112.203 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.27 157.27 8.42 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.551 1.072 . . . . 2.02 111.43 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.59 -45.32 26.37 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.622 2.214 . . . . 1.24 110.474 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.99 -55.49 6.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.75 1.22 . . . . 9.78 112.762 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -56.53 -48.36 77.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.004 0.907 . . . . 3.97 111.056 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.51 -51.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.642 -0.708 . . . . 1.59 109.317 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -49.43 -60.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 C-N-CA 123.16 0.584 . . . . 2.84 109.428 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -45.51 -49.0 14.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.538 0.735 . . . . 3.55 109.707 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.1 m -63.15 -48.52 78.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.021 -0.672 . . . . 1.76 110.741 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.6 mt -52.19 -64.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.322 0.649 . . . . 2.06 109.841 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -47.67 84.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.135 -0.626 . . . . 2.81 109.718 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -61.44 -19.56 62.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.128 -1.415 . . . . 1.53 113.583 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.08 -70.04 0.26 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 121.296 1.862 . . . . 2.76 109.654 166.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.55 24.82 0.27 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.862 -1.521 . . . . 1.34 115.877 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.71 173.79 10.01 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.089 1.944 . . . . 3.26 113.431 -164.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.74 152.61 20.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.234 -2.135 . . . . 3.61 105.234 154.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.8 162.47 41.24 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.202 0.91 . . . . 2.1 111.449 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.19 141.8 17.78 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.253 0.221 . . . . 2.81 111.571 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.81 70.32 3.26 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.368 1.067 . . . . 3.87 111.211 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.05 -161.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.976 0.91 . . . . 3.02 110.807 171.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 156.11 45.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.372 -2.084 . . . . 6.71 105.372 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.8 tt -118.45 133.79 64.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 103.28 -2.859 . . . . 6.5 103.28 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 13.1 pt-20 . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.049 1.468 . . . . 10.81 111.868 -163.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 105.452 -2.055 . . . . 12.82 105.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.58 49.82 63.38 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.03 -1.628 . . . . 5.72 109.03 -167.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -148.99 172.05 15.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.38 1.472 . . . . 4.75 107.8 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.63 160.87 13.22 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.103 -1.599 . . . . 1.98 109.103 164.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.8 152.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 125.407 1.483 . . . . 3.04 107.621 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -141.77 109.92 5.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.979 -1.489 . . . . 3.77 106.979 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -122.03 112.33 18.12 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.433 0.693 . . . . 2.52 110.745 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.44 142.38 51.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.856 1.347 . . . . 3.48 110.031 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.33 138.1 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.369 -1.715 . . . . 2.96 106.369 166.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.9 152.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.144 -1.058 . . . . 3.16 108.144 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -138.01 131.16 30.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.798 0.839 . . . . 7.15 109.031 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 9.49 85.04 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.813 -0.915 . . . . 1.84 110.813 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -102.25 126.37 49.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.149 1.779 . . . . 3.29 106.798 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 t -158.7 155.61 28.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.483 0.583 . . . . 3.13 109.884 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m 66.0 164.1 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.962 1.705 . . . . 3.82 112.763 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -43.92 49.02 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.924 -1.035 . . . . 2.22 110.891 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 p -43.33 -74.23 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.173 1.789 . . . . 1.0 114.12 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -49.92 -44.24 50.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.486 0.714 . . . . 2.39 109.528 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.35 -66.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.16 0.584 . . . . 2.36 111.952 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -68.08 -28.48 67.4 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.263 -0.898 . . . . 2.65 110.688 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -57.65 -52.86 63.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.612 0.642 . . . . 4.84 109.782 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -54.45 -61.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.783 -0.821 . . . . 1.77 108.783 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.77 -55.09 33.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.302 0.241 . . . . 2.81 111.077 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 t -54.11 -34.74 61.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.317 1.047 . . . . 1.99 111.313 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -69.37 -65.86 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.048 0.84 . . . . 1.87 109.894 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.98 -44.74 71.05 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.253 1.021 . . . . 3.55 112.091 -170.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.6 p -54.55 -25.42 25.8 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.92 -0.487 . . . . 3.3 112.097 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.85 -20.29 63.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.604 0.762 . . . . 6.08 111.698 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -64.25 -38.37 90.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.901 -0.778 . . . . 2.31 108.901 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 70.25 -2.33 2.16 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.282 2.233 . . . . 6.18 113.127 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.91 37.87 3.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.291 -1.123 . . . . 0.97 110.291 167.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.54 139.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.524 -2.028 . . . . 3.31 105.524 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.88 -40.17 9.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.006 0.523 . . . . 3.8 110.379 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -155.02 164.13 39.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.369 0.531 . . . . 3.79 111.344 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -153.56 125.09 7.62 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.753 2.421 . . . . 3.26 106.669 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -132.11 106.67 8.14 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.278 -1.749 . . . . 2.44 106.278 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -88.18 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.453 -1.314 . . . . 3.15 107.453 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.88 89.44 5.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.244 -1.021 . . . . 1.93 108.244 -171.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.32 -42.99 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.588 1.955 . . . . 2.9 111.012 165.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.07 62.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.646 1.178 . . . . 2.03 112.39 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -116.43 17.97 15.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.614 1.565 . . . . 2.53 109.246 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 19.42 59.59 0.02 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.489 2.716 . . . . 3.06 113.422 -164.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.9 144.89 39.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.034 0.534 . . . . 1.76 109.748 -174.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.2 106.85 18.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.796 -1.187 . . . . 1.7 107.796 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.37 100.72 12.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.712 -1.958 . . . . 0.93 105.712 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.72 146.09 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.791 -1.559 . . . . 3.26 106.791 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -122.17 133.74 54.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.239 -2.134 . . . . 3.38 105.239 165.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.15 169.16 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.615 0.366 . . . . 4.56 110.299 -160.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.21 139.46 24.2 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.052 -1.832 . . . . 4.12 106.052 159.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.35 -34.75 1.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.146 1.898 . . . . 2.57 113.138 -175.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.65 -28.46 15.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.357 0.981 . . . . 3.41 112.348 -163.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.54 -24.62 29.47 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 118.998 0.817 . . . . 3.0 110.638 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 tt -121.61 -44.18 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.517 0.562 . . . . 2.88 112.517 -169.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 120.08 0.24 Allowed Glycine 0 CA--C 1.534 1.224 0 N-CA-C 109.16 -1.576 . . . . 2.31 109.16 -168.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.7 -38.05 94.75 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 120.673 2.237 . . . . 1.73 111.138 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -23.26 63.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.157 1.169 . . . . 10.06 114.157 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.57 -51.93 67.71 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.91 1.232 . . . . 3.53 109.451 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -56.47 -49.31 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.538 -0.744 . . . . 1.83 110.071 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.6 -59.44 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.232 0.924 . . . . 2.57 110.164 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -49.14 -50.04 39.33 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.837 0.855 . . . . 4.45 109.344 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.8 m -57.51 -52.06 66.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.181 -0.463 . . . . 1.63 110.231 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.29 -57.25 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 119.23 -0.414 . . . . 1.96 110.574 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.83 -51.02 71.52 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.725 -0.79 . . . . 3.38 110.019 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -57.81 -35.99 71.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.226 1.01 . . . . 2.73 111.241 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mp -52.12 -68.61 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.518 0.599 . . . . 3.4 111.518 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.75 14.99 0.18 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.187 -1.341 . . . . 1.1 115.571 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -133.82 175.04 9.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.413 1.607 . . . . 3.3 113.869 -156.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.23 152.61 22.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.367 -2.086 . . . . 4.01 105.367 155.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.09 139.91 23.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.023 1.329 . . . . 1.86 109.567 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 m -155.41 110.44 2.99 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.25 -0.906 . . . . 2.09 111.101 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.23 139.98 7.91 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.139 -1.059 . . . . 4.15 108.139 166.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.73 35.2 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.128 0.571 . . . . 2.64 109.961 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt 157.14 146.32 0.01 OUTLIER 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 128.288 2.635 . . . . 7.64 106.545 -169.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.0 mt 78.01 -54.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.078 1.351 . . . . 10.05 108.506 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 . . . . . 0 C--O 1.259 1.562 0 N-CA-C 105.672 -1.973 . . . . 13.21 105.672 157.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttm . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 108.328 -0.99 . . . . 9.41 108.328 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -56.29 128.19 45.43 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 104.264 -3.535 . . . . 5.29 104.264 135.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.17 150.65 33.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.748 0.774 . . . . 5.18 111.47 -162.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.78 109.14 2.74 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.294 -1.922 . . . . 2.07 108.294 160.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.56 129.84 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.5 -1.296 . . . . 4.26 107.5 170.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -113.26 128.23 56.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.628 -1.99 . . . . 3.1 105.628 166.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -121.17 104.08 9.49 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.287 -0.634 . . . . 2.42 109.287 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.35 129.76 36.53 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.757 -1.571 . . . . 3.68 106.757 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.4 131.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.423 -2.066 . . . . 2.8 105.423 155.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -108.1 150.44 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.161 -1.792 . . . . 2.89 106.161 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -135.38 125.27 25.67 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.05 -0.722 . . . . 5.6 109.05 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.47 -13.97 5.87 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.294 1.426 . . . . 1.73 112.517 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.1 ptp -65.74 149.4 50.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.54 1.17 . . . . 3.63 110.26 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -163.17 139.6 7.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.659 -1.608 . . . . 3.1 106.659 168.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.8 t 73.46 142.01 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.681 1.592 . . . . 3.56 112.582 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.12 -36.2 0.29 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.911 2.085 . . . . 2.14 113.166 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -56.55 -77.08 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.192 0.997 . . . . 1.21 112.805 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -55.11 -33.68 63.05 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 124.076 0.95 . . . . 2.72 110.531 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -52.69 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 O-C-N 123.662 0.601 . . . . 2.36 109.497 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.302 0.3 OUTLIER -66.98 -16.51 64.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.855 -0.528 . . . . 2.01 112.01 -168.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -55.94 -44.14 78.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.957 -1.127 . . . . 5.21 107.957 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.6 -63.86 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.246 -1.02 . . . . 1.82 108.246 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -60.18 -50.88 71.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.313 0.486 . . . . 2.9 112.313 -172.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.3 t -50.24 -52.22 37.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.888 0.875 . . . . 1.7 109.548 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -56.77 -54.73 42.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.942 0.337 . . . . 1.59 110.897 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.17 -34.4 77.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 118.871 -1.132 . . . . 2.88 111.211 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 m -61.25 -10.73 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.977 -1.077 . . . . 2.3 112.28 173.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -75.86 -20.52 58.03 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 120.924 -1.11 . . . . 5.57 112.197 172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.56 -169.12 0.39 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.987 -1.116 . . . . 2.76 107.987 167.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -126.87 -0.84 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.411 -0.806 . . . . 6.88 112.347 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.03 -19.96 22.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.214 0.461 . . . . 0.89 113.023 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mp -79.9 113.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.984 -1.487 . . . . 3.93 106.984 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -79.73 -36.51 37.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.817 1.247 . . . . 2.47 110.202 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -154.91 150.6 27.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.44 -1.319 . . . . 3.87 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -155.65 86.92 1.07 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.983 -0.376 . . . . 2.02 109.983 -164.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.7 m -112.77 107.14 15.67 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.472 0.709 . . . . 2.57 109.933 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.19 90.2 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 122.813 1.292 . . . . 2.79 110.232 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 92.6 8.22 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.414 -0.958 . . . . 1.82 108.414 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -40.58 -39.87 1.14 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.552 1.541 . . . . 2.98 112.395 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.1 61.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.628 0.771 . . . . 1.73 111.872 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -116.1 11.09 15.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.588 1.555 . . . . 2.44 110.047 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.32 39.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.812 2.445 . . . . 3.3 112.917 -173.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 141.09 52.35 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.49 0.716 . . . . 2.04 110.251 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.72 96.57 7.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.784 1.634 . . . . 1.62 108.415 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -77.17 101.29 6.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.762 -1.94 . . . . 0.96 105.762 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.6 mt -109.92 112.49 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 125.215 1.406 . . . . 1.96 107.512 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.74 124.85 34.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.694 -1.595 . . . . 3.15 106.694 169.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.21 177.5 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.925 -1.509 . . . . 3.66 106.925 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.98 137.02 28.65 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.342 0.974 . . . . 3.94 109.277 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.24 67.74 5.17 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.012 3.808 . . . . 2.64 110.703 -173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -172.97 -45.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.013 1.725 . . . . 3.63 109.298 -171.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -85.3 -28.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.617 0.767 . . . . 4.26 109.676 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.8 tt -158.08 156.22 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.09 -1.078 . . . . 2.63 108.09 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.43 163.01 27.25 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.624 -0.991 . . . . 1.69 110.624 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.09 -45.52 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.699 2.266 . . . . 0.89 110.819 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.4 HH21 ' CD2' ' A' ' 60' ' ' HIS . 27.4 tpt180 -61.19 -30.75 70.61 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.952 -0.468 . . . . 9.0 110.896 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -57.47 11.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.838 1.655 . . . . 3.67 109.072 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -56.61 -49.86 76.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.09 -0.707 . . . . 2.05 109.09 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.15 -48.33 84.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.994 -0.527 . . . . 2.46 110.782 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.4 ' CD2' HH21 ' A' ' 56' ' ' ARG . 14.1 m170 -53.11 -43.99 67.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.689 0.796 . . . . 3.96 109.069 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 m -62.59 -42.98 99.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.838 -0.745 . . . . 1.86 110.158 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.47 -46.35 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.224 -0.922 . . . . 2.07 111.787 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.05 -55.13 22.59 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.019 0.928 . . . . 3.16 108.918 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t -53.25 -51.19 63.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.145 1.378 . . . . 1.32 111.276 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.55 -44.42 96.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.51 -0.744 . . . . 2.92 112.263 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.29 -46.63 0.02 OUTLIER Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.844 -0.693 . . . . 1.86 114.751 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -125.75 142.8 51.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.432 -0.907 . . . . 3.33 113.031 -126.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.47 80.67 4.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.315 -0.624 . . . . 3.75 109.315 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.92 158.61 30.59 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.424 -0.797 . . . . 1.84 110.764 -171.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -155.21 117.45 4.19 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.866 -1.146 . . . . 2.3 111.235 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.26 121.04 11.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.465 1.106 . . . . 3.69 111.006 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.32 43.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.131 1.372 . . . . 3.24 109.855 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.28 -148.13 0.33 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.871 -0.788 . . . . 5.93 108.871 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.64 66.85 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.489 -1.671 . . . . 7.04 106.489 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.975 -1.488 . . . . 8.63 108.041 165.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.101 -1.444 . . . . 11.73 107.101 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.58 -178.9 41.01 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.834 -2.106 . . . . 5.35 107.834 140.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.12 121.34 0.38 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.014 2.525 . . . . 4.97 113.113 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.16 166.94 50.47 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.078 -2.009 . . . . 2.07 108.078 151.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.2 79.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 123.019 1.39 . . . . 3.53 108.122 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 tp -80.16 79.74 6.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 123.113 1.435 . . . . 3.31 107.175 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.9 122.68 25.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.579 -2.1 . . . . 2.59 105.784 164.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.01 139.72 43.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.428 -0.582 . . . . 2.83 109.428 172.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.07 111.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.116 -1.809 . . . . 3.3 106.116 169.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.49 164.51 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.527 -2.027 . . . . 2.62 105.527 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -138.22 130.99 29.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.118 -0.989 . . . . 6.53 108.805 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.82 5.65 17.79 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.852 1.215 . . . . 1.6 112.377 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 mtp -75.2 87.37 2.46 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.834 1.317 . . . . 2.56 108.07 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -83.27 -30.13 27.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.859 0.864 . . . . 2.99 111.995 -173.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.3 t -153.76 152.41 30.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.521 -0.737 . . . . 2.62 110.451 -168.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.09 -46.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.976 2.51 . . . . 2.02 113.732 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.0 p -39.95 -60.87 0.94 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.95 113.712 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -59.61 -43.49 93.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.774 1.23 . . . . 1.9 108.06 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -52.92 -70.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.185 -0.916 . . . . 2.39 110.418 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -28.94 68.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.501 -0.75 . . . . 1.62 110.706 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -55.02 -54.77 38.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.388 -0.815 . . . . 5.29 109.926 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mt -56.06 -54.08 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 119.475 1.034 . . . . 1.87 110.625 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -54.86 -51.22 66.62 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.311 -0.556 . . . . 3.26 109.773 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -56.35 -44.62 80.27 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.481 0.712 . . . . 1.94 111.757 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -64.96 -39.91 94.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.561 1.144 . . . . 3.67 111.809 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.71 -45.67 50.78 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.969 -0.693 . . . . 3.17 111.45 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -68.25 72.47 0.2 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.303 1.041 . . . . 2.6 110.75 -174.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -34.96 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.74 2.416 . . . . 7.18 110.639 -169.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -53.72 -70.09 0.1 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 119.684 1.129 . . . . 2.95 112.536 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 131.97 -4.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.01 3.724 . . . . 6.53 113.611 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.34 18.39 33.11 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.643 1.11 . . . . 1.09 112.466 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.18 121.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.799 1.639 . . . . 5.0 107.932 -175.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.8 mt -95.09 -38.04 10.81 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.089 0.555 . . . . 2.35 110.113 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -156.07 157.51 36.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.397 -1.335 . . . . 3.51 107.397 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.23 58.93 0.65 Allowed 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.218 0.607 . . . . 3.25 110.24 -163.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -79.19 104.1 9.58 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.361 -0.607 . . . . 2.11 109.361 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.58 95.43 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.381 1.086 . . . . 2.5 110.165 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.17 95.11 10.05 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.902 -1.124 . . . . 2.04 109.331 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 tt -42.79 -38.93 2.29 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.778 1.631 . . . . 2.63 112.36 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.55 61.31 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 124.59 1.156 . . . . 1.76 111.529 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.8 t -116.48 14.74 15.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.227 1.411 . . . . 2.62 109.545 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.27 52.02 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.716 2.406 . . . . 2.88 111.41 -169.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.455 -0.778 . . . . 2.55 110.503 -171.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 109.79 22.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.53 1.532 . . . . 1.84 107.872 171.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -82.82 93.07 7.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.574 -1.639 . . . . 0.88 106.574 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.7 mt -103.97 110.42 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.344 1.068 . . . . 2.17 109.754 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -78.06 71.93 4.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.521 -1.659 . . . . 3.71 106.521 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.46 162.36 27.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.992 -0.549 . . . . 3.08 109.606 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -116.27 105.32 50.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.833 -0.803 . . . . 3.08 108.833 167.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.51 -32.73 83.74 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.67 2.247 . . . . 1.75 113.365 -168.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.18 -30.24 59.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.38 0.536 . . . . 3.86 112.26 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.89 -3.0 9.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 113.503 0.927 . . . . 3.44 113.503 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 tt -157.57 131.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.246 -1.39 . . . . 2.3 107.246 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.44 155.0 46.57 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.347 -1.901 . . . . 2.03 108.347 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -59.29 -40.17 70.97 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.795 -1.271 . . . . 0.84 108.795 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -44.92 26.79 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.507 1.123 . . . . 10.74 112.526 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.57 -54.89 41.77 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.275 0.943 . . . . 2.96 109.597 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.32 -47.65 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.357 -0.838 . . . . 1.67 110.006 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.77 -52.26 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.239 -0.652 . . . . 2.7 109.239 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -54.73 -47.38 73.86 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.374 -0.346 . . . . 3.54 110.517 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -51.21 -54.62 23.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.137 0.88 . . . . 2.23 110.401 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -57.69 -58.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 119.213 -0.422 . . . . 3.03 110.222 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -63.94 -44.39 93.0 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.158 -1.017 . . . . 4.2 111.18 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.9 t -62.84 -20.29 64.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 117.768 -1.111 . . . . 1.17 112.609 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.86 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.212 1.369 . . . . 3.05 109.89 165.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.36 25.05 0.32 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.606 -1.108 . . . . 1.19 114.126 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.23 172.56 7.5 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.85 1.325 . . . . 3.2 113.235 -165.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -95.55 161.4 14.07 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.33 -1.73 . . . . 4.95 106.33 156.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.26 94.9 2.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.861 0.864 . . . . 2.06 112.297 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -87.69 119.67 28.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.602 0.761 . . . . 2.39 109.788 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -63.66 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.125 0.875 . . . . 4.07 110.702 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.83 -166.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.485 1.114 . . . . 3.06 109.515 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.92 66.95 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.316 -1.49 . . . . 6.3 110.372 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.263 3.0 mp 71.7 59.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 126.012 1.725 . . . . 6.56 108.243 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 . . . . . 0 C--O 1.253 1.281 0 N-CA-C 101.805 -3.406 . . . . 9.51 101.805 156.167 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.807 -1.183 . . . . 12.32 107.807 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.71 49.27 3.43 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 107.889 -2.084 . . . . 5.67 107.889 -170.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.35 173.63 7.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.914 1.685 . . . . 6.31 109.7 -156.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.63 144.76 33.49 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 122.361 0.978 . . . . 2.02 112.509 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.26 147.86 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 106.447 -1.686 . . . . 3.31 106.447 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 tp -142.36 136.4 29.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.516 -2.031 . . . . 2.97 105.516 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -115.07 145.32 42.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.407 -0.96 . . . . 2.34 108.407 156.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -133.15 146.03 51.2 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 124.668 1.23 . . . . 3.32 107.837 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.18 131.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.535 -1.654 . . . . 3.48 106.535 160.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.54 157.27 3.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 106.153 -1.795 . . . . 3.21 106.153 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -139.07 132.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.273 -1.01 . . . . 5.83 108.273 163.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.35 10.06 12.25 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.663 1.601 . . . . 1.92 112.761 -173.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.5 mtt -62.69 150.46 40.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.034 1.417 . . . . 2.46 109.48 167.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -154.41 86.92 1.16 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.469 0.652 . . . . 3.18 109.937 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.5 t 73.62 90.32 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.086 1.354 . . . . 3.37 112.916 165.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.11 -124.3 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.786 -1.102 . . . . 2.86 108.174 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.5 p 49.47 -81.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.779 2.032 . . . . 1.57 114.165 163.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -46.35 -43.75 16.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.608 0.763 . . . . 2.7 109.747 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.0 t -48.46 -74.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.52 1.128 . . . . 2.08 111.197 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -30.13 69.7 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 122.069 -0.395 . . . . 1.94 111.475 -172.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -51.54 -56.04 15.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.248 -0.649 . . . . 5.16 109.248 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.09 -60.19 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.325 -0.62 . . . . 1.72 109.325 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -49.88 -55.73 13.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.236 0.614 . . . . 3.04 111.142 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.2 t -54.26 -59.77 4.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.456 1.102 . . . . 1.46 109.45 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -52.08 -49.97 62.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.687 0.279 . . . . 1.42 110.939 -174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.9 -49.7 69.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.111 0.411 . . . . 2.67 112.111 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.261 4.5 t -60.6 -25.09 65.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 118.549 -1.26 . . . . 3.86 111.541 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -55.35 -25.65 36.28 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.189 0.811 . . . . 4.72 113.189 173.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -54.92 -31.44 60.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.018 0.827 . . . . 2.39 111.286 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -3.66 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.088 1.755 . . . . 9.28 111.811 -162.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.8 -35.81 15.2 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.553 -1.019 . . . . 1.5 110.553 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 97.89 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.694 -1.595 . . . . 3.84 106.694 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.11 -24.22 43.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.357 -0.838 . . . . 3.34 110.124 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -155.78 153.74 30.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.971 -0.752 . . . . 4.01 108.971 169.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.7 113.49 5.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.783 2.033 . . . . 3.19 107.311 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -119.4 104.77 10.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.425 -1.324 . . . . 2.41 107.425 165.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.34 78.38 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.754 1.264 . . . . 3.26 107.657 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.93 88.84 5.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.954 -1.021 . . . . 1.95 108.502 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.7 tt -38.67 -39.66 0.52 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.06 1.744 . . . . 2.92 112.413 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -36.41 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.454 1.102 . . . . 2.05 112.084 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 t -111.72 11.61 21.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.642 1.577 . . . . 2.4 109.934 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.35 41.28 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.234 2.614 . . . . 3.05 113.399 -170.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.95 45.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.8 0.84 . . . . 2.05 109.422 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.12 111.45 24.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.854 -1.906 . . . . 1.67 105.854 170.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -82.34 114.28 20.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.408 -2.071 . . . . 0.98 105.408 163.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -121.87 109.08 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 125.002 1.321 . . . . 2.07 107.483 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -79.45 72.38 6.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.856 -1.535 . . . . 3.77 106.856 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 176.36 9.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.298 1.039 . . . . 4.38 108.618 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.86 130.16 8.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 118.387 0.54 . . . . 3.66 110.196 160.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -51.88 -34.98 57.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.283 2.656 . . . . 1.72 113.589 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.95 -22.6 66.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.075 0.852 . . . . 4.69 112.999 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 pt -110.89 -22.52 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 119.122 0.873 . . . . 3.8 110.486 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -162.53 130.17 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.978 -1.119 . . . . 3.83 107.978 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.76 170.51 48.08 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.974 -0.851 . . . . 1.72 110.974 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.26 -57.06 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.104 1.869 . . . . 1.33 110.689 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.33 -26.79 68.63 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.847 -0.533 . . . . 9.93 111.743 -173.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -51.55 63.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.981 1.312 . . . . 4.56 110.159 173.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.9 -53.0 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.23 -0.919 . . . . 1.92 109.694 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -55.46 -50.73 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.405 -0.591 . . . . 2.82 109.405 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -49.47 -46.12 47.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.79 0.836 . . . . 4.72 110.396 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -58.23 -50.2 74.4 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.586 -0.524 . . . . 2.11 109.586 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.8 -54.82 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.971 0.509 . . . . 2.15 110.838 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -55.39 -53.42 56.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.243 -0.651 . . . . 4.57 109.243 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -48.4 -47.71 37.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.97 1.308 . . . . 1.15 111.676 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.66 -48.57 79.12 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.372 0.987 . . . . 2.82 113.478 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 0.11 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 118.293 2.077 . . . . 1.19 118.293 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -138.97 177.47 7.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.814 1.807 . . . . 3.25 112.617 -144.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -104.0 158.68 16.25 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.093 -1.447 . . . . 2.94 107.093 145.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.88 154.13 37.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.559 0.695 . . . . 2.21 110.905 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.0 m -156.13 103.79 2.22 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.419 -0.8 . . . . 2.3 110.438 -164.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.94 134.41 16.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.474 1.109 . . . . 3.97 111.94 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m -130.47 144.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.976 1.311 . . . . 2.5 109.099 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 48.52 55.41 9.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.566 1.146 . . . . 9.24 111.32 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 tp -154.35 148.21 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.11 -1.811 . . . . 8.83 106.11 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.825 2.05 . . . . 11.65 113.634 -172.012 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 106.941 -1.503 . . . . 11.58 106.941 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.93 152.9 9.06 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.15 -1.18 . . . . 5.94 110.15 -172.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 57.99 -178.02 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.416 1.886 . . . . 5.44 112.028 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.14 132.32 11.06 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 105.564 -3.014 . . . . 1.98 105.564 158.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 m -136.51 146.32 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.211 1.006 . . . . 4.06 110.131 -170.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 tp -155.23 153.37 30.55 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.041 -1.466 . . . . 3.59 107.041 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -115.4 148.52 39.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.858 -0.793 . . . . 2.93 108.858 165.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.0 mt -121.85 128.82 52.06 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.063 -1.829 . . . . 3.91 106.063 165.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.6 142.1 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.465 -2.42 . . . . 2.84 104.465 161.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.38 120.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 124.616 1.166 . . . . 3.25 108.575 -171.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 131.53 53.88 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.085 0.954 . . . . 8.41 110.986 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.22 -19.28 5.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.965 1.745 . . . . 1.86 109.938 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 mtm -63.32 163.75 10.08 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.204 -0.586 . . . . 2.63 110.531 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -150.47 -44.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.618 0.367 . . . . 2.63 111.455 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.3 m -139.36 169.44 17.75 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.78 -0.575 . . . . 3.63 109.697 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.31 -36.86 1.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.938 2.095 . . . . 2.25 113.272 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -48.26 -44.09 33.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.268 1.827 . . . . 0.99 113.786 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.8 m -70.56 -46.92 62.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.166 -1.42 . . . . 1.92 107.166 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.07 -63.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.336 . . . . 3.01 111.001 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -26.53 64.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.496 -0.752 . . . . 1.67 111.703 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.78 -54.68 39.0 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.727 -0.842 . . . . 5.42 108.727 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -53.88 -60.34 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.591 -0.522 . . . . 2.06 109.591 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -53.22 -52.94 57.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.529 0.331 . . . . 3.28 111.31 -171.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -58.76 -54.6 45.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.94 0.496 . . . . 1.48 110.217 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 t -55.31 -38.92 69.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.37 0.668 . . . . 1.51 111.864 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.1 mt -75.21 -54.65 6.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 113.595 0.961 . . . . 2.68 113.595 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -54.58 -35.96 63.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.349 -0.844 . . . . 2.85 110.931 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -25.16 9.98 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.338 1.236 . . . . 4.46 114.338 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.673 1.124 . . . . 2.22 111.095 176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 77.85 -3.73 2.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.698 2.399 . . . . 7.39 113.898 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.12 -23.84 16.3 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.848 -0.901 . . . . 1.12 110.848 172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.41 105.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.728 -1.953 . . . . 4.02 105.728 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.66 -30.51 41.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.227 1.011 . . . . 2.41 109.434 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.08 139.99 18.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.473 -0.936 . . . . 3.51 108.473 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -133.06 119.19 19.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.579 -2.008 . . . . 2.22 105.579 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -125.74 106.96 10.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.784 -1.561 . . . . 2.59 106.784 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.24 87.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.297 1.046 . . . . 3.33 108.878 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.2 86.23 5.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.017 -1.475 . . . . 1.79 107.017 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -40.91 -38.71 1.0 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.826 1.651 . . . . 3.47 111.201 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.53 -36.17 43.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.592 1.157 . . . . 1.65 112.726 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -113.95 13.22 18.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.353 1.461 . . . . 2.33 110.049 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 40.52 41.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.39 1.876 . . . . 2.03 112.057 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 143.45 50.83 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.143 0.577 . . . . 1.95 110.368 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.71 108.28 19.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.447 -2.057 . . . . 1.69 105.447 170.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -78.59 115.8 18.54 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.651 -1.981 . . . . 1.52 105.651 165.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -120.07 114.7 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.083 -1.08 . . . . 2.4 108.083 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -100.07 115.4 29.69 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.633 -1.617 . . . . 4.13 106.633 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.13 145.98 22.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.797 1.239 . . . . 3.04 108.503 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -85.91 137.03 35.78 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 119.054 0.843 . . . . 4.4 109.577 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.34 -31.69 13.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.186 1.924 . . . . 2.55 111.765 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.52 46.86 0.99 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.774 1.23 . . . . 5.03 112.538 -169.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -50.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 128.295 2.638 . . . . 5.44 106.028 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.4 -89.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.887 1.275 . . . . 2.98 107.61 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.5 139.01 9.97 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.492 -1.443 . . . . 2.06 109.492 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.7 -37.27 94.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.421 2.747 . . . . 0.87 112.812 -164.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -35.98 -49.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 10.83 112.825 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -68.22 -46.15 71.37 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.018 -0.734 . . . . 3.02 109.018 -171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 mt -60.47 -47.35 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.499 -0.773 . . . . 1.69 109.219 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.38 -57.4 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.306 0.642 . . . . 2.98 109.494 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -52.81 -45.82 67.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.655 0.382 . . . . 3.64 110.09 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.8 m -59.48 -54.75 43.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.841 -0.429 . . . . 1.74 109.841 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.1 mt -51.76 -55.45 9.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.593 1.157 . . . . 2.09 110.754 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.35 -57.84 10.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.407 -0.59 . . . . 3.07 109.407 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.3 t -52.94 -37.48 61.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.1 1.36 . . . . 1.31 111.598 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.35 -54.71 28.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.51 0.724 . . . . 3.48 112.632 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.27 -8.36 0.04 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 117.539 1.776 . . . . 1.23 117.539 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.76 176.2 8.67 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.41 1.605 . . . . 3.18 112.475 -142.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -124.54 152.61 43.25 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.922 -2.251 . . . . 3.15 104.922 161.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.61 164.84 30.47 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.015 0.746 . . . . 1.82 113.015 -168.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -153.81 138.88 17.32 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 122.978 0.511 . . . . 3.26 111.379 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.58 66.74 1.45 Allowed 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.547 1.539 . . . . 4.09 110.71 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.2 147.73 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.392 -0.595 . . . . 2.48 109.392 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -128.33 89.22 2.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.078 -1.823 . . . . 7.85 106.078 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.77 -178.72 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 127.145 2.178 . . . . 7.2 105.892 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 108.387 -0.968 . . . . 10.68 108.387 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 106.242 -1.762 . . . . 9.42 106.242 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.96 177.85 51.76 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.364 -1.494 . . . . 5.1 109.364 157.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.08 146.74 30.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.266 1.426 . . . . 5.02 109.154 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.24 89.73 0.7 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.378 -1.489 . . . . 1.89 109.378 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.08 142.28 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.608 0.704 . . . . 3.9 109.782 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.2 83.63 1.84 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.768 -1.567 . . . . 3.91 106.768 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.4 116.54 27.67 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.891 -1.504 . . . . 2.31 107.148 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.34 142.22 51.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.746 0.248 . . . . 2.94 110.677 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.88 145.21 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.36 -1.348 . . . . 2.86 107.36 166.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.7 161.62 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.6 1.56 . . . . 2.96 107.441 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.09 140.1 30.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.874 -0.787 . . . . 9.17 108.874 160.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.67 -34.15 3.54 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.0 -1.24 . . . . 1.53 110.0 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.1 mtp -56.18 115.46 2.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.41 -0.464 . . . . 2.13 109.832 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -125.65 -20.49 4.68 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.946 0.899 . . . . 3.06 111.98 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.5 t -153.92 151.59 29.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.052 -1.03 . . . . 2.81 109.707 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -30.99 -45.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.562 2.345 . . . . 1.67 113.526 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 p -39.96 -58.62 1.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.508 1.523 . . . . 0.86 113.733 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.3 -46.99 87.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.241 -1.392 . . . . 2.01 107.241 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -51.16 -66.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.473 -1.24 . . . . 2.06 110.404 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -27.33 64.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.887 -0.725 . . . . 1.62 111.193 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.74 -53.49 57.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.624 0.647 . . . . 5.31 110.259 172.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.14 -60.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -54.63 -51.02 66.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.543 -0.299 . . . . 3.25 110.939 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.5 t -60.23 -42.82 96.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.522 0.729 . . . . 1.88 111.237 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 t -65.88 -36.78 84.35 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.827 -0.546 . . . . 1.63 111.102 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.18 -52.64 13.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.266 -0.574 . . . . 2.97 111.85 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 m -67.09 76.46 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.228 1.011 . . . . 2.51 110.683 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.45 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.458 2.703 . . . . 4.57 110.518 -171.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -56.33 -30.26 62.35 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.576 1.08 . . . . 2.77 113.296 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 37.97 2.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.245 1.018 . . . . 8.74 110.251 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.33 -2.01 0.73 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 121.573 -0.705 . . . . 0.99 112.897 165.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.05 127.4 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.776 -1.564 . . . . 3.76 106.776 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.78 -43.35 18.47 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.981 1.312 . . . . 2.89 109.417 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -152.11 155.25 37.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 110.203 -0.295 . . . . 3.3 110.203 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.47 136.85 35.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.731 1.612 . . . . 3.13 107.004 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -151.52 87.92 1.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.229 -1.397 . . . . 3.49 107.229 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.27 0.3 OUTLIER -92.52 92.08 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.714 1.245 . . . . 2.61 109.958 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.64 92.98 9.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.177 -0.952 . . . . 1.74 108.986 -170.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.05 -42.37 2.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.302 1.441 . . . . 2.96 111.701 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.25 -33.54 42.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.435 1.094 . . . . 1.63 112.46 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -117.78 14.43 14.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.887 1.275 . . . . 2.58 110.364 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 30.26 53.97 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.686 2.394 . . . . 3.0 112.363 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 150.22 46.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.733 0.813 . . . . 2.07 109.175 -174.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.67 27.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.572 1.149 . . . . 1.87 107.965 168.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -81.22 99.18 8.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 104.337 -2.468 . . . . 0.87 104.337 154.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.54 147.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.49 -1.67 . . . . 2.01 106.49 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -124.58 130.93 53.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.352 -2.092 . . . . 4.18 105.352 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -146.41 173.13 12.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 119.095 0.861 . . . . 3.28 111.365 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -107.77 94.12 11.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.112 0.965 . . . . 4.33 109.587 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 63.25 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.659 3.573 . . . . 2.58 111.851 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -155.09 -54.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 128.702 2.801 . . . . 3.74 106.692 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.4 pt -99.82 -13.41 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 124.843 1.257 . . . . 3.3 111.849 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -151.55 142.34 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.638 -1.616 . . . . 2.25 106.638 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.39 168.48 40.36 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.977 -0.849 . . . . 2.06 110.977 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.83 -47.49 1.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.563 2.176 . . . . 0.85 110.779 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -24.73 66.81 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.992 -0.442 . . . . 9.06 110.534 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -56.15 25.28 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.893 -1.754 . . . . 3.34 109.27 172.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.49 -55.12 21.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 108.869 -0.789 . . . . 2.59 108.869 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -58.05 -44.7 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.43 -0.35 . . . . 2.5 110.105 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.5 -37.26 83.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.906 1.282 . . . . 6.24 109.999 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -58.53 -51.83 68.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.751 -0.833 . . . . 1.61 108.751 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.98 -52.61 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 119.206 -0.426 . . . . 1.87 111.006 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -47.07 -52.2 15.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.156 0.983 . . . . 3.12 109.911 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.4 t -70.43 -9.71 57.17 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.754 1.622 . . . . 1.33 113.683 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.48 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.197 -1.409 . . . . 4.03 107.197 159.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.59 37.43 0.51 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.909 -0.94 . . . . 1.31 112.343 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -136.29 124.69 23.39 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.222 1.011 . . . . 3.27 110.266 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.75 -1.204 . . . . 4.63 107.75 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.31 163.1 40.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.918 -0.488 . . . . 2.12 111.462 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -145.62 126.69 14.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.607 1.163 . . . . 3.22 108.983 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.85 119.78 11.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.649 1.179 . . . . 4.52 108.314 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.44 13.41 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.83 0.741 . . . . 2.16 111.782 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 67.89 -71.84 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.82 1.648 . . . . 6.28 110.564 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 tp -164.94 173.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.723 -1.214 . . . . 5.74 107.723 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.253 1.252 0 N-CA-C 104.843 -2.28 . . . . 11.23 104.843 172.57 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' H3 ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 107.031 -1.47 . . . . 9.88 107.031 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.74 169.81 45.63 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.669 0.668 . . . . 6.15 111.869 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.67 64.12 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.408 1.083 . . . . 4.93 109.807 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.92 130.73 12.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.187 0.898 . . . . 1.7 111.04 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -103.97 126.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-N 117.634 0.717 . . . . 3.78 109.573 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 95.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.476 1.132 . . . . 5.0 108.873 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 5.0 tp10 -78.51 122.64 26.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.612 -1.255 . . . . 2.44 107.612 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.43 145.54 48.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.994 -0.373 . . . . 2.63 109.994 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.98 142.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.069 -1.826 . . . . 2.99 106.069 164.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.06 95.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 125.246 1.418 . . . . 3.35 108.618 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -97.47 143.5 28.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.523 0.729 . . . . 7.01 111.149 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.81 -36.38 3.0 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.627 1.108 . . . . 1.64 110.806 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -64.51 153.43 39.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.133 0.492 . . . . 2.77 112.171 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -153.58 149.5 27.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 170.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m 70.43 151.39 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.468 1.507 . . . . 3.2 112.486 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.5 -35.37 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.515 1.926 . . . . 2.15 112.559 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 -65.48 0.57 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.251 1.42 . . . . 1.36 112.649 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -68.91 -40.42 79.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.462 -1.31 . . . . 2.29 107.462 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.7 t -42.92 -68.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 113.98 -1.464 . . . . 2.17 110.238 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.304 0.4 OUTLIER -69.62 -20.06 63.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.704 -0.798 . . . . 2.37 110.995 -175.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.53 -42.21 87.58 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.113 -0.992 . . . . 3.73 108.992 -174.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -53.54 -66.53 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.816 -0.809 . . . . 1.97 108.816 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.24 -56.17 20.98 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.035 0.534 . . . . 3.14 111.962 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -53.43 -36.49 61.6 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.512 1.125 . . . . 1.84 111.174 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -70.22 -62.08 1.53 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.502 -0.749 . . . . 1.46 110.357 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -46.29 66.5 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.699 0.8 . . . . 3.46 111.961 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 p -50.85 -33.43 23.78 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.779 0.432 . . . . 3.81 111.129 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -64.26 -18.5 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.847 0.684 . . . . 5.3 112.847 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.434 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 12.2 m170 -60.48 -28.63 68.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 2.46 110.456 173.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 74.83 -1.85 2.98 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.311 1.844 . . . . 7.45 112.285 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 24.96 25.35 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.377 -0.689 . . . . 1.2 111.377 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mm -121.04 144.92 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.171 -1.789 . . . . 3.42 106.171 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.13 -45.86 7.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.832 -0.803 . . . . 4.23 108.832 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -155.55 153.4 30.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.375 0.534 . . . . 3.69 109.939 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.0 m -135.02 113.1 11.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 104.986 -2.227 . . . . 3.36 104.986 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.41 96.09 5.81 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.162 -1.051 . . . . 2.62 108.162 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.03 95.12 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.445 0.64 . . . . 3.09 109.667 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.71 91.72 6.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.372 -0.83 . . . . 1.75 110.185 -168.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -37.3 -50.87 1.04 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 2.88 112.819 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.52 31.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 2.44 112.528 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.7 t -105.93 -15.54 14.89 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.829 1.252 . . . . 2.66 110.729 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.72 41.52 14.86 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.837 0.855 . . . . 2.69 109.425 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -120.53 147.57 44.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.66 1.184 . . . . 2.23 108.794 176.007 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.1 114.18 27.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.859 -1.534 . . . . 1.55 106.859 162.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -78.2 94.37 4.75 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.144 -2.169 . . . . 0.9 105.144 167.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 mt -98.74 111.92 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.708 -0.849 . . . . 2.52 108.708 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.15 115.59 26.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.323 -1.732 . . . . 3.77 106.323 159.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.62 140.19 28.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.979 1.312 . . . . 3.9 107.792 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.52 ' CG ' ' H3 ' ' A' ' 1' ' ' MET . 50.0 t0 -87.37 114.16 57.41 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.381 -0.97 . . . . 3.72 108.381 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.12 -48.78 15.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.17 1.913 . . . . 2.16 113.194 -172.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.59 -21.42 60.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.804 1.039 . . . . 3.31 113.804 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -97.18 -4.54 9.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 119.728 1.149 . . . . 3.35 112.7 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.05 -46.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.454 1.279 . . . . 2.69 114.454 -175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.84 155.65 2.36 Favored Glycine 0 CA--C 1.541 1.674 0 O-C-N 121.609 -0.682 . . . . 2.23 112.889 -171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 -51.58 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.25 2.634 . . . . 1.57 112.252 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -47.9 -44.6 29.77 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.679 0.791 . . . . 8.24 112.187 -170.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -52.35 -56.13 16.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.023 0.929 . . . . 3.96 110.859 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.17 -48.87 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 O-C-N 121.814 -0.554 . . . . 1.97 110.547 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mm -51.81 -51.34 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 119.014 -0.517 . . . . 3.04 110.27 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -50.51 -54.45 22.28 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 122.968 0.507 . . . . 3.56 109.896 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.434 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 50.0 m -56.41 -47.29 79.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.255 -0.978 . . . . 2.13 110.733 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 -54.8 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 118.534 0.606 . . . . 2.34 111.949 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -67.01 -43.63 82.4 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.582 -0.447 . . . . 4.99 110.678 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 t -57.9 -40.7 80.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.51 0.724 . . . . 1.53 110.978 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.13 -59.97 4.5 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.389 0.995 . . . . 2.49 110.736 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.57 -40.45 0.02 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 115.762 1.065 . . . . 1.46 115.762 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -112.33 139.72 47.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.948 -0.737 . . . . 3.18 111.549 -135.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.02 133.0 36.11 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 106.48 -1.674 . . . . 3.18 106.48 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.18 31.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.044 0.384 . . . . 1.91 111.477 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.48 145.55 25.28 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 109.447 -0.575 . . . . 2.37 109.447 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.15 130.3 35.13 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.927 -0.768 . . . . 3.39 108.927 -174.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.94 -37.34 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.257 0.623 . . . . 2.06 112.19 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 54.82 79.71 0.14 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.8 1.24 . . . . 5.48 112.02 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.3 155.14 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.151 -2.166 . . . . 6.46 105.151 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.552 -1.213 . . . . 12.47 109.428 -159.242 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 106.399 -1.704 . . . . 9.33 106.399 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.64 158.27 26.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 109.601 -1.4 . . . . 5.73 109.601 -167.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -83.78 159.28 21.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.392 1.877 . . . . 5.46 109.072 174.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.87 100.62 0.34 Allowed Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.679 -0.568 . . . . 1.67 111.679 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.21 138.31 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.208 -1.172 . . . . 2.94 109.302 172.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.23 88.1 2.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.601 -1.629 . . . . 3.17 106.601 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -79.65 123.3 27.52 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.372 -1.714 . . . . 2.25 106.372 171.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.12 133.41 46.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.84 0.291 . . . . 3.1 110.336 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.3 145.71 9.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.57 -0.9 . . . . 3.98 108.57 172.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.4 122.0 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.211 1.004 . . . . 2.87 110.117 -169.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.48 132.96 51.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.139 -0.689 . . . . 5.7 109.139 170.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.61 -25.67 5.87 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.995 2.236 . . . . 1.86 109.149 178.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 mtp -57.2 107.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.53 0.732 . . . . 2.58 109.889 164.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -139.99 9.36 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.913 1.285 . . . . 2.44 112.588 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -172.53 147.58 1.88 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.521 1.055 . . . . 2.78 109.92 -173.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.73 -38.02 1.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.339 1.856 . . . . 1.81 113.176 178.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 p -60.58 -77.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.863 0.865 . . . . 0.85 112.04 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 p -48.59 -29.88 4.75 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.071 1.348 . . . . 3.32 112.122 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.98 -72.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 2.02 109.867 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 0.3 OUTLIER -68.62 -12.74 61.73 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.015 -1.053 . . . . 1.54 112.942 -171.367 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -52.7 -42.86 65.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.237 -1.023 . . . . 5.06 108.237 172.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.92 -60.83 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.478 1.511 . . . . 1.68 109.666 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.23 -48.32 82.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.944 -0.391 . . . . 4.78 109.944 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.31 -48.69 80.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.458 -0.942 . . . . 1.68 108.458 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -51.01 -57.29 9.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.667 1.122 . . . . 1.5 111.01 176.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.25 -38.83 75.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.006 -1.078 . . . . 2.66 111.451 -169.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -55.07 -15.65 2.29 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.985 -1.072 . . . . 2.92 113.078 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -66.42 -37.24 84.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.369 -0.832 . . . . 6.06 110.766 173.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -69.56 124.94 25.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.716 -1.216 . . . . 2.15 107.716 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.61 47.32 0.83 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.161 -0.962 . . . . 8.71 109.943 172.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.88 -17.21 0.83 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.305 1.907 . . . . 1.12 111.998 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.1 tt -105.54 138.19 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.114 -1.069 . . . . 3.7 108.114 176.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -86.06 -49.38 7.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.531 1.133 . . . . 2.77 109.803 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -152.79 162.54 41.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.717 0.407 . . . . 4.4 110.304 -176.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.58 89.5 1.56 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.219 1.008 . . . . 2.16 109.973 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.94 90.05 8.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.071 -0.714 . . . . 2.47 109.071 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -85.94 98.42 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.559 1.144 . . . . 3.52 109.304 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.73 92.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.377 0.671 . . . . 1.97 109.849 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -36.89 -44.19 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.707 2.003 . . . . 2.68 110.869 165.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.17 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.008 0.923 . . . . 1.97 112.461 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.46 14.97 10.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.077 1.351 . . . . 2.57 109.983 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 34.92 55.39 0.74 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.763 2.025 . . . . 2.17 111.876 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.01 153.54 36.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.63 -0.878 . . . . 1.87 108.63 -173.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.01 127.49 54.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.637 0.586 . . . . 2.27 109.977 163.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -86.01 91.4 8.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.02 105.706 170.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.23 137.84 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.124 -1.436 . . . . 2.79 107.124 172.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -115.31 119.05 34.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.365 -2.087 . . . . 3.01 105.365 163.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 178.85 7.39 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 127.213 2.205 . . . . 2.94 106.096 -176.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -132.23 132.63 23.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.95 . . . . 3.67 110.386 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.71 64.09 7.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.918 3.745 . . . . 2.35 112.161 -167.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -166.74 -45.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.738 1.215 . . . . 3.75 110.239 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.77 -27.11 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.184 -0.673 . . . . 3.49 109.184 174.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -154.89 150.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.771 -1.196 . . . . 2.62 107.771 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.86 166.06 33.73 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.338 -1.105 . . . . 1.68 110.338 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.47 -48.57 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.373 2.049 . . . . 1.09 110.479 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.407 HH21 ' CD2' ' A' ' 60' ' ' HIS . 25.4 tpt180 -56.96 -27.42 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.924 0.489 . . . . 9.07 111.274 -177.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -55.59 31.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.299 1.839 . . . . 3.7 109.078 175.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt -56.23 -47.21 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.62 -0.882 . . . . 1.75 108.62 174.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mm -55.84 -50.97 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 119.28 -0.391 . . . . 3.21 111.0 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.407 ' CD2' HH21 ' A' ' 56' ' ' ARG . 17.2 m170 -54.36 -46.51 73.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.162 0.985 . . . . 3.97 109.302 178.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 m -58.05 -50.08 74.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.609 -0.515 . . . . 1.84 109.609 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.93 -51.9 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.15 -0.969 . . . . 2.04 111.782 178.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -50.86 -56.68 11.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.438 1.095 . . . . 3.13 109.241 175.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.3 t -52.34 -51.46 58.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.741 1.616 . . . . 1.88 111.365 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.49 -41.21 89.25 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.45 -0.781 . . . . 4.09 111.85 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.27 -50.52 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.328 -0.939 . . . . 1.5 114.624 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.58 144.99 38.61 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 118.973 -1.091 . . . . 3.23 113.806 -128.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.1 59.4 3.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.345 -0.613 . . . . 4.28 109.345 -176.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.82 168.47 19.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.689 0.626 . . . . 2.52 112.689 -166.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.06 132.01 10.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.819 -0.808 . . . . 2.47 108.819 173.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 130.73 47.88 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.864 -0.791 . . . . 3.25 108.864 167.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.67 173.67 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.322 -0.992 . . . . 3.56 108.322 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 75' ' ' GLU . 3.8 mmmp? -134.71 77.7 1.7 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.895 -0.78 . . . . 7.18 108.895 172.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mt -63.62 -47.85 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.485 -0.932 . . . . 5.84 108.485 171.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 7.8 pt-20 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 103.875 -2.639 . . . . 9.38 103.875 158.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttm . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 105.515 -2.032 . . . . 9.06 105.515 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.76 157.04 2.13 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 108.06 -2.016 . . . . 5.87 108.06 -132.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -96.7 159.89 14.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.151 1.781 . . . . 5.53 108.932 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.71 162.69 50.74 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 121.803 0.669 . . . . 1.95 111.794 -171.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.24 149.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.987 -0.713 . . . . 3.14 110.071 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 tp -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.433 1.893 . . . . 3.42 106.346 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -128.81 157.37 41.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.05 -1.092 . . . . 2.62 108.05 163.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.69 142.92 49.94 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.358 1.036 . . . . 3.93 108.997 162.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.8 t -76.84 128.92 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.797 -1.927 . . . . 2.94 105.797 165.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.93 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.375 -1.343 . . . . 3.02 107.375 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.97 142.72 45.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.09 -1.448 . . . . 5.62 107.09 166.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.2 -47.63 1.34 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.726 -0.95 . . . . 1.49 110.726 167.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.82 143.57 54.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.229 -0.656 . . . . 3.32 109.229 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.62 -66.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.289 -0.257 . . . . 3.92 110.969 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -64.14 148.06 50.83 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.642 -0.661 . . . . 3.13 110.983 -171.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.35 -47.11 0.29 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.278 1.831 . . . . 2.05 112.507 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.2 p -60.08 -37.59 80.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.556 1.543 . . . . 1.29 113.64 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.65 -46.98 28.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.612 -1.305 . . . . 2.19 109.756 172.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.87 -67.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.292 1.037 . . . . 2.03 111.157 177.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -27.1 64.33 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.792 -0.568 . . . . 1.38 111.161 -173.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.06 -53.2 60.04 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.18 -0.914 . . . . 5.45 108.994 175.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.82 -55.68 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.423 1.01 . . . . 1.85 109.862 174.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -51.67 -59.26 4.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.275 -0.269 . . . . 3.16 110.275 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -53.82 -43.37 69.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 2.03 111.812 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -60.07 -50.42 73.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.28 1.032 . . . . 2.54 109.181 -176.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.42 -37.27 71.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.078 -0.649 . . . . 3.36 112.097 179.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -53.57 -23.99 12.4 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.029 -1.044 . . . . 2.64 113.458 177.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -60.21 -31.35 70.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.759 1.163 . . . . 7.67 112.18 174.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -70.52 148.52 48.14 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.867 0.758 . . . . 2.25 109.05 -175.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -105.25 37.77 2.11 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.788 -0.57 . . . . 7.46 111.905 -171.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.03 24.56 0.61 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.12 -0.392 . . . . 1.41 112.12 170.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -114.01 134.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.107 -1.812 . . . . 3.8 106.107 168.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.25 -40.11 10.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 2.68 109.069 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.53 136.89 14.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.201 -0.296 . . . . 3.32 110.201 178.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.91 132.61 56.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.962 -2.607 . . . . 2.34 103.962 164.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.6 t -138.22 138.17 38.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 117.977 -1.489 . . . . 3.84 109.096 146.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.286 6.7 p -106.03 94.32 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 122.638 1.209 . . . . 3.12 110.512 -174.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.23 88.62 6.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.495 -0.928 . . . . 1.67 108.495 -168.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tt -30.67 -50.02 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.048 2.139 . . . . 3.12 111.996 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.74 -32.56 52.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.19 0.996 . . . . 2.05 112.754 -175.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -118.93 15.24 13.37 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.7 1.6 . . . . 2.49 110.212 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 16.89 58.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.968 2.907 . . . . 3.31 114.597 -167.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 148.65 52.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.523 -0.917 . . . . 1.79 108.523 178.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.88 111.59 23.94 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.167 -2.16 . . . . 1.57 105.167 169.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -79.6 120.58 24.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.577 -1.638 . . . . 0.95 106.577 167.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mt -125.6 97.28 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 O-C-N 124.592 1.183 . . . . 2.1 107.882 -171.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -80.53 120.89 25.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.779 -1.563 . . . . 3.34 106.779 166.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.18 164.29 15.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.819 -1.549 . . . . 4.05 106.819 -165.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.06 132.54 24.4 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 108.245 -1.02 . . . . 4.03 108.245 172.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.65 -52.74 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.992 2.462 . . . . 2.42 112.466 -160.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.83 -32.84 46.56 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.252 0.834 . . . . 3.13 113.252 -172.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 pt -88.49 5.51 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.322 0.86 . . . . 3.88 113.322 -177.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.39 -52.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.531 1.06 . . . . 3.35 111.584 -172.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.48 114.0 0.37 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 108.97 -1.652 . . . . 1.87 108.97 -171.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -56.9 -31.77 90.27 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 119.991 1.896 . . . . 1.06 111.204 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -54.16 -36.79 63.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.956 -0.545 . . . . 7.8 112.034 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -67.16 -47.0 72.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.396 0.998 . . . . 4.2 110.352 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 mt -54.92 -51.83 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.653 -0.654 . . . . 1.78 110.601 170.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.35 -52.87 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 119.007 -0.52 . . . . 2.62 110.125 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -46.32 -47.95 18.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.305 1.042 . . . . 3.56 109.25 174.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.0 m -62.86 -49.53 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.107 -0.637 . . . . 1.68 110.663 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.58 -51.12 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.414 0.686 . . . . 1.79 111.162 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.65 -40.18 76.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.867 0.303 . . . . 3.13 111.634 179.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -65.35 -23.17 66.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 117.507 -1.235 . . . . 1.24 112.524 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.84 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.52 1.509 . . . . 2.65 109.407 165.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.99 19.04 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.319 -1.267 . . . . 1.32 114.943 174.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -136.1 116.35 13.52 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.367 1.584 . . . . 3.34 110.251 -163.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 154.46 37.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 117.109 -1.836 . . . . 4.26 107.568 177.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.11 164.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.797 0.839 . . . . 1.99 110.53 -173.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.9 m -148.63 92.91 2.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.472 -0.936 . . . . 2.23 108.472 171.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -55.11 126.47 24.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.855 0.862 . . . . 3.78 110.963 174.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.46 146.32 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.393 1.077 . . . . 2.55 109.088 -172.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -66.19 -52.94 43.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.44 -0.578 . . . . 6.18 109.44 175.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.313 12.6 tt 43.66 -135.67 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.535 1.134 . . . . 5.81 110.443 -169.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 104.589 -2.375 . . . . 10.34 104.589 177.975 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtm . . . . . 0 N--CA 1.475 0.818 0 CA-C-O 121.161 0.505 . . . . 8.58 110.424 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.49 52.9 0.12 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 104.591 -3.404 . . . . 6.53 104.591 176.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 169.45 143.83 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.6 2.36 . . . . 4.93 106.619 -156.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.6 139.48 9.14 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 107.165 -2.374 . . . . 1.84 107.165 169.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.4 139.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.708 -0.849 . . . . 4.21 108.708 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.32 87.67 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.333 -1.728 . . . . 2.92 106.333 167.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.1 134.06 36.74 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 118.156 -1.417 . . . . 2.57 108.27 167.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 146.88 46.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 124.23 0.956 . . . . 3.87 108.716 164.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.14 135.51 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.662 -1.977 . . . . 2.85 105.662 169.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.8 135.38 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.541 1.536 . . . . 4.04 108.258 -177.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -145.64 136.03 24.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.861 -2.274 . . . . 5.92 104.861 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.75 -53.82 0.65 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.74 -1.744 . . . . 1.64 108.74 -171.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 ptm -65.5 149.71 49.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.395 -0.474 . . . . 2.73 110.623 173.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.13 -1.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.633 0.975 . . . . 2.64 113.633 -168.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -169.21 157.53 7.71 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.021 1.282 . . . . 3.19 109.848 -166.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.55 -50.46 1.13 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.183 2.193 . . . . 2.26 113.267 -174.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -33.45 75.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.063 1.345 . . . . 1.59 113.056 -176.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.9 m -72.56 -53.92 10.61 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.377 -1.342 . . . . 1.94 107.377 168.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -43.99 -64.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.637 1.575 . . . . 2.11 111.689 -173.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -16.21 64.14 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.038 -0.414 . . . . 1.85 111.749 -173.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.5 98.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.668 -0.864 . . . . 5.68 108.668 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -60.49 -58.63 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.169 -1.049 . . . . 2.0 108.169 -178.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -53.73 -56.28 18.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.092 0.557 . . . . 3.15 110.803 178.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -49.52 -45.03 46.79 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.569 0.748 . . . . 1.38 111.235 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.7 t -63.14 -61.04 2.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.445 0.698 . . . . 1.49 110.774 175.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.96 -39.49 94.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.009 -1.076 . . . . 2.8 111.405 -168.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 m -53.4 -16.92 1.57 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.202 0.815 . . . . 2.69 113.202 176.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -61.72 -42.82 99.46 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.036 -1.04 . . . . 5.69 111.212 171.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.46 135.63 39.39 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.285 -0.635 . . . . 2.45 109.285 -176.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -78.97 -1.53 35.81 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.718 -0.613 . . . . 7.21 112.639 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.94 -19.21 56.55 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.381 0.537 . . . . 0.9 112.664 -178.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.1 tt -93.81 137.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.913 -0.773 . . . . 3.72 108.913 175.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.27 -38.36 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.428 1.491 . . . . 2.32 110.087 -174.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -140.16 149.78 43.4 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.919 -0.771 . . . . 4.04 108.919 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 t -153.99 119.12 5.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 106.593 -1.632 . . . . 2.17 106.593 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -145.85 111.21 5.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.062 -0.718 . . . . 2.8 109.062 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.88 108.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.586 0.708 . . . . 2.98 111.321 -175.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.33 101.7 10.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.004 0.922 . . . . 1.9 109.472 -170.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -43.08 -38.92 2.53 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.706 1.202 . . . . 3.38 111.222 168.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.53 -29.18 23.92 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.914 0.886 . . . . 2.14 112.065 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -128.06 16.03 6.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.49 1.116 . . . . 2.4 109.9 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 35.06 47.23 0.26 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.309 1.843 . . . . 2.57 112.569 -174.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.27 145.71 41.63 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.75 -0.594 . . . . 1.95 110.457 -171.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.96 106.88 17.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.711 -1.589 . . . . 1.68 106.711 172.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -79.44 98.63 6.86 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.43 -1.693 . . . . 1.07 106.43 168.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.45 140.74 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.897 -1.89 . . . . 2.73 105.897 164.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.13 132.21 55.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.452 -1.314 . . . . 3.36 107.452 156.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -148.92 169.12 21.27 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.943 0.897 . . . . 3.29 109.5 -172.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.68 111.33 55.34 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.666 -0.683 . . . . 3.7 109.34 174.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.12 52.05 3.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.048 3.165 . . . . 2.3 112.362 -176.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -139.78 -64.57 0.48 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.467 1.507 . . . . 4.13 107.294 178.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.28 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.118 0.967 . . . . 5.1 111.364 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 142.84 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.851 -1.537 . . . . 2.69 106.851 176.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.05 159.29 35.66 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.045 -1.222 . . . . 2.03 110.045 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.69 -47.31 11.49 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.825 1.683 . . . . 0.98 110.054 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -48.43 -42.33 31.93 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 122.999 0.52 . . . . 7.61 111.952 178.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -51.71 54.56 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.414 1.486 . . . . 3.47 109.723 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mt -60.88 -52.23 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.427 -0.806 . . . . 1.78 109.364 175.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.77 -54.13 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 118.602 0.637 . . . . 3.08 110.411 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -47.67 -53.2 15.64 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.581 1.553 . . . . 3.87 109.789 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.1 m -56.35 -51.33 68.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.456 . . . . 1.84 109.855 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.5 -53.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 O-C-N 121.993 -0.442 . . . . 2.03 110.742 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.9 -47.63 84.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.963 0.802 . . . . 3.89 110.195 -178.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -68.94 -9.86 54.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.928 -1.035 . . . . 1.32 113.023 -175.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.01 -78.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.253 1.388 . . . . 3.67 108.396 158.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.19 26.89 0.32 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.61 -1.106 . . . . 1.05 114.55 171.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -125.36 172.76 9.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.061 1.43 . . . . 3.16 113.36 -160.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 70.38 0.82 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.342 1.068 . . . . 3.81 108.666 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.41 144.51 35.8 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.329 -0.857 . . . . 1.95 111.274 -165.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -151.29 110.09 3.85 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.166 -0.959 . . . . 2.52 113.089 -172.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 76.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.475 2.31 . . . . 3.45 115.189 -175.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.8 m -60.25 -45.94 95.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 124.241 1.016 . . . . 2.11 112.331 168.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm 59.34 47.45 11.33 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.548 -1.345 . . . . 6.92 111.042 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mp 57.47 67.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.049 -0.723 . . . . 5.76 109.049 -167.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 N-CA-C 103.861 -2.644 . . . . 9.33 103.861 162.189 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 107.329 -1.36 . . . . 9.5 107.329 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.89 178.46 6.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 108.232 -1.947 . . . . 5.25 108.232 -142.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.91 114.98 1.94 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.748 1.219 . . . . 5.51 110.657 -179.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.59 111.07 3.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.148 -2.781 . . . . 1.92 106.148 159.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.43 137.34 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.655 1.228 . . . . 3.4 109.598 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.36 79.47 1.61 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.88 1.324 . . . . 2.98 107.935 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.37 102.06 8.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.012 -1.477 . . . . 2.79 107.012 168.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.31 141.28 47.21 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.698 0.399 . . . . 3.02 109.951 176.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.38 140.86 16.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.986 -1.486 . . . . 2.86 106.986 172.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -117.46 107.46 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.433 -1.321 . . . . 2.64 107.433 174.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -78.19 137.91 38.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.114 -1.439 . . . . 6.3 107.114 170.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.08 -41.44 2.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 123.965 0.793 . . . . 1.57 111.415 161.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -58.61 143.05 47.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.574 -0.368 . . . . 2.96 111.632 -178.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -145.85 142.0 28.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.44 1.096 . . . . 3.0 110.543 177.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.9 m 69.68 164.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.096 1.758 . . . . 3.92 114.186 167.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.61 -35.51 2.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.67 1.988 . . . . 1.84 112.194 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -55.63 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.169 0.988 . . . . 1.0 112.268 173.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -54.37 -37.62 65.19 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 120.831 -1.168 . . . . 2.06 109.623 -177.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -49.21 -65.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.893 0.477 . . . . 2.01 111.157 172.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.274 0.2 OUTLIER -68.12 -22.42 64.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.759 -0.588 . . . . 1.59 111.486 -175.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -60.28 -56.24 23.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.095 -1.076 . . . . 4.19 108.095 174.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.8 mt -57.62 -58.61 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.693 -0.854 . . . . 1.69 108.693 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.86 -56.47 21.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.369 0.531 . . . . 3.12 111.643 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -59.28 -38.86 81.18 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.742 -0.598 . . . . 1.71 111.243 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -65.28 -61.39 2.15 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.829 -0.545 . . . . 1.77 110.543 175.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.27 -31.61 72.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.429 -0.794 . . . . 3.77 111.963 -169.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.4 -10.49 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.666 1.121 . . . . 3.44 113.514 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -69.13 -21.2 64.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.435 1.016 . . . . 6.35 112.212 170.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -69.53 115.59 8.96 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.613 0.765 . . . . 2.35 109.362 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -78.57 46.26 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.41 -0.806 . . . . 7.96 112.659 -174.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.05 24.6 0.1 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.271 1.415 . . . . 1.42 110.785 170.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.14 122.11 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.416 -1.698 . . . . 3.41 106.416 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.9 mt -85.18 -38.54 18.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.735 0.814 . . . . 3.04 109.204 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -155.17 156.33 35.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.377 -1.342 . . . . 3.93 107.377 -176.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.2 t -146.67 59.75 1.2 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.03 -1.1 . . . . 2.55 108.03 178.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.38 94.28 3.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.356 -0.979 . . . . 3.49 108.356 -163.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.346 2.6 p -90.06 83.95 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 123.579 1.657 . . . . 2.67 111.242 -169.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.94 87.06 4.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.68 -1.145 . . . . 1.72 108.772 -178.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -40.34 -44.02 1.87 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.297 1.439 . . . . 3.57 110.632 162.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.03 -37.03 0.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.815 1.646 . . . . 2.27 113.556 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -132.43 26.0 4.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.114 1.366 . . . . 3.83 109.688 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 29.92 52.8 0.11 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.36 2.664 . . . . 2.09 112.571 -175.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 154.53 42.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.602 0.593 . . . . 4.29 112.602 -178.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.1 106.72 17.37 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.232 1.813 . . . . 1.66 109.508 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -78.78 83.09 4.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.517 -1.661 . . . . 1.63 106.517 167.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -79.06 145.48 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.522 -1.288 . . . . 2.66 107.522 173.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.4 134.85 50.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.299 -2.482 . . . . 3.82 104.299 161.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.88 172.28 17.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.773 0.715 . . . . 2.96 109.803 -168.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.74 81.78 1.23 Allowed Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.24 1.416 . . . . 4.48 107.952 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.72 -35.48 47.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.302 2.668 . . . . 1.67 112.733 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.95 -20.47 6.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.125 1.157 . . . . 4.35 114.125 176.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.9 pt -120.43 -57.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 119.621 1.101 . . . . 3.35 111.702 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tp -87.46 -36.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.007 -0.368 . . . . 3.26 110.007 -161.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.53 149.94 3.18 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.49 -0.644 . . . . 2.36 111.49 -177.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.52 -41.16 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.242 1.961 . . . . 0.89 110.33 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -54.61 -37.65 65.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.965 0.906 . . . . 7.55 111.148 -176.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -57.81 11.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.79 0.436 . . . . 3.68 110.821 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -54.42 -45.32 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 2.48 110.02 176.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -56.32 -51.59 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.626 -0.671 . . . . 2.39 111.322 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -49.39 -47.12 47.98 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.512 0.725 . . . . 3.66 109.279 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -49.68 76.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 119.681 -0.807 . . . . 2.4 109.645 -177.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.12 -50.32 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.545 0.338 . . . . 1.83 111.561 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.9 -46.63 83.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.405 -0.518 . . . . 4.13 111.042 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.6 t -57.55 -44.63 85.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.557 0.743 . . . . 1.81 111.232 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.8 -54.4 46.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.376 -0.828 . . . . 2.6 110.738 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.55 -42.13 0.02 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.859 1.104 . . . . 1.52 115.859 -178.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.79 134.47 55.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.376 -0.821 . . . . 3.22 111.138 -131.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.24 104.31 6.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.6 1.546 . . . . 4.6 108.715 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.98 154.34 29.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.921 0.889 . . . . 2.04 110.331 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -152.87 103.93 2.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 2.3 109.52 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -66.62 71.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.14 1.376 . . . . 3.59 112.643 177.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.78 -49.93 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 123.996 0.918 . . . . 2.45 111.082 176.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? 67.24 152.97 0.08 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.243 1.017 . . . . 5.51 109.324 -166.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -66.97 -51.99 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.654 -1.239 . . . . 5.86 107.654 167.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 . . . . . 0 C--O 1.259 1.57 0 N-CA-C 102.034 -3.321 . . . . 9.8 102.034 164.182 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mtm . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 108.905 -0.776 . . . . 8.28 108.905 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.81 -112.62 4.97 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 106.021 -2.832 . . . . 5.28 106.021 -165.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.91 142.33 18.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.565 -1.272 . . . . 5.06 107.565 153.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.47 84.43 0.44 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.46 -1.456 . . . . 2.05 109.46 174.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.33 129.35 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.236 -0.653 . . . . 2.85 109.236 -174.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -140.51 101.04 4.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.918 0.866 . . . . 4.13 109.105 -169.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.41 106.15 18.14 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.019 -1.104 . . . . 2.15 108.019 178.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.93 139.49 48.53 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.303 0.501 . . . . 3.06 110.343 170.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.15 143.77 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.125 -1.435 . . . . 2.66 107.125 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.75 156.02 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.33 -1.359 . . . . 2.92 107.33 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -138.34 122.23 17.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.405 1.082 . . . . 9.1 108.218 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.5 -45.79 1.13 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.925 -1.27 . . . . 1.54 109.925 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -56.0 140.4 43.43 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.851 -0.426 . . . . 2.73 109.851 170.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -166.32 22.79 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.83 0.308 . . . . 2.73 111.83 -172.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -169.33 147.2 3.64 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.11 0.868 . . . . 2.69 109.377 -174.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.0 0.38 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.017 2.127 . . . . 1.91 113.167 175.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 p -54.5 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.846 0.858 . . . . 0.92 111.659 172.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -41.32 -47.37 3.47 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 125.5 1.52 . . . . 2.17 110.834 176.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 t -46.63 -66.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.603 1.161 . . . . 1.72 110.933 173.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.318 0.3 OUTLIER -69.82 -17.61 63.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 119.692 -0.803 . . . . 1.83 111.302 -176.087 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -69.11 -45.02 71.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.31 -0.996 . . . . 3.98 108.31 -176.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.4 mt -53.7 -69.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.702 -0.851 . . . . 1.68 108.702 175.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.54 -59.08 3.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.522 0.729 . . . . 3.7 112.548 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -54.88 -41.76 71.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.232 0.613 . . . . 1.77 110.37 -177.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -61.4 -61.07 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.095 -0.378 . . . . 1.64 110.96 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.35 -35.63 79.72 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 118.627 -1.229 . . . . 2.72 111.406 -169.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -57.89 -13.98 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.109 0.411 . . . . 2.46 112.109 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -61.99 -40.68 96.46 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.093 -1.005 . . . . 5.11 111.15 169.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -67.78 122.44 18.11 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.454 -0.573 . . . . 2.17 109.454 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.68 48.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.173 -0.954 . . . . 7.13 111.095 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.94 0.1 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.08 1.324 . . . . 1.05 111.524 -178.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.37 142.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.052 -0.721 . . . . 3.66 109.052 173.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.96 -34.14 9.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.814 1.246 . . . . 2.61 110.461 -176.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -154.65 155.26 34.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.154 -0.684 . . . . 4.02 109.154 -175.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.7 t -155.76 80.08 1.01 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.73 0.812 . . . . 2.25 110.569 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -86.21 97.18 10.22 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.466 -0.771 . . . . 2.4 110.321 172.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -85.08 80.23 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.77 1.628 . . . . 3.2 108.651 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.18 93.92 9.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.856 -0.794 . . . . 1.69 108.856 -174.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -46.8 -35.49 6.32 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.448 1.099 . . . . 2.78 111.862 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.53 -30.39 41.41 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.567 0.747 . . . . 1.78 111.878 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -121.1 13.35 11.25 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.524 1.53 . . . . 2.42 109.782 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.04 33.19 6.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.167 2.187 . . . . 2.54 112.979 176.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.01 147.47 46.27 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.353 0.661 . . . . 1.89 111.57 -161.397 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.88 108.69 20.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.818 1.647 . . . . 1.66 108.657 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.96 87.41 4.78 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.804 -2.295 . . . . 1.05 104.804 162.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.8 mt -79.67 150.28 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.896 -1.52 . . . . 2.45 106.896 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -126.65 122.55 35.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 104.824 -2.287 . . . . 3.47 104.824 156.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -145.6 128.87 16.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 107.341 -1.355 . . . . 3.97 107.341 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.3 121.61 75.31 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 106.942 -1.503 . . . . 3.59 106.942 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.93 -46.63 18.59 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.378 2.052 . . . . 2.08 112.799 -165.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -56.94 -8.86 0.69 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.964 1.706 . . . . 3.61 115.249 -166.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 pt -115.17 -10.18 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.415 1.086 . . . . 3.15 113.65 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.89 -42.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.736 1.153 . . . . 2.92 113.097 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.91 153.44 5.33 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.6 -1.0 . . . . 2.15 110.6 -174.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.59 -35.48 17.03 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.261 1.974 . . . . 1.09 110.652 -174.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 -37.28 61.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.358 0.663 . . . . 7.99 112.291 -172.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.11 -58.09 9.72 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.227 0.467 . . . . 4.36 110.024 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mp -51.29 -49.71 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.287 -0.635 . . . . 2.65 109.287 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.83 -54.16 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.971 -0.537 . . . . 3.03 110.783 179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -48.84 -52.07 26.18 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.498 0.719 . . . . 3.82 109.844 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -56.07 -51.57 67.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 122.123 -0.361 . . . . 1.94 110.487 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.0 mt -55.74 -47.73 78.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.748 -0.595 . . . . 1.98 111.877 -176.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.343 0.519 . . . . 4.9 111.477 176.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -66.85 -15.62 63.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.243 -0.884 . . . . 1.54 112.466 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.33 -89.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.602 -1.258 . . . . 4.03 107.602 155.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.49 20.23 0.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.898 -1.501 . . . . 1.36 114.8 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -123.76 139.05 54.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.957 1.878 . . . . 3.25 113.121 -160.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -77.33 139.59 39.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.049 -1.463 . . . . 4.28 107.049 171.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.02 146.58 43.95 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.509 1.124 . . . . 2.19 109.357 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -153.06 112.25 3.81 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 121.673 -0.642 . . . . 2.21 110.575 176.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.06 121.36 7.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.847 0.859 . . . . 3.76 109.347 173.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 m -104.01 -42.56 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.293 0.637 . . . . 2.24 110.287 172.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.3 83.44 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.436 . . . . 5.45 111.331 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.11 150.02 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.282 0.633 . . . . 6.53 110.733 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 129.087 2.955 . . . . 9.3 103.512 167.586 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ptp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 106.976 -1.49 . . . . 9.78 106.976 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.25 -61.71 2.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.87 -2.092 . . . . 6.0 107.87 -169.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.29 -179.89 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.497 0.665 . . . . 10.01 109.838 151.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.57 -41.26 1.05 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.609 -1.396 . . . . 2.91 109.609 -159.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.18 147.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.134 1.373 . . . . 3.63 109.994 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -145.31 103.77 3.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 4.13 108.6 175.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.97 117.8 31.97 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.025 -0.989 . . . . 2.22 108.47 178.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.58 142.12 50.46 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.515 0.598 . . . . 2.95 110.851 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.71 134.84 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 107.033 -1.469 . . . . 3.08 107.033 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.61 119.87 60.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.839 1.256 . . . . 2.68 107.687 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -87.14 62.8 7.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.125 0.57 . . . . 6.77 110.484 -164.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.54 -104.63 0.2 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.69 -0.964 . . . . 3.57 110.69 174.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mtm 57.66 65.53 1.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.419 1.087 . . . . 2.53 111.873 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 p -65.97 -23.81 66.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.356 1.243 . . . . 4.13 114.356 -168.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.3 t -166.66 155.48 10.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.786 0.721 . . . . 2.56 109.143 -165.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.64 -39.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.659 2.384 . . . . 1.69 113.301 172.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 p -52.98 -76.08 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.603 1.161 . . . . 0.88 112.726 169.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.2 m -46.97 -41.03 15.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.165 1.786 . . . . 2.28 111.124 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.1 t -51.72 -73.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.931 0.893 . . . . 2.14 110.01 168.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.301 0.3 OUTLIER -67.31 -14.86 63.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.388 0.613 . . . . 1.81 112.275 -167.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.05 -42.15 93.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.032 -1.042 . . . . 5.62 108.494 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.46 -65.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.712 -0.847 . . . . 1.61 108.712 -175.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.21 -66.16 0.45 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.107 0.963 . . . . 3.82 112.234 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -47.55 -45.28 26.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.591 0.756 . . . . 1.46 111.068 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 t -60.95 -62.56 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.224 0.466 . . . . 1.82 111.12 175.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.59 -31.5 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.122 0.874 . . . . 2.9 111.163 -171.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 m -54.31 -19.54 5.56 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.116 -0.99 . . . . 2.79 112.646 176.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -37.97 77.4 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.711 -1.243 . . . . 6.76 112.59 170.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.86 165.09 16.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 2.76 109.992 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.92 42.13 3.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.758 0.823 . . . . 8.52 110.032 169.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.84 18.4 3.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.222 -1.151 . . . . 1.13 110.222 164.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.71 148.93 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.807 -2.294 . . . . 4.82 104.807 167.154 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.34 -37.12 5.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.784 1.233 . . . . 2.94 110.276 -174.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -157.63 162.4 38.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.675 -0.861 . . . . 3.97 108.675 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -143.37 73.85 1.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.194 0.997 . . . . 3.07 110.779 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.85 83.6 5.75 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.161 -0.681 . . . . 2.75 109.161 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.4 103.43 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.522 0.677 . . . . 2.72 110.503 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.71 100.16 9.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.383 1.073 . . . . 1.73 108.906 -172.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -38.18 4.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.254 1.422 . . . . 3.15 110.575 170.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.85 39.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.394 1.078 . . . . 1.7 112.262 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.24 16.0 10.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.641 1.177 . . . . 2.32 109.688 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.08 43.51 1.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.212 2.205 . . . . 2.09 112.512 -178.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.17 144.34 34.74 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 122.149 -0.345 . . . . 2.0 110.826 -166.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.65 108.13 20.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.443 1.497 . . . . 1.58 108.556 168.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.79 83.44 7.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.354 -2.091 . . . . 0.86 105.354 157.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 59.8 mt -83.06 153.29 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.32 -1.733 . . . . 2.1 106.32 170.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -121.76 141.98 50.65 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.876 -1.898 . . . . 4.83 105.876 166.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.09 165.5 24.6 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 118.742 0.701 . . . . 3.1 112.186 -163.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.74 97.46 44.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 123.986 0.804 . . . . 4.2 110.736 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.72 -21.05 72.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.839 2.359 . . . . 1.73 114.641 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.44 -31.18 14.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.973 0.806 . . . . 4.11 111.875 168.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -66.86 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 123.229 0.611 . . . . 5.77 110.208 175.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.29 116.02 41.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.333 -0.988 . . . . 2.69 108.333 -166.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.16 161.91 38.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.378 -1.489 . . . . 1.83 109.378 -176.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -54.03 -37.88 86.68 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.856 1.704 . . . . 1.17 109.485 171.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 57' ' ' ASP . 12.8 ptt180 -35.96 -53.39 0.76 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 11.63 112.05 168.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 56' ' ' ARG . 64.6 m-20 -71.52 -52.02 20.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.709 -1.589 . . . . 2.96 106.709 -164.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -56.08 -52.37 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.384 -1.28 . . . . 2.13 109.406 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -53.38 -56.59 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.042 0.537 . . . . 2.55 109.683 179.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -56.93 -38.1 72.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.206 0.457 . . . . 4.2 110.247 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.7 m -65.08 -46.89 79.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.259 0.481 . . . . 1.87 110.609 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.78 -46.43 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.294 1.038 . . . . 1.76 110.431 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.28 -55.65 28.96 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 123.575 0.75 . . . . 2.94 109.672 173.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -51.85 -46.6 64.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.636 1.174 . . . . 1.75 111.357 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.79 -45.24 79.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.219 -0.926 . . . . 2.77 112.107 177.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.86 -46.46 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.999 0.76 . . . . 1.49 114.999 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -129.13 134.78 48.2 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 120.482 -0.487 . . . . 3.16 112.011 -135.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.46 154.94 32.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.731 -1.211 . . . . 3.27 107.731 168.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.29 165.08 28.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.907 0.483 . . . . 2.16 110.962 -166.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 m -132.58 112.09 11.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.571 1.549 . . . . 3.5 107.949 177.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 tp -73.1 78.59 1.23 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.796 1.238 . . . . 4.08 108.698 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.69 -36.61 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.583 -0.735 . . . . 2.01 111.377 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.88 68.68 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.365 1.866 . . . . 5.27 112.332 -179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.1 pt -46.27 147.26 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.388 1.075 . . . . 5.91 111.014 176.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 128.013 2.525 . . . . 10.62 113.074 -165.682 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 106.058 -1.83 . . . . 11.05 106.058 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.75 171.17 40.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 107.735 -2.146 . . . . 4.91 107.735 177.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.55 162.96 1.43 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.13 1.372 . . . . 5.27 112.785 -174.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.9 171.89 39.7 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.385 -1.086 . . . . 2.14 110.385 152.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.89 132.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.188 -1.412 . . . . 3.14 107.188 163.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.85 124.42 44.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 103.771 -2.677 . . . . 4.49 103.771 169.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.4 127.03 40.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.096 -1.816 . . . . 2.46 106.096 -179.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.94 144.97 35.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.283 -0.266 . . . . 2.9 110.283 -172.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.84 139.29 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.212 -1.403 . . . . 3.12 107.212 168.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.98 99.49 6.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 126.235 1.814 . . . . 3.12 108.031 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -84.86 140.9 30.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.464 1.106 . . . . 6.29 108.061 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.92 -11.63 34.65 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.328 0.966 . . . . 1.65 112.818 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.72 146.89 53.33 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.292 1.046 . . . . 2.78 111.295 177.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -162.04 143.47 10.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.875 -1.898 . . . . 2.97 105.875 166.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.4 t 69.64 145.58 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.351 1.46 . . . . 3.18 113.147 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.19 -32.32 0.47 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.248 1.819 . . . . 1.8 113.176 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 p -51.66 -81.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.724 1.209 . . . . 1.01 112.936 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.5 m -45.7 -43.67 12.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.835 1.254 . . . . 2.17 110.68 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.1 -65.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.444 1.098 . . . . 2.32 110.976 174.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.293 0.3 OUTLIER -68.91 -20.21 64.23 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.549 0.69 . . . . 1.93 111.003 -176.559 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.03 -40.46 97.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.92 -1.113 . . . . 5.06 109.023 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.7 -67.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.933 0.893 . . . . 1.88 109.096 176.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.99 -64.17 0.87 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.942 0.497 . . . . 3.48 111.64 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -48.48 -47.56 38.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.933 0.893 . . . . 3.89 111.935 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 t -67.82 -39.94 83.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 O-C-N 121.336 -0.852 . . . . 1.55 112.285 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.97 -37.57 69.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.672 1.124 . . . . 2.83 110.937 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -68.87 73.13 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.17 1.388 . . . . 2.55 110.091 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 129.36 3.064 . . . . 6.57 109.648 -172.396 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -54.17 -40.79 67.82 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 119.114 0.87 . . . . 2.59 112.282 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 77.91 -5.17 2.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.674 2.389 . . . . 8.39 111.338 -163.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.53 47.09 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 121.304 -0.873 . . . . 1.66 111.456 176.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.28 133.93 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.114 1.366 . . . . 4.65 107.894 173.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -102.16 -31.89 10.37 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.413 1.085 . . . . 2.64 110.731 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -155.1 153.61 31.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.821 -0.609 . . . . 3.35 109.715 174.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -150.02 96.17 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.272 1.029 . . . . 2.03 110.846 -171.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.9 104.39 16.28 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.141 -0.689 . . . . 2.67 109.141 171.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.6 82.45 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.996 0.918 . . . . 3.51 108.85 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 90.21 6.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.071 -1.085 . . . . 1.86 108.071 -176.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -47.56 -32.68 5.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.773 0.829 . . . . 2.78 111.304 169.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.75 -32.57 31.18 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.941 0.896 . . . . 2.03 111.876 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -122.53 18.05 10.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.405 1.482 . . . . 2.49 109.68 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 m120 36.83 45.16 0.4 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.965 2.106 . . . . 2.65 112.916 -175.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.28 143.99 42.45 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.493 0.588 . . . . 2.59 111.82 -174.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.11 112.91 24.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.427 1.491 . . . . 1.64 108.131 168.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -86.23 105.68 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.475 -1.676 . . . . 1.04 106.475 164.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.72 103.62 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.586 1.554 . . . . 2.09 108.338 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.34 83.66 4.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.57 -1.641 . . . . 4.24 106.57 172.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 165.0 14.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.287 1.035 . . . . 3.1 112.3 177.233 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.97 101.12 39.59 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.394 1.078 . . . . 3.78 110.195 174.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 60.62 6.88 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.489 3.46 . . . . 2.31 113.796 -166.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -157.23 -40.07 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.657 0.783 . . . . 4.17 111.42 167.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.06 -13.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.208 0.603 . . . . 3.05 110.249 174.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -149.48 144.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 108.071 -1.085 . . . . 2.31 108.071 175.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.4 148.75 20.8 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 108.317 -1.913 . . . . 2.18 108.317 170.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.46 -42.93 56.19 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.466 1.444 . . . . 0.89 109.702 178.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.59 -42.28 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.173 1.389 . . . . 8.55 113.218 168.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.26 -41.6 76.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.262 0.937 . . . . 3.32 109.597 -175.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 mt -63.59 -49.27 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.422 -0.955 . . . . 1.58 108.422 176.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -50.0 -56.85 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.879 -0.415 . . . . 2.83 109.879 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -51.49 -51.66 53.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.073 0.549 . . . . 3.93 110.114 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.6 m -58.97 -52.57 65.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.625 -0.43 . . . . 1.89 110.056 -176.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.83 -60.55 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.862 0.865 . . . . 1.89 110.024 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.4 -45.06 80.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.802 -0.444 . . . . 3.87 109.802 -176.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -62.97 -9.17 8.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.227 -1.368 . . . . 1.12 114.278 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.76 -87.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 121.359 1.89 . . . . 3.87 107.808 155.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.13 42.49 0.47 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.833 -0.982 . . . . 1.22 112.307 174.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.4 170.83 11.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.327 1.064 . . . . 3.27 112.912 -171.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -117.42 122.47 43.89 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 104.684 -2.339 . . . . 3.45 104.684 167.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.79 154.82 26.74 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.732 0.813 . . . . 2.11 111.073 -171.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.4 m -156.24 121.46 4.76 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.455 -0.778 . . . . 2.18 110.363 172.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.44 128.62 38.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 4.74 110.149 173.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.32 158.24 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.547 1.539 . . . . 2.37 109.528 178.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -87.4 72.72 9.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.155 -0.966 . . . . 5.76 108.987 -176.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.7 mm 74.41 -70.23 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 125.862 1.665 . . . . 6.53 108.795 -172.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.735 2.014 . . . . 10.03 112.156 176.539 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptp . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.327 -0.62 . . . . 12.48 109.327 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.06 -66.82 1.45 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.114 -1.594 . . . . 8.95 109.114 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -104.86 -168.78 1.52 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.786 1.235 . . . . 5.95 109.562 172.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.27 -19.67 10.07 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.327 -1.263 . . . . 3.48 115.069 148.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.67 100.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 120.169 1.985 . . . . 3.22 110.975 176.101 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -104.17 101.45 11.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.825 2.05 . . . . 3.73 107.288 174.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -97.51 107.15 19.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.97 -0.752 . . . . 2.44 108.97 172.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -99.94 148.25 24.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 124.14 0.9 . . . . 3.3 108.952 166.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.15 145.73 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.161 -1.792 . . . . 2.78 106.161 158.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.05 139.23 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.746 1.218 . . . . 3.5 108.766 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -133.56 153.58 51.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.766 0.826 . . . . 7.72 111.023 -178.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.03 -21.0 28.0 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.862 1.22 . . . . 1.95 110.965 -174.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.5 mtm -66.75 150.55 48.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.156 -0.614 . . . . 2.14 109.681 174.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t -151.35 10.81 0.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.105 0.78 . . . . 2.44 113.105 177.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.5 t -171.87 151.56 2.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.544 1.066 . . . . 2.85 109.528 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.28 -31.94 0.71 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.696 1.998 . . . . 2.1 113.012 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -53.3 -67.5 0.25 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.377 1.071 . . . . 0.74 113.145 170.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.5 m -43.15 -50.96 6.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.217 1.407 . . . . 1.94 108.346 176.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 t -50.02 -66.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.743 -1.117 . . . . 2.21 111.551 177.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.327 0.1 OUTLIER -65.83 -28.98 69.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.683 -0.407 . . . . 1.34 111.112 -171.404 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.07 -52.29 56.57 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.32 1.448 . . . . 3.86 108.281 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -51.76 -65.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.092 -1.077 . . . . 1.98 108.092 171.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.44 -42.07 88.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.91 -0.586 . . . . 2.96 110.759 -158.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -59.54 -45.66 91.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.739 0.815 . . . . 1.73 110.39 173.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -59.5 -49.67 76.87 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.761 -0.459 . . . . 1.31 109.761 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.07 -45.23 75.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.751 -0.593 . . . . 3.4 110.985 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -61.55 -7.03 2.81 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.395 1.257 . . . . 3.54 114.395 179.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -66.63 -31.94 72.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.492 1.042 . . . . 5.03 110.654 169.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.452 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 11.6 m170 -64.74 121.5 14.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.627 0.771 . . . . 2.65 109.168 -176.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.06 46.05 0.78 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.445 0.906 . . . . 6.5 113.445 -165.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.62 20.38 0.13 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.469 1.033 . . . . 1.99 111.335 166.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.68 140.18 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.093 -1.077 . . . . 3.37 108.093 174.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.3 mt -109.28 -35.9 6.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.366 1.066 . . . . 2.73 111.433 -173.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -155.46 158.42 38.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.462 1.028 . . . . 3.49 109.854 -177.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 p -155.91 140.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.742 2.417 . . . . 3.14 105.467 -177.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -156.45 90.59 1.18 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.362 -1.718 . . . . 2.45 106.362 170.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.48 76.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.603 -1.258 . . . . 3.22 107.603 -172.14 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.86 93.24 4.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.572 -0.705 . . . . 2.1 109.133 -171.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tt -42.98 -37.17 1.79 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.252 1.421 . . . . 3.22 111.566 168.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.23 -32.91 39.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 2.24 112.452 178.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -116.05 12.23 15.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.255 1.422 . . . . 2.66 110.125 178.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 40.44 37.74 0.49 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.823 2.049 . . . . 2.14 112.141 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 154.89 45.54 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.489 0.716 . . . . 2.51 109.762 -169.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.68 112.12 11.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.413 -1.328 . . . . 1.8 107.413 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -92.08 96.94 10.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.899 2.479 . . . . 1.4 104.602 170.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.79 135.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 104.707 -2.331 . . . . 2.98 104.707 172.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.1 127.88 54.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.501 -1.666 . . . . 4.19 106.501 168.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -165.35 168.47 16.78 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.111 0.965 . . . . 4.49 109.74 -173.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -92.13 119.05 68.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.412 1.07 . . . . 4.0 108.905 171.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.62 -32.51 93.43 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.543 1.495 . . . . 2.15 113.039 176.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -84.88 49.88 1.81 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.901 1.228 . . . . 5.55 111.843 -165.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.97 -47.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 127.395 2.278 . . . . 5.12 107.83 178.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -53.62 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.308 1.043 . . . . 3.48 109.595 -173.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.06 145.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.717 -0.614 . . . . 2.18 111.7 -166.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -52.5 -39.63 74.03 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.514 2.143 . . . . 1.17 111.354 178.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -37.95 -48.76 1.2 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.435 1.494 . . . . 8.89 112.697 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.57 -50.24 59.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.864 0.84 . . . . 3.69 109.506 -172.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.3 -52.58 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.598 -0.689 . . . . 2.28 110.896 175.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.86 -50.8 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.946 -0.761 . . . . 3.04 108.946 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -55.37 -47.04 76.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.008 0.523 . . . . 6.56 110.373 -179.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.452 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 99.1 m -60.08 -48.4 81.89 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.856 0.753 . . . . 2.09 110.936 176.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.7 -51.69 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.865 0.757 . . . . 2.09 110.837 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.95 -55.5 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.119 0.968 . . . . 2.86 109.943 177.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -57.09 -34.95 68.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.751 1.22 . . . . 1.27 111.597 -177.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.67 -58.1 4.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.529 0.604 . . . . 3.44 110.275 172.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 -41.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.826 1.09 . . . . 1.57 115.826 -176.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -117.25 142.69 46.74 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 117.421 0.61 . . . . 3.32 111.65 -135.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.8 150.49 30.71 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.838 -1.542 . . . . 3.69 106.838 173.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.41 164.61 35.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.235 0.471 . . . . 2.02 111.994 -176.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.7 m -158.2 132.04 7.85 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 118.282 -0.866 . . . . 1.93 110.624 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.49 128.68 37.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.893 1.224 . . . . 3.67 108.777 172.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.58 22.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 123.442 0.697 . . . . 3.05 111.967 177.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -161.65 -68.32 0.06 Allowed 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.703 -0.48 . . . . 9.32 109.703 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.273 5.0 tp 21.64 68.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.963 2.105 . . . . 9.45 113.712 -165.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-N 114.51 -1.223 . . . . 10.44 109.526 167.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 106.076 -1.824 . . . . 8.38 106.076 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.24 -167.37 12.62 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 107.229 -2.348 . . . . 5.59 107.229 -133.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.8 95.74 7.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.542 1.171 . . . . 6.01 109.017 172.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.9 31.73 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.796 -0.521 . . . . 2.13 111.796 178.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.42 128.9 74.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.089 0.956 . . . . 4.56 110.727 -175.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.25 120.3 28.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.108 1.363 . . . . 5.66 108.076 173.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.83 107.89 19.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.185 -1.043 . . . . 2.41 108.185 177.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -117.78 148.55 41.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.036 0.534 . . . . 3.08 110.998 -174.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.7 151.2 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.884 0.873 . . . . 3.1 108.971 173.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.72 86.76 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.981 1.312 . . . . 3.28 109.339 174.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 107.48 18.78 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.664 -0.648 . . . . 7.52 110.416 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.62 -20.77 0.39 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.357 0.98 . . . . 1.54 112.133 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.7 mtm -62.5 169.7 2.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.176 0.988 . . . . 2.16 111.79 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 t -158.9 -44.66 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.519 0.727 . . . . 2.57 110.856 -177.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.9 m -138.44 164.3 29.71 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.189 0.449 . . . . 3.02 110.665 -168.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -38.64 3.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.48 1.912 . . . . 2.19 112.464 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.8 p -52.68 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.782 1.233 . . . . 1.0 112.265 170.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.4 m -42.69 -41.97 3.33 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.638 1.175 . . . . 2.28 111.43 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.22 -72.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.024 0.53 . . . . 2.02 111.121 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -17.88 65.08 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.465 -0.772 . . . . 1.36 112.334 -170.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -54.99 -46.4 75.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.859 0.864 . . . . 4.27 109.36 173.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.08 -60.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.895 -1.15 . . . . 1.82 107.895 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -50.84 -58.17 6.62 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.794 0.438 . . . . 2.97 110.654 178.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -56.2 -33.69 65.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.473 0.709 . . . . 1.87 111.908 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -70.62 -64.46 0.89 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.581 0.628 . . . . 1.93 110.609 172.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.12 -32.89 74.82 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.052 -1.03 . . . . 3.18 111.583 -167.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -56.93 -16.45 6.88 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 3.11 112.701 175.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -63.08 -35.8 81.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.398 -0.814 . . . . 5.88 111.126 171.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -72.98 109.7 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.53 -0.915 . . . . 2.58 108.53 177.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -65.87 -3.74 5.62 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.928 -1.107 . . . . 7.98 110.898 167.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.73 -25.37 71.69 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.623 1.106 . . . . 1.39 112.833 166.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 pp -99.84 156.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 119.142 1.471 . . . . 4.28 110.519 175.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.22 -38.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.557 1.543 . . . . 2.43 110.046 -177.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -155.65 157.06 36.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.651 0.659 . . . . 3.75 109.409 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -140.64 131.78 26.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.073 -1.454 . . . . 2.08 107.073 170.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.45 98.31 3.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.344 1.458 . . . . 2.82 107.651 -177.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.33 106.55 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.334 0.654 . . . . 2.99 111.761 -174.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.13 97.67 8.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.545 -0.722 . . . . 2.1 109.223 -174.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -48.98 -40.2 29.62 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.19 0.996 . . . . 2.81 111.597 175.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.55 -32.95 1.02 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.384 1.074 . . . . 1.89 113.226 175.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -125.82 13.76 7.98 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.084 0.953 . . . . 2.28 111.154 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 34.52 49.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.776 . . . . 2.03 112.277 -172.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 139.71 53.59 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.164 0.585 . . . . 3.93 109.856 -179.001 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.96 112.17 24.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.223 1.409 . . . . 1.75 107.738 162.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -79.18 102.16 8.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.281 -2.488 . . . . 1.57 104.281 160.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.0 mt -106.76 124.73 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.336 -1.728 . . . . 2.07 106.336 174.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -97.48 114.74 26.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.219 -2.141 . . . . 4.59 105.219 166.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.66 151.62 29.0 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.76 -1.941 . . . . 4.41 105.76 -178.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.62 129.43 23.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.409 0.443 . . . . 3.83 110.883 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -56.94 -35.31 98.6 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.898 2.399 . . . . 1.73 111.737 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.64 -25.87 65.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.13 0.789 . . . . 3.71 113.13 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.9 pt -106.86 -26.96 3.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 118.965 0.802 . . . . 3.83 112.161 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -152.93 131.97 3.12 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 CA-C-N 119.246 0.93 . . . . 2.78 109.584 172.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.71 166.75 53.4 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.473 -0.651 . . . . 1.7 111.473 -177.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.02 -55.54 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.86 2.374 . . . . 1.36 110.586 177.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -56.97 -32.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 122.391 -0.193 . . . . 8.59 111.03 -174.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -56.88 13.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.659 1.584 . . . . 4.02 109.184 175.049 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.66 -50.33 68.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.059 -0.719 . . . . 3.1 109.059 176.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.2 -46.97 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.007 -0.542 . . . . 3.18 110.524 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -52.71 -51.73 59.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.984 0.811 . . . . 3.64 109.714 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -52.33 -58.39 6.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.466 0.575 . . . . 1.85 110.302 175.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.3 -55.78 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.043 0.537 . . . . 1.94 111.179 -172.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -53.67 -45.6 70.33 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.709 0.804 . . . . 4.19 109.635 176.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -66.98 -9.88 43.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.617 -1.182 . . . . 1.31 113.392 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.96 -100.99 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.276 1.398 . . . . 3.72 107.85 156.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.86 38.92 0.5 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.243 0.929 . . . . 1.64 112.871 177.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -130.81 122.71 27.61 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.311 1.056 . . . . 3.27 109.336 -171.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -79.91 133.61 36.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.971 -1.863 . . . . 3.01 105.971 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.28 161.15 30.88 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 113.791 1.034 . . . . 1.9 113.791 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -158.22 137.71 11.87 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.912 1.285 . . . . 1.91 108.572 177.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -82.43 48.22 1.26 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.747 1.612 . . . . 4.28 111.232 -175.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -41.25 -32.79 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 117.209 2.3 . . . . 2.68 117.209 -160.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.11 -30.95 61.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.135 1.334 . . . . 11.06 112.283 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.03 84.44 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.647 1.579 . . . . 8.74 108.279 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 . . . . . 0 C--O 1.251 1.137 0 N-CA-C 105.684 -1.969 . . . . 11.72 105.684 169.637 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 104.501 -2.407 . . . . 9.77 104.501 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.36 178.48 3.97 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 109.27 -1.532 . . . . 7.82 109.27 138.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -118.9 -44.16 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.98 2.112 . . . . 9.13 109.591 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.9 2.55 38.74 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.427 -1.207 . . . . 2.65 115.292 168.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 p -156.63 127.7 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 120.371 2.086 . . . . 2.68 110.29 172.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.48 108.97 6.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.787 -1.19 . . . . 4.62 107.787 172.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.35 119.44 28.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.434 -1.321 . . . . 2.26 107.434 169.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -119.69 140.49 50.58 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.707 1.139 . . . . 3.82 110.494 170.046 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.81 119.87 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.718 -1.216 . . . . 2.61 107.718 173.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.54 94.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.569 1.148 . . . . 3.65 108.37 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -78.45 86.16 4.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.937 -1.505 . . . . 8.29 106.937 176.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.12 -138.25 5.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 103.48 -3.848 . . . . 3.38 103.48 175.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 mtm 65.78 166.97 0.19 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.951 1.3 . . . . 2.24 111.62 -170.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.6 p -147.21 -83.41 0.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.993 0.517 . . . . 4.34 110.134 -176.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t -146.29 103.46 3.71 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.595 0.758 . . . . 3.52 110.389 -166.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 45.33 -129.98 1.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.458 -0.941 . . . . 2.77 108.458 -169.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.1 p 43.53 -87.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.463 1.905 . . . . 1.48 113.962 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -39.83 -43.75 1.51 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.087 1.755 . . . . 1.83 110.391 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -44.42 -67.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 2.12 110.649 172.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.326 0.4 OUTLIER -71.78 -21.6 61.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 119.797 -0.761 . . . . 1.41 112.512 -177.525 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.56 -45.32 92.17 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.362 -1.347 . . . . 5.03 107.362 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.43 -69.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.62 -0.718 . . . . 1.81 109.085 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -56.6 -48.14 78.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.774 0.261 . . . . 4.77 111.589 -165.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -70.45 -20.77 62.87 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.23 0.612 . . . . 1.59 110.485 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.7 t -66.85 -62.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.33 -1.481 . . . . 1.91 109.036 162.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.66 -50.58 35.18 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 113.62 0.97 . . . . 2.96 113.62 -162.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -44.15 -28.26 0.48 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.015 1.326 . . . . 3.6 113.58 -167.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -63.17 -40.48 97.67 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.192 2.597 . . . . 4.86 112.944 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -62.2 129.06 39.02 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.254 -1.017 . . . . 2.41 108.254 172.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.88 -3.47 3.44 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.795 1.405 . . . . 11.87 114.795 -166.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.16 -14.13 56.49 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 119.546 -0.585 . . . . 1.36 112.214 -178.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mm -88.91 104.86 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.037 -1.098 . . . . 3.54 108.037 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.0 mt -78.99 -38.96 35.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.004 -0.739 . . . . 2.73 109.004 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -155.31 145.68 21.95 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.599 -0.889 . . . . 3.72 108.599 176.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.75 105.99 6.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.307 -1.368 . . . . 2.53 107.307 175.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 t -120.94 103.6 9.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.963 -1.125 . . . . 2.35 107.963 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.04 127.78 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.072 0.549 . . . . 2.94 110.481 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.03 108.94 11.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.035 0.934 . . . . 2.37 110.247 -170.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.81 -41.51 5.06 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.933 1.293 . . . . 3.61 111.08 168.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.77 14.36 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 124.109 0.964 . . . . 1.69 112.475 -175.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -130.07 14.28 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.212 1.005 . . . . 2.53 110.006 -177.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 m120 29.97 53.55 0.13 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 126.169 1.788 . . . . 2.29 111.831 -169.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.29 141.17 37.76 Favored 'General case' 0 N--CA 1.461 0.085 0 O-C-N 121.577 -0.702 . . . . 1.83 110.712 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.19 112.61 24.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.753 1.621 . . . . 1.61 108.424 168.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -79.91 104.0 10.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.055 -1.832 . . . . 0.96 106.055 162.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.41 113.0 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.482 -0.933 . . . . 2.16 108.482 175.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -84.1 107.38 16.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 105.699 -1.963 . . . . 3.85 105.699 164.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -147.2 167.48 24.09 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.67 -1.604 . . . . 3.93 106.67 174.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.35 136.65 27.34 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.757 1.021 . . . . 4.37 113.757 174.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.34 48.59 2.93 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.506 3.471 . . . . 2.06 113.023 -165.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -155.85 -47.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.004 1.322 . . . . 3.11 109.464 -173.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.6 pt -67.75 -32.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.228 -1.027 . . . . 4.03 108.228 166.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.31 17.6 tt -131.67 -91.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 123.735 0.647 . . . . 2.4 112.579 170.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.67 152.78 6.49 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.536 -1.426 . . . . 2.47 109.536 -168.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.71 -57.17 0.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.197 1.931 . . . . 1.29 109.033 172.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptt85 -29.28 -55.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.223 2.209 . . . . 11.29 113.22 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.23 -51.06 65.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.552 -0.907 . . . . 2.85 108.552 -171.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.81 -49.95 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.536 -0.542 . . . . 1.88 109.536 177.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.1 mm -50.28 -57.99 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 119.09 -0.481 . . . . 2.79 109.795 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -51.46 -46.31 63.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.055 0.542 . . . . 3.75 110.258 177.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -57.57 -47.9 80.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.388 -0.339 . . . . 1.72 110.986 178.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.0 -50.6 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.278 0.945 . . . . 3.11 110.989 -177.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -50.28 73.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.337 0.517 . . . . 2.95 110.243 176.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -52.0 -42.0 62.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.526 0.73 . . . . 1.43 111.132 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.74 -49.29 48.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.305 -0.872 . . . . 2.81 111.687 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.9 -44.22 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 116.001 1.16 . . . . 1.37 116.001 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.87 156.8 39.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.813 0.672 . . . . 3.19 112.813 -135.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.21 139.71 39.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.651 -1.611 . . . . 5.65 106.651 171.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.85 70.59 1.21 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.401 1.48 . . . . 2.54 110.1 -166.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -84.99 100.32 11.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.425 0.631 . . . . 2.27 109.629 -170.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.33 73.88 0.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.68 1.592 . . . . 3.52 112.651 -178.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -52.66 -33.28 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.086 1.354 . . . . 2.25 111.682 167.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 tttp 66.49 -62.17 0.29 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.218 2.607 . . . . 7.04 112.67 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.8 mt 71.35 -61.3 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.719 1.607 . . . . 5.77 111.162 -177.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.12 1.368 . . . . 10.92 107.833 174.571 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 108.862 -1.695 . . . . 1.46 108.862 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.14 147.54 5.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.06 -1.089 . . . . 2.2 108.06 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.5 tp -150.64 82.92 1.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.509 -0.552 . . . . 2.26 109.509 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -77.92 100.73 6.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 110.035 -0.357 . . . . 3.49 110.035 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.78 118.21 27.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.04 -1.467 . . . . 2.62 107.04 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.77 119.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 105.498 -2.038 . . . . 1.82 105.498 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.67 93.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 125.513 1.525 . . . . 2.15 107.967 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -78.47 112.36 15.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.009 -1.478 . . . . 6.53 107.009 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.64 -136.76 7.82 Favored Glycine 0 N--CA 1.434 -1.479 1 N-CA-C 101.994 -4.442 . . . . 3.54 101.994 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.63 173.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.874 0.87 . . . . 2.21 112.683 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -154.03 -81.03 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.954 1.302 . . . . 3.29 108.674 -167.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -172.13 131.37 0.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 125.361 1.464 . . . . 5.37 107.957 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 48.45 -146.12 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.558 -0.734 . . . . 2.8 109.21 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.1 p 51.61 -86.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.907 1.447 . . . . 1.39 114.907 161.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.5 p -45.31 -41.7 9.03 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.214 -0.929 . . . . 3.54 111.53 166.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.03 -72.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.3 1.44 . . . . 0.82 110.064 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -25.82 66.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.806 -0.616 . . . . 1.17 111.241 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -53.21 -57.52 10.22 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.527 -0.916 . . . . 4.73 108.527 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.69 -60.12 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.908 -0.775 . . . . 0.58 108.908 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -54.16 -57.03 12.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.85 0.357 . . . . 3.27 111.373 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -57.0 -47.58 80.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.433 0.693 . . . . 1.04 110.07 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -60.03 -65.23 0.71 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.931 -0.396 . . . . 0.84 109.931 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.75 -29.43 69.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.006 -1.078 . . . . 2.86 111.217 -166.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -55.82 -20.38 15.0 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.163 -0.961 . . . . 1.58 112.348 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -30.64 69.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.808 -1.183 . . . . 6.64 112.417 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -70.07 116.04 9.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.209 -1.034 . . . . 2.36 108.209 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 32.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.418 -0.802 . . . . 7.84 113.082 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.08 -8.53 5.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.037 1.78 . . . . 0.72 111.82 166.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.02 118.64 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 105.974 -1.861 . . . . 2.5 105.974 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.83 -37.75 18.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.222 -0.659 . . . . 1.73 109.222 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.4 162.12 40.86 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.052 0.387 . . . . 2.89 110.866 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.91 96.08 2.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.433 1.893 . . . . 1.91 108.957 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 m -99.73 99.78 10.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.719 1.608 . . . . 1.96 107.545 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.96 92.53 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 122.819 1.295 . . . . 1.9 109.286 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.72 82.22 3.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.484 -1.302 . . . . 1.28 107.484 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -37.5 -44.07 0.63 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.248 1.819 . . . . 2.59 110.378 163.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.4 -32.93 28.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.121 . . . . 1.08 113.067 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -120.95 20.45 11.57 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.416 1.086 . . . . 2.53 110.296 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 34.59 56.66 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.368 1.867 . . . . 2.23 111.523 -170.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -140.69 125.58 18.23 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.968 0.359 . . . . 1.6 111.968 -167.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.74 98.99 8.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.62 107.245 165.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -77.25 96.29 4.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 104.787 -2.301 . . . . 1.09 104.787 159.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.67 150.0 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.249 -1.342 . . . . 1.23 107.996 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.14 133.74 55.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.427 -2.064 . . . . 3.06 105.427 166.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -156.26 161.82 40.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.176 -1.416 . . . . 2.42 107.176 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.18 140.99 22.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 4.15 107.088 161.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.45 -22.58 28.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.399 2.066 . . . . 1.71 111.628 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.648 0.779 . . . . 4.06 111.169 -172.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.98 -11.29 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.647 0.379 . . . . 2.42 111.957 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.88 130.99 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.315 -0.624 . . . . 2.39 109.315 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.01 154.08 47.68 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.177 -1.569 . . . . 0.76 109.177 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.04 -40.52 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.585 1.523 . . . . 0.75 109.34 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 11.3 tpt180 -59.09 -38.26 79.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.381 -0.342 . . . . 8.24 111.202 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -53.0 47.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.154 1.382 . . . . 3.51 109.745 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.35 -51.87 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.031 -0.986 . . . . 0.85 109.04 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.46 -52.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.695 -0.669 . . . . 1.28 111.446 -177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 32.5 m170 -48.06 -49.41 31.57 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.935 1.294 . . . . 2.96 109.496 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -63.37 -47.44 82.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.98 -0.555 . . . . 1.13 109.642 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.79 -58.81 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 121.471 -0.768 . . . . 1.0 111.29 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.68 -49.04 76.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.692 -0.855 . . . . 2.73 108.692 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.7 t -48.37 -50.32 31.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.238 1.015 . . . . 1.23 111.712 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.13 -42.76 86.53 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.168 1.173 . . . . 1.79 114.168 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.89 -2.92 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 N-CA-C 119.127 2.411 . . . . 1.23 119.127 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -142.27 177.64 8.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.963 1.881 . . . . 1.86 111.846 -144.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -110.62 140.3 45.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.184 -1.784 . . . . 5.18 106.184 150.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.0 116.15 16.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.861 0.864 . . . . 2.25 110.827 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -122.55 116.99 24.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.394 1.078 . . . . 1.69 111.417 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.88 72.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.93 1.692 . . . . 2.22 112.407 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 123.818 0.847 . . . . 1.99 110.443 169.173 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.601 0 N-CA-C 109.255 -1.538 . . . . 1.58 109.255 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.4 151.96 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.229 -0.656 . . . . 2.3 109.229 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.8 tp -152.37 111.07 3.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.271 -1.011 . . . . 2.09 108.271 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -106.49 117.53 34.28 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.096 0.474 . . . . 2.86 111.693 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.6 mt -106.78 129.91 54.57 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.81 -1.182 . . . . 2.79 107.81 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.74 101.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.18 -1.415 . . . . 1.95 107.18 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 22' ' ' ILE . 49.0 t -79.91 78.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.578 -1.638 . . . . 1.85 106.578 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -77.68 116.06 17.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 5.62 107.458 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.39 -11.71 3.25 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.504 1.049 . . . . 1.45 112.631 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.407 ' CE ' HG22 ' A' ' 19' ' ' VAL . 31.0 mtp -63.76 149.55 46.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.053 0.926 . . . . 1.47 109.922 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.4 17.72 0.34 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.795 0.665 . . . . 2.35 112.795 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -171.39 152.09 3.22 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.787 1.176 . . . . 2.22 110.786 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.14 -35.97 3.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.295 1.838 . . . . 1.21 112.739 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -59.18 -69.64 0.19 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.8 111.798 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.2 m -40.35 -45.73 2.21 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.908 1.283 . . . . 1.31 110.414 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG22 ' CE ' ' A' ' 13' ' ' MET . 10.5 t -53.32 -73.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 123.842 0.714 . . . . 0.78 111.108 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -21.51 64.33 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.706 -0.621 . . . . 1.07 112.13 -166.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -55.8 -47.31 77.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.364 1.066 . . . . 3.82 109.362 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.401 HD13 HG11 ' A' ' 10' ' ' VAL . 54.8 mt -62.56 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.453 -0.943 . . . . 0.57 108.453 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -49.94 -60.6 2.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.539 0.736 . . . . 3.19 110.428 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 t -52.39 -44.49 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.726 0.81 . . . . 1.03 110.989 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -61.51 -62.79 1.57 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.107 0.412 . . . . 0.87 110.494 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.38 -33.35 75.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.241 -0.912 . . . . 1.81 111.434 -166.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.1 p -60.02 -11.99 7.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.449 -0.782 . . . . 2.02 112.649 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -62.65 -39.51 94.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.008 0.822 . . . . 4.81 110.908 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -70.71 125.85 27.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.047 -1.094 . . . . 2.37 108.047 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -75.76 48.86 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.899 0.879 . . . . 7.14 110.334 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.86 -39.67 0.15 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 126.516 2.008 . . . . 0.84 110.566 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -79.26 119.75 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.43 -1.693 . . . . 2.91 106.43 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.96 -26.11 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.456 0.702 . . . . 2.04 110.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -155.3 155.11 33.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.959 -0.756 . . . . 2.46 108.959 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -149.75 131.6 15.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.409 -1.33 . . . . 1.97 107.409 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -142.28 118.87 11.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.055 -1.091 . . . . 1.71 108.055 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p -99.76 97.87 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.265 1.031 . . . . 1.84 110.938 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 97.82 11.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.687 -0.856 . . . . 0.72 108.687 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -49.99 -34.12 20.03 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.88 0.872 . . . . 2.65 111.684 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.96 60.64 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.742 0.817 . . . . 1.12 111.66 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -119.37 11.67 12.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.086 1.354 . . . . 1.57 109.763 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 m120 37.71 38.73 0.17 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.722 2.009 . . . . 1.79 111.95 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.58 133.52 54.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 121.681 -0.637 . . . . 1.08 109.594 -168.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 101.46 13.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.335 -1.728 . . . . 0.53 106.335 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -76.67 92.62 3.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.684 -2.339 . . . . 1.03 104.684 166.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.74 150.54 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.822 -1.548 . . . . 1.12 106.822 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -126.17 142.48 51.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.794 -1.558 . . . . 3.0 106.794 155.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.42 175.57 13.81 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.196 0.999 . . . . 2.06 108.996 -170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.98 125.78 26.55 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 108.671 -0.863 . . . . 3.53 108.671 171.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.26 61.06 6.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.364 3.376 . . . . 2.21 111.509 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -168.07 -43.22 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.894 1.678 . . . . 3.57 110.119 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.3 pt -73.26 -30.18 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.748 -0.834 . . . . 2.69 108.748 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -153.49 149.14 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.515 -0.92 . . . . 2.37 108.515 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 167.25 31.74 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 110.62 -0.992 . . . . 0.77 110.62 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.58 -46.22 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.499 2.133 . . . . 0.72 110.756 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -45.72 -40.8 9.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.872 1.269 . . . . 7.86 111.105 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -57.5 12.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.447 1.899 . . . . 3.39 107.969 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mt -63.3 -48.82 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.73 109.575 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.8 -60.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.931 0.893 . . . . 1.53 109.139 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -57.83 -42.44 84.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.701 1.2 . . . . 4.87 109.738 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 m -61.3 -47.13 87.37 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.468 -0.493 . . . . 0.83 110.564 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.16 -45.05 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.69 111.065 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -57.27 -52.95 63.25 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.103 0.561 . . . . 3.04 109.728 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -54.75 -42.22 71.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.818 1.247 . . . . 0.78 111.146 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.82 -55.49 19.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.0 0.818 . . . . 1.77 111.106 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.28 -42.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.65 1.02 . . . . 1.45 115.65 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.68 140.98 52.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 117.754 0.777 . . . . 2.0 112.194 -137.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.82 79.76 4.29 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.247 0.546 . . . . 3.34 110.316 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.91 141.16 44.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.571 -0.706 . . . . 1.55 110.284 -165.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -156.41 128.38 7.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.173 -0.955 . . . . 2.15 111.209 -167.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.9 116.96 2.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.174 1.39 . . . . 2.22 110.931 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.222 -0.358 0 C-N-CA 124.565 1.146 . . . . 2.71 109.051 168.577 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 2.35 111.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.74 92.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.321 1.058 . . . . 2.12 108.508 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.8 tp -95.31 101.19 12.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.032 1.733 . . . . 2.15 106.961 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -95.42 120.41 35.61 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.514 -1.291 . . . . 2.81 107.514 156.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.88 148.51 25.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.73 1.269 . . . . 2.71 108.255 158.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.89 143.54 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.534 -2.025 . . . . 1.91 105.534 160.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.21 127.56 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.556 1.542 . . . . 2.47 108.308 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -118.24 155.41 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.391 0.677 . . . . 6.58 110.021 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.89 -31.88 6.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.278 1.418 . . . . 1.54 110.582 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mtp -51.12 130.52 26.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.556 0.742 . . . . 1.54 110.273 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -154.03 17.38 0.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.246 -0.407 . . . . 2.38 112.087 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -169.36 151.17 4.45 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.143 0.883 . . . . 2.27 109.378 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.46 -37.73 12.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.798 1.639 . . . . 1.13 112.013 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.6 p -57.92 -71.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.99 0.916 . . . . 0.85 111.67 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.8 m -40.32 -44.07 1.86 Allowed 'General case' 0 C--N 1.338 0.109 0 C-N-CA 125.096 1.358 . . . . 1.23 111.012 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.84 -73.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 123.703 0.627 . . . . 0.87 111.041 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -20.31 66.08 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.567 -0.708 . . . . 1.15 112.206 -168.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.33 -42.53 82.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.865 0.866 . . . . 3.09 109.729 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.5 mt -62.17 -57.26 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.501 -0.926 . . . . 0.47 108.501 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.32 -57.95 8.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.968 0.907 . . . . 3.4 109.866 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -52.29 -54.36 32.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.033 0.933 . . . . 0.9 110.442 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -59.03 -40.08 83.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.888 -0.577 . . . . 0.79 112.092 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -73.67 -36.82 65.37 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.331 0.969 . . . . 1.75 112.512 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 m -70.81 70.39 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.034 0.921 . . . . 2.51 110.357 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -174.0 -23.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.687 2.795 . . . . 5.75 112.394 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.249 1.386 . . . . 2.53 111.189 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 67.84 -3.85 1.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.603 2.361 . . . . 6.08 113.67 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.83 -28.87 40.6 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.412 -1.075 . . . . 0.82 110.412 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.88 129.48 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.259 0.624 . . . . 2.68 109.397 171.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.19 -42.74 12.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.291 1.036 . . . . 1.38 109.294 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.337 -0.246 . . . . 1.9 110.337 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -137.67 130.77 30.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.666 1.586 . . . . 1.99 107.006 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -134.4 103.61 5.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.976 -1.49 . . . . 1.74 106.976 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.334 2.8 p -89.73 88.25 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 123.461 1.601 . . . . 1.81 110.231 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.1 84.81 4.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.305 -1.316 . . . . 1.27 107.839 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.53 -36.56 4.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.725 1.61 . . . . 2.91 111.147 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.85 -33.45 23.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.394 0.678 . . . . 1.16 111.936 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -113.83 4.51 15.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.043 1.737 . . . . 2.38 110.967 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 44.23 52.63 7.04 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.23 1.012 . . . . 1.95 110.3 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -139.81 142.66 36.66 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 122.721 0.408 . . . . 1.6 110.696 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.34 101.19 10.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.698 -1.223 . . . . 0.66 107.698 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -78.27 104.89 9.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.115 -2.18 . . . . 0.92 105.115 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.67 121.72 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.743 -1.577 . . . . 0.91 106.743 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -102.22 123.8 46.69 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.443 -1.688 . . . . 2.6 106.443 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.33 152.62 32.33 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.364 0.666 . . . . 2.41 109.478 -171.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -95.67 108.4 39.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 107.647 -1.242 . . . . 3.84 107.647 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.97 -46.72 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.213 1.942 . . . . 2.5 112.587 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.2 -32.13 15.62 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.989 1.107 . . . . 3.88 113.989 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 pt -96.05 7.47 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 118.521 0.6 . . . . 2.46 112.467 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.72 -55.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.098 0.863 . . . . 3.23 111.69 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.46 143.3 5.25 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.827 1.68 . . . . 0.91 110.266 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -57.94 -39.58 85.16 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.819 2.346 . . . . 0.86 110.603 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -29.23 -50.88 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.006 2.122 . . . . 10.54 113.218 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -71.62 -49.71 37.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.5 1.12 . . . . 4.17 109.767 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.0 mt -58.71 -54.07 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.703 -0.68 . . . . 0.74 109.362 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -53.88 -54.68 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.461 -0.57 . . . . 1.93 109.461 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -53.33 -45.12 68.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.882 0.473 . . . . 5.06 110.351 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -59.8 -52.55 64.98 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.104 0.411 . . . . 0.77 110.415 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.6 mt -51.78 -58.66 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.86 109.361 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -52.07 -57.67 8.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.627 0.727 . . . . 3.43 109.805 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -58.66 -26.11 63.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.322 1.449 . . . . 0.76 113.371 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.27 -76.9 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.592 1.542 . . . . 1.8 110.968 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.6 31.91 0.43 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.775 -1.014 . . . . 1.42 112.989 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -132.68 173.48 11.3 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.368 1.084 . . . . 1.96 112.571 -165.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.58 155.8 34.27 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 105.65 -1.981 . . . . 3.81 105.65 157.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.75 166.36 33.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.01 0.823 . . . . 1.04 112.371 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.88 132.04 10.05 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.561 1.144 . . . . 2.25 110.571 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.11 125.98 21.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.721 1.209 . . . . 2.64 110.309 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 124.825 1.25 . . . . 2.09 111.949 173.847 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.051 0 CA-C-O 122.091 0.828 . . . . 1.49 113.003 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.16 145.31 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.328 -1.101 . . . . 2.15 109.059 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -147.85 119.94 8.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.35 -2.093 . . . . 2.07 105.35 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.98 113.05 22.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.61 -1.626 . . . . 2.49 106.61 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -110.91 131.85 54.7 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.415 -1.328 . . . . 3.43 107.415 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -75.88 126.32 36.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 105.032 -2.211 . . . . 1.77 105.032 154.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -119.34 108.73 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.334 -1.728 . . . . 2.15 106.334 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -79.84 98.77 7.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.767 . . . . 5.0 108.93 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 -105.23 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.23 -2.348 . . . . 3.54 107.23 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.657 ' HE3' HG22 ' A' ' 37' ' ' VAL . 41.5 mtp 57.49 35.25 25.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.629 0.772 . . . . 3.29 112.1 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -74.58 121.22 21.24 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.731 -0.606 . . . . 3.08 110.043 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t 68.46 152.53 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.77 1.628 . . . . 2.32 113.239 169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.25 72.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.158 1.783 . . . . 3.39 110.566 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 p -178.8 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.672 1.189 . . . . 1.6 109.466 -160.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.7 m -73.15 -51.1 19.15 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.922 -0.77 . . . . 1.1 108.922 159.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -42.7 -73.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.476 1.911 . . . . 0.96 111.58 -175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -25.73 68.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.089 -0.382 . . . . 1.29 111.903 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -67.41 -49.43 63.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.154 0.981 . . . . 4.48 108.925 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -53.34 -62.3 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 108.207 -1.035 . . . . 0.65 108.207 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -53.42 -57.1 11.82 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.366 0.267 . . . . 3.08 110.713 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -49.71 -50.88 42.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.854 -0.594 . . . . 1.09 110.331 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 t -55.53 -50.59 69.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.347 0.521 . . . . 0.83 110.801 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 mt -67.83 -38.22 82.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.59 -1.644 . . . . 1.78 110.557 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.8 m -59.95 -10.23 3.88 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.667 -0.646 . . . . 1.63 112.591 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -62.77 -40.83 98.52 Favored 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.718 -1.238 . . . . 5.22 109.83 168.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -72.38 135.35 45.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.777 -1.194 . . . . 2.66 107.777 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.48 -0.74 55.82 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.868 -0.52 . . . . 6.37 110.961 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.62 -15.07 64.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.402 0.525 . . . . 0.71 113.306 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.7 tt -88.82 124.46 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.028 -1.101 . . . . 2.91 108.028 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.7 mt -82.23 -40.26 21.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.047 0.939 . . . . 1.54 109.5 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -155.21 148.62 25.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 110.127 -0.323 . . . . 1.97 110.127 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.4 t -132.9 138.98 47.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.963 1.305 . . . . 1.96 107.703 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 m -143.92 102.38 3.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.004 -1.11 . . . . 1.5 108.004 164.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.657 HG22 ' HE3' ' A' ' 13' ' ' MET 0.327 1.2 p -88.76 80.88 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 123.708 1.718 . . . . 1.61 108.809 -177.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 90.4 4.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.93 1.692 . . . . 0.86 110.158 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pp -54.53 -29.9 52.1 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.571 1.148 . . . . 3.1 112.427 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.9 26.04 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.156 0.582 . . . . 0.89 111.43 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 p -114.63 9.25 16.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.354 1.462 . . . . 2.07 111.658 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.97 45.0 3.18 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.254 1.422 . . . . 1.83 111.247 -171.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -133.26 136.49 45.57 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 122.73 0.412 . . . . 1.08 111.734 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -89.63 109.19 20.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.565 1.146 . . . . 0.6 108.247 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -78.58 114.18 17.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.846 -2.279 . . . . 0.89 104.846 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.12 107.19 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.337 -1.357 . . . . 1.05 107.337 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -87.31 105.3 17.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.672 -1.603 . . . . 3.38 106.672 163.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.26 175.22 6.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.529 1.932 . . . . 1.99 106.293 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.35 130.77 23.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.239 -0.652 . . . . 3.71 109.239 166.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -57.52 -35.12 98.89 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.681 2.254 . . . . 1.83 110.938 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.2 -6.56 24.12 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.5 0.926 . . . . 4.4 113.5 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 pt -120.97 -31.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.421 0 CA-C-N 119.703 1.138 . . . . 3.08 113.047 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 tt -152.04 144.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 119.783 1.174 . . . . 2.44 108.781 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.67 159.78 51.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.788 -1.325 . . . . 0.75 109.788 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.8 -48.29 1.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.958 1.772 . . . . 0.72 109.274 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 tpt85 -55.7 -34.8 65.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.821 0.849 . . . . 7.84 111.744 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -61.04 2.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.696 2.399 . . . . 3.45 108.807 174.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.05 -43.68 81.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.493 0.717 . . . . 0.94 110.139 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.28 -43.23 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.749 -0.643 . . . . 1.99 110.749 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -54.51 -45.26 73.26 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.248 0.931 . . . . 2.69 110.409 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.5 m -55.31 -53.39 56.68 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.531 0.605 . . . . 0.9 110.559 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.17 -53.93 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.461 0.704 . . . . 1.72 111.335 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -54.11 -57.48 10.93 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.458 1.103 . . . . 3.19 109.807 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.5 t -52.66 -49.75 64.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.545 1.538 . . . . 1.15 111.071 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -61.18 -54.56 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.099 0.409 . . . . 3.13 110.96 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.87 -42.44 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.782 -1.199 . . . . 1.59 115.42 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.68 141.47 47.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.031 -0.668 . . . . 1.97 111.517 -133.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -78.24 123.43 26.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.225 -1.398 . . . . 3.44 107.225 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.18 159.0 15.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 1.37 110.757 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 m -151.35 114.51 4.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.272 1.029 . . . . 1.97 108.348 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.73 127.13 29.85 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.654 -0.869 . . . . 2.84 108.654 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 123.398 0.679 . . . . 1.99 110.949 177.62 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 109.642 -1.383 . . . . 1.66 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.62 145.41 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 118.524 1.162 . . . . 2.43 108.864 169.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.43 91.09 2.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.903 -1.517 . . . . 2.51 106.903 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.32 105.65 17.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.109 -0.7 . . . . 2.95 109.109 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 62' ' ' ILE . 4.1 pp -110.29 147.88 33.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.806 0.692 . . . . 2.11 109.48 173.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.45 133.44 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.832 -1.914 . . . . 1.7 105.832 161.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.35 137.1 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 125.123 1.369 . . . . 2.34 107.808 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -140.04 153.28 46.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.776 0.831 . . . . 7.3 109.862 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.8 -43.85 1.67 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.829 -1.308 . . . . 1.69 109.829 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -48.43 114.35 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.318 1.447 . . . . 2.14 114.103 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 p -97.48 115.93 28.73 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.133 1.373 . . . . 3.91 110.397 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.7 m 69.73 176.88 0.27 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.157 0.979 . . . . 3.29 113.31 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.18 -37.96 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.543 2.337 . . . . 1.19 112.523 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 p -64.51 -56.96 10.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.802 0.667 . . . . 0.88 112.802 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 119.966 -1.709 . . . . 1.13 108.542 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.93 -66.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.623 0.769 . . . . 0.82 110.776 172.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.258 0.0 OUTLIER -68.89 -26.04 64.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 121.795 -0.565 . . . . 1.1 111.285 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -59.77 -53.76 54.24 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 3.69 109.116 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.29 -60.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.727 -0.842 . . . . 0.6 108.727 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -55.18 -52.95 61.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.012 0.195 . . . . 3.16 110.743 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 t -57.73 -43.05 85.04 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.438 0.695 . . . . 1.01 111.603 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -62.22 -48.26 80.78 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.278 0.561 . . . . 0.81 109.919 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.61 ' O ' HG21 ' A' ' 32' ' ' ILE . 8.3 mp -70.06 -37.84 75.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.779 -0.629 . . . . 2.39 111.047 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.9 m -71.09 61.73 0.29 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 120.643 1.565 . . . . 2.36 111.334 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -148.98 -69.98 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.556 1.942 . . . . 4.02 109.252 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.547 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -63.51 111.98 2.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 2.3 111.653 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -77.99 47.08 0.62 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.817 1.784 . . . . 5.59 115.817 -152.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.84 2.87 5.26 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.992 0.815 . . . . 0.91 113.058 164.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.61 HG21 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -94.0 115.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.101 1.761 . . . . 2.81 107.049 178.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.9 mt -85.7 -43.69 13.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.827 0.851 . . . . 1.52 110.555 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -145.32 146.91 31.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.839 -0.43 . . . . 2.31 109.839 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.8 p -134.68 134.81 41.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.435 1.494 . . . . 3.21 107.397 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -151.06 104.66 3.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.966 -1.494 . . . . 1.67 106.966 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.33 3.4 p -92.89 88.7 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.445 1.593 . . . . 1.79 110.562 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.28 80.41 4.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.514 -1.221 . . . . 1.14 108.459 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.1 tt -42.38 -38.93 2.01 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.68 1.992 . . . . 1.7 111.226 166.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.17 -35.01 47.62 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.666 0.786 . . . . 0.92 112.065 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 p -108.64 8.52 27.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.466 1.506 . . . . 2.2 111.015 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.6 45.44 5.73 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.595 1.558 . . . . 2.09 110.392 -171.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -133.24 137.92 46.29 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.045 0.538 . . . . 1.12 110.239 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -98.34 107.85 20.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.469 -1.308 . . . . 0.56 107.469 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -84.03 97.4 9.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.966 -2.235 . . . . 0.8 104.966 162.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.416 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -93.84 154.38 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.512 -1.662 . . . . 1.76 106.512 162.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -128.55 145.01 51.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.57 -1.27 . . . . 2.98 107.57 159.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -160.18 172.43 17.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.492 0.717 . . . . 2.03 111.448 -165.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -105.93 100.17 26.57 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.155 1.382 . . . . 3.91 109.935 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -72.76 67.56 3.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.989 3.126 . . . . 2.35 112.298 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -166.34 -47.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.813 1.245 . . . . 3.75 110.343 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.17 -17.28 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 123.74 0.816 . . . . 2.52 110.462 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 tt -148.56 154.72 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.472 -2.048 . . . . 2.35 105.472 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.8 167.8 25.84 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.51 -1.436 . . . . 0.9 109.51 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.09 -39.83 76.1 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.664 1.576 . . . . 0.76 109.064 165.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -44.65 -52.36 8.28 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.261 1.424 . . . . 7.23 112.178 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -52.36 64.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.543 1.065 . . . . 2.82 110.321 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.83 -56.14 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.068 -0.715 . . . . 1.22 109.068 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.87 -56.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 122.805 0.442 . . . . 1.57 109.851 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -52.73 -49.53 65.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.165 1.386 . . . . 4.97 110.078 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.1 m -58.69 -45.77 88.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.112 -0.329 . . . . 0.75 110.112 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 8' ' ' LEU . 51.7 mt -56.6 -65.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.777 -0.453 . . . . 0.97 109.777 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.28 -46.87 72.82 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.419 -0.513 . . . . 2.92 110.393 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -60.61 -20.3 60.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.134 -1.412 . . . . 0.87 113.688 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.64 -73.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.162 1.801 . . . . 1.8 109.655 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.56 29.21 0.39 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.723 -1.043 . . . . 1.12 113.23 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.31 172.42 8.66 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 118.763 1.281 . . . . 1.95 113.362 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -103.88 146.39 28.72 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.203 -2.147 . . . . 4.25 105.203 158.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.6 137.94 20.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.833 0.853 . . . . 1.32 111.162 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 m -157.07 111.73 2.75 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.084 -1.01 . . . . 1.97 112.593 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -39.22 128.48 1.75 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.407 1.483 . . . . 3.67 110.583 165.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.454 -0.233 0 C-N-CA 124.589 1.156 . . . . 1.98 109.1 169.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 110.876 -0.89 . . . . 2.52 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.41 141.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 126.702 2.001 . . . . 1.84 106.385 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.0 tp -153.87 113.86 3.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.407 1.483 . . . . 2.23 107.037 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.87 121.23 37.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 2.07 108.209 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 145.45 50.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.343 0.52 . . . . 2.52 111.875 170.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.89 136.73 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.062 -1.459 . . . . 1.84 107.062 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.72 95.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 127.019 2.128 . . . . 1.96 106.006 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -79.57 126.11 30.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.51 -0.876 . . . . 5.12 108.848 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.46 8.99 4.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.202 1.382 . . . . 1.58 113.555 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.464 ' CE ' HG22 ' A' ' 37' ' ' VAL . 36.0 mtp -78.6 117.21 19.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.437 1.118 . . . . 1.79 108.268 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -143.73 16.39 1.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.146 0.795 . . . . 2.32 113.146 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -169.26 141.32 2.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.23 0.923 . . . . 2.55 109.453 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.03 -39.67 0.91 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.485 1.914 . . . . 1.22 113.63 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -59.52 -75.56 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.816 0.846 . . . . 1.23 111.847 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -46.97 -36.78 8.12 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 125.636 1.575 . . . . 1.85 111.521 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.21 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.872 0.869 . . . . 1.16 109.123 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -64.73 -15.96 62.25 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.656 -0.653 . . . . 1.64 112.742 -166.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -57.44 -40.43 78.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.42 1.088 . . . . 3.13 108.698 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.43 -63.78 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.292 -1.003 . . . . 0.56 108.292 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -58.35 6.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.495 0.318 . . . . 3.06 110.648 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 t -50.97 -47.32 61.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.127 0.971 . . . . 1.05 111.201 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -62.23 -57.44 11.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.823 -0.548 . . . . 0.83 109.654 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.43 -39.69 70.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.406 0.682 . . . . 2.29 111.497 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -48.46 -35.81 13.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.345 -0.847 . . . . 1.74 112.136 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 1.29 2.03 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.115 -0.991 . . . . 6.57 113.316 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.632 ' CB ' HD11 ' A' ' 53' ' ' ILE . 10.7 m170 -83.71 -19.85 34.5 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.134 -1.604 . . . . 2.4 110.738 171.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 65.92 -3.02 0.81 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.723 1.609 . . . . 6.93 115.236 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.79 15.79 51.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.28 0.945 . . . . 0.85 111.833 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -113.19 142.02 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.955 -1.498 . . . . 2.19 106.955 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.73 -40.57 9.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.581 0.752 . . . . 2.49 109.466 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -155.14 156.3 35.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.369 0.531 . . . . 2.4 110.691 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 m -137.29 116.58 12.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.54 -2.022 . . . . 2.6 105.54 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.62 99.6 7.65 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.253 -1.388 . . . . 1.41 107.253 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG22 ' CE ' ' A' ' 13' ' ' MET 0.285 0.6 OUTLIER -94.38 91.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 123.107 1.432 . . . . 1.41 110.484 -173.015 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.15 91.79 7.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.678 1.591 . . . . 0.95 111.23 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -44.55 -42.27 7.13 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.4 1.88 . . . . 1.71 112.521 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.28 -35.16 59.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.585 0.754 . . . . 1.46 111.463 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -107.5 3.67 25.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.397 1.479 . . . . 2.23 110.955 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.35 59.13 1.21 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.487 1.915 . . . . 2.86 109.832 -166.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 140.66 37.01 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.083 0.553 . . . . 1.12 111.013 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.47 113.83 26.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.52 108.384 165.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.59 99.33 8.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.621 -1.992 . . . . 0.97 105.621 158.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.75 141.8 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.377 -1.342 . . . . 1.26 107.377 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -125.19 116.34 21.86 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.231 -1.766 . . . . 3.47 106.231 165.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.09 165.0 37.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.591 1.157 . . . . 1.89 109.401 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.23 137.74 27.62 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.844 -1.169 . . . . 4.32 107.844 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.49 -40.44 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.165 1.91 . . . . 2.46 112.262 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.09 -31.69 23.23 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.336 0.516 . . . . 3.58 111.373 -164.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -56.4 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.402 -0.592 . . . . 3.79 109.402 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.632 HD11 ' CB ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -92.73 -41.92 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.673 -0.24 . . . . 3.11 110.944 -163.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.73 115.44 0.09 OUTLIER Glycine 0 CA--C 1.534 1.253 0 N-CA-C 109.423 -1.471 . . . . 1.2 109.423 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.72 -33.19 79.26 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 CA-C-N 120.306 2.053 . . . . 0.91 112.44 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -47.55 -43.14 24.85 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.968 0.729 . . . . 6.88 112.968 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -58.67 -55.19 38.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.078 0.942 . . . . 4.1 109.903 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.1 mt -50.96 -52.92 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.822 -0.626 . . . . 0.96 110.671 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.39 -48.24 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-O 118.64 -0.695 . . . . 1.79 110.117 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -51.09 -48.69 61.61 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.619 -0.511 . . . . 2.9 109.619 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -61.37 -48.13 82.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 118.513 -1.275 . . . . 1.2 109.907 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.9 mt -54.35 -57.05 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 119.388 -0.339 . . . . 0.9 111.167 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.25 -46.1 88.43 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.503 0.592 . . . . 4.67 110.414 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -66.79 -15.97 63.95 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.718 -1.135 . . . . 0.83 112.517 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.81 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.461 1.482 . . . . 1.78 110.496 162.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.96 36.2 0.5 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.017 -0.88 . . . . 1.47 113.548 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -132.81 175.09 9.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.352 1.076 . . . . 1.83 111.265 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -129.74 121.98 27.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.001 -1.111 . . . . 3.36 108.001 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.13 163.46 13.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.454 0.701 . . . . 1.37 111.934 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -155.98 123.99 5.7 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.601 1.56 . . . . 1.56 108.53 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.87 138.27 58.4 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.815 0.734 . . . . 2.49 109.963 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 123.182 0.593 . . . . 2.08 111.443 177.128 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 N-CA-C 108.392 -1.883 . . . . 1.94 108.392 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.72 138.4 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.294 -0.533 . . . . 2.05 110.008 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -142.43 88.43 2.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.256 1.822 . . . . 2.1 107.541 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -82.57 121.28 26.6 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.873 -1.528 . . . . 2.25 106.873 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -128.71 137.71 51.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.179 -0.325 . . . . 1.89 110.238 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.45 145.81 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.711 -1.218 . . . . 1.73 107.711 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.26 155.19 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.472 -1.677 . . . . 1.9 106.472 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -126.31 132.68 51.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.393 -1.336 . . . . 4.89 107.393 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.25 23.81 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.288 1.423 . . . . 1.83 112.201 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mtp -72.37 78.0 1.02 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.259 1.029 . . . . 2.14 109.189 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 t -97.26 -3.48 40.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.791 0.836 . . . . 2.26 112.813 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -163.41 144.65 9.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.591 1.087 . . . . 2.26 110.795 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.05 -37.43 0.16 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 127.88 2.472 . . . . 1.2 113.37 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -52.46 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.198 0.999 . . . . 0.87 112.339 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.8 m -43.04 -49.51 6.11 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 126.504 1.921 . . . . 1.3 110.191 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.4 t -45.82 -69.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 125.432 1.493 . . . . 1.03 110.554 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.281 0.0 OUTLIER -70.21 -17.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.428 -0.509 . . . . 1.55 111.638 -175.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -70.24 -42.32 72.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.301 -1.0 . . . . 4.64 108.301 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -51.2 -61.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.53 108.92 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -58.8 -54.32 48.45 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.809 -0.557 . . . . 2.72 112.103 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.4 t -54.4 -30.99 53.98 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.831 0.852 . . . . 1.01 111.483 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 t -71.03 -69.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.497 -0.752 . . . . 0.93 110.275 167.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -50.85 -47.31 60.36 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.26 1.424 . . . . 2.37 113.462 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.7 p -46.08 -34.19 3.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.682 0.793 . . . . 2.15 111.83 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -64.09 -21.79 66.67 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.706 1.203 . . . . 6.1 111.788 -175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.529 ' CB ' HD11 ' A' ' 53' ' ' ILE . 12.5 m170 -64.21 -29.75 70.84 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.472 0.578 . . . . 2.2 110.384 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 67.68 -1.95 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.137 1.775 . . . . 5.06 114.771 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.01 32.64 5.74 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.885 1.22 . . . . 0.87 110.785 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mt -138.37 126.65 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.099 -1.815 . . . . 2.21 106.099 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.52 -37.66 13.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 123.64 0.588 . . . . 1.86 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -144.76 148.56 34.25 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.161 -1.051 . . . . 3.13 108.161 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -157.07 68.17 0.55 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.132 -1.062 . . . . 2.01 108.132 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 m -84.9 108.69 17.67 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.053 -0.351 . . . . 1.67 110.053 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.21 112.87 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.983 -0.747 . . . . 2.33 108.983 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.41 98.5 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.657 0.783 . . . . 0.96 110.429 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -38.75 -47.48 1.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.126 1.77 . . . . 1.92 112.148 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.12 66.55 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.493 1.117 . . . . 0.98 111.79 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -117.09 10.63 13.96 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.723 1.209 . . . . 1.68 109.943 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.32 59.59 0.27 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.438 2.295 . . . . 2.57 112.305 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.12 152.78 37.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.559 0.744 . . . . 1.09 109.76 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.52 118.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.994 1.318 . . . . 0.56 108.101 164.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -81.1 96.52 7.2 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 105.251 -2.129 . . . . 0.76 105.251 163.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.83 141.21 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.837 -1.542 . . . . 0.96 106.837 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -122.87 121.83 37.15 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.53 -2.396 . . . . 2.54 104.53 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -137.78 169.27 18.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.776 0.716 . . . . 2.31 112.293 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -108.01 99.88 33.21 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.651 0.78 . . . . 4.66 109.237 -171.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.67 48.16 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.114 2.542 . . . . 2.45 112.835 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -137.12 17.96 2.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.048 1.339 . . . . 5.04 110.323 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.11 -56.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 124.422 1.089 . . . . 4.66 108.576 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.529 HD11 ' CB ' ' A' ' 29' ' ' HIS . 1.6 mt -95.67 142.65 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.154 -1.425 . . . . 2.18 107.154 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.0 151.24 20.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.657 -1.377 . . . . 1.07 109.657 160.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.79 -38.58 29.79 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.957 1.771 . . . . 0.7 110.605 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -50.02 -44.52 51.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.433 0.693 . . . . 7.39 111.303 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -53.47 37.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.5 1.12 . . . . 3.34 108.881 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.67 -54.49 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.993 -0.549 . . . . 0.74 109.784 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.91 -52.69 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.449 -0.575 . . . . 1.33 109.449 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -56.21 -47.2 78.86 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.76 0.824 . . . . 4.78 110.263 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.3 m -58.37 -46.08 87.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.235 0.471 . . . . 0.86 110.437 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 54.6 mt -54.3 -64.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.131 -0.692 . . . . 0.74 109.131 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -55.0 -47.82 74.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.948 0.404 . . . . 4.25 110.197 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -58.47 -20.3 44.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.116 -1.421 . . . . 0.98 113.825 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.25 -76.4 0.09 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-N 121.189 1.813 . . . . 1.66 109.439 167.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.72 35.56 0.46 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.522 -1.154 . . . . 1.38 113.281 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -129.81 175.15 9.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 1.365 . . . . 1.86 112.749 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.33 145.62 44.97 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 104.483 -2.414 . . . . 3.29 104.483 161.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.49 162.62 35.03 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.786 1.176 . . . . 1.11 112.503 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 t -155.84 112.86 3.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.623 0.769 . . . . 1.9 108.949 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.82 126.22 26.91 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.411 0.551 . . . . 2.63 109.962 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 109.052 -0.721 . . . . 2.18 109.052 -176.911 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 N-CA-C 106.318 -2.713 . . . . 2.16 106.318 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.93 80.44 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.632 -1.247 . . . . 2.21 107.632 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.1 78.58 4.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.772 -1.566 . . . . 2.4 106.772 172.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.28 121.73 24.8 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.385 -2.08 . . . . 2.42 105.385 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -131.57 145.46 51.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.248 -0.649 . . . . 2.1 109.248 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.23 136.88 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.154 -1.795 . . . . 1.99 106.154 165.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.17 157.09 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 107.148 -1.427 . . . . 2.29 107.148 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -146.37 149.42 33.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.409 -0.589 . . . . 5.89 109.409 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.85 -13.89 31.96 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.144 1.354 . . . . 1.65 111.547 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.8 mtm -66.9 113.79 5.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.496 1.148 . . . . 1.51 110.064 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -82.1 -50.96 8.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.531 1.133 . . . . 3.69 110.471 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -169.67 172.28 6.95 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.395 1.078 . . . . 2.33 110.076 -160.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.85 -47.67 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.089 2.956 . . . . 1.18 114.906 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p -67.89 -47.61 68.38 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.861 -0.525 . . . . 1.23 112.108 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.8 m -70.65 -35.35 72.84 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.347 -0.983 . . . . 1.58 108.347 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.34 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 124.633 1.173 . . . . 1.08 109.729 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.275 0.3 OUTLIER -71.02 -16.64 62.63 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.671 0.989 . . . . 1.16 113.671 -165.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -45.34 -47.54 13.31 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 108.858 -0.793 . . . . 3.99 108.858 165.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.38 -65.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.085 -0.709 . . . . 0.5 109.085 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -55.18 -48.14 74.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 123.133 0.27 . . . . 4.38 111.056 -166.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.7 t -54.32 -60.27 3.57 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.486 -0.931 . . . . 1.07 108.486 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 t -51.91 -42.59 62.89 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.904 0.481 . . . . 0.88 111.698 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 mt -71.9 -53.82 11.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.635 -0.826 . . . . 1.65 111.94 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.0 m -49.23 -33.36 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.729 -1.232 . . . . 1.77 111.902 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -51.93 -32.79 34.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.222 1.193 . . . . 6.11 114.222 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -55.0 -29.75 57.93 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.756 0.707 . . . . 2.37 111.013 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 73.01 -1.04 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.054 1.742 . . . . 5.35 112.001 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 52' ' ' ILE . . . -88.02 -42.43 5.97 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 110.604 -0.998 . . . . 1.95 110.604 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 53' ' ' ILE . 2.1 mp -74.52 125.9 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.102 -1.444 . . . . 3.04 107.102 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.88 -38.71 32.07 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.771 0.828 . . . . 2.75 109.96 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.74 154.88 37.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.376 -0.601 . . . . 2.08 109.376 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 t -155.19 63.64 0.63 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.241 0.543 . . . . 1.83 112.144 -164.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 99.75 7.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.96 0.504 . . . . 1.3 109.845 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.295 0.8 OUTLIER -89.04 93.68 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 122.477 1.132 . . . . 1.55 110.269 172.697 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.8 96.55 9.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.365 1.466 . . . . 0.79 109.9 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.0 tp -51.08 -39.25 55.64 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.164 1.786 . . . . 2.33 112.555 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.82 73.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.257 0.551 . . . . 1.13 110.674 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -81.05 -22.81 39.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.482 1.113 . . . . 2.26 111.231 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.53 55.8 4.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.773 1.629 . . . . 2.97 107.991 -168.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.57 144.33 46.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.896 -1.047 . . . . 1.0 108.611 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.588 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -104.63 113.74 27.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.588 1.155 . . . . 0.47 108.778 171.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -87.98 91.41 8.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.947 -1.872 . . . . 0.78 105.947 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.588 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.51 125.69 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.731 -1.211 . . . . 1.45 107.731 170.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -96.76 110.45 22.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.85 -1.537 . . . . 3.61 106.85 162.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -125.64 158.36 34.93 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.919 0.888 . . . . 2.14 108.812 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -97.97 113.21 63.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.841 1.256 . . . . 4.11 108.43 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.44 70.0 4.94 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.999 3.133 . . . . 2.89 110.915 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -163.13 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.333 1.453 . . . . 3.78 109.56 -173.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.519 HD11 ' HA3' ' A' ' 31' ' ' GLY . 1.8 pp -92.94 -33.88 5.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 122.749 0.419 . . . . 2.9 111.332 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.439 HD13 HD11 ' A' ' 32' ' ' ILE . 5.9 tt -132.66 149.14 31.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.556 -0.905 . . . . 2.46 108.556 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.69 160.02 23.27 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.427 -1.069 . . . . 0.67 110.427 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -41.39 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.43 2.087 . . . . 0.82 110.483 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -57.18 -35.44 69.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 119.299 -0.382 . . . . 8.01 111.236 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -56.58 20.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.0 2.52 . . . . 3.87 109.143 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.98 -50.38 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.931 -0.766 . . . . 0.86 108.931 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.05 -47.24 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 118.772 -0.632 . . . . 1.37 110.538 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -52.77 -48.58 66.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.366 1.067 . . . . 3.08 109.191 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.4 m -60.25 -49.95 75.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.158 -0.682 . . . . 0.88 109.158 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.91 -62.44 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.527 0.731 . . . . 0.81 110.865 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.08 -49.22 72.23 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.315 -0.624 . . . . 2.89 109.315 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.1 t -51.14 -44.7 61.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.045 0.938 . . . . 0.99 112.546 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.78 -52.41 65.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.904 1.229 . . . . 1.85 113.302 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.61 10.53 0.12 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.281 -1.288 . . . . 1.46 116.056 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -139.04 176.14 8.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.346 1.573 . . . . 1.84 112.89 -148.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 151.87 37.57 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.534 -2.025 . . . . 3.18 105.534 154.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 157.04 43.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.967 0.507 . . . . 0.97 111.545 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -147.54 115.55 6.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.587 1.555 . . . . 2.01 108.69 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.31 134.39 50.26 Favored 'General case' 0 N--CA 1.458 -0.034 0 C-N-CA 122.637 0.375 . . . . 2.65 111.801 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.534 0.337 0 C-N-CA 123.847 0.859 . . . . 2.33 110.08 -179.132 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.044 0 N-CA-C 110.392 -1.083 . . . . 2.05 110.392 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.25 143.46 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.689 1.196 . . . . 2.07 109.179 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 tt -147.76 115.42 6.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.62 1.568 . . . . 3.05 107.204 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.74 124.41 49.52 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.144 -0.688 . . . . 2.26 109.144 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.8 mt -102.82 142.41 34.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.355 -1.72 . . . . 2.42 106.355 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -75.71 138.99 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.387 -2.079 . . . . 2.14 105.387 148.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 131.39 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.597 1.559 . . . . 1.97 108.015 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -126.3 144.56 50.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.776 1.231 . . . . 5.0 108.263 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.09 -31.77 6.32 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.849 1.214 . . . . 1.67 110.186 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtm -58.75 141.96 51.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.518 -0.549 . . . . 1.46 109.518 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -152.62 10.99 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.8 0.667 . . . . 2.36 112.8 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -171.18 152.1 3.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 2.29 109.17 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.31 -43.11 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.301 1.84 . . . . 1.15 112.276 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 p -44.3 -66.9 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.479 1.512 . . . . 0.79 113.096 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.8 m -47.51 -48.38 27.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.628 1.171 . . . . 1.07 109.488 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.35 -67.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.158 -0.928 . . . . 0.81 111.101 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -27.13 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.233 -0.917 . . . . 1.2 111.632 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -53.39 -49.1 67.94 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.234 0.614 . . . . 3.24 109.838 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -54.47 -65.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.088 -0.708 . . . . 0.64 109.088 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.1 -61.6 1.81 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.404 1.082 . . . . 2.76 110.916 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -48.95 -45.99 42.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.057 1.343 . . . . 1.06 110.574 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 t -62.25 -65.91 0.62 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.817 -0.611 . . . . 0.89 110.701 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.54 -35.09 76.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.503 1.047 . . . . 1.78 111.806 -163.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.4 m -46.65 -31.6 2.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.842 -0.536 . . . . 2.08 112.119 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -34.14 23.26 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.353 0.871 . . . . 4.19 113.353 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -61.07 -41.4 96.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.038 0.381 . . . . 2.54 110.329 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.84 -2.23 2.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.657 2.383 . . . . 5.71 113.329 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.28 -31.96 36.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.598 -1.001 . . . . 0.92 110.598 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.11 106.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.204 -2.147 . . . . 3.01 105.204 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.7 mt -79.94 -33.3 39.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.995 0.518 . . . . 2.12 109.92 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -147.35 156.47 42.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.539 -0.541 . . . . 2.46 109.539 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.86 134.74 17.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.866 -1.531 . . . . 1.86 106.866 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -144.21 116.16 8.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.389 -1.338 . . . . 2.18 107.389 164.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.15 111.4 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.573 0.701 . . . . 1.71 110.376 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.44 104.35 12.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.982 0.913 . . . . 1.29 109.659 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -44.88 -37.09 3.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.609 1.163 . . . . 2.72 111.346 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.08 -30.75 16.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.796 0.838 . . . . 1.11 112.056 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -127.92 17.4 6.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.385 1.074 . . . . 1.6 109.77 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 31.51 47.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.778 2.031 . . . . 2.13 112.672 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.76 143.6 47.22 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.854 0.462 . . . . 1.29 111.346 -170.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.28 98.49 8.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.575 1.95 . . . . 0.68 107.786 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -79.15 104.06 9.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.376 -2.083 . . . . 0.97 105.376 167.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.28 136.63 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.307 -1.738 . . . . 1.12 106.307 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -107.46 114.47 28.5 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.719 -1.586 . . . . 3.33 106.719 160.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -129.2 175.69 8.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.13 -2.544 . . . . 1.98 104.13 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.39 132.28 24.17 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 107.746 -1.205 . . . . 3.69 107.746 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.98 59.87 5.28 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 125.058 3.839 . . . . 2.79 110.883 -173.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -155.64 -54.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 128.428 2.691 . . . . 3.38 107.264 -168.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -88.45 -25.4 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.349 1.059 . . . . 2.98 110.407 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.55 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.425 -0.954 . . . . 2.86 108.425 170.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.35 164.76 30.91 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 111.001 -0.839 . . . . 0.86 111.001 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.67 -45.19 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.916 2.41 . . . . 1.05 110.866 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.2 -42.63 69.95 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 122.995 0.518 . . . . 8.28 110.587 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -56.28 9.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.732 1.613 . . . . 3.98 109.37 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mt -59.19 -49.71 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.999 0.519 . . . . 0.99 109.602 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -53.78 -52.63 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.793 -0.447 . . . . 1.44 109.793 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -50.92 -51.29 53.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.973 0.509 . . . . 3.58 109.816 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -57.64 -53.37 58.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.226 -0.59 . . . . 0.94 110.262 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.0 mt -53.73 -59.92 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 124.196 0.999 . . . . 0.93 110.466 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.53 -50.46 73.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.224 -0.658 . . . . 4.56 109.224 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -48.69 -46.13 40.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 1.05 112.016 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.66 -56.54 19.15 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.255 0.934 . . . . 1.87 113.425 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 10.98 0.12 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.953 -1.471 . . . . 1.39 116.655 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.46 176.02 9.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.851 1.825 . . . . 1.89 112.655 -153.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -120.12 158.48 26.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.756 -1.572 . . . . 3.69 106.756 156.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.01 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.04 0.936 . . . . 1.81 112.482 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -157.56 111.45 2.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.072 1.349 . . . . 2.79 109.781 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 84.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.614 1.097 . . . . 2.43 108.809 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 124.439 1.096 . . . . 3.21 113.53 -176.153 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 N-CA-C 111.473 -0.651 . . . . 1.97 111.473 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.97 91.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.345 -0.983 . . . . 3.07 108.345 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -108.34 111.46 23.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 2.98 107.838 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 25.2 mt-10 -83.41 135.21 34.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.952 -1.129 . . . . 2.77 107.952 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.33 130.25 54.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.396 -1.335 . . . . 2.79 107.396 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.83 129.51 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 107.807 -1.183 . . . . 3.17 107.807 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.37 151.55 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 125.083 1.353 . . . . 1.81 109.189 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -129.5 144.23 51.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.437 -0.949 . . . . 6.02 108.437 163.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.58 3.11 35.02 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.5 1.524 . . . . 1.93 112.333 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 82.6 mtp -66.94 158.0 31.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.647 -0.914 . . . . 1.98 110.886 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 t -164.67 128.46 2.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.415 1.086 . . . . 3.32 108.556 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.3 m 62.41 177.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.54 1.536 . . . . 2.29 112.949 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.29 -27.67 56.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.869 -1.059 . . . . 1.26 111.461 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -56.61 -70.39 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.285 1.434 . . . . 0.78 113.648 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.5 m -49.46 -42.19 42.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.457 -0.777 . . . . 1.22 109.707 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 t -51.53 -71.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.407 0.683 . . . . 0.89 111.625 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 -29.29 69.1 Favored 'General case' 0 C--N 1.34 0.163 0 O-C-N 121.513 -0.742 . . . . 1.27 111.007 -173.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -55.03 -56.42 20.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.35 -0.611 . . . . 4.12 109.35 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.52 -54.2 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.631 -0.507 . . . . 0.84 109.631 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.5 -54.81 19.41 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.888 0.375 . . . . 3.11 110.99 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -52.92 -56.74 13.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.121 0.968 . . . . 1.17 110.381 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -50.25 -56.35 11.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.735 1.214 . . . . 1.92 109.919 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.87 -45.62 64.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.41 -0.516 . . . . 2.61 111.599 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.4 m -52.12 -36.16 50.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.097 0.862 . . . . 1.65 111.02 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.87 -26.13 23.23 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.12 1.156 . . . . 4.57 114.12 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.25 -29.26 70.62 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.219 1.372 . . . . 2.23 111.093 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 72.04 -3.59 2.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 6.25 113.03 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.59 -30.77 38.92 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.321 -1.112 . . . . 0.88 110.321 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.75 116.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.222 -1.399 . . . . 2.83 107.222 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -79.01 -33.9 44.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.157 0.583 . . . . 1.37 109.452 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.08 146.54 24.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.226 -0.657 . . . . 1.9 109.226 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.5 t -139.82 130.89 26.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.294 -1.743 . . . . 1.86 106.294 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -145.36 116.81 8.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.586 -0.894 . . . . 1.86 108.586 167.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.54 85.41 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.935 -1.135 . . . . 1.97 107.935 -166.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 93.46 8.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.66 -0.867 . . . . 0.92 108.66 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.1 tt -44.69 -39.83 5.43 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.715 1.206 . . . . 1.81 111.826 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.93 -30.08 22.92 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.857 0.863 . . . . 1.12 112.438 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -123.35 14.8 9.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.275 1.43 . . . . 1.53 110.175 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 m120 30.56 53.32 0.15 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 127.376 2.271 . . . . 2.31 112.829 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -133.83 140.25 46.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.221 0.608 . . . . 1.38 109.437 -173.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.34 101.48 10.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.169 1.788 . . . . 0.55 107.032 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -77.82 107.08 10.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.287 -1.746 . . . . 0.98 106.287 170.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -112.7 118.95 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.021 -1.474 . . . . 0.96 107.021 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -96.12 119.15 34.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.9 -1.519 . . . . 3.09 106.9 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -158.57 127.42 5.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.449 0.3 . . . . 2.72 110.744 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.11 128.11 91.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.382 -0.97 . . . . 3.38 108.382 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.88 -50.5 5.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.251 1.967 . . . . 2.44 111.71 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.15 -21.9 36.23 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.721 1.378 . . . . 3.23 114.721 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.35 -1.89 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.041 0.837 . . . . 2.33 112.104 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.82 -47.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.322 0.965 . . . . 2.95 113.594 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 148.64 8.46 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.446 1.022 . . . . 0.67 112.1 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.05 -47.52 17.47 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.251 2.634 . . . . 0.94 111.402 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.433 HH21 ' N ' ' A' ' 60' ' ' HIS . 7.8 tpm_? -47.81 -43.87 28.19 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.148 0.979 . . . . 7.62 111.843 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.89 -53.88 51.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.868 0.867 . . . . 3.92 110.987 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.26 -52.86 53.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.43 -0.581 . . . . 0.67 109.43 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -57.48 -47.38 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.033 -0.728 . . . . 1.57 109.033 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.433 ' N ' HH21 ' A' ' 56' ' ' ARG . 52.4 t-80 -59.09 -41.91 89.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.693 0.797 . . . . 4.69 110.126 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.9 m -63.0 -45.76 90.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.102 -0.333 . . . . 0.93 110.102 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.31 -49.94 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.327 0.651 . . . . 0.78 110.824 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -49.95 -59.19 4.11 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.108 0.963 . . . . 2.99 109.749 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -52.92 -48.55 67.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.753 1.621 . . . . 0.92 111.189 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.21 -55.42 35.2 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.939 -0.476 . . . . 1.63 110.976 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.84 -40.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.663 1.025 . . . . 1.67 115.663 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -122.95 132.53 54.2 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.326 0.563 . . . . 1.97 110.874 -133.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.44 133.12 37.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.02 -1.845 . . . . 4.24 106.02 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.74 145.33 30.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.058 -0.401 . . . . 1.49 110.372 -172.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -135.89 110.7 8.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.424 1.09 . . . . 2.5 109.576 -170.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.95 116.56 1.11 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.215 0.606 . . . . 2.12 109.918 164.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.796 -1.187 . . . . 2.66 107.796 178.424 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 N-CA-C 109.2 -1.56 . . . . 1.64 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.12 146.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 121.657 -0.908 . . . . 2.19 109.95 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.05 116.45 22.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.471 2.308 . . . . 2.73 105.497 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.11 107.26 12.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.385 -0.969 . . . . 2.53 108.385 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -119.62 143.79 47.48 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 125.128 1.518 . . . . 2.19 109.423 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.31 136.72 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.891 -1.892 . . . . 2.29 105.891 162.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.38 122.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.015 1.726 . . . . 2.26 106.905 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -104.35 150.53 24.41 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.082 0.953 . . . . 5.48 110.912 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 -49.58 4.14 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 107.978 -2.049 . . . . 1.83 107.978 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -27.53 112.44 0.06 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.844 2.458 . . . . 2.01 112.312 163.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -157.56 160.52 38.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.443 0.697 . . . . 3.1 109.572 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.3 m 63.68 155.84 0.06 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.356 1.862 . . . . 2.59 113.106 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.98 -36.24 2.39 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.64 1.576 . . . . 1.3 111.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.53 -48.26 79.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.712 2.005 . . . . 1.07 114.127 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.2 -43.76 64.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.339 -1.356 . . . . 1.29 107.339 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.59 -64.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.465 1.106 . . . . 1.27 111.785 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.97 -31.05 68.56 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.869 -0.519 . . . . 1.64 111.446 -174.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.8 -55.92 26.72 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.339 -0.985 . . . . 4.57 108.339 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.18 -61.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.454 -0.573 . . . . 0.75 109.454 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 1.7 pp20? -64.33 -44.24 92.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.905 -0.718 . . . . 4.95 111.168 -165.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -64.21 -47.35 80.08 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 t -56.88 -42.78 80.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.835 -0.602 . . . . 1.12 110.949 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.05 -64.47 0.93 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 119.373 0.988 . . . . 1.79 112.026 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.9 m -44.01 -34.48 1.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.763 1.225 . . . . 1.63 114.014 -162.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.28 -29.76 0.15 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.221 1.563 . . . . 6.12 115.221 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -55.82 -40.65 73.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.314 0.961 . . . . 2.25 111.102 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp-105 70.52 -1.67 2.46 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.717 2.007 . . . . 5.97 112.666 -167.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.09 -32.41 35.81 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 1.01 110.51 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 46' ' ' ILE . 4.2 mp -84.13 118.13 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.286 -1.746 . . . . 2.74 106.286 172.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.4 mt -81.42 -33.39 32.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.203 1.001 . . . . 1.37 110.427 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -150.55 133.97 16.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.988 -1.486 . . . . 2.39 106.988 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.0 t -133.74 62.51 1.65 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.776 0.83 . . . . 1.94 110.253 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 95.54 8.02 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.648 -0.706 . . . . 1.81 109.674 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.27 85.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.6 1.19 . . . . 2.32 107.823 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 80.22 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.05 1.34 . . . . 1.16 108.334 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -38.99 -43.8 1.01 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.67 2.388 . . . . 2.3 111.152 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.54 -33.51 45.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.645 0.778 . . . . 1.25 111.834 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 p -112.33 8.26 19.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.558 1.543 . . . . 2.5 111.513 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.26 45.92 5.14 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.274 1.43 . . . . 2.08 110.761 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -134.24 144.77 48.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.488 0.715 . . . . 1.03 110.594 -171.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.88 105.47 17.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.144 -1.428 . . . . 0.46 107.144 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -83.96 100.41 11.02 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.901 -1.889 . . . . 0.74 105.901 165.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 32' ' ' ILE . 14.5 mt -112.07 108.35 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 124.786 1.234 . . . . 1.23 107.716 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.7 115.23 19.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.033 -1.469 . . . . 2.21 107.033 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -144.52 162.58 36.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.46 -2.052 . . . . 1.87 105.46 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.99 139.42 32.49 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 107.004 -1.48 . . . . 4.51 107.004 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.56 69.06 5.26 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.351 3.368 . . . . 2.49 111.481 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -165.28 -46.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.561 1.544 . . . . 4.27 110.216 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -81.68 -25.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 3.38 109.668 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -158.33 157.11 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.4 164.49 26.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.728 -0.949 . . . . 0.75 110.728 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.86 -47.49 1.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.996 2.464 . . . . 0.82 110.802 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -61.87 -34.09 75.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.211 -0.306 . . . . 7.18 111.211 -175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -57.31 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.495 1.518 . . . . 3.69 108.586 173.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.49 -51.73 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.263 -0.88 . . . . 0.88 109.451 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.5 mt -52.39 -56.84 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.472 0.309 . . . . 1.51 110.206 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -49.39 -48.81 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.479 0.712 . . . . 3.16 109.819 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.6 m -60.12 -52.23 66.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 119.9 -0.72 . . . . 0.99 110.121 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.68 -57.43 5.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 124.036 0.934 . . . . 0.78 110.468 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.66 -52.23 66.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.441 -0.577 . . . . 4.74 109.441 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -51.19 -40.91 59.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.974 0.909 . . . . 1.24 111.895 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.63 -48.68 80.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.713 1.142 . . . . 1.8 113.367 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.28 -1.47 0.06 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 118.371 2.108 . . . . 1.03 118.371 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -138.57 176.64 8.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.788 1.794 . . . . 2.1 113.432 -145.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.58 139.1 53.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.851 -1.907 . . . . 3.35 105.851 167.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.16 161.0 22.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.202 1.001 . . . . 1.66 112.459 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.7 m -157.05 116.2 3.36 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.493 -1.241 . . . . 1.83 110.059 171.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 mt -49.99 140.8 11.7 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.782 1.174 . . . . 3.1 109.18 164.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 124.827 1.251 . . . . 3.08 110.611 177.71 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 111.209 -0.756 . . . . 1.58 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.13 140.4 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.653 -1.24 . . . . 2.32 107.653 159.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 tp -137.35 91.68 2.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.428 -1.323 . . . . 2.15 107.428 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.99 116.62 26.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.677 -1.601 . . . . 2.55 106.677 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -124.91 140.7 52.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.2 -0.312 . . . . 2.96 110.518 174.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.68 139.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.829 -1.545 . . . . 1.66 106.829 167.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.82 150.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 123.898 0.879 . . . . 2.44 108.76 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -146.53 168.0 22.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 4.85 108.791 -170.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.4 -55.79 3.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.716 -1.754 . . . . 1.62 108.716 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 ptm -60.48 138.93 57.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.466 -0.431 . . . . 1.65 110.767 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -159.07 19.84 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.444 -0.343 . . . . 2.55 111.863 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.6 p -173.33 159.35 3.75 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.907 0.776 . . . . 3.54 110.219 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.72 -41.07 55.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.975 1.71 . . . . 1.16 113.149 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.2 p -63.22 -67.08 0.45 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.137 0.575 . . . . 1.07 111.342 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -43.73 -42.25 5.32 Favored 'General case' 0 N--CA 1.461 0.075 0 O-C-N 121.389 -0.819 . . . . 1.27 110.759 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.07 -73.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 123.205 0.602 . . . . 0.8 111.011 173.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -21.04 66.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.521 -0.737 . . . . 0.99 111.921 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -58.12 -47.71 82.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.001 0.92 . . . . 4.04 110.03 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.7 mt -59.9 -54.25 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.701 -0.852 . . . . 0.58 108.701 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -54.0 -59.82 4.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.641 0.588 . . . . 2.95 109.57 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.3 t -51.37 -49.15 62.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.086 1.354 . . . . 1.02 111.135 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -58.33 -51.11 71.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.85 110.386 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.01 -36.54 84.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 118.705 -1.198 . . . . 2.05 110.158 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.8 m -63.85 7.32 0.12 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.119 -0.988 . . . . 2.09 113.306 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.81 -46.72 43.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.42 -1.425 . . . . 4.45 110.296 157.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.467 0.707 . . . . 2.63 110.613 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -0.52 11.86 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.507 -0.746 . . . . 7.6 112.292 170.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.72 -15.25 61.85 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.031 0.378 . . . . 0.84 112.319 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -94.0 142.8 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.484 -1.302 . . . . 3.17 107.484 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.27 -45.75 4.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.321 1.048 . . . . 3.09 110.025 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.13 153.98 49.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.291 1.036 . . . . 2.33 108.829 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 p -156.02 59.63 0.59 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.435 0.694 . . . . 2.99 111.463 -170.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 m -87.06 104.63 16.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.509 -0.758 . . . . 1.94 111.429 -175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.303 2.7 p -92.68 92.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 122.655 1.217 . . . . 1.93 111.654 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.68 90.66 7.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.785 -1.191 . . . . 0.79 107.785 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tt -44.15 -37.35 3.07 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.55 1.14 . . . . 1.71 111.453 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.14 22.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.906 0.882 . . . . 1.02 112.247 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -120.8 15.44 11.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.012 1.325 . . . . 1.48 110.41 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.15 50.6 0.72 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.548 1.939 . . . . 2.01 111.733 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.75 143.6 35.04 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.222 0.609 . . . . 1.05 109.372 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.84 118.74 36.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.972 -1.122 . . . . 0.55 107.972 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -87.33 95.58 10.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.844 -2.28 . . . . 1.04 104.844 162.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.1 mt -93.48 140.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.848 -1.538 . . . . 1.02 106.848 169.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -118.68 136.86 53.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.94 -1.874 . . . . 3.6 105.94 161.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.62 173.7 15.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.964 1.306 . . . . 1.84 108.126 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -113.29 117.48 45.34 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.62 -1.252 . . . . 3.91 107.62 164.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.26 -40.11 83.82 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.456 1.437 . . . . 2.2 111.945 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -67.64 -12.62 60.86 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.709 0.686 . . . . 4.97 112.663 -167.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 pt -117.97 6.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 123.928 0.891 . . . . 2.41 112.946 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.37 -42.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.474 0.916 . . . . 2.69 113.474 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.49 159.29 5.55 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.201 -0.76 . . . . 0.94 111.201 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.31 -34.54 66.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.526 2.151 . . . . 0.71 110.837 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.11 -46.13 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.534 0.938 . . . . 6.82 113.534 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.45 -35.29 70.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.2 0.909 . . . . 4.11 112.182 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mt -58.19 -47.11 88.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.834 -0.802 . . . . 0.92 108.834 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.83 -48.5 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 118.147 -0.93 . . . . 1.71 109.985 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -47.07 -49.46 21.58 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.957 0.799 . . . . 3.44 109.523 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.0 m -59.21 -55.78 30.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.338 -0.545 . . . . 1.36 110.017 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -63.52 -45.5 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 122.537 0.335 . . . . 0.84 110.702 -170.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.92 -54.64 39.06 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.974 0.509 . . . . 3.12 110.315 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -64.88 -20.7 66.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.829 -1.081 . . . . 0.88 112.416 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.16 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 119.849 1.204 . . . . 1.81 109.05 160.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 18.0 0.24 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.152 -1.36 . . . . 1.14 115.111 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.15 122.9 40.26 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.95 1.875 . . . . 1.93 112.683 -157.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.76 86.84 4.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.889 -0.782 . . . . 3.41 108.889 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.11 163.11 26.92 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.13 -0.981 . . . . 1.04 110.709 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.0 m -154.68 104.53 2.54 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.738 -0.838 . . . . 1.89 108.738 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 126.42 27.3 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 122.86 0.464 . . . . 2.17 111.443 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.341 0.218 0 CA-C-O 121.541 0.686 . . . . 1.96 110.853 -173.713 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 111.35 -0.7 . . . . 2.74 111.35 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.83 117.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.58 -1.267 . . . . 3.12 107.58 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.12 135.63 14.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.909 0.861 . . . . 3.15 111.026 164.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.39 117.36 33.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.75 1.22 . . . . 2.43 109.766 -170.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.95 126.43 46.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.966 -1.494 . . . . 2.82 106.966 172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.46 137.97 21.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.001 -2.222 . . . . 2.45 105.001 160.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.25 107.47 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.306 -1.368 . . . . 1.87 107.306 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -102.25 115.1 29.85 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.965 -1.124 . . . . 5.83 107.965 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.65 -45.18 0.99 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.978 -1.649 . . . . 1.51 108.978 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -55.69 137.2 49.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.909 0.483 . . . . 1.81 110.224 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -165.97 12.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 2.91 112.766 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -170.74 144.41 2.29 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 117.908 -1.044 . . . . 2.07 108.355 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.81 -50.49 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.621 2.369 . . . . 1.25 113.437 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -57.12 -47.7 80.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.797 1.239 . . . . 1.13 114.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.38 -49.63 32.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.388 1.075 . . . . 1.07 108.171 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -43.23 -64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.335 1.854 . . . . 0.86 110.487 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -9.54 55.09 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 120.348 -0.541 . . . . 1.36 111.554 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -47.49 59.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.48 -1.387 . . . . 4.82 107.96 -172.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.28 -57.28 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.836 -1.074 . . . . 0.76 108.345 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -70.32 0.09 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.234 0.614 . . . . 4.3 111.968 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -47.85 -47.13 31.68 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.611 0.641 . . . . 2.37 111.881 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -59.56 -65.68 0.63 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.853 -0.425 . . . . 0.9 109.853 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.04 -34.66 70.33 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.436 0.562 . . . . 1.77 111.318 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -55.3 -25.32 33.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.298 0.481 . . . . 1.58 112.298 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -18.94 64.35 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.663 1.119 . . . . 5.76 112.654 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -84.88 119.97 25.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.54 -1.282 . . . . 2.37 107.54 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -69.07 -0.82 6.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.088 -1.008 . . . . 6.55 113.704 -172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.48 -20.98 61.0 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.523 -0.736 . . . . 0.85 113.595 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.99 138.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 117.818 0.809 . . . . 3.64 110.486 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -100.62 -42.61 6.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.836 1.655 . . . . 1.55 110.196 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -148.36 149.99 32.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.445 -0.576 . . . . 2.31 109.445 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 t -141.75 74.22 1.44 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.857 0.837 . . . . 1.92 110.332 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -85.4 82.92 8.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.216 0.606 . . . . 2.32 109.957 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.07 126.34 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 112.594 0.591 . . . . 1.89 112.594 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.35 104.22 7.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.337 1.455 . . . . 0.91 108.684 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.48 -30.02 38.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.314 0.645 . . . . 2.77 111.321 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.68 50.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.923 0.889 . . . . 1.16 111.61 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -122.08 14.2 10.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 1.69 110.027 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 34.19 55.14 0.62 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.457 1.903 . . . . 1.79 111.713 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.59 143.34 25.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.088 -0.383 . . . . 1.45 110.241 -172.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 112.31 24.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.608 1.963 . . . . 0.59 108.747 165.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.55 95.6 5.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 104.627 -2.36 . . . . 1.1 104.627 160.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 mt -91.27 142.31 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 106.288 -1.745 . . . . 1.12 106.288 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -119.26 111.51 18.31 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.868 -2.271 . . . . 2.87 104.868 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -152.5 155.62 37.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.246 1.019 . . . . 3.29 108.674 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.21 100.17 7.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 123.873 0.733 . . . . 3.22 109.458 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 -42.05 71.76 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.826 2.351 . . . . 2.37 111.427 -172.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -20.34 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.871 2.468 . . . . 4.49 114.385 166.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 pt -112.56 16.1 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.074 0.95 . . . . 2.34 113.112 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 tt -160.53 -46.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.961 0.801 . . . . 2.95 112.203 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.27 157.27 8.42 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.551 1.072 . . . . 0.73 111.43 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.59 -45.32 26.37 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.622 2.214 . . . . 1.04 110.474 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.99 -55.49 6.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.75 1.22 . . . . 8.39 112.762 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -56.53 -48.36 77.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.004 0.907 . . . . 3.97 111.056 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.51 -51.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.642 -0.708 . . . . 0.65 109.317 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -49.43 -60.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 C-N-CA 123.16 0.584 . . . . 1.66 109.428 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -45.51 -49.0 14.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.538 0.735 . . . . 2.72 109.707 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.1 m -63.15 -48.52 78.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.021 -0.672 . . . . 0.86 110.741 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.6 mt -52.19 -64.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.322 0.649 . . . . 0.88 109.841 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -47.67 84.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.135 -0.626 . . . . 2.81 109.718 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -61.44 -19.56 62.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.128 -1.415 . . . . 1.05 113.583 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.08 -70.04 0.26 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 121.296 1.862 . . . . 1.77 109.654 166.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.55 24.82 0.27 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.862 -1.521 . . . . 1.34 115.877 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.71 173.79 10.01 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.089 1.944 . . . . 1.88 113.431 -164.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.74 152.61 20.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.234 -2.135 . . . . 3.61 105.234 154.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.8 162.47 41.24 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.202 0.91 . . . . 1.12 111.449 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.19 141.8 17.78 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.253 0.221 . . . . 2.46 111.571 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.81 70.32 3.26 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.368 1.067 . . . . 2.91 111.211 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 123.976 0.91 . . . . 3.02 110.807 171.72 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 109.103 -1.599 . . . . 1.61 109.103 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.8 152.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 125.407 1.483 . . . . 2.11 107.621 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -141.77 109.92 5.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.979 -1.489 . . . . 2.59 106.979 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -122.03 112.33 18.12 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.433 0.693 . . . . 2.52 110.745 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.44 142.38 51.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.856 1.347 . . . . 2.29 110.031 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.33 138.1 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.369 -1.715 . . . . 1.94 106.369 166.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.9 152.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.144 -1.058 . . . . 1.92 108.144 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -138.01 131.16 30.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.798 0.839 . . . . 6.31 109.031 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 9.49 85.04 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.813 -0.915 . . . . 1.84 110.813 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -102.25 126.37 49.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.149 1.779 . . . . 2.17 106.798 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 t -158.7 155.61 28.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.483 0.583 . . . . 3.13 109.884 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m 66.0 164.1 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.962 1.705 . . . . 2.71 112.763 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -43.92 49.02 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.924 -1.035 . . . . 1.24 110.891 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 p -43.33 -74.23 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.173 1.789 . . . . 0.92 114.12 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -49.92 -44.24 50.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.486 0.714 . . . . 1.18 109.528 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.35 -66.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.16 0.584 . . . . 1.2 111.952 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -68.08 -28.48 67.4 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.263 -0.898 . . . . 1.96 110.688 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -57.65 -52.86 63.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.612 0.642 . . . . 4.02 109.782 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -54.45 -61.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.783 -0.821 . . . . 0.69 108.783 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.77 -55.09 33.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.302 0.241 . . . . 2.81 111.077 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 t -54.11 -34.74 61.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.317 1.047 . . . . 1.36 111.313 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -69.37 -65.86 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.048 0.84 . . . . 1.07 109.894 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.98 -44.74 71.05 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.253 1.021 . . . . 2.32 112.091 -170.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.6 p -54.55 -25.42 25.8 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.92 -0.487 . . . . 2.31 112.097 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.85 -20.29 63.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.604 0.762 . . . . 5.19 111.698 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -64.25 -38.37 90.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.901 -0.778 . . . . 2.28 108.901 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 70.25 -2.33 2.16 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.282 2.233 . . . . 5.48 113.127 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.91 37.87 3.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.291 -1.123 . . . . 0.84 110.291 167.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.54 139.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.524 -2.028 . . . . 2.16 105.524 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.88 -40.17 9.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.006 0.523 . . . . 2.75 110.379 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -155.02 164.13 39.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.369 0.531 . . . . 2.42 111.344 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -153.56 125.09 7.62 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.753 2.421 . . . . 3.26 106.669 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -132.11 106.67 8.14 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.278 -1.749 . . . . 1.57 106.278 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -88.18 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.453 -1.314 . . . . 2.05 107.453 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.88 89.44 5.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.244 -1.021 . . . . 0.78 108.244 -171.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.32 -42.99 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.588 1.955 . . . . 1.86 111.012 165.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.07 62.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.646 1.178 . . . . 1.08 112.39 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -116.43 17.97 15.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.614 1.565 . . . . 1.55 109.246 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 19.42 59.59 0.02 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.489 2.716 . . . . 3.06 113.422 -164.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.9 144.89 39.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.034 0.534 . . . . 0.97 109.748 -174.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.2 106.85 18.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.796 -1.187 . . . . 0.42 107.796 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.37 100.72 12.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.712 -1.958 . . . . 0.83 105.712 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.72 146.09 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.791 -1.559 . . . . 1.95 106.791 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -122.17 133.74 54.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.239 -2.134 . . . . 2.7 105.239 165.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.15 169.16 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.615 0.366 . . . . 3.1 110.299 -160.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.21 139.46 24.2 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.052 -1.832 . . . . 4.12 106.052 159.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.35 -34.75 1.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.146 1.898 . . . . 2.57 113.138 -175.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.65 -28.46 15.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.357 0.981 . . . . 3.41 112.348 -163.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.54 -24.62 29.47 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 118.998 0.817 . . . . 2.25 110.638 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 tt -121.61 -44.18 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.517 0.562 . . . . 2.64 112.517 -169.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 120.08 0.24 Allowed Glycine 0 CA--C 1.534 1.224 0 N-CA-C 109.16 -1.576 . . . . 0.91 109.16 -168.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.7 -38.05 94.75 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 120.673 2.237 . . . . 1.56 111.138 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -23.26 63.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.157 1.169 . . . . 8.89 114.157 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.57 -51.93 67.71 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.91 1.232 . . . . 3.53 109.451 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -56.47 -49.31 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.538 -0.744 . . . . 0.8 110.071 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.6 -59.44 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.232 0.924 . . . . 1.57 110.164 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -49.14 -50.04 39.33 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.837 0.855 . . . . 3.59 109.344 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.8 m -57.51 -52.06 66.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.84 110.231 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.29 -57.25 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 119.23 -0.414 . . . . 0.88 110.574 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.83 -51.02 71.52 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.725 -0.79 . . . . 3.38 110.019 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -57.81 -35.99 71.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.226 1.01 . . . . 1.58 111.241 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mp -52.12 -68.61 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.518 0.599 . . . . 2.27 111.518 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.75 14.99 0.18 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.187 -1.341 . . . . 1.1 115.571 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -133.82 175.04 9.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.413 1.607 . . . . 1.96 113.869 -156.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.23 152.61 22.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.367 -2.086 . . . . 4.01 105.367 155.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.09 139.91 23.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.023 1.329 . . . . 0.99 109.567 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 m -155.41 110.44 2.99 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.25 -0.906 . . . . 1.5 111.101 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.23 139.98 7.91 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.139 -1.059 . . . . 2.9 108.139 166.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 123.128 0.571 . . . . 2.64 109.961 179.566 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.871 0 N-CA-C 108.294 -1.922 . . . . 1.89 108.294 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.56 129.84 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.5 -1.296 . . . . 3.07 107.5 170.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -113.26 128.23 56.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.628 -1.99 . . . . 2.13 105.628 166.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -121.17 104.08 9.49 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.287 -0.634 . . . . 2.42 109.287 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.35 129.76 36.53 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.757 -1.571 . . . . 2.7 106.757 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.4 131.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.423 -2.066 . . . . 1.85 105.423 155.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -108.1 150.44 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.161 -1.792 . . . . 1.83 106.161 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -135.38 125.27 25.67 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.05 -0.722 . . . . 4.81 109.05 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.47 -13.97 5.87 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.294 1.426 . . . . 1.73 112.517 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.1 ptp -65.74 149.4 50.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.54 1.17 . . . . 2.16 110.26 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -163.17 139.6 7.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.659 -1.608 . . . . 3.1 106.659 168.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.8 t 73.46 142.01 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.681 1.592 . . . . 2.9 112.582 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.12 -36.2 0.29 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.911 2.085 . . . . 1.3 113.166 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -56.55 -77.08 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.192 0.997 . . . . 1.2 112.805 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -55.11 -33.68 63.05 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 124.076 0.95 . . . . 2.03 110.531 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -52.69 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 O-C-N 123.662 0.601 . . . . 1.23 109.497 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.302 0.0 OUTLIER -66.98 -16.51 64.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.855 -0.528 . . . . 1.51 112.01 -168.177 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -55.94 -44.14 78.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.957 -1.127 . . . . 4.43 107.957 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.6 -63.86 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.246 -1.02 . . . . 0.72 108.246 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 2.8 pt-20 -60.18 -50.88 71.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.313 0.486 . . . . 2.9 112.313 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.3 t -50.24 -52.22 37.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.888 0.875 . . . . 1.04 109.548 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -56.77 -54.73 42.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.942 0.337 . . . . 0.81 110.897 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.17 -34.4 77.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 118.871 -1.132 . . . . 1.72 111.211 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 m -61.25 -10.73 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.977 -1.077 . . . . 1.49 112.28 173.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -75.86 -20.52 58.03 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 120.924 -1.11 . . . . 4.82 112.197 172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.56 -169.12 0.39 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.987 -1.116 . . . . 2.76 107.987 167.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -126.87 -0.84 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.411 -0.806 . . . . 6.15 112.347 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.03 -19.96 22.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.214 0.461 . . . . 0.85 113.023 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.5 mp -79.9 113.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.984 -1.487 . . . . 2.94 106.984 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -79.73 -36.51 37.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.817 1.247 . . . . 1.5 110.202 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -154.91 150.6 27.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.44 -1.319 . . . . 2.48 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -155.65 86.92 1.07 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.983 -0.376 . . . . 1.85 109.983 -164.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.7 m -112.77 107.14 15.67 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.472 0.709 . . . . 1.82 109.933 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.19 90.2 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 122.813 1.292 . . . . 1.74 110.232 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 92.6 8.22 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.414 -0.958 . . . . 0.82 108.414 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -40.58 -39.87 1.14 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.552 1.541 . . . . 1.97 112.395 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.1 61.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.628 0.771 . . . . 0.79 111.872 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -116.1 11.09 15.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.588 1.555 . . . . 1.49 110.047 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.32 39.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.812 2.445 . . . . 2.14 112.917 -173.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 141.09 52.35 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.49 0.716 . . . . 1.11 110.251 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.72 96.57 7.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.784 1.634 . . . . 0.64 108.415 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -77.17 101.29 6.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.762 -1.94 . . . . 0.8 105.762 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.6 mt -109.92 112.49 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 125.215 1.406 . . . . 0.98 107.512 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.74 124.85 34.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.694 -1.595 . . . . 2.37 106.694 169.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.21 177.5 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.925 -1.509 . . . . 2.23 106.925 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.98 137.02 28.65 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.342 0.974 . . . . 3.94 109.277 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.24 67.74 5.17 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.012 3.808 . . . . 2.64 110.703 -173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -172.97 -45.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.013 1.725 . . . . 3.63 109.298 -171.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -85.3 -28.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.617 0.767 . . . . 3.26 109.676 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.8 tt -158.08 156.22 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.09 -1.078 . . . . 2.63 108.09 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.43 163.01 27.25 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.624 -0.991 . . . . 0.64 110.624 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.09 -45.52 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.699 2.266 . . . . 0.77 110.819 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -61.19 -30.75 70.61 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.952 -0.468 . . . . 7.81 110.896 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -57.47 11.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.838 1.655 . . . . 3.67 109.072 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -56.61 -49.86 76.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.09 -0.707 . . . . 0.76 109.09 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.15 -48.33 84.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.994 -0.527 . . . . 1.39 110.782 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -53.11 -43.99 67.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.689 0.796 . . . . 3.07 109.069 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 m -62.59 -42.98 99.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.838 -0.745 . . . . 0.91 110.158 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.47 -46.35 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.224 -0.922 . . . . 0.85 111.787 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.05 -55.13 22.59 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.019 0.928 . . . . 3.16 108.918 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t -53.25 -51.19 63.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.145 1.378 . . . . 0.86 111.276 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.55 -44.42 96.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.51 -0.744 . . . . 1.98 112.263 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.29 -46.63 0.02 OUTLIER Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.844 -0.693 . . . . 1.86 114.751 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -125.75 142.8 51.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.432 -0.907 . . . . 2.0 113.031 -126.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.47 80.67 4.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.315 -0.624 . . . . 3.75 109.315 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.92 158.61 30.59 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.424 -0.797 . . . . 0.98 110.764 -171.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -155.21 117.45 4.19 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.866 -1.146 . . . . 1.98 111.235 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.26 121.04 11.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.465 1.106 . . . . 2.62 111.006 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 125.131 1.372 . . . . 3.24 109.855 173.525 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.958 0 N-CA-C 108.078 -2.009 . . . . 1.49 108.078 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.2 79.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 123.019 1.39 . . . . 2.49 108.122 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 tp -80.16 79.74 6.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 123.113 1.435 . . . . 2.51 107.175 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.9 122.68 25.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.579 -2.1 . . . . 2.59 105.784 164.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.01 139.72 43.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.428 -0.582 . . . . 1.83 109.428 172.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.07 111.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.116 -1.809 . . . . 1.97 106.116 169.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.49 164.51 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.527 -2.027 . . . . 1.73 105.527 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -138.22 130.99 29.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.118 -0.989 . . . . 5.44 108.805 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.82 5.65 17.79 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.852 1.215 . . . . 1.6 112.377 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.479 ' CE ' HG22 ' A' ' 37' ' ' VAL . 25.0 mtp -75.2 87.37 2.46 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.834 1.317 . . . . 2.01 108.07 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -83.27 -30.13 27.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.859 0.864 . . . . 2.51 111.995 -173.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.3 t -153.76 152.41 30.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.521 -0.737 . . . . 2.04 110.451 -168.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.09 -46.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.976 2.51 . . . . 1.18 113.732 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.0 p -39.95 -60.87 0.94 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.95 113.712 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -59.61 -43.49 93.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.774 1.23 . . . . 1.24 108.06 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -52.92 -70.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.185 -0.916 . . . . 1.11 110.418 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -28.94 68.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.501 -0.75 . . . . 1.06 110.706 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -55.02 -54.77 38.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.388 -0.815 . . . . 4.38 109.926 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mt -56.06 -54.08 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 119.475 1.034 . . . . 0.6 110.625 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -54.86 -51.22 66.62 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.311 -0.556 . . . . 3.26 109.773 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -56.35 -44.62 80.27 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.481 0.712 . . . . 0.95 111.757 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -64.96 -39.91 94.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.561 1.144 . . . . 2.45 111.809 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.71 -45.67 50.78 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.969 -0.693 . . . . 2.28 111.45 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -68.25 72.47 0.2 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.303 1.041 . . . . 2.6 110.75 -174.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -34.96 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.74 2.416 . . . . 6.17 110.639 -169.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -53.72 -70.09 0.1 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 119.684 1.129 . . . . 2.95 112.536 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 131.97 -4.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.01 3.724 . . . . 5.57 113.611 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.34 18.39 33.11 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.643 1.11 . . . . 0.9 112.466 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.18 121.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.799 1.639 . . . . 4.04 107.932 -175.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.8 mt -95.09 -38.04 10.81 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.089 0.555 . . . . 1.4 110.113 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -156.07 157.51 36.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.397 -1.335 . . . . 2.11 107.397 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.23 58.93 0.65 Allowed 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.218 0.607 . . . . 2.78 110.24 -163.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -79.19 104.1 9.58 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.361 -0.607 . . . . 1.55 109.361 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' CE ' ' A' ' 13' ' ' MET . 0.9 OUTLIER -95.58 95.43 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.381 1.086 . . . . 1.51 110.165 -177.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.17 95.11 10.05 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.902 -1.124 . . . . 0.78 109.331 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 tt -42.79 -38.93 2.29 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.778 1.631 . . . . 1.63 112.36 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.55 61.31 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 124.59 1.156 . . . . 1.07 111.529 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.8 t -116.48 14.74 15.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.227 1.411 . . . . 1.72 109.545 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.27 52.02 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.716 2.406 . . . . 2.88 111.41 -169.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.455 -0.778 . . . . 1.49 110.503 -171.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 109.79 22.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.53 1.532 . . . . 0.63 107.872 171.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -82.82 93.07 7.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.574 -1.639 . . . . 0.77 106.574 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.7 mt -103.97 110.42 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.344 1.068 . . . . 1.2 109.754 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -78.06 71.93 4.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.521 -1.659 . . . . 2.92 106.521 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.46 162.36 27.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.992 -0.549 . . . . 2.04 109.606 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -116.27 105.32 50.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.833 -0.803 . . . . 3.08 108.833 167.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.51 -32.73 83.74 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.67 2.247 . . . . 1.75 113.365 -168.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.18 -30.24 59.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.38 0.536 . . . . 3.86 112.26 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.89 -3.0 9.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 113.503 0.927 . . . . 2.48 113.503 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 tt -157.57 131.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.246 -1.39 . . . . 2.3 107.246 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.44 155.0 46.57 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.347 -1.901 . . . . 0.88 108.347 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -59.29 -40.17 70.97 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.795 -1.271 . . . . 0.73 108.795 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -44.92 26.79 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.507 1.123 . . . . 9.52 112.526 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.57 -54.89 41.77 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.275 0.943 . . . . 2.96 109.597 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.32 -47.65 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.357 -0.838 . . . . 0.71 110.006 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.77 -52.26 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.239 -0.652 . . . . 1.42 109.239 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -54.73 -47.38 73.86 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.374 -0.346 . . . . 2.73 110.517 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -51.21 -54.62 23.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.137 0.88 . . . . 1.31 110.401 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -57.69 -58.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 119.213 -0.422 . . . . 1.68 110.222 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -63.94 -44.39 93.0 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.158 -1.017 . . . . 4.2 111.18 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.9 t -62.84 -20.29 64.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 117.768 -1.111 . . . . 0.71 112.609 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.86 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.212 1.369 . . . . 1.98 109.89 165.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.36 25.05 0.32 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.606 -1.108 . . . . 1.1 114.126 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.23 172.56 7.5 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.85 1.325 . . . . 1.86 113.235 -165.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -95.55 161.4 14.07 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.33 -1.73 . . . . 4.95 106.33 156.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.26 94.9 2.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.861 0.864 . . . . 1.64 112.297 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -87.69 119.67 28.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.602 0.761 . . . . 1.73 109.788 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -63.66 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.125 0.875 . . . . 3.04 110.702 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 124.485 1.114 . . . . 3.06 109.515 173.642 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 CA-C-O 122.361 0.978 . . . . 2.02 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.26 147.86 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 106.447 -1.686 . . . . 2.03 106.447 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 tp -142.36 136.4 29.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.516 -2.031 . . . . 2.06 105.516 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -115.07 145.32 42.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.407 -0.96 . . . . 2.34 108.407 156.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -133.15 146.03 51.2 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 124.668 1.23 . . . . 2.22 107.837 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.18 131.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.535 -1.654 . . . . 2.1 106.535 160.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.54 157.27 3.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 106.153 -1.795 . . . . 2.0 106.153 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -139.07 132.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.273 -1.01 . . . . 4.96 108.273 163.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.35 10.06 12.25 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.663 1.601 . . . . 1.92 112.761 -173.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.5 mtt -62.69 150.46 40.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.034 1.417 . . . . 2.08 109.48 167.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -154.41 86.92 1.16 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.469 0.652 . . . . 3.18 109.937 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.5 t 73.62 90.32 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.086 1.354 . . . . 2.85 112.916 165.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.11 -124.3 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.786 -1.102 . . . . 2.86 108.174 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.5 p 49.47 -81.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.779 2.032 . . . . 1.14 114.165 163.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -46.35 -43.75 16.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.608 0.763 . . . . 1.27 109.747 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.0 t -48.46 -74.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.52 1.128 . . . . 0.88 111.197 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -30.13 69.7 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 122.069 -0.395 . . . . 1.35 111.475 -172.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -51.54 -56.04 15.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.248 -0.649 . . . . 4.24 109.248 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.09 -60.19 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.325 -0.62 . . . . 0.52 109.325 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -49.88 -55.73 13.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.236 0.614 . . . . 3.04 111.142 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.2 t -54.26 -59.77 4.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.456 1.102 . . . . 1.13 109.45 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -52.08 -49.97 62.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.687 0.279 . . . . 0.94 110.939 -174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.9 -49.7 69.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.111 0.411 . . . . 1.77 112.111 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.261 4.5 t -60.6 -25.09 65.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 118.549 -1.26 . . . . 2.97 111.541 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -55.35 -25.65 36.28 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.189 0.811 . . . . 4.19 113.189 173.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -54.92 -31.44 60.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.018 0.827 . . . . 2.33 111.286 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -3.66 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.088 1.755 . . . . 8.45 111.811 -162.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.8 -35.81 15.2 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.553 -1.019 . . . . 1.14 110.553 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 46' ' ' ILE . 4.4 mp -92.36 97.89 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.694 -1.595 . . . . 2.9 106.694 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.11 -24.22 43.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.357 -0.838 . . . . 2.13 110.124 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -155.78 153.74 30.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.971 -0.752 . . . . 2.64 108.971 169.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.7 113.49 5.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.783 2.033 . . . . 3.19 107.311 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -119.4 104.77 10.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.425 -1.324 . . . . 1.5 107.425 165.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.34 78.38 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.754 1.264 . . . . 2.04 107.657 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.93 88.84 5.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.954 -1.021 . . . . 0.88 108.502 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.7 tt -38.67 -39.66 0.52 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.06 1.744 . . . . 1.77 112.413 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -36.41 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.454 1.102 . . . . 0.95 112.084 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 t -111.72 11.61 21.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.642 1.577 . . . . 1.56 109.934 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.35 41.28 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.234 2.614 . . . . 2.43 113.399 -170.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.95 45.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.8 0.84 . . . . 1.15 109.422 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.12 111.45 24.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.854 -1.906 . . . . 0.54 105.854 170.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -82.34 114.28 20.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.408 -2.071 . . . . 0.78 105.408 163.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 32' ' ' ILE . 9.8 mt -121.87 109.08 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 125.002 1.321 . . . . 0.93 107.483 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -79.45 72.38 6.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.856 -1.535 . . . . 2.86 106.856 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 176.36 9.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.298 1.039 . . . . 2.88 108.618 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.86 130.16 8.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 118.387 0.54 . . . . 3.66 110.196 160.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -51.88 -34.98 57.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.283 2.656 . . . . 1.72 113.589 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.95 -22.6 66.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.075 0.852 . . . . 4.69 112.999 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 pt -110.89 -22.52 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 119.122 0.873 . . . . 2.9 110.486 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -162.53 130.17 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.978 -1.119 . . . . 3.01 107.978 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.76 170.51 48.08 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.974 -0.851 . . . . 1.19 110.974 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.26 -57.06 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.104 1.869 . . . . 1.23 110.689 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.33 -26.79 68.63 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.847 -0.533 . . . . 8.73 111.743 -173.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -51.55 63.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.981 1.312 . . . . 4.56 110.159 173.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.9 -53.0 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.23 -0.919 . . . . 0.95 109.694 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -55.46 -50.73 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.405 -0.591 . . . . 1.76 109.405 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -49.47 -46.12 47.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.79 0.836 . . . . 3.79 110.396 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -58.23 -50.2 74.4 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.586 -0.524 . . . . 1.21 109.586 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.8 -54.82 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.971 0.509 . . . . 0.75 110.838 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -55.39 -53.42 56.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.243 -0.651 . . . . 4.57 109.243 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -48.4 -47.71 37.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.97 1.308 . . . . 0.89 111.676 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.66 -48.57 79.12 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.372 0.987 . . . . 1.92 113.478 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 0.11 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 118.293 2.077 . . . . 1.19 118.293 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -138.97 177.47 7.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.814 1.807 . . . . 1.91 112.617 -144.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -104.0 158.68 16.25 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.093 -1.447 . . . . 2.94 107.093 145.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.88 154.13 37.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.559 0.695 . . . . 1.01 110.905 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.0 m -156.13 103.79 2.22 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.419 -0.8 . . . . 1.94 110.438 -164.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.94 134.41 16.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.474 1.109 . . . . 2.85 111.94 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 124.976 1.311 . . . . 2.5 109.099 178.834 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 105.564 -3.014 . . . . 1.67 105.564 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 m -136.51 146.32 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.211 1.006 . . . . 2.78 110.131 -170.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 tp -155.23 153.37 30.55 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.041 -1.466 . . . . 2.64 107.041 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -115.4 148.52 39.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.858 -0.793 . . . . 2.93 108.858 165.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.0 mt -121.85 128.82 52.06 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.063 -1.829 . . . . 2.78 106.063 165.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.6 142.1 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.465 -2.42 . . . . 1.75 104.465 161.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.38 120.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 124.616 1.166 . . . . 2.12 108.575 -171.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 131.53 53.88 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.085 0.954 . . . . 7.45 110.986 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.22 -19.28 5.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.965 1.745 . . . . 1.86 109.938 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 mtm -63.32 163.75 10.08 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.204 -0.586 . . . . 1.89 110.531 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -150.47 -44.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.618 0.367 . . . . 2.55 111.455 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.3 m -139.36 169.44 17.75 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.78 -0.575 . . . . 2.56 109.697 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.31 -36.86 1.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.938 2.095 . . . . 1.45 113.272 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -48.26 -44.09 33.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.268 1.827 . . . . 0.92 113.786 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.8 m -70.56 -46.92 62.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.166 -1.42 . . . . 1.22 107.166 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.07 -63.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.336 . . . . 1.61 111.001 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -26.53 64.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.496 -0.752 . . . . 1.2 111.703 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.78 -54.68 39.0 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.727 -0.842 . . . . 4.43 108.727 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -53.88 -60.34 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.591 -0.522 . . . . 0.75 109.591 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -53.22 -52.94 57.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.529 0.331 . . . . 3.28 111.31 -171.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -58.76 -54.6 45.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.94 0.496 . . . . 1.44 110.217 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 t -55.31 -38.92 69.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.37 0.668 . . . . 1.11 111.864 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.1 mt -75.21 -54.65 6.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 113.595 0.961 . . . . 1.77 113.595 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -54.58 -35.96 63.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.349 -0.844 . . . . 2.03 110.931 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -25.16 9.98 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.338 1.236 . . . . 3.84 114.338 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.752 ' HB3' HD11 ' A' ' 53' ' ' ILE . 12.1 m170 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.673 1.124 . . . . 2.22 111.095 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 77.85 -3.73 2.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.698 2.399 . . . . 6.38 113.898 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA3' HD12 ' A' ' 53' ' ' ILE . . . -96.12 -23.84 16.3 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.848 -0.901 . . . . 1.1 110.848 172.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.623 HD12 HD13 ' A' ' 53' ' ' ILE . 3.1 mp -78.41 105.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.728 -1.953 . . . . 2.9 105.728 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.66 -30.51 41.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.227 1.011 . . . . 1.38 109.434 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.08 139.99 18.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.473 -0.936 . . . . 2.26 108.473 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -133.06 119.19 19.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.579 -2.008 . . . . 2.22 105.579 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -125.74 106.96 10.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.784 -1.561 . . . . 1.74 106.784 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.24 87.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.297 1.046 . . . . 2.02 108.878 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.2 86.23 5.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.017 -1.475 . . . . 0.89 107.017 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -40.91 -38.71 1.0 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.826 1.651 . . . . 2.42 111.201 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.53 -36.17 43.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.592 1.157 . . . . 0.83 112.726 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -113.95 13.22 18.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.353 1.461 . . . . 1.62 110.049 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 40.52 41.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.39 1.876 . . . . 1.94 112.057 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 143.45 50.83 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.143 0.577 . . . . 1.18 110.368 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.71 108.28 19.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.447 -2.057 . . . . 0.43 105.447 170.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -78.59 115.8 18.54 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.651 -1.981 . . . . 1.22 105.651 165.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -120.07 114.7 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.083 -1.08 . . . . 1.06 108.083 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -100.07 115.4 29.69 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.633 -1.617 . . . . 3.28 106.633 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.13 145.98 22.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.797 1.239 . . . . 1.96 108.503 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -85.91 137.03 35.78 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 119.054 0.843 . . . . 4.4 109.577 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.34 -31.69 13.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.186 1.924 . . . . 2.55 111.765 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.52 46.86 0.99 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.774 1.23 . . . . 5.03 112.538 -169.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -50.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 128.295 2.638 . . . . 4.46 106.028 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 29' ' ' HIS . 1.2 mt -104.4 -89.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.887 1.275 . . . . 2.81 107.61 -176.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 95.5 139.01 9.97 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.492 -1.443 . . . . 0.91 109.492 -165.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.7 -37.27 94.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.421 2.747 . . . . 0.74 112.812 -164.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -35.98 -49.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 9.6 112.825 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -68.22 -46.15 71.37 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.018 -0.734 . . . . 3.02 109.018 -171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 mt -60.47 -47.35 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.72 109.219 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.38 -57.4 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.306 0.642 . . . . 1.79 109.494 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -52.81 -45.82 67.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.655 0.382 . . . . 2.76 110.09 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.8 m -59.48 -54.75 43.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.1 mt -51.76 -55.45 9.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.593 1.157 . . . . 0.8 110.754 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.35 -57.84 10.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.407 -0.59 . . . . 3.07 109.407 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.3 t -52.94 -37.48 61.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.1 1.36 . . . . 0.8 111.598 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.35 -54.71 28.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.51 0.724 . . . . 2.27 112.632 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.27 -8.36 0.04 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 117.539 1.776 . . . . 1.13 117.539 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.76 176.2 8.67 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.41 1.605 . . . . 1.85 112.475 -142.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -124.54 152.61 43.25 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.922 -2.251 . . . . 3.15 104.922 161.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.61 164.84 30.47 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.015 0.746 . . . . 1.29 113.015 -168.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -153.81 138.88 17.32 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 122.978 0.511 . . . . 2.07 111.379 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.58 66.74 1.45 Allowed 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.547 1.539 . . . . 2.88 110.71 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.392 -0.595 . . . . 2.48 109.392 165.526 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.569 0 N-CA-C 109.378 -1.489 . . . . 1.89 109.378 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.08 142.28 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.608 0.704 . . . . 2.79 109.782 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.2 83.63 1.84 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.768 -1.567 . . . . 2.77 106.768 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.4 116.54 27.67 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.891 -1.504 . . . . 2.31 107.148 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 3.2 pp -128.34 142.22 51.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.746 0.248 . . . . 2.06 110.677 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.88 145.21 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.36 -1.348 . . . . 1.86 107.36 166.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.7 161.62 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.6 1.56 . . . . 1.87 107.441 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.09 140.1 30.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.874 -0.787 . . . . 7.99 108.874 160.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.67 -34.15 3.54 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.0 -1.24 . . . . 1.53 110.0 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.1 mtp -56.18 115.46 2.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.41 -0.464 . . . . 1.52 109.832 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -125.65 -20.49 4.68 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.946 0.899 . . . . 2.4 111.98 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.5 t -153.92 151.59 29.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.052 -1.03 . . . . 2.13 109.707 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -30.99 -45.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.562 2.345 . . . . 1.14 113.526 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 p -39.96 -58.62 1.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.508 1.523 . . . . 0.86 113.733 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.3 -46.99 87.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.241 -1.392 . . . . 1.24 107.241 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -51.16 -66.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.473 -1.24 . . . . 0.94 110.404 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -27.33 64.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.887 -0.725 . . . . 1.1 111.193 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.74 -53.49 57.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.624 0.647 . . . . 4.51 110.259 172.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.14 -60.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.861 -0.792 . . . . 0.45 108.861 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -54.63 -51.02 66.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.543 -0.299 . . . . 3.25 110.939 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.5 t -60.23 -42.82 96.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.522 0.729 . . . . 0.95 111.237 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 t -65.88 -36.78 84.35 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.827 -0.546 . . . . 0.81 111.102 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.18 -52.64 13.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.266 -0.574 . . . . 2.01 111.85 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 m -67.09 76.46 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.228 1.011 . . . . 2.51 110.683 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.45 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.458 2.703 . . . . 3.91 110.518 -171.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -56.33 -30.26 62.35 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.576 1.08 . . . . 2.77 113.296 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 37.97 2.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.245 1.018 . . . . 7.61 110.251 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.33 -2.01 0.73 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 121.573 -0.705 . . . . 0.99 112.897 165.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.05 127.4 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.776 -1.564 . . . . 2.66 106.776 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.78 -43.35 18.47 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.981 1.312 . . . . 1.85 109.417 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -152.11 155.25 37.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 110.203 -0.295 . . . . 2.1 110.203 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.47 136.85 35.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.731 1.612 . . . . 3.03 107.004 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -151.52 87.92 1.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.229 -1.397 . . . . 2.29 107.229 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.27 0.3 OUTLIER -92.52 92.08 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.714 1.245 . . . . 1.66 109.958 -176.894 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.64 92.98 9.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.177 -0.952 . . . . 0.69 108.986 -170.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.05 -42.37 2.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.302 1.441 . . . . 1.87 111.701 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.25 -33.54 42.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.435 1.094 . . . . 0.83 112.46 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -117.78 14.43 14.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.887 1.275 . . . . 1.5 110.364 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 30.26 53.97 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.686 2.394 . . . . 3.0 112.363 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 150.22 46.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.733 0.813 . . . . 1.11 109.175 -174.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -101.84 113.67 27.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.572 1.149 . . . . 0.63 107.965 168.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -81.22 99.18 8.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 104.337 -2.468 . . . . 0.76 104.337 154.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.54 147.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.49 -1.67 . . . . 0.95 106.49 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -124.58 130.93 53.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.352 -2.092 . . . . 3.11 105.352 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -146.41 173.13 12.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 119.095 0.861 . . . . 2.17 111.365 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -107.77 94.12 11.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.112 0.965 . . . . 4.33 109.587 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 63.25 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.659 3.573 . . . . 2.58 111.851 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -155.09 -54.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 128.702 2.801 . . . . 3.74 106.692 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.4 pt -99.82 -13.41 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 124.843 1.257 . . . . 2.45 111.849 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -151.55 142.34 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.638 -1.616 . . . . 2.25 106.638 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.39 168.48 40.36 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.977 -0.849 . . . . 0.91 110.977 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.83 -47.49 1.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.563 2.176 . . . . 0.7 110.779 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -24.73 66.81 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.992 -0.442 . . . . 8.24 110.534 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -56.15 25.28 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.893 -1.754 . . . . 3.34 109.27 172.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.49 -55.12 21.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 108.869 -0.789 . . . . 1.22 108.869 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -58.05 -44.7 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.43 -0.35 . . . . 1.33 110.105 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.5 -37.26 83.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.906 1.282 . . . . 4.73 109.999 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -58.53 -51.83 68.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.751 -0.833 . . . . 0.77 108.751 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.98 -52.61 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 119.206 -0.426 . . . . 0.78 111.006 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -47.07 -52.2 15.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.156 0.983 . . . . 3.12 109.911 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.4 t -70.43 -9.71 57.17 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.754 1.622 . . . . 1.3 113.683 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.48 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.197 -1.409 . . . . 2.65 107.197 159.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.59 37.43 0.51 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.909 -0.94 . . . . 1.24 112.343 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -136.29 124.69 23.39 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.222 1.011 . . . . 1.92 110.266 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.75 -1.204 . . . . 4.63 107.75 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.31 163.1 40.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.918 -0.488 . . . . 1.05 111.462 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -145.62 126.69 14.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.607 1.163 . . . . 2.06 108.983 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.85 119.78 11.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.649 1.179 . . . . 3.55 108.314 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.47 0.527 0 CA-C-N 118.83 0.741 . . . . 2.03 111.782 -178.156 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.894 0 N-CA-C 111.04 -0.824 . . . . 1.57 111.04 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -103.97 126.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-N 117.634 0.717 . . . . 2.73 109.573 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 95.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.476 1.132 . . . . 4.02 108.873 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -78.51 122.64 26.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.612 -1.255 . . . . 2.44 107.612 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.43 145.54 48.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.994 -0.373 . . . . 1.77 109.994 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.98 142.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.069 -1.826 . . . . 1.93 106.069 164.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.06 95.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 125.246 1.418 . . . . 2.22 108.618 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -97.47 143.5 28.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.523 0.729 . . . . 5.92 111.149 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.81 -36.38 3.0 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.627 1.108 . . . . 1.64 110.806 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -64.51 153.43 39.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.133 0.492 . . . . 1.61 112.171 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -153.58 149.5 27.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 170.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m 70.43 151.39 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.468 1.507 . . . . 2.34 112.486 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.5 -35.37 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.515 1.926 . . . . 1.49 112.559 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 -65.48 0.57 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.251 1.42 . . . . 1.36 112.649 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -68.91 -40.42 79.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.462 -1.31 . . . . 1.26 107.462 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.7 t -42.92 -68.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 113.98 -1.464 . . . . 1.08 110.238 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.304 0.0 OUTLIER -69.62 -20.06 63.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.704 -0.798 . . . . 1.86 110.995 -175.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.53 -42.21 87.58 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.113 -0.992 . . . . 3.08 108.992 -174.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -53.54 -66.53 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.816 -0.809 . . . . 0.77 108.816 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.24 -56.17 20.98 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.035 0.534 . . . . 3.14 111.962 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -53.43 -36.49 61.6 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.512 1.125 . . . . 1.34 111.174 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -70.22 -62.08 1.53 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.502 -0.749 . . . . 0.83 110.357 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -46.29 66.5 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.699 0.8 . . . . 2.26 111.961 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 p -50.85 -33.43 23.78 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.779 0.432 . . . . 2.47 111.129 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -64.26 -18.5 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.847 0.684 . . . . 4.45 112.847 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -60.48 -28.63 68.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 2.46 110.456 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 74.83 -1.85 2.98 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.311 1.844 . . . . 6.74 112.285 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 24.96 25.35 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.377 -0.689 . . . . 1.2 111.377 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mm -121.04 144.92 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.171 -1.789 . . . . 2.57 106.171 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.13 -45.86 7.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.832 -0.803 . . . . 2.83 108.832 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -155.55 153.4 30.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.375 0.534 . . . . 2.25 109.939 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.0 m -135.02 113.1 11.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 104.986 -2.227 . . . . 2.57 104.986 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.41 96.09 5.81 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.162 -1.051 . . . . 1.56 108.162 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.03 95.12 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.445 0.64 . . . . 1.88 109.667 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.71 91.72 6.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.372 -0.83 . . . . 0.73 110.185 -168.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -37.3 -50.87 1.04 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 1.97 112.819 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.52 31.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 1.27 112.528 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.7 t -105.93 -15.54 14.89 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.829 1.252 . . . . 1.6 110.729 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.72 41.52 14.86 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.837 0.855 . . . . 2.46 109.425 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.53 147.57 44.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.66 1.184 . . . . 1.13 108.794 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.1 114.18 27.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.859 -1.534 . . . . 0.41 106.859 162.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -78.2 94.37 4.75 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.144 -2.169 . . . . 0.74 105.144 167.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 mt -98.74 111.92 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.708 -0.849 . . . . 1.21 108.708 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.15 115.59 26.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.323 -1.732 . . . . 2.87 106.323 159.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.62 140.19 28.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.979 1.312 . . . . 2.62 107.792 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -87.37 114.16 57.41 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.381 -0.97 . . . . 3.72 108.381 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.12 -48.78 15.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.17 1.913 . . . . 2.16 113.194 -172.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.59 -21.42 60.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.804 1.039 . . . . 3.31 113.804 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -97.18 -4.54 9.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 119.728 1.149 . . . . 2.53 112.7 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.05 -46.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.454 1.279 . . . . 2.69 114.454 -175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.84 155.65 2.36 Favored Glycine 0 CA--C 1.541 1.674 0 O-C-N 121.609 -0.682 . . . . 0.83 112.889 -171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 -51.58 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.25 2.634 . . . . 1.27 112.252 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -47.9 -44.6 29.77 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.679 0.791 . . . . 7.08 112.187 -170.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -52.35 -56.13 16.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.023 0.929 . . . . 3.96 110.859 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.17 -48.87 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 O-C-N 121.814 -0.554 . . . . 0.76 110.547 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mm -51.81 -51.34 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 119.014 -0.517 . . . . 1.84 110.27 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -50.51 -54.45 22.28 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 122.968 0.507 . . . . 2.74 109.896 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.0 m -56.41 -47.29 79.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.255 -0.978 . . . . 1.1 110.733 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 -54.8 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 118.534 0.606 . . . . 1.06 111.949 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -67.01 -43.63 82.4 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.582 -0.447 . . . . 4.99 110.678 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 t -57.9 -40.7 80.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.51 0.724 . . . . 1.0 110.978 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.13 -59.97 4.5 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.389 0.995 . . . . 1.66 110.736 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.57 -40.45 0.02 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 115.762 1.065 . . . . 1.46 115.762 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -112.33 139.72 47.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.948 -0.737 . . . . 1.86 111.549 -135.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.02 133.0 36.11 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 106.48 -1.674 . . . . 3.18 106.48 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.18 31.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.044 0.384 . . . . 1.07 111.477 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.48 145.55 25.28 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 109.447 -0.575 . . . . 1.89 109.447 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.15 130.3 35.13 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.927 -0.768 . . . . 2.32 108.927 -174.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.536 0.415 0 C-N-CA 123.257 0.623 . . . . 2.06 112.19 -178.381 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 N-CA-C 111.679 -0.568 . . . . 1.62 111.679 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.21 138.31 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.208 -1.172 . . . . 1.97 109.302 172.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.23 88.1 2.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.601 -1.629 . . . . 2.23 106.601 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -79.65 123.3 27.52 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.372 -1.714 . . . . 2.25 106.372 171.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.12 133.41 46.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.84 0.291 . . . . 2.15 110.336 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.3 145.71 9.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 172.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.4 122.0 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.211 1.004 . . . . 1.63 110.117 -169.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.48 132.96 51.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.139 -0.689 . . . . 4.95 109.139 170.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.61 -25.67 5.87 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.995 2.236 . . . . 1.86 109.149 178.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 mtp -57.2 107.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.53 0.732 . . . . 1.75 109.889 164.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -139.99 9.36 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.913 1.285 . . . . 2.34 112.588 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -172.53 147.58 1.88 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.521 1.055 . . . . 2.23 109.92 -173.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.73 -38.02 1.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.339 1.856 . . . . 1.23 113.176 178.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 p -60.58 -77.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.863 0.865 . . . . 0.82 112.04 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 p -48.59 -29.88 4.75 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.071 1.348 . . . . 2.09 112.122 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.98 -72.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 0.92 109.867 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -68.62 -12.74 61.73 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.015 -1.053 . . . . 1.17 112.942 -171.367 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -52.7 -42.86 65.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.237 -1.023 . . . . 4.3 108.237 172.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.92 -60.83 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.478 1.511 . . . . 0.55 109.666 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.23 -48.32 82.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.944 -0.391 . . . . 4.78 109.944 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.31 -48.69 80.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.458 -0.942 . . . . 1.18 108.458 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -51.01 -57.29 9.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.667 1.122 . . . . 1.34 111.01 176.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.25 -38.83 75.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.006 -1.078 . . . . 1.8 111.451 -169.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -55.07 -15.65 2.29 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.985 -1.072 . . . . 2.33 113.078 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -66.42 -37.24 84.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.369 -0.832 . . . . 5.38 110.766 173.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -69.56 124.94 25.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.716 -1.216 . . . . 2.15 107.716 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.61 47.32 0.83 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.161 -0.962 . . . . 7.56 109.943 172.378 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.88 -17.21 0.83 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.305 1.907 . . . . 0.89 111.998 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.1 tt -105.54 138.19 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.114 -1.069 . . . . 2.56 108.114 176.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -86.06 -49.38 7.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.531 1.133 . . . . 1.62 109.803 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -152.79 162.54 41.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.717 0.407 . . . . 3.01 110.304 -176.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.58 89.5 1.56 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.219 1.008 . . . . 2.07 109.973 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.94 90.05 8.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.071 -0.714 . . . . 1.39 109.071 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -85.94 98.42 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.559 1.144 . . . . 2.43 109.304 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.73 92.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.377 0.671 . . . . 0.82 109.849 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -36.89 -44.19 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.707 2.003 . . . . 1.76 110.869 165.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.17 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.008 0.923 . . . . 0.94 112.461 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.46 14.97 10.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.077 1.351 . . . . 1.53 109.983 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 34.92 55.39 0.74 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.763 2.025 . . . . 2.17 111.876 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.01 153.54 36.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.63 -0.878 . . . . 1.07 108.63 -173.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.01 127.49 54.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.637 0.586 . . . . 1.1 109.977 163.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -86.01 91.4 8.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.706 -1.961 . . . . 0.86 105.706 170.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.23 137.84 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.124 -1.436 . . . . 1.55 107.124 172.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -115.31 119.05 34.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.365 -2.087 . . . . 2.18 105.365 163.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 178.85 7.39 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 127.213 2.205 . . . . 1.87 106.096 -176.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -132.23 132.63 23.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.95 . . . . 3.67 110.386 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.71 64.09 7.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.918 3.745 . . . . 2.35 112.161 -167.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -166.74 -45.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.738 1.215 . . . . 3.75 110.239 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.77 -27.11 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.184 -0.673 . . . . 2.72 109.184 174.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -154.89 150.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.771 -1.196 . . . . 2.62 107.771 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.86 166.06 33.73 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.338 -1.105 . . . . 0.75 110.338 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.47 -48.57 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.373 2.049 . . . . 0.93 110.479 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.404 HH21 ' CD2' ' A' ' 60' ' ' HIS . 25.4 tpt180 -56.96 -27.42 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.924 0.489 . . . . 7.87 111.274 -177.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -55.59 31.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.299 1.839 . . . . 3.7 109.078 175.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt -56.23 -47.21 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.62 -0.882 . . . . 0.69 108.62 174.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mm -55.84 -50.97 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 119.28 -0.391 . . . . 1.99 111.0 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CD2' HH21 ' A' ' 56' ' ' ARG . 17.2 m170 -54.36 -46.51 73.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.162 0.985 . . . . 3.06 109.302 178.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 m -58.05 -50.08 74.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.609 -0.515 . . . . 0.8 109.609 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.93 -51.9 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.15 -0.969 . . . . 0.79 111.782 178.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -50.86 -56.68 11.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.438 1.095 . . . . 3.13 109.241 175.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.3 t -52.34 -51.46 58.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.741 1.616 . . . . 0.8 111.365 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.49 -41.21 89.25 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.45 -0.781 . . . . 2.96 111.85 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.27 -50.52 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.328 -0.939 . . . . 1.5 114.624 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.58 144.99 38.61 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 118.973 -1.091 . . . . 1.92 113.806 -128.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.1 59.4 3.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.345 -0.613 . . . . 4.28 109.345 -176.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.82 168.47 19.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.689 0.626 . . . . 1.25 112.689 -166.21 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.06 132.01 10.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.819 -0.808 . . . . 1.88 108.819 173.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 130.73 47.88 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.864 -0.791 . . . . 2.31 108.864 167.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 108.322 -0.992 . . . . 2.82 108.322 177.23 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 CA-C-O 121.803 0.669 . . . . 1.82 111.794 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.24 149.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.987 -0.713 . . . . 2.02 110.071 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 tp -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.433 1.893 . . . . 2.76 106.346 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -128.81 157.37 41.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.05 -1.092 . . . . 2.62 108.05 163.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.69 142.92 49.94 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.358 1.036 . . . . 2.98 108.997 162.407 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.8 t -76.84 128.92 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.797 -1.927 . . . . 1.86 105.797 165.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.93 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.375 -1.343 . . . . 1.99 107.375 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.97 142.72 45.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.09 -1.448 . . . . 5.01 107.09 166.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.2 -47.63 1.34 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.726 -0.95 . . . . 1.49 110.726 167.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.82 143.57 54.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.229 -0.656 . . . . 2.05 109.229 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.62 -66.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.289 -0.257 . . . . 3.33 110.969 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -64.14 148.06 50.83 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.642 -0.661 . . . . 2.29 110.983 -171.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.35 -47.11 0.29 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.278 1.831 . . . . 1.17 112.507 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.2 p -60.08 -37.59 80.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.556 1.543 . . . . 1.29 113.64 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.65 -46.98 28.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.612 -1.305 . . . . 1.49 109.756 172.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.87 -67.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.292 1.037 . . . . 0.88 111.157 177.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -27.1 64.33 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.792 -0.568 . . . . 1.01 111.161 -173.292 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.06 -53.2 60.04 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.18 -0.914 . . . . 4.56 108.994 175.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.82 -55.68 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.423 1.01 . . . . 0.71 109.862 174.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -51.67 -59.26 4.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.275 -0.269 . . . . 3.16 110.275 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -53.82 -43.37 69.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 1.07 111.812 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -60.07 -50.42 73.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.28 1.032 . . . . 2.24 109.181 -176.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.42 -37.27 71.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.078 -0.649 . . . . 2.24 112.097 179.258 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -53.57 -23.99 12.4 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.029 -1.044 . . . . 1.49 113.458 177.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -60.21 -31.35 70.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.759 1.163 . . . . 6.52 112.18 174.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -70.52 148.52 48.14 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.867 0.758 . . . . 2.25 109.05 -175.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -105.25 37.77 2.11 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.788 -0.57 . . . . 6.73 111.905 -171.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.03 24.56 0.61 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.12 -0.392 . . . . 1.04 112.12 170.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -114.01 134.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.107 -1.812 . . . . 2.63 106.107 168.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.25 -40.11 10.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 1.62 109.069 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.53 136.89 14.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.201 -0.296 . . . . 2.19 110.201 178.314 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.91 132.61 56.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.962 -2.607 . . . . 2.21 103.962 164.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.6 t -138.22 138.17 38.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 117.977 -1.489 . . . . 2.84 109.096 146.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.286 6.7 p -106.03 94.32 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 122.638 1.209 . . . . 2.08 110.512 -174.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.23 88.62 6.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.495 -0.928 . . . . 0.68 108.495 -168.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tt -30.67 -50.02 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.048 2.139 . . . . 1.95 111.996 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.74 -32.56 52.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.19 0.996 . . . . 0.84 112.754 -175.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -118.93 15.24 13.37 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.7 1.6 . . . . 1.4 110.212 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 16.89 58.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.968 2.907 . . . . 3.31 114.597 -167.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 148.65 52.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.523 -0.917 . . . . 0.99 108.523 178.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.88 111.59 23.94 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.167 -2.16 . . . . 0.43 105.167 169.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -79.6 120.58 24.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.577 -1.638 . . . . 0.78 106.577 167.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mt -125.6 97.28 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 O-C-N 124.592 1.183 . . . . 1.05 107.882 -171.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -80.53 120.89 25.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.779 -1.563 . . . . 2.54 106.779 166.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.18 164.29 15.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.819 -1.549 . . . . 2.59 106.819 -165.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.06 132.54 24.4 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 108.245 -1.02 . . . . 4.03 108.245 172.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.65 -52.74 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.992 2.462 . . . . 2.42 112.466 -160.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.83 -32.84 46.56 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.252 0.834 . . . . 3.13 113.252 -172.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 pt -88.49 5.51 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.322 0.86 . . . . 2.89 113.322 -177.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.39 -52.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.531 1.06 . . . . 3.04 111.584 -172.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.48 114.0 0.37 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 108.97 -1.652 . . . . 0.99 108.97 -171.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -56.9 -31.77 90.27 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 119.991 1.896 . . . . 0.89 111.204 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -54.16 -36.79 63.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.956 -0.545 . . . . 6.61 112.034 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -67.16 -47.0 72.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.396 0.998 . . . . 4.2 110.352 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 mt -54.92 -51.83 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.653 -0.654 . . . . 0.83 110.601 170.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.35 -52.87 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 119.007 -0.52 . . . . 1.42 110.125 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -46.32 -47.95 18.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.305 1.042 . . . . 2.74 109.25 174.005 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.0 m -62.86 -49.53 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.107 -0.637 . . . . 0.86 110.663 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.58 -51.12 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.414 0.686 . . . . 0.69 111.162 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.65 -40.18 76.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.867 0.303 . . . . 2.82 111.634 179.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -65.35 -23.17 66.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 117.507 -1.235 . . . . 0.85 112.524 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.84 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.52 1.509 . . . . 1.66 109.407 165.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.99 19.04 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.319 -1.267 . . . . 1.07 114.943 174.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -136.1 116.35 13.52 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.367 1.584 . . . . 2.06 110.251 -163.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 154.46 37.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 117.109 -1.836 . . . . 4.26 107.568 177.084 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.11 164.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.797 0.839 . . . . 1.17 110.53 -173.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.9 m -148.63 92.91 2.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.472 -0.936 . . . . 1.89 108.472 171.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -55.11 126.47 24.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.855 0.862 . . . . 2.83 110.963 174.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 124.393 1.077 . . . . 2.55 109.088 -172.995 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.618 0 N-CA-C 107.165 -2.374 . . . . 1.74 107.165 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.4 139.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.708 -0.849 . . . . 3.07 108.708 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.32 87.67 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.333 -1.728 . . . . 2.18 106.333 167.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.1 134.06 36.74 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 118.156 -1.417 . . . . 2.57 108.27 167.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.65 146.88 46.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 124.23 0.956 . . . . 2.87 108.716 164.159 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.14 135.51 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.662 -1.977 . . . . 1.7 105.662 169.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.8 135.38 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.541 1.536 . . . . 2.78 108.258 -177.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -145.64 136.03 24.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.861 -2.274 . . . . 5.18 104.861 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.75 -53.82 0.65 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.74 -1.744 . . . . 1.64 108.74 -171.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 ptm -65.5 149.71 49.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.395 -0.474 . . . . 1.53 110.623 173.307 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.13 -1.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.633 0.975 . . . . 2.52 113.633 -168.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -169.21 157.53 7.71 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.021 1.282 . . . . 3.18 109.848 -166.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.55 -50.46 1.13 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.183 2.193 . . . . 1.21 113.267 -174.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -33.45 75.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.063 1.345 . . . . 1.59 113.056 -176.073 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.9 m -72.56 -53.92 10.61 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.377 -1.342 . . . . 1.14 107.377 168.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -43.99 -64.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.637 1.575 . . . . 0.84 111.689 -173.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -16.21 64.14 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.038 -0.414 . . . . 1.48 111.749 -173.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.5 98.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.668 -0.864 . . . . 4.8 108.668 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -60.49 -58.63 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.169 -1.049 . . . . 0.62 108.169 -178.409 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -53.73 -56.28 18.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.092 0.557 . . . . 3.15 110.803 178.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -49.52 -45.03 46.79 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.569 0.748 . . . . 1.16 111.235 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.7 t -63.14 -61.04 2.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.445 0.698 . . . . 1.22 110.774 175.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.96 -39.49 94.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.009 -1.076 . . . . 1.9 111.405 -168.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 m -53.4 -16.92 1.57 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.202 0.815 . . . . 1.68 113.202 176.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -61.72 -42.82 99.46 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.036 -1.04 . . . . 4.83 111.212 171.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.46 135.63 39.39 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.285 -0.635 . . . . 2.45 109.285 -176.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -78.97 -1.53 35.81 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.718 -0.613 . . . . 6.41 112.639 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.94 -19.21 56.55 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.381 0.537 . . . . 0.84 112.664 -178.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.1 tt -93.81 137.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.913 -0.773 . . . . 2.63 108.913 175.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.27 -38.36 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.428 1.491 . . . . 1.36 110.087 -174.128 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -140.16 149.78 43.4 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.919 -0.771 . . . . 2.74 108.919 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 t -153.99 119.12 5.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 106.593 -1.632 . . . . 1.72 106.593 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -145.85 111.21 5.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.062 -0.718 . . . . 1.89 109.062 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 44' ' ' ALA . 3.5 p -105.88 108.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.586 0.708 . . . . 1.92 111.321 -175.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.33 101.7 10.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.004 0.922 . . . . 0.74 109.472 -170.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -43.08 -38.92 2.53 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.706 1.202 . . . . 2.31 111.222 168.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.53 -29.18 23.92 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.914 0.886 . . . . 1.53 112.065 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -128.06 16.03 6.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.49 1.116 . . . . 1.59 109.9 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 35.06 47.23 0.26 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.309 1.843 . . . . 2.57 112.569 -174.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.27 145.71 41.63 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.75 -0.594 . . . . 1.14 110.457 -171.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -108.96 106.88 17.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.711 -1.589 . . . . 0.47 106.711 172.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -79.44 98.63 6.86 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.43 -1.693 . . . . 0.89 106.43 168.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.45 140.74 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.897 -1.89 . . . . 1.44 105.897 164.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.13 132.21 55.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.452 -1.314 . . . . 2.61 107.452 156.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -148.92 169.12 21.27 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.943 0.897 . . . . 2.17 109.5 -172.248 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.68 111.33 55.34 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.666 -0.683 . . . . 3.7 109.34 174.262 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.12 52.05 3.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.048 3.165 . . . . 2.3 112.362 -176.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -139.78 -64.57 0.48 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.467 1.507 . . . . 4.13 107.294 178.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.28 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.118 0.967 . . . . 4.01 111.364 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 142.84 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.851 -1.537 . . . . 2.33 106.851 176.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.05 159.29 35.66 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.045 -1.222 . . . . 0.94 110.045 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.69 -47.31 11.49 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.825 1.683 . . . . 0.85 110.054 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -48.43 -42.33 31.93 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 122.999 0.52 . . . . 6.54 111.952 178.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -51.71 54.56 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.414 1.486 . . . . 3.47 109.723 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mt -60.88 -52.23 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.76 109.364 175.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.77 -54.13 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 118.602 0.637 . . . . 1.91 110.411 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -47.67 -53.2 15.64 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.581 1.553 . . . . 3.06 109.789 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.1 m -56.35 -51.33 68.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.456 . . . . 0.73 109.855 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.5 -53.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 O-C-N 121.993 -0.442 . . . . 0.9 110.742 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.9 -47.63 84.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.963 0.802 . . . . 3.89 110.195 -178.019 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -68.94 -9.86 54.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.928 -1.035 . . . . 1.01 113.023 -175.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.01 -78.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.253 1.388 . . . . 2.52 108.396 158.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.19 26.89 0.32 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.61 -1.106 . . . . 1.05 114.55 171.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -125.36 172.76 9.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.061 1.43 . . . . 1.82 113.36 -160.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 70.38 0.82 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.342 1.068 . . . . 3.81 108.666 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.41 144.51 35.8 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.329 -0.857 . . . . 1.22 111.274 -165.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -151.29 110.09 3.85 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.166 -0.959 . . . . 1.92 113.089 -172.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 76.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.475 2.31 . . . . 2.45 115.189 -175.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.221 -0.428 0 C-N-CA 124.241 1.016 . . . . 1.86 112.331 168.544 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.556 0 N-CA-C 106.148 -2.781 . . . . 1.74 106.148 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.43 137.34 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.655 1.228 . . . . 2.31 109.598 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.36 79.47 1.61 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.88 1.324 . . . . 2.07 107.935 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.37 102.06 8.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.012 -1.477 . . . . 2.79 107.012 168.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.31 141.28 47.21 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.698 0.399 . . . . 1.94 109.951 176.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.38 140.86 16.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.986 -1.486 . . . . 1.76 106.986 172.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -117.46 107.46 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.433 -1.321 . . . . 1.73 107.433 174.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -78.19 137.91 38.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.114 -1.439 . . . . 5.32 107.114 170.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.08 -41.44 2.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 123.965 0.793 . . . . 1.57 111.415 161.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -58.61 143.05 47.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.574 -0.368 . . . . 1.57 111.632 -178.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -145.85 142.0 28.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.44 1.096 . . . . 2.97 110.543 177.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.9 m 69.68 164.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.096 1.758 . . . . 3.04 114.186 167.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.61 -35.51 2.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.67 1.988 . . . . 1.34 112.194 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -55.63 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.169 0.988 . . . . 0.97 112.268 173.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -54.37 -37.62 65.19 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 120.831 -1.168 . . . . 1.09 109.623 -177.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -49.21 -65.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.893 0.477 . . . . 1.02 111.157 172.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.274 0.0 OUTLIER -68.12 -22.42 64.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.759 -0.588 . . . . 1.28 111.486 -175.816 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -60.28 -56.24 23.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.095 -1.076 . . . . 3.49 108.095 174.249 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.8 mt -57.62 -58.61 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.693 -0.854 . . . . 0.56 108.693 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.86 -56.47 21.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.369 0.531 . . . . 3.12 111.643 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -59.28 -38.86 81.18 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.742 -0.598 . . . . 1.16 111.243 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -65.28 -61.39 2.15 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.829 -0.545 . . . . 0.86 110.543 175.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.27 -31.61 72.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.429 -0.794 . . . . 2.64 111.963 -169.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.4 -10.49 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.666 1.121 . . . . 2.25 113.514 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -69.13 -21.2 64.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.435 1.016 . . . . 5.64 112.212 170.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -69.53 115.59 8.96 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.613 0.765 . . . . 2.34 109.362 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -78.57 46.26 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.41 -0.806 . . . . 6.86 112.659 -174.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.05 24.6 0.1 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.271 1.415 . . . . 0.93 110.785 170.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.14 122.11 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.416 -1.698 . . . . 2.44 106.416 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.9 mt -85.18 -38.54 18.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.735 0.814 . . . . 1.89 109.204 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -155.17 156.33 35.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.377 -1.342 . . . . 2.68 107.377 -176.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.2 t -146.67 59.75 1.2 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.03 -1.1 . . . . 2.51 108.03 178.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.38 94.28 3.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.356 -0.979 . . . . 2.28 108.356 -163.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.346 2.6 p -90.06 83.95 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 123.579 1.657 . . . . 1.62 111.242 -169.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.94 87.06 4.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.68 -1.145 . . . . 0.69 108.772 -178.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -40.34 -44.02 1.87 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.297 1.439 . . . . 2.29 110.632 162.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.03 -37.03 0.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.815 1.646 . . . . 1.04 113.556 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -132.43 26.0 4.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.114 1.366 . . . . 2.62 109.688 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 29.92 52.8 0.11 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.36 2.664 . . . . 1.99 112.571 -175.452 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 154.53 42.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.602 0.593 . . . . 2.93 112.602 -178.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.1 106.72 17.37 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.232 1.813 . . . . 0.38 109.508 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -78.78 83.09 4.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.517 -1.661 . . . . 1.42 106.517 167.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.452 HD13 HG21 ' A' ' 58' ' ' ILE . 11.6 mt -79.06 145.48 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.522 -1.288 . . . . 1.37 107.522 173.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.4 134.85 50.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.299 -2.482 . . . . 2.73 104.299 161.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.88 172.28 17.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.773 0.715 . . . . 1.85 109.803 -168.056 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.74 81.78 1.23 Allowed Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.24 1.416 . . . . 4.48 107.952 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.72 -35.48 47.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.302 2.668 . . . . 1.67 112.733 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.95 -20.47 6.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.125 1.157 . . . . 4.35 114.125 176.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.9 pt -120.43 -57.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 119.621 1.101 . . . . 2.45 111.702 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tp -87.46 -36.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.007 -0.368 . . . . 2.64 110.007 -161.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.53 149.94 3.18 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -177.275 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.52 -41.16 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.242 1.961 . . . . 0.77 110.33 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -54.61 -37.65 65.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.965 0.906 . . . . 6.47 111.148 -176.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -57.81 11.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.79 0.436 . . . . 3.68 110.821 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 46' ' ' ILE . 3.4 mp -54.42 -45.32 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 1.31 110.02 176.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -56.32 -51.59 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.626 -0.671 . . . . 1.29 111.322 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -49.39 -47.12 47.98 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.512 0.725 . . . . 2.85 109.279 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -49.68 76.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 119.681 -0.807 . . . . 1.21 109.645 -177.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.12 -50.32 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.545 0.338 . . . . 0.73 111.561 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.9 -46.63 83.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.405 -0.518 . . . . 4.13 111.042 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.6 t -57.55 -44.63 85.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.557 0.743 . . . . 0.88 111.232 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.8 -54.4 46.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.376 -0.828 . . . . 1.6 110.738 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.55 -42.13 0.02 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.859 1.104 . . . . 1.52 115.859 -178.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.79 134.47 55.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.376 -0.821 . . . . 1.87 111.138 -131.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.24 104.31 6.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.6 1.546 . . . . 4.6 108.715 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.98 154.34 29.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.921 0.889 . . . . 1.0 110.331 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -152.87 103.93 2.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 1.71 109.52 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 71' ' ' LEU . 1.9 pt? -66.62 71.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.14 1.376 . . . . 2.63 112.643 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 123.996 0.918 . . . . 2.45 111.082 176.089 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 N-CA-C 109.46 -1.456 . . . . 2.05 109.46 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.33 129.35 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.236 -0.653 . . . . 1.85 109.236 -174.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -140.51 101.04 4.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.918 0.866 . . . . 3.04 109.105 -169.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.41 106.15 18.14 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.019 -1.104 . . . . 2.11 108.019 178.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.93 139.49 48.53 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.303 0.501 . . . . 1.96 110.343 170.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.15 143.77 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.125 -1.435 . . . . 1.62 107.125 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.75 156.02 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.33 -1.359 . . . . 1.72 107.33 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -138.34 122.23 17.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.405 1.082 . . . . 7.74 108.218 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.5 -45.79 1.13 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.925 -1.27 . . . . 1.54 109.925 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -56.0 140.4 43.43 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.851 -0.426 . . . . 2.19 109.851 170.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -166.32 22.79 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.83 0.308 . . . . 2.73 111.83 -172.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -169.33 147.2 3.64 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.11 0.868 . . . . 2.04 109.377 -174.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.0 0.38 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.017 2.127 . . . . 1.18 113.167 175.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 p -54.5 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.846 0.858 . . . . 0.92 111.659 172.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -41.32 -47.37 3.47 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 125.5 1.52 . . . . 1.12 110.834 176.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 t -46.63 -66.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.603 1.161 . . . . 0.82 110.933 173.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.318 0.0 OUTLIER -69.82 -17.61 63.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 119.692 -0.803 . . . . 1.33 111.302 -176.087 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -69.11 -45.02 71.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.31 -0.996 . . . . 3.34 108.31 -176.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.4 mt -53.7 -69.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.702 -0.851 . . . . 0.52 108.702 175.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.54 -59.08 3.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.522 0.729 . . . . 3.7 112.548 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -54.88 -41.76 71.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.232 0.613 . . . . 1.06 110.37 -177.24 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -61.4 -61.07 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.095 -0.378 . . . . 0.81 110.96 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.538 HD13 HG23 ' A' ' 58' ' ' ILE . 14.5 mt -62.35 -35.63 79.72 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 118.627 -1.229 . . . . 1.72 111.406 -169.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -57.89 -13.98 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.109 0.411 . . . . 1.37 112.109 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -61.99 -40.68 96.46 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.093 -1.005 . . . . 4.49 111.15 169.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -67.78 122.44 18.11 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.454 -0.573 . . . . 2.17 109.454 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.68 48.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.173 -0.954 . . . . 6.37 111.095 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.94 0.1 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.08 1.324 . . . . 0.89 111.524 -178.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.37 142.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.052 -0.721 . . . . 2.65 109.052 173.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.96 -34.14 9.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.814 1.246 . . . . 1.63 110.461 -176.045 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -154.65 155.26 34.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.154 -0.684 . . . . 2.8 109.154 -175.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.7 t -155.76 80.08 1.01 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.73 0.812 . . . . 2.23 110.569 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -86.21 97.18 10.22 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.466 -0.771 . . . . 1.45 110.321 172.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -85.08 80.23 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.77 1.628 . . . . 2.08 108.651 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.18 93.92 9.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.856 -0.794 . . . . 0.75 108.856 -174.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -46.8 -35.49 6.32 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.448 1.099 . . . . 1.89 111.862 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.53 -30.39 41.41 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.567 0.747 . . . . 0.97 111.878 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -121.1 13.35 11.25 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.524 1.53 . . . . 1.44 109.782 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.04 33.19 6.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.167 2.187 . . . . 1.88 112.979 176.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.01 147.47 46.27 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.353 0.661 . . . . 1.03 111.57 -161.397 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.88 108.69 20.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.818 1.647 . . . . 0.43 108.657 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.96 87.41 4.78 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.804 -2.295 . . . . 0.84 104.804 162.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 58' ' ' ILE . 18.8 mt -79.67 150.28 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.896 -1.52 . . . . 1.51 106.896 169.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -126.65 122.55 35.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 104.824 -2.287 . . . . 2.59 104.824 156.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -145.6 128.87 16.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 107.341 -1.355 . . . . 2.53 107.341 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.3 121.61 75.31 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 106.942 -1.503 . . . . 3.59 106.942 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.93 -46.63 18.59 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.378 2.052 . . . . 2.08 112.799 -165.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -56.94 -8.86 0.69 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.964 1.706 . . . . 3.61 115.249 -166.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 pt -115.17 -10.18 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.415 1.086 . . . . 2.32 113.65 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.89 -42.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.736 1.153 . . . . 2.92 113.097 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.91 153.44 5.33 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.6 -1.0 . . . . 0.86 110.6 -174.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.59 -35.48 17.03 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.261 1.974 . . . . 0.94 110.652 -174.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 -37.28 61.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.358 0.663 . . . . 6.77 112.291 -172.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.11 -58.09 9.72 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.227 0.467 . . . . 4.36 110.024 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 26' ' ' LEU . 2.6 mp -51.29 -49.71 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.287 -0.635 . . . . 1.39 109.287 177.056 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.83 -54.16 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.971 -0.537 . . . . 1.75 110.783 179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -48.84 -52.07 26.18 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.498 0.719 . . . . 3.03 109.844 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -56.07 -51.57 67.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 122.123 -0.361 . . . . 0.94 110.487 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.0 mt -55.74 -47.73 78.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.748 -0.595 . . . . 0.79 111.877 -176.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.343 0.519 . . . . 4.9 111.477 176.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -66.85 -15.62 63.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.243 -0.884 . . . . 1.43 112.466 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.33 -89.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.602 -1.258 . . . . 2.99 107.602 155.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.49 20.23 0.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.898 -1.501 . . . . 1.01 114.8 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -123.76 139.05 54.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.957 1.878 . . . . 1.91 113.121 -160.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -77.33 139.59 39.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.049 -1.463 . . . . 4.28 107.049 171.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.02 146.58 43.95 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.509 1.124 . . . . 1.12 109.357 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -153.06 112.25 3.81 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 121.673 -0.642 . . . . 1.57 110.575 176.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.06 121.36 7.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.847 0.859 . . . . 2.55 109.347 173.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 CA--C 1.529 0.17 0 C-N-CA 123.293 0.637 . . . . 2.24 110.287 172.879 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 109.609 -1.396 . . . . 1.77 109.609 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.18 147.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.134 1.373 . . . . 2.56 109.994 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 7.0 tt -145.31 103.77 3.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 2.98 108.6 175.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.97 117.8 31.97 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.025 -0.989 . . . . 2.22 108.47 178.059 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.58 142.12 50.46 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.515 0.598 . . . . 1.94 110.851 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.71 134.84 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 107.033 -1.469 . . . . 1.92 107.033 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.61 119.87 60.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.839 1.256 . . . . 1.78 107.687 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -87.14 62.8 7.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.125 0.57 . . . . 5.92 110.484 -164.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.54 -104.63 0.2 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.69 -0.964 . . . . 3.57 110.69 174.326 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mtm 57.66 65.53 1.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.419 1.087 . . . . 2.16 111.873 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 p -65.97 -23.81 66.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.356 1.243 . . . . 3.81 114.356 -168.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.3 t -166.66 155.48 10.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.786 0.721 . . . . 2.21 109.143 -165.067 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.64 -39.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.659 2.384 . . . . 1.12 113.301 172.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 p -52.98 -76.08 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.603 1.161 . . . . 0.81 112.726 169.3 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.2 m -46.97 -41.03 15.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.165 1.786 . . . . 1.39 111.124 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.1 t -51.72 -73.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.931 0.893 . . . . 1.0 110.01 168.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.301 0.0 OUTLIER -67.31 -14.86 63.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.388 0.613 . . . . 1.3 112.275 -167.89 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.05 -42.15 93.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.032 -1.042 . . . . 4.52 108.494 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.46 -65.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.712 -0.847 . . . . 0.5 108.712 -175.155 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.21 -66.16 0.45 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.107 0.963 . . . . 3.82 112.234 175.723 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -47.55 -45.28 26.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.591 0.756 . . . . 1.1 111.068 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 t -60.95 -62.56 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.224 0.466 . . . . 0.96 111.12 175.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.59 -31.5 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.122 0.874 . . . . 1.74 111.163 -171.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 m -54.31 -19.54 5.56 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.116 -0.99 . . . . 1.78 112.646 176.324 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -37.97 77.4 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.711 -1.243 . . . . 6.0 112.59 170.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.86 165.09 16.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 2.76 109.992 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.92 42.13 3.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.758 0.823 . . . . 7.47 110.032 169.406 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.84 18.4 3.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.222 -1.151 . . . . 1.13 110.222 164.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -115.71 148.93 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.807 -2.294 . . . . 3.62 104.807 167.154 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.34 -37.12 5.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.784 1.233 . . . . 1.76 110.276 -174.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -157.63 162.4 38.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.675 -0.861 . . . . 2.58 108.675 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -143.37 73.85 1.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.194 0.997 . . . . 2.49 110.779 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.85 83.6 5.75 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.161 -0.681 . . . . 1.55 109.161 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.4 103.43 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.522 0.677 . . . . 1.55 110.503 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.71 100.16 9.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.383 1.073 . . . . 0.76 108.906 -172.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -38.18 4.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.254 1.422 . . . . 2.03 110.575 170.457 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.85 39.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.394 1.078 . . . . 0.76 112.262 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.24 16.0 10.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.641 1.177 . . . . 1.36 109.688 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.08 43.51 1.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.212 2.205 . . . . 1.88 112.512 -178.211 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.17 144.34 34.74 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 122.149 -0.345 . . . . 1.08 110.826 -166.64 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HB1' HG13 ' A' ' 46' ' ' ILE . . . -98.65 108.13 20.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.443 1.497 . . . . 0.41 108.556 168.394 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.79 83.44 7.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.354 -2.091 . . . . 0.73 105.354 157.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.421 HG13 ' HB1' ' A' ' 44' ' ' ALA . 59.8 mt -83.06 153.29 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.32 -1.733 . . . . 1.07 106.32 170.223 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -121.76 141.98 50.65 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.876 -1.898 . . . . 3.88 105.876 166.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -163.09 165.5 24.6 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 118.742 0.701 . . . . 1.99 112.186 -163.758 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.74 97.46 44.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 123.986 0.804 . . . . 4.2 110.736 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.72 -21.05 72.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.839 2.359 . . . . 1.73 114.641 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.44 -31.18 14.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.973 0.806 . . . . 4.11 111.875 168.48 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -66.86 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 123.229 0.611 . . . . 4.73 110.208 175.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.29 116.02 41.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.333 -0.988 . . . . 2.69 108.333 -166.382 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.16 161.91 38.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.378 -1.489 . . . . 0.87 109.378 -176.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -54.03 -37.88 86.68 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.856 1.704 . . . . 1.01 109.485 171.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 57' ' ' ASP . 12.8 ptt180 -35.96 -53.39 0.76 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 10.26 112.05 168.526 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 56' ' ' ARG . 64.6 m-20 -71.52 -52.02 20.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.709 -1.589 . . . . 2.96 106.709 -164.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -56.08 -52.37 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.384 -1.28 . . . . 0.96 109.406 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -53.38 -56.59 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.042 0.537 . . . . 1.56 109.683 179.032 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -56.93 -38.1 72.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.206 0.457 . . . . 3.13 110.247 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.7 m -65.08 -46.89 79.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.259 0.481 . . . . 0.74 110.609 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.78 -46.43 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.294 1.038 . . . . 0.68 110.431 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.28 -55.65 28.96 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 123.575 0.75 . . . . 2.94 109.672 173.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -51.85 -46.6 64.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.636 1.174 . . . . 1.24 111.357 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.79 -45.24 79.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.219 -0.926 . . . . 1.92 112.107 177.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.86 -46.46 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.999 0.76 . . . . 1.49 114.999 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -129.13 134.78 48.2 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 120.482 -0.487 . . . . 1.81 112.011 -135.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.46 154.94 32.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.731 -1.211 . . . . 3.27 107.731 168.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.29 165.08 28.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.907 0.483 . . . . 1.28 110.962 -166.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 m -132.58 112.09 11.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.571 1.549 . . . . 2.19 107.949 177.063 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 tp -73.1 78.59 1.23 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.796 1.238 . . . . 2.95 108.698 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.536 0.404 0 CA-C-N 115.583 -0.735 . . . . 2.01 111.377 178.523 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.094 0 N-CA-C 110.385 -1.086 . . . . 2.14 110.385 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.89 132.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.188 -1.412 . . . . 2.18 107.188 163.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.85 124.42 44.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 103.771 -2.677 . . . . 3.36 103.771 169.355 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.4 127.03 40.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.096 -1.816 . . . . 2.46 106.096 -179.111 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.94 144.97 35.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.283 -0.266 . . . . 1.94 110.283 -172.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.84 139.29 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.212 -1.403 . . . . 1.79 107.212 168.028 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.98 99.49 6.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 126.235 1.814 . . . . 1.95 108.031 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -84.86 140.9 30.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.464 1.106 . . . . 5.53 108.061 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.92 -11.63 34.65 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.328 0.966 . . . . 1.65 112.818 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.72 146.89 53.33 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.292 1.046 . . . . 1.49 111.295 177.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -162.04 143.47 10.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.875 -1.898 . . . . 2.97 105.875 166.443 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.4 t 69.64 145.58 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.351 1.46 . . . . 2.47 113.147 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.19 -32.32 0.47 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.248 1.819 . . . . 1.2 113.176 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 p -51.66 -81.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.724 1.209 . . . . 1.01 112.936 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.5 m -45.7 -43.67 12.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.835 1.254 . . . . 1.21 110.68 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.1 -65.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.444 1.098 . . . . 1.14 110.976 174.024 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.293 0.0 OUTLIER -68.91 -20.21 64.23 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.549 0.69 . . . . 1.43 111.003 -176.559 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.03 -40.46 97.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.92 -1.113 . . . . 4.16 109.023 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.7 -67.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.933 0.893 . . . . 0.74 109.096 176.049 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.99 -64.17 0.87 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.942 0.497 . . . . 3.48 111.64 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -48.48 -47.56 38.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.933 0.893 . . . . 2.83 111.935 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 t -67.82 -39.94 83.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 O-C-N 121.336 -0.852 . . . . 0.84 112.285 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.97 -37.57 69.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.672 1.124 . . . . 1.77 110.937 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -68.87 73.13 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.17 1.388 . . . . 2.55 110.091 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 129.36 3.064 . . . . 5.53 109.648 -172.396 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -54.17 -40.79 67.82 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 119.114 0.87 . . . . 2.59 112.282 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 77.91 -5.17 2.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.674 2.389 . . . . 7.57 111.338 -163.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.53 47.09 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 121.304 -0.873 . . . . 1.27 111.456 176.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.28 133.93 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.114 1.366 . . . . 3.74 107.894 173.064 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -102.16 -31.89 10.37 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.413 1.085 . . . . 1.59 110.731 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -155.1 153.61 31.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.821 -0.609 . . . . 2.09 109.715 174.245 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -150.02 96.17 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.272 1.029 . . . . 2.03 110.846 -171.445 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.9 104.39 16.28 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.141 -0.689 . . . . 1.46 109.141 171.435 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.6 82.45 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.996 0.918 . . . . 2.16 108.85 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 90.21 6.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.071 -1.085 . . . . 0.91 108.071 -176.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -47.56 -32.68 5.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.773 0.829 . . . . 1.81 111.304 169.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.75 -32.57 31.18 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.941 0.896 . . . . 0.98 111.876 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -122.53 18.05 10.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.405 1.482 . . . . 1.67 109.68 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 m120 36.83 45.16 0.4 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.965 2.106 . . . . 2.65 112.916 -175.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.28 143.99 42.45 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.493 0.588 . . . . 1.61 111.82 -174.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.11 112.91 24.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.427 1.491 . . . . 0.42 108.131 168.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -86.23 105.68 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.475 -1.676 . . . . 0.89 106.475 164.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.72 103.62 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.586 1.554 . . . . 1.24 108.338 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.34 83.66 4.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.57 -1.641 . . . . 3.39 106.57 172.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 165.0 14.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.287 1.035 . . . . 2.0 112.3 177.233 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.97 101.12 39.59 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.394 1.078 . . . . 3.78 110.195 174.018 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 60.62 6.88 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.489 3.46 . . . . 2.31 113.796 -166.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -157.23 -40.07 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.657 0.783 . . . . 4.17 111.42 167.383 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.06 -13.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.208 0.603 . . . . 2.26 110.249 174.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -149.48 144.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 108.071 -1.085 . . . . 2.2 108.071 175.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.4 148.75 20.8 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 108.317 -1.913 . . . . 1.06 108.317 170.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.46 -42.93 56.19 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.466 1.444 . . . . 0.72 109.702 178.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.59 -42.28 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.173 1.389 . . . . 7.31 113.218 168.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.26 -41.6 76.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.262 0.937 . . . . 3.32 109.597 -175.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 mt -63.59 -49.27 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.422 -0.955 . . . . 0.68 108.422 176.163 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -50.0 -56.85 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.879 -0.415 . . . . 1.56 109.879 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -51.49 -51.66 53.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.073 0.549 . . . . 3.04 110.114 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.6 m -58.97 -52.57 65.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.625 -0.43 . . . . 0.81 110.056 -176.775 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.83 -60.55 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.862 0.865 . . . . 0.75 110.024 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.4 -45.06 80.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.802 -0.444 . . . . 3.87 109.802 -176.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -62.97 -9.17 8.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.227 -1.368 . . . . 1.11 114.278 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.76 -87.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 121.359 1.89 . . . . 2.54 107.808 155.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.13 42.49 0.47 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.833 -0.982 . . . . 1.22 112.307 174.218 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.4 170.83 11.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.327 1.064 . . . . 1.93 112.912 -171.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -117.42 122.47 43.89 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 104.684 -2.339 . . . . 3.45 104.684 167.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.79 154.82 26.74 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.732 0.813 . . . . 1.04 111.073 -171.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.4 m -156.24 121.46 4.76 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.455 -0.778 . . . . 1.55 110.363 172.368 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.44 128.62 38.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 3.73 110.149 173.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 125.547 1.539 . . . . 2.37 109.528 178.407 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 CA-C-O 118.327 -1.263 . . . . 2.88 115.069 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.67 100.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 120.169 1.985 . . . . 2.3 110.975 176.101 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -104.17 101.45 11.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.825 2.05 . . . . 2.62 107.288 174.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -97.51 107.15 19.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.97 -0.752 . . . . 2.44 108.97 172.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -99.94 148.25 24.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 124.14 0.9 . . . . 2.33 108.952 166.417 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.15 145.73 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.161 -1.792 . . . . 1.72 106.161 158.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.05 139.23 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.746 1.218 . . . . 2.29 108.766 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -133.56 153.58 51.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.766 0.826 . . . . 6.85 111.023 -178.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.03 -21.0 28.0 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.862 1.22 . . . . 1.95 110.965 -174.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.5 mtm -66.75 150.55 48.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.156 -0.614 . . . . 1.8 109.681 174.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t -151.35 10.81 0.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.105 0.78 . . . . 2.44 113.105 177.374 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.5 t -171.87 151.56 2.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.544 1.066 . . . . 2.29 109.528 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.28 -31.94 0.71 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.696 1.998 . . . . 1.2 113.012 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -53.3 -67.5 0.25 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.377 1.071 . . . . 0.72 113.145 170.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.5 m -43.15 -50.96 6.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.217 1.407 . . . . 1.07 108.346 176.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 t -50.02 -66.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.743 -1.117 . . . . 0.84 111.551 177.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' GLU 0.327 0.0 OUTLIER -65.83 -28.98 69.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.98 111.112 -171.404 . . . . . . . . 4 4 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.07 -52.29 56.57 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.32 1.448 . . . . 3.06 108.281 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -51.76 -65.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.092 -1.077 . . . . 0.76 108.092 171.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 20' ' ' HIS . 11.4 pt-20 -66.44 -42.07 88.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.91 -0.586 . . . . 2.96 110.759 -158.175 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -59.54 -45.66 91.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.739 0.815 . . . . 1.55 110.39 173.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -59.5 -49.67 76.87 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.761 -0.459 . . . . 0.97 109.761 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.07 -45.23 75.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.751 -0.593 . . . . 2.49 110.985 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -61.55 -7.03 2.81 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.395 1.257 . . . . 2.27 114.395 179.11 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -66.63 -31.94 72.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.492 1.042 . . . . 4.35 110.654 169.562 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -64.74 121.5 14.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.627 0.771 . . . . 2.26 109.168 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.06 46.05 0.78 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.445 0.906 . . . . 5.6 113.445 -165.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.62 20.38 0.13 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.469 1.033 . . . . 1.41 111.335 166.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.68 140.18 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.093 -1.077 . . . . 2.38 108.093 174.088 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.3 mt -109.28 -35.9 6.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.366 1.066 . . . . 1.6 111.433 -173.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -155.46 158.42 38.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.462 1.028 . . . . 2.24 109.854 -177.151 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 p -155.91 140.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.742 2.417 . . . . 3.13 105.467 -177.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -156.45 90.59 1.18 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.362 -1.718 . . . . 1.55 106.362 170.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.48 76.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.603 -1.258 . . . . 1.92 107.603 -172.14 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.86 93.24 4.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.572 -0.705 . . . . 1.0 109.133 -171.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tt -42.98 -37.17 1.79 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.252 1.421 . . . . 2.17 111.566 168.394 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.23 -32.91 39.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 1.11 112.452 178.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -116.05 12.23 15.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.255 1.422 . . . . 1.6 110.125 178.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 40.44 37.74 0.49 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.823 2.049 . . . . 2.14 112.141 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 154.89 45.54 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.489 0.716 . . . . 1.44 109.762 -169.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.68 112.12 11.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.413 -1.328 . . . . 0.61 107.413 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -92.08 96.94 10.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.899 2.479 . . . . 1.29 104.602 170.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.2 mp -92.79 135.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 104.707 -2.331 . . . . 1.57 104.707 172.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.1 127.88 54.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.501 -1.666 . . . . 3.2 106.501 168.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -165.35 168.47 16.78 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.111 0.965 . . . . 2.98 109.74 -173.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -92.13 119.05 68.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.412 1.07 . . . . 4.0 108.905 171.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.62 -32.51 93.43 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.543 1.495 . . . . 2.15 113.039 176.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -84.88 49.88 1.81 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.901 1.228 . . . . 5.55 111.843 -165.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.97 -47.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 127.395 2.278 . . . . 4.15 107.83 178.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -53.62 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.308 1.043 . . . . 2.84 109.595 -173.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.06 145.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.717 -0.614 . . . . 0.92 111.7 -166.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -52.5 -39.63 74.03 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.514 2.143 . . . . 0.94 111.354 178.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -37.95 -48.76 1.2 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.435 1.494 . . . . 7.66 112.697 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.57 -50.24 59.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.864 0.84 . . . . 3.69 109.506 -172.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.3 -52.58 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.598 -0.689 . . . . 1.04 110.896 175.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.86 -50.8 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.946 -0.761 . . . . 1.71 108.946 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -55.37 -47.04 76.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.008 0.523 . . . . 5.05 110.373 -179.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -60.08 -48.4 81.89 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.856 0.753 . . . . 0.95 110.936 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.7 -51.69 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.865 0.757 . . . . 0.88 110.837 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.95 -55.5 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.119 0.968 . . . . 2.86 109.943 177.139 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -57.09 -34.95 68.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.751 1.22 . . . . 1.03 111.597 -177.016 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.67 -58.1 4.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.529 0.604 . . . . 2.37 110.275 172.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 -41.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.826 1.09 . . . . 1.57 115.826 -176.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -117.25 142.69 46.74 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 117.421 0.61 . . . . 1.98 111.65 -135.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.8 150.49 30.71 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.838 -1.542 . . . . 3.69 106.838 173.503 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.41 164.61 35.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.235 0.471 . . . . 1.09 111.994 -176.5 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.7 m -158.2 132.04 7.85 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 118.282 -0.866 . . . . 1.4 110.624 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.49 128.68 37.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.893 1.224 . . . . 2.55 108.777 172.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.465 0.284 0 C-N-CA 123.442 0.697 . . . . 3.05 111.967 177.343 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 111.796 -0.521 . . . . 1.78 111.796 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.42 128.9 74.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.089 0.956 . . . . 3.36 110.727 -175.717 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.25 120.3 28.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.108 1.363 . . . . 4.37 108.076 173.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.83 107.89 19.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.185 -1.043 . . . . 2.41 108.185 177.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -117.78 148.55 41.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.036 0.534 . . . . 1.94 110.998 -174.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.7 151.2 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.884 0.873 . . . . 1.81 108.971 173.211 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.72 86.76 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.981 1.312 . . . . 2.19 109.339 174.193 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 107.48 18.78 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.664 -0.648 . . . . 6.58 110.416 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.62 -20.77 0.39 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.357 0.98 . . . . 1.54 112.133 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.7 mtm -62.5 169.7 2.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.176 0.988 . . . . 1.72 111.79 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 t -158.9 -44.66 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.519 0.727 . . . . 2.35 110.856 -177.625 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.9 m -138.44 164.3 29.71 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.189 0.449 . . . . 2.62 110.665 -168.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -38.64 3.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.48 1.912 . . . . 1.23 112.464 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.8 p -52.68 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.782 1.233 . . . . 0.88 112.265 170.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.4 m -42.69 -41.97 3.33 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.638 1.175 . . . . 1.23 111.43 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.22 -72.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.024 0.53 . . . . 0.84 111.121 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -17.88 65.08 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.465 -0.772 . . . . 1.0 112.334 -170.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -54.99 -46.4 75.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.859 0.864 . . . . 3.51 109.36 173.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.08 -60.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.895 -1.15 . . . . 0.59 107.895 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -50.84 -58.17 6.62 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.794 0.438 . . . . 2.97 110.654 178.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -56.2 -33.69 65.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.473 0.709 . . . . 1.09 111.908 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -70.62 -64.46 0.89 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.581 0.628 . . . . 0.99 110.609 172.436 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.12 -32.89 74.82 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.052 -1.03 . . . . 2.15 111.583 -167.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -56.93 -16.45 6.88 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 2.23 112.701 175.211 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -63.08 -35.8 81.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.398 -0.814 . . . . 4.97 111.126 171.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -72.98 109.7 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.53 -0.915 . . . . 2.58 108.53 177.381 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -65.87 -3.74 5.62 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.928 -1.107 . . . . 7.23 110.898 167.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.73 -25.37 71.69 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.623 1.106 . . . . 1.02 112.833 166.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 pp -99.84 156.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 119.142 1.471 . . . . 3.31 110.519 175.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.22 -38.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.557 1.543 . . . . 1.48 110.046 -177.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -155.65 157.06 36.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.651 0.659 . . . . 2.55 109.409 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -140.64 131.78 26.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.073 -1.454 . . . . 1.95 107.073 170.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.45 98.31 3.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.344 1.458 . . . . 1.63 107.651 -177.486 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.33 106.55 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.334 0.654 . . . . 1.71 111.761 -174.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.13 97.67 8.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.545 -0.722 . . . . 0.9 109.223 -174.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -48.98 -40.2 29.62 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.19 0.996 . . . . 1.76 111.597 175.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.55 -32.95 1.02 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.384 1.074 . . . . 0.86 113.226 175.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -125.82 13.76 7.98 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.084 0.953 . . . . 1.36 111.154 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 34.52 49.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.776 . . . . 1.88 112.277 -172.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 139.71 53.59 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.164 0.585 . . . . 2.77 109.856 -179.001 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.96 112.17 24.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.223 1.409 . . . . 0.6 107.738 162.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -79.18 102.16 8.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.281 -2.488 . . . . 1.35 104.281 160.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.0 mt -106.76 124.73 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.336 -1.728 . . . . 0.95 106.336 174.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -97.48 114.74 26.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.219 -2.141 . . . . 3.52 105.219 166.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.66 151.62 29.0 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.76 -1.941 . . . . 2.94 105.76 -178.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.62 129.43 23.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.409 0.443 . . . . 3.83 110.883 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -56.94 -35.31 98.6 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.898 2.399 . . . . 1.73 111.737 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.64 -25.87 65.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.13 0.789 . . . . 3.71 113.13 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.9 pt -106.86 -26.96 3.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 118.965 0.802 . . . . 2.83 112.161 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -152.93 131.97 3.12 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 CA-C-N 119.246 0.93 . . . . 2.78 109.584 172.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.71 166.75 53.4 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.473 -0.651 . . . . 0.85 111.473 -177.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.02 -55.54 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.86 2.374 . . . . 1.18 110.586 177.717 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -56.97 -32.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 122.391 -0.193 . . . . 7.49 111.03 -174.451 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -56.88 13.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.659 1.584 . . . . 4.02 109.184 175.049 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.66 -50.33 68.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.059 -0.719 . . . . 1.41 109.059 176.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.2 -46.97 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.007 -0.542 . . . . 1.98 110.524 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -52.71 -51.73 59.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.984 0.811 . . . . 2.79 109.714 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -52.33 -58.39 6.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.466 0.575 . . . . 0.9 110.302 175.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.3 -55.78 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.043 0.537 . . . . 0.78 111.179 -172.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -53.67 -45.6 70.33 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.709 0.804 . . . . 4.19 109.635 176.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -66.98 -9.88 43.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.617 -1.182 . . . . 1.08 113.392 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.96 -100.99 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.276 1.398 . . . . 2.6 107.85 156.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.86 38.92 0.5 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.243 0.929 . . . . 1.64 112.871 177.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -130.81 122.71 27.61 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.311 1.056 . . . . 1.97 109.336 -171.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -79.91 133.61 36.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.971 -1.863 . . . . 3.01 105.971 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.28 161.15 30.88 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 113.791 1.034 . . . . 1.08 113.791 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -158.22 137.71 11.87 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.912 1.285 . . . . 1.48 108.572 177.201 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -82.43 48.22 1.26 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.747 1.612 . . . . 3.22 111.232 -175.518 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 117.209 2.3 . . . . 2.67 117.209 -160.65 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.427 -1.207 . . . . 2.13 115.292 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 p -156.63 127.7 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 120.371 2.086 . . . . 1.8 110.29 172.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.48 108.97 6.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.787 -1.19 . . . . 3.38 107.787 172.79 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.35 119.44 28.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.434 -1.321 . . . . 2.18 107.434 169.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -119.69 140.49 50.58 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.707 1.139 . . . . 2.8 110.494 170.046 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.81 119.87 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.718 -1.216 . . . . 1.59 107.718 173.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.54 94.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.569 1.148 . . . . 2.54 108.37 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -78.45 86.16 4.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.937 -1.505 . . . . 7.09 106.937 176.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.12 -138.25 5.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 103.48 -3.848 . . . . 3.38 103.48 175.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 mtm 65.78 166.97 0.19 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.951 1.3 . . . . 2.18 111.62 -170.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.6 p -147.21 -83.41 0.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.993 0.517 . . . . 3.66 110.134 -176.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t -146.29 103.46 3.71 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.595 0.758 . . . . 2.94 110.389 -166.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 45.33 -129.98 1.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.458 -0.941 . . . . 2.77 108.458 -169.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.1 p 43.53 -87.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.463 1.905 . . . . 0.8 113.962 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -39.83 -43.75 1.51 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.087 1.755 . . . . 1.09 110.391 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -44.42 -67.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 0.95 110.649 172.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HA ' ' HG3' ' A' ' 23' ' ' GLU 0.326 0.0 OUTLIER -71.78 -21.6 61.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 119.797 -0.761 . . . . 0.94 112.512 -177.525 . . . . . . . . 4 4 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.56 -45.32 92.17 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.362 -1.347 . . . . 4.19 107.362 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.43 -69.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.62 -0.718 . . . . 0.61 109.085 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 2.1 pp20? -56.6 -48.14 78.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.774 0.261 . . . . 4.77 111.589 -165.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -70.45 -20.77 62.87 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.23 0.612 . . . . 1.2 110.485 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.7 t -66.85 -62.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.33 -1.481 . . . . 0.99 109.036 162.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.66 -50.58 35.18 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 113.62 0.97 . . . . 1.85 113.62 -162.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -44.15 -28.26 0.48 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.015 1.326 . . . . 2.25 113.58 -167.513 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -63.17 -40.48 97.67 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.192 2.597 . . . . 4.16 112.944 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -62.2 129.06 39.02 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.254 -1.017 . . . . 2.41 108.254 172.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.88 -3.47 3.44 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.795 1.405 . . . . 10.75 114.795 -166.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' HD12 ' A' ' 52' ' ' ILE . . . -92.16 -14.13 56.49 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 119.546 -0.585 . . . . 1.16 112.214 -178.381 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mm -88.91 104.86 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.037 -1.098 . . . . 2.45 108.037 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.0 mt -78.99 -38.96 35.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.004 -0.739 . . . . 1.62 109.004 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -155.31 145.68 21.95 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.599 -0.889 . . . . 2.31 108.599 176.278 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.75 105.99 6.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.307 -1.368 . . . . 1.89 107.307 175.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 t -120.94 103.6 9.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.963 -1.125 . . . . 1.52 107.963 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.04 127.78 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.072 0.549 . . . . 1.87 110.481 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.03 108.94 11.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.035 0.934 . . . . 1.2 110.247 -170.075 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.81 -41.51 5.06 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.933 1.293 . . . . 2.41 111.08 168.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.77 14.36 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 124.109 0.964 . . . . 0.79 112.475 -175.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -130.07 14.28 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.212 1.005 . . . . 1.4 110.006 -177.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 m120 29.97 53.55 0.13 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 126.169 1.788 . . . . 2.29 111.831 -169.025 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.29 141.17 37.76 Favored 'General case' 0 N--CA 1.461 0.085 0 O-C-N 121.577 -0.702 . . . . 0.99 110.712 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.19 112.61 24.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.753 1.621 . . . . 0.47 108.424 168.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -79.91 104.0 10.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.055 -1.832 . . . . 0.84 106.055 162.169 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.41 113.0 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.482 -0.933 . . . . 0.9 108.482 175.809 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -84.1 107.38 16.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 105.699 -1.963 . . . . 3.06 105.699 164.716 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -147.2 167.48 24.09 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.67 -1.604 . . . . 2.66 106.67 174.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.35 136.65 27.34 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.757 1.021 . . . . 4.37 113.757 174.4 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.34 48.59 2.93 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.506 3.471 . . . . 2.06 113.023 -165.522 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -155.85 -47.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.004 1.322 . . . . 3.11 109.464 -173.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.531 HD12 ' HA2' ' A' ' 31' ' ' GLY . 7.6 pt -67.75 -32.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.228 -1.027 . . . . 3.23 108.228 166.059 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.56 HG23 ' H ' ' A' ' 54' ' ' GLY 0.31 17.6 tt -131.67 -91.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 123.735 0.647 . . . . 2.4 112.579 170.029 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 135.67 152.78 6.49 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.536 -1.426 . . . . 1.15 109.536 -168.201 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.71 -57.17 0.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.197 1.931 . . . . 1.01 109.033 172.773 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptt85 -29.28 -55.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.223 2.209 . . . . 10.04 113.22 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.23 -51.06 65.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.552 -0.907 . . . . 2.85 108.552 -171.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.81 -49.95 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.536 -0.542 . . . . 0.81 109.536 177.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.1 mm -50.28 -57.99 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 119.09 -0.481 . . . . 1.53 109.795 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -51.46 -46.31 63.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.055 0.542 . . . . 2.82 110.258 177.09 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -57.57 -47.9 80.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.388 -0.339 . . . . 0.69 110.986 178.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.0 -50.6 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.278 0.945 . . . . 1.66 110.989 -177.197 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -50.28 73.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.337 0.517 . . . . 2.95 110.243 176.009 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -52.0 -42.0 62.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.526 0.73 . . . . 0.9 111.132 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.74 -49.29 48.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.305 -0.872 . . . . 1.84 111.687 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.9 -44.22 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 116.001 1.16 . . . . 1.37 116.001 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.87 156.8 39.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.813 0.672 . . . . 1.88 112.813 -135.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.21 139.71 39.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.651 -1.611 . . . . 5.65 106.651 171.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.85 70.59 1.21 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.401 1.48 . . . . 2.54 110.1 -166.129 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -84.99 100.32 11.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.425 0.631 . . . . 1.68 109.629 -170.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.33 73.88 0.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.68 1.592 . . . . 2.63 112.651 -178.167 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.541 0.6 0 C-N-CA 125.086 1.354 . . . . 2.0 111.682 167.082 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 109.728 -0.471 . . . . 11.74 109.728 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.03 37.73 86.63 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.282 0.468 . . . . 4.79 112.06 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.84 -52.14 9.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.165 0.986 . . . . 6.22 110.061 -163.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.45 113.31 0.3 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.862 -1.695 . . . . 1.46 108.862 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.14 147.54 5.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.06 -1.089 . . . . 2.2 108.06 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.5 tp -150.64 82.92 1.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.509 -0.552 . . . . 2.26 109.509 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 74' ' ' ILE . 44.8 mp0 -77.92 100.73 6.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 110.035 -0.357 . . . . 3.49 110.035 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.78 118.21 27.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.04 -1.467 . . . . 2.62 107.04 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.77 119.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 105.498 -2.038 . . . . 1.82 105.498 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.67 93.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 125.513 1.525 . . . . 2.15 107.967 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -78.47 112.36 15.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.009 -1.478 . . . . 6.53 107.009 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.64 -136.76 7.82 Favored Glycine 0 N--CA 1.434 -1.479 1 N-CA-C 101.994 -4.442 . . . . 3.54 101.994 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.63 173.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.874 0.87 . . . . 2.21 112.683 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -154.03 -81.03 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.954 1.302 . . . . 3.29 108.674 -167.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -172.13 131.37 0.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 125.361 1.464 . . . . 5.37 107.957 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 48.45 -146.12 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.558 -0.734 . . . . 2.8 109.21 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.1 p 51.61 -86.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.907 1.447 . . . . 1.39 114.907 161.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.5 p -45.31 -41.7 9.03 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.214 -0.929 . . . . 3.54 111.53 166.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.03 -72.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.3 1.44 . . . . 0.82 110.064 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -25.82 66.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.806 -0.616 . . . . 1.17 111.241 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -53.21 -57.52 10.22 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.527 -0.916 . . . . 4.73 108.527 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.69 -60.12 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.908 -0.775 . . . . 0.58 108.908 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -54.16 -57.03 12.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.85 0.357 . . . . 3.27 111.373 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -57.0 -47.58 80.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.433 0.693 . . . . 1.04 110.07 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -60.03 -65.23 0.71 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.931 -0.396 . . . . 0.84 109.931 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.75 -29.43 69.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.006 -1.078 . . . . 2.86 111.217 -166.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -55.82 -20.38 15.0 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.163 -0.961 . . . . 1.58 112.348 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -30.64 69.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.808 -1.183 . . . . 6.64 112.417 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -70.07 116.04 9.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.209 -1.034 . . . . 2.36 108.209 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 32.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.418 -0.802 . . . . 7.84 113.082 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.08 -8.53 5.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.037 1.78 . . . . 0.72 111.82 166.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.02 118.64 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 105.974 -1.861 . . . . 2.5 105.974 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.83 -37.75 18.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.222 -0.659 . . . . 1.73 109.222 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.4 162.12 40.86 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.052 0.387 . . . . 2.89 110.866 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.91 96.08 2.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.433 1.893 . . . . 1.91 108.957 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 m -99.73 99.78 10.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.719 1.608 . . . . 1.96 107.545 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.96 92.53 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 122.819 1.295 . . . . 1.9 109.286 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.72 82.22 3.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.484 -1.302 . . . . 1.28 107.484 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -37.5 -44.07 0.63 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.248 1.819 . . . . 2.59 110.378 163.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.4 -32.93 28.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.121 . . . . 1.08 113.067 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -120.95 20.45 11.57 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.416 1.086 . . . . 2.53 110.296 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 34.59 56.66 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.368 1.867 . . . . 2.23 111.523 -170.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -140.69 125.58 18.23 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.968 0.359 . . . . 1.6 111.968 -167.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.74 98.99 8.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.62 107.245 165.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -77.25 96.29 4.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 104.787 -2.301 . . . . 1.09 104.787 159.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.67 150.0 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.249 -1.342 . . . . 1.23 107.996 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.14 133.74 55.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.427 -2.064 . . . . 3.06 105.427 166.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -156.26 161.82 40.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.176 -1.416 . . . . 2.42 107.176 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.18 140.99 22.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 4.15 107.088 161.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.45 -22.58 28.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.399 2.066 . . . . 1.71 111.628 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.648 0.779 . . . . 4.06 111.169 -172.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.98 -11.29 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.647 0.379 . . . . 2.42 111.957 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.88 130.99 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.315 -0.624 . . . . 2.39 109.315 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.01 154.08 47.68 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.177 -1.569 . . . . 0.76 109.177 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.04 -40.52 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.585 1.523 . . . . 0.75 109.34 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 11.3 tpt180 -59.09 -38.26 79.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.381 -0.342 . . . . 8.24 111.202 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -53.0 47.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.154 1.382 . . . . 3.51 109.745 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.35 -51.87 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.031 -0.986 . . . . 0.85 109.04 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.46 -52.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.695 -0.669 . . . . 1.28 111.446 -177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 32.5 m170 -48.06 -49.41 31.57 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.935 1.294 . . . . 2.96 109.496 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -63.37 -47.44 82.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.98 -0.555 . . . . 1.13 109.642 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.79 -58.81 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 121.471 -0.768 . . . . 1.0 111.29 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.68 -49.04 76.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.692 -0.855 . . . . 2.73 108.692 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.7 t -48.37 -50.32 31.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.238 1.015 . . . . 1.23 111.712 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.13 -42.76 86.53 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.168 1.173 . . . . 1.79 114.168 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.89 -2.92 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 N-CA-C 119.127 2.411 . . . . 1.23 119.127 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -142.27 177.64 8.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.963 1.881 . . . . 1.86 111.846 -144.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -110.62 140.3 45.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.184 -1.784 . . . . 5.18 106.184 150.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.0 116.15 16.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.861 0.864 . . . . 2.25 110.827 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -122.55 116.99 24.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.394 1.078 . . . . 1.69 111.417 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.88 72.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.93 1.692 . . . . 2.22 112.407 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m -55.39 -40.76 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.818 0.847 . . . . 1.99 110.443 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt 65.34 101.72 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.72 1.208 . . . . 4.83 110.602 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.439 ' H ' ' CD ' ' A' ' 7' ' ' GLU 0.319 4.7 tp 31.55 63.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.936 2.494 . . . . 5.41 113.989 -161.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 . . . . . 0 C--O 1.255 1.394 0 N-CA-C 101.169 -3.641 . . . . 10.45 101.169 133.956 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 105.726 -1.953 . . . . 7.98 105.726 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.75 -174.48 7.79 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 108.875 -1.69 . . . . 4.63 108.875 138.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.02 59.61 4.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.331 1.453 . . . . 5.25 110.253 -170.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.79 139.23 22.61 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.255 -1.538 . . . . 1.58 109.255 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.4 151.96 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.229 -0.656 . . . . 2.3 109.229 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.8 tp -152.37 111.07 3.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.271 -1.011 . . . . 2.09 108.271 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -106.49 117.53 34.28 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.096 0.474 . . . . 2.86 111.693 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.6 mt -106.78 129.91 54.57 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.81 -1.182 . . . . 2.79 107.81 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.74 101.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.18 -1.415 . . . . 1.95 107.18 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 22' ' ' ILE . 49.0 t -79.91 78.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.578 -1.638 . . . . 1.85 106.578 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -77.68 116.06 17.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 5.62 107.458 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.39 -11.71 3.25 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.504 1.049 . . . . 1.45 112.631 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.407 ' CE ' HG22 ' A' ' 19' ' ' VAL . 31.0 mtp -63.76 149.55 46.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.053 0.926 . . . . 1.47 109.922 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.4 17.72 0.34 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.795 0.665 . . . . 2.35 112.795 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -171.39 152.09 3.22 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.787 1.176 . . . . 2.22 110.786 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.14 -35.97 3.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.295 1.838 . . . . 1.21 112.739 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -59.18 -69.64 0.19 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.8 111.798 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.2 m -40.35 -45.73 2.21 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.908 1.283 . . . . 1.31 110.414 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG22 ' CE ' ' A' ' 13' ' ' MET . 10.5 t -53.32 -73.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 123.842 0.714 . . . . 0.78 111.108 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -21.51 64.33 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.706 -0.621 . . . . 1.07 112.13 -166.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -55.8 -47.31 77.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.364 1.066 . . . . 3.82 109.362 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.401 HD13 HG11 ' A' ' 10' ' ' VAL . 54.8 mt -62.56 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.453 -0.943 . . . . 0.57 108.453 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -49.94 -60.6 2.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.539 0.736 . . . . 3.19 110.428 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 t -52.39 -44.49 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.726 0.81 . . . . 1.03 110.989 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -61.51 -62.79 1.57 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.107 0.412 . . . . 0.87 110.494 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.38 -33.35 75.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.241 -0.912 . . . . 1.81 111.434 -166.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.1 p -60.02 -11.99 7.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.449 -0.782 . . . . 2.02 112.649 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -62.65 -39.51 94.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.008 0.822 . . . . 4.81 110.908 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -70.71 125.85 27.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.047 -1.094 . . . . 2.37 108.047 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -75.76 48.86 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.899 0.879 . . . . 7.14 110.334 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.86 -39.67 0.15 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 126.516 2.008 . . . . 0.84 110.566 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -79.26 119.75 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.43 -1.693 . . . . 2.91 106.43 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.96 -26.11 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.456 0.702 . . . . 2.04 110.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -155.3 155.11 33.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.959 -0.756 . . . . 2.46 108.959 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -149.75 131.6 15.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.409 -1.33 . . . . 1.97 107.409 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -142.28 118.87 11.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.055 -1.091 . . . . 1.71 108.055 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p -99.76 97.87 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.265 1.031 . . . . 1.84 110.938 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 97.82 11.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.687 -0.856 . . . . 0.72 108.687 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -49.99 -34.12 20.03 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.88 0.872 . . . . 2.65 111.684 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.96 60.64 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.742 0.817 . . . . 1.12 111.66 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -119.37 11.67 12.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.086 1.354 . . . . 1.57 109.763 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 m120 37.71 38.73 0.17 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.722 2.009 . . . . 1.79 111.95 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.58 133.52 54.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 121.681 -0.637 . . . . 1.08 109.594 -168.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 101.46 13.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.335 -1.728 . . . . 0.53 106.335 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -76.67 92.62 3.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.684 -2.339 . . . . 1.03 104.684 166.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.74 150.54 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.822 -1.548 . . . . 1.12 106.822 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -126.17 142.48 51.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.794 -1.558 . . . . 3.0 106.794 155.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.42 175.57 13.81 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.196 0.999 . . . . 2.06 108.996 -170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.98 125.78 26.55 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 108.671 -0.863 . . . . 3.53 108.671 171.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.26 61.06 6.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.364 3.376 . . . . 2.21 111.509 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -168.07 -43.22 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.894 1.678 . . . . 3.57 110.119 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.3 pt -73.26 -30.18 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.748 -0.834 . . . . 2.69 108.748 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -153.49 149.14 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.515 -0.92 . . . . 2.37 108.515 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 167.25 31.74 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 110.62 -0.992 . . . . 0.77 110.62 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.58 -46.22 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.499 2.133 . . . . 0.72 110.756 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -45.72 -40.8 9.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.872 1.269 . . . . 7.86 111.105 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -57.5 12.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.447 1.899 . . . . 3.39 107.969 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mt -63.3 -48.82 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.73 109.575 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.8 -60.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.931 0.893 . . . . 1.53 109.139 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -57.83 -42.44 84.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.701 1.2 . . . . 4.87 109.738 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 m -61.3 -47.13 87.37 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.468 -0.493 . . . . 0.83 110.564 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.16 -45.05 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.69 111.065 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -57.27 -52.95 63.25 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.103 0.561 . . . . 3.04 109.728 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -54.75 -42.22 71.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.818 1.247 . . . . 0.78 111.146 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.82 -55.49 19.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.0 0.818 . . . . 1.77 111.106 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.28 -42.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.65 1.02 . . . . 1.45 115.65 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.68 140.98 52.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 117.754 0.777 . . . . 2.0 112.194 -137.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.82 79.76 4.29 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.247 0.546 . . . . 3.34 110.316 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.91 141.16 44.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.571 -0.706 . . . . 1.55 110.284 -165.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -156.41 128.38 7.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.173 -0.955 . . . . 2.15 111.209 -167.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.9 116.96 2.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.174 1.39 . . . . 2.22 110.931 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.21 98.08 5.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 124.565 1.146 . . . . 2.71 109.051 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.06 54.5 0.67 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 5.24 111.014 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.14 52.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.124 0.97 . . . . 6.91 111.804 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 116.265 -1.826 . . . . 8.58 107.362 175.033 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.009 -1.848 . . . . 8.26 106.009 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.98 16.1 63.62 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.387 -0.674 . . . . 3.75 112.979 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -12.35 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.77 2.828 . . . . 4.63 116.967 -170.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 38.65 71.12 0.25 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.419 1.485 . . . . 2.35 111.372 -165.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.74 92.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.321 1.058 . . . . 2.12 108.508 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.8 tp -95.31 101.19 12.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.032 1.733 . . . . 2.15 106.961 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -95.42 120.41 35.61 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.514 -1.291 . . . . 2.81 107.514 156.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.88 148.51 25.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.73 1.269 . . . . 2.71 108.255 158.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.89 143.54 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.534 -2.025 . . . . 1.91 105.534 160.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.21 127.56 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.556 1.542 . . . . 2.47 108.308 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -118.24 155.41 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.391 0.677 . . . . 6.58 110.021 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.89 -31.88 6.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.278 1.418 . . . . 1.54 110.582 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mtp -51.12 130.52 26.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.556 0.742 . . . . 1.54 110.273 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -154.03 17.38 0.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.246 -0.407 . . . . 2.38 112.087 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -169.36 151.17 4.45 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.143 0.883 . . . . 2.27 109.378 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.46 -37.73 12.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.798 1.639 . . . . 1.13 112.013 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.6 p -57.92 -71.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.99 0.916 . . . . 0.85 111.67 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.8 m -40.32 -44.07 1.86 Allowed 'General case' 0 C--N 1.338 0.109 0 C-N-CA 125.096 1.358 . . . . 1.23 111.012 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.84 -73.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 123.703 0.627 . . . . 0.87 111.041 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -20.31 66.08 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.567 -0.708 . . . . 1.15 112.206 -168.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.33 -42.53 82.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.865 0.866 . . . . 3.09 109.729 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.5 mt -62.17 -57.26 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.501 -0.926 . . . . 0.47 108.501 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.32 -57.95 8.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.968 0.907 . . . . 3.4 109.866 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -52.29 -54.36 32.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.033 0.933 . . . . 0.9 110.442 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -59.03 -40.08 83.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.888 -0.577 . . . . 0.79 112.092 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -73.67 -36.82 65.37 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.331 0.969 . . . . 1.75 112.512 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 m -70.81 70.39 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.034 0.921 . . . . 2.51 110.357 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -174.0 -23.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.687 2.795 . . . . 5.75 112.394 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.249 1.386 . . . . 2.53 111.189 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 67.84 -3.85 1.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.603 2.361 . . . . 6.08 113.67 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.83 -28.87 40.6 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.412 -1.075 . . . . 0.82 110.412 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.88 129.48 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.259 0.624 . . . . 2.68 109.397 171.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.19 -42.74 12.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.291 1.036 . . . . 1.38 109.294 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.337 -0.246 . . . . 1.9 110.337 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -137.67 130.77 30.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.666 1.586 . . . . 1.99 107.006 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -134.4 103.61 5.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.976 -1.49 . . . . 1.74 106.976 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.334 2.8 p -89.73 88.25 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 123.461 1.601 . . . . 1.81 110.231 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.1 84.81 4.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.305 -1.316 . . . . 1.27 107.839 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.53 -36.56 4.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.725 1.61 . . . . 2.91 111.147 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.85 -33.45 23.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.394 0.678 . . . . 1.16 111.936 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -113.83 4.51 15.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.043 1.737 . . . . 2.38 110.967 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 44.23 52.63 7.04 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.23 1.012 . . . . 1.95 110.3 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -139.81 142.66 36.66 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 122.721 0.408 . . . . 1.6 110.696 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.34 101.19 10.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.698 -1.223 . . . . 0.66 107.698 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -78.27 104.89 9.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.115 -2.18 . . . . 0.92 105.115 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.67 121.72 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.743 -1.577 . . . . 0.91 106.743 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -102.22 123.8 46.69 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.443 -1.688 . . . . 2.6 106.443 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.33 152.62 32.33 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.364 0.666 . . . . 2.41 109.478 -171.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -95.67 108.4 39.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 107.647 -1.242 . . . . 3.84 107.647 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.97 -46.72 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.213 1.942 . . . . 2.5 112.587 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.2 -32.13 15.62 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.989 1.107 . . . . 3.88 113.989 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 pt -96.05 7.47 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 118.521 0.6 . . . . 2.46 112.467 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.72 -55.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.098 0.863 . . . . 3.23 111.69 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.46 143.3 5.25 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.827 1.68 . . . . 0.91 110.266 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -57.94 -39.58 85.16 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.819 2.346 . . . . 0.86 110.603 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -29.23 -50.88 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.006 2.122 . . . . 10.54 113.218 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -71.62 -49.71 37.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.5 1.12 . . . . 4.17 109.767 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.0 mt -58.71 -54.07 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.703 -0.68 . . . . 0.74 109.362 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -53.88 -54.68 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.461 -0.57 . . . . 1.93 109.461 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -53.33 -45.12 68.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.882 0.473 . . . . 5.06 110.351 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -59.8 -52.55 64.98 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.104 0.411 . . . . 0.77 110.415 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.6 mt -51.78 -58.66 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.86 109.361 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -52.07 -57.67 8.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.627 0.727 . . . . 3.43 109.805 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -58.66 -26.11 63.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.322 1.449 . . . . 0.76 113.371 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.27 -76.9 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.592 1.542 . . . . 1.8 110.968 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.6 31.91 0.43 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.775 -1.014 . . . . 1.42 112.989 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -132.68 173.48 11.3 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.368 1.084 . . . . 1.96 112.571 -165.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.58 155.8 34.27 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 105.65 -1.981 . . . . 3.81 105.65 157.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.75 166.36 33.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.01 0.823 . . . . 1.04 112.371 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.88 132.04 10.05 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.561 1.144 . . . . 2.25 110.571 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.11 125.98 21.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.721 1.209 . . . . 2.64 110.309 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.98 -47.18 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.825 1.25 . . . . 2.09 111.949 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.5 mttm 55.87 92.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.286 1.034 . . . . 5.99 112.289 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.1 mm 75.72 52.97 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.393 1.477 . . . . 6.37 109.711 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--O 1.252 1.23 0 N-CA-C 101.757 -3.423 . . . . 12.22 101.757 151.17 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 105.504 -2.035 . . . . 10.37 105.504 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 -149.18 35.08 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.086 -1.606 . . . . 4.54 109.086 -167.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -141.67 92.59 2.47 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 5.74 107.86 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.18 165.66 12.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.385 0.993 . . . . 1.49 113.003 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.16 145.31 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.328 -1.101 . . . . 2.15 109.059 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -147.85 119.94 8.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.35 -2.093 . . . . 2.07 105.35 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.98 113.05 22.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.61 -1.626 . . . . 2.49 106.61 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -110.91 131.85 54.7 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.415 -1.328 . . . . 3.43 107.415 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -75.88 126.32 36.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 105.032 -2.211 . . . . 1.77 105.032 154.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -119.34 108.73 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.334 -1.728 . . . . 2.15 106.334 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -79.84 98.77 7.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.767 . . . . 5.0 108.93 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 -105.23 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.23 -2.348 . . . . 3.54 107.23 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.657 ' HE3' HG22 ' A' ' 37' ' ' VAL . 41.5 mtp 57.49 35.25 25.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.629 0.772 . . . . 3.29 112.1 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -74.58 121.22 21.24 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.731 -0.606 . . . . 3.08 110.043 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t 68.46 152.53 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.77 1.628 . . . . 2.32 113.239 169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.25 72.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.158 1.783 . . . . 3.39 110.566 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 p -178.8 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.672 1.189 . . . . 1.6 109.466 -160.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.7 m -73.15 -51.1 19.15 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.922 -0.77 . . . . 1.1 108.922 159.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -42.7 -73.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.476 1.911 . . . . 0.96 111.58 -175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -25.73 68.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.089 -0.382 . . . . 1.29 111.903 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -67.41 -49.43 63.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.154 0.981 . . . . 4.48 108.925 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -53.34 -62.3 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 108.207 -1.035 . . . . 0.65 108.207 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -53.42 -57.1 11.82 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.366 0.267 . . . . 3.08 110.713 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -49.71 -50.88 42.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.854 -0.594 . . . . 1.09 110.331 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 t -55.53 -50.59 69.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.347 0.521 . . . . 0.83 110.801 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 mt -67.83 -38.22 82.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.59 -1.644 . . . . 1.78 110.557 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.8 m -59.95 -10.23 3.88 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.667 -0.646 . . . . 1.63 112.591 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -62.77 -40.83 98.52 Favored 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.718 -1.238 . . . . 5.22 109.83 168.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -72.38 135.35 45.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.777 -1.194 . . . . 2.66 107.777 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.48 -0.74 55.82 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.868 -0.52 . . . . 6.37 110.961 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.62 -15.07 64.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.402 0.525 . . . . 0.71 113.306 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.7 tt -88.82 124.46 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.028 -1.101 . . . . 2.91 108.028 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.7 mt -82.23 -40.26 21.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.047 0.939 . . . . 1.54 109.5 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -155.21 148.62 25.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 110.127 -0.323 . . . . 1.97 110.127 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.4 t -132.9 138.98 47.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.963 1.305 . . . . 1.96 107.703 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 m -143.92 102.38 3.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.004 -1.11 . . . . 1.5 108.004 164.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.657 HG22 ' HE3' ' A' ' 13' ' ' MET 0.327 1.2 p -88.76 80.88 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 123.708 1.718 . . . . 1.61 108.809 -177.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 90.4 4.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.93 1.692 . . . . 0.86 110.158 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pp -54.53 -29.9 52.1 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.571 1.148 . . . . 3.1 112.427 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.9 26.04 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.156 0.582 . . . . 0.89 111.43 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 p -114.63 9.25 16.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.354 1.462 . . . . 2.07 111.658 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.97 45.0 3.18 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.254 1.422 . . . . 1.83 111.247 -171.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -133.26 136.49 45.57 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 122.73 0.412 . . . . 1.08 111.734 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -89.63 109.19 20.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.565 1.146 . . . . 0.6 108.247 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -78.58 114.18 17.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.846 -2.279 . . . . 0.89 104.846 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.12 107.19 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.337 -1.357 . . . . 1.05 107.337 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -87.31 105.3 17.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.672 -1.603 . . . . 3.38 106.672 163.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.26 175.22 6.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.529 1.932 . . . . 1.99 106.293 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.35 130.77 23.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.239 -0.652 . . . . 3.71 109.239 166.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -57.52 -35.12 98.89 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.681 2.254 . . . . 1.83 110.938 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.2 -6.56 24.12 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.5 0.926 . . . . 4.4 113.5 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 pt -120.97 -31.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.421 0 CA-C-N 119.703 1.138 . . . . 3.08 113.047 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 tt -152.04 144.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 119.783 1.174 . . . . 2.44 108.781 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.67 159.78 51.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.788 -1.325 . . . . 0.75 109.788 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.8 -48.29 1.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.958 1.772 . . . . 0.72 109.274 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 tpt85 -55.7 -34.8 65.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.821 0.849 . . . . 7.84 111.744 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -61.04 2.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.696 2.399 . . . . 3.45 108.807 174.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.05 -43.68 81.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.493 0.717 . . . . 0.94 110.139 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.28 -43.23 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.749 -0.643 . . . . 1.99 110.749 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -54.51 -45.26 73.26 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.248 0.931 . . . . 2.69 110.409 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.5 m -55.31 -53.39 56.68 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.531 0.605 . . . . 0.9 110.559 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.17 -53.93 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.461 0.704 . . . . 1.72 111.335 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -54.11 -57.48 10.93 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.458 1.103 . . . . 3.19 109.807 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.5 t -52.66 -49.75 64.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.545 1.538 . . . . 1.15 111.071 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -61.18 -54.56 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.099 0.409 . . . . 3.13 110.96 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.87 -42.44 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.782 -1.199 . . . . 1.59 115.42 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.68 141.47 47.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.031 -0.668 . . . . 1.97 111.517 -133.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -78.24 123.43 26.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.225 -1.398 . . . . 3.44 107.225 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.18 159.0 15.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 1.37 110.757 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 m -151.35 114.51 4.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.272 1.029 . . . . 1.97 108.348 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.73 127.13 29.85 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.654 -0.869 . . . . 2.84 108.654 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.74 131.82 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.398 0.679 . . . . 1.99 110.949 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -72.47 81.99 1.07 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.859 0.464 . . . . 5.52 109.759 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -27.94 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.849 -0.614 . . . . 5.2 110.323 163.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.972 2.109 . . . . 8.27 111.704 177.914 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 106.078 -1.823 . . . . 14.9 106.078 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.11 -66.66 1.83 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.923 -2.071 . . . . 5.65 107.923 -156.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 7.9 p-10 -70.71 171.37 10.57 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.809 -0.441 . . . . 5.25 109.809 162.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.0 111.93 4.25 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.642 -1.383 . . . . 1.66 109.642 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.62 145.41 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 118.524 1.162 . . . . 2.43 108.864 169.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.43 91.09 2.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.903 -1.517 . . . . 2.51 106.903 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.32 105.65 17.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.109 -0.7 . . . . 2.95 109.109 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 62' ' ' ILE . 4.1 pp -110.29 147.88 33.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.806 0.692 . . . . 2.11 109.48 173.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.45 133.44 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.832 -1.914 . . . . 1.7 105.832 161.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.35 137.1 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 125.123 1.369 . . . . 2.34 107.808 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -140.04 153.28 46.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.776 0.831 . . . . 7.3 109.862 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.8 -43.85 1.67 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.829 -1.308 . . . . 1.69 109.829 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -48.43 114.35 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.318 1.447 . . . . 2.14 114.103 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 p -97.48 115.93 28.73 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.133 1.373 . . . . 3.91 110.397 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.7 m 69.73 176.88 0.27 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.157 0.979 . . . . 3.29 113.31 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.18 -37.96 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.543 2.337 . . . . 1.19 112.523 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 p -64.51 -56.96 10.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.802 0.667 . . . . 0.88 112.802 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 119.966 -1.709 . . . . 1.13 108.542 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.93 -66.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.623 0.769 . . . . 0.82 110.776 172.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.258 0.0 OUTLIER -68.89 -26.04 64.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 121.795 -0.565 . . . . 1.1 111.285 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -59.77 -53.76 54.24 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 3.69 109.116 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.29 -60.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.727 -0.842 . . . . 0.6 108.727 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -55.18 -52.95 61.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.012 0.195 . . . . 3.16 110.743 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 t -57.73 -43.05 85.04 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.438 0.695 . . . . 1.01 111.603 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -62.22 -48.26 80.78 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.278 0.561 . . . . 0.81 109.919 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.61 ' O ' HG21 ' A' ' 32' ' ' ILE . 8.3 mp -70.06 -37.84 75.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.779 -0.629 . . . . 2.39 111.047 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.9 m -71.09 61.73 0.29 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 120.643 1.565 . . . . 2.36 111.334 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -148.98 -69.98 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.556 1.942 . . . . 4.02 109.252 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.547 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -63.51 111.98 2.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 2.3 111.653 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -77.99 47.08 0.62 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.817 1.784 . . . . 5.59 115.817 -152.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.84 2.87 5.26 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.992 0.815 . . . . 0.91 113.058 164.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.61 HG21 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -94.0 115.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.101 1.761 . . . . 2.81 107.049 178.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.9 mt -85.7 -43.69 13.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.827 0.851 . . . . 1.52 110.555 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -145.32 146.91 31.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.839 -0.43 . . . . 2.31 109.839 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.8 p -134.68 134.81 41.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.435 1.494 . . . . 3.21 107.397 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -151.06 104.66 3.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.966 -1.494 . . . . 1.67 106.966 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.33 3.4 p -92.89 88.7 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.445 1.593 . . . . 1.79 110.562 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.28 80.41 4.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.514 -1.221 . . . . 1.14 108.459 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.1 tt -42.38 -38.93 2.01 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.68 1.992 . . . . 1.7 111.226 166.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.17 -35.01 47.62 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.666 0.786 . . . . 0.92 112.065 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 p -108.64 8.52 27.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.466 1.506 . . . . 2.2 111.015 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.6 45.44 5.73 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.595 1.558 . . . . 2.09 110.392 -171.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -133.24 137.92 46.29 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.045 0.538 . . . . 1.12 110.239 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -98.34 107.85 20.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.469 -1.308 . . . . 0.56 107.469 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -84.03 97.4 9.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.966 -2.235 . . . . 0.8 104.966 162.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.416 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -93.84 154.38 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.512 -1.662 . . . . 1.76 106.512 162.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 5.2 mtmp? -128.55 145.01 51.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.57 -1.27 . . . . 2.98 107.57 159.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -160.18 172.43 17.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.492 0.717 . . . . 2.03 111.448 -165.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -105.93 100.17 26.57 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.155 1.382 . . . . 3.91 109.935 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -72.76 67.56 3.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.989 3.126 . . . . 2.35 112.298 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -166.34 -47.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.813 1.245 . . . . 3.75 110.343 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.17 -17.28 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 123.74 0.816 . . . . 2.52 110.462 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 tt -148.56 154.72 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.472 -2.048 . . . . 2.35 105.472 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.8 167.8 25.84 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.51 -1.436 . . . . 0.9 109.51 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.09 -39.83 76.1 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.664 1.576 . . . . 0.76 109.064 165.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -44.65 -52.36 8.28 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.261 1.424 . . . . 7.23 112.178 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -52.36 64.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.543 1.065 . . . . 2.82 110.321 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.83 -56.14 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.068 -0.715 . . . . 1.22 109.068 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.87 -56.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 122.805 0.442 . . . . 1.57 109.851 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -52.73 -49.53 65.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.165 1.386 . . . . 4.97 110.078 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.1 m -58.69 -45.77 88.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.112 -0.329 . . . . 0.75 110.112 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 8' ' ' LEU . 51.7 mt -56.6 -65.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.777 -0.453 . . . . 0.97 109.777 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.28 -46.87 72.82 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.419 -0.513 . . . . 2.92 110.393 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -60.61 -20.3 60.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.134 -1.412 . . . . 0.87 113.688 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.64 -73.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.162 1.801 . . . . 1.8 109.655 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.56 29.21 0.39 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.723 -1.043 . . . . 1.12 113.23 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.31 172.42 8.66 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 118.763 1.281 . . . . 1.95 113.362 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -103.88 146.39 28.72 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.203 -2.147 . . . . 4.25 105.203 158.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.6 137.94 20.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.833 0.853 . . . . 1.32 111.162 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 m -157.07 111.73 2.75 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.084 -1.01 . . . . 1.97 112.593 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -39.22 128.48 1.75 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.407 1.483 . . . . 3.67 110.583 165.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m -127.72 142.76 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.589 1.156 . . . . 1.98 109.1 169.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -74.86 85.46 2.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.582 -1.266 . . . . 5.71 107.582 158.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.33 151.42 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.422 -1.325 . . . . 6.2 107.422 155.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 C--O 1.255 1.377 0 N-CA-C 105.25 -2.13 . . . . 8.87 105.25 173.052 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 106.752 -1.573 . . . . 8.85 106.752 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.31 -135.23 48.0 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 105.412 -3.075 . . . . 6.23 105.412 -130.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.56 -110.12 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.379 1.09 . . . . 9.54 108.812 161.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.15 -12.32 31.98 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.876 -0.89 . . . . 2.52 110.876 -162.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.41 141.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 126.702 2.001 . . . . 1.84 106.385 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.0 tp -153.87 113.86 3.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.407 1.483 . . . . 2.23 107.037 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.87 121.23 37.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 2.07 108.209 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 145.45 50.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.343 0.52 . . . . 2.52 111.875 170.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.89 136.73 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.062 -1.459 . . . . 1.84 107.062 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.72 95.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 127.019 2.128 . . . . 1.96 106.006 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -79.57 126.11 30.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.51 -0.876 . . . . 5.12 108.848 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.46 8.99 4.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.202 1.382 . . . . 1.58 113.555 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.464 ' CE ' HG22 ' A' ' 37' ' ' VAL . 36.0 mtp -78.6 117.21 19.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.437 1.118 . . . . 1.79 108.268 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -143.73 16.39 1.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.146 0.795 . . . . 2.32 113.146 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -169.26 141.32 2.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.23 0.923 . . . . 2.55 109.453 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.03 -39.67 0.91 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.485 1.914 . . . . 1.22 113.63 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -59.52 -75.56 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.816 0.846 . . . . 1.23 111.847 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -46.97 -36.78 8.12 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 125.636 1.575 . . . . 1.85 111.521 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.21 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.872 0.869 . . . . 1.16 109.123 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.256 0.0 OUTLIER -64.73 -15.96 62.25 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.656 -0.653 . . . . 1.64 112.742 -166.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -57.44 -40.43 78.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.42 1.088 . . . . 3.13 108.698 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.43 -63.78 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.292 -1.003 . . . . 0.56 108.292 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -58.35 6.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.495 0.318 . . . . 3.06 110.648 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 t -50.97 -47.32 61.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.127 0.971 . . . . 1.05 111.201 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -62.23 -57.44 11.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.823 -0.548 . . . . 0.83 109.654 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.43 -39.69 70.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.406 0.682 . . . . 2.29 111.497 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -48.46 -35.81 13.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.345 -0.847 . . . . 1.74 112.136 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 1.29 2.03 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.115 -0.991 . . . . 6.57 113.316 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.632 ' CB ' HD11 ' A' ' 53' ' ' ILE . 10.7 m170 -83.71 -19.85 34.5 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.134 -1.604 . . . . 2.4 110.738 171.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 65.92 -3.02 0.81 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.723 1.609 . . . . 6.93 115.236 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.79 15.79 51.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.28 0.945 . . . . 0.85 111.833 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -113.19 142.02 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.955 -1.498 . . . . 2.19 106.955 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.73 -40.57 9.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.581 0.752 . . . . 2.49 109.466 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -155.14 156.3 35.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.369 0.531 . . . . 2.4 110.691 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 m -137.29 116.58 12.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.54 -2.022 . . . . 2.6 105.54 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.62 99.6 7.65 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.253 -1.388 . . . . 1.41 107.253 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG22 ' CE ' ' A' ' 13' ' ' MET 0.285 0.6 OUTLIER -94.38 91.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 123.107 1.432 . . . . 1.41 110.484 -173.015 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.15 91.79 7.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.678 1.591 . . . . 0.95 111.23 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -44.55 -42.27 7.13 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.4 1.88 . . . . 1.71 112.521 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.28 -35.16 59.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.585 0.754 . . . . 1.46 111.463 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -107.5 3.67 25.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.397 1.479 . . . . 2.23 110.955 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.35 59.13 1.21 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.487 1.915 . . . . 2.86 109.832 -166.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 140.66 37.01 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.083 0.553 . . . . 1.12 111.013 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.47 113.83 26.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.52 108.384 165.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.59 99.33 8.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.621 -1.992 . . . . 0.97 105.621 158.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.75 141.8 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.377 -1.342 . . . . 1.26 107.377 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -125.19 116.34 21.86 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.231 -1.766 . . . . 3.47 106.231 165.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.09 165.0 37.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.591 1.157 . . . . 1.89 109.401 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.23 137.74 27.62 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.844 -1.169 . . . . 4.32 107.844 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.49 -40.44 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.165 1.91 . . . . 2.46 112.262 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.09 -31.69 23.23 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.336 0.516 . . . . 3.58 111.373 -164.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -56.4 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.402 -0.592 . . . . 3.79 109.402 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.632 HD11 ' CB ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -92.73 -41.92 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.673 -0.24 . . . . 3.11 110.944 -163.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.73 115.44 0.09 OUTLIER Glycine 0 CA--C 1.534 1.253 0 N-CA-C 109.423 -1.471 . . . . 1.2 109.423 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.72 -33.19 79.26 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 CA-C-N 120.306 2.053 . . . . 0.91 112.44 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -47.55 -43.14 24.85 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.968 0.729 . . . . 6.88 112.968 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -58.67 -55.19 38.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.078 0.942 . . . . 4.1 109.903 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.1 mt -50.96 -52.92 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.822 -0.626 . . . . 0.96 110.671 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.39 -48.24 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-O 118.64 -0.695 . . . . 1.79 110.117 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -51.09 -48.69 61.61 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.619 -0.511 . . . . 2.9 109.619 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -61.37 -48.13 82.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 118.513 -1.275 . . . . 1.2 109.907 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.9 mt -54.35 -57.05 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 119.388 -0.339 . . . . 0.9 111.167 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.25 -46.1 88.43 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.503 0.592 . . . . 4.67 110.414 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -66.79 -15.97 63.95 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.718 -1.135 . . . . 0.83 112.517 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.81 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.461 1.482 . . . . 1.78 110.496 162.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.96 36.2 0.5 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.017 -0.88 . . . . 1.47 113.548 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -132.81 175.09 9.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.352 1.076 . . . . 1.83 111.265 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -129.74 121.98 27.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.001 -1.111 . . . . 3.36 108.001 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.13 163.46 13.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.454 0.701 . . . . 1.37 111.934 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -155.98 123.99 5.7 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.601 1.56 . . . . 1.56 108.53 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.87 138.27 58.4 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.815 0.734 . . . . 2.49 109.963 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.6 -34.01 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.182 0.593 . . . . 2.08 111.443 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttm 42.54 61.43 2.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.733 2.013 . . . . 6.48 113.332 172.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 pt -73.91 68.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.426 0.691 . . . . 5.56 110.291 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.409 1.884 . . . . 9.21 108.114 178.253 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 105.146 -2.168 . . . . 10.31 105.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 54.84 -150.08 19.08 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 117.28 -2.39 . . . . 6.43 107.851 -129.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 178.14 0.21 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.342 1.857 . . . . 5.41 112.345 -176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.22 77.18 0.72 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.392 -1.883 . . . . 1.94 108.392 162.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.72 138.4 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.294 -0.533 . . . . 2.05 110.008 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -142.43 88.43 2.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.256 1.822 . . . . 2.1 107.541 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -82.57 121.28 26.6 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.873 -1.528 . . . . 2.25 106.873 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -128.71 137.71 51.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.179 -0.325 . . . . 1.89 110.238 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.45 145.81 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.711 -1.218 . . . . 1.73 107.711 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.26 155.19 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.472 -1.677 . . . . 1.9 106.472 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -126.31 132.68 51.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.393 -1.336 . . . . 4.89 107.393 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.25 23.81 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.288 1.423 . . . . 1.83 112.201 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mtp -72.37 78.0 1.02 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.259 1.029 . . . . 2.14 109.189 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 t -97.26 -3.48 40.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.791 0.836 . . . . 2.26 112.813 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -163.41 144.65 9.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.591 1.087 . . . . 2.26 110.795 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.05 -37.43 0.16 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 127.88 2.472 . . . . 1.2 113.37 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -52.46 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.198 0.999 . . . . 0.87 112.339 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.8 m -43.04 -49.51 6.11 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 126.504 1.921 . . . . 1.3 110.191 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.4 t -45.82 -69.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 125.432 1.493 . . . . 1.03 110.554 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.281 0.0 OUTLIER -70.21 -17.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.428 -0.509 . . . . 1.55 111.638 -175.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -70.24 -42.32 72.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.301 -1.0 . . . . 4.64 108.301 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -51.2 -61.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.53 108.92 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -58.8 -54.32 48.45 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.809 -0.557 . . . . 2.72 112.103 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.4 t -54.4 -30.99 53.98 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.831 0.852 . . . . 1.01 111.483 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 t -71.03 -69.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.497 -0.752 . . . . 0.93 110.275 167.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -50.85 -47.31 60.36 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.26 1.424 . . . . 2.37 113.462 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.7 p -46.08 -34.19 3.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.682 0.793 . . . . 2.15 111.83 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -64.09 -21.79 66.67 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.706 1.203 . . . . 6.1 111.788 -175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.529 ' CB ' HD11 ' A' ' 53' ' ' ILE . 12.5 m170 -64.21 -29.75 70.84 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.472 0.578 . . . . 2.2 110.384 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 67.68 -1.95 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.137 1.775 . . . . 5.06 114.771 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.01 32.64 5.74 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.885 1.22 . . . . 0.87 110.785 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mt -138.37 126.65 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.099 -1.815 . . . . 2.21 106.099 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.52 -37.66 13.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 123.64 0.588 . . . . 1.86 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -144.76 148.56 34.25 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.161 -1.051 . . . . 3.13 108.161 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -157.07 68.17 0.55 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.132 -1.062 . . . . 2.01 108.132 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 m -84.9 108.69 17.67 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.053 -0.351 . . . . 1.67 110.053 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.21 112.87 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.983 -0.747 . . . . 2.33 108.983 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.41 98.5 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.657 0.783 . . . . 0.96 110.429 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -38.75 -47.48 1.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.126 1.77 . . . . 1.92 112.148 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.12 66.55 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.493 1.117 . . . . 0.98 111.79 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -117.09 10.63 13.96 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.723 1.209 . . . . 1.68 109.943 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.32 59.59 0.27 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.438 2.295 . . . . 2.57 112.305 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.12 152.78 37.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.559 0.744 . . . . 1.09 109.76 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.52 118.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.994 1.318 . . . . 0.56 108.101 164.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -81.1 96.52 7.2 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 105.251 -2.129 . . . . 0.76 105.251 163.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.83 141.21 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.837 -1.542 . . . . 0.96 106.837 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -122.87 121.83 37.15 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.53 -2.396 . . . . 2.54 104.53 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -137.78 169.27 18.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.776 0.716 . . . . 2.31 112.293 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -108.01 99.88 33.21 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.651 0.78 . . . . 4.66 109.237 -171.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.67 48.16 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.114 2.542 . . . . 2.45 112.835 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -137.12 17.96 2.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.048 1.339 . . . . 5.04 110.323 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.11 -56.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 124.422 1.089 . . . . 4.66 108.576 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.529 HD11 ' CB ' ' A' ' 29' ' ' HIS . 1.6 mt -95.67 142.65 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.154 -1.425 . . . . 2.18 107.154 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.0 151.24 20.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.657 -1.377 . . . . 1.07 109.657 160.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.79 -38.58 29.79 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.957 1.771 . . . . 0.7 110.605 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -50.02 -44.52 51.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.433 0.693 . . . . 7.39 111.303 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -53.47 37.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.5 1.12 . . . . 3.34 108.881 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.67 -54.49 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.993 -0.549 . . . . 0.74 109.784 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.91 -52.69 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.449 -0.575 . . . . 1.33 109.449 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -56.21 -47.2 78.86 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.76 0.824 . . . . 4.78 110.263 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.3 m -58.37 -46.08 87.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.235 0.471 . . . . 0.86 110.437 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 54.6 mt -54.3 -64.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.131 -0.692 . . . . 0.74 109.131 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -55.0 -47.82 74.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.948 0.404 . . . . 4.25 110.197 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -58.47 -20.3 44.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.116 -1.421 . . . . 0.98 113.825 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.25 -76.4 0.09 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-N 121.189 1.813 . . . . 1.66 109.439 167.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.72 35.56 0.46 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.522 -1.154 . . . . 1.38 113.281 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -129.81 175.15 9.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 1.365 . . . . 1.86 112.749 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.33 145.62 44.97 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 104.483 -2.414 . . . . 3.29 104.483 161.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.49 162.62 35.03 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.786 1.176 . . . . 1.11 112.503 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 t -155.84 112.86 3.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.623 0.769 . . . . 1.9 108.949 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.82 126.22 26.91 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.411 0.551 . . . . 2.63 109.962 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.94 118.65 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.052 -0.721 . . . . 2.18 109.052 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -76.06 70.75 2.77 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.558 0.743 . . . . 5.54 109.179 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.35 -44.03 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.969 0.908 . . . . 4.92 113.167 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.196 0 C-N-CA 123.583 0.753 . . . . 7.99 110.286 -162.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.087 -0.338 . . . . 13.83 110.087 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.92 160.49 52.8 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.113 -1.195 . . . . 6.01 110.113 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.57 177.27 4.79 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.162 -1.051 . . . . 4.78 108.162 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.03 78.71 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 106.318 -2.713 . . . . 2.16 106.318 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.93 80.44 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.632 -1.247 . . . . 2.21 107.632 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.1 78.58 4.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.772 -1.566 . . . . 2.4 106.772 172.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.28 121.73 24.8 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.385 -2.08 . . . . 2.42 105.385 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -131.57 145.46 51.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.248 -0.649 . . . . 2.1 109.248 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.23 136.88 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.154 -1.795 . . . . 1.99 106.154 165.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.17 157.09 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 107.148 -1.427 . . . . 2.29 107.148 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -146.37 149.42 33.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.409 -0.589 . . . . 5.89 109.409 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.85 -13.89 31.96 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.144 1.354 . . . . 1.65 111.547 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.8 mtm -66.9 113.79 5.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.496 1.148 . . . . 1.51 110.064 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -82.1 -50.96 8.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.531 1.133 . . . . 3.69 110.471 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -169.67 172.28 6.95 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.395 1.078 . . . . 2.33 110.076 -160.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.85 -47.67 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.089 2.956 . . . . 1.18 114.906 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p -67.89 -47.61 68.38 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.861 -0.525 . . . . 1.23 112.108 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.8 m -70.65 -35.35 72.84 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.347 -0.983 . . . . 1.58 108.347 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.34 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 124.633 1.173 . . . . 1.08 109.729 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.275 0.3 OUTLIER -71.02 -16.64 62.63 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.671 0.989 . . . . 1.16 113.671 -165.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -45.34 -47.54 13.31 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 108.858 -0.793 . . . . 3.99 108.858 165.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.38 -65.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.085 -0.709 . . . . 0.5 109.085 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -55.18 -48.14 74.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 123.133 0.27 . . . . 4.38 111.056 -166.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.7 t -54.32 -60.27 3.57 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.486 -0.931 . . . . 1.07 108.486 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 t -51.91 -42.59 62.89 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.904 0.481 . . . . 0.88 111.698 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 mt -71.9 -53.82 11.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.635 -0.826 . . . . 1.65 111.94 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.0 m -49.23 -33.36 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.729 -1.232 . . . . 1.77 111.902 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -51.93 -32.79 34.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.222 1.193 . . . . 6.11 114.222 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -55.0 -29.75 57.93 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.756 0.707 . . . . 2.37 111.013 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 73.01 -1.04 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.054 1.742 . . . . 5.35 112.001 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 52' ' ' ILE . . . -88.02 -42.43 5.97 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 110.604 -0.998 . . . . 1.95 110.604 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 53' ' ' ILE . 2.1 mp -74.52 125.9 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.102 -1.444 . . . . 3.04 107.102 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.88 -38.71 32.07 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.771 0.828 . . . . 2.75 109.96 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.74 154.88 37.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.376 -0.601 . . . . 2.08 109.376 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 t -155.19 63.64 0.63 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.241 0.543 . . . . 1.83 112.144 -164.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 99.75 7.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.96 0.504 . . . . 1.3 109.845 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.295 0.8 OUTLIER -89.04 93.68 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 122.477 1.132 . . . . 1.55 110.269 172.697 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.8 96.55 9.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.365 1.466 . . . . 0.79 109.9 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.0 tp -51.08 -39.25 55.64 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.164 1.786 . . . . 2.33 112.555 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.82 73.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.257 0.551 . . . . 1.13 110.674 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -81.05 -22.81 39.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.482 1.113 . . . . 2.26 111.231 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.53 55.8 4.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.773 1.629 . . . . 2.97 107.991 -168.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.57 144.33 46.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.896 -1.047 . . . . 1.0 108.611 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.588 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -104.63 113.74 27.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.588 1.155 . . . . 0.47 108.778 171.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -87.98 91.41 8.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.947 -1.872 . . . . 0.78 105.947 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.588 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.51 125.69 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.731 -1.211 . . . . 1.45 107.731 170.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -96.76 110.45 22.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.85 -1.537 . . . . 3.61 106.85 162.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -125.64 158.36 34.93 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.919 0.888 . . . . 2.14 108.812 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -97.97 113.21 63.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.841 1.256 . . . . 4.11 108.43 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.44 70.0 4.94 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.999 3.133 . . . . 2.89 110.915 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -163.13 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.333 1.453 . . . . 3.78 109.56 -173.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.519 HD11 ' HA3' ' A' ' 31' ' ' GLY . 1.8 pp -92.94 -33.88 5.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 122.749 0.419 . . . . 2.9 111.332 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.439 HD13 HD11 ' A' ' 32' ' ' ILE . 5.9 tt -132.66 149.14 31.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.556 -0.905 . . . . 2.46 108.556 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.69 160.02 23.27 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.427 -1.069 . . . . 0.67 110.427 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -41.39 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.43 2.087 . . . . 0.82 110.483 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -57.18 -35.44 69.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 119.299 -0.382 . . . . 8.01 111.236 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -56.58 20.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.0 2.52 . . . . 3.87 109.143 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.98 -50.38 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.931 -0.766 . . . . 0.86 108.931 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.05 -47.24 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 118.772 -0.632 . . . . 1.37 110.538 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -52.77 -48.58 66.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.366 1.067 . . . . 3.08 109.191 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.4 m -60.25 -49.95 75.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.158 -0.682 . . . . 0.88 109.158 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.91 -62.44 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.527 0.731 . . . . 0.81 110.865 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.08 -49.22 72.23 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.315 -0.624 . . . . 2.89 109.315 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.1 t -51.14 -44.7 61.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.045 0.938 . . . . 0.99 112.546 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.78 -52.41 65.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.904 1.229 . . . . 1.85 113.302 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.61 10.53 0.12 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.281 -1.288 . . . . 1.46 116.056 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -139.04 176.14 8.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.346 1.573 . . . . 1.84 112.89 -148.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 151.87 37.57 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.534 -2.025 . . . . 3.18 105.534 154.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 157.04 43.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.967 0.507 . . . . 0.97 111.545 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -147.54 115.55 6.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.587 1.555 . . . . 2.01 108.69 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.31 134.39 50.26 Favored 'General case' 0 N--CA 1.458 -0.034 0 C-N-CA 122.637 0.375 . . . . 2.65 111.801 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.82 -42.56 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.847 0.859 . . . . 2.33 110.08 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.69 64.09 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.215 -1.402 . . . . 4.56 107.215 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.5 mp 64.48 -74.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.549 1.54 . . . . 5.26 108.087 -164.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 131.685 3.994 . . . . 10.42 105.503 169.176 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 105.803 -1.925 . . . . 8.95 105.803 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.51 115.88 0.96 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.334 -1.506 . . . . 5.23 109.334 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.42 92.11 0.13 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.427 1.091 . . . . 8.71 110.451 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.95 58.6 3.53 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.392 -1.083 . . . . 2.05 110.392 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.25 143.46 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.689 1.196 . . . . 2.07 109.179 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 74' ' ' ILE . 3.0 tt -147.76 115.42 6.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.62 1.568 . . . . 3.05 107.204 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.74 124.41 49.52 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.144 -0.688 . . . . 2.26 109.144 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.8 mt -102.82 142.41 34.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.355 -1.72 . . . . 2.42 106.355 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -75.71 138.99 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.387 -2.079 . . . . 2.14 105.387 148.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 131.39 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.597 1.559 . . . . 1.97 108.015 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -126.3 144.56 50.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.776 1.231 . . . . 5.0 108.263 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.09 -31.77 6.32 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.849 1.214 . . . . 1.67 110.186 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtm -58.75 141.96 51.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.518 -0.549 . . . . 1.46 109.518 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -152.62 10.99 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.8 0.667 . . . . 2.36 112.8 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -171.18 152.1 3.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 2.29 109.17 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.31 -43.11 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.301 1.84 . . . . 1.15 112.276 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 p -44.3 -66.9 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.479 1.512 . . . . 0.79 113.096 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.8 m -47.51 -48.38 27.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.628 1.171 . . . . 1.07 109.488 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.35 -67.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.158 -0.928 . . . . 0.81 111.101 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -27.13 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.233 -0.917 . . . . 1.2 111.632 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -53.39 -49.1 67.94 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.234 0.614 . . . . 3.24 109.838 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -54.47 -65.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.088 -0.708 . . . . 0.64 109.088 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.1 -61.6 1.81 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.404 1.082 . . . . 2.76 110.916 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -48.95 -45.99 42.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.057 1.343 . . . . 1.06 110.574 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 t -62.25 -65.91 0.62 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.817 -0.611 . . . . 0.89 110.701 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.54 -35.09 76.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.503 1.047 . . . . 1.78 111.806 -163.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.4 m -46.65 -31.6 2.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.842 -0.536 . . . . 2.08 112.119 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -34.14 23.26 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.353 0.871 . . . . 4.19 113.353 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -61.07 -41.4 96.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.038 0.381 . . . . 2.54 110.329 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.84 -2.23 2.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.657 2.383 . . . . 5.71 113.329 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.28 -31.96 36.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.598 -1.001 . . . . 0.92 110.598 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.11 106.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.204 -2.147 . . . . 3.01 105.204 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.7 mt -79.94 -33.3 39.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.995 0.518 . . . . 2.12 109.92 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -147.35 156.47 42.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.539 -0.541 . . . . 2.46 109.539 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.86 134.74 17.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.866 -1.531 . . . . 1.86 106.866 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -144.21 116.16 8.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.389 -1.338 . . . . 2.18 107.389 164.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.15 111.4 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.573 0.701 . . . . 1.71 110.376 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.44 104.35 12.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.982 0.913 . . . . 1.29 109.659 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -44.88 -37.09 3.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.609 1.163 . . . . 2.72 111.346 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.08 -30.75 16.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.796 0.838 . . . . 1.11 112.056 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -127.92 17.4 6.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.385 1.074 . . . . 1.6 109.77 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 31.51 47.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.778 2.031 . . . . 2.13 112.672 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.76 143.6 47.22 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.854 0.462 . . . . 1.29 111.346 -170.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.28 98.49 8.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.575 1.95 . . . . 0.68 107.786 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -79.15 104.06 9.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.376 -2.083 . . . . 0.97 105.376 167.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.28 136.63 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.307 -1.738 . . . . 1.12 106.307 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -107.46 114.47 28.5 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.719 -1.586 . . . . 3.33 106.719 160.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -129.2 175.69 8.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.13 -2.544 . . . . 1.98 104.13 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.39 132.28 24.17 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 107.746 -1.205 . . . . 3.69 107.746 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.98 59.87 5.28 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 125.058 3.839 . . . . 2.79 110.883 -173.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -155.64 -54.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 128.428 2.691 . . . . 3.38 107.264 -168.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -88.45 -25.4 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.349 1.059 . . . . 2.98 110.407 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.55 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.425 -0.954 . . . . 2.86 108.425 170.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.35 164.76 30.91 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 111.001 -0.839 . . . . 0.86 111.001 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.67 -45.19 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.916 2.41 . . . . 1.05 110.866 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.2 -42.63 69.95 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 122.995 0.518 . . . . 8.28 110.587 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -56.28 9.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.732 1.613 . . . . 3.98 109.37 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mt -59.19 -49.71 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.999 0.519 . . . . 0.99 109.602 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -53.78 -52.63 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.793 -0.447 . . . . 1.44 109.793 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -50.92 -51.29 53.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.973 0.509 . . . . 3.58 109.816 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -57.64 -53.37 58.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.226 -0.59 . . . . 0.94 110.262 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.0 mt -53.73 -59.92 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 124.196 0.999 . . . . 0.93 110.466 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.53 -50.46 73.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.224 -0.658 . . . . 4.56 109.224 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -48.69 -46.13 40.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 1.05 112.016 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.66 -56.54 19.15 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.255 0.934 . . . . 1.87 113.425 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 10.98 0.12 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.953 -1.471 . . . . 1.39 116.655 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.46 176.02 9.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.851 1.825 . . . . 1.89 112.655 -153.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -120.12 158.48 26.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.756 -1.572 . . . . 3.69 106.756 156.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.01 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.04 0.936 . . . . 1.81 112.482 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -157.56 111.45 2.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.072 1.349 . . . . 2.79 109.781 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 84.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.614 1.097 . . . . 2.43 108.809 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m -61.4 -20.62 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.439 1.096 . . . . 3.21 113.53 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.45 -118.41 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.857 -1.164 . . . . 5.78 107.857 164.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 6' ' ' LEU 0.279 21.1 pt 40.45 27.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.012 1.725 . . . . 8.21 114.638 -167.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.252 1.224 1 N-CA-C 99.689 -4.189 . . . . 11.86 99.689 156.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 109.135 -0.691 . . . . 9.76 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.12 -82.46 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 105.036 -3.226 . . . . 3.93 105.036 -171.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 75.85 -50.86 0.62 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.2 1.8 . . . . 5.62 114.254 149.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.84 49.86 67.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.332 0.968 . . . . 1.97 111.473 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.97 91.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.345 -0.983 . . . . 3.07 108.345 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -108.34 111.46 23.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 2.98 107.838 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 25.2 mt-10 -83.41 135.21 34.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.952 -1.129 . . . . 2.77 107.952 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.33 130.25 54.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.396 -1.335 . . . . 2.79 107.396 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.83 129.51 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 107.807 -1.183 . . . . 3.17 107.807 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.37 151.55 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 125.083 1.353 . . . . 1.81 109.189 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -129.5 144.23 51.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.437 -0.949 . . . . 6.02 108.437 163.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.58 3.11 35.02 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.5 1.524 . . . . 1.93 112.333 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 82.6 mtp -66.94 158.0 31.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.647 -0.914 . . . . 1.98 110.886 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 t -164.67 128.46 2.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.415 1.086 . . . . 3.32 108.556 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.3 m 62.41 177.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.54 1.536 . . . . 2.29 112.949 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.29 -27.67 56.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.869 -1.059 . . . . 1.26 111.461 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -56.61 -70.39 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.285 1.434 . . . . 0.78 113.648 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.5 m -49.46 -42.19 42.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.457 -0.777 . . . . 1.22 109.707 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 t -51.53 -71.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.407 0.683 . . . . 0.89 111.625 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 -29.29 69.1 Favored 'General case' 0 C--N 1.34 0.163 0 O-C-N 121.513 -0.742 . . . . 1.27 111.007 -173.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -55.03 -56.42 20.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.35 -0.611 . . . . 4.12 109.35 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.52 -54.2 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.631 -0.507 . . . . 0.84 109.631 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.5 -54.81 19.41 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.888 0.375 . . . . 3.11 110.99 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -52.92 -56.74 13.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.121 0.968 . . . . 1.17 110.381 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -50.25 -56.35 11.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.735 1.214 . . . . 1.92 109.919 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.87 -45.62 64.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.41 -0.516 . . . . 2.61 111.599 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.4 m -52.12 -36.16 50.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.097 0.862 . . . . 1.65 111.02 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.87 -26.13 23.23 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.12 1.156 . . . . 4.57 114.12 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.25 -29.26 70.62 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.219 1.372 . . . . 2.23 111.093 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 72.04 -3.59 2.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 6.25 113.03 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.59 -30.77 38.92 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.321 -1.112 . . . . 0.88 110.321 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.75 116.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.222 -1.399 . . . . 2.83 107.222 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -79.01 -33.9 44.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.157 0.583 . . . . 1.37 109.452 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.08 146.54 24.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.226 -0.657 . . . . 1.9 109.226 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.5 t -139.82 130.89 26.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.294 -1.743 . . . . 1.86 106.294 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -145.36 116.81 8.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.586 -0.894 . . . . 1.86 108.586 167.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.54 85.41 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.935 -1.135 . . . . 1.97 107.935 -166.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 93.46 8.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.66 -0.867 . . . . 0.92 108.66 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.1 tt -44.69 -39.83 5.43 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.715 1.206 . . . . 1.81 111.826 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.93 -30.08 22.92 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.857 0.863 . . . . 1.12 112.438 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -123.35 14.8 9.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.275 1.43 . . . . 1.53 110.175 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 m120 30.56 53.32 0.15 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 127.376 2.271 . . . . 2.31 112.829 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -133.83 140.25 46.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.221 0.608 . . . . 1.38 109.437 -173.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.34 101.48 10.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.169 1.788 . . . . 0.55 107.032 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -77.82 107.08 10.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.287 -1.746 . . . . 0.98 106.287 170.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -112.7 118.95 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.021 -1.474 . . . . 0.96 107.021 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -96.12 119.15 34.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.9 -1.519 . . . . 3.09 106.9 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -158.57 127.42 5.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.449 0.3 . . . . 2.72 110.744 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.11 128.11 91.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.382 -0.97 . . . . 3.38 108.382 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.88 -50.5 5.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.251 1.967 . . . . 2.44 111.71 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.15 -21.9 36.23 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.721 1.378 . . . . 3.23 114.721 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.35 -1.89 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.041 0.837 . . . . 2.33 112.104 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.82 -47.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.322 0.965 . . . . 2.95 113.594 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 148.64 8.46 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.446 1.022 . . . . 0.67 112.1 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.05 -47.52 17.47 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.251 2.634 . . . . 0.94 111.402 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.433 HH21 ' N ' ' A' ' 60' ' ' HIS . 7.8 tpm_? -47.81 -43.87 28.19 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.148 0.979 . . . . 7.62 111.843 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.89 -53.88 51.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.868 0.867 . . . . 3.92 110.987 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.26 -52.86 53.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.43 -0.581 . . . . 0.67 109.43 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -57.48 -47.38 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.033 -0.728 . . . . 1.57 109.033 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.433 ' N ' HH21 ' A' ' 56' ' ' ARG . 52.4 t-80 -59.09 -41.91 89.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.693 0.797 . . . . 4.69 110.126 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.9 m -63.0 -45.76 90.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.102 -0.333 . . . . 0.93 110.102 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.31 -49.94 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.327 0.651 . . . . 0.78 110.824 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -49.95 -59.19 4.11 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.108 0.963 . . . . 2.99 109.749 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -52.92 -48.55 67.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.753 1.621 . . . . 0.92 111.189 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.21 -55.42 35.2 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.939 -0.476 . . . . 1.63 110.976 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.84 -40.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.663 1.025 . . . . 1.67 115.663 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -122.95 132.53 54.2 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.326 0.563 . . . . 1.97 110.874 -133.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.44 133.12 37.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.02 -1.845 . . . . 4.24 106.02 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.74 145.33 30.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.058 -0.401 . . . . 1.49 110.372 -172.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -135.89 110.7 8.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.424 1.09 . . . . 2.5 109.576 -170.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.95 116.56 1.11 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.215 0.606 . . . . 2.12 109.918 164.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 m -66.92 152.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.796 -1.187 . . . . 2.66 107.796 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -102.26 84.91 2.55 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 108.394 -0.965 . . . . 8.51 108.394 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.3 pt -75.78 -46.78 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.923 -0.769 . . . . 5.49 108.923 162.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 116.422 -1.751 . . . . 9.43 111.057 -177.571 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 106.99 -1.485 . . . . 8.07 106.99 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.98 -166.6 6.25 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 107.51 -2.236 . . . . 4.05 107.51 -140.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.14 98.51 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.593 1.157 . . . . 5.53 113.347 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.82 160.19 34.29 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 109.2 -1.56 . . . . 1.64 109.2 156.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.12 146.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 121.657 -0.908 . . . . 2.19 109.95 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.05 116.45 22.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.471 2.308 . . . . 2.73 105.497 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.11 107.26 12.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.385 -0.969 . . . . 2.53 108.385 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -119.62 143.79 47.48 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 125.128 1.518 . . . . 2.19 109.423 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.31 136.72 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.891 -1.892 . . . . 2.29 105.891 162.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.38 122.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.015 1.726 . . . . 2.26 106.905 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -104.35 150.53 24.41 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.082 0.953 . . . . 5.48 110.912 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 -49.58 4.14 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 107.978 -2.049 . . . . 1.83 107.978 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -27.53 112.44 0.06 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.844 2.458 . . . . 2.01 112.312 163.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -157.56 160.52 38.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.443 0.697 . . . . 3.1 109.572 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.3 m 63.68 155.84 0.06 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.356 1.862 . . . . 2.59 113.106 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.98 -36.24 2.39 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.64 1.576 . . . . 1.3 111.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.53 -48.26 79.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.712 2.005 . . . . 1.07 114.127 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.2 -43.76 64.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.339 -1.356 . . . . 1.29 107.339 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.59 -64.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.465 1.106 . . . . 1.27 111.785 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.97 -31.05 68.56 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.869 -0.519 . . . . 1.64 111.446 -174.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.8 -55.92 26.72 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.339 -0.985 . . . . 4.57 108.339 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.18 -61.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.454 -0.573 . . . . 0.75 109.454 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 1.7 pp20? -64.33 -44.24 92.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.905 -0.718 . . . . 4.95 111.168 -165.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -64.21 -47.35 80.08 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 t -56.88 -42.78 80.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.835 -0.602 . . . . 1.12 110.949 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.05 -64.47 0.93 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 119.373 0.988 . . . . 1.79 112.026 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.9 m -44.01 -34.48 1.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.763 1.225 . . . . 1.63 114.014 -162.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.28 -29.76 0.15 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.221 1.563 . . . . 6.12 115.221 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -55.82 -40.65 73.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.314 0.961 . . . . 2.25 111.102 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp-105 70.52 -1.67 2.46 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.717 2.007 . . . . 5.97 112.666 -167.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.09 -32.41 35.81 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 1.01 110.51 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 46' ' ' ILE . 4.2 mp -84.13 118.13 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.286 -1.746 . . . . 2.74 106.286 172.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.4 mt -81.42 -33.39 32.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.203 1.001 . . . . 1.37 110.427 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -150.55 133.97 16.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.988 -1.486 . . . . 2.39 106.988 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.0 t -133.74 62.51 1.65 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.776 0.83 . . . . 1.94 110.253 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 95.54 8.02 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.648 -0.706 . . . . 1.81 109.674 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.27 85.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.6 1.19 . . . . 2.32 107.823 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 80.22 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.05 1.34 . . . . 1.16 108.334 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -38.99 -43.8 1.01 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.67 2.388 . . . . 2.3 111.152 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.54 -33.51 45.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.645 0.778 . . . . 1.25 111.834 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 p -112.33 8.26 19.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.558 1.543 . . . . 2.5 111.513 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.26 45.92 5.14 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.274 1.43 . . . . 2.08 110.761 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -134.24 144.77 48.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.488 0.715 . . . . 1.03 110.594 -171.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.88 105.47 17.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.144 -1.428 . . . . 0.46 107.144 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -83.96 100.41 11.02 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.901 -1.889 . . . . 0.74 105.901 165.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 32' ' ' ILE . 14.5 mt -112.07 108.35 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 124.786 1.234 . . . . 1.23 107.716 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.7 115.23 19.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.033 -1.469 . . . . 2.21 107.033 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -144.52 162.58 36.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.46 -2.052 . . . . 1.87 105.46 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.99 139.42 32.49 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 107.004 -1.48 . . . . 4.51 107.004 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.56 69.06 5.26 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.351 3.368 . . . . 2.49 111.481 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -165.28 -46.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.561 1.544 . . . . 4.27 110.216 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -81.68 -25.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 3.38 109.668 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -158.33 157.11 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.4 164.49 26.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.728 -0.949 . . . . 0.75 110.728 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.86 -47.49 1.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.996 2.464 . . . . 0.82 110.802 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -61.87 -34.09 75.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.211 -0.306 . . . . 7.18 111.211 -175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -57.31 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.495 1.518 . . . . 3.69 108.586 173.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.49 -51.73 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.263 -0.88 . . . . 0.88 109.451 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.5 mt -52.39 -56.84 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.472 0.309 . . . . 1.51 110.206 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -49.39 -48.81 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.479 0.712 . . . . 3.16 109.819 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.6 m -60.12 -52.23 66.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 119.9 -0.72 . . . . 0.99 110.121 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.68 -57.43 5.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 124.036 0.934 . . . . 0.78 110.468 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.66 -52.23 66.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.441 -0.577 . . . . 4.74 109.441 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -51.19 -40.91 59.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.974 0.909 . . . . 1.24 111.895 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.63 -48.68 80.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.713 1.142 . . . . 1.8 113.367 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.28 -1.47 0.06 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 118.371 2.108 . . . . 1.03 118.371 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -138.57 176.64 8.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.788 1.794 . . . . 2.1 113.432 -145.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.58 139.1 53.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.851 -1.907 . . . . 3.35 105.851 167.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.16 161.0 22.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.202 1.001 . . . . 1.66 112.459 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.7 m -157.05 116.2 3.36 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.493 -1.241 . . . . 1.83 110.059 171.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 mt -49.99 140.8 11.7 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.782 1.174 . . . . 3.1 109.18 164.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.83 40.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.827 1.251 . . . . 3.08 110.611 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 -64.7 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.913 0.885 . . . . 6.17 109.165 -173.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 74' ' ' ILE . 3.4 mp -87.15 63.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 105.956 -1.868 . . . . 8.89 105.956 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 117.751 -1.119 . . . . 11.98 108.937 -152.623 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 108.883 -0.784 . . . . 7.78 108.883 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.99 41.25 44.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.619 0.628 . . . . 5.41 111.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.09 154.64 37.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.276 0.63 . . . . 5.63 110.657 -162.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.66 76.12 0.84 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.209 -0.756 . . . . 1.58 111.209 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.13 140.4 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.653 -1.24 . . . . 2.32 107.653 159.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 tp -137.35 91.68 2.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.428 -1.323 . . . . 2.15 107.428 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.99 116.62 26.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.677 -1.601 . . . . 2.55 106.677 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -124.91 140.7 52.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.2 -0.312 . . . . 2.96 110.518 174.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.68 139.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.829 -1.545 . . . . 1.66 106.829 167.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.82 150.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 123.898 0.879 . . . . 2.44 108.76 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -146.53 168.0 22.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 4.85 108.791 -170.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.4 -55.79 3.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.716 -1.754 . . . . 1.62 108.716 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 ptm -60.48 138.93 57.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.466 -0.431 . . . . 1.65 110.767 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -159.07 19.84 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.444 -0.343 . . . . 2.55 111.863 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.6 p -173.33 159.35 3.75 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.907 0.776 . . . . 3.54 110.219 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.72 -41.07 55.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.975 1.71 . . . . 1.16 113.149 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.2 p -63.22 -67.08 0.45 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.137 0.575 . . . . 1.07 111.342 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -43.73 -42.25 5.32 Favored 'General case' 0 N--CA 1.461 0.075 0 O-C-N 121.389 -0.819 . . . . 1.27 110.759 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.07 -73.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 123.205 0.602 . . . . 0.8 111.011 173.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -21.04 66.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.521 -0.737 . . . . 0.99 111.921 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -58.12 -47.71 82.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.001 0.92 . . . . 4.04 110.03 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.7 mt -59.9 -54.25 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.701 -0.852 . . . . 0.58 108.701 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -54.0 -59.82 4.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.641 0.588 . . . . 2.95 109.57 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.3 t -51.37 -49.15 62.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.086 1.354 . . . . 1.02 111.135 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -58.33 -51.11 71.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.85 110.386 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.01 -36.54 84.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 118.705 -1.198 . . . . 2.05 110.158 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.8 m -63.85 7.32 0.12 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.119 -0.988 . . . . 2.09 113.306 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.81 -46.72 43.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.42 -1.425 . . . . 4.45 110.296 157.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.467 0.707 . . . . 2.63 110.613 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -0.52 11.86 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.507 -0.746 . . . . 7.6 112.292 170.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.72 -15.25 61.85 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.031 0.378 . . . . 0.84 112.319 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -94.0 142.8 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.484 -1.302 . . . . 3.17 107.484 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.27 -45.75 4.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.321 1.048 . . . . 3.09 110.025 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.13 153.98 49.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.291 1.036 . . . . 2.33 108.829 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 p -156.02 59.63 0.59 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.435 0.694 . . . . 2.99 111.463 -170.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 m -87.06 104.63 16.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.509 -0.758 . . . . 1.94 111.429 -175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.303 2.7 p -92.68 92.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 122.655 1.217 . . . . 1.93 111.654 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.68 90.66 7.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.785 -1.191 . . . . 0.79 107.785 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tt -44.15 -37.35 3.07 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.55 1.14 . . . . 1.71 111.453 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.14 22.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.906 0.882 . . . . 1.02 112.247 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -120.8 15.44 11.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.012 1.325 . . . . 1.48 110.41 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.15 50.6 0.72 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.548 1.939 . . . . 2.01 111.733 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.75 143.6 35.04 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.222 0.609 . . . . 1.05 109.372 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.84 118.74 36.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.972 -1.122 . . . . 0.55 107.972 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -87.33 95.58 10.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.844 -2.28 . . . . 1.04 104.844 162.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.1 mt -93.48 140.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.848 -1.538 . . . . 1.02 106.848 169.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -118.68 136.86 53.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.94 -1.874 . . . . 3.6 105.94 161.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.62 173.7 15.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.964 1.306 . . . . 1.84 108.126 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -113.29 117.48 45.34 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.62 -1.252 . . . . 3.91 107.62 164.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.26 -40.11 83.82 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.456 1.437 . . . . 2.2 111.945 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -67.64 -12.62 60.86 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.709 0.686 . . . . 4.97 112.663 -167.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 pt -117.97 6.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 123.928 0.891 . . . . 2.41 112.946 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.37 -42.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.474 0.916 . . . . 2.69 113.474 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.49 159.29 5.55 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.201 -0.76 . . . . 0.94 111.201 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.31 -34.54 66.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.526 2.151 . . . . 0.71 110.837 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.11 -46.13 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.534 0.938 . . . . 6.82 113.534 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.45 -35.29 70.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.2 0.909 . . . . 4.11 112.182 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mt -58.19 -47.11 88.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.834 -0.802 . . . . 0.92 108.834 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.83 -48.5 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 118.147 -0.93 . . . . 1.71 109.985 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -47.07 -49.46 21.58 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.957 0.799 . . . . 3.44 109.523 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.0 m -59.21 -55.78 30.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.338 -0.545 . . . . 1.36 110.017 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -63.52 -45.5 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 122.537 0.335 . . . . 0.84 110.702 -170.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.92 -54.64 39.06 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.974 0.509 . . . . 3.12 110.315 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -64.88 -20.7 66.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.829 -1.081 . . . . 0.88 112.416 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.16 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 119.849 1.204 . . . . 1.81 109.05 160.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 18.0 0.24 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.152 -1.36 . . . . 1.14 115.111 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.15 122.9 40.26 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.95 1.875 . . . . 1.93 112.683 -157.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.76 86.84 4.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.889 -0.782 . . . . 3.41 108.889 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.11 163.11 26.92 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.13 -0.981 . . . . 1.04 110.709 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.0 m -154.68 104.53 2.54 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.738 -0.838 . . . . 1.89 108.738 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 126.42 27.3 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 122.86 0.464 . . . . 2.17 111.443 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 m -101.8 113.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.541 0.686 . . . . 1.96 110.853 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -69.97 75.98 0.48 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.573 0.749 . . . . 5.64 109.526 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.2 mt -72.95 90.71 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.665 -1.235 . . . . 5.16 107.665 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.986 2.114 . . . . 8.7 105.324 173.733 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.807 -0.072 . . . . 12.89 110.807 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.1 -75.75 0.47 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.988 0.804 . . . . 6.24 111.114 175.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 66.83 -62.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.108 2.163 . . . . 7.96 112.283 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.11 44.09 55.01 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 123.946 0.784 . . . . 2.74 111.35 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.83 117.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.58 -1.267 . . . . 3.12 107.58 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.12 135.63 14.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.909 0.861 . . . . 3.15 111.026 164.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.39 117.36 33.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.75 1.22 . . . . 2.43 109.766 -170.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.95 126.43 46.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.966 -1.494 . . . . 2.82 106.966 172.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.46 137.97 21.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.001 -2.222 . . . . 2.45 105.001 160.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.25 107.47 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.306 -1.368 . . . . 1.87 107.306 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -102.25 115.1 29.85 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.965 -1.124 . . . . 5.83 107.965 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.65 -45.18 0.99 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.978 -1.649 . . . . 1.51 108.978 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -55.69 137.2 49.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.909 0.483 . . . . 1.81 110.224 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -165.97 12.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 2.91 112.766 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -170.74 144.41 2.29 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 117.908 -1.044 . . . . 2.07 108.355 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.81 -50.49 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.621 2.369 . . . . 1.25 113.437 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -57.12 -47.7 80.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.797 1.239 . . . . 1.13 114.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.38 -49.63 32.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.388 1.075 . . . . 1.07 108.171 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -43.23 -64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.335 1.854 . . . . 0.86 110.487 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -9.54 55.09 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 120.348 -0.541 . . . . 1.36 111.554 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -47.49 59.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.48 -1.387 . . . . 4.82 107.96 -172.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.28 -57.28 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.836 -1.074 . . . . 0.76 108.345 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -70.32 0.09 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.234 0.614 . . . . 4.3 111.968 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -47.85 -47.13 31.68 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.611 0.641 . . . . 2.37 111.881 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -59.56 -65.68 0.63 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.853 -0.425 . . . . 0.9 109.853 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.04 -34.66 70.33 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.436 0.562 . . . . 1.77 111.318 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -55.3 -25.32 33.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.298 0.481 . . . . 1.58 112.298 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -18.94 64.35 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.663 1.119 . . . . 5.76 112.654 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -84.88 119.97 25.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.54 -1.282 . . . . 2.37 107.54 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -69.07 -0.82 6.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.088 -1.008 . . . . 6.55 113.704 -172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.48 -20.98 61.0 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.523 -0.736 . . . . 0.85 113.595 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.99 138.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 117.818 0.809 . . . . 3.64 110.486 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -100.62 -42.61 6.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.836 1.655 . . . . 1.55 110.196 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -148.36 149.99 32.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.445 -0.576 . . . . 2.31 109.445 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 t -141.75 74.22 1.44 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.857 0.837 . . . . 1.92 110.332 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -85.4 82.92 8.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.216 0.606 . . . . 2.32 109.957 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.07 126.34 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 112.594 0.591 . . . . 1.89 112.594 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.35 104.22 7.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.337 1.455 . . . . 0.91 108.684 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.48 -30.02 38.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.314 0.645 . . . . 2.77 111.321 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.68 50.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.923 0.889 . . . . 1.16 111.61 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -122.08 14.2 10.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 1.69 110.027 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 34.19 55.14 0.62 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.457 1.903 . . . . 1.79 111.713 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.59 143.34 25.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.088 -0.383 . . . . 1.45 110.241 -172.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 112.31 24.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.608 1.963 . . . . 0.59 108.747 165.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.55 95.6 5.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 104.627 -2.36 . . . . 1.1 104.627 160.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 mt -91.27 142.31 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 106.288 -1.745 . . . . 1.12 106.288 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -119.26 111.51 18.31 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.868 -2.271 . . . . 2.87 104.868 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -152.5 155.62 37.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.246 1.019 . . . . 3.29 108.674 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.21 100.17 7.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 123.873 0.733 . . . . 3.22 109.458 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 -42.05 71.76 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.826 2.351 . . . . 2.37 111.427 -172.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -20.34 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.871 2.468 . . . . 4.49 114.385 166.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 pt -112.56 16.1 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.074 0.95 . . . . 2.34 113.112 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 tt -160.53 -46.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.961 0.801 . . . . 2.95 112.203 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.27 157.27 8.42 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.551 1.072 . . . . 0.73 111.43 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.59 -45.32 26.37 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.622 2.214 . . . . 1.04 110.474 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.99 -55.49 6.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.75 1.22 . . . . 8.39 112.762 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -56.53 -48.36 77.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.004 0.907 . . . . 3.97 111.056 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.51 -51.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.642 -0.708 . . . . 0.65 109.317 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -49.43 -60.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 C-N-CA 123.16 0.584 . . . . 1.66 109.428 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -45.51 -49.0 14.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.538 0.735 . . . . 2.72 109.707 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.1 m -63.15 -48.52 78.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.021 -0.672 . . . . 0.86 110.741 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.6 mt -52.19 -64.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.322 0.649 . . . . 0.88 109.841 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -47.67 84.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.135 -0.626 . . . . 2.81 109.718 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -61.44 -19.56 62.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.128 -1.415 . . . . 1.05 113.583 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.08 -70.04 0.26 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 121.296 1.862 . . . . 1.77 109.654 166.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.55 24.82 0.27 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.862 -1.521 . . . . 1.34 115.877 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.71 173.79 10.01 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.089 1.944 . . . . 1.88 113.431 -164.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.74 152.61 20.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.234 -2.135 . . . . 3.61 105.234 154.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.8 162.47 41.24 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.202 0.91 . . . . 1.12 111.449 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.19 141.8 17.78 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.253 0.221 . . . . 2.46 111.571 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.81 70.32 3.26 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.368 1.067 . . . . 2.91 111.211 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.05 -161.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.976 0.91 . . . . 3.02 110.807 171.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 156.11 45.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.372 -2.084 . . . . 5.92 105.372 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.8 tt -118.45 133.79 64.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 103.28 -2.859 . . . . 5.67 103.28 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 13.1 pt-20 . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.049 1.468 . . . . 10.81 111.868 -163.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 105.452 -2.055 . . . . 12.05 105.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.58 49.82 63.38 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.03 -1.628 . . . . 5.19 109.03 -167.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.419 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 1.7 p30 -148.99 172.05 15.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.38 1.472 . . . . 4.75 107.8 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.63 160.87 13.22 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.103 -1.599 . . . . 1.61 109.103 164.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.8 152.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 125.407 1.483 . . . . 2.11 107.621 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -141.77 109.92 5.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.979 -1.489 . . . . 2.59 106.979 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -122.03 112.33 18.12 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.433 0.693 . . . . 2.52 110.745 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.44 142.38 51.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.856 1.347 . . . . 2.29 110.031 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.33 138.1 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.369 -1.715 . . . . 1.94 106.369 166.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.9 152.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.144 -1.058 . . . . 1.92 108.144 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -138.01 131.16 30.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.798 0.839 . . . . 6.31 109.031 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 9.49 85.04 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.813 -0.915 . . . . 1.84 110.813 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -102.25 126.37 49.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.149 1.779 . . . . 2.17 106.798 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 t -158.7 155.61 28.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.483 0.583 . . . . 3.13 109.884 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m 66.0 164.1 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.962 1.705 . . . . 2.71 112.763 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -43.92 49.02 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.924 -1.035 . . . . 1.24 110.891 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 p -43.33 -74.23 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.173 1.789 . . . . 0.92 114.12 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -49.92 -44.24 50.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.486 0.714 . . . . 1.18 109.528 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.35 -66.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.16 0.584 . . . . 1.2 111.952 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -68.08 -28.48 67.4 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.263 -0.898 . . . . 1.96 110.688 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -57.65 -52.86 63.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.612 0.642 . . . . 4.02 109.782 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -54.45 -61.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.783 -0.821 . . . . 0.69 108.783 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.77 -55.09 33.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.302 0.241 . . . . 2.81 111.077 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 t -54.11 -34.74 61.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.317 1.047 . . . . 1.36 111.313 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -69.37 -65.86 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.048 0.84 . . . . 1.07 109.894 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.98 -44.74 71.05 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.253 1.021 . . . . 2.32 112.091 -170.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.6 p -54.55 -25.42 25.8 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.92 -0.487 . . . . 2.31 112.097 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.85 -20.29 63.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.604 0.762 . . . . 5.19 111.698 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -64.25 -38.37 90.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.901 -0.778 . . . . 2.28 108.901 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 70.25 -2.33 2.16 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.282 2.233 . . . . 5.48 113.127 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.91 37.87 3.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.291 -1.123 . . . . 0.84 110.291 167.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.54 139.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.524 -2.028 . . . . 2.16 105.524 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.88 -40.17 9.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.006 0.523 . . . . 2.75 110.379 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -155.02 164.13 39.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.369 0.531 . . . . 2.42 111.344 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -153.56 125.09 7.62 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.753 2.421 . . . . 3.26 106.669 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -132.11 106.67 8.14 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.278 -1.749 . . . . 1.57 106.278 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -88.18 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.453 -1.314 . . . . 2.05 107.453 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.88 89.44 5.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.244 -1.021 . . . . 0.78 108.244 -171.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.32 -42.99 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.588 1.955 . . . . 1.86 111.012 165.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.07 62.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.646 1.178 . . . . 1.08 112.39 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -116.43 17.97 15.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.614 1.565 . . . . 1.55 109.246 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 19.42 59.59 0.02 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.489 2.716 . . . . 3.06 113.422 -164.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.9 144.89 39.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.034 0.534 . . . . 0.97 109.748 -174.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.2 106.85 18.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.796 -1.187 . . . . 0.42 107.796 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.37 100.72 12.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.712 -1.958 . . . . 0.83 105.712 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.72 146.09 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.791 -1.559 . . . . 1.95 106.791 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' NZ ' ' OD1' ' A' ' 3' ' ' ASP . 19.2 mmmt -122.17 133.74 54.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.239 -2.134 . . . . 2.7 105.239 165.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.15 169.16 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.615 0.366 . . . . 3.1 110.299 -160.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.21 139.46 24.2 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.052 -1.832 . . . . 4.12 106.052 159.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.35 -34.75 1.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.146 1.898 . . . . 2.57 113.138 -175.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.65 -28.46 15.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.357 0.981 . . . . 3.41 112.348 -163.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.54 -24.62 29.47 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 118.998 0.817 . . . . 2.25 110.638 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 tt -121.61 -44.18 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.517 0.562 . . . . 2.64 112.517 -169.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 120.08 0.24 Allowed Glycine 0 CA--C 1.534 1.224 0 N-CA-C 109.16 -1.576 . . . . 0.91 109.16 -168.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.7 -38.05 94.75 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 120.673 2.237 . . . . 1.56 111.138 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -23.26 63.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.157 1.169 . . . . 8.89 114.157 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.57 -51.93 67.71 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.91 1.232 . . . . 3.53 109.451 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -56.47 -49.31 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.538 -0.744 . . . . 0.8 110.071 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.6 -59.44 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.232 0.924 . . . . 1.57 110.164 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -49.14 -50.04 39.33 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.837 0.855 . . . . 3.59 109.344 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.8 m -57.51 -52.06 66.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.84 110.231 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.29 -57.25 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 119.23 -0.414 . . . . 0.88 110.574 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.83 -51.02 71.52 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.725 -0.79 . . . . 3.38 110.019 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -57.81 -35.99 71.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.226 1.01 . . . . 1.58 111.241 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mp -52.12 -68.61 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.518 0.599 . . . . 2.27 111.518 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.75 14.99 0.18 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.187 -1.341 . . . . 1.1 115.571 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -133.82 175.04 9.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.413 1.607 . . . . 1.96 113.869 -156.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.23 152.61 22.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.367 -2.086 . . . . 4.01 105.367 155.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.09 139.91 23.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.023 1.329 . . . . 0.99 109.567 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 m -155.41 110.44 2.99 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.25 -0.906 . . . . 1.5 111.101 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.23 139.98 7.91 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.139 -1.059 . . . . 2.9 108.139 166.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.73 35.2 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.128 0.571 . . . . 2.64 109.961 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt 157.14 146.32 0.01 OUTLIER 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 128.288 2.635 . . . . 6.99 106.545 -169.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.0 mt 78.01 -54.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.078 1.351 . . . . 9.16 108.506 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 . . . . . 0 C--O 1.259 1.562 0 N-CA-C 105.672 -1.973 . . . . 13.21 105.672 157.913 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttm . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 108.328 -0.99 . . . . 8.78 108.328 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -56.29 128.19 45.43 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 104.264 -3.535 . . . . 4.49 104.264 135.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.17 150.65 33.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.748 0.774 . . . . 5.18 111.47 -162.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.78 109.14 2.74 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.294 -1.922 . . . . 1.89 108.294 160.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.56 129.84 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.5 -1.296 . . . . 3.07 107.5 170.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -113.26 128.23 56.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.628 -1.99 . . . . 2.13 105.628 166.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 73' ' ' LYS . 24.8 mt-10 -121.17 104.08 9.49 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.287 -0.634 . . . . 2.42 109.287 165.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.35 129.76 36.53 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.757 -1.571 . . . . 2.7 106.757 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.4 131.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.423 -2.066 . . . . 1.85 105.423 155.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -108.1 150.44 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.161 -1.792 . . . . 1.83 106.161 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -135.38 125.27 25.67 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.05 -0.722 . . . . 4.81 109.05 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.47 -13.97 5.87 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.294 1.426 . . . . 1.73 112.517 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.1 ptp -65.74 149.4 50.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.54 1.17 . . . . 2.16 110.26 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -163.17 139.6 7.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.659 -1.608 . . . . 3.1 106.659 168.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.8 t 73.46 142.01 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.681 1.592 . . . . 2.9 112.582 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.12 -36.2 0.29 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.911 2.085 . . . . 1.3 113.166 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -56.55 -77.08 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.192 0.997 . . . . 1.2 112.805 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -55.11 -33.68 63.05 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 124.076 0.95 . . . . 2.03 110.531 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -52.69 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 O-C-N 123.662 0.601 . . . . 1.23 109.497 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.302 0.0 OUTLIER -66.98 -16.51 64.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.855 -0.528 . . . . 1.51 112.01 -168.177 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -55.94 -44.14 78.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.957 -1.127 . . . . 4.43 107.957 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.6 -63.86 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.246 -1.02 . . . . 0.72 108.246 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 2.8 pt-20 -60.18 -50.88 71.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.313 0.486 . . . . 2.9 112.313 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.3 t -50.24 -52.22 37.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.888 0.875 . . . . 1.04 109.548 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -56.77 -54.73 42.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.942 0.337 . . . . 0.81 110.897 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.17 -34.4 77.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 118.871 -1.132 . . . . 1.72 111.211 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 m -61.25 -10.73 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.977 -1.077 . . . . 1.49 112.28 173.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -75.86 -20.52 58.03 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 120.924 -1.11 . . . . 4.82 112.197 172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.56 -169.12 0.39 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.987 -1.116 . . . . 2.76 107.987 167.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -126.87 -0.84 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.411 -0.806 . . . . 6.15 112.347 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.03 -19.96 22.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.214 0.461 . . . . 0.85 113.023 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.5 mp -79.9 113.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.984 -1.487 . . . . 2.94 106.984 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -79.73 -36.51 37.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.817 1.247 . . . . 1.5 110.202 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -154.91 150.6 27.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.44 -1.319 . . . . 2.48 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -155.65 86.92 1.07 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.983 -0.376 . . . . 1.85 109.983 -164.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.7 m -112.77 107.14 15.67 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.472 0.709 . . . . 1.82 109.933 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.19 90.2 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 122.813 1.292 . . . . 1.74 110.232 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 92.6 8.22 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.414 -0.958 . . . . 0.82 108.414 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -40.58 -39.87 1.14 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.552 1.541 . . . . 1.97 112.395 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.1 61.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.628 0.771 . . . . 0.79 111.872 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -116.1 11.09 15.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.588 1.555 . . . . 1.49 110.047 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.32 39.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.812 2.445 . . . . 2.14 112.917 -173.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 141.09 52.35 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.49 0.716 . . . . 1.11 110.251 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.72 96.57 7.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.784 1.634 . . . . 0.64 108.415 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -77.17 101.29 6.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.762 -1.94 . . . . 0.8 105.762 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.6 mt -109.92 112.49 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 125.215 1.406 . . . . 0.98 107.512 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.74 124.85 34.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.694 -1.595 . . . . 2.37 106.694 169.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.21 177.5 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.925 -1.509 . . . . 2.23 106.925 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.98 137.02 28.65 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.342 0.974 . . . . 3.94 109.277 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.24 67.74 5.17 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.012 3.808 . . . . 2.64 110.703 -173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -172.97 -45.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.013 1.725 . . . . 3.63 109.298 -171.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -85.3 -28.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.617 0.767 . . . . 3.26 109.676 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.8 tt -158.08 156.22 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.09 -1.078 . . . . 2.63 108.09 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.43 163.01 27.25 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.624 -0.991 . . . . 0.64 110.624 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.09 -45.52 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.699 2.266 . . . . 0.77 110.819 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -61.19 -30.75 70.61 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.952 -0.468 . . . . 7.81 110.896 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -57.47 11.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.838 1.655 . . . . 3.67 109.072 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -56.61 -49.86 76.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.09 -0.707 . . . . 0.76 109.09 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.15 -48.33 84.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.994 -0.527 . . . . 1.39 110.782 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -53.11 -43.99 67.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.689 0.796 . . . . 3.07 109.069 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 m -62.59 -42.98 99.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.838 -0.745 . . . . 0.91 110.158 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.47 -46.35 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.224 -0.922 . . . . 0.85 111.787 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.05 -55.13 22.59 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.019 0.928 . . . . 3.16 108.918 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t -53.25 -51.19 63.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.145 1.378 . . . . 0.86 111.276 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.55 -44.42 96.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.51 -0.744 . . . . 1.98 112.263 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.29 -46.63 0.02 OUTLIER Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.844 -0.693 . . . . 1.86 114.751 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -125.75 142.8 51.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.432 -0.907 . . . . 2.0 113.031 -126.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.47 80.67 4.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.315 -0.624 . . . . 3.75 109.315 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.92 158.61 30.59 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.424 -0.797 . . . . 0.98 110.764 -171.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -155.21 117.45 4.19 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.866 -1.146 . . . . 1.98 111.235 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.26 121.04 11.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.465 1.106 . . . . 2.62 111.006 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.32 43.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.131 1.372 . . . . 3.24 109.855 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HB3' ' H ' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -98.28 -148.13 0.33 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.871 -0.788 . . . . 5.04 108.871 -171.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.585 ' H ' HD12 ' A' ' 74' ' ' ILE . 3.6 mp -77.64 66.85 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.489 -1.671 . . . . 6.36 106.489 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.975 -1.488 . . . . 8.63 108.041 165.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.101 -1.444 . . . . 11.16 107.101 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.58 -178.9 41.01 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.834 -2.106 . . . . 4.8 107.834 140.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.12 121.34 0.38 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.014 2.525 . . . . 4.97 113.113 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.16 166.94 50.47 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.078 -2.009 . . . . 1.49 108.078 151.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.2 79.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 123.019 1.39 . . . . 2.49 108.122 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 tp -80.16 79.74 6.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 123.113 1.435 . . . . 2.51 107.175 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.9 122.68 25.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.579 -2.1 . . . . 2.59 105.784 164.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.01 139.72 43.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.428 -0.582 . . . . 1.83 109.428 172.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.07 111.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.116 -1.809 . . . . 1.97 106.116 169.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.49 164.51 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.527 -2.027 . . . . 1.73 105.527 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -138.22 130.99 29.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.118 -0.989 . . . . 5.44 108.805 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.82 5.65 17.79 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.852 1.215 . . . . 1.6 112.377 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.479 ' CE ' HG22 ' A' ' 37' ' ' VAL . 25.0 mtp -75.2 87.37 2.46 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.834 1.317 . . . . 2.01 108.07 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -83.27 -30.13 27.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.859 0.864 . . . . 2.51 111.995 -173.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.3 t -153.76 152.41 30.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.521 -0.737 . . . . 2.04 110.451 -168.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.09 -46.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.976 2.51 . . . . 1.18 113.732 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.0 p -39.95 -60.87 0.94 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.95 113.712 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -59.61 -43.49 93.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.774 1.23 . . . . 1.24 108.06 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -52.92 -70.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.185 -0.916 . . . . 1.11 110.418 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -28.94 68.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.501 -0.75 . . . . 1.06 110.706 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -55.02 -54.77 38.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.388 -0.815 . . . . 4.38 109.926 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mt -56.06 -54.08 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 119.475 1.034 . . . . 0.6 110.625 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -54.86 -51.22 66.62 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.311 -0.556 . . . . 3.26 109.773 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -56.35 -44.62 80.27 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.481 0.712 . . . . 0.95 111.757 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -64.96 -39.91 94.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.561 1.144 . . . . 2.45 111.809 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.71 -45.67 50.78 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.969 -0.693 . . . . 2.28 111.45 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -68.25 72.47 0.2 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.303 1.041 . . . . 2.6 110.75 -174.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -34.96 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.74 2.416 . . . . 6.17 110.639 -169.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -53.72 -70.09 0.1 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 119.684 1.129 . . . . 2.95 112.536 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 131.97 -4.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.01 3.724 . . . . 5.57 113.611 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.34 18.39 33.11 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.643 1.11 . . . . 0.9 112.466 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.18 121.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.799 1.639 . . . . 4.04 107.932 -175.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.8 mt -95.09 -38.04 10.81 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.089 0.555 . . . . 1.4 110.113 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -156.07 157.51 36.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.397 -1.335 . . . . 2.11 107.397 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.23 58.93 0.65 Allowed 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.218 0.607 . . . . 2.78 110.24 -163.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -79.19 104.1 9.58 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.361 -0.607 . . . . 1.55 109.361 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' CE ' ' A' ' 13' ' ' MET . 0.9 OUTLIER -95.58 95.43 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.381 1.086 . . . . 1.51 110.165 -177.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.17 95.11 10.05 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.902 -1.124 . . . . 0.78 109.331 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 tt -42.79 -38.93 2.29 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.778 1.631 . . . . 1.63 112.36 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.55 61.31 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 124.59 1.156 . . . . 1.07 111.529 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.8 t -116.48 14.74 15.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.227 1.411 . . . . 1.72 109.545 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.27 52.02 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.716 2.406 . . . . 2.88 111.41 -169.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.455 -0.778 . . . . 1.49 110.503 -171.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 109.79 22.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.53 1.532 . . . . 0.63 107.872 171.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -82.82 93.07 7.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.574 -1.639 . . . . 0.77 106.574 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.7 mt -103.97 110.42 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.344 1.068 . . . . 1.2 109.754 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -78.06 71.93 4.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.521 -1.659 . . . . 2.92 106.521 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.46 162.36 27.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.992 -0.549 . . . . 2.04 109.606 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -116.27 105.32 50.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.833 -0.803 . . . . 3.08 108.833 167.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.51 -32.73 83.74 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.67 2.247 . . . . 1.75 113.365 -168.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.18 -30.24 59.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.38 0.536 . . . . 3.86 112.26 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.89 -3.0 9.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 113.503 0.927 . . . . 2.48 113.503 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 tt -157.57 131.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.246 -1.39 . . . . 2.3 107.246 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.44 155.0 46.57 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.347 -1.901 . . . . 0.88 108.347 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -59.29 -40.17 70.97 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.795 -1.271 . . . . 0.73 108.795 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -44.92 26.79 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.507 1.123 . . . . 9.52 112.526 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.57 -54.89 41.77 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.275 0.943 . . . . 2.96 109.597 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.32 -47.65 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.357 -0.838 . . . . 0.71 110.006 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.77 -52.26 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.239 -0.652 . . . . 1.42 109.239 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -54.73 -47.38 73.86 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.374 -0.346 . . . . 2.73 110.517 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -51.21 -54.62 23.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.137 0.88 . . . . 1.31 110.401 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -57.69 -58.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 119.213 -0.422 . . . . 1.68 110.222 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -63.94 -44.39 93.0 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.158 -1.017 . . . . 4.2 111.18 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.9 t -62.84 -20.29 64.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 117.768 -1.111 . . . . 0.71 112.609 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.86 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.212 1.369 . . . . 1.98 109.89 165.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.36 25.05 0.32 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.606 -1.108 . . . . 1.1 114.126 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.23 172.56 7.5 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.85 1.325 . . . . 1.86 113.235 -165.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -95.55 161.4 14.07 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.33 -1.73 . . . . 4.95 106.33 156.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.26 94.9 2.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.861 0.864 . . . . 1.64 112.297 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -87.69 119.67 28.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.602 0.761 . . . . 1.73 109.788 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -63.66 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.125 0.875 . . . . 3.04 110.702 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.83 -166.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.485 1.114 . . . . 3.06 109.515 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.92 66.95 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.316 -1.49 . . . . 5.53 110.372 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 74' ' ' ILE 0.263 3.0 mp 71.7 59.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 126.012 1.725 . . . . 5.71 108.243 -175.531 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 . . . . . 0 C--O 1.253 1.281 0 N-CA-C 101.805 -3.406 . . . . 9.49 101.805 156.167 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.807 -1.183 . . . . 11.6 107.807 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.71 49.27 3.43 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 107.889 -2.084 . . . . 5.14 107.889 -170.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.35 173.63 7.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.914 1.685 . . . . 6.31 109.7 -156.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.63 144.76 33.49 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 122.361 0.978 . . . . 2.02 112.509 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.26 147.86 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 106.447 -1.686 . . . . 2.03 106.447 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 tp -142.36 136.4 29.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.516 -2.031 . . . . 2.06 105.516 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -115.07 145.32 42.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.407 -0.96 . . . . 2.34 108.407 156.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -133.15 146.03 51.2 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 124.668 1.23 . . . . 2.22 107.837 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.18 131.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.535 -1.654 . . . . 2.1 106.535 160.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.54 157.27 3.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 106.153 -1.795 . . . . 2.0 106.153 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -139.07 132.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.273 -1.01 . . . . 4.96 108.273 163.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.35 10.06 12.25 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.663 1.601 . . . . 1.92 112.761 -173.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.5 mtt -62.69 150.46 40.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.034 1.417 . . . . 2.08 109.48 167.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -154.41 86.92 1.16 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.469 0.652 . . . . 3.18 109.937 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.5 t 73.62 90.32 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.086 1.354 . . . . 2.85 112.916 165.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.11 -124.3 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.786 -1.102 . . . . 2.86 108.174 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.5 p 49.47 -81.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.779 2.032 . . . . 1.14 114.165 163.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -46.35 -43.75 16.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.608 0.763 . . . . 1.27 109.747 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.0 t -48.46 -74.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.52 1.128 . . . . 0.88 111.197 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -30.13 69.7 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 122.069 -0.395 . . . . 1.35 111.475 -172.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -51.54 -56.04 15.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.248 -0.649 . . . . 4.24 109.248 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.09 -60.19 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.325 -0.62 . . . . 0.52 109.325 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -49.88 -55.73 13.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.236 0.614 . . . . 3.04 111.142 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.2 t -54.26 -59.77 4.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.456 1.102 . . . . 1.13 109.45 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -52.08 -49.97 62.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.687 0.279 . . . . 0.94 110.939 -174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.9 -49.7 69.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.111 0.411 . . . . 1.77 112.111 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.261 4.5 t -60.6 -25.09 65.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 118.549 -1.26 . . . . 2.97 111.541 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -55.35 -25.65 36.28 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.189 0.811 . . . . 4.19 113.189 173.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -54.92 -31.44 60.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.018 0.827 . . . . 2.33 111.286 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -3.66 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.088 1.755 . . . . 8.45 111.811 -162.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.8 -35.81 15.2 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.553 -1.019 . . . . 1.14 110.553 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 46' ' ' ILE . 4.4 mp -92.36 97.89 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.694 -1.595 . . . . 2.9 106.694 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.11 -24.22 43.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.357 -0.838 . . . . 2.13 110.124 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -155.78 153.74 30.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.971 -0.752 . . . . 2.64 108.971 169.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.7 113.49 5.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.783 2.033 . . . . 3.19 107.311 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -119.4 104.77 10.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.425 -1.324 . . . . 1.5 107.425 165.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.34 78.38 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.754 1.264 . . . . 2.04 107.657 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.93 88.84 5.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.954 -1.021 . . . . 0.88 108.502 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.7 tt -38.67 -39.66 0.52 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.06 1.744 . . . . 1.77 112.413 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -36.41 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.454 1.102 . . . . 0.95 112.084 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 t -111.72 11.61 21.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.642 1.577 . . . . 1.56 109.934 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.35 41.28 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.234 2.614 . . . . 2.43 113.399 -170.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.95 45.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.8 0.84 . . . . 1.15 109.422 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.12 111.45 24.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.854 -1.906 . . . . 0.54 105.854 170.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -82.34 114.28 20.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.408 -2.071 . . . . 0.78 105.408 163.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 32' ' ' ILE . 9.8 mt -121.87 109.08 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 125.002 1.321 . . . . 0.93 107.483 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -79.45 72.38 6.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.856 -1.535 . . . . 2.86 106.856 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 176.36 9.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.298 1.039 . . . . 2.88 108.618 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.86 130.16 8.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 118.387 0.54 . . . . 3.66 110.196 160.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -51.88 -34.98 57.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.283 2.656 . . . . 1.72 113.589 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.95 -22.6 66.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.075 0.852 . . . . 4.69 112.999 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 pt -110.89 -22.52 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 119.122 0.873 . . . . 2.9 110.486 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -162.53 130.17 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.978 -1.119 . . . . 3.01 107.978 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.76 170.51 48.08 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.974 -0.851 . . . . 1.19 110.974 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.26 -57.06 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.104 1.869 . . . . 1.23 110.689 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.33 -26.79 68.63 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.847 -0.533 . . . . 8.73 111.743 -173.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -51.55 63.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.981 1.312 . . . . 4.56 110.159 173.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.9 -53.0 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.23 -0.919 . . . . 0.95 109.694 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -55.46 -50.73 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.405 -0.591 . . . . 1.76 109.405 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -49.47 -46.12 47.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.79 0.836 . . . . 3.79 110.396 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -58.23 -50.2 74.4 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.586 -0.524 . . . . 1.21 109.586 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.8 -54.82 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.971 0.509 . . . . 0.75 110.838 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -55.39 -53.42 56.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.243 -0.651 . . . . 4.57 109.243 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -48.4 -47.71 37.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.97 1.308 . . . . 0.89 111.676 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.66 -48.57 79.12 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.372 0.987 . . . . 1.92 113.478 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 0.11 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 118.293 2.077 . . . . 1.19 118.293 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -138.97 177.47 7.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.814 1.807 . . . . 1.91 112.617 -144.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -104.0 158.68 16.25 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.093 -1.447 . . . . 2.94 107.093 145.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.88 154.13 37.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.559 0.695 . . . . 1.01 110.905 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.0 m -156.13 103.79 2.22 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.419 -0.8 . . . . 1.94 110.438 -164.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.94 134.41 16.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.474 1.109 . . . . 2.85 111.94 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m -130.47 144.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.976 1.311 . . . . 2.5 109.099 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 48.52 55.41 9.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.566 1.146 . . . . 8.34 111.32 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 tp -154.35 148.21 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.11 -1.811 . . . . 7.97 106.11 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.825 2.05 . . . . 11.65 113.634 -172.012 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 106.941 -1.503 . . . . 11.4 106.941 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.93 152.9 9.06 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.15 -1.18 . . . . 5.93 110.15 -172.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 57.99 -178.02 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.416 1.886 . . . . 5.44 112.028 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.14 132.32 11.06 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 105.564 -3.014 . . . . 1.67 105.564 158.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 m -136.51 146.32 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.211 1.006 . . . . 2.78 110.131 -170.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 tp -155.23 153.37 30.55 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.041 -1.466 . . . . 2.64 107.041 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -115.4 148.52 39.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.858 -0.793 . . . . 2.93 108.858 165.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.0 mt -121.85 128.82 52.06 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.063 -1.829 . . . . 2.78 106.063 165.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.6 142.1 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.465 -2.42 . . . . 1.75 104.465 161.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.38 120.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 124.616 1.166 . . . . 2.12 108.575 -171.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 131.53 53.88 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.085 0.954 . . . . 7.45 110.986 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.22 -19.28 5.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.965 1.745 . . . . 1.86 109.938 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 mtm -63.32 163.75 10.08 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.204 -0.586 . . . . 1.89 110.531 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -150.47 -44.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.618 0.367 . . . . 2.55 111.455 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.3 m -139.36 169.44 17.75 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.78 -0.575 . . . . 2.56 109.697 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.31 -36.86 1.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.938 2.095 . . . . 1.45 113.272 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -48.26 -44.09 33.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.268 1.827 . . . . 0.92 113.786 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.8 m -70.56 -46.92 62.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.166 -1.42 . . . . 1.22 107.166 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.07 -63.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.336 . . . . 1.61 111.001 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -26.53 64.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.496 -0.752 . . . . 1.2 111.703 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.78 -54.68 39.0 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.727 -0.842 . . . . 4.43 108.727 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -53.88 -60.34 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.591 -0.522 . . . . 0.75 109.591 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -53.22 -52.94 57.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.529 0.331 . . . . 3.28 111.31 -171.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -58.76 -54.6 45.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.94 0.496 . . . . 1.44 110.217 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 t -55.31 -38.92 69.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.37 0.668 . . . . 1.11 111.864 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.1 mt -75.21 -54.65 6.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 113.595 0.961 . . . . 1.77 113.595 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -54.58 -35.96 63.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.349 -0.844 . . . . 2.03 110.931 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -25.16 9.98 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.338 1.236 . . . . 3.84 114.338 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.752 ' HB3' HD11 ' A' ' 53' ' ' ILE . 12.1 m170 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.673 1.124 . . . . 2.22 111.095 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 77.85 -3.73 2.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.698 2.399 . . . . 6.38 113.898 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA3' HD12 ' A' ' 53' ' ' ILE . . . -96.12 -23.84 16.3 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.848 -0.901 . . . . 1.1 110.848 172.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.623 HD12 HD13 ' A' ' 53' ' ' ILE . 3.1 mp -78.41 105.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.728 -1.953 . . . . 2.9 105.728 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.66 -30.51 41.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.227 1.011 . . . . 1.38 109.434 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.08 139.99 18.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.473 -0.936 . . . . 2.26 108.473 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -133.06 119.19 19.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.579 -2.008 . . . . 2.22 105.579 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -125.74 106.96 10.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.784 -1.561 . . . . 1.74 106.784 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.24 87.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.297 1.046 . . . . 2.02 108.878 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.2 86.23 5.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.017 -1.475 . . . . 0.89 107.017 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -40.91 -38.71 1.0 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.826 1.651 . . . . 2.42 111.201 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.53 -36.17 43.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.592 1.157 . . . . 0.83 112.726 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -113.95 13.22 18.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.353 1.461 . . . . 1.62 110.049 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 40.52 41.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.39 1.876 . . . . 1.94 112.057 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 143.45 50.83 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.143 0.577 . . . . 1.18 110.368 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.71 108.28 19.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.447 -2.057 . . . . 0.43 105.447 170.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -78.59 115.8 18.54 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.651 -1.981 . . . . 1.22 105.651 165.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -120.07 114.7 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.083 -1.08 . . . . 1.06 108.083 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -100.07 115.4 29.69 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.633 -1.617 . . . . 3.28 106.633 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.13 145.98 22.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.797 1.239 . . . . 1.96 108.503 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -85.91 137.03 35.78 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 119.054 0.843 . . . . 4.4 109.577 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.34 -31.69 13.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.186 1.924 . . . . 2.55 111.765 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.52 46.86 0.99 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.774 1.23 . . . . 5.03 112.538 -169.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -50.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 128.295 2.638 . . . . 4.46 106.028 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 29' ' ' HIS . 1.2 mt -104.4 -89.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.887 1.275 . . . . 2.81 107.61 -176.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 95.5 139.01 9.97 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.492 -1.443 . . . . 0.91 109.492 -165.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.7 -37.27 94.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.421 2.747 . . . . 0.74 112.812 -164.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -35.98 -49.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 9.6 112.825 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -68.22 -46.15 71.37 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.018 -0.734 . . . . 3.02 109.018 -171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 mt -60.47 -47.35 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.72 109.219 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.38 -57.4 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.306 0.642 . . . . 1.79 109.494 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -52.81 -45.82 67.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.655 0.382 . . . . 2.76 110.09 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.8 m -59.48 -54.75 43.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.1 mt -51.76 -55.45 9.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.593 1.157 . . . . 0.8 110.754 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.35 -57.84 10.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.407 -0.59 . . . . 3.07 109.407 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.3 t -52.94 -37.48 61.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.1 1.36 . . . . 0.8 111.598 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.35 -54.71 28.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.51 0.724 . . . . 2.27 112.632 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.27 -8.36 0.04 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 117.539 1.776 . . . . 1.13 117.539 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.76 176.2 8.67 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.41 1.605 . . . . 1.85 112.475 -142.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -124.54 152.61 43.25 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.922 -2.251 . . . . 3.15 104.922 161.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.61 164.84 30.47 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.015 0.746 . . . . 1.29 113.015 -168.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -153.81 138.88 17.32 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 122.978 0.511 . . . . 2.07 111.379 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.58 66.74 1.45 Allowed 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.547 1.539 . . . . 2.88 110.71 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.2 147.73 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.392 -0.595 . . . . 2.48 109.392 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -128.33 89.22 2.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.078 -1.823 . . . . 6.82 106.078 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.77 -178.72 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 127.145 2.178 . . . . 6.53 105.892 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 108.387 -0.968 . . . . 10.68 108.387 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 106.242 -1.762 . . . . 8.55 106.242 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.96 177.85 51.76 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.364 -1.494 . . . . 4.2 109.364 157.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.08 146.74 30.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.266 1.426 . . . . 5.02 109.154 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.24 89.73 0.7 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.378 -1.489 . . . . 1.89 109.378 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.08 142.28 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.608 0.704 . . . . 2.79 109.782 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.2 83.63 1.84 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.768 -1.567 . . . . 2.77 106.768 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.4 116.54 27.67 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.891 -1.504 . . . . 2.31 107.148 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 3.2 pp -128.34 142.22 51.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.746 0.248 . . . . 2.06 110.677 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.88 145.21 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.36 -1.348 . . . . 1.86 107.36 166.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.7 161.62 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.6 1.56 . . . . 1.87 107.441 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.09 140.1 30.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.874 -0.787 . . . . 7.99 108.874 160.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.67 -34.15 3.54 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.0 -1.24 . . . . 1.53 110.0 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.1 mtp -56.18 115.46 2.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.41 -0.464 . . . . 1.52 109.832 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -125.65 -20.49 4.68 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.946 0.899 . . . . 2.4 111.98 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.5 t -153.92 151.59 29.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.052 -1.03 . . . . 2.13 109.707 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -30.99 -45.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.562 2.345 . . . . 1.14 113.526 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 p -39.96 -58.62 1.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.508 1.523 . . . . 0.86 113.733 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.3 -46.99 87.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.241 -1.392 . . . . 1.24 107.241 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -51.16 -66.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.473 -1.24 . . . . 0.94 110.404 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -27.33 64.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.887 -0.725 . . . . 1.1 111.193 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.74 -53.49 57.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.624 0.647 . . . . 4.51 110.259 172.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.14 -60.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.861 -0.792 . . . . 0.45 108.861 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -54.63 -51.02 66.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.543 -0.299 . . . . 3.25 110.939 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.5 t -60.23 -42.82 96.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.522 0.729 . . . . 0.95 111.237 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 t -65.88 -36.78 84.35 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.827 -0.546 . . . . 0.81 111.102 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.18 -52.64 13.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.266 -0.574 . . . . 2.01 111.85 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 m -67.09 76.46 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.228 1.011 . . . . 2.51 110.683 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.45 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.458 2.703 . . . . 3.91 110.518 -171.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -56.33 -30.26 62.35 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.576 1.08 . . . . 2.77 113.296 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 37.97 2.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.245 1.018 . . . . 7.61 110.251 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.33 -2.01 0.73 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 121.573 -0.705 . . . . 0.99 112.897 165.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.05 127.4 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.776 -1.564 . . . . 2.66 106.776 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.78 -43.35 18.47 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.981 1.312 . . . . 1.85 109.417 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -152.11 155.25 37.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 110.203 -0.295 . . . . 2.1 110.203 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.47 136.85 35.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.731 1.612 . . . . 3.03 107.004 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -151.52 87.92 1.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.229 -1.397 . . . . 2.29 107.229 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.27 0.3 OUTLIER -92.52 92.08 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.714 1.245 . . . . 1.66 109.958 -176.894 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.64 92.98 9.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.177 -0.952 . . . . 0.69 108.986 -170.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.05 -42.37 2.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.302 1.441 . . . . 1.87 111.701 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.25 -33.54 42.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.435 1.094 . . . . 0.83 112.46 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -117.78 14.43 14.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.887 1.275 . . . . 1.5 110.364 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 30.26 53.97 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.686 2.394 . . . . 3.0 112.363 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 150.22 46.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.733 0.813 . . . . 1.11 109.175 -174.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -101.84 113.67 27.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.572 1.149 . . . . 0.63 107.965 168.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -81.22 99.18 8.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 104.337 -2.468 . . . . 0.76 104.337 154.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.54 147.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.49 -1.67 . . . . 0.95 106.49 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -124.58 130.93 53.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.352 -2.092 . . . . 3.11 105.352 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -146.41 173.13 12.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 119.095 0.861 . . . . 2.17 111.365 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -107.77 94.12 11.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.112 0.965 . . . . 4.33 109.587 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 63.25 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.659 3.573 . . . . 2.58 111.851 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -155.09 -54.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 128.702 2.801 . . . . 3.74 106.692 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.4 pt -99.82 -13.41 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 124.843 1.257 . . . . 2.45 111.849 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -151.55 142.34 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.638 -1.616 . . . . 2.25 106.638 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.39 168.48 40.36 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.977 -0.849 . . . . 0.91 110.977 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.83 -47.49 1.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.563 2.176 . . . . 0.7 110.779 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -24.73 66.81 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.992 -0.442 . . . . 8.24 110.534 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -56.15 25.28 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.893 -1.754 . . . . 3.34 109.27 172.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.49 -55.12 21.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 108.869 -0.789 . . . . 1.22 108.869 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -58.05 -44.7 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.43 -0.35 . . . . 1.33 110.105 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.5 -37.26 83.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.906 1.282 . . . . 4.73 109.999 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -58.53 -51.83 68.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.751 -0.833 . . . . 0.77 108.751 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.98 -52.61 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 119.206 -0.426 . . . . 0.78 111.006 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -47.07 -52.2 15.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.156 0.983 . . . . 3.12 109.911 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.4 t -70.43 -9.71 57.17 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.754 1.622 . . . . 1.3 113.683 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.48 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.197 -1.409 . . . . 2.65 107.197 159.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.59 37.43 0.51 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.909 -0.94 . . . . 1.24 112.343 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -136.29 124.69 23.39 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.222 1.011 . . . . 1.92 110.266 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.75 -1.204 . . . . 4.63 107.75 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.31 163.1 40.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.918 -0.488 . . . . 1.05 111.462 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -145.62 126.69 14.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.607 1.163 . . . . 2.06 108.983 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.85 119.78 11.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.649 1.179 . . . . 3.55 108.314 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.44 13.41 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.83 0.741 . . . . 2.03 111.782 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 67.89 -71.84 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.82 1.648 . . . . 5.57 110.564 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 74' ' ' ILE . 4.4 tp -164.94 173.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.723 -1.214 . . . . 4.93 107.723 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.253 1.252 0 N-CA-C 104.843 -2.28 . . . . 11.23 104.843 172.57 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 107.031 -1.47 . . . . 9.05 107.031 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.74 169.81 45.63 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.669 0.668 . . . . 5.23 111.869 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.67 64.12 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.408 1.083 . . . . 4.93 109.807 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.92 130.73 12.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.187 0.898 . . . . 1.57 111.04 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -103.97 126.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-N 117.634 0.717 . . . . 2.73 109.573 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 95.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.476 1.132 . . . . 4.02 108.873 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 5.0 tp10 -78.51 122.64 26.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.612 -1.255 . . . . 2.44 107.612 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.43 145.54 48.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.994 -0.373 . . . . 1.77 109.994 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.98 142.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.069 -1.826 . . . . 1.93 106.069 164.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.06 95.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 125.246 1.418 . . . . 2.22 108.618 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -97.47 143.5 28.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.523 0.729 . . . . 5.92 111.149 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.81 -36.38 3.0 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.627 1.108 . . . . 1.64 110.806 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -64.51 153.43 39.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.133 0.492 . . . . 1.61 112.171 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -153.58 149.5 27.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 170.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m 70.43 151.39 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.468 1.507 . . . . 2.34 112.486 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.5 -35.37 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.515 1.926 . . . . 1.49 112.559 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 -65.48 0.57 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.251 1.42 . . . . 1.36 112.649 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -68.91 -40.42 79.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.462 -1.31 . . . . 1.26 107.462 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.7 t -42.92 -68.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 113.98 -1.464 . . . . 1.08 110.238 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.304 0.0 OUTLIER -69.62 -20.06 63.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.704 -0.798 . . . . 1.86 110.995 -175.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.53 -42.21 87.58 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.113 -0.992 . . . . 3.08 108.992 -174.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -53.54 -66.53 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.816 -0.809 . . . . 0.77 108.816 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.24 -56.17 20.98 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.035 0.534 . . . . 3.14 111.962 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -53.43 -36.49 61.6 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.512 1.125 . . . . 1.34 111.174 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -70.22 -62.08 1.53 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.502 -0.749 . . . . 0.83 110.357 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -46.29 66.5 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.699 0.8 . . . . 2.26 111.961 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 p -50.85 -33.43 23.78 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.779 0.432 . . . . 2.47 111.129 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -64.26 -18.5 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.847 0.684 . . . . 4.45 112.847 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -60.48 -28.63 68.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 2.46 110.456 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 74.83 -1.85 2.98 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.311 1.844 . . . . 6.74 112.285 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 24.96 25.35 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.377 -0.689 . . . . 1.2 111.377 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mm -121.04 144.92 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.171 -1.789 . . . . 2.57 106.171 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.13 -45.86 7.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.832 -0.803 . . . . 2.83 108.832 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -155.55 153.4 30.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.375 0.534 . . . . 2.25 109.939 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.0 m -135.02 113.1 11.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 104.986 -2.227 . . . . 2.57 104.986 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.41 96.09 5.81 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.162 -1.051 . . . . 1.56 108.162 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.03 95.12 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.445 0.64 . . . . 1.88 109.667 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.71 91.72 6.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.372 -0.83 . . . . 0.73 110.185 -168.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -37.3 -50.87 1.04 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 1.97 112.819 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.52 31.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 1.27 112.528 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.7 t -105.93 -15.54 14.89 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.829 1.252 . . . . 1.6 110.729 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.72 41.52 14.86 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.837 0.855 . . . . 2.46 109.425 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -120.53 147.57 44.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.66 1.184 . . . . 1.13 108.794 176.007 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.1 114.18 27.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.859 -1.534 . . . . 0.41 106.859 162.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -78.2 94.37 4.75 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.144 -2.169 . . . . 0.74 105.144 167.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 mt -98.74 111.92 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.708 -0.849 . . . . 1.21 108.708 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.15 115.59 26.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.323 -1.732 . . . . 2.87 106.323 159.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.62 140.19 28.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.979 1.312 . . . . 2.62 107.792 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -87.37 114.16 57.41 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.381 -0.97 . . . . 3.72 108.381 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.12 -48.78 15.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.17 1.913 . . . . 2.16 113.194 -172.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.59 -21.42 60.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.804 1.039 . . . . 3.31 113.804 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -97.18 -4.54 9.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 119.728 1.149 . . . . 2.53 112.7 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.05 -46.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.454 1.279 . . . . 2.69 114.454 -175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.84 155.65 2.36 Favored Glycine 0 CA--C 1.541 1.674 0 O-C-N 121.609 -0.682 . . . . 0.83 112.889 -171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 -51.58 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.25 2.634 . . . . 1.27 112.252 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -47.9 -44.6 29.77 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.679 0.791 . . . . 7.08 112.187 -170.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -52.35 -56.13 16.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.023 0.929 . . . . 3.96 110.859 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.17 -48.87 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 O-C-N 121.814 -0.554 . . . . 0.76 110.547 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mm -51.81 -51.34 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 119.014 -0.517 . . . . 1.84 110.27 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -50.51 -54.45 22.28 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 122.968 0.507 . . . . 2.74 109.896 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.0 m -56.41 -47.29 79.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.255 -0.978 . . . . 1.1 110.733 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 -54.8 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 118.534 0.606 . . . . 1.06 111.949 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -67.01 -43.63 82.4 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.582 -0.447 . . . . 4.99 110.678 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 t -57.9 -40.7 80.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.51 0.724 . . . . 1.0 110.978 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.13 -59.97 4.5 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.389 0.995 . . . . 1.66 110.736 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.57 -40.45 0.02 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 115.762 1.065 . . . . 1.46 115.762 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -112.33 139.72 47.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.948 -0.737 . . . . 1.86 111.549 -135.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.02 133.0 36.11 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 106.48 -1.674 . . . . 3.18 106.48 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.18 31.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.044 0.384 . . . . 1.07 111.477 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.48 145.55 25.28 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 109.447 -0.575 . . . . 1.89 109.447 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.15 130.3 35.13 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.927 -0.768 . . . . 2.32 108.927 -174.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.94 -37.34 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.257 0.623 . . . . 2.06 112.19 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 54.82 79.71 0.14 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.8 1.24 . . . . 4.82 112.02 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.3 155.14 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.151 -2.166 . . . . 6.17 105.151 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.552 -1.213 . . . . 12.47 109.428 -159.242 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 106.399 -1.704 . . . . 8.65 106.399 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.64 158.27 26.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 109.601 -1.4 . . . . 4.91 109.601 -167.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -83.78 159.28 21.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.392 1.877 . . . . 5.46 109.072 174.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.87 100.62 0.34 Allowed Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.679 -0.568 . . . . 1.62 111.679 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.21 138.31 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.208 -1.172 . . . . 1.97 109.302 172.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.23 88.1 2.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.601 -1.629 . . . . 2.23 106.601 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -79.65 123.3 27.52 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.372 -1.714 . . . . 2.25 106.372 171.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.12 133.41 46.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.84 0.291 . . . . 2.15 110.336 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.3 145.71 9.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 172.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.4 122.0 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.211 1.004 . . . . 1.63 110.117 -169.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.48 132.96 51.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.139 -0.689 . . . . 4.95 109.139 170.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.61 -25.67 5.87 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.995 2.236 . . . . 1.86 109.149 178.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 mtp -57.2 107.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.53 0.732 . . . . 1.75 109.889 164.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -139.99 9.36 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.913 1.285 . . . . 2.34 112.588 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -172.53 147.58 1.88 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.521 1.055 . . . . 2.23 109.92 -173.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.73 -38.02 1.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.339 1.856 . . . . 1.23 113.176 178.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 p -60.58 -77.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.863 0.865 . . . . 0.82 112.04 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 p -48.59 -29.88 4.75 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.071 1.348 . . . . 2.09 112.122 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.98 -72.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 0.92 109.867 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -68.62 -12.74 61.73 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.015 -1.053 . . . . 1.17 112.942 -171.367 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -52.7 -42.86 65.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.237 -1.023 . . . . 4.3 108.237 172.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.92 -60.83 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.478 1.511 . . . . 0.55 109.666 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.23 -48.32 82.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.944 -0.391 . . . . 4.78 109.944 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.31 -48.69 80.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.458 -0.942 . . . . 1.18 108.458 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -51.01 -57.29 9.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.667 1.122 . . . . 1.34 111.01 176.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.25 -38.83 75.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.006 -1.078 . . . . 1.8 111.451 -169.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -55.07 -15.65 2.29 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.985 -1.072 . . . . 2.33 113.078 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -66.42 -37.24 84.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.369 -0.832 . . . . 5.38 110.766 173.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -69.56 124.94 25.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.716 -1.216 . . . . 2.15 107.716 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.61 47.32 0.83 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.161 -0.962 . . . . 7.56 109.943 172.378 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.88 -17.21 0.83 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.305 1.907 . . . . 0.89 111.998 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.1 tt -105.54 138.19 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.114 -1.069 . . . . 2.56 108.114 176.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -86.06 -49.38 7.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.531 1.133 . . . . 1.62 109.803 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -152.79 162.54 41.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.717 0.407 . . . . 3.01 110.304 -176.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.58 89.5 1.56 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.219 1.008 . . . . 2.07 109.973 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.94 90.05 8.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.071 -0.714 . . . . 1.39 109.071 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -85.94 98.42 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.559 1.144 . . . . 2.43 109.304 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.73 92.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.377 0.671 . . . . 0.82 109.849 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -36.89 -44.19 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.707 2.003 . . . . 1.76 110.869 165.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.17 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.008 0.923 . . . . 0.94 112.461 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.46 14.97 10.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.077 1.351 . . . . 1.53 109.983 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 34.92 55.39 0.74 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.763 2.025 . . . . 2.17 111.876 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.01 153.54 36.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.63 -0.878 . . . . 1.07 108.63 -173.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.01 127.49 54.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.637 0.586 . . . . 1.1 109.977 163.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -86.01 91.4 8.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.706 -1.961 . . . . 0.86 105.706 170.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.23 137.84 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.124 -1.436 . . . . 1.55 107.124 172.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -115.31 119.05 34.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.365 -2.087 . . . . 2.18 105.365 163.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 178.85 7.39 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 127.213 2.205 . . . . 1.87 106.096 -176.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -132.23 132.63 23.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.95 . . . . 3.67 110.386 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.71 64.09 7.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.918 3.745 . . . . 2.35 112.161 -167.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -166.74 -45.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.738 1.215 . . . . 3.75 110.239 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.77 -27.11 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.184 -0.673 . . . . 2.72 109.184 174.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -154.89 150.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.771 -1.196 . . . . 2.62 107.771 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.86 166.06 33.73 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.338 -1.105 . . . . 0.75 110.338 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.47 -48.57 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.373 2.049 . . . . 0.93 110.479 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.404 HH21 ' CD2' ' A' ' 60' ' ' HIS . 25.4 tpt180 -56.96 -27.42 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.924 0.489 . . . . 7.87 111.274 -177.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -55.59 31.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.299 1.839 . . . . 3.7 109.078 175.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt -56.23 -47.21 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.62 -0.882 . . . . 0.69 108.62 174.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mm -55.84 -50.97 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 119.28 -0.391 . . . . 1.99 111.0 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CD2' HH21 ' A' ' 56' ' ' ARG . 17.2 m170 -54.36 -46.51 73.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.162 0.985 . . . . 3.06 109.302 178.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 m -58.05 -50.08 74.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.609 -0.515 . . . . 0.8 109.609 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.93 -51.9 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.15 -0.969 . . . . 0.79 111.782 178.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -50.86 -56.68 11.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.438 1.095 . . . . 3.13 109.241 175.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.3 t -52.34 -51.46 58.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.741 1.616 . . . . 0.8 111.365 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.49 -41.21 89.25 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.45 -0.781 . . . . 2.96 111.85 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.27 -50.52 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.328 -0.939 . . . . 1.5 114.624 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.58 144.99 38.61 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 118.973 -1.091 . . . . 1.92 113.806 -128.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.1 59.4 3.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.345 -0.613 . . . . 4.28 109.345 -176.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.82 168.47 19.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.689 0.626 . . . . 1.25 112.689 -166.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.06 132.01 10.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.819 -0.808 . . . . 1.88 108.819 173.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 130.73 47.88 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.864 -0.791 . . . . 2.31 108.864 167.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.67 173.67 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.322 -0.992 . . . . 2.82 108.322 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 75' ' ' GLU . 3.8 mmmp? -134.71 77.7 1.7 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.895 -0.78 . . . . 6.36 108.895 172.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mt -63.62 -47.85 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.485 -0.932 . . . . 5.84 108.485 171.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 7.8 pt-20 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 103.875 -2.639 . . . . 9.38 103.875 158.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttm . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 105.515 -2.032 . . . . 8.41 105.515 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.76 157.04 2.13 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 108.06 -2.016 . . . . 5.16 108.06 -132.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -96.7 159.89 14.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.151 1.781 . . . . 5.53 108.932 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.71 162.69 50.74 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 121.803 0.669 . . . . 1.82 111.794 -171.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.24 149.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.987 -0.713 . . . . 2.02 110.071 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 tp -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.433 1.893 . . . . 2.76 106.346 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -128.81 157.37 41.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.05 -1.092 . . . . 2.62 108.05 163.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.69 142.92 49.94 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.358 1.036 . . . . 2.98 108.997 162.407 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.8 t -76.84 128.92 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.797 -1.927 . . . . 1.86 105.797 165.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.93 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.375 -1.343 . . . . 1.99 107.375 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.97 142.72 45.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.09 -1.448 . . . . 5.01 107.09 166.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.2 -47.63 1.34 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.726 -0.95 . . . . 1.49 110.726 167.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.82 143.57 54.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.229 -0.656 . . . . 2.05 109.229 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.62 -66.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.289 -0.257 . . . . 3.33 110.969 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -64.14 148.06 50.83 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.642 -0.661 . . . . 2.29 110.983 -171.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.35 -47.11 0.29 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.278 1.831 . . . . 1.17 112.507 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.2 p -60.08 -37.59 80.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.556 1.543 . . . . 1.29 113.64 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.65 -46.98 28.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.612 -1.305 . . . . 1.49 109.756 172.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.87 -67.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.292 1.037 . . . . 0.88 111.157 177.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -27.1 64.33 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.792 -0.568 . . . . 1.01 111.161 -173.292 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.06 -53.2 60.04 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.18 -0.914 . . . . 4.56 108.994 175.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.82 -55.68 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.423 1.01 . . . . 0.71 109.862 174.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -51.67 -59.26 4.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.275 -0.269 . . . . 3.16 110.275 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -53.82 -43.37 69.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 1.07 111.812 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -60.07 -50.42 73.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.28 1.032 . . . . 2.24 109.181 -176.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.42 -37.27 71.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.078 -0.649 . . . . 2.24 112.097 179.258 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -53.57 -23.99 12.4 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.029 -1.044 . . . . 1.49 113.458 177.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -60.21 -31.35 70.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.759 1.163 . . . . 6.52 112.18 174.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -70.52 148.52 48.14 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.867 0.758 . . . . 2.25 109.05 -175.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -105.25 37.77 2.11 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.788 -0.57 . . . . 6.73 111.905 -171.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.03 24.56 0.61 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.12 -0.392 . . . . 1.04 112.12 170.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -114.01 134.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.107 -1.812 . . . . 2.63 106.107 168.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.25 -40.11 10.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 1.62 109.069 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.53 136.89 14.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.201 -0.296 . . . . 2.19 110.201 178.314 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.91 132.61 56.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.962 -2.607 . . . . 2.21 103.962 164.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.6 t -138.22 138.17 38.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 117.977 -1.489 . . . . 2.84 109.096 146.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.286 6.7 p -106.03 94.32 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 122.638 1.209 . . . . 2.08 110.512 -174.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.23 88.62 6.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.495 -0.928 . . . . 0.68 108.495 -168.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tt -30.67 -50.02 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.048 2.139 . . . . 1.95 111.996 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.74 -32.56 52.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.19 0.996 . . . . 0.84 112.754 -175.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -118.93 15.24 13.37 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.7 1.6 . . . . 1.4 110.212 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 16.89 58.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.968 2.907 . . . . 3.31 114.597 -167.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 148.65 52.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.523 -0.917 . . . . 0.99 108.523 178.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.88 111.59 23.94 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.167 -2.16 . . . . 0.43 105.167 169.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -79.6 120.58 24.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.577 -1.638 . . . . 0.78 106.577 167.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mt -125.6 97.28 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 O-C-N 124.592 1.183 . . . . 1.05 107.882 -171.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -80.53 120.89 25.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.779 -1.563 . . . . 2.54 106.779 166.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.18 164.29 15.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.819 -1.549 . . . . 2.59 106.819 -165.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.06 132.54 24.4 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 108.245 -1.02 . . . . 4.03 108.245 172.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.65 -52.74 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.992 2.462 . . . . 2.42 112.466 -160.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.83 -32.84 46.56 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.252 0.834 . . . . 3.13 113.252 -172.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 pt -88.49 5.51 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.322 0.86 . . . . 2.89 113.322 -177.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.39 -52.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.531 1.06 . . . . 3.04 111.584 -172.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.48 114.0 0.37 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 108.97 -1.652 . . . . 0.99 108.97 -171.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -56.9 -31.77 90.27 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 119.991 1.896 . . . . 0.89 111.204 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -54.16 -36.79 63.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.956 -0.545 . . . . 6.61 112.034 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -67.16 -47.0 72.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.396 0.998 . . . . 4.2 110.352 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 mt -54.92 -51.83 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.653 -0.654 . . . . 0.83 110.601 170.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.35 -52.87 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 119.007 -0.52 . . . . 1.42 110.125 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -46.32 -47.95 18.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.305 1.042 . . . . 2.74 109.25 174.005 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.0 m -62.86 -49.53 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.107 -0.637 . . . . 0.86 110.663 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.58 -51.12 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.414 0.686 . . . . 0.69 111.162 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.65 -40.18 76.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.867 0.303 . . . . 2.82 111.634 179.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -65.35 -23.17 66.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 117.507 -1.235 . . . . 0.85 112.524 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.84 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.52 1.509 . . . . 1.66 109.407 165.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.99 19.04 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.319 -1.267 . . . . 1.07 114.943 174.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -136.1 116.35 13.52 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.367 1.584 . . . . 2.06 110.251 -163.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 154.46 37.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 117.109 -1.836 . . . . 4.26 107.568 177.084 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.11 164.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.797 0.839 . . . . 1.17 110.53 -173.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.9 m -148.63 92.91 2.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.472 -0.936 . . . . 1.89 108.472 171.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -55.11 126.47 24.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.855 0.862 . . . . 2.83 110.963 174.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.46 146.32 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.393 1.077 . . . . 2.55 109.088 -172.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -66.19 -52.94 43.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.44 -0.578 . . . . 5.32 109.44 175.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 75' ' ' GLU 0.313 12.6 tt 43.66 -135.67 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.535 1.134 . . . . 5.11 110.443 -169.897 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' H ' HG12 ' A' ' 74' ' ' ILE . 43.2 mt-10 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 104.589 -2.375 . . . . 10.34 104.589 177.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtm . . . . . 0 N--CA 1.475 0.818 0 CA-C-O 121.161 0.505 . . . . 8.02 110.424 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.49 52.9 0.12 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 104.591 -3.404 . . . . 6.06 104.591 176.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 169.45 143.83 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.6 2.36 . . . . 4.93 106.619 -156.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.6 139.48 9.14 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 107.165 -2.374 . . . . 1.74 107.165 169.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.4 139.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.708 -0.849 . . . . 3.07 108.708 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.32 87.67 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.333 -1.728 . . . . 2.18 106.333 167.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.1 134.06 36.74 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 118.156 -1.417 . . . . 2.57 108.27 167.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.65 146.88 46.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 124.23 0.956 . . . . 2.87 108.716 164.159 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.14 135.51 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.662 -1.977 . . . . 1.7 105.662 169.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.8 135.38 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.541 1.536 . . . . 2.78 108.258 -177.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -145.64 136.03 24.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.861 -2.274 . . . . 5.18 104.861 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.75 -53.82 0.65 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.74 -1.744 . . . . 1.64 108.74 -171.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 ptm -65.5 149.71 49.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.395 -0.474 . . . . 1.53 110.623 173.307 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.13 -1.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.633 0.975 . . . . 2.52 113.633 -168.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -169.21 157.53 7.71 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.021 1.282 . . . . 3.18 109.848 -166.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.55 -50.46 1.13 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.183 2.193 . . . . 1.21 113.267 -174.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -33.45 75.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.063 1.345 . . . . 1.59 113.056 -176.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.9 m -72.56 -53.92 10.61 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.377 -1.342 . . . . 1.14 107.377 168.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -43.99 -64.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.637 1.575 . . . . 0.84 111.689 -173.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -16.21 64.14 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.038 -0.414 . . . . 1.48 111.749 -173.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.5 98.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.668 -0.864 . . . . 4.8 108.668 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -60.49 -58.63 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.169 -1.049 . . . . 0.62 108.169 -178.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -53.73 -56.28 18.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.092 0.557 . . . . 3.15 110.803 178.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -49.52 -45.03 46.79 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.569 0.748 . . . . 1.16 111.235 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.7 t -63.14 -61.04 2.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.445 0.698 . . . . 1.22 110.774 175.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.96 -39.49 94.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.009 -1.076 . . . . 1.9 111.405 -168.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 m -53.4 -16.92 1.57 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.202 0.815 . . . . 1.68 113.202 176.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -61.72 -42.82 99.46 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.036 -1.04 . . . . 4.83 111.212 171.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.46 135.63 39.39 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.285 -0.635 . . . . 2.45 109.285 -176.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -78.97 -1.53 35.81 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.718 -0.613 . . . . 6.41 112.639 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.94 -19.21 56.55 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.381 0.537 . . . . 0.84 112.664 -178.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.1 tt -93.81 137.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.913 -0.773 . . . . 2.63 108.913 175.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.27 -38.36 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.428 1.491 . . . . 1.36 110.087 -174.128 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -140.16 149.78 43.4 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.919 -0.771 . . . . 2.74 108.919 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 t -153.99 119.12 5.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 106.593 -1.632 . . . . 1.72 106.593 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -145.85 111.21 5.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.062 -0.718 . . . . 1.89 109.062 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 44' ' ' ALA . 3.5 p -105.88 108.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.586 0.708 . . . . 1.92 111.321 -175.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.33 101.7 10.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.004 0.922 . . . . 0.74 109.472 -170.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -43.08 -38.92 2.53 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.706 1.202 . . . . 2.31 111.222 168.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.53 -29.18 23.92 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.914 0.886 . . . . 1.53 112.065 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -128.06 16.03 6.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.49 1.116 . . . . 1.59 109.9 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 35.06 47.23 0.26 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.309 1.843 . . . . 2.57 112.569 -174.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.27 145.71 41.63 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.75 -0.594 . . . . 1.14 110.457 -171.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -108.96 106.88 17.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.711 -1.589 . . . . 0.47 106.711 172.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -79.44 98.63 6.86 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.43 -1.693 . . . . 0.89 106.43 168.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.45 140.74 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.897 -1.89 . . . . 1.44 105.897 164.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.13 132.21 55.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.452 -1.314 . . . . 2.61 107.452 156.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -148.92 169.12 21.27 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.943 0.897 . . . . 2.17 109.5 -172.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.68 111.33 55.34 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.666 -0.683 . . . . 3.7 109.34 174.262 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.12 52.05 3.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.048 3.165 . . . . 2.3 112.362 -176.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -139.78 -64.57 0.48 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.467 1.507 . . . . 4.13 107.294 178.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.28 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.118 0.967 . . . . 4.01 111.364 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 142.84 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.851 -1.537 . . . . 2.33 106.851 176.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.05 159.29 35.66 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.045 -1.222 . . . . 0.94 110.045 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.69 -47.31 11.49 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.825 1.683 . . . . 0.85 110.054 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -48.43 -42.33 31.93 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 122.999 0.52 . . . . 6.54 111.952 178.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -51.71 54.56 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.414 1.486 . . . . 3.47 109.723 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mt -60.88 -52.23 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.76 109.364 175.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.77 -54.13 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 118.602 0.637 . . . . 1.91 110.411 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -47.67 -53.2 15.64 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.581 1.553 . . . . 3.06 109.789 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.1 m -56.35 -51.33 68.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.456 . . . . 0.73 109.855 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.5 -53.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 O-C-N 121.993 -0.442 . . . . 0.9 110.742 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.9 -47.63 84.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.963 0.802 . . . . 3.89 110.195 -178.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -68.94 -9.86 54.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.928 -1.035 . . . . 1.01 113.023 -175.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.01 -78.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.253 1.388 . . . . 2.52 108.396 158.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.19 26.89 0.32 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.61 -1.106 . . . . 1.05 114.55 171.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -125.36 172.76 9.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.061 1.43 . . . . 1.82 113.36 -160.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 70.38 0.82 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.342 1.068 . . . . 3.81 108.666 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.41 144.51 35.8 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.329 -0.857 . . . . 1.22 111.274 -165.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -151.29 110.09 3.85 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.166 -0.959 . . . . 1.92 113.089 -172.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 76.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.475 2.31 . . . . 2.45 115.189 -175.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.8 m -60.25 -45.94 95.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 124.241 1.016 . . . . 1.86 112.331 168.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm 59.34 47.45 11.33 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.548 -1.345 . . . . 5.95 111.042 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mp 57.47 67.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.049 -0.723 . . . . 5.15 109.049 -167.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 N-CA-C 103.861 -2.644 . . . . 9.33 103.861 162.189 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 107.329 -1.36 . . . . 9.29 107.329 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.89 178.46 6.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 108.232 -1.947 . . . . 4.35 108.232 -142.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.91 114.98 1.94 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.748 1.219 . . . . 5.51 110.657 -179.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.59 111.07 3.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.148 -2.781 . . . . 1.74 106.148 159.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.43 137.34 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.655 1.228 . . . . 2.31 109.598 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.36 79.47 1.61 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.88 1.324 . . . . 2.07 107.935 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.37 102.06 8.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.012 -1.477 . . . . 2.79 107.012 168.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.31 141.28 47.21 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.698 0.399 . . . . 1.94 109.951 176.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.38 140.86 16.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.986 -1.486 . . . . 1.76 106.986 172.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -117.46 107.46 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.433 -1.321 . . . . 1.73 107.433 174.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -78.19 137.91 38.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.114 -1.439 . . . . 5.32 107.114 170.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.08 -41.44 2.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 123.965 0.793 . . . . 1.57 111.415 161.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -58.61 143.05 47.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.574 -0.368 . . . . 1.57 111.632 -178.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -145.85 142.0 28.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.44 1.096 . . . . 2.97 110.543 177.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.9 m 69.68 164.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.096 1.758 . . . . 3.04 114.186 167.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.61 -35.51 2.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.67 1.988 . . . . 1.34 112.194 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -55.63 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.169 0.988 . . . . 0.97 112.268 173.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -54.37 -37.62 65.19 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 120.831 -1.168 . . . . 1.09 109.623 -177.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -49.21 -65.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.893 0.477 . . . . 1.02 111.157 172.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.274 0.0 OUTLIER -68.12 -22.42 64.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.759 -0.588 . . . . 1.28 111.486 -175.816 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -60.28 -56.24 23.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.095 -1.076 . . . . 3.49 108.095 174.249 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.8 mt -57.62 -58.61 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.693 -0.854 . . . . 0.56 108.693 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.86 -56.47 21.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.369 0.531 . . . . 3.12 111.643 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -59.28 -38.86 81.18 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.742 -0.598 . . . . 1.16 111.243 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -65.28 -61.39 2.15 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.829 -0.545 . . . . 0.86 110.543 175.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.27 -31.61 72.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.429 -0.794 . . . . 2.64 111.963 -169.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.4 -10.49 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.666 1.121 . . . . 2.25 113.514 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -69.13 -21.2 64.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.435 1.016 . . . . 5.64 112.212 170.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -69.53 115.59 8.96 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.613 0.765 . . . . 2.34 109.362 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -78.57 46.26 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.41 -0.806 . . . . 6.86 112.659 -174.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.05 24.6 0.1 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.271 1.415 . . . . 0.93 110.785 170.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.14 122.11 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.416 -1.698 . . . . 2.44 106.416 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.9 mt -85.18 -38.54 18.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.735 0.814 . . . . 1.89 109.204 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -155.17 156.33 35.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.377 -1.342 . . . . 2.68 107.377 -176.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.2 t -146.67 59.75 1.2 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.03 -1.1 . . . . 2.51 108.03 178.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.38 94.28 3.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.356 -0.979 . . . . 2.28 108.356 -163.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.346 2.6 p -90.06 83.95 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 123.579 1.657 . . . . 1.62 111.242 -169.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.94 87.06 4.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.68 -1.145 . . . . 0.69 108.772 -178.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -40.34 -44.02 1.87 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.297 1.439 . . . . 2.29 110.632 162.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.03 -37.03 0.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.815 1.646 . . . . 1.04 113.556 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -132.43 26.0 4.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.114 1.366 . . . . 2.62 109.688 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 29.92 52.8 0.11 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.36 2.664 . . . . 1.99 112.571 -175.452 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 154.53 42.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.602 0.593 . . . . 2.93 112.602 -178.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.1 106.72 17.37 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.232 1.813 . . . . 0.38 109.508 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -78.78 83.09 4.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.517 -1.661 . . . . 1.42 106.517 167.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.452 HD13 HG21 ' A' ' 58' ' ' ILE . 11.6 mt -79.06 145.48 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.522 -1.288 . . . . 1.37 107.522 173.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.4 134.85 50.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.299 -2.482 . . . . 2.73 104.299 161.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.88 172.28 17.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.773 0.715 . . . . 1.85 109.803 -168.056 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.74 81.78 1.23 Allowed Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.24 1.416 . . . . 4.48 107.952 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.72 -35.48 47.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.302 2.668 . . . . 1.67 112.733 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.95 -20.47 6.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.125 1.157 . . . . 4.35 114.125 176.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.9 pt -120.43 -57.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 119.621 1.101 . . . . 2.45 111.702 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tp -87.46 -36.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.007 -0.368 . . . . 2.64 110.007 -161.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.53 149.94 3.18 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -177.275 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.52 -41.16 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.242 1.961 . . . . 0.77 110.33 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -54.61 -37.65 65.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.965 0.906 . . . . 6.47 111.148 -176.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -57.81 11.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.79 0.436 . . . . 3.68 110.821 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 46' ' ' ILE . 3.4 mp -54.42 -45.32 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 1.31 110.02 176.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -56.32 -51.59 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.626 -0.671 . . . . 1.29 111.322 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -49.39 -47.12 47.98 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.512 0.725 . . . . 2.85 109.279 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -49.68 76.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 119.681 -0.807 . . . . 1.21 109.645 -177.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.12 -50.32 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.545 0.338 . . . . 0.73 111.561 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.9 -46.63 83.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.405 -0.518 . . . . 4.13 111.042 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.6 t -57.55 -44.63 85.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.557 0.743 . . . . 0.88 111.232 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.8 -54.4 46.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.376 -0.828 . . . . 1.6 110.738 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.55 -42.13 0.02 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.859 1.104 . . . . 1.52 115.859 -178.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.79 134.47 55.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.376 -0.821 . . . . 1.87 111.138 -131.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.24 104.31 6.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.6 1.546 . . . . 4.6 108.715 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.98 154.34 29.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.921 0.889 . . . . 1.0 110.331 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -152.87 103.93 2.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 1.71 109.52 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 71' ' ' LEU . 1.9 pt? -66.62 71.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.14 1.376 . . . . 2.63 112.643 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.78 -49.93 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 123.996 0.918 . . . . 2.45 111.082 176.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 75' ' ' GLU . 3.7 mtpm? 67.24 152.97 0.08 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.243 1.017 . . . . 4.84 109.324 -166.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -66.97 -51.99 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.654 -1.239 . . . . 5.22 107.654 167.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 74.4 tt0 . . . . . 0 C--O 1.259 1.57 0 N-CA-C 102.034 -3.321 . . . . 9.8 102.034 164.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mtm . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 108.905 -0.776 . . . . 8.24 108.905 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.81 -112.62 4.97 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 106.021 -2.832 . . . . 5.2 106.021 -165.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.91 142.33 18.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.565 -1.272 . . . . 5.06 107.565 153.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.47 84.43 0.44 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.46 -1.456 . . . . 2.05 109.46 174.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.33 129.35 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.236 -0.653 . . . . 1.85 109.236 -174.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -140.51 101.04 4.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.918 0.866 . . . . 3.04 109.105 -169.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.41 106.15 18.14 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.019 -1.104 . . . . 2.11 108.019 178.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.93 139.49 48.53 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.303 0.501 . . . . 1.96 110.343 170.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.15 143.77 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.125 -1.435 . . . . 1.62 107.125 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.75 156.02 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.33 -1.359 . . . . 1.72 107.33 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -138.34 122.23 17.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.405 1.082 . . . . 7.74 108.218 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.5 -45.79 1.13 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.925 -1.27 . . . . 1.54 109.925 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -56.0 140.4 43.43 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.851 -0.426 . . . . 2.19 109.851 170.139 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -166.32 22.79 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.83 0.308 . . . . 2.73 111.83 -172.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -169.33 147.2 3.64 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.11 0.868 . . . . 2.04 109.377 -174.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.0 0.38 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.017 2.127 . . . . 1.18 113.167 175.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 p -54.5 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.846 0.858 . . . . 0.92 111.659 172.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -41.32 -47.37 3.47 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 125.5 1.52 . . . . 1.12 110.834 176.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 t -46.63 -66.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.603 1.161 . . . . 0.82 110.933 173.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.318 0.0 OUTLIER -69.82 -17.61 63.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 119.692 -0.803 . . . . 1.33 111.302 -176.087 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -69.11 -45.02 71.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.31 -0.996 . . . . 3.34 108.31 -176.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.4 mt -53.7 -69.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.702 -0.851 . . . . 0.52 108.702 175.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.54 -59.08 3.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.522 0.729 . . . . 3.7 112.548 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -54.88 -41.76 71.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.232 0.613 . . . . 1.06 110.37 -177.24 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -61.4 -61.07 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.095 -0.378 . . . . 0.81 110.96 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.538 HD13 HG23 ' A' ' 58' ' ' ILE . 14.5 mt -62.35 -35.63 79.72 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 118.627 -1.229 . . . . 1.72 111.406 -169.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -57.89 -13.98 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.109 0.411 . . . . 1.37 112.109 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -61.99 -40.68 96.46 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.093 -1.005 . . . . 4.49 111.15 169.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -67.78 122.44 18.11 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.454 -0.573 . . . . 2.17 109.454 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.68 48.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.173 -0.954 . . . . 6.37 111.095 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.94 0.1 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.08 1.324 . . . . 0.89 111.524 -178.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.37 142.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.052 -0.721 . . . . 2.65 109.052 173.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.96 -34.14 9.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.814 1.246 . . . . 1.63 110.461 -176.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -154.65 155.26 34.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.154 -0.684 . . . . 2.8 109.154 -175.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.7 t -155.76 80.08 1.01 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.73 0.812 . . . . 2.23 110.569 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -86.21 97.18 10.22 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.466 -0.771 . . . . 1.45 110.321 172.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -85.08 80.23 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.77 1.628 . . . . 2.08 108.651 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.18 93.92 9.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.856 -0.794 . . . . 0.75 108.856 -174.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -46.8 -35.49 6.32 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.448 1.099 . . . . 1.89 111.862 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.53 -30.39 41.41 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.567 0.747 . . . . 0.97 111.878 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -121.1 13.35 11.25 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.524 1.53 . . . . 1.44 109.782 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.04 33.19 6.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.167 2.187 . . . . 1.88 112.979 176.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.01 147.47 46.27 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.353 0.661 . . . . 1.03 111.57 -161.397 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.88 108.69 20.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.818 1.647 . . . . 0.43 108.657 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.96 87.41 4.78 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.804 -2.295 . . . . 0.84 104.804 162.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 58' ' ' ILE . 18.8 mt -79.67 150.28 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.896 -1.52 . . . . 1.51 106.896 169.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -126.65 122.55 35.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 104.824 -2.287 . . . . 2.59 104.824 156.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -145.6 128.87 16.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 107.341 -1.355 . . . . 2.53 107.341 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.3 121.61 75.31 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 106.942 -1.503 . . . . 3.59 106.942 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.93 -46.63 18.59 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.378 2.052 . . . . 2.08 112.799 -165.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -56.94 -8.86 0.69 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.964 1.706 . . . . 3.61 115.249 -166.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 pt -115.17 -10.18 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.415 1.086 . . . . 2.32 113.65 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.89 -42.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.736 1.153 . . . . 2.92 113.097 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.91 153.44 5.33 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.6 -1.0 . . . . 0.86 110.6 -174.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.59 -35.48 17.03 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.261 1.974 . . . . 0.94 110.652 -174.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 -37.28 61.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.358 0.663 . . . . 6.77 112.291 -172.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.11 -58.09 9.72 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.227 0.467 . . . . 4.36 110.024 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 26' ' ' LEU . 2.6 mp -51.29 -49.71 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.287 -0.635 . . . . 1.39 109.287 177.056 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.83 -54.16 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.971 -0.537 . . . . 1.75 110.783 179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -48.84 -52.07 26.18 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.498 0.719 . . . . 3.03 109.844 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -56.07 -51.57 67.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 122.123 -0.361 . . . . 0.94 110.487 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.0 mt -55.74 -47.73 78.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.748 -0.595 . . . . 0.79 111.877 -176.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.343 0.519 . . . . 4.9 111.477 176.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -66.85 -15.62 63.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.243 -0.884 . . . . 1.43 112.466 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.33 -89.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.602 -1.258 . . . . 2.99 107.602 155.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.49 20.23 0.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.898 -1.501 . . . . 1.01 114.8 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -123.76 139.05 54.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.957 1.878 . . . . 1.91 113.121 -160.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -77.33 139.59 39.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.049 -1.463 . . . . 4.28 107.049 171.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.02 146.58 43.95 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.509 1.124 . . . . 1.12 109.357 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -153.06 112.25 3.81 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 121.673 -0.642 . . . . 1.57 110.575 176.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.06 121.36 7.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.847 0.859 . . . . 2.55 109.347 173.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 m -104.01 -42.56 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.293 0.637 . . . . 2.24 110.287 172.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.3 83.44 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.436 . . . . 4.88 111.331 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.11 150.02 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.282 0.633 . . . . 5.76 110.733 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 129.087 2.955 . . . . 9.3 103.512 167.586 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ptp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 106.976 -1.49 . . . . 9.0 106.976 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.25 -61.71 2.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.87 -2.092 . . . . 5.1 107.87 -169.23 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.29 -179.89 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.497 0.665 . . . . 10.01 109.838 151.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.57 -41.26 1.05 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.609 -1.396 . . . . 1.77 109.609 -159.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.18 147.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.134 1.373 . . . . 2.56 109.994 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 7.0 tt -145.31 103.77 3.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 2.98 108.6 175.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.97 117.8 31.97 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.025 -0.989 . . . . 2.22 108.47 178.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.58 142.12 50.46 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.515 0.598 . . . . 1.94 110.851 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.71 134.84 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 107.033 -1.469 . . . . 1.92 107.033 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.61 119.87 60.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.839 1.256 . . . . 1.78 107.687 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -87.14 62.8 7.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.125 0.57 . . . . 5.92 110.484 -164.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.54 -104.63 0.2 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.69 -0.964 . . . . 3.57 110.69 174.326 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mtm 57.66 65.53 1.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.419 1.087 . . . . 2.16 111.873 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 p -65.97 -23.81 66.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.356 1.243 . . . . 3.81 114.356 -168.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.3 t -166.66 155.48 10.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.786 0.721 . . . . 2.21 109.143 -165.067 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.64 -39.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.659 2.384 . . . . 1.12 113.301 172.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 p -52.98 -76.08 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.603 1.161 . . . . 0.81 112.726 169.3 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.2 m -46.97 -41.03 15.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.165 1.786 . . . . 1.39 111.124 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.1 t -51.72 -73.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.931 0.893 . . . . 1.0 110.01 168.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.301 0.0 OUTLIER -67.31 -14.86 63.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.388 0.613 . . . . 1.3 112.275 -167.89 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.05 -42.15 93.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.032 -1.042 . . . . 4.52 108.494 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.46 -65.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.712 -0.847 . . . . 0.5 108.712 -175.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.21 -66.16 0.45 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.107 0.963 . . . . 3.82 112.234 175.723 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -47.55 -45.28 26.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.591 0.756 . . . . 1.1 111.068 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 t -60.95 -62.56 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.224 0.466 . . . . 0.96 111.12 175.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.59 -31.5 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.122 0.874 . . . . 1.74 111.163 -171.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 m -54.31 -19.54 5.56 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.116 -0.99 . . . . 1.78 112.646 176.324 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -37.97 77.4 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.711 -1.243 . . . . 6.0 112.59 170.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.86 165.09 16.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 2.76 109.992 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.92 42.13 3.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.758 0.823 . . . . 7.47 110.032 169.406 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.84 18.4 3.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.222 -1.151 . . . . 1.13 110.222 164.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -115.71 148.93 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.807 -2.294 . . . . 3.62 104.807 167.154 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.34 -37.12 5.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.784 1.233 . . . . 1.76 110.276 -174.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -157.63 162.4 38.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.675 -0.861 . . . . 2.58 108.675 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -143.37 73.85 1.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.194 0.997 . . . . 2.49 110.779 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.85 83.6 5.75 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.161 -0.681 . . . . 1.55 109.161 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.4 103.43 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.522 0.677 . . . . 1.55 110.503 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.71 100.16 9.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.383 1.073 . . . . 0.76 108.906 -172.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -38.18 4.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.254 1.422 . . . . 2.03 110.575 170.457 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.85 39.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.394 1.078 . . . . 0.76 112.262 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.24 16.0 10.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.641 1.177 . . . . 1.36 109.688 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.08 43.51 1.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.212 2.205 . . . . 1.88 112.512 -178.211 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.17 144.34 34.74 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 122.149 -0.345 . . . . 1.08 110.826 -166.64 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HB1' HG13 ' A' ' 46' ' ' ILE . . . -98.65 108.13 20.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.443 1.497 . . . . 0.41 108.556 168.394 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.79 83.44 7.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.354 -2.091 . . . . 0.73 105.354 157.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.421 HG13 ' HB1' ' A' ' 44' ' ' ALA . 59.8 mt -83.06 153.29 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.32 -1.733 . . . . 1.07 106.32 170.223 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -121.76 141.98 50.65 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.876 -1.898 . . . . 3.88 105.876 166.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -163.09 165.5 24.6 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 118.742 0.701 . . . . 1.99 112.186 -163.758 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.74 97.46 44.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 123.986 0.804 . . . . 4.2 110.736 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.72 -21.05 72.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.839 2.359 . . . . 1.73 114.641 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.44 -31.18 14.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.973 0.806 . . . . 4.11 111.875 168.48 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -66.86 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 123.229 0.611 . . . . 4.73 110.208 175.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.29 116.02 41.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.333 -0.988 . . . . 2.69 108.333 -166.382 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.16 161.91 38.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.378 -1.489 . . . . 0.87 109.378 -176.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -54.03 -37.88 86.68 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.856 1.704 . . . . 1.01 109.485 171.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 57' ' ' ASP . 12.8 ptt180 -35.96 -53.39 0.76 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 10.26 112.05 168.526 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 56' ' ' ARG . 64.6 m-20 -71.52 -52.02 20.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.709 -1.589 . . . . 2.96 106.709 -164.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -56.08 -52.37 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.384 -1.28 . . . . 0.96 109.406 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -53.38 -56.59 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.042 0.537 . . . . 1.56 109.683 179.032 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -56.93 -38.1 72.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.206 0.457 . . . . 3.13 110.247 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.7 m -65.08 -46.89 79.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.259 0.481 . . . . 0.74 110.609 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.78 -46.43 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.294 1.038 . . . . 0.68 110.431 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.28 -55.65 28.96 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 123.575 0.75 . . . . 2.94 109.672 173.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -51.85 -46.6 64.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.636 1.174 . . . . 1.24 111.357 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.79 -45.24 79.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.219 -0.926 . . . . 1.92 112.107 177.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.86 -46.46 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.999 0.76 . . . . 1.49 114.999 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -129.13 134.78 48.2 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 120.482 -0.487 . . . . 1.81 112.011 -135.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.46 154.94 32.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.731 -1.211 . . . . 3.27 107.731 168.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.29 165.08 28.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.907 0.483 . . . . 1.28 110.962 -166.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 m -132.58 112.09 11.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.571 1.549 . . . . 2.19 107.949 177.063 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 tp -73.1 78.59 1.23 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.796 1.238 . . . . 2.95 108.698 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.69 -36.61 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.583 -0.735 . . . . 2.01 111.377 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.88 68.68 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.365 1.866 . . . . 4.73 112.332 -179.575 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.1 pt -46.27 147.26 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.388 1.075 . . . . 4.91 111.014 176.021 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 128.013 2.525 . . . . 10.62 113.074 -165.682 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 106.058 -1.83 . . . . 10.16 106.058 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.75 171.17 40.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 107.735 -2.146 . . . . 4.43 107.735 177.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.55 162.96 1.43 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.13 1.372 . . . . 5.27 112.785 -174.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.9 171.89 39.7 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.385 -1.086 . . . . 2.14 110.385 152.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.89 132.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.188 -1.412 . . . . 2.18 107.188 163.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.85 124.42 44.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 103.771 -2.677 . . . . 3.36 103.771 169.355 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.4 127.03 40.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.096 -1.816 . . . . 2.46 106.096 -179.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.94 144.97 35.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.283 -0.266 . . . . 1.94 110.283 -172.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.84 139.29 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.212 -1.403 . . . . 1.79 107.212 168.028 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.98 99.49 6.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 126.235 1.814 . . . . 1.95 108.031 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -84.86 140.9 30.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.464 1.106 . . . . 5.53 108.061 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.92 -11.63 34.65 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.328 0.966 . . . . 1.65 112.818 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.72 146.89 53.33 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.292 1.046 . . . . 1.49 111.295 177.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -162.04 143.47 10.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.875 -1.898 . . . . 2.97 105.875 166.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.4 t 69.64 145.58 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.351 1.46 . . . . 2.47 113.147 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.19 -32.32 0.47 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.248 1.819 . . . . 1.2 113.176 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 p -51.66 -81.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.724 1.209 . . . . 1.01 112.936 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.5 m -45.7 -43.67 12.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.835 1.254 . . . . 1.21 110.68 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.1 -65.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.444 1.098 . . . . 1.14 110.976 174.024 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.293 0.0 OUTLIER -68.91 -20.21 64.23 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.549 0.69 . . . . 1.43 111.003 -176.559 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.03 -40.46 97.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.92 -1.113 . . . . 4.16 109.023 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.7 -67.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.933 0.893 . . . . 0.74 109.096 176.049 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.99 -64.17 0.87 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.942 0.497 . . . . 3.48 111.64 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -48.48 -47.56 38.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.933 0.893 . . . . 2.83 111.935 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 t -67.82 -39.94 83.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 O-C-N 121.336 -0.852 . . . . 0.84 112.285 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.97 -37.57 69.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.672 1.124 . . . . 1.77 110.937 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -68.87 73.13 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.17 1.388 . . . . 2.55 110.091 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 129.36 3.064 . . . . 5.53 109.648 -172.396 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -54.17 -40.79 67.82 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 119.114 0.87 . . . . 2.59 112.282 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 77.91 -5.17 2.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.674 2.389 . . . . 7.57 111.338 -163.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.53 47.09 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 121.304 -0.873 . . . . 1.27 111.456 176.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.28 133.93 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.114 1.366 . . . . 3.74 107.894 173.064 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -102.16 -31.89 10.37 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.413 1.085 . . . . 1.59 110.731 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -155.1 153.61 31.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.821 -0.609 . . . . 2.09 109.715 174.245 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -150.02 96.17 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.272 1.029 . . . . 2.03 110.846 -171.445 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.9 104.39 16.28 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.141 -0.689 . . . . 1.46 109.141 171.435 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.6 82.45 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.996 0.918 . . . . 2.16 108.85 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 90.21 6.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.071 -1.085 . . . . 0.91 108.071 -176.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -47.56 -32.68 5.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.773 0.829 . . . . 1.81 111.304 169.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.75 -32.57 31.18 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.941 0.896 . . . . 0.98 111.876 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -122.53 18.05 10.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.405 1.482 . . . . 1.67 109.68 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 m120 36.83 45.16 0.4 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.965 2.106 . . . . 2.65 112.916 -175.212 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.28 143.99 42.45 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.493 0.588 . . . . 1.61 111.82 -174.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.11 112.91 24.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.427 1.491 . . . . 0.42 108.131 168.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -86.23 105.68 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.475 -1.676 . . . . 0.89 106.475 164.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.72 103.62 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.586 1.554 . . . . 1.24 108.338 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.34 83.66 4.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.57 -1.641 . . . . 3.39 106.57 172.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 165.0 14.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.287 1.035 . . . . 2.0 112.3 177.233 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.97 101.12 39.59 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.394 1.078 . . . . 3.78 110.195 174.018 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 60.62 6.88 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.489 3.46 . . . . 2.31 113.796 -166.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -157.23 -40.07 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.657 0.783 . . . . 4.17 111.42 167.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.06 -13.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.208 0.603 . . . . 2.26 110.249 174.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -149.48 144.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 108.071 -1.085 . . . . 2.2 108.071 175.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.4 148.75 20.8 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 108.317 -1.913 . . . . 1.06 108.317 170.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.46 -42.93 56.19 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.466 1.444 . . . . 0.72 109.702 178.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.59 -42.28 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.173 1.389 . . . . 7.31 113.218 168.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.26 -41.6 76.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.262 0.937 . . . . 3.32 109.597 -175.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 mt -63.59 -49.27 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.422 -0.955 . . . . 0.68 108.422 176.163 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -50.0 -56.85 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.879 -0.415 . . . . 1.56 109.879 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -51.49 -51.66 53.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.073 0.549 . . . . 3.04 110.114 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.6 m -58.97 -52.57 65.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.625 -0.43 . . . . 0.81 110.056 -176.775 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.83 -60.55 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.862 0.865 . . . . 0.75 110.024 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.4 -45.06 80.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.802 -0.444 . . . . 3.87 109.802 -176.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -62.97 -9.17 8.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.227 -1.368 . . . . 1.11 114.278 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.76 -87.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 121.359 1.89 . . . . 2.54 107.808 155.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.13 42.49 0.47 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.833 -0.982 . . . . 1.22 112.307 174.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.4 170.83 11.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.327 1.064 . . . . 1.93 112.912 -171.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -117.42 122.47 43.89 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 104.684 -2.339 . . . . 3.45 104.684 167.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.79 154.82 26.74 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.732 0.813 . . . . 1.04 111.073 -171.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.4 m -156.24 121.46 4.76 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.455 -0.778 . . . . 1.55 110.363 172.368 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.44 128.62 38.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 3.73 110.149 173.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.32 158.24 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.547 1.539 . . . . 2.37 109.528 178.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -87.4 72.72 9.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.155 -0.966 . . . . 5.0 108.987 -176.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.7 mm 74.41 -70.23 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 125.862 1.665 . . . . 6.53 108.795 -172.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.735 2.014 . . . . 10.03 112.156 176.539 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptp . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.327 -0.62 . . . . 11.62 109.327 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.06 -66.82 1.45 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.114 -1.594 . . . . 7.85 109.114 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -104.86 -168.78 1.52 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.786 1.235 . . . . 5.53 109.562 172.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.27 -19.67 10.07 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.327 -1.263 . . . . 2.88 115.069 148.357 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.67 100.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 120.169 1.985 . . . . 2.3 110.975 176.101 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -104.17 101.45 11.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.825 2.05 . . . . 2.62 107.288 174.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -97.51 107.15 19.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.97 -0.752 . . . . 2.44 108.97 172.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -99.94 148.25 24.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 124.14 0.9 . . . . 2.33 108.952 166.417 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.15 145.73 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.161 -1.792 . . . . 1.72 106.161 158.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.05 139.23 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.746 1.218 . . . . 2.29 108.766 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -133.56 153.58 51.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.766 0.826 . . . . 6.85 111.023 -178.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.03 -21.0 28.0 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.862 1.22 . . . . 1.95 110.965 -174.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.5 mtm -66.75 150.55 48.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.156 -0.614 . . . . 1.8 109.681 174.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t -151.35 10.81 0.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.105 0.78 . . . . 2.44 113.105 177.374 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.5 t -171.87 151.56 2.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.544 1.066 . . . . 2.29 109.528 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.28 -31.94 0.71 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.696 1.998 . . . . 1.2 113.012 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -53.3 -67.5 0.25 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.377 1.071 . . . . 0.72 113.145 170.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.5 m -43.15 -50.96 6.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.217 1.407 . . . . 1.07 108.346 176.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 t -50.02 -66.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.743 -1.117 . . . . 0.84 111.551 177.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' GLU 0.327 0.0 OUTLIER -65.83 -28.98 69.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.98 111.112 -171.404 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.07 -52.29 56.57 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.32 1.448 . . . . 3.06 108.281 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -51.76 -65.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.092 -1.077 . . . . 0.76 108.092 171.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 20' ' ' HIS . 11.4 pt-20 -66.44 -42.07 88.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.91 -0.586 . . . . 2.96 110.759 -158.175 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -59.54 -45.66 91.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.739 0.815 . . . . 1.55 110.39 173.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -59.5 -49.67 76.87 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.761 -0.459 . . . . 0.97 109.761 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.07 -45.23 75.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.751 -0.593 . . . . 2.49 110.985 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -61.55 -7.03 2.81 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.395 1.257 . . . . 2.27 114.395 179.11 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -66.63 -31.94 72.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.492 1.042 . . . . 4.35 110.654 169.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -64.74 121.5 14.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.627 0.771 . . . . 2.26 109.168 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.06 46.05 0.78 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.445 0.906 . . . . 5.6 113.445 -165.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.62 20.38 0.13 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.469 1.033 . . . . 1.41 111.335 166.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.68 140.18 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.093 -1.077 . . . . 2.38 108.093 174.088 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.3 mt -109.28 -35.9 6.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.366 1.066 . . . . 1.6 111.433 -173.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -155.46 158.42 38.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.462 1.028 . . . . 2.24 109.854 -177.151 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 p -155.91 140.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.742 2.417 . . . . 3.13 105.467 -177.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -156.45 90.59 1.18 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.362 -1.718 . . . . 1.55 106.362 170.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.48 76.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.603 -1.258 . . . . 1.92 107.603 -172.14 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.86 93.24 4.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.572 -0.705 . . . . 1.0 109.133 -171.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tt -42.98 -37.17 1.79 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.252 1.421 . . . . 2.17 111.566 168.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.23 -32.91 39.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 1.11 112.452 178.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -116.05 12.23 15.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.255 1.422 . . . . 1.6 110.125 178.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 40.44 37.74 0.49 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.823 2.049 . . . . 2.14 112.141 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 154.89 45.54 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.489 0.716 . . . . 1.44 109.762 -169.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.68 112.12 11.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.413 -1.328 . . . . 0.61 107.413 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -92.08 96.94 10.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.899 2.479 . . . . 1.29 104.602 170.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.2 mp -92.79 135.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 104.707 -2.331 . . . . 1.57 104.707 172.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.1 127.88 54.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.501 -1.666 . . . . 3.2 106.501 168.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -165.35 168.47 16.78 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.111 0.965 . . . . 2.98 109.74 -173.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -92.13 119.05 68.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.412 1.07 . . . . 4.0 108.905 171.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.62 -32.51 93.43 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.543 1.495 . . . . 2.15 113.039 176.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -84.88 49.88 1.81 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.901 1.228 . . . . 5.55 111.843 -165.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.97 -47.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 127.395 2.278 . . . . 4.15 107.83 178.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -53.62 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.308 1.043 . . . . 2.84 109.595 -173.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.06 145.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.717 -0.614 . . . . 0.92 111.7 -166.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -52.5 -39.63 74.03 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.514 2.143 . . . . 0.94 111.354 178.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -37.95 -48.76 1.2 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.435 1.494 . . . . 7.66 112.697 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.57 -50.24 59.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.864 0.84 . . . . 3.69 109.506 -172.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.3 -52.58 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.598 -0.689 . . . . 1.04 110.896 175.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.86 -50.8 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.946 -0.761 . . . . 1.71 108.946 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -55.37 -47.04 76.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.008 0.523 . . . . 5.05 110.373 -179.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -60.08 -48.4 81.89 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.856 0.753 . . . . 0.95 110.936 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.7 -51.69 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.865 0.757 . . . . 0.88 110.837 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.95 -55.5 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.119 0.968 . . . . 2.86 109.943 177.139 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -57.09 -34.95 68.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.751 1.22 . . . . 1.03 111.597 -177.016 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.67 -58.1 4.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.529 0.604 . . . . 2.37 110.275 172.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 -41.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.826 1.09 . . . . 1.57 115.826 -176.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -117.25 142.69 46.74 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 117.421 0.61 . . . . 1.98 111.65 -135.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.8 150.49 30.71 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.838 -1.542 . . . . 3.69 106.838 173.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.41 164.61 35.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.235 0.471 . . . . 1.09 111.994 -176.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.7 m -158.2 132.04 7.85 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 118.282 -0.866 . . . . 1.4 110.624 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.49 128.68 37.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.893 1.224 . . . . 2.55 108.777 172.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.58 22.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 123.442 0.697 . . . . 3.05 111.967 177.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -161.65 -68.32 0.06 Allowed 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.703 -0.48 . . . . 8.55 109.703 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.273 5.0 tp 21.64 68.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.963 2.105 . . . . 8.48 113.712 -165.171 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-N 114.51 -1.223 . . . . 10.44 109.526 167.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 106.076 -1.824 . . . . 7.79 106.076 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.24 -167.37 12.62 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 107.229 -2.348 . . . . 4.49 107.229 -133.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.8 95.74 7.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.542 1.171 . . . . 6.01 109.017 172.1 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.9 31.73 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.796 -0.521 . . . . 1.78 111.796 178.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.42 128.9 74.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.089 0.956 . . . . 3.36 110.727 -175.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.25 120.3 28.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.108 1.363 . . . . 4.37 108.076 173.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.83 107.89 19.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.185 -1.043 . . . . 2.41 108.185 177.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -117.78 148.55 41.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.036 0.534 . . . . 1.94 110.998 -174.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.7 151.2 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.884 0.873 . . . . 1.81 108.971 173.211 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.72 86.76 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.981 1.312 . . . . 2.19 109.339 174.193 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 107.48 18.78 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.664 -0.648 . . . . 6.58 110.416 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.62 -20.77 0.39 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.357 0.98 . . . . 1.54 112.133 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.7 mtm -62.5 169.7 2.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.176 0.988 . . . . 1.72 111.79 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 t -158.9 -44.66 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.519 0.727 . . . . 2.35 110.856 -177.625 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.9 m -138.44 164.3 29.71 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.189 0.449 . . . . 2.62 110.665 -168.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -38.64 3.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.48 1.912 . . . . 1.23 112.464 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.8 p -52.68 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.782 1.233 . . . . 0.88 112.265 170.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.4 m -42.69 -41.97 3.33 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.638 1.175 . . . . 1.23 111.43 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.22 -72.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.024 0.53 . . . . 0.84 111.121 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -17.88 65.08 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.465 -0.772 . . . . 1.0 112.334 -170.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -54.99 -46.4 75.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.859 0.864 . . . . 3.51 109.36 173.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.08 -60.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.895 -1.15 . . . . 0.59 107.895 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -50.84 -58.17 6.62 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.794 0.438 . . . . 2.97 110.654 178.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -56.2 -33.69 65.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.473 0.709 . . . . 1.09 111.908 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -70.62 -64.46 0.89 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.581 0.628 . . . . 0.99 110.609 172.436 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.12 -32.89 74.82 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.052 -1.03 . . . . 2.15 111.583 -167.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -56.93 -16.45 6.88 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 2.23 112.701 175.211 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -63.08 -35.8 81.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.398 -0.814 . . . . 4.97 111.126 171.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -72.98 109.7 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.53 -0.915 . . . . 2.58 108.53 177.381 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -65.87 -3.74 5.62 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.928 -1.107 . . . . 7.23 110.898 167.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.73 -25.37 71.69 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.623 1.106 . . . . 1.02 112.833 166.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 pp -99.84 156.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 119.142 1.471 . . . . 3.31 110.519 175.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.22 -38.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.557 1.543 . . . . 1.48 110.046 -177.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -155.65 157.06 36.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.651 0.659 . . . . 2.55 109.409 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -140.64 131.78 26.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.073 -1.454 . . . . 1.95 107.073 170.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.45 98.31 3.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.344 1.458 . . . . 1.63 107.651 -177.486 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.33 106.55 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.334 0.654 . . . . 1.71 111.761 -174.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.13 97.67 8.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.545 -0.722 . . . . 0.9 109.223 -174.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -48.98 -40.2 29.62 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.19 0.996 . . . . 1.76 111.597 175.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.55 -32.95 1.02 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.384 1.074 . . . . 0.86 113.226 175.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -125.82 13.76 7.98 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.084 0.953 . . . . 1.36 111.154 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 34.52 49.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.776 . . . . 1.88 112.277 -172.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 139.71 53.59 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.164 0.585 . . . . 2.77 109.856 -179.001 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.96 112.17 24.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.223 1.409 . . . . 0.6 107.738 162.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -79.18 102.16 8.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.281 -2.488 . . . . 1.35 104.281 160.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.0 mt -106.76 124.73 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.336 -1.728 . . . . 0.95 106.336 174.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -97.48 114.74 26.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.219 -2.141 . . . . 3.52 105.219 166.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.66 151.62 29.0 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.76 -1.941 . . . . 2.94 105.76 -178.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.62 129.43 23.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.409 0.443 . . . . 3.83 110.883 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -56.94 -35.31 98.6 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.898 2.399 . . . . 1.73 111.737 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.64 -25.87 65.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.13 0.789 . . . . 3.71 113.13 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.9 pt -106.86 -26.96 3.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 118.965 0.802 . . . . 2.83 112.161 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -152.93 131.97 3.12 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 CA-C-N 119.246 0.93 . . . . 2.78 109.584 172.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.71 166.75 53.4 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.473 -0.651 . . . . 0.85 111.473 -177.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.02 -55.54 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.86 2.374 . . . . 1.18 110.586 177.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -56.97 -32.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 122.391 -0.193 . . . . 7.49 111.03 -174.451 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -56.88 13.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.659 1.584 . . . . 4.02 109.184 175.049 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.66 -50.33 68.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.059 -0.719 . . . . 1.41 109.059 176.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.2 -46.97 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.007 -0.542 . . . . 1.98 110.524 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -52.71 -51.73 59.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.984 0.811 . . . . 2.79 109.714 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -52.33 -58.39 6.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.466 0.575 . . . . 0.9 110.302 175.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.3 -55.78 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.043 0.537 . . . . 0.78 111.179 -172.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -53.67 -45.6 70.33 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.709 0.804 . . . . 4.19 109.635 176.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -66.98 -9.88 43.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.617 -1.182 . . . . 1.08 113.392 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.96 -100.99 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.276 1.398 . . . . 2.6 107.85 156.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.86 38.92 0.5 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.243 0.929 . . . . 1.64 112.871 177.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -130.81 122.71 27.61 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.311 1.056 . . . . 1.97 109.336 -171.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -79.91 133.61 36.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.971 -1.863 . . . . 3.01 105.971 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.28 161.15 30.88 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 113.791 1.034 . . . . 1.08 113.791 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -158.22 137.71 11.87 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.912 1.285 . . . . 1.48 108.572 177.201 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -82.43 48.22 1.26 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.747 1.612 . . . . 3.22 111.232 -175.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -41.25 -32.79 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 117.209 2.3 . . . . 2.67 117.209 -160.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.11 -30.95 61.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.135 1.334 . . . . 10.1 112.283 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.03 84.44 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.647 1.579 . . . . 7.95 108.279 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 . . . . . 0 C--O 1.251 1.137 0 N-CA-C 105.684 -1.969 . . . . 11.72 105.684 169.637 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 104.501 -2.407 . . . . 9.0 104.501 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.36 178.48 3.97 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 109.27 -1.532 . . . . 6.76 109.27 138.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -118.9 -44.16 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.98 2.112 . . . . 9.13 109.591 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.9 2.55 38.74 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.427 -1.207 . . . . 2.13 115.292 168.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 p -156.63 127.7 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 120.371 2.086 . . . . 1.8 110.29 172.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.48 108.97 6.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.787 -1.19 . . . . 3.38 107.787 172.79 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.35 119.44 28.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.434 -1.321 . . . . 2.18 107.434 169.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -119.69 140.49 50.58 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.707 1.139 . . . . 2.8 110.494 170.046 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.81 119.87 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.718 -1.216 . . . . 1.59 107.718 173.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.54 94.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.569 1.148 . . . . 2.54 108.37 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -78.45 86.16 4.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.937 -1.505 . . . . 7.09 106.937 176.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.12 -138.25 5.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 103.48 -3.848 . . . . 3.38 103.48 175.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 mtm 65.78 166.97 0.19 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.951 1.3 . . . . 2.18 111.62 -170.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.6 p -147.21 -83.41 0.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.993 0.517 . . . . 3.66 110.134 -176.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t -146.29 103.46 3.71 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.595 0.758 . . . . 2.94 110.389 -166.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 45.33 -129.98 1.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.458 -0.941 . . . . 2.77 108.458 -169.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.1 p 43.53 -87.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.463 1.905 . . . . 0.8 113.962 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -39.83 -43.75 1.51 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.087 1.755 . . . . 1.09 110.391 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -44.42 -67.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 0.95 110.649 172.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HA ' ' HG3' ' A' ' 23' ' ' GLU 0.326 0.0 OUTLIER -71.78 -21.6 61.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 119.797 -0.761 . . . . 0.94 112.512 -177.525 . . . . . . . . 4 4 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.56 -45.32 92.17 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.362 -1.347 . . . . 4.19 107.362 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.43 -69.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.62 -0.718 . . . . 0.61 109.085 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 2.1 pp20? -56.6 -48.14 78.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.774 0.261 . . . . 4.77 111.589 -165.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -70.45 -20.77 62.87 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.23 0.612 . . . . 1.2 110.485 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.7 t -66.85 -62.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.33 -1.481 . . . . 0.99 109.036 162.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.66 -50.58 35.18 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 113.62 0.97 . . . . 1.85 113.62 -162.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -44.15 -28.26 0.48 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.015 1.326 . . . . 2.25 113.58 -167.513 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -63.17 -40.48 97.67 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.192 2.597 . . . . 4.16 112.944 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -62.2 129.06 39.02 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.254 -1.017 . . . . 2.41 108.254 172.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.88 -3.47 3.44 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.795 1.405 . . . . 10.75 114.795 -166.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' HD12 ' A' ' 52' ' ' ILE . . . -92.16 -14.13 56.49 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 119.546 -0.585 . . . . 1.16 112.214 -178.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mm -88.91 104.86 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.037 -1.098 . . . . 2.45 108.037 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.0 mt -78.99 -38.96 35.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.004 -0.739 . . . . 1.62 109.004 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -155.31 145.68 21.95 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.599 -0.889 . . . . 2.31 108.599 176.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.75 105.99 6.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.307 -1.368 . . . . 1.89 107.307 175.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 t -120.94 103.6 9.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.963 -1.125 . . . . 1.52 107.963 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.04 127.78 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.072 0.549 . . . . 1.87 110.481 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.03 108.94 11.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.035 0.934 . . . . 1.2 110.247 -170.075 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.81 -41.51 5.06 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.933 1.293 . . . . 2.41 111.08 168.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.77 14.36 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 124.109 0.964 . . . . 0.79 112.475 -175.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -130.07 14.28 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.212 1.005 . . . . 1.4 110.006 -177.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 m120 29.97 53.55 0.13 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 126.169 1.788 . . . . 2.29 111.831 -169.025 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.29 141.17 37.76 Favored 'General case' 0 N--CA 1.461 0.085 0 O-C-N 121.577 -0.702 . . . . 0.99 110.712 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.19 112.61 24.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.753 1.621 . . . . 0.47 108.424 168.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -79.91 104.0 10.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.055 -1.832 . . . . 0.84 106.055 162.169 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.41 113.0 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.482 -0.933 . . . . 0.9 108.482 175.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -84.1 107.38 16.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 105.699 -1.963 . . . . 3.06 105.699 164.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -147.2 167.48 24.09 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.67 -1.604 . . . . 2.66 106.67 174.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.35 136.65 27.34 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.757 1.021 . . . . 4.37 113.757 174.4 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.34 48.59 2.93 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.506 3.471 . . . . 2.06 113.023 -165.522 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -155.85 -47.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.004 1.322 . . . . 3.11 109.464 -173.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.531 HD12 ' HA2' ' A' ' 31' ' ' GLY . 7.6 pt -67.75 -32.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.228 -1.027 . . . . 3.23 108.228 166.059 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.56 HG23 ' H ' ' A' ' 54' ' ' GLY 0.31 17.6 tt -131.67 -91.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 123.735 0.647 . . . . 2.4 112.579 170.029 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 135.67 152.78 6.49 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.536 -1.426 . . . . 1.15 109.536 -168.201 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.71 -57.17 0.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.197 1.931 . . . . 1.01 109.033 172.773 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptt85 -29.28 -55.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.223 2.209 . . . . 10.04 113.22 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.23 -51.06 65.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.552 -0.907 . . . . 2.85 108.552 -171.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.81 -49.95 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.536 -0.542 . . . . 0.81 109.536 177.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.1 mm -50.28 -57.99 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 119.09 -0.481 . . . . 1.53 109.795 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -51.46 -46.31 63.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.055 0.542 . . . . 2.82 110.258 177.09 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -57.57 -47.9 80.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.388 -0.339 . . . . 0.69 110.986 178.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.0 -50.6 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.278 0.945 . . . . 1.66 110.989 -177.197 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -50.28 73.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.337 0.517 . . . . 2.95 110.243 176.009 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -52.0 -42.0 62.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.526 0.73 . . . . 0.9 111.132 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.74 -49.29 48.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.305 -0.872 . . . . 1.84 111.687 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.9 -44.22 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 116.001 1.16 . . . . 1.37 116.001 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.87 156.8 39.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.813 0.672 . . . . 1.88 112.813 -135.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.21 139.71 39.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.651 -1.611 . . . . 5.65 106.651 171.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.85 70.59 1.21 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.401 1.48 . . . . 2.54 110.1 -166.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -84.99 100.32 11.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.425 0.631 . . . . 1.68 109.629 -170.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.33 73.88 0.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.68 1.592 . . . . 2.63 112.651 -178.167 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -52.66 -33.28 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.086 1.354 . . . . 2.0 111.682 167.082 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 tttp 66.49 -62.17 0.29 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.218 2.607 . . . . 6.27 112.67 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.8 mt 71.35 -61.3 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.719 1.607 . . . . 5.1 111.162 -177.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.12 1.368 . . . . 10.92 107.833 174.571 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 108.862 -1.695 . . . . 1.46 108.862 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.14 147.54 5.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.06 -1.089 . . . . 2.2 108.06 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.5 tp -150.64 82.92 1.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.509 -0.552 . . . . 2.26 109.509 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 mp0 -77.92 100.73 6.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 110.035 -0.357 . . . . 3.49 110.035 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.78 118.21 27.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.04 -1.467 . . . . 2.62 107.04 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.77 119.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 105.498 -2.038 . . . . 1.82 105.498 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.67 93.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 125.513 1.525 . . . . 2.15 107.967 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -78.47 112.36 15.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.009 -1.478 . . . . 6.53 107.009 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.64 -136.76 7.82 Favored Glycine 0 N--CA 1.434 -1.479 1 N-CA-C 101.994 -4.442 . . . . 3.54 101.994 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.63 173.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.874 0.87 . . . . 2.21 112.683 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -154.03 -81.03 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.954 1.302 . . . . 3.29 108.674 -167.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -172.13 131.37 0.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 125.361 1.464 . . . . 5.37 107.957 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 48.45 -146.12 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.558 -0.734 . . . . 2.8 109.21 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.1 p 51.61 -86.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.907 1.447 . . . . 1.39 114.907 161.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.5 p -45.31 -41.7 9.03 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.214 -0.929 . . . . 3.54 111.53 166.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.03 -72.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.3 1.44 . . . . 0.82 110.064 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -25.82 66.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.806 -0.616 . . . . 1.17 111.241 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -53.21 -57.52 10.22 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.527 -0.916 . . . . 4.73 108.527 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.69 -60.12 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.908 -0.775 . . . . 0.58 108.908 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -54.16 -57.03 12.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.85 0.357 . . . . 3.27 111.373 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -57.0 -47.58 80.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.433 0.693 . . . . 1.04 110.07 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -60.03 -65.23 0.71 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.931 -0.396 . . . . 0.84 109.931 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.75 -29.43 69.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.006 -1.078 . . . . 2.86 111.217 -166.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -55.82 -20.38 15.0 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.163 -0.961 . . . . 1.58 112.348 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -30.64 69.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.808 -1.183 . . . . 6.64 112.417 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -70.07 116.04 9.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.209 -1.034 . . . . 2.36 108.209 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 32.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.418 -0.802 . . . . 7.84 113.082 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.08 -8.53 5.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.037 1.78 . . . . 0.72 111.82 166.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.02 118.64 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 105.974 -1.861 . . . . 2.5 105.974 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.83 -37.75 18.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.222 -0.659 . . . . 1.73 109.222 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.4 162.12 40.86 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.052 0.387 . . . . 2.89 110.866 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.91 96.08 2.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.433 1.893 . . . . 1.91 108.957 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 m -99.73 99.78 10.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.719 1.608 . . . . 1.96 107.545 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.96 92.53 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 122.819 1.295 . . . . 1.9 109.286 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.72 82.22 3.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.484 -1.302 . . . . 1.28 107.484 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -37.5 -44.07 0.63 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.248 1.819 . . . . 2.59 110.378 163.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.4 -32.93 28.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.121 . . . . 1.08 113.067 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -120.95 20.45 11.57 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.416 1.086 . . . . 2.53 110.296 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 34.59 56.66 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.368 1.867 . . . . 2.23 111.523 -170.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -140.69 125.58 18.23 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.968 0.359 . . . . 1.6 111.968 -167.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.74 98.99 8.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.62 107.245 165.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -77.25 96.29 4.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 104.787 -2.301 . . . . 1.09 104.787 159.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.67 150.0 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.249 -1.342 . . . . 1.23 107.996 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.14 133.74 55.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.427 -2.064 . . . . 3.06 105.427 166.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -156.26 161.82 40.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.176 -1.416 . . . . 2.42 107.176 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.18 140.99 22.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 4.15 107.088 161.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.45 -22.58 28.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.399 2.066 . . . . 1.71 111.628 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.648 0.779 . . . . 4.06 111.169 -172.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.98 -11.29 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.647 0.379 . . . . 2.42 111.957 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.88 130.99 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.315 -0.624 . . . . 2.39 109.315 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.01 154.08 47.68 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.177 -1.569 . . . . 0.76 109.177 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.04 -40.52 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.585 1.523 . . . . 0.75 109.34 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 11.3 tpt180 -59.09 -38.26 79.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.381 -0.342 . . . . 8.24 111.202 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -53.0 47.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.154 1.382 . . . . 3.51 109.745 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.35 -51.87 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.031 -0.986 . . . . 0.85 109.04 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.46 -52.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.695 -0.669 . . . . 1.28 111.446 -177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 32.5 m170 -48.06 -49.41 31.57 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.935 1.294 . . . . 2.96 109.496 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -63.37 -47.44 82.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.98 -0.555 . . . . 1.13 109.642 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.79 -58.81 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 121.471 -0.768 . . . . 1.0 111.29 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.68 -49.04 76.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.692 -0.855 . . . . 2.73 108.692 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.7 t -48.37 -50.32 31.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.238 1.015 . . . . 1.23 111.712 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.13 -42.76 86.53 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.168 1.173 . . . . 1.79 114.168 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.89 -2.92 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 N-CA-C 119.127 2.411 . . . . 1.23 119.127 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -142.27 177.64 8.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.963 1.881 . . . . 1.86 111.846 -144.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -110.62 140.3 45.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.184 -1.784 . . . . 5.18 106.184 150.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.0 116.15 16.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.861 0.864 . . . . 2.25 110.827 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -122.55 116.99 24.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.394 1.078 . . . . 1.69 111.417 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.88 72.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.93 1.692 . . . . 2.22 112.407 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 123.818 0.847 . . . . 1.99 110.443 169.173 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.601 0 N-CA-C 109.255 -1.538 . . . . 1.58 109.255 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.4 151.96 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.229 -0.656 . . . . 2.3 109.229 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.8 tp -152.37 111.07 3.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.271 -1.011 . . . . 2.09 108.271 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -106.49 117.53 34.28 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.096 0.474 . . . . 2.86 111.693 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.6 mt -106.78 129.91 54.57 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.81 -1.182 . . . . 2.79 107.81 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.74 101.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.18 -1.415 . . . . 1.95 107.18 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 22' ' ' ILE . 49.0 t -79.91 78.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.578 -1.638 . . . . 1.85 106.578 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -77.68 116.06 17.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 5.62 107.458 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.39 -11.71 3.25 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.504 1.049 . . . . 1.45 112.631 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.407 ' CE ' HG22 ' A' ' 19' ' ' VAL . 31.0 mtp -63.76 149.55 46.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.053 0.926 . . . . 1.47 109.922 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.4 17.72 0.34 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.795 0.665 . . . . 2.35 112.795 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -171.39 152.09 3.22 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.787 1.176 . . . . 2.22 110.786 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.14 -35.97 3.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.295 1.838 . . . . 1.21 112.739 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -59.18 -69.64 0.19 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.8 111.798 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.2 m -40.35 -45.73 2.21 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.908 1.283 . . . . 1.31 110.414 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG22 ' CE ' ' A' ' 13' ' ' MET . 10.5 t -53.32 -73.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 123.842 0.714 . . . . 0.78 111.108 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -21.51 64.33 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.706 -0.621 . . . . 1.07 112.13 -166.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -55.8 -47.31 77.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.364 1.066 . . . . 3.82 109.362 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.401 HD13 HG11 ' A' ' 10' ' ' VAL . 54.8 mt -62.56 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.453 -0.943 . . . . 0.57 108.453 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -49.94 -60.6 2.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.539 0.736 . . . . 3.19 110.428 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 t -52.39 -44.49 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.726 0.81 . . . . 1.03 110.989 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -61.51 -62.79 1.57 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.107 0.412 . . . . 0.87 110.494 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.38 -33.35 75.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.241 -0.912 . . . . 1.81 111.434 -166.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.1 p -60.02 -11.99 7.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.449 -0.782 . . . . 2.02 112.649 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -62.65 -39.51 94.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.008 0.822 . . . . 4.81 110.908 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -70.71 125.85 27.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.047 -1.094 . . . . 2.37 108.047 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -75.76 48.86 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.899 0.879 . . . . 7.14 110.334 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.86 -39.67 0.15 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 126.516 2.008 . . . . 0.84 110.566 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -79.26 119.75 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.43 -1.693 . . . . 2.91 106.43 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.96 -26.11 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.456 0.702 . . . . 2.04 110.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -155.3 155.11 33.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.959 -0.756 . . . . 2.46 108.959 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -149.75 131.6 15.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.409 -1.33 . . . . 1.97 107.409 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -142.28 118.87 11.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.055 -1.091 . . . . 1.71 108.055 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p -99.76 97.87 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.265 1.031 . . . . 1.84 110.938 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 97.82 11.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.687 -0.856 . . . . 0.72 108.687 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -49.99 -34.12 20.03 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.88 0.872 . . . . 2.65 111.684 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.96 60.64 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.742 0.817 . . . . 1.12 111.66 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -119.37 11.67 12.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.086 1.354 . . . . 1.57 109.763 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 m120 37.71 38.73 0.17 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.722 2.009 . . . . 1.79 111.95 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.58 133.52 54.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 121.681 -0.637 . . . . 1.08 109.594 -168.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 101.46 13.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.335 -1.728 . . . . 0.53 106.335 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -76.67 92.62 3.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.684 -2.339 . . . . 1.03 104.684 166.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.74 150.54 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.822 -1.548 . . . . 1.12 106.822 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -126.17 142.48 51.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.794 -1.558 . . . . 3.0 106.794 155.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.42 175.57 13.81 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.196 0.999 . . . . 2.06 108.996 -170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.98 125.78 26.55 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 108.671 -0.863 . . . . 3.53 108.671 171.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.26 61.06 6.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.364 3.376 . . . . 2.21 111.509 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -168.07 -43.22 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.894 1.678 . . . . 3.57 110.119 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.3 pt -73.26 -30.18 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.748 -0.834 . . . . 2.69 108.748 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -153.49 149.14 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.515 -0.92 . . . . 2.37 108.515 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 167.25 31.74 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 110.62 -0.992 . . . . 0.77 110.62 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.58 -46.22 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.499 2.133 . . . . 0.72 110.756 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -45.72 -40.8 9.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.872 1.269 . . . . 7.86 111.105 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -57.5 12.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.447 1.899 . . . . 3.39 107.969 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mt -63.3 -48.82 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.73 109.575 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.8 -60.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.931 0.893 . . . . 1.53 109.139 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -57.83 -42.44 84.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.701 1.2 . . . . 4.87 109.738 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 m -61.3 -47.13 87.37 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.468 -0.493 . . . . 0.83 110.564 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.16 -45.05 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.69 111.065 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -57.27 -52.95 63.25 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.103 0.561 . . . . 3.04 109.728 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -54.75 -42.22 71.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.818 1.247 . . . . 0.78 111.146 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.82 -55.49 19.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.0 0.818 . . . . 1.77 111.106 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.28 -42.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.65 1.02 . . . . 1.45 115.65 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.68 140.98 52.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 117.754 0.777 . . . . 2.0 112.194 -137.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.82 79.76 4.29 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.247 0.546 . . . . 3.34 110.316 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.91 141.16 44.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.571 -0.706 . . . . 1.55 110.284 -165.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -156.41 128.38 7.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.173 -0.955 . . . . 2.15 111.209 -167.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.9 116.96 2.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.174 1.39 . . . . 2.22 110.931 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.222 -0.358 0 C-N-CA 124.565 1.146 . . . . 2.71 109.051 168.577 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 111.372 -0.691 . . . . 2.35 111.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.74 92.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.321 1.058 . . . . 2.12 108.508 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.8 tp -95.31 101.19 12.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.032 1.733 . . . . 2.15 106.961 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -95.42 120.41 35.61 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.514 -1.291 . . . . 2.81 107.514 156.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.88 148.51 25.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.73 1.269 . . . . 2.71 108.255 158.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.89 143.54 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.534 -2.025 . . . . 1.91 105.534 160.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.21 127.56 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.556 1.542 . . . . 2.47 108.308 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -118.24 155.41 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.391 0.677 . . . . 6.58 110.021 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.89 -31.88 6.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.278 1.418 . . . . 1.54 110.582 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mtp -51.12 130.52 26.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.556 0.742 . . . . 1.54 110.273 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -154.03 17.38 0.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.246 -0.407 . . . . 2.38 112.087 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -169.36 151.17 4.45 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.143 0.883 . . . . 2.27 109.378 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.46 -37.73 12.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.798 1.639 . . . . 1.13 112.013 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.6 p -57.92 -71.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.99 0.916 . . . . 0.85 111.67 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.8 m -40.32 -44.07 1.86 Allowed 'General case' 0 C--N 1.338 0.109 0 C-N-CA 125.096 1.358 . . . . 1.23 111.012 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.84 -73.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 123.703 0.627 . . . . 0.87 111.041 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -20.31 66.08 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.567 -0.708 . . . . 1.15 112.206 -168.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.33 -42.53 82.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.865 0.866 . . . . 3.09 109.729 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.5 mt -62.17 -57.26 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.501 -0.926 . . . . 0.47 108.501 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.32 -57.95 8.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.968 0.907 . . . . 3.4 109.866 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -52.29 -54.36 32.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.033 0.933 . . . . 0.9 110.442 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -59.03 -40.08 83.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.888 -0.577 . . . . 0.79 112.092 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -73.67 -36.82 65.37 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.331 0.969 . . . . 1.75 112.512 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 m -70.81 70.39 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.034 0.921 . . . . 2.51 110.357 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -174.0 -23.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.687 2.795 . . . . 5.75 112.394 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.249 1.386 . . . . 2.53 111.189 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 67.84 -3.85 1.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.603 2.361 . . . . 6.08 113.67 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.83 -28.87 40.6 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.412 -1.075 . . . . 0.82 110.412 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.88 129.48 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.259 0.624 . . . . 2.68 109.397 171.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.19 -42.74 12.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.291 1.036 . . . . 1.38 109.294 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.337 -0.246 . . . . 1.9 110.337 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -137.67 130.77 30.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.666 1.586 . . . . 1.99 107.006 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -134.4 103.61 5.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.976 -1.49 . . . . 1.74 106.976 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.334 2.8 p -89.73 88.25 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 123.461 1.601 . . . . 1.81 110.231 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.1 84.81 4.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.305 -1.316 . . . . 1.27 107.839 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.53 -36.56 4.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.725 1.61 . . . . 2.91 111.147 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.85 -33.45 23.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.394 0.678 . . . . 1.16 111.936 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -113.83 4.51 15.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.043 1.737 . . . . 2.38 110.967 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 44.23 52.63 7.04 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.23 1.012 . . . . 1.95 110.3 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -139.81 142.66 36.66 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 122.721 0.408 . . . . 1.6 110.696 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.34 101.19 10.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.698 -1.223 . . . . 0.66 107.698 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -78.27 104.89 9.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.115 -2.18 . . . . 0.92 105.115 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.67 121.72 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.743 -1.577 . . . . 0.91 106.743 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -102.22 123.8 46.69 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.443 -1.688 . . . . 2.6 106.443 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.33 152.62 32.33 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.364 0.666 . . . . 2.41 109.478 -171.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -95.67 108.4 39.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 107.647 -1.242 . . . . 3.84 107.647 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.97 -46.72 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.213 1.942 . . . . 2.5 112.587 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.2 -32.13 15.62 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.989 1.107 . . . . 3.88 113.989 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 pt -96.05 7.47 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 118.521 0.6 . . . . 2.46 112.467 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.72 -55.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.098 0.863 . . . . 3.23 111.69 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.46 143.3 5.25 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.827 1.68 . . . . 0.91 110.266 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -57.94 -39.58 85.16 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.819 2.346 . . . . 0.86 110.603 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -29.23 -50.88 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.006 2.122 . . . . 10.54 113.218 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -71.62 -49.71 37.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.5 1.12 . . . . 4.17 109.767 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.0 mt -58.71 -54.07 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.703 -0.68 . . . . 0.74 109.362 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -53.88 -54.68 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.461 -0.57 . . . . 1.93 109.461 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -53.33 -45.12 68.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.882 0.473 . . . . 5.06 110.351 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -59.8 -52.55 64.98 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.104 0.411 . . . . 0.77 110.415 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.6 mt -51.78 -58.66 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.86 109.361 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -52.07 -57.67 8.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.627 0.727 . . . . 3.43 109.805 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -58.66 -26.11 63.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.322 1.449 . . . . 0.76 113.371 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.27 -76.9 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.592 1.542 . . . . 1.8 110.968 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.6 31.91 0.43 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.775 -1.014 . . . . 1.42 112.989 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -132.68 173.48 11.3 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.368 1.084 . . . . 1.96 112.571 -165.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.58 155.8 34.27 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 105.65 -1.981 . . . . 3.81 105.65 157.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.75 166.36 33.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.01 0.823 . . . . 1.04 112.371 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.88 132.04 10.05 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.561 1.144 . . . . 2.25 110.571 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.11 125.98 21.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.721 1.209 . . . . 2.64 110.309 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 124.825 1.25 . . . . 2.09 111.949 173.847 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.051 0 CA-C-O 122.091 0.828 . . . . 1.49 113.003 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.16 145.31 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.328 -1.101 . . . . 2.15 109.059 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -147.85 119.94 8.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.35 -2.093 . . . . 2.07 105.35 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.98 113.05 22.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.61 -1.626 . . . . 2.49 106.61 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -110.91 131.85 54.7 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.415 -1.328 . . . . 3.43 107.415 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -75.88 126.32 36.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 105.032 -2.211 . . . . 1.77 105.032 154.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -119.34 108.73 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.334 -1.728 . . . . 2.15 106.334 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -79.84 98.77 7.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.767 . . . . 5.0 108.93 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 -105.23 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.23 -2.348 . . . . 3.54 107.23 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.657 ' HE3' HG22 ' A' ' 37' ' ' VAL . 41.5 mtp 57.49 35.25 25.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.629 0.772 . . . . 3.29 112.1 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -74.58 121.22 21.24 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.731 -0.606 . . . . 3.08 110.043 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t 68.46 152.53 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.77 1.628 . . . . 2.32 113.239 169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.25 72.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.158 1.783 . . . . 3.39 110.566 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 p -178.8 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.672 1.189 . . . . 1.6 109.466 -160.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.7 m -73.15 -51.1 19.15 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.922 -0.77 . . . . 1.1 108.922 159.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -42.7 -73.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.476 1.911 . . . . 0.96 111.58 -175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -25.73 68.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.089 -0.382 . . . . 1.29 111.903 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -67.41 -49.43 63.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.154 0.981 . . . . 4.48 108.925 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -53.34 -62.3 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 108.207 -1.035 . . . . 0.65 108.207 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -53.42 -57.1 11.82 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.366 0.267 . . . . 3.08 110.713 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -49.71 -50.88 42.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.854 -0.594 . . . . 1.09 110.331 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 t -55.53 -50.59 69.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.347 0.521 . . . . 0.83 110.801 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 mt -67.83 -38.22 82.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.59 -1.644 . . . . 1.78 110.557 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.8 m -59.95 -10.23 3.88 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.667 -0.646 . . . . 1.63 112.591 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -62.77 -40.83 98.52 Favored 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.718 -1.238 . . . . 5.22 109.83 168.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -72.38 135.35 45.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.777 -1.194 . . . . 2.66 107.777 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.48 -0.74 55.82 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.868 -0.52 . . . . 6.37 110.961 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.62 -15.07 64.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.402 0.525 . . . . 0.71 113.306 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.7 tt -88.82 124.46 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.028 -1.101 . . . . 2.91 108.028 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.7 mt -82.23 -40.26 21.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.047 0.939 . . . . 1.54 109.5 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -155.21 148.62 25.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 110.127 -0.323 . . . . 1.97 110.127 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.4 t -132.9 138.98 47.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.963 1.305 . . . . 1.96 107.703 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 m -143.92 102.38 3.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.004 -1.11 . . . . 1.5 108.004 164.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.657 HG22 ' HE3' ' A' ' 13' ' ' MET 0.327 1.2 p -88.76 80.88 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 123.708 1.718 . . . . 1.61 108.809 -177.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 90.4 4.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.93 1.692 . . . . 0.86 110.158 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pp -54.53 -29.9 52.1 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.571 1.148 . . . . 3.1 112.427 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.9 26.04 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.156 0.582 . . . . 0.89 111.43 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 p -114.63 9.25 16.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.354 1.462 . . . . 2.07 111.658 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.97 45.0 3.18 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.254 1.422 . . . . 1.83 111.247 -171.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -133.26 136.49 45.57 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 122.73 0.412 . . . . 1.08 111.734 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -89.63 109.19 20.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.565 1.146 . . . . 0.6 108.247 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -78.58 114.18 17.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.846 -2.279 . . . . 0.89 104.846 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.12 107.19 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.337 -1.357 . . . . 1.05 107.337 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -87.31 105.3 17.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.672 -1.603 . . . . 3.38 106.672 163.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.26 175.22 6.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.529 1.932 . . . . 1.99 106.293 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.35 130.77 23.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.239 -0.652 . . . . 3.71 109.239 166.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -57.52 -35.12 98.89 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.681 2.254 . . . . 1.83 110.938 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.2 -6.56 24.12 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.5 0.926 . . . . 4.4 113.5 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 pt -120.97 -31.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.421 0 CA-C-N 119.703 1.138 . . . . 3.08 113.047 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 tt -152.04 144.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 119.783 1.174 . . . . 2.44 108.781 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.67 159.78 51.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.788 -1.325 . . . . 0.75 109.788 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.8 -48.29 1.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.958 1.772 . . . . 0.72 109.274 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 tpt85 -55.7 -34.8 65.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.821 0.849 . . . . 7.84 111.744 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -61.04 2.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.696 2.399 . . . . 3.45 108.807 174.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.05 -43.68 81.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.493 0.717 . . . . 0.94 110.139 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.28 -43.23 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.749 -0.643 . . . . 1.99 110.749 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -54.51 -45.26 73.26 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.248 0.931 . . . . 2.69 110.409 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.5 m -55.31 -53.39 56.68 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.531 0.605 . . . . 0.9 110.559 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.17 -53.93 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.461 0.704 . . . . 1.72 111.335 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -54.11 -57.48 10.93 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.458 1.103 . . . . 3.19 109.807 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.5 t -52.66 -49.75 64.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.545 1.538 . . . . 1.15 111.071 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -61.18 -54.56 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.099 0.409 . . . . 3.13 110.96 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.87 -42.44 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.782 -1.199 . . . . 1.59 115.42 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.68 141.47 47.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.031 -0.668 . . . . 1.97 111.517 -133.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -78.24 123.43 26.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.225 -1.398 . . . . 3.44 107.225 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.18 159.0 15.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 1.37 110.757 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 m -151.35 114.51 4.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.272 1.029 . . . . 1.97 108.348 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.73 127.13 29.85 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.654 -0.869 . . . . 2.84 108.654 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 123.398 0.679 . . . . 1.99 110.949 177.62 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 109.642 -1.383 . . . . 1.66 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.62 145.41 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 118.524 1.162 . . . . 2.43 108.864 169.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.43 91.09 2.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.903 -1.517 . . . . 2.51 106.903 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.32 105.65 17.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.109 -0.7 . . . . 2.95 109.109 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 62' ' ' ILE . 4.1 pp -110.29 147.88 33.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.806 0.692 . . . . 2.11 109.48 173.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.45 133.44 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.832 -1.914 . . . . 1.7 105.832 161.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.35 137.1 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 125.123 1.369 . . . . 2.34 107.808 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -140.04 153.28 46.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.776 0.831 . . . . 7.3 109.862 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.8 -43.85 1.67 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.829 -1.308 . . . . 1.69 109.829 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -48.43 114.35 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.318 1.447 . . . . 2.14 114.103 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 p -97.48 115.93 28.73 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.133 1.373 . . . . 3.91 110.397 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.7 m 69.73 176.88 0.27 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.157 0.979 . . . . 3.29 113.31 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.18 -37.96 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.543 2.337 . . . . 1.19 112.523 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 p -64.51 -56.96 10.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.802 0.667 . . . . 0.88 112.802 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 119.966 -1.709 . . . . 1.13 108.542 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.93 -66.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.623 0.769 . . . . 0.82 110.776 172.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.258 0.1 OUTLIER -68.89 -26.04 64.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 121.795 -0.565 . . . . 1.1 111.285 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -59.77 -53.76 54.24 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 3.69 109.116 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.29 -60.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.727 -0.842 . . . . 0.6 108.727 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -55.18 -52.95 61.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.012 0.195 . . . . 3.16 110.743 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 t -57.73 -43.05 85.04 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.438 0.695 . . . . 1.01 111.603 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -62.22 -48.26 80.78 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.278 0.561 . . . . 0.81 109.919 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.61 ' O ' HG21 ' A' ' 32' ' ' ILE . 8.3 mp -70.06 -37.84 75.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.779 -0.629 . . . . 2.39 111.047 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.9 m -71.09 61.73 0.29 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 120.643 1.565 . . . . 2.36 111.334 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -148.98 -69.98 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.556 1.942 . . . . 4.02 109.252 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.547 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -63.51 111.98 2.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 2.3 111.653 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -77.99 47.08 0.62 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.817 1.784 . . . . 5.59 115.817 -152.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.84 2.87 5.26 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.992 0.815 . . . . 0.91 113.058 164.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.61 HG21 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -94.0 115.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.101 1.761 . . . . 2.81 107.049 178.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.9 mt -85.7 -43.69 13.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.827 0.851 . . . . 1.52 110.555 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -145.32 146.91 31.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.839 -0.43 . . . . 2.31 109.839 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.8 p -134.68 134.81 41.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.435 1.494 . . . . 3.21 107.397 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -151.06 104.66 3.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.966 -1.494 . . . . 1.67 106.966 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.33 3.4 p -92.89 88.7 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.445 1.593 . . . . 1.79 110.562 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.28 80.41 4.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.514 -1.221 . . . . 1.14 108.459 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.1 tt -42.38 -38.93 2.01 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.68 1.992 . . . . 1.7 111.226 166.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.17 -35.01 47.62 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.666 0.786 . . . . 0.92 112.065 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 p -108.64 8.52 27.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.466 1.506 . . . . 2.2 111.015 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.6 45.44 5.73 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.595 1.558 . . . . 2.09 110.392 -171.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -133.24 137.92 46.29 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.045 0.538 . . . . 1.12 110.239 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -98.34 107.85 20.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.469 -1.308 . . . . 0.56 107.469 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -84.03 97.4 9.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.966 -2.235 . . . . 0.8 104.966 162.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.416 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -93.84 154.38 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.512 -1.662 . . . . 1.76 106.512 162.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -128.55 145.01 51.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.57 -1.27 . . . . 2.98 107.57 159.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -160.18 172.43 17.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.492 0.717 . . . . 2.03 111.448 -165.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -105.93 100.17 26.57 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.155 1.382 . . . . 3.91 109.935 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -72.76 67.56 3.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.989 3.126 . . . . 2.35 112.298 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -166.34 -47.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.813 1.245 . . . . 3.75 110.343 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.17 -17.28 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 123.74 0.816 . . . . 2.52 110.462 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 tt -148.56 154.72 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.472 -2.048 . . . . 2.35 105.472 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.8 167.8 25.84 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.51 -1.436 . . . . 0.9 109.51 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.09 -39.83 76.1 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.664 1.576 . . . . 0.76 109.064 165.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -44.65 -52.36 8.28 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.261 1.424 . . . . 7.23 112.178 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -52.36 64.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.543 1.065 . . . . 2.82 110.321 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.83 -56.14 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.068 -0.715 . . . . 1.22 109.068 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.87 -56.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 122.805 0.442 . . . . 1.57 109.851 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -52.73 -49.53 65.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.165 1.386 . . . . 4.97 110.078 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.1 m -58.69 -45.77 88.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.112 -0.329 . . . . 0.75 110.112 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 8' ' ' LEU . 51.7 mt -56.6 -65.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.777 -0.453 . . . . 0.97 109.777 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.28 -46.87 72.82 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.419 -0.513 . . . . 2.92 110.393 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -60.61 -20.3 60.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.134 -1.412 . . . . 0.87 113.688 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.64 -73.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.162 1.801 . . . . 1.8 109.655 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.56 29.21 0.39 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.723 -1.043 . . . . 1.12 113.23 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.31 172.42 8.66 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 118.763 1.281 . . . . 1.95 113.362 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -103.88 146.39 28.72 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.203 -2.147 . . . . 4.25 105.203 158.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.6 137.94 20.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.833 0.853 . . . . 1.32 111.162 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 m -157.07 111.73 2.75 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.084 -1.01 . . . . 1.97 112.593 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -39.22 128.48 1.75 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.407 1.483 . . . . 3.67 110.583 165.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.454 -0.233 0 C-N-CA 124.589 1.156 . . . . 1.98 109.1 169.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 110.876 -0.89 . . . . 2.52 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.41 141.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 126.702 2.001 . . . . 1.84 106.385 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.0 tp -153.87 113.86 3.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.407 1.483 . . . . 2.23 107.037 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.87 121.23 37.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 2.07 108.209 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 145.45 50.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.343 0.52 . . . . 2.52 111.875 170.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.89 136.73 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.062 -1.459 . . . . 1.84 107.062 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.72 95.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 127.019 2.128 . . . . 1.96 106.006 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -79.57 126.11 30.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.51 -0.876 . . . . 5.12 108.848 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.46 8.99 4.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.202 1.382 . . . . 1.58 113.555 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.464 ' CE ' HG22 ' A' ' 37' ' ' VAL . 36.0 mtp -78.6 117.21 19.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.437 1.118 . . . . 1.79 108.268 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -143.73 16.39 1.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.146 0.795 . . . . 2.32 113.146 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -169.26 141.32 2.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.23 0.923 . . . . 2.55 109.453 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.03 -39.67 0.91 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.485 1.914 . . . . 1.22 113.63 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -59.52 -75.56 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.816 0.846 . . . . 1.23 111.847 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -46.97 -36.78 8.12 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 125.636 1.575 . . . . 1.85 111.521 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.21 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.872 0.869 . . . . 1.16 109.123 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.256 0.3 OUTLIER -64.73 -15.96 62.25 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.656 -0.653 . . . . 1.64 112.742 -166.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -57.44 -40.43 78.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.42 1.088 . . . . 3.13 108.698 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.43 -63.78 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.292 -1.003 . . . . 0.56 108.292 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -58.35 6.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.495 0.318 . . . . 3.06 110.648 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 t -50.97 -47.32 61.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.127 0.971 . . . . 1.05 111.201 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -62.23 -57.44 11.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.823 -0.548 . . . . 0.83 109.654 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.43 -39.69 70.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.406 0.682 . . . . 2.29 111.497 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -48.46 -35.81 13.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.345 -0.847 . . . . 1.74 112.136 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 1.29 2.03 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.115 -0.991 . . . . 6.57 113.316 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.632 ' CB ' HD11 ' A' ' 53' ' ' ILE . 10.7 m170 -83.71 -19.85 34.5 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.134 -1.604 . . . . 2.4 110.738 171.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 65.92 -3.02 0.81 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.723 1.609 . . . . 6.93 115.236 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.79 15.79 51.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.28 0.945 . . . . 0.85 111.833 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -113.19 142.02 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.955 -1.498 . . . . 2.19 106.955 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.73 -40.57 9.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.581 0.752 . . . . 2.49 109.466 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -155.14 156.3 35.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.369 0.531 . . . . 2.4 110.691 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 m -137.29 116.58 12.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.54 -2.022 . . . . 2.6 105.54 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.62 99.6 7.65 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.253 -1.388 . . . . 1.41 107.253 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG22 ' CE ' ' A' ' 13' ' ' MET 0.285 0.6 OUTLIER -94.38 91.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 123.107 1.432 . . . . 1.41 110.484 -173.015 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.15 91.79 7.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.678 1.591 . . . . 0.95 111.23 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -44.55 -42.27 7.13 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.4 1.88 . . . . 1.71 112.521 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.28 -35.16 59.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.585 0.754 . . . . 1.46 111.463 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -107.5 3.67 25.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.397 1.479 . . . . 2.23 110.955 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.35 59.13 1.21 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.487 1.915 . . . . 2.86 109.832 -166.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 140.66 37.01 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.083 0.553 . . . . 1.12 111.013 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.47 113.83 26.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.52 108.384 165.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.59 99.33 8.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.621 -1.992 . . . . 0.97 105.621 158.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.75 141.8 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.377 -1.342 . . . . 1.26 107.377 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -125.19 116.34 21.86 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.231 -1.766 . . . . 3.47 106.231 165.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.09 165.0 37.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.591 1.157 . . . . 1.89 109.401 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.23 137.74 27.62 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.844 -1.169 . . . . 4.32 107.844 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.49 -40.44 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.165 1.91 . . . . 2.46 112.262 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.09 -31.69 23.23 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.336 0.516 . . . . 3.58 111.373 -164.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -56.4 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.402 -0.592 . . . . 3.79 109.402 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.632 HD11 ' CB ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -92.73 -41.92 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.673 -0.24 . . . . 3.11 110.944 -163.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.73 115.44 0.09 OUTLIER Glycine 0 CA--C 1.534 1.253 0 N-CA-C 109.423 -1.471 . . . . 1.2 109.423 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.72 -33.19 79.26 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 CA-C-N 120.306 2.053 . . . . 0.91 112.44 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -47.55 -43.14 24.85 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.968 0.729 . . . . 6.88 112.968 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -58.67 -55.19 38.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.078 0.942 . . . . 4.1 109.903 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.1 mt -50.96 -52.92 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.822 -0.626 . . . . 0.96 110.671 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.39 -48.24 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-O 118.64 -0.695 . . . . 1.79 110.117 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -51.09 -48.69 61.61 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.619 -0.511 . . . . 2.9 109.619 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -61.37 -48.13 82.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 118.513 -1.275 . . . . 1.2 109.907 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.9 mt -54.35 -57.05 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 119.388 -0.339 . . . . 0.9 111.167 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.25 -46.1 88.43 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.503 0.592 . . . . 4.67 110.414 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -66.79 -15.97 63.95 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.718 -1.135 . . . . 0.83 112.517 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.81 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.461 1.482 . . . . 1.78 110.496 162.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.96 36.2 0.5 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.017 -0.88 . . . . 1.47 113.548 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -132.81 175.09 9.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.352 1.076 . . . . 1.83 111.265 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -129.74 121.98 27.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.001 -1.111 . . . . 3.36 108.001 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.13 163.46 13.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.454 0.701 . . . . 1.37 111.934 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -155.98 123.99 5.7 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.601 1.56 . . . . 1.56 108.53 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.87 138.27 58.4 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.815 0.734 . . . . 2.49 109.963 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 123.182 0.593 . . . . 2.08 111.443 177.128 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 N-CA-C 108.392 -1.883 . . . . 1.94 108.392 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.72 138.4 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.294 -0.533 . . . . 2.05 110.008 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -142.43 88.43 2.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.256 1.822 . . . . 2.1 107.541 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -82.57 121.28 26.6 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.873 -1.528 . . . . 2.25 106.873 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -128.71 137.71 51.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.179 -0.325 . . . . 1.89 110.238 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.45 145.81 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.711 -1.218 . . . . 1.73 107.711 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.26 155.19 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.472 -1.677 . . . . 1.9 106.472 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -126.31 132.68 51.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.393 -1.336 . . . . 4.89 107.393 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.25 23.81 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.288 1.423 . . . . 1.83 112.201 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mtp -72.37 78.0 1.02 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.259 1.029 . . . . 2.14 109.189 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 t -97.26 -3.48 40.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.791 0.836 . . . . 2.26 112.813 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -163.41 144.65 9.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.591 1.087 . . . . 2.26 110.795 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.05 -37.43 0.16 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 127.88 2.472 . . . . 1.2 113.37 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -52.46 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.198 0.999 . . . . 0.87 112.339 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.8 m -43.04 -49.51 6.11 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 126.504 1.921 . . . . 1.3 110.191 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.4 t -45.82 -69.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 125.432 1.493 . . . . 1.03 110.554 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.281 0.3 OUTLIER -70.21 -17.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.428 -0.509 . . . . 1.55 111.638 -175.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -70.24 -42.32 72.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.301 -1.0 . . . . 4.64 108.301 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -51.2 -61.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.53 108.92 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -58.8 -54.32 48.45 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.809 -0.557 . . . . 2.72 112.103 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.4 t -54.4 -30.99 53.98 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.831 0.852 . . . . 1.01 111.483 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 t -71.03 -69.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.497 -0.752 . . . . 0.93 110.275 167.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -50.85 -47.31 60.36 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.26 1.424 . . . . 2.37 113.462 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.7 p -46.08 -34.19 3.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.682 0.793 . . . . 2.15 111.83 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -64.09 -21.79 66.67 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.706 1.203 . . . . 6.1 111.788 -175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.529 ' CB ' HD11 ' A' ' 53' ' ' ILE . 12.5 m170 -64.21 -29.75 70.84 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.472 0.578 . . . . 2.2 110.384 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 67.68 -1.95 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.137 1.775 . . . . 5.06 114.771 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.01 32.64 5.74 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.885 1.22 . . . . 0.87 110.785 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mt -138.37 126.65 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.099 -1.815 . . . . 2.21 106.099 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.52 -37.66 13.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 123.64 0.588 . . . . 1.86 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -144.76 148.56 34.25 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.161 -1.051 . . . . 3.13 108.161 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -157.07 68.17 0.55 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.132 -1.062 . . . . 2.01 108.132 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 m -84.9 108.69 17.67 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.053 -0.351 . . . . 1.67 110.053 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.21 112.87 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.983 -0.747 . . . . 2.33 108.983 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.41 98.5 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.657 0.783 . . . . 0.96 110.429 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -38.75 -47.48 1.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.126 1.77 . . . . 1.92 112.148 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.12 66.55 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.493 1.117 . . . . 0.98 111.79 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -117.09 10.63 13.96 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.723 1.209 . . . . 1.68 109.943 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.32 59.59 0.27 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.438 2.295 . . . . 2.57 112.305 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.12 152.78 37.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.559 0.744 . . . . 1.09 109.76 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.52 118.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.994 1.318 . . . . 0.56 108.101 164.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -81.1 96.52 7.2 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 105.251 -2.129 . . . . 0.76 105.251 163.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.83 141.21 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.837 -1.542 . . . . 0.96 106.837 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -122.87 121.83 37.15 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.53 -2.396 . . . . 2.54 104.53 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -137.78 169.27 18.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.776 0.716 . . . . 2.31 112.293 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -108.01 99.88 33.21 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.651 0.78 . . . . 4.66 109.237 -171.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.67 48.16 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.114 2.542 . . . . 2.45 112.835 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -137.12 17.96 2.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.048 1.339 . . . . 5.04 110.323 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.11 -56.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 124.422 1.089 . . . . 4.66 108.576 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.529 HD11 ' CB ' ' A' ' 29' ' ' HIS . 1.6 mt -95.67 142.65 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.154 -1.425 . . . . 2.18 107.154 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.0 151.24 20.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.657 -1.377 . . . . 1.07 109.657 160.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.79 -38.58 29.79 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.957 1.771 . . . . 0.7 110.605 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -50.02 -44.52 51.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.433 0.693 . . . . 7.39 111.303 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -53.47 37.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.5 1.12 . . . . 3.34 108.881 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.67 -54.49 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.993 -0.549 . . . . 0.74 109.784 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.91 -52.69 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.449 -0.575 . . . . 1.33 109.449 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -56.21 -47.2 78.86 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.76 0.824 . . . . 4.78 110.263 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.3 m -58.37 -46.08 87.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.235 0.471 . . . . 0.86 110.437 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 54.6 mt -54.3 -64.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.131 -0.692 . . . . 0.74 109.131 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -55.0 -47.82 74.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.948 0.404 . . . . 4.25 110.197 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -58.47 -20.3 44.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.116 -1.421 . . . . 0.98 113.825 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.25 -76.4 0.09 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-N 121.189 1.813 . . . . 1.66 109.439 167.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.72 35.56 0.46 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.522 -1.154 . . . . 1.38 113.281 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -129.81 175.15 9.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 1.365 . . . . 1.86 112.749 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.33 145.62 44.97 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 104.483 -2.414 . . . . 3.29 104.483 161.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.49 162.62 35.03 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.786 1.176 . . . . 1.11 112.503 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 t -155.84 112.86 3.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.623 0.769 . . . . 1.9 108.949 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.82 126.22 26.91 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.411 0.551 . . . . 2.63 109.962 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 109.052 -0.721 . . . . 2.18 109.052 -176.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 N-CA-C 106.318 -2.713 . . . . 2.16 106.318 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.93 80.44 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.632 -1.247 . . . . 2.21 107.632 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.1 78.58 4.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.772 -1.566 . . . . 2.4 106.772 172.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.28 121.73 24.8 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.385 -2.08 . . . . 2.42 105.385 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -131.57 145.46 51.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.248 -0.649 . . . . 2.1 109.248 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.23 136.88 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.154 -1.795 . . . . 1.99 106.154 165.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.17 157.09 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 107.148 -1.427 . . . . 2.29 107.148 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -146.37 149.42 33.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.409 -0.589 . . . . 5.89 109.409 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.85 -13.89 31.96 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.144 1.354 . . . . 1.65 111.547 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.8 mtm -66.9 113.79 5.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.496 1.148 . . . . 1.51 110.064 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -82.1 -50.96 8.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.531 1.133 . . . . 3.69 110.471 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -169.67 172.28 6.95 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.395 1.078 . . . . 2.33 110.076 -160.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.85 -47.67 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.089 2.956 . . . . 1.18 114.906 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p -67.89 -47.61 68.38 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.861 -0.525 . . . . 1.23 112.108 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.8 m -70.65 -35.35 72.84 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.347 -0.983 . . . . 1.58 108.347 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.34 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 124.633 1.173 . . . . 1.08 109.729 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.275 0.3 OUTLIER -71.02 -16.64 62.63 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.671 0.989 . . . . 1.16 113.671 -165.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -45.34 -47.54 13.31 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 108.858 -0.793 . . . . 3.99 108.858 165.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.38 -65.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.085 -0.709 . . . . 0.5 109.085 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -55.18 -48.14 74.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 123.133 0.27 . . . . 4.38 111.056 -166.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.7 t -54.32 -60.27 3.57 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.486 -0.931 . . . . 1.07 108.486 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 t -51.91 -42.59 62.89 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.904 0.481 . . . . 0.88 111.698 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 mt -71.9 -53.82 11.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.635 -0.826 . . . . 1.65 111.94 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.0 m -49.23 -33.36 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.729 -1.232 . . . . 1.77 111.902 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -51.93 -32.79 34.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.222 1.193 . . . . 6.11 114.222 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -55.0 -29.75 57.93 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.756 0.707 . . . . 2.37 111.013 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 73.01 -1.04 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.054 1.742 . . . . 5.35 112.001 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 52' ' ' ILE . . . -88.02 -42.43 5.97 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 110.604 -0.998 . . . . 1.95 110.604 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 53' ' ' ILE . 2.1 mp -74.52 125.9 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.102 -1.444 . . . . 3.04 107.102 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.88 -38.71 32.07 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.771 0.828 . . . . 2.75 109.96 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.74 154.88 37.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.376 -0.601 . . . . 2.08 109.376 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 t -155.19 63.64 0.63 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.241 0.543 . . . . 1.83 112.144 -164.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 99.75 7.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.96 0.504 . . . . 1.3 109.845 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.295 0.8 OUTLIER -89.04 93.68 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 122.477 1.132 . . . . 1.55 110.269 172.697 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.8 96.55 9.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.365 1.466 . . . . 0.79 109.9 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.0 tp -51.08 -39.25 55.64 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.164 1.786 . . . . 2.33 112.555 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.82 73.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.257 0.551 . . . . 1.13 110.674 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -81.05 -22.81 39.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.482 1.113 . . . . 2.26 111.231 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.53 55.8 4.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.773 1.629 . . . . 2.97 107.991 -168.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.57 144.33 46.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.896 -1.047 . . . . 1.0 108.611 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.588 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -104.63 113.74 27.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.588 1.155 . . . . 0.47 108.778 171.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -87.98 91.41 8.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.947 -1.872 . . . . 0.78 105.947 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.588 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.51 125.69 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.731 -1.211 . . . . 1.45 107.731 170.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -96.76 110.45 22.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.85 -1.537 . . . . 3.61 106.85 162.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -125.64 158.36 34.93 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.919 0.888 . . . . 2.14 108.812 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -97.97 113.21 63.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.841 1.256 . . . . 4.11 108.43 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.44 70.0 4.94 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.999 3.133 . . . . 2.89 110.915 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -163.13 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.333 1.453 . . . . 3.78 109.56 -173.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.519 HD11 ' HA3' ' A' ' 31' ' ' GLY . 1.8 pp -92.94 -33.88 5.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 122.749 0.419 . . . . 2.9 111.332 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.439 HD13 HD11 ' A' ' 32' ' ' ILE . 5.9 tt -132.66 149.14 31.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.556 -0.905 . . . . 2.46 108.556 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.69 160.02 23.27 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.427 -1.069 . . . . 0.67 110.427 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -41.39 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.43 2.087 . . . . 0.82 110.483 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -57.18 -35.44 69.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 119.299 -0.382 . . . . 8.01 111.236 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -56.58 20.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.0 2.52 . . . . 3.87 109.143 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.98 -50.38 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.931 -0.766 . . . . 0.86 108.931 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.05 -47.24 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 118.772 -0.632 . . . . 1.37 110.538 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -52.77 -48.58 66.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.366 1.067 . . . . 3.08 109.191 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.4 m -60.25 -49.95 75.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.158 -0.682 . . . . 0.88 109.158 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.91 -62.44 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.527 0.731 . . . . 0.81 110.865 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.08 -49.22 72.23 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.315 -0.624 . . . . 2.89 109.315 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.1 t -51.14 -44.7 61.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.045 0.938 . . . . 0.99 112.546 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.78 -52.41 65.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.904 1.229 . . . . 1.85 113.302 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.61 10.53 0.12 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.281 -1.288 . . . . 1.46 116.056 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -139.04 176.14 8.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.346 1.573 . . . . 1.84 112.89 -148.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 151.87 37.57 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.534 -2.025 . . . . 3.18 105.534 154.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 157.04 43.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.967 0.507 . . . . 0.97 111.545 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -147.54 115.55 6.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.587 1.555 . . . . 2.01 108.69 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.31 134.39 50.26 Favored 'General case' 0 N--CA 1.458 -0.034 0 C-N-CA 122.637 0.375 . . . . 2.65 111.801 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.534 0.337 0 C-N-CA 123.847 0.859 . . . . 2.33 110.08 -179.132 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.044 0 N-CA-C 110.392 -1.083 . . . . 2.05 110.392 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.25 143.46 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.689 1.196 . . . . 2.07 109.179 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 tt -147.76 115.42 6.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.62 1.568 . . . . 3.05 107.204 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.74 124.41 49.52 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.144 -0.688 . . . . 2.26 109.144 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.8 mt -102.82 142.41 34.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.355 -1.72 . . . . 2.42 106.355 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -75.71 138.99 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.387 -2.079 . . . . 2.14 105.387 148.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 131.39 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.597 1.559 . . . . 1.97 108.015 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -126.3 144.56 50.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.776 1.231 . . . . 5.0 108.263 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.09 -31.77 6.32 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.849 1.214 . . . . 1.67 110.186 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtm -58.75 141.96 51.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.518 -0.549 . . . . 1.46 109.518 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -152.62 10.99 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.8 0.667 . . . . 2.36 112.8 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -171.18 152.1 3.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 2.29 109.17 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.31 -43.11 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.301 1.84 . . . . 1.15 112.276 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 p -44.3 -66.9 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.479 1.512 . . . . 0.79 113.096 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.8 m -47.51 -48.38 27.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.628 1.171 . . . . 1.07 109.488 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.35 -67.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.158 -0.928 . . . . 0.81 111.101 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -27.13 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.233 -0.917 . . . . 1.2 111.632 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -53.39 -49.1 67.94 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.234 0.614 . . . . 3.24 109.838 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -54.47 -65.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.088 -0.708 . . . . 0.64 109.088 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.1 -61.6 1.81 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.404 1.082 . . . . 2.76 110.916 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -48.95 -45.99 42.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.057 1.343 . . . . 1.06 110.574 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 t -62.25 -65.91 0.62 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.817 -0.611 . . . . 0.89 110.701 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.54 -35.09 76.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.503 1.047 . . . . 1.78 111.806 -163.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.4 m -46.65 -31.6 2.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.842 -0.536 . . . . 2.08 112.119 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -34.14 23.26 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.353 0.871 . . . . 4.19 113.353 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -61.07 -41.4 96.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.038 0.381 . . . . 2.54 110.329 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.84 -2.23 2.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.657 2.383 . . . . 5.71 113.329 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.28 -31.96 36.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.598 -1.001 . . . . 0.92 110.598 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.11 106.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.204 -2.147 . . . . 3.01 105.204 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.7 mt -79.94 -33.3 39.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.995 0.518 . . . . 2.12 109.92 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -147.35 156.47 42.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.539 -0.541 . . . . 2.46 109.539 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.86 134.74 17.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.866 -1.531 . . . . 1.86 106.866 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -144.21 116.16 8.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.389 -1.338 . . . . 2.18 107.389 164.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.15 111.4 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.573 0.701 . . . . 1.71 110.376 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.44 104.35 12.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.982 0.913 . . . . 1.29 109.659 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -44.88 -37.09 3.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.609 1.163 . . . . 2.72 111.346 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.08 -30.75 16.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.796 0.838 . . . . 1.11 112.056 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -127.92 17.4 6.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.385 1.074 . . . . 1.6 109.77 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 31.51 47.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.778 2.031 . . . . 2.13 112.672 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.76 143.6 47.22 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.854 0.462 . . . . 1.29 111.346 -170.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.28 98.49 8.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.575 1.95 . . . . 0.68 107.786 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -79.15 104.06 9.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.376 -2.083 . . . . 0.97 105.376 167.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.28 136.63 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.307 -1.738 . . . . 1.12 106.307 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -107.46 114.47 28.5 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.719 -1.586 . . . . 3.33 106.719 160.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -129.2 175.69 8.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.13 -2.544 . . . . 1.98 104.13 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.39 132.28 24.17 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 107.746 -1.205 . . . . 3.69 107.746 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.98 59.87 5.28 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 125.058 3.839 . . . . 2.79 110.883 -173.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -155.64 -54.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 128.428 2.691 . . . . 3.38 107.264 -168.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -88.45 -25.4 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.349 1.059 . . . . 2.98 110.407 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.55 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.425 -0.954 . . . . 2.86 108.425 170.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.35 164.76 30.91 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 111.001 -0.839 . . . . 0.86 111.001 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.67 -45.19 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.916 2.41 . . . . 1.05 110.866 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.2 -42.63 69.95 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 122.995 0.518 . . . . 8.28 110.587 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -56.28 9.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.732 1.613 . . . . 3.98 109.37 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mt -59.19 -49.71 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.999 0.519 . . . . 0.99 109.602 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -53.78 -52.63 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.793 -0.447 . . . . 1.44 109.793 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -50.92 -51.29 53.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.973 0.509 . . . . 3.58 109.816 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -57.64 -53.37 58.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.226 -0.59 . . . . 0.94 110.262 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.0 mt -53.73 -59.92 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 124.196 0.999 . . . . 0.93 110.466 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.53 -50.46 73.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.224 -0.658 . . . . 4.56 109.224 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -48.69 -46.13 40.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 1.05 112.016 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.66 -56.54 19.15 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.255 0.934 . . . . 1.87 113.425 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 10.98 0.12 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.953 -1.471 . . . . 1.39 116.655 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.46 176.02 9.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.851 1.825 . . . . 1.89 112.655 -153.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -120.12 158.48 26.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.756 -1.572 . . . . 3.69 106.756 156.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.01 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.04 0.936 . . . . 1.81 112.482 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -157.56 111.45 2.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.072 1.349 . . . . 2.79 109.781 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 84.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.614 1.097 . . . . 2.43 108.809 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 124.439 1.096 . . . . 3.21 113.53 -176.153 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 N-CA-C 111.473 -0.651 . . . . 1.97 111.473 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.97 91.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.345 -0.983 . . . . 3.07 108.345 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -108.34 111.46 23.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 2.98 107.838 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 25.2 mt-10 -83.41 135.21 34.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.952 -1.129 . . . . 2.77 107.952 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.33 130.25 54.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.396 -1.335 . . . . 2.79 107.396 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.83 129.51 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 107.807 -1.183 . . . . 3.17 107.807 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.37 151.55 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 125.083 1.353 . . . . 1.81 109.189 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -129.5 144.23 51.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.437 -0.949 . . . . 6.02 108.437 163.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.58 3.11 35.02 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.5 1.524 . . . . 1.93 112.333 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 82.6 mtp -66.94 158.0 31.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.647 -0.914 . . . . 1.98 110.886 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 t -164.67 128.46 2.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.415 1.086 . . . . 3.32 108.556 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.3 m 62.41 177.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.54 1.536 . . . . 2.29 112.949 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.29 -27.67 56.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.869 -1.059 . . . . 1.26 111.461 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -56.61 -70.39 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.285 1.434 . . . . 0.78 113.648 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.5 m -49.46 -42.19 42.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.457 -0.777 . . . . 1.22 109.707 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 t -51.53 -71.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.407 0.683 . . . . 0.89 111.625 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 -29.29 69.1 Favored 'General case' 0 C--N 1.34 0.163 0 O-C-N 121.513 -0.742 . . . . 1.27 111.007 -173.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -55.03 -56.42 20.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.35 -0.611 . . . . 4.12 109.35 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.52 -54.2 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.631 -0.507 . . . . 0.84 109.631 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.5 -54.81 19.41 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.888 0.375 . . . . 3.11 110.99 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -52.92 -56.74 13.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.121 0.968 . . . . 1.17 110.381 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -50.25 -56.35 11.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.735 1.214 . . . . 1.92 109.919 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.87 -45.62 64.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.41 -0.516 . . . . 2.61 111.599 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.4 m -52.12 -36.16 50.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.097 0.862 . . . . 1.65 111.02 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.87 -26.13 23.23 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.12 1.156 . . . . 4.57 114.12 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.25 -29.26 70.62 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.219 1.372 . . . . 2.23 111.093 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 72.04 -3.59 2.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 6.25 113.03 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.59 -30.77 38.92 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.321 -1.112 . . . . 0.88 110.321 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.75 116.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.222 -1.399 . . . . 2.83 107.222 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -79.01 -33.9 44.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.157 0.583 . . . . 1.37 109.452 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.08 146.54 24.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.226 -0.657 . . . . 1.9 109.226 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.5 t -139.82 130.89 26.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.294 -1.743 . . . . 1.86 106.294 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -145.36 116.81 8.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.586 -0.894 . . . . 1.86 108.586 167.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.54 85.41 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.935 -1.135 . . . . 1.97 107.935 -166.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 93.46 8.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.66 -0.867 . . . . 0.92 108.66 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.1 tt -44.69 -39.83 5.43 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.715 1.206 . . . . 1.81 111.826 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.93 -30.08 22.92 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.857 0.863 . . . . 1.12 112.438 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -123.35 14.8 9.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.275 1.43 . . . . 1.53 110.175 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 m120 30.56 53.32 0.15 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 127.376 2.271 . . . . 2.31 112.829 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -133.83 140.25 46.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.221 0.608 . . . . 1.38 109.437 -173.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.34 101.48 10.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.169 1.788 . . . . 0.55 107.032 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -77.82 107.08 10.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.287 -1.746 . . . . 0.98 106.287 170.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -112.7 118.95 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.021 -1.474 . . . . 0.96 107.021 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -96.12 119.15 34.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.9 -1.519 . . . . 3.09 106.9 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -158.57 127.42 5.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.449 0.3 . . . . 2.72 110.744 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.11 128.11 91.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.382 -0.97 . . . . 3.38 108.382 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.88 -50.5 5.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.251 1.967 . . . . 2.44 111.71 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.15 -21.9 36.23 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.721 1.378 . . . . 3.23 114.721 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.35 -1.89 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.041 0.837 . . . . 2.33 112.104 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.82 -47.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.322 0.965 . . . . 2.95 113.594 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 148.64 8.46 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.446 1.022 . . . . 0.67 112.1 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.05 -47.52 17.47 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.251 2.634 . . . . 0.94 111.402 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.433 HH21 ' N ' ' A' ' 60' ' ' HIS . 7.8 tpm_? -47.81 -43.87 28.19 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.148 0.979 . . . . 7.62 111.843 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.89 -53.88 51.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.868 0.867 . . . . 3.92 110.987 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.26 -52.86 53.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.43 -0.581 . . . . 0.67 109.43 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -57.48 -47.38 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.033 -0.728 . . . . 1.57 109.033 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.433 ' N ' HH21 ' A' ' 56' ' ' ARG . 52.4 t-80 -59.09 -41.91 89.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.693 0.797 . . . . 4.69 110.126 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.9 m -63.0 -45.76 90.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.102 -0.333 . . . . 0.93 110.102 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.31 -49.94 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.327 0.651 . . . . 0.78 110.824 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -49.95 -59.19 4.11 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.108 0.963 . . . . 2.99 109.749 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -52.92 -48.55 67.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.753 1.621 . . . . 0.92 111.189 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.21 -55.42 35.2 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.939 -0.476 . . . . 1.63 110.976 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.84 -40.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.663 1.025 . . . . 1.67 115.663 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -122.95 132.53 54.2 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.326 0.563 . . . . 1.97 110.874 -133.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.44 133.12 37.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.02 -1.845 . . . . 4.24 106.02 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.74 145.33 30.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.058 -0.401 . . . . 1.49 110.372 -172.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -135.89 110.7 8.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.424 1.09 . . . . 2.5 109.576 -170.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.95 116.56 1.11 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.215 0.606 . . . . 2.12 109.918 164.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.796 -1.187 . . . . 2.66 107.796 178.424 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 N-CA-C 109.2 -1.56 . . . . 1.64 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.12 146.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 121.657 -0.908 . . . . 2.19 109.95 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.05 116.45 22.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.471 2.308 . . . . 2.73 105.497 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.11 107.26 12.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.385 -0.969 . . . . 2.53 108.385 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -119.62 143.79 47.48 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 125.128 1.518 . . . . 2.19 109.423 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.31 136.72 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.891 -1.892 . . . . 2.29 105.891 162.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.38 122.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.015 1.726 . . . . 2.26 106.905 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -104.35 150.53 24.41 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.082 0.953 . . . . 5.48 110.912 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 -49.58 4.14 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 107.978 -2.049 . . . . 1.83 107.978 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -27.53 112.44 0.06 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.844 2.458 . . . . 2.01 112.312 163.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -157.56 160.52 38.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.443 0.697 . . . . 3.1 109.572 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.3 m 63.68 155.84 0.06 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.356 1.862 . . . . 2.59 113.106 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.98 -36.24 2.39 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.64 1.576 . . . . 1.3 111.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.53 -48.26 79.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.712 2.005 . . . . 1.07 114.127 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.2 -43.76 64.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.339 -1.356 . . . . 1.29 107.339 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.59 -64.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.465 1.106 . . . . 1.27 111.785 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.97 -31.05 68.56 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.869 -0.519 . . . . 1.64 111.446 -174.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.8 -55.92 26.72 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.339 -0.985 . . . . 4.57 108.339 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.18 -61.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.454 -0.573 . . . . 0.75 109.454 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 1.7 pp20? -64.33 -44.24 92.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.905 -0.718 . . . . 4.95 111.168 -165.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -64.21 -47.35 80.08 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 t -56.88 -42.78 80.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.835 -0.602 . . . . 1.12 110.949 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.05 -64.47 0.93 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 119.373 0.988 . . . . 1.79 112.026 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.9 m -44.01 -34.48 1.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.763 1.225 . . . . 1.63 114.014 -162.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.28 -29.76 0.15 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.221 1.563 . . . . 6.12 115.221 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -55.82 -40.65 73.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.314 0.961 . . . . 2.25 111.102 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp-105 70.52 -1.67 2.46 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.717 2.007 . . . . 5.97 112.666 -167.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.09 -32.41 35.81 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 1.01 110.51 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 46' ' ' ILE . 4.2 mp -84.13 118.13 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.286 -1.746 . . . . 2.74 106.286 172.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.4 mt -81.42 -33.39 32.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.203 1.001 . . . . 1.37 110.427 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -150.55 133.97 16.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.988 -1.486 . . . . 2.39 106.988 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.0 t -133.74 62.51 1.65 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.776 0.83 . . . . 1.94 110.253 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 95.54 8.02 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.648 -0.706 . . . . 1.81 109.674 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.27 85.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.6 1.19 . . . . 2.32 107.823 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 80.22 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.05 1.34 . . . . 1.16 108.334 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -38.99 -43.8 1.01 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.67 2.388 . . . . 2.3 111.152 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.54 -33.51 45.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.645 0.778 . . . . 1.25 111.834 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 p -112.33 8.26 19.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.558 1.543 . . . . 2.5 111.513 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.26 45.92 5.14 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.274 1.43 . . . . 2.08 110.761 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -134.24 144.77 48.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.488 0.715 . . . . 1.03 110.594 -171.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.88 105.47 17.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.144 -1.428 . . . . 0.46 107.144 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -83.96 100.41 11.02 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.901 -1.889 . . . . 0.74 105.901 165.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 32' ' ' ILE . 14.5 mt -112.07 108.35 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 124.786 1.234 . . . . 1.23 107.716 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.7 115.23 19.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.033 -1.469 . . . . 2.21 107.033 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -144.52 162.58 36.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.46 -2.052 . . . . 1.87 105.46 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.99 139.42 32.49 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 107.004 -1.48 . . . . 4.51 107.004 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.56 69.06 5.26 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.351 3.368 . . . . 2.49 111.481 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -165.28 -46.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.561 1.544 . . . . 4.27 110.216 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -81.68 -25.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 3.38 109.668 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -158.33 157.11 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.4 164.49 26.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.728 -0.949 . . . . 0.75 110.728 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.86 -47.49 1.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.996 2.464 . . . . 0.82 110.802 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -61.87 -34.09 75.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.211 -0.306 . . . . 7.18 111.211 -175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -57.31 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.495 1.518 . . . . 3.69 108.586 173.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.49 -51.73 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.263 -0.88 . . . . 0.88 109.451 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.5 mt -52.39 -56.84 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.472 0.309 . . . . 1.51 110.206 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -49.39 -48.81 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.479 0.712 . . . . 3.16 109.819 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.6 m -60.12 -52.23 66.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 119.9 -0.72 . . . . 0.99 110.121 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.68 -57.43 5.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 124.036 0.934 . . . . 0.78 110.468 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.66 -52.23 66.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.441 -0.577 . . . . 4.74 109.441 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -51.19 -40.91 59.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.974 0.909 . . . . 1.24 111.895 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.63 -48.68 80.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.713 1.142 . . . . 1.8 113.367 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.28 -1.47 0.06 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 118.371 2.108 . . . . 1.03 118.371 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -138.57 176.64 8.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.788 1.794 . . . . 2.1 113.432 -145.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.58 139.1 53.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.851 -1.907 . . . . 3.35 105.851 167.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.16 161.0 22.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.202 1.001 . . . . 1.66 112.459 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.7 m -157.05 116.2 3.36 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.493 -1.241 . . . . 1.83 110.059 171.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 mt -49.99 140.8 11.7 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.782 1.174 . . . . 3.1 109.18 164.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 CA--C 1.531 0.227 0 C-N-CA 124.827 1.251 . . . . 3.08 110.611 177.71 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 111.209 -0.756 . . . . 1.58 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.13 140.4 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.653 -1.24 . . . . 2.32 107.653 159.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 tp -137.35 91.68 2.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.428 -1.323 . . . . 2.15 107.428 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.99 116.62 26.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.677 -1.601 . . . . 2.55 106.677 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -124.91 140.7 52.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.2 -0.312 . . . . 2.96 110.518 174.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.68 139.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.829 -1.545 . . . . 1.66 106.829 167.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.82 150.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 123.898 0.879 . . . . 2.44 108.76 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -146.53 168.0 22.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 4.85 108.791 -170.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.4 -55.79 3.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.716 -1.754 . . . . 1.62 108.716 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 ptm -60.48 138.93 57.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.466 -0.431 . . . . 1.65 110.767 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -159.07 19.84 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.444 -0.343 . . . . 2.55 111.863 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.6 p -173.33 159.35 3.75 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.907 0.776 . . . . 3.54 110.219 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.72 -41.07 55.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.975 1.71 . . . . 1.16 113.149 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.2 p -63.22 -67.08 0.45 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.137 0.575 . . . . 1.07 111.342 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -43.73 -42.25 5.32 Favored 'General case' 0 N--CA 1.461 0.075 0 O-C-N 121.389 -0.819 . . . . 1.27 110.759 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.07 -73.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 123.205 0.602 . . . . 0.8 111.011 173.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -21.04 66.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.521 -0.737 . . . . 0.99 111.921 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -58.12 -47.71 82.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.001 0.92 . . . . 4.04 110.03 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.7 mt -59.9 -54.25 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.701 -0.852 . . . . 0.58 108.701 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -54.0 -59.82 4.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.641 0.588 . . . . 2.95 109.57 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.3 t -51.37 -49.15 62.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.086 1.354 . . . . 1.02 111.135 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -58.33 -51.11 71.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.85 110.386 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.01 -36.54 84.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 118.705 -1.198 . . . . 2.05 110.158 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.8 m -63.85 7.32 0.12 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.119 -0.988 . . . . 2.09 113.306 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.81 -46.72 43.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.42 -1.425 . . . . 4.45 110.296 157.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.467 0.707 . . . . 2.63 110.613 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -0.52 11.86 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.507 -0.746 . . . . 7.6 112.292 170.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.72 -15.25 61.85 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.031 0.378 . . . . 0.84 112.319 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -94.0 142.8 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.484 -1.302 . . . . 3.17 107.484 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.27 -45.75 4.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.321 1.048 . . . . 3.09 110.025 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.13 153.98 49.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.291 1.036 . . . . 2.33 108.829 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 p -156.02 59.63 0.59 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.435 0.694 . . . . 2.99 111.463 -170.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 m -87.06 104.63 16.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.509 -0.758 . . . . 1.94 111.429 -175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.303 2.7 p -92.68 92.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 122.655 1.217 . . . . 1.93 111.654 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.68 90.66 7.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.785 -1.191 . . . . 0.79 107.785 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tt -44.15 -37.35 3.07 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.55 1.14 . . . . 1.71 111.453 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.14 22.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.906 0.882 . . . . 1.02 112.247 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -120.8 15.44 11.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.012 1.325 . . . . 1.48 110.41 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.15 50.6 0.72 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.548 1.939 . . . . 2.01 111.733 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.75 143.6 35.04 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.222 0.609 . . . . 1.05 109.372 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.84 118.74 36.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.972 -1.122 . . . . 0.55 107.972 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -87.33 95.58 10.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.844 -2.28 . . . . 1.04 104.844 162.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.1 mt -93.48 140.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.848 -1.538 . . . . 1.02 106.848 169.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -118.68 136.86 53.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.94 -1.874 . . . . 3.6 105.94 161.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.62 173.7 15.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.964 1.306 . . . . 1.84 108.126 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -113.29 117.48 45.34 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.62 -1.252 . . . . 3.91 107.62 164.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.26 -40.11 83.82 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.456 1.437 . . . . 2.2 111.945 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -67.64 -12.62 60.86 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.709 0.686 . . . . 4.97 112.663 -167.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 pt -117.97 6.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 123.928 0.891 . . . . 2.41 112.946 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.37 -42.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.474 0.916 . . . . 2.69 113.474 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.49 159.29 5.55 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.201 -0.76 . . . . 0.94 111.201 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.31 -34.54 66.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.526 2.151 . . . . 0.71 110.837 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.11 -46.13 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.534 0.938 . . . . 6.82 113.534 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.45 -35.29 70.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.2 0.909 . . . . 4.11 112.182 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mt -58.19 -47.11 88.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.834 -0.802 . . . . 0.92 108.834 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.83 -48.5 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 118.147 -0.93 . . . . 1.71 109.985 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -47.07 -49.46 21.58 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.957 0.799 . . . . 3.44 109.523 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.0 m -59.21 -55.78 30.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.338 -0.545 . . . . 1.36 110.017 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -63.52 -45.5 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 122.537 0.335 . . . . 0.84 110.702 -170.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.92 -54.64 39.06 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.974 0.509 . . . . 3.12 110.315 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -64.88 -20.7 66.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.829 -1.081 . . . . 0.88 112.416 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.16 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 119.849 1.204 . . . . 1.81 109.05 160.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 18.0 0.24 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.152 -1.36 . . . . 1.14 115.111 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.15 122.9 40.26 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.95 1.875 . . . . 1.93 112.683 -157.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.76 86.84 4.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.889 -0.782 . . . . 3.41 108.889 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.11 163.11 26.92 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.13 -0.981 . . . . 1.04 110.709 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.0 m -154.68 104.53 2.54 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.738 -0.838 . . . . 1.89 108.738 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 126.42 27.3 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 122.86 0.464 . . . . 2.17 111.443 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.341 0.218 0 CA-C-O 121.541 0.686 . . . . 1.96 110.853 -173.713 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 111.35 -0.7 . . . . 2.74 111.35 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.83 117.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.58 -1.267 . . . . 3.12 107.58 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.12 135.63 14.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.909 0.861 . . . . 3.15 111.026 164.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.39 117.36 33.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.75 1.22 . . . . 2.43 109.766 -170.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.95 126.43 46.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.966 -1.494 . . . . 2.82 106.966 172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.46 137.97 21.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.001 -2.222 . . . . 2.45 105.001 160.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.25 107.47 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.306 -1.368 . . . . 1.87 107.306 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -102.25 115.1 29.85 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.965 -1.124 . . . . 5.83 107.965 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.65 -45.18 0.99 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.978 -1.649 . . . . 1.51 108.978 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -55.69 137.2 49.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.909 0.483 . . . . 1.81 110.224 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -165.97 12.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 2.91 112.766 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -170.74 144.41 2.29 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 117.908 -1.044 . . . . 2.07 108.355 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.81 -50.49 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.621 2.369 . . . . 1.25 113.437 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -57.12 -47.7 80.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.797 1.239 . . . . 1.13 114.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.38 -49.63 32.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.388 1.075 . . . . 1.07 108.171 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -43.23 -64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.335 1.854 . . . . 0.86 110.487 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -9.54 55.09 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 120.348 -0.541 . . . . 1.36 111.554 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -47.49 59.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.48 -1.387 . . . . 4.82 107.96 -172.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.28 -57.28 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.836 -1.074 . . . . 0.76 108.345 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -70.32 0.09 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.234 0.614 . . . . 4.3 111.968 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -47.85 -47.13 31.68 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.611 0.641 . . . . 2.37 111.881 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -59.56 -65.68 0.63 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.853 -0.425 . . . . 0.9 109.853 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.04 -34.66 70.33 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.436 0.562 . . . . 1.77 111.318 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -55.3 -25.32 33.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.298 0.481 . . . . 1.58 112.298 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -18.94 64.35 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.663 1.119 . . . . 5.76 112.654 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -84.88 119.97 25.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.54 -1.282 . . . . 2.37 107.54 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -69.07 -0.82 6.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.088 -1.008 . . . . 6.55 113.704 -172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.48 -20.98 61.0 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.523 -0.736 . . . . 0.85 113.595 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.99 138.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 117.818 0.809 . . . . 3.64 110.486 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -100.62 -42.61 6.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.836 1.655 . . . . 1.55 110.196 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -148.36 149.99 32.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.445 -0.576 . . . . 2.31 109.445 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 t -141.75 74.22 1.44 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.857 0.837 . . . . 1.92 110.332 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -85.4 82.92 8.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.216 0.606 . . . . 2.32 109.957 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.07 126.34 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 112.594 0.591 . . . . 1.89 112.594 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.35 104.22 7.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.337 1.455 . . . . 0.91 108.684 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.48 -30.02 38.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.314 0.645 . . . . 2.77 111.321 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.68 50.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.923 0.889 . . . . 1.16 111.61 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -122.08 14.2 10.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 1.69 110.027 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 34.19 55.14 0.62 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.457 1.903 . . . . 1.79 111.713 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.59 143.34 25.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.088 -0.383 . . . . 1.45 110.241 -172.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 112.31 24.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.608 1.963 . . . . 0.59 108.747 165.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.55 95.6 5.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 104.627 -2.36 . . . . 1.1 104.627 160.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 mt -91.27 142.31 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 106.288 -1.745 . . . . 1.12 106.288 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -119.26 111.51 18.31 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.868 -2.271 . . . . 2.87 104.868 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -152.5 155.62 37.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.246 1.019 . . . . 3.29 108.674 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.21 100.17 7.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 123.873 0.733 . . . . 3.22 109.458 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 -42.05 71.76 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.826 2.351 . . . . 2.37 111.427 -172.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -20.34 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.871 2.468 . . . . 4.49 114.385 166.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 pt -112.56 16.1 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.074 0.95 . . . . 2.34 113.112 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 tt -160.53 -46.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.961 0.801 . . . . 2.95 112.203 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.27 157.27 8.42 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.551 1.072 . . . . 0.73 111.43 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.59 -45.32 26.37 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.622 2.214 . . . . 1.04 110.474 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.99 -55.49 6.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.75 1.22 . . . . 8.39 112.762 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -56.53 -48.36 77.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.004 0.907 . . . . 3.97 111.056 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.51 -51.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.642 -0.708 . . . . 0.65 109.317 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -49.43 -60.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 C-N-CA 123.16 0.584 . . . . 1.66 109.428 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -45.51 -49.0 14.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.538 0.735 . . . . 2.72 109.707 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.1 m -63.15 -48.52 78.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.021 -0.672 . . . . 0.86 110.741 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.6 mt -52.19 -64.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.322 0.649 . . . . 0.88 109.841 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -47.67 84.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.135 -0.626 . . . . 2.81 109.718 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -61.44 -19.56 62.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.128 -1.415 . . . . 1.05 113.583 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.08 -70.04 0.26 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 121.296 1.862 . . . . 1.77 109.654 166.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.55 24.82 0.27 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.862 -1.521 . . . . 1.34 115.877 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.71 173.79 10.01 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.089 1.944 . . . . 1.88 113.431 -164.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.74 152.61 20.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.234 -2.135 . . . . 3.61 105.234 154.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.8 162.47 41.24 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.202 0.91 . . . . 1.12 111.449 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.19 141.8 17.78 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.253 0.221 . . . . 2.46 111.571 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.81 70.32 3.26 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.368 1.067 . . . . 2.91 111.211 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 123.976 0.91 . . . . 3.02 110.807 171.72 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 109.103 -1.599 . . . . 1.61 109.103 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.8 152.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 125.407 1.483 . . . . 2.11 107.621 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -141.77 109.92 5.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.979 -1.489 . . . . 2.59 106.979 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -122.03 112.33 18.12 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.433 0.693 . . . . 2.52 110.745 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.44 142.38 51.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.856 1.347 . . . . 2.29 110.031 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.33 138.1 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.369 -1.715 . . . . 1.94 106.369 166.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.9 152.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.144 -1.058 . . . . 1.92 108.144 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -138.01 131.16 30.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.798 0.839 . . . . 6.31 109.031 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 9.49 85.04 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.813 -0.915 . . . . 1.84 110.813 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -102.25 126.37 49.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.149 1.779 . . . . 2.17 106.798 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 t -158.7 155.61 28.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.483 0.583 . . . . 3.13 109.884 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m 66.0 164.1 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.962 1.705 . . . . 2.71 112.763 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -43.92 49.02 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.924 -1.035 . . . . 1.24 110.891 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 p -43.33 -74.23 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.173 1.789 . . . . 0.92 114.12 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -49.92 -44.24 50.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.486 0.714 . . . . 1.18 109.528 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.35 -66.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.16 0.584 . . . . 1.2 111.952 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -68.08 -28.48 67.4 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.263 -0.898 . . . . 1.96 110.688 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -57.65 -52.86 63.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.612 0.642 . . . . 4.02 109.782 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -54.45 -61.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.783 -0.821 . . . . 0.69 108.783 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.77 -55.09 33.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.302 0.241 . . . . 2.81 111.077 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 t -54.11 -34.74 61.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.317 1.047 . . . . 1.36 111.313 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -69.37 -65.86 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.048 0.84 . . . . 1.07 109.894 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.98 -44.74 71.05 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.253 1.021 . . . . 2.32 112.091 -170.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.6 p -54.55 -25.42 25.8 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.92 -0.487 . . . . 2.31 112.097 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.85 -20.29 63.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.604 0.762 . . . . 5.19 111.698 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -64.25 -38.37 90.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.901 -0.778 . . . . 2.28 108.901 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 70.25 -2.33 2.16 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.282 2.233 . . . . 5.48 113.127 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.91 37.87 3.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.291 -1.123 . . . . 0.84 110.291 167.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.54 139.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.524 -2.028 . . . . 2.16 105.524 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.88 -40.17 9.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.006 0.523 . . . . 2.75 110.379 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -155.02 164.13 39.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.369 0.531 . . . . 2.42 111.344 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -153.56 125.09 7.62 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.753 2.421 . . . . 3.26 106.669 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -132.11 106.67 8.14 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.278 -1.749 . . . . 1.57 106.278 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -88.18 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.453 -1.314 . . . . 2.05 107.453 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.88 89.44 5.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.244 -1.021 . . . . 0.78 108.244 -171.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.32 -42.99 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.588 1.955 . . . . 1.86 111.012 165.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.07 62.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.646 1.178 . . . . 1.08 112.39 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -116.43 17.97 15.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.614 1.565 . . . . 1.55 109.246 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 19.42 59.59 0.02 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.489 2.716 . . . . 3.06 113.422 -164.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.9 144.89 39.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.034 0.534 . . . . 0.97 109.748 -174.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.2 106.85 18.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.796 -1.187 . . . . 0.42 107.796 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.37 100.72 12.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.712 -1.958 . . . . 0.83 105.712 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.72 146.09 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.791 -1.559 . . . . 1.95 106.791 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -122.17 133.74 54.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.239 -2.134 . . . . 2.7 105.239 165.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.15 169.16 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.615 0.366 . . . . 3.1 110.299 -160.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.21 139.46 24.2 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.052 -1.832 . . . . 4.12 106.052 159.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.35 -34.75 1.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.146 1.898 . . . . 2.57 113.138 -175.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.65 -28.46 15.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.357 0.981 . . . . 3.41 112.348 -163.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.54 -24.62 29.47 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 118.998 0.817 . . . . 2.25 110.638 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 tt -121.61 -44.18 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.517 0.562 . . . . 2.64 112.517 -169.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 120.08 0.24 Allowed Glycine 0 CA--C 1.534 1.224 0 N-CA-C 109.16 -1.576 . . . . 0.91 109.16 -168.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.7 -38.05 94.75 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 120.673 2.237 . . . . 1.56 111.138 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -23.26 63.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.157 1.169 . . . . 8.89 114.157 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.57 -51.93 67.71 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.91 1.232 . . . . 3.53 109.451 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -56.47 -49.31 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.538 -0.744 . . . . 0.8 110.071 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.6 -59.44 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.232 0.924 . . . . 1.57 110.164 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -49.14 -50.04 39.33 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.837 0.855 . . . . 3.59 109.344 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.8 m -57.51 -52.06 66.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.84 110.231 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.29 -57.25 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 119.23 -0.414 . . . . 0.88 110.574 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.83 -51.02 71.52 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.725 -0.79 . . . . 3.38 110.019 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -57.81 -35.99 71.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.226 1.01 . . . . 1.58 111.241 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mp -52.12 -68.61 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.518 0.599 . . . . 2.27 111.518 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.75 14.99 0.18 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.187 -1.341 . . . . 1.1 115.571 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -133.82 175.04 9.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.413 1.607 . . . . 1.96 113.869 -156.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.23 152.61 22.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.367 -2.086 . . . . 4.01 105.367 155.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.09 139.91 23.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.023 1.329 . . . . 0.99 109.567 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 m -155.41 110.44 2.99 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.25 -0.906 . . . . 1.5 111.101 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.23 139.98 7.91 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.139 -1.059 . . . . 2.9 108.139 166.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 123.128 0.571 . . . . 2.64 109.961 179.566 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.871 0 N-CA-C 108.294 -1.922 . . . . 1.89 108.294 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.56 129.84 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.5 -1.296 . . . . 3.07 107.5 170.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -113.26 128.23 56.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.628 -1.99 . . . . 2.13 105.628 166.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -121.17 104.08 9.49 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.287 -0.634 . . . . 2.42 109.287 165.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.35 129.76 36.53 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.757 -1.571 . . . . 2.7 106.757 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.4 131.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.423 -2.066 . . . . 1.85 105.423 155.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -108.1 150.44 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.161 -1.792 . . . . 1.83 106.161 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -135.38 125.27 25.67 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.05 -0.722 . . . . 4.81 109.05 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.47 -13.97 5.87 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.294 1.426 . . . . 1.73 112.517 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.1 ptp -65.74 149.4 50.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.54 1.17 . . . . 2.16 110.26 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -163.17 139.6 7.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.659 -1.608 . . . . 3.1 106.659 168.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.8 t 73.46 142.01 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.681 1.592 . . . . 2.9 112.582 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.12 -36.2 0.29 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.911 2.085 . . . . 1.3 113.166 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -56.55 -77.08 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.192 0.997 . . . . 1.2 112.805 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -55.11 -33.68 63.05 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 124.076 0.95 . . . . 2.03 110.531 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -52.69 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 O-C-N 123.662 0.601 . . . . 1.23 109.497 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.302 0.3 OUTLIER -66.98 -16.51 64.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.855 -0.528 . . . . 1.51 112.01 -168.177 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -55.94 -44.14 78.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.957 -1.127 . . . . 4.43 107.957 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.6 -63.86 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.246 -1.02 . . . . 0.72 108.246 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 2.8 pt-20 -60.18 -50.88 71.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.313 0.486 . . . . 2.9 112.313 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.3 t -50.24 -52.22 37.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.888 0.875 . . . . 1.04 109.548 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -56.77 -54.73 42.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.942 0.337 . . . . 0.81 110.897 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.17 -34.4 77.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 118.871 -1.132 . . . . 1.72 111.211 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 m -61.25 -10.73 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.977 -1.077 . . . . 1.49 112.28 173.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -75.86 -20.52 58.03 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 120.924 -1.11 . . . . 4.82 112.197 172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.56 -169.12 0.39 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.987 -1.116 . . . . 2.76 107.987 167.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -126.87 -0.84 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.411 -0.806 . . . . 6.15 112.347 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.03 -19.96 22.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.214 0.461 . . . . 0.85 113.023 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.5 mp -79.9 113.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.984 -1.487 . . . . 2.94 106.984 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -79.73 -36.51 37.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.817 1.247 . . . . 1.5 110.202 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -154.91 150.6 27.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.44 -1.319 . . . . 2.48 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -155.65 86.92 1.07 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.983 -0.376 . . . . 1.85 109.983 -164.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.7 m -112.77 107.14 15.67 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.472 0.709 . . . . 1.82 109.933 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.19 90.2 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 122.813 1.292 . . . . 1.74 110.232 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 92.6 8.22 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.414 -0.958 . . . . 0.82 108.414 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -40.58 -39.87 1.14 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.552 1.541 . . . . 1.97 112.395 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.1 61.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.628 0.771 . . . . 0.79 111.872 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -116.1 11.09 15.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.588 1.555 . . . . 1.49 110.047 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.32 39.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.812 2.445 . . . . 2.14 112.917 -173.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 141.09 52.35 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.49 0.716 . . . . 1.11 110.251 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.72 96.57 7.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.784 1.634 . . . . 0.64 108.415 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -77.17 101.29 6.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.762 -1.94 . . . . 0.8 105.762 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.6 mt -109.92 112.49 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 125.215 1.406 . . . . 0.98 107.512 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.74 124.85 34.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.694 -1.595 . . . . 2.37 106.694 169.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.21 177.5 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.925 -1.509 . . . . 2.23 106.925 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.98 137.02 28.65 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.342 0.974 . . . . 3.94 109.277 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.24 67.74 5.17 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.012 3.808 . . . . 2.64 110.703 -173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -172.97 -45.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.013 1.725 . . . . 3.63 109.298 -171.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -85.3 -28.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.617 0.767 . . . . 3.26 109.676 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.8 tt -158.08 156.22 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.09 -1.078 . . . . 2.63 108.09 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.43 163.01 27.25 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.624 -0.991 . . . . 0.64 110.624 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.09 -45.52 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.699 2.266 . . . . 0.77 110.819 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -61.19 -30.75 70.61 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.952 -0.468 . . . . 7.81 110.896 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -57.47 11.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.838 1.655 . . . . 3.67 109.072 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -56.61 -49.86 76.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.09 -0.707 . . . . 0.76 109.09 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.15 -48.33 84.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.994 -0.527 . . . . 1.39 110.782 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -53.11 -43.99 67.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.689 0.796 . . . . 3.07 109.069 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 m -62.59 -42.98 99.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.838 -0.745 . . . . 0.91 110.158 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.47 -46.35 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.224 -0.922 . . . . 0.85 111.787 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.05 -55.13 22.59 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.019 0.928 . . . . 3.16 108.918 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t -53.25 -51.19 63.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.145 1.378 . . . . 0.86 111.276 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.55 -44.42 96.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.51 -0.744 . . . . 1.98 112.263 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.29 -46.63 0.02 OUTLIER Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.844 -0.693 . . . . 1.86 114.751 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -125.75 142.8 51.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.432 -0.907 . . . . 2.0 113.031 -126.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.47 80.67 4.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.315 -0.624 . . . . 3.75 109.315 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.92 158.61 30.59 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.424 -0.797 . . . . 0.98 110.764 -171.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -155.21 117.45 4.19 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.866 -1.146 . . . . 1.98 111.235 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.26 121.04 11.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.465 1.106 . . . . 2.62 111.006 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 125.131 1.372 . . . . 3.24 109.855 173.525 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.958 0 N-CA-C 108.078 -2.009 . . . . 1.49 108.078 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.2 79.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 123.019 1.39 . . . . 2.49 108.122 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 tp -80.16 79.74 6.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 123.113 1.435 . . . . 2.51 107.175 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.9 122.68 25.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.579 -2.1 . . . . 2.59 105.784 164.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.01 139.72 43.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.428 -0.582 . . . . 1.83 109.428 172.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.07 111.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.116 -1.809 . . . . 1.97 106.116 169.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.49 164.51 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.527 -2.027 . . . . 1.73 105.527 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -138.22 130.99 29.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.118 -0.989 . . . . 5.44 108.805 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.82 5.65 17.79 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.852 1.215 . . . . 1.6 112.377 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.479 ' CE ' HG22 ' A' ' 37' ' ' VAL . 25.0 mtp -75.2 87.37 2.46 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.834 1.317 . . . . 2.01 108.07 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -83.27 -30.13 27.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.859 0.864 . . . . 2.51 111.995 -173.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.3 t -153.76 152.41 30.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.521 -0.737 . . . . 2.04 110.451 -168.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.09 -46.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.976 2.51 . . . . 1.18 113.732 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.0 p -39.95 -60.87 0.94 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.95 113.712 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -59.61 -43.49 93.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.774 1.23 . . . . 1.24 108.06 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -52.92 -70.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.185 -0.916 . . . . 1.11 110.418 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -28.94 68.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.501 -0.75 . . . . 1.06 110.706 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -55.02 -54.77 38.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.388 -0.815 . . . . 4.38 109.926 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mt -56.06 -54.08 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 119.475 1.034 . . . . 0.6 110.625 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -54.86 -51.22 66.62 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.311 -0.556 . . . . 3.26 109.773 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -56.35 -44.62 80.27 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.481 0.712 . . . . 0.95 111.757 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -64.96 -39.91 94.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.561 1.144 . . . . 2.45 111.809 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.71 -45.67 50.78 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.969 -0.693 . . . . 2.28 111.45 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -68.25 72.47 0.2 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.303 1.041 . . . . 2.6 110.75 -174.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -34.96 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.74 2.416 . . . . 6.17 110.639 -169.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -53.72 -70.09 0.1 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 119.684 1.129 . . . . 2.95 112.536 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 131.97 -4.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.01 3.724 . . . . 5.57 113.611 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.34 18.39 33.11 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.643 1.11 . . . . 0.9 112.466 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.18 121.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.799 1.639 . . . . 4.04 107.932 -175.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.8 mt -95.09 -38.04 10.81 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.089 0.555 . . . . 1.4 110.113 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -156.07 157.51 36.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.397 -1.335 . . . . 2.11 107.397 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.23 58.93 0.65 Allowed 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.218 0.607 . . . . 2.78 110.24 -163.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -79.19 104.1 9.58 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.361 -0.607 . . . . 1.55 109.361 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' CE ' ' A' ' 13' ' ' MET . 0.9 OUTLIER -95.58 95.43 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.381 1.086 . . . . 1.51 110.165 -177.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.17 95.11 10.05 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.902 -1.124 . . . . 0.78 109.331 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 tt -42.79 -38.93 2.29 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.778 1.631 . . . . 1.63 112.36 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.55 61.31 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 124.59 1.156 . . . . 1.07 111.529 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.8 t -116.48 14.74 15.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.227 1.411 . . . . 1.72 109.545 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.27 52.02 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.716 2.406 . . . . 2.88 111.41 -169.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.455 -0.778 . . . . 1.49 110.503 -171.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 109.79 22.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.53 1.532 . . . . 0.63 107.872 171.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -82.82 93.07 7.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.574 -1.639 . . . . 0.77 106.574 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.7 mt -103.97 110.42 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.344 1.068 . . . . 1.2 109.754 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -78.06 71.93 4.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.521 -1.659 . . . . 2.92 106.521 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.46 162.36 27.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.992 -0.549 . . . . 2.04 109.606 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -116.27 105.32 50.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.833 -0.803 . . . . 3.08 108.833 167.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.51 -32.73 83.74 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.67 2.247 . . . . 1.75 113.365 -168.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.18 -30.24 59.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.38 0.536 . . . . 3.86 112.26 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.89 -3.0 9.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 113.503 0.927 . . . . 2.48 113.503 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 tt -157.57 131.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.246 -1.39 . . . . 2.3 107.246 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.44 155.0 46.57 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.347 -1.901 . . . . 0.88 108.347 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -59.29 -40.17 70.97 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.795 -1.271 . . . . 0.73 108.795 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -44.92 26.79 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.507 1.123 . . . . 9.52 112.526 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.57 -54.89 41.77 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.275 0.943 . . . . 2.96 109.597 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.32 -47.65 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.357 -0.838 . . . . 0.71 110.006 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.77 -52.26 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.239 -0.652 . . . . 1.42 109.239 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -54.73 -47.38 73.86 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.374 -0.346 . . . . 2.73 110.517 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -51.21 -54.62 23.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.137 0.88 . . . . 1.31 110.401 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -57.69 -58.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 119.213 -0.422 . . . . 1.68 110.222 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -63.94 -44.39 93.0 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.158 -1.017 . . . . 4.2 111.18 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.9 t -62.84 -20.29 64.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 117.768 -1.111 . . . . 0.71 112.609 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.86 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.212 1.369 . . . . 1.98 109.89 165.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.36 25.05 0.32 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.606 -1.108 . . . . 1.1 114.126 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.23 172.56 7.5 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.85 1.325 . . . . 1.86 113.235 -165.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -95.55 161.4 14.07 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.33 -1.73 . . . . 4.95 106.33 156.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.26 94.9 2.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.861 0.864 . . . . 1.64 112.297 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -87.69 119.67 28.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.602 0.761 . . . . 1.73 109.788 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -63.66 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.125 0.875 . . . . 3.04 110.702 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 124.485 1.114 . . . . 3.06 109.515 173.642 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 CA-C-O 122.361 0.978 . . . . 2.02 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.26 147.86 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 106.447 -1.686 . . . . 2.03 106.447 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 tp -142.36 136.4 29.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.516 -2.031 . . . . 2.06 105.516 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -115.07 145.32 42.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.407 -0.96 . . . . 2.34 108.407 156.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -133.15 146.03 51.2 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 124.668 1.23 . . . . 2.22 107.837 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.18 131.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.535 -1.654 . . . . 2.1 106.535 160.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.54 157.27 3.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 106.153 -1.795 . . . . 2.0 106.153 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -139.07 132.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.273 -1.01 . . . . 4.96 108.273 163.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.35 10.06 12.25 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.663 1.601 . . . . 1.92 112.761 -173.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.5 mtt -62.69 150.46 40.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.034 1.417 . . . . 2.08 109.48 167.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -154.41 86.92 1.16 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.469 0.652 . . . . 3.18 109.937 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.5 t 73.62 90.32 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.086 1.354 . . . . 2.85 112.916 165.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.11 -124.3 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.786 -1.102 . . . . 2.86 108.174 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.5 p 49.47 -81.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.779 2.032 . . . . 1.14 114.165 163.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -46.35 -43.75 16.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.608 0.763 . . . . 1.27 109.747 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.0 t -48.46 -74.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.52 1.128 . . . . 0.88 111.197 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -30.13 69.7 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 122.069 -0.395 . . . . 1.35 111.475 -172.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -51.54 -56.04 15.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.248 -0.649 . . . . 4.24 109.248 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.09 -60.19 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.325 -0.62 . . . . 0.52 109.325 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -49.88 -55.73 13.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.236 0.614 . . . . 3.04 111.142 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.2 t -54.26 -59.77 4.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.456 1.102 . . . . 1.13 109.45 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -52.08 -49.97 62.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.687 0.279 . . . . 0.94 110.939 -174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.9 -49.7 69.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.111 0.411 . . . . 1.77 112.111 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.261 4.5 t -60.6 -25.09 65.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 118.549 -1.26 . . . . 2.97 111.541 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -55.35 -25.65 36.28 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.189 0.811 . . . . 4.19 113.189 173.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -54.92 -31.44 60.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.018 0.827 . . . . 2.33 111.286 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -3.66 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.088 1.755 . . . . 8.45 111.811 -162.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.8 -35.81 15.2 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.553 -1.019 . . . . 1.14 110.553 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 46' ' ' ILE . 4.4 mp -92.36 97.89 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.694 -1.595 . . . . 2.9 106.694 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.11 -24.22 43.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.357 -0.838 . . . . 2.13 110.124 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -155.78 153.74 30.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.971 -0.752 . . . . 2.64 108.971 169.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.7 113.49 5.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.783 2.033 . . . . 3.19 107.311 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -119.4 104.77 10.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.425 -1.324 . . . . 1.5 107.425 165.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.34 78.38 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.754 1.264 . . . . 2.04 107.657 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.93 88.84 5.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.954 -1.021 . . . . 0.88 108.502 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.7 tt -38.67 -39.66 0.52 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.06 1.744 . . . . 1.77 112.413 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -36.41 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.454 1.102 . . . . 0.95 112.084 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 t -111.72 11.61 21.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.642 1.577 . . . . 1.56 109.934 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.35 41.28 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.234 2.614 . . . . 2.43 113.399 -170.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.95 45.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.8 0.84 . . . . 1.15 109.422 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.12 111.45 24.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.854 -1.906 . . . . 0.54 105.854 170.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -82.34 114.28 20.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.408 -2.071 . . . . 0.78 105.408 163.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 32' ' ' ILE . 9.8 mt -121.87 109.08 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 125.002 1.321 . . . . 0.93 107.483 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -79.45 72.38 6.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.856 -1.535 . . . . 2.86 106.856 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 176.36 9.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.298 1.039 . . . . 2.88 108.618 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.86 130.16 8.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 118.387 0.54 . . . . 3.66 110.196 160.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -51.88 -34.98 57.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.283 2.656 . . . . 1.72 113.589 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.95 -22.6 66.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.075 0.852 . . . . 4.69 112.999 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 pt -110.89 -22.52 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 119.122 0.873 . . . . 2.9 110.486 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -162.53 130.17 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.978 -1.119 . . . . 3.01 107.978 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.76 170.51 48.08 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.974 -0.851 . . . . 1.19 110.974 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.26 -57.06 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.104 1.869 . . . . 1.23 110.689 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.33 -26.79 68.63 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.847 -0.533 . . . . 8.73 111.743 -173.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -51.55 63.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.981 1.312 . . . . 4.56 110.159 173.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.9 -53.0 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.23 -0.919 . . . . 0.95 109.694 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -55.46 -50.73 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.405 -0.591 . . . . 1.76 109.405 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -49.47 -46.12 47.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.79 0.836 . . . . 3.79 110.396 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -58.23 -50.2 74.4 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.586 -0.524 . . . . 1.21 109.586 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.8 -54.82 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.971 0.509 . . . . 0.75 110.838 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -55.39 -53.42 56.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.243 -0.651 . . . . 4.57 109.243 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -48.4 -47.71 37.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.97 1.308 . . . . 0.89 111.676 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.66 -48.57 79.12 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.372 0.987 . . . . 1.92 113.478 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 0.11 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 118.293 2.077 . . . . 1.19 118.293 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -138.97 177.47 7.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.814 1.807 . . . . 1.91 112.617 -144.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -104.0 158.68 16.25 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.093 -1.447 . . . . 2.94 107.093 145.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.88 154.13 37.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.559 0.695 . . . . 1.01 110.905 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.0 m -156.13 103.79 2.22 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.419 -0.8 . . . . 1.94 110.438 -164.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.94 134.41 16.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.474 1.109 . . . . 2.85 111.94 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 124.976 1.311 . . . . 2.5 109.099 178.834 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 105.564 -3.014 . . . . 1.67 105.564 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 m -136.51 146.32 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.211 1.006 . . . . 2.78 110.131 -170.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 tp -155.23 153.37 30.55 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.041 -1.466 . . . . 2.64 107.041 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -115.4 148.52 39.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.858 -0.793 . . . . 2.93 108.858 165.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.0 mt -121.85 128.82 52.06 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.063 -1.829 . . . . 2.78 106.063 165.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.6 142.1 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.465 -2.42 . . . . 1.75 104.465 161.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.38 120.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 124.616 1.166 . . . . 2.12 108.575 -171.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 131.53 53.88 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.085 0.954 . . . . 7.45 110.986 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.22 -19.28 5.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.965 1.745 . . . . 1.86 109.938 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 mtm -63.32 163.75 10.08 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.204 -0.586 . . . . 1.89 110.531 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -150.47 -44.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.618 0.367 . . . . 2.55 111.455 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.3 m -139.36 169.44 17.75 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.78 -0.575 . . . . 2.56 109.697 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.31 -36.86 1.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.938 2.095 . . . . 1.45 113.272 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -48.26 -44.09 33.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.268 1.827 . . . . 0.92 113.786 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.8 m -70.56 -46.92 62.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.166 -1.42 . . . . 1.22 107.166 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.07 -63.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.336 . . . . 1.61 111.001 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -26.53 64.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.496 -0.752 . . . . 1.2 111.703 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.78 -54.68 39.0 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.727 -0.842 . . . . 4.43 108.727 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -53.88 -60.34 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.591 -0.522 . . . . 0.75 109.591 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -53.22 -52.94 57.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.529 0.331 . . . . 3.28 111.31 -171.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -58.76 -54.6 45.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.94 0.496 . . . . 1.44 110.217 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 t -55.31 -38.92 69.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.37 0.668 . . . . 1.11 111.864 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.1 mt -75.21 -54.65 6.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 113.595 0.961 . . . . 1.77 113.595 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -54.58 -35.96 63.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.349 -0.844 . . . . 2.03 110.931 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -25.16 9.98 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.338 1.236 . . . . 3.84 114.338 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.752 ' HB3' HD11 ' A' ' 53' ' ' ILE . 12.1 m170 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.673 1.124 . . . . 2.22 111.095 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 77.85 -3.73 2.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.698 2.399 . . . . 6.38 113.898 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA3' HD12 ' A' ' 53' ' ' ILE . . . -96.12 -23.84 16.3 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.848 -0.901 . . . . 1.1 110.848 172.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.623 HD12 HD13 ' A' ' 53' ' ' ILE . 3.1 mp -78.41 105.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.728 -1.953 . . . . 2.9 105.728 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.66 -30.51 41.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.227 1.011 . . . . 1.38 109.434 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.08 139.99 18.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.473 -0.936 . . . . 2.26 108.473 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -133.06 119.19 19.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.579 -2.008 . . . . 2.22 105.579 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -125.74 106.96 10.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.784 -1.561 . . . . 1.74 106.784 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.24 87.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.297 1.046 . . . . 2.02 108.878 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.2 86.23 5.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.017 -1.475 . . . . 0.89 107.017 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -40.91 -38.71 1.0 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.826 1.651 . . . . 2.42 111.201 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.53 -36.17 43.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.592 1.157 . . . . 0.83 112.726 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -113.95 13.22 18.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.353 1.461 . . . . 1.62 110.049 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 40.52 41.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.39 1.876 . . . . 1.94 112.057 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 143.45 50.83 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.143 0.577 . . . . 1.18 110.368 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.71 108.28 19.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.447 -2.057 . . . . 0.43 105.447 170.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -78.59 115.8 18.54 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.651 -1.981 . . . . 1.22 105.651 165.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -120.07 114.7 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.083 -1.08 . . . . 1.06 108.083 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -100.07 115.4 29.69 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.633 -1.617 . . . . 3.28 106.633 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.13 145.98 22.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.797 1.239 . . . . 1.96 108.503 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -85.91 137.03 35.78 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 119.054 0.843 . . . . 4.4 109.577 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.34 -31.69 13.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.186 1.924 . . . . 2.55 111.765 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.52 46.86 0.99 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.774 1.23 . . . . 5.03 112.538 -169.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -50.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 128.295 2.638 . . . . 4.46 106.028 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 29' ' ' HIS . 1.2 mt -104.4 -89.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.887 1.275 . . . . 2.81 107.61 -176.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 95.5 139.01 9.97 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.492 -1.443 . . . . 0.91 109.492 -165.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.7 -37.27 94.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.421 2.747 . . . . 0.74 112.812 -164.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -35.98 -49.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 9.6 112.825 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -68.22 -46.15 71.37 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.018 -0.734 . . . . 3.02 109.018 -171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 mt -60.47 -47.35 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.72 109.219 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.38 -57.4 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.306 0.642 . . . . 1.79 109.494 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -52.81 -45.82 67.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.655 0.382 . . . . 2.76 110.09 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.8 m -59.48 -54.75 43.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.1 mt -51.76 -55.45 9.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.593 1.157 . . . . 0.8 110.754 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.35 -57.84 10.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.407 -0.59 . . . . 3.07 109.407 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.3 t -52.94 -37.48 61.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.1 1.36 . . . . 0.8 111.598 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.35 -54.71 28.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.51 0.724 . . . . 2.27 112.632 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.27 -8.36 0.04 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 117.539 1.776 . . . . 1.13 117.539 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.76 176.2 8.67 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.41 1.605 . . . . 1.85 112.475 -142.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -124.54 152.61 43.25 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.922 -2.251 . . . . 3.15 104.922 161.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.61 164.84 30.47 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.015 0.746 . . . . 1.29 113.015 -168.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -153.81 138.88 17.32 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 122.978 0.511 . . . . 2.07 111.379 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.58 66.74 1.45 Allowed 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.547 1.539 . . . . 2.88 110.71 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.392 -0.595 . . . . 2.48 109.392 165.526 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.569 0 N-CA-C 109.378 -1.489 . . . . 1.89 109.378 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.08 142.28 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.608 0.704 . . . . 2.79 109.782 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.2 83.63 1.84 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.768 -1.567 . . . . 2.77 106.768 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.4 116.54 27.67 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.891 -1.504 . . . . 2.31 107.148 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 3.2 pp -128.34 142.22 51.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.746 0.248 . . . . 2.06 110.677 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.88 145.21 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.36 -1.348 . . . . 1.86 107.36 166.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.7 161.62 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.6 1.56 . . . . 1.87 107.441 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.09 140.1 30.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.874 -0.787 . . . . 7.99 108.874 160.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.67 -34.15 3.54 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.0 -1.24 . . . . 1.53 110.0 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.1 mtp -56.18 115.46 2.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.41 -0.464 . . . . 1.52 109.832 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -125.65 -20.49 4.68 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.946 0.899 . . . . 2.4 111.98 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.5 t -153.92 151.59 29.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.052 -1.03 . . . . 2.13 109.707 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -30.99 -45.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.562 2.345 . . . . 1.14 113.526 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 p -39.96 -58.62 1.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.508 1.523 . . . . 0.86 113.733 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.3 -46.99 87.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.241 -1.392 . . . . 1.24 107.241 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -51.16 -66.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.473 -1.24 . . . . 0.94 110.404 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -27.33 64.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.887 -0.725 . . . . 1.1 111.193 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.74 -53.49 57.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.624 0.647 . . . . 4.51 110.259 172.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.14 -60.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.861 -0.792 . . . . 0.45 108.861 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -54.63 -51.02 66.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.543 -0.299 . . . . 3.25 110.939 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.5 t -60.23 -42.82 96.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.522 0.729 . . . . 0.95 111.237 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 t -65.88 -36.78 84.35 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.827 -0.546 . . . . 0.81 111.102 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.18 -52.64 13.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.266 -0.574 . . . . 2.01 111.85 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 m -67.09 76.46 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.228 1.011 . . . . 2.51 110.683 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.45 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.458 2.703 . . . . 3.91 110.518 -171.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -56.33 -30.26 62.35 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.576 1.08 . . . . 2.77 113.296 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 37.97 2.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.245 1.018 . . . . 7.61 110.251 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.33 -2.01 0.73 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 121.573 -0.705 . . . . 0.99 112.897 165.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.05 127.4 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.776 -1.564 . . . . 2.66 106.776 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.78 -43.35 18.47 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.981 1.312 . . . . 1.85 109.417 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -152.11 155.25 37.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 110.203 -0.295 . . . . 2.1 110.203 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.47 136.85 35.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.731 1.612 . . . . 3.03 107.004 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -151.52 87.92 1.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.229 -1.397 . . . . 2.29 107.229 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.27 0.3 OUTLIER -92.52 92.08 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.714 1.245 . . . . 1.66 109.958 -176.894 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.64 92.98 9.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.177 -0.952 . . . . 0.69 108.986 -170.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.05 -42.37 2.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.302 1.441 . . . . 1.87 111.701 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.25 -33.54 42.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.435 1.094 . . . . 0.83 112.46 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -117.78 14.43 14.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.887 1.275 . . . . 1.5 110.364 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 30.26 53.97 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.686 2.394 . . . . 3.0 112.363 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 150.22 46.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.733 0.813 . . . . 1.11 109.175 -174.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -101.84 113.67 27.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.572 1.149 . . . . 0.63 107.965 168.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -81.22 99.18 8.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 104.337 -2.468 . . . . 0.76 104.337 154.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.54 147.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.49 -1.67 . . . . 0.95 106.49 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -124.58 130.93 53.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.352 -2.092 . . . . 3.11 105.352 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -146.41 173.13 12.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 119.095 0.861 . . . . 2.17 111.365 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -107.77 94.12 11.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.112 0.965 . . . . 4.33 109.587 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 63.25 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.659 3.573 . . . . 2.58 111.851 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -155.09 -54.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 128.702 2.801 . . . . 3.74 106.692 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.4 pt -99.82 -13.41 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 124.843 1.257 . . . . 2.45 111.849 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -151.55 142.34 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.638 -1.616 . . . . 2.25 106.638 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.39 168.48 40.36 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.977 -0.849 . . . . 0.91 110.977 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.83 -47.49 1.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.563 2.176 . . . . 0.7 110.779 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -24.73 66.81 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.992 -0.442 . . . . 8.24 110.534 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -56.15 25.28 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.893 -1.754 . . . . 3.34 109.27 172.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.49 -55.12 21.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 108.869 -0.789 . . . . 1.22 108.869 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -58.05 -44.7 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.43 -0.35 . . . . 1.33 110.105 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.5 -37.26 83.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.906 1.282 . . . . 4.73 109.999 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -58.53 -51.83 68.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.751 -0.833 . . . . 0.77 108.751 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.98 -52.61 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 119.206 -0.426 . . . . 0.78 111.006 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -47.07 -52.2 15.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.156 0.983 . . . . 3.12 109.911 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.4 t -70.43 -9.71 57.17 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.754 1.622 . . . . 1.3 113.683 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.48 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.197 -1.409 . . . . 2.65 107.197 159.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.59 37.43 0.51 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.909 -0.94 . . . . 1.24 112.343 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -136.29 124.69 23.39 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.222 1.011 . . . . 1.92 110.266 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.75 -1.204 . . . . 4.63 107.75 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.31 163.1 40.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.918 -0.488 . . . . 1.05 111.462 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -145.62 126.69 14.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.607 1.163 . . . . 2.06 108.983 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.85 119.78 11.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.649 1.179 . . . . 3.55 108.314 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.47 0.527 0 CA-C-N 118.83 0.741 . . . . 2.03 111.782 -178.156 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.894 0 N-CA-C 111.04 -0.824 . . . . 1.57 111.04 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -103.97 126.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-N 117.634 0.717 . . . . 2.73 109.573 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 95.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.476 1.132 . . . . 4.02 108.873 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -78.51 122.64 26.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.612 -1.255 . . . . 2.44 107.612 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.43 145.54 48.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.994 -0.373 . . . . 1.77 109.994 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.98 142.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.069 -1.826 . . . . 1.93 106.069 164.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.06 95.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 125.246 1.418 . . . . 2.22 108.618 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -97.47 143.5 28.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.523 0.729 . . . . 5.92 111.149 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.81 -36.38 3.0 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.627 1.108 . . . . 1.64 110.806 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -64.51 153.43 39.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.133 0.492 . . . . 1.61 112.171 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -153.58 149.5 27.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 170.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m 70.43 151.39 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.468 1.507 . . . . 2.34 112.486 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.5 -35.37 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.515 1.926 . . . . 1.49 112.559 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 -65.48 0.57 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.251 1.42 . . . . 1.36 112.649 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -68.91 -40.42 79.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.462 -1.31 . . . . 1.26 107.462 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.7 t -42.92 -68.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 113.98 -1.464 . . . . 1.08 110.238 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.304 0.4 OUTLIER -69.62 -20.06 63.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.704 -0.798 . . . . 1.86 110.995 -175.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.53 -42.21 87.58 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.113 -0.992 . . . . 3.08 108.992 -174.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -53.54 -66.53 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.816 -0.809 . . . . 0.77 108.816 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.24 -56.17 20.98 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.035 0.534 . . . . 3.14 111.962 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -53.43 -36.49 61.6 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.512 1.125 . . . . 1.34 111.174 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -70.22 -62.08 1.53 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.502 -0.749 . . . . 0.83 110.357 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -46.29 66.5 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.699 0.8 . . . . 2.26 111.961 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 p -50.85 -33.43 23.78 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.779 0.432 . . . . 2.47 111.129 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -64.26 -18.5 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.847 0.684 . . . . 4.45 112.847 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -60.48 -28.63 68.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 2.46 110.456 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 74.83 -1.85 2.98 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.311 1.844 . . . . 6.74 112.285 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 24.96 25.35 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.377 -0.689 . . . . 1.2 111.377 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mm -121.04 144.92 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.171 -1.789 . . . . 2.57 106.171 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.13 -45.86 7.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.832 -0.803 . . . . 2.83 108.832 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -155.55 153.4 30.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.375 0.534 . . . . 2.25 109.939 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.0 m -135.02 113.1 11.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 104.986 -2.227 . . . . 2.57 104.986 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.41 96.09 5.81 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.162 -1.051 . . . . 1.56 108.162 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.03 95.12 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.445 0.64 . . . . 1.88 109.667 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.71 91.72 6.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.372 -0.83 . . . . 0.73 110.185 -168.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -37.3 -50.87 1.04 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 1.97 112.819 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.52 31.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 1.27 112.528 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.7 t -105.93 -15.54 14.89 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.829 1.252 . . . . 1.6 110.729 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.72 41.52 14.86 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.837 0.855 . . . . 2.46 109.425 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.53 147.57 44.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.66 1.184 . . . . 1.13 108.794 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.1 114.18 27.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.859 -1.534 . . . . 0.41 106.859 162.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -78.2 94.37 4.75 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.144 -2.169 . . . . 0.74 105.144 167.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 mt -98.74 111.92 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.708 -0.849 . . . . 1.21 108.708 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.15 115.59 26.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.323 -1.732 . . . . 2.87 106.323 159.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.62 140.19 28.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.979 1.312 . . . . 2.62 107.792 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -87.37 114.16 57.41 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.381 -0.97 . . . . 3.72 108.381 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.12 -48.78 15.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.17 1.913 . . . . 2.16 113.194 -172.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.59 -21.42 60.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.804 1.039 . . . . 3.31 113.804 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -97.18 -4.54 9.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 119.728 1.149 . . . . 2.53 112.7 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.05 -46.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.454 1.279 . . . . 2.69 114.454 -175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.84 155.65 2.36 Favored Glycine 0 CA--C 1.541 1.674 0 O-C-N 121.609 -0.682 . . . . 0.83 112.889 -171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 -51.58 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.25 2.634 . . . . 1.27 112.252 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -47.9 -44.6 29.77 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.679 0.791 . . . . 7.08 112.187 -170.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -52.35 -56.13 16.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.023 0.929 . . . . 3.96 110.859 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.17 -48.87 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 O-C-N 121.814 -0.554 . . . . 0.76 110.547 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mm -51.81 -51.34 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 119.014 -0.517 . . . . 1.84 110.27 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -50.51 -54.45 22.28 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 122.968 0.507 . . . . 2.74 109.896 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.0 m -56.41 -47.29 79.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.255 -0.978 . . . . 1.1 110.733 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 -54.8 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 118.534 0.606 . . . . 1.06 111.949 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -67.01 -43.63 82.4 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.582 -0.447 . . . . 4.99 110.678 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 t -57.9 -40.7 80.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.51 0.724 . . . . 1.0 110.978 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.13 -59.97 4.5 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.389 0.995 . . . . 1.66 110.736 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.57 -40.45 0.02 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 115.762 1.065 . . . . 1.46 115.762 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -112.33 139.72 47.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.948 -0.737 . . . . 1.86 111.549 -135.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.02 133.0 36.11 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 106.48 -1.674 . . . . 3.18 106.48 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.18 31.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.044 0.384 . . . . 1.07 111.477 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.48 145.55 25.28 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 109.447 -0.575 . . . . 1.89 109.447 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.15 130.3 35.13 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.927 -0.768 . . . . 2.32 108.927 -174.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.536 0.415 0 C-N-CA 123.257 0.623 . . . . 2.06 112.19 -178.381 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 N-CA-C 111.679 -0.568 . . . . 1.62 111.679 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.21 138.31 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.208 -1.172 . . . . 1.97 109.302 172.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.23 88.1 2.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.601 -1.629 . . . . 2.23 106.601 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -79.65 123.3 27.52 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.372 -1.714 . . . . 2.25 106.372 171.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.12 133.41 46.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.84 0.291 . . . . 2.15 110.336 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.3 145.71 9.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 172.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.4 122.0 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.211 1.004 . . . . 1.63 110.117 -169.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.48 132.96 51.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.139 -0.689 . . . . 4.95 109.139 170.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.61 -25.67 5.87 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.995 2.236 . . . . 1.86 109.149 178.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 mtp -57.2 107.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.53 0.732 . . . . 1.75 109.889 164.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -139.99 9.36 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.913 1.285 . . . . 2.34 112.588 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -172.53 147.58 1.88 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.521 1.055 . . . . 2.23 109.92 -173.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.73 -38.02 1.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.339 1.856 . . . . 1.23 113.176 178.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 p -60.58 -77.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.863 0.865 . . . . 0.82 112.04 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 p -48.59 -29.88 4.75 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.071 1.348 . . . . 2.09 112.122 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.98 -72.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 0.92 109.867 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 0.3 OUTLIER -68.62 -12.74 61.73 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.015 -1.053 . . . . 1.17 112.942 -171.367 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -52.7 -42.86 65.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.237 -1.023 . . . . 4.3 108.237 172.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.92 -60.83 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.478 1.511 . . . . 0.55 109.666 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.23 -48.32 82.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.944 -0.391 . . . . 4.78 109.944 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.31 -48.69 80.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.458 -0.942 . . . . 1.18 108.458 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -51.01 -57.29 9.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.667 1.122 . . . . 1.34 111.01 176.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.25 -38.83 75.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.006 -1.078 . . . . 1.8 111.451 -169.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -55.07 -15.65 2.29 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.985 -1.072 . . . . 2.33 113.078 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -66.42 -37.24 84.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.369 -0.832 . . . . 5.38 110.766 173.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -69.56 124.94 25.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.716 -1.216 . . . . 2.15 107.716 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.61 47.32 0.83 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.161 -0.962 . . . . 7.56 109.943 172.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.88 -17.21 0.83 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.305 1.907 . . . . 0.89 111.998 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.1 tt -105.54 138.19 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.114 -1.069 . . . . 2.56 108.114 176.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -86.06 -49.38 7.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.531 1.133 . . . . 1.62 109.803 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -152.79 162.54 41.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.717 0.407 . . . . 3.01 110.304 -176.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.58 89.5 1.56 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.219 1.008 . . . . 2.07 109.973 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.94 90.05 8.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.071 -0.714 . . . . 1.39 109.071 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -85.94 98.42 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.559 1.144 . . . . 2.43 109.304 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.73 92.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.377 0.671 . . . . 0.82 109.849 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -36.89 -44.19 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.707 2.003 . . . . 1.76 110.869 165.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.17 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.008 0.923 . . . . 0.94 112.461 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.46 14.97 10.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.077 1.351 . . . . 1.53 109.983 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 34.92 55.39 0.74 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.763 2.025 . . . . 2.17 111.876 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.01 153.54 36.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.63 -0.878 . . . . 1.07 108.63 -173.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.01 127.49 54.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.637 0.586 . . . . 1.1 109.977 163.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -86.01 91.4 8.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.706 -1.961 . . . . 0.86 105.706 170.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.23 137.84 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.124 -1.436 . . . . 1.55 107.124 172.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -115.31 119.05 34.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.365 -2.087 . . . . 2.18 105.365 163.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 178.85 7.39 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 127.213 2.205 . . . . 1.87 106.096 -176.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -132.23 132.63 23.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.95 . . . . 3.67 110.386 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.71 64.09 7.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.918 3.745 . . . . 2.35 112.161 -167.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -166.74 -45.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.738 1.215 . . . . 3.75 110.239 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.77 -27.11 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.184 -0.673 . . . . 2.72 109.184 174.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -154.89 150.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.771 -1.196 . . . . 2.62 107.771 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.86 166.06 33.73 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.338 -1.105 . . . . 0.75 110.338 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.47 -48.57 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.373 2.049 . . . . 0.93 110.479 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.404 HH21 ' CD2' ' A' ' 60' ' ' HIS . 25.4 tpt180 -56.96 -27.42 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.924 0.489 . . . . 7.87 111.274 -177.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -55.59 31.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.299 1.839 . . . . 3.7 109.078 175.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt -56.23 -47.21 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.62 -0.882 . . . . 0.69 108.62 174.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mm -55.84 -50.97 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 119.28 -0.391 . . . . 1.99 111.0 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CD2' HH21 ' A' ' 56' ' ' ARG . 17.2 m170 -54.36 -46.51 73.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.162 0.985 . . . . 3.06 109.302 178.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 m -58.05 -50.08 74.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.609 -0.515 . . . . 0.8 109.609 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.93 -51.9 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.15 -0.969 . . . . 0.79 111.782 178.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -50.86 -56.68 11.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.438 1.095 . . . . 3.13 109.241 175.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.3 t -52.34 -51.46 58.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.741 1.616 . . . . 0.8 111.365 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.49 -41.21 89.25 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.45 -0.781 . . . . 2.96 111.85 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.27 -50.52 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.328 -0.939 . . . . 1.5 114.624 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.58 144.99 38.61 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 118.973 -1.091 . . . . 1.92 113.806 -128.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.1 59.4 3.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.345 -0.613 . . . . 4.28 109.345 -176.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.82 168.47 19.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.689 0.626 . . . . 1.25 112.689 -166.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.06 132.01 10.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.819 -0.808 . . . . 1.88 108.819 173.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 130.73 47.88 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.864 -0.791 . . . . 2.31 108.864 167.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 108.322 -0.992 . . . . 2.82 108.322 177.23 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 CA-C-O 121.803 0.669 . . . . 1.82 111.794 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.24 149.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.987 -0.713 . . . . 2.02 110.071 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 tp -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.433 1.893 . . . . 2.76 106.346 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -128.81 157.37 41.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.05 -1.092 . . . . 2.62 108.05 163.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.69 142.92 49.94 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.358 1.036 . . . . 2.98 108.997 162.407 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.8 t -76.84 128.92 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.797 -1.927 . . . . 1.86 105.797 165.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.93 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.375 -1.343 . . . . 1.99 107.375 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.97 142.72 45.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.09 -1.448 . . . . 5.01 107.09 166.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.2 -47.63 1.34 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.726 -0.95 . . . . 1.49 110.726 167.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.82 143.57 54.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.229 -0.656 . . . . 2.05 109.229 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.62 -66.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.289 -0.257 . . . . 3.33 110.969 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -64.14 148.06 50.83 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.642 -0.661 . . . . 2.29 110.983 -171.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.35 -47.11 0.29 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.278 1.831 . . . . 1.17 112.507 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.2 p -60.08 -37.59 80.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.556 1.543 . . . . 1.29 113.64 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.65 -46.98 28.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.612 -1.305 . . . . 1.49 109.756 172.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.87 -67.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.292 1.037 . . . . 0.88 111.157 177.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -27.1 64.33 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.792 -0.568 . . . . 1.01 111.161 -173.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.06 -53.2 60.04 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.18 -0.914 . . . . 4.56 108.994 175.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.82 -55.68 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.423 1.01 . . . . 0.71 109.862 174.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -51.67 -59.26 4.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.275 -0.269 . . . . 3.16 110.275 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -53.82 -43.37 69.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 1.07 111.812 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -60.07 -50.42 73.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.28 1.032 . . . . 2.24 109.181 -176.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.42 -37.27 71.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.078 -0.649 . . . . 2.24 112.097 179.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -53.57 -23.99 12.4 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.029 -1.044 . . . . 1.49 113.458 177.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -60.21 -31.35 70.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.759 1.163 . . . . 6.52 112.18 174.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -70.52 148.52 48.14 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.867 0.758 . . . . 2.25 109.05 -175.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -105.25 37.77 2.11 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.788 -0.57 . . . . 6.73 111.905 -171.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.03 24.56 0.61 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.12 -0.392 . . . . 1.04 112.12 170.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -114.01 134.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.107 -1.812 . . . . 2.63 106.107 168.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.25 -40.11 10.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 1.62 109.069 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.53 136.89 14.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.201 -0.296 . . . . 2.19 110.201 178.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.91 132.61 56.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.962 -2.607 . . . . 2.21 103.962 164.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.6 t -138.22 138.17 38.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 117.977 -1.489 . . . . 2.84 109.096 146.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.286 6.7 p -106.03 94.32 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 122.638 1.209 . . . . 2.08 110.512 -174.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.23 88.62 6.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.495 -0.928 . . . . 0.68 108.495 -168.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tt -30.67 -50.02 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.048 2.139 . . . . 1.95 111.996 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.74 -32.56 52.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.19 0.996 . . . . 0.84 112.754 -175.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -118.93 15.24 13.37 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.7 1.6 . . . . 1.4 110.212 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 16.89 58.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.968 2.907 . . . . 3.31 114.597 -167.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 148.65 52.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.523 -0.917 . . . . 0.99 108.523 178.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.88 111.59 23.94 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.167 -2.16 . . . . 0.43 105.167 169.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -79.6 120.58 24.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.577 -1.638 . . . . 0.78 106.577 167.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mt -125.6 97.28 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 O-C-N 124.592 1.183 . . . . 1.05 107.882 -171.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -80.53 120.89 25.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.779 -1.563 . . . . 2.54 106.779 166.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.18 164.29 15.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.819 -1.549 . . . . 2.59 106.819 -165.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.06 132.54 24.4 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 108.245 -1.02 . . . . 4.03 108.245 172.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.65 -52.74 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.992 2.462 . . . . 2.42 112.466 -160.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.83 -32.84 46.56 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.252 0.834 . . . . 3.13 113.252 -172.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 pt -88.49 5.51 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.322 0.86 . . . . 2.89 113.322 -177.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.39 -52.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.531 1.06 . . . . 3.04 111.584 -172.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.48 114.0 0.37 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 108.97 -1.652 . . . . 0.99 108.97 -171.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -56.9 -31.77 90.27 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 119.991 1.896 . . . . 0.89 111.204 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -54.16 -36.79 63.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.956 -0.545 . . . . 6.61 112.034 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -67.16 -47.0 72.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.396 0.998 . . . . 4.2 110.352 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 mt -54.92 -51.83 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.653 -0.654 . . . . 0.83 110.601 170.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.35 -52.87 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 119.007 -0.52 . . . . 1.42 110.125 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -46.32 -47.95 18.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.305 1.042 . . . . 2.74 109.25 174.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.0 m -62.86 -49.53 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.107 -0.637 . . . . 0.86 110.663 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.58 -51.12 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.414 0.686 . . . . 0.69 111.162 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.65 -40.18 76.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.867 0.303 . . . . 2.82 111.634 179.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -65.35 -23.17 66.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 117.507 -1.235 . . . . 0.85 112.524 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.84 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.52 1.509 . . . . 1.66 109.407 165.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.99 19.04 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.319 -1.267 . . . . 1.07 114.943 174.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -136.1 116.35 13.52 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.367 1.584 . . . . 2.06 110.251 -163.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 154.46 37.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 117.109 -1.836 . . . . 4.26 107.568 177.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.11 164.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.797 0.839 . . . . 1.17 110.53 -173.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.9 m -148.63 92.91 2.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.472 -0.936 . . . . 1.89 108.472 171.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -55.11 126.47 24.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.855 0.862 . . . . 2.83 110.963 174.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 124.393 1.077 . . . . 2.55 109.088 -172.995 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.618 0 N-CA-C 107.165 -2.374 . . . . 1.74 107.165 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.4 139.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.708 -0.849 . . . . 3.07 108.708 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.32 87.67 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.333 -1.728 . . . . 2.18 106.333 167.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.1 134.06 36.74 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 118.156 -1.417 . . . . 2.57 108.27 167.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.65 146.88 46.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 124.23 0.956 . . . . 2.87 108.716 164.159 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.14 135.51 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.662 -1.977 . . . . 1.7 105.662 169.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.8 135.38 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.541 1.536 . . . . 2.78 108.258 -177.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -145.64 136.03 24.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.861 -2.274 . . . . 5.18 104.861 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.75 -53.82 0.65 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.74 -1.744 . . . . 1.64 108.74 -171.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 ptm -65.5 149.71 49.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.395 -0.474 . . . . 1.53 110.623 173.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.13 -1.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.633 0.975 . . . . 2.52 113.633 -168.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -169.21 157.53 7.71 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.021 1.282 . . . . 3.18 109.848 -166.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.55 -50.46 1.13 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.183 2.193 . . . . 1.21 113.267 -174.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -33.45 75.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.063 1.345 . . . . 1.59 113.056 -176.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.9 m -72.56 -53.92 10.61 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.377 -1.342 . . . . 1.14 107.377 168.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -43.99 -64.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.637 1.575 . . . . 0.84 111.689 -173.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -16.21 64.14 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.038 -0.414 . . . . 1.48 111.749 -173.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.5 98.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.668 -0.864 . . . . 4.8 108.668 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -60.49 -58.63 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.169 -1.049 . . . . 0.62 108.169 -178.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -53.73 -56.28 18.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.092 0.557 . . . . 3.15 110.803 178.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -49.52 -45.03 46.79 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.569 0.748 . . . . 1.16 111.235 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.7 t -63.14 -61.04 2.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.445 0.698 . . . . 1.22 110.774 175.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.96 -39.49 94.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.009 -1.076 . . . . 1.9 111.405 -168.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 m -53.4 -16.92 1.57 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.202 0.815 . . . . 1.68 113.202 176.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -61.72 -42.82 99.46 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.036 -1.04 . . . . 4.83 111.212 171.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.46 135.63 39.39 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.285 -0.635 . . . . 2.45 109.285 -176.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -78.97 -1.53 35.81 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.718 -0.613 . . . . 6.41 112.639 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.94 -19.21 56.55 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.381 0.537 . . . . 0.84 112.664 -178.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.1 tt -93.81 137.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.913 -0.773 . . . . 2.63 108.913 175.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.27 -38.36 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.428 1.491 . . . . 1.36 110.087 -174.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -140.16 149.78 43.4 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.919 -0.771 . . . . 2.74 108.919 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 t -153.99 119.12 5.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 106.593 -1.632 . . . . 1.72 106.593 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -145.85 111.21 5.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.062 -0.718 . . . . 1.89 109.062 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 44' ' ' ALA . 3.5 p -105.88 108.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.586 0.708 . . . . 1.92 111.321 -175.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.33 101.7 10.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.004 0.922 . . . . 0.74 109.472 -170.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -43.08 -38.92 2.53 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.706 1.202 . . . . 2.31 111.222 168.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.53 -29.18 23.92 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.914 0.886 . . . . 1.53 112.065 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -128.06 16.03 6.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.49 1.116 . . . . 1.59 109.9 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 35.06 47.23 0.26 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.309 1.843 . . . . 2.57 112.569 -174.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.27 145.71 41.63 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.75 -0.594 . . . . 1.14 110.457 -171.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -108.96 106.88 17.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.711 -1.589 . . . . 0.47 106.711 172.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -79.44 98.63 6.86 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.43 -1.693 . . . . 0.89 106.43 168.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.45 140.74 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.897 -1.89 . . . . 1.44 105.897 164.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.13 132.21 55.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.452 -1.314 . . . . 2.61 107.452 156.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -148.92 169.12 21.27 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.943 0.897 . . . . 2.17 109.5 -172.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.68 111.33 55.34 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.666 -0.683 . . . . 3.7 109.34 174.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.12 52.05 3.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.048 3.165 . . . . 2.3 112.362 -176.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -139.78 -64.57 0.48 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.467 1.507 . . . . 4.13 107.294 178.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.28 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.118 0.967 . . . . 4.01 111.364 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 142.84 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.851 -1.537 . . . . 2.33 106.851 176.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.05 159.29 35.66 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.045 -1.222 . . . . 0.94 110.045 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.69 -47.31 11.49 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.825 1.683 . . . . 0.85 110.054 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -48.43 -42.33 31.93 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 122.999 0.52 . . . . 6.54 111.952 178.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -51.71 54.56 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.414 1.486 . . . . 3.47 109.723 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mt -60.88 -52.23 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.76 109.364 175.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.77 -54.13 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 118.602 0.637 . . . . 1.91 110.411 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -47.67 -53.2 15.64 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.581 1.553 . . . . 3.06 109.789 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.1 m -56.35 -51.33 68.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.456 . . . . 0.73 109.855 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.5 -53.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 O-C-N 121.993 -0.442 . . . . 0.9 110.742 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.9 -47.63 84.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.963 0.802 . . . . 3.89 110.195 -178.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -68.94 -9.86 54.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.928 -1.035 . . . . 1.01 113.023 -175.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.01 -78.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.253 1.388 . . . . 2.52 108.396 158.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.19 26.89 0.32 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.61 -1.106 . . . . 1.05 114.55 171.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -125.36 172.76 9.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.061 1.43 . . . . 1.82 113.36 -160.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 70.38 0.82 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.342 1.068 . . . . 3.81 108.666 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.41 144.51 35.8 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.329 -0.857 . . . . 1.22 111.274 -165.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -151.29 110.09 3.85 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.166 -0.959 . . . . 1.92 113.089 -172.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 76.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.475 2.31 . . . . 2.45 115.189 -175.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.221 -0.428 0 C-N-CA 124.241 1.016 . . . . 1.86 112.331 168.544 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.556 0 N-CA-C 106.148 -2.781 . . . . 1.74 106.148 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.43 137.34 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.655 1.228 . . . . 2.31 109.598 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.36 79.47 1.61 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.88 1.324 . . . . 2.07 107.935 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.37 102.06 8.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.012 -1.477 . . . . 2.79 107.012 168.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.31 141.28 47.21 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.698 0.399 . . . . 1.94 109.951 176.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.38 140.86 16.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.986 -1.486 . . . . 1.76 106.986 172.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -117.46 107.46 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.433 -1.321 . . . . 1.73 107.433 174.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -78.19 137.91 38.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.114 -1.439 . . . . 5.32 107.114 170.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.08 -41.44 2.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 123.965 0.793 . . . . 1.57 111.415 161.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -58.61 143.05 47.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.574 -0.368 . . . . 1.57 111.632 -178.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -145.85 142.0 28.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.44 1.096 . . . . 2.97 110.543 177.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.9 m 69.68 164.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.096 1.758 . . . . 3.04 114.186 167.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.61 -35.51 2.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.67 1.988 . . . . 1.34 112.194 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -55.63 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.169 0.988 . . . . 0.97 112.268 173.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -54.37 -37.62 65.19 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 120.831 -1.168 . . . . 1.09 109.623 -177.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -49.21 -65.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.893 0.477 . . . . 1.02 111.157 172.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.274 0.2 OUTLIER -68.12 -22.42 64.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.759 -0.588 . . . . 1.28 111.486 -175.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -60.28 -56.24 23.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.095 -1.076 . . . . 3.49 108.095 174.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.8 mt -57.62 -58.61 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.693 -0.854 . . . . 0.56 108.693 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.86 -56.47 21.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.369 0.531 . . . . 3.12 111.643 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -59.28 -38.86 81.18 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.742 -0.598 . . . . 1.16 111.243 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -65.28 -61.39 2.15 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.829 -0.545 . . . . 0.86 110.543 175.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.27 -31.61 72.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.429 -0.794 . . . . 2.64 111.963 -169.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.4 -10.49 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.666 1.121 . . . . 2.25 113.514 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -69.13 -21.2 64.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.435 1.016 . . . . 5.64 112.212 170.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -69.53 115.59 8.96 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.613 0.765 . . . . 2.34 109.362 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -78.57 46.26 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.41 -0.806 . . . . 6.86 112.659 -174.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.05 24.6 0.1 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.271 1.415 . . . . 0.93 110.785 170.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.14 122.11 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.416 -1.698 . . . . 2.44 106.416 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.9 mt -85.18 -38.54 18.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.735 0.814 . . . . 1.89 109.204 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -155.17 156.33 35.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.377 -1.342 . . . . 2.68 107.377 -176.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.2 t -146.67 59.75 1.2 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.03 -1.1 . . . . 2.51 108.03 178.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.38 94.28 3.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.356 -0.979 . . . . 2.28 108.356 -163.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.346 2.6 p -90.06 83.95 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 123.579 1.657 . . . . 1.62 111.242 -169.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.94 87.06 4.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.68 -1.145 . . . . 0.69 108.772 -178.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -40.34 -44.02 1.87 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.297 1.439 . . . . 2.29 110.632 162.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.03 -37.03 0.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.815 1.646 . . . . 1.04 113.556 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -132.43 26.0 4.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.114 1.366 . . . . 2.62 109.688 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 29.92 52.8 0.11 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.36 2.664 . . . . 1.99 112.571 -175.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 154.53 42.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.602 0.593 . . . . 2.93 112.602 -178.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.1 106.72 17.37 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.232 1.813 . . . . 0.38 109.508 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -78.78 83.09 4.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.517 -1.661 . . . . 1.42 106.517 167.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.452 HD13 HG21 ' A' ' 58' ' ' ILE . 11.6 mt -79.06 145.48 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.522 -1.288 . . . . 1.37 107.522 173.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.4 134.85 50.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.299 -2.482 . . . . 2.73 104.299 161.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.88 172.28 17.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.773 0.715 . . . . 1.85 109.803 -168.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.74 81.78 1.23 Allowed Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.24 1.416 . . . . 4.48 107.952 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.72 -35.48 47.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.302 2.668 . . . . 1.67 112.733 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.95 -20.47 6.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.125 1.157 . . . . 4.35 114.125 176.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.9 pt -120.43 -57.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 119.621 1.101 . . . . 2.45 111.702 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tp -87.46 -36.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.007 -0.368 . . . . 2.64 110.007 -161.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.53 149.94 3.18 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -177.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.52 -41.16 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.242 1.961 . . . . 0.77 110.33 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -54.61 -37.65 65.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.965 0.906 . . . . 6.47 111.148 -176.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -57.81 11.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.79 0.436 . . . . 3.68 110.821 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 46' ' ' ILE . 3.4 mp -54.42 -45.32 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 1.31 110.02 176.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -56.32 -51.59 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.626 -0.671 . . . . 1.29 111.322 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -49.39 -47.12 47.98 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.512 0.725 . . . . 2.85 109.279 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -49.68 76.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 119.681 -0.807 . . . . 1.21 109.645 -177.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.12 -50.32 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.545 0.338 . . . . 0.73 111.561 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.9 -46.63 83.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.405 -0.518 . . . . 4.13 111.042 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.6 t -57.55 -44.63 85.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.557 0.743 . . . . 0.88 111.232 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.8 -54.4 46.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.376 -0.828 . . . . 1.6 110.738 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.55 -42.13 0.02 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.859 1.104 . . . . 1.52 115.859 -178.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.79 134.47 55.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.376 -0.821 . . . . 1.87 111.138 -131.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.24 104.31 6.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.6 1.546 . . . . 4.6 108.715 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.98 154.34 29.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.921 0.889 . . . . 1.0 110.331 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -152.87 103.93 2.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 1.71 109.52 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 71' ' ' LEU . 1.9 pt? -66.62 71.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.14 1.376 . . . . 2.63 112.643 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.45 -0.461 0 C-N-CA 123.996 0.918 . . . . 2.45 111.082 176.089 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.921 0 N-CA-C 109.46 -1.456 . . . . 2.05 109.46 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.33 129.35 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.236 -0.653 . . . . 1.85 109.236 -174.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -140.51 101.04 4.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.918 0.866 . . . . 3.04 109.105 -169.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.41 106.15 18.14 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.019 -1.104 . . . . 2.11 108.019 178.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.93 139.49 48.53 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.303 0.501 . . . . 1.96 110.343 170.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.15 143.77 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.125 -1.435 . . . . 1.62 107.125 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.75 156.02 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.33 -1.359 . . . . 1.72 107.33 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -138.34 122.23 17.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.405 1.082 . . . . 7.74 108.218 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.5 -45.79 1.13 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.925 -1.27 . . . . 1.54 109.925 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -56.0 140.4 43.43 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.851 -0.426 . . . . 2.19 109.851 170.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -166.32 22.79 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.83 0.308 . . . . 2.73 111.83 -172.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -169.33 147.2 3.64 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.11 0.868 . . . . 2.04 109.377 -174.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.0 0.38 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.017 2.127 . . . . 1.18 113.167 175.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 p -54.5 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.846 0.858 . . . . 0.92 111.659 172.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -41.32 -47.37 3.47 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 125.5 1.52 . . . . 1.12 110.834 176.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 t -46.63 -66.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.603 1.161 . . . . 0.82 110.933 173.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.318 0.3 OUTLIER -69.82 -17.61 63.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 119.692 -0.803 . . . . 1.33 111.302 -176.087 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -69.11 -45.02 71.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.31 -0.996 . . . . 3.34 108.31 -176.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.4 mt -53.7 -69.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.702 -0.851 . . . . 0.52 108.702 175.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.54 -59.08 3.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.522 0.729 . . . . 3.7 112.548 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -54.88 -41.76 71.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.232 0.613 . . . . 1.06 110.37 -177.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -61.4 -61.07 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.095 -0.378 . . . . 0.81 110.96 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.538 HD13 HG23 ' A' ' 58' ' ' ILE . 14.5 mt -62.35 -35.63 79.72 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 118.627 -1.229 . . . . 1.72 111.406 -169.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -57.89 -13.98 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.109 0.411 . . . . 1.37 112.109 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -61.99 -40.68 96.46 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.093 -1.005 . . . . 4.49 111.15 169.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -67.78 122.44 18.11 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.454 -0.573 . . . . 2.17 109.454 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.68 48.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.173 -0.954 . . . . 6.37 111.095 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.94 0.1 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.08 1.324 . . . . 0.89 111.524 -178.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.37 142.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.052 -0.721 . . . . 2.65 109.052 173.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.96 -34.14 9.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.814 1.246 . . . . 1.63 110.461 -176.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -154.65 155.26 34.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.154 -0.684 . . . . 2.8 109.154 -175.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.7 t -155.76 80.08 1.01 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.73 0.812 . . . . 2.23 110.569 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -86.21 97.18 10.22 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.466 -0.771 . . . . 1.45 110.321 172.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -85.08 80.23 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.77 1.628 . . . . 2.08 108.651 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.18 93.92 9.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.856 -0.794 . . . . 0.75 108.856 -174.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -46.8 -35.49 6.32 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.448 1.099 . . . . 1.89 111.862 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.53 -30.39 41.41 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.567 0.747 . . . . 0.97 111.878 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -121.1 13.35 11.25 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.524 1.53 . . . . 1.44 109.782 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.04 33.19 6.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.167 2.187 . . . . 1.88 112.979 176.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.01 147.47 46.27 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.353 0.661 . . . . 1.03 111.57 -161.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.88 108.69 20.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.818 1.647 . . . . 0.43 108.657 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.96 87.41 4.78 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.804 -2.295 . . . . 0.84 104.804 162.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 58' ' ' ILE . 18.8 mt -79.67 150.28 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.896 -1.52 . . . . 1.51 106.896 169.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -126.65 122.55 35.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 104.824 -2.287 . . . . 2.59 104.824 156.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -145.6 128.87 16.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 107.341 -1.355 . . . . 2.53 107.341 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.3 121.61 75.31 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 106.942 -1.503 . . . . 3.59 106.942 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.93 -46.63 18.59 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.378 2.052 . . . . 2.08 112.799 -165.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -56.94 -8.86 0.69 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.964 1.706 . . . . 3.61 115.249 -166.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 pt -115.17 -10.18 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.415 1.086 . . . . 2.32 113.65 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.89 -42.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.736 1.153 . . . . 2.92 113.097 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.91 153.44 5.33 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.6 -1.0 . . . . 0.86 110.6 -174.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.59 -35.48 17.03 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.261 1.974 . . . . 0.94 110.652 -174.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 -37.28 61.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.358 0.663 . . . . 6.77 112.291 -172.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.11 -58.09 9.72 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.227 0.467 . . . . 4.36 110.024 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 26' ' ' LEU . 2.6 mp -51.29 -49.71 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.287 -0.635 . . . . 1.39 109.287 177.056 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.83 -54.16 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.971 -0.537 . . . . 1.75 110.783 179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -48.84 -52.07 26.18 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.498 0.719 . . . . 3.03 109.844 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -56.07 -51.57 67.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 122.123 -0.361 . . . . 0.94 110.487 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.0 mt -55.74 -47.73 78.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.748 -0.595 . . . . 0.79 111.877 -176.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.343 0.519 . . . . 4.9 111.477 176.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -66.85 -15.62 63.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.243 -0.884 . . . . 1.43 112.466 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.33 -89.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.602 -1.258 . . . . 2.99 107.602 155.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.49 20.23 0.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.898 -1.501 . . . . 1.01 114.8 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -123.76 139.05 54.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.957 1.878 . . . . 1.91 113.121 -160.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -77.33 139.59 39.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.049 -1.463 . . . . 4.28 107.049 171.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.02 146.58 43.95 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.509 1.124 . . . . 1.12 109.357 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -153.06 112.25 3.81 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 121.673 -0.642 . . . . 1.57 110.575 176.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.06 121.36 7.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.847 0.859 . . . . 2.55 109.347 173.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 CA--C 1.529 0.17 0 C-N-CA 123.293 0.637 . . . . 2.24 110.287 172.879 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 109.609 -1.396 . . . . 1.77 109.609 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.18 147.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.134 1.373 . . . . 2.56 109.994 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 7.0 tt -145.31 103.77 3.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 2.98 108.6 175.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.97 117.8 31.97 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.025 -0.989 . . . . 2.22 108.47 178.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.58 142.12 50.46 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.515 0.598 . . . . 1.94 110.851 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.71 134.84 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 107.033 -1.469 . . . . 1.92 107.033 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.61 119.87 60.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.839 1.256 . . . . 1.78 107.687 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -87.14 62.8 7.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.125 0.57 . . . . 5.92 110.484 -164.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.54 -104.63 0.2 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.69 -0.964 . . . . 3.57 110.69 174.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mtm 57.66 65.53 1.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.419 1.087 . . . . 2.16 111.873 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 p -65.97 -23.81 66.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.356 1.243 . . . . 3.81 114.356 -168.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.3 t -166.66 155.48 10.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.786 0.721 . . . . 2.21 109.143 -165.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.64 -39.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.659 2.384 . . . . 1.12 113.301 172.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 p -52.98 -76.08 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.603 1.161 . . . . 0.81 112.726 169.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.2 m -46.97 -41.03 15.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.165 1.786 . . . . 1.39 111.124 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.1 t -51.72 -73.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.931 0.893 . . . . 1.0 110.01 168.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.301 0.3 OUTLIER -67.31 -14.86 63.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.388 0.613 . . . . 1.3 112.275 -167.89 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.05 -42.15 93.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.032 -1.042 . . . . 4.52 108.494 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.46 -65.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.712 -0.847 . . . . 0.5 108.712 -175.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.21 -66.16 0.45 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.107 0.963 . . . . 3.82 112.234 175.723 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -47.55 -45.28 26.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.591 0.756 . . . . 1.1 111.068 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 t -60.95 -62.56 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.224 0.466 . . . . 0.96 111.12 175.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.59 -31.5 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.122 0.874 . . . . 1.74 111.163 -171.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 m -54.31 -19.54 5.56 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.116 -0.99 . . . . 1.78 112.646 176.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -37.97 77.4 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.711 -1.243 . . . . 6.0 112.59 170.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.86 165.09 16.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 2.76 109.992 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.92 42.13 3.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.758 0.823 . . . . 7.47 110.032 169.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.84 18.4 3.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.222 -1.151 . . . . 1.13 110.222 164.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -115.71 148.93 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.807 -2.294 . . . . 3.62 104.807 167.154 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.34 -37.12 5.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.784 1.233 . . . . 1.76 110.276 -174.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -157.63 162.4 38.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.675 -0.861 . . . . 2.58 108.675 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -143.37 73.85 1.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.194 0.997 . . . . 2.49 110.779 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.85 83.6 5.75 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.161 -0.681 . . . . 1.55 109.161 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.4 103.43 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.522 0.677 . . . . 1.55 110.503 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.71 100.16 9.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.383 1.073 . . . . 0.76 108.906 -172.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -38.18 4.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.254 1.422 . . . . 2.03 110.575 170.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.85 39.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.394 1.078 . . . . 0.76 112.262 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.24 16.0 10.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.641 1.177 . . . . 1.36 109.688 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.08 43.51 1.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.212 2.205 . . . . 1.88 112.512 -178.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.17 144.34 34.74 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 122.149 -0.345 . . . . 1.08 110.826 -166.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HB1' HG13 ' A' ' 46' ' ' ILE . . . -98.65 108.13 20.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.443 1.497 . . . . 0.41 108.556 168.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.79 83.44 7.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.354 -2.091 . . . . 0.73 105.354 157.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.421 HG13 ' HB1' ' A' ' 44' ' ' ALA . 59.8 mt -83.06 153.29 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.32 -1.733 . . . . 1.07 106.32 170.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -121.76 141.98 50.65 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.876 -1.898 . . . . 3.88 105.876 166.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -163.09 165.5 24.6 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 118.742 0.701 . . . . 1.99 112.186 -163.758 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.74 97.46 44.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 123.986 0.804 . . . . 4.2 110.736 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.72 -21.05 72.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.839 2.359 . . . . 1.73 114.641 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.44 -31.18 14.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.973 0.806 . . . . 4.11 111.875 168.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -66.86 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 123.229 0.611 . . . . 4.73 110.208 175.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.29 116.02 41.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.333 -0.988 . . . . 2.69 108.333 -166.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.16 161.91 38.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.378 -1.489 . . . . 0.87 109.378 -176.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -54.03 -37.88 86.68 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.856 1.704 . . . . 1.01 109.485 171.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 57' ' ' ASP . 12.8 ptt180 -35.96 -53.39 0.76 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 10.26 112.05 168.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 56' ' ' ARG . 64.6 m-20 -71.52 -52.02 20.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.709 -1.589 . . . . 2.96 106.709 -164.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -56.08 -52.37 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.384 -1.28 . . . . 0.96 109.406 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -53.38 -56.59 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.042 0.537 . . . . 1.56 109.683 179.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -56.93 -38.1 72.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.206 0.457 . . . . 3.13 110.247 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.7 m -65.08 -46.89 79.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.259 0.481 . . . . 0.74 110.609 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.78 -46.43 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.294 1.038 . . . . 0.68 110.431 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.28 -55.65 28.96 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 123.575 0.75 . . . . 2.94 109.672 173.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -51.85 -46.6 64.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.636 1.174 . . . . 1.24 111.357 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.79 -45.24 79.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.219 -0.926 . . . . 1.92 112.107 177.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.86 -46.46 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.999 0.76 . . . . 1.49 114.999 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -129.13 134.78 48.2 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 120.482 -0.487 . . . . 1.81 112.011 -135.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.46 154.94 32.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.731 -1.211 . . . . 3.27 107.731 168.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.29 165.08 28.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.907 0.483 . . . . 1.28 110.962 -166.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 m -132.58 112.09 11.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.571 1.549 . . . . 2.19 107.949 177.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 tp -73.1 78.59 1.23 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.796 1.238 . . . . 2.95 108.698 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.536 0.404 0 CA-C-N 115.583 -0.735 . . . . 2.01 111.377 178.523 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.094 0 N-CA-C 110.385 -1.086 . . . . 2.14 110.385 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.89 132.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.188 -1.412 . . . . 2.18 107.188 163.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.85 124.42 44.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 103.771 -2.677 . . . . 3.36 103.771 169.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.4 127.03 40.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.096 -1.816 . . . . 2.46 106.096 -179.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.94 144.97 35.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.283 -0.266 . . . . 1.94 110.283 -172.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.84 139.29 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.212 -1.403 . . . . 1.79 107.212 168.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.98 99.49 6.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 126.235 1.814 . . . . 1.95 108.031 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -84.86 140.9 30.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.464 1.106 . . . . 5.53 108.061 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.92 -11.63 34.65 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.328 0.966 . . . . 1.65 112.818 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.72 146.89 53.33 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.292 1.046 . . . . 1.49 111.295 177.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -162.04 143.47 10.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.875 -1.898 . . . . 2.97 105.875 166.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.4 t 69.64 145.58 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.351 1.46 . . . . 2.47 113.147 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.19 -32.32 0.47 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.248 1.819 . . . . 1.2 113.176 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 p -51.66 -81.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.724 1.209 . . . . 1.01 112.936 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.5 m -45.7 -43.67 12.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.835 1.254 . . . . 1.21 110.68 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.1 -65.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.444 1.098 . . . . 1.14 110.976 174.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.293 0.3 OUTLIER -68.91 -20.21 64.23 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.549 0.69 . . . . 1.43 111.003 -176.559 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.03 -40.46 97.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.92 -1.113 . . . . 4.16 109.023 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.7 -67.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.933 0.893 . . . . 0.74 109.096 176.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.99 -64.17 0.87 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.942 0.497 . . . . 3.48 111.64 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -48.48 -47.56 38.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.933 0.893 . . . . 2.83 111.935 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 t -67.82 -39.94 83.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 O-C-N 121.336 -0.852 . . . . 0.84 112.285 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.97 -37.57 69.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.672 1.124 . . . . 1.77 110.937 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -68.87 73.13 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.17 1.388 . . . . 2.55 110.091 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 129.36 3.064 . . . . 5.53 109.648 -172.396 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -54.17 -40.79 67.82 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 119.114 0.87 . . . . 2.59 112.282 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 77.91 -5.17 2.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.674 2.389 . . . . 7.57 111.338 -163.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.53 47.09 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 121.304 -0.873 . . . . 1.27 111.456 176.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.28 133.93 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.114 1.366 . . . . 3.74 107.894 173.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -102.16 -31.89 10.37 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.413 1.085 . . . . 1.59 110.731 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -155.1 153.61 31.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.821 -0.609 . . . . 2.09 109.715 174.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -150.02 96.17 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.272 1.029 . . . . 2.03 110.846 -171.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.9 104.39 16.28 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.141 -0.689 . . . . 1.46 109.141 171.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.6 82.45 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.996 0.918 . . . . 2.16 108.85 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 90.21 6.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.071 -1.085 . . . . 0.91 108.071 -176.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -47.56 -32.68 5.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.773 0.829 . . . . 1.81 111.304 169.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.75 -32.57 31.18 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.941 0.896 . . . . 0.98 111.876 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -122.53 18.05 10.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.405 1.482 . . . . 1.67 109.68 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 m120 36.83 45.16 0.4 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.965 2.106 . . . . 2.65 112.916 -175.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.28 143.99 42.45 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.493 0.588 . . . . 1.61 111.82 -174.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.11 112.91 24.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.427 1.491 . . . . 0.42 108.131 168.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -86.23 105.68 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.475 -1.676 . . . . 0.89 106.475 164.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.72 103.62 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.586 1.554 . . . . 1.24 108.338 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.34 83.66 4.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.57 -1.641 . . . . 3.39 106.57 172.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 165.0 14.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.287 1.035 . . . . 2.0 112.3 177.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.97 101.12 39.59 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.394 1.078 . . . . 3.78 110.195 174.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 60.62 6.88 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.489 3.46 . . . . 2.31 113.796 -166.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -157.23 -40.07 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.657 0.783 . . . . 4.17 111.42 167.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.06 -13.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.208 0.603 . . . . 2.26 110.249 174.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -149.48 144.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 108.071 -1.085 . . . . 2.2 108.071 175.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.4 148.75 20.8 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 108.317 -1.913 . . . . 1.06 108.317 170.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.46 -42.93 56.19 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.466 1.444 . . . . 0.72 109.702 178.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.59 -42.28 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.173 1.389 . . . . 7.31 113.218 168.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.26 -41.6 76.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.262 0.937 . . . . 3.32 109.597 -175.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 mt -63.59 -49.27 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.422 -0.955 . . . . 0.68 108.422 176.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -50.0 -56.85 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.879 -0.415 . . . . 1.56 109.879 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -51.49 -51.66 53.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.073 0.549 . . . . 3.04 110.114 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.6 m -58.97 -52.57 65.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.625 -0.43 . . . . 0.81 110.056 -176.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.83 -60.55 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.862 0.865 . . . . 0.75 110.024 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.4 -45.06 80.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.802 -0.444 . . . . 3.87 109.802 -176.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -62.97 -9.17 8.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.227 -1.368 . . . . 1.11 114.278 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.76 -87.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 121.359 1.89 . . . . 2.54 107.808 155.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.13 42.49 0.47 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.833 -0.982 . . . . 1.22 112.307 174.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.4 170.83 11.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.327 1.064 . . . . 1.93 112.912 -171.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -117.42 122.47 43.89 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 104.684 -2.339 . . . . 3.45 104.684 167.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.79 154.82 26.74 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.732 0.813 . . . . 1.04 111.073 -171.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.4 m -156.24 121.46 4.76 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.455 -0.778 . . . . 1.55 110.363 172.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.44 128.62 38.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 3.73 110.149 173.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 125.547 1.539 . . . . 2.37 109.528 178.407 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 CA-C-O 118.327 -1.263 . . . . 2.88 115.069 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.67 100.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 120.169 1.985 . . . . 2.3 110.975 176.101 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -104.17 101.45 11.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.825 2.05 . . . . 2.62 107.288 174.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -97.51 107.15 19.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.97 -0.752 . . . . 2.44 108.97 172.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -99.94 148.25 24.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 124.14 0.9 . . . . 2.33 108.952 166.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.15 145.73 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.161 -1.792 . . . . 1.72 106.161 158.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.05 139.23 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.746 1.218 . . . . 2.29 108.766 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -133.56 153.58 51.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.766 0.826 . . . . 6.85 111.023 -178.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.03 -21.0 28.0 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.862 1.22 . . . . 1.95 110.965 -174.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.5 mtm -66.75 150.55 48.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.156 -0.614 . . . . 1.8 109.681 174.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t -151.35 10.81 0.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.105 0.78 . . . . 2.44 113.105 177.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.5 t -171.87 151.56 2.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.544 1.066 . . . . 2.29 109.528 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.28 -31.94 0.71 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.696 1.998 . . . . 1.2 113.012 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -53.3 -67.5 0.25 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.377 1.071 . . . . 0.72 113.145 170.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.5 m -43.15 -50.96 6.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.217 1.407 . . . . 1.07 108.346 176.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 t -50.02 -66.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.743 -1.117 . . . . 0.84 111.551 177.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' GLU 0.327 0.1 OUTLIER -65.83 -28.98 69.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.98 111.112 -171.404 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.07 -52.29 56.57 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.32 1.448 . . . . 3.06 108.281 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -51.76 -65.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.092 -1.077 . . . . 0.76 108.092 171.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 20' ' ' HIS . 11.4 pt-20 -66.44 -42.07 88.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.91 -0.586 . . . . 2.96 110.759 -158.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -59.54 -45.66 91.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.739 0.815 . . . . 1.55 110.39 173.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -59.5 -49.67 76.87 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.761 -0.459 . . . . 0.97 109.761 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.07 -45.23 75.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.751 -0.593 . . . . 2.49 110.985 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -61.55 -7.03 2.81 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.395 1.257 . . . . 2.27 114.395 179.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -66.63 -31.94 72.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.492 1.042 . . . . 4.35 110.654 169.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -64.74 121.5 14.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.627 0.771 . . . . 2.26 109.168 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.06 46.05 0.78 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.445 0.906 . . . . 5.6 113.445 -165.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.62 20.38 0.13 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.469 1.033 . . . . 1.41 111.335 166.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.68 140.18 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.093 -1.077 . . . . 2.38 108.093 174.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.3 mt -109.28 -35.9 6.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.366 1.066 . . . . 1.6 111.433 -173.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -155.46 158.42 38.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.462 1.028 . . . . 2.24 109.854 -177.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 p -155.91 140.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.742 2.417 . . . . 3.13 105.467 -177.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -156.45 90.59 1.18 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.362 -1.718 . . . . 1.55 106.362 170.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.48 76.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.603 -1.258 . . . . 1.92 107.603 -172.14 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.86 93.24 4.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.572 -0.705 . . . . 1.0 109.133 -171.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tt -42.98 -37.17 1.79 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.252 1.421 . . . . 2.17 111.566 168.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.23 -32.91 39.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 1.11 112.452 178.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -116.05 12.23 15.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.255 1.422 . . . . 1.6 110.125 178.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 40.44 37.74 0.49 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.823 2.049 . . . . 2.14 112.141 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 154.89 45.54 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.489 0.716 . . . . 1.44 109.762 -169.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.68 112.12 11.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.413 -1.328 . . . . 0.61 107.413 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -92.08 96.94 10.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.899 2.479 . . . . 1.29 104.602 170.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.2 mp -92.79 135.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 104.707 -2.331 . . . . 1.57 104.707 172.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.1 127.88 54.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.501 -1.666 . . . . 3.2 106.501 168.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -165.35 168.47 16.78 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.111 0.965 . . . . 2.98 109.74 -173.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -92.13 119.05 68.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.412 1.07 . . . . 4.0 108.905 171.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.62 -32.51 93.43 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.543 1.495 . . . . 2.15 113.039 176.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -84.88 49.88 1.81 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.901 1.228 . . . . 5.55 111.843 -165.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.97 -47.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 127.395 2.278 . . . . 4.15 107.83 178.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -53.62 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.308 1.043 . . . . 2.84 109.595 -173.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.06 145.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.717 -0.614 . . . . 0.92 111.7 -166.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -52.5 -39.63 74.03 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.514 2.143 . . . . 0.94 111.354 178.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -37.95 -48.76 1.2 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.435 1.494 . . . . 7.66 112.697 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.57 -50.24 59.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.864 0.84 . . . . 3.69 109.506 -172.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.3 -52.58 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.598 -0.689 . . . . 1.04 110.896 175.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.86 -50.8 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.946 -0.761 . . . . 1.71 108.946 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -55.37 -47.04 76.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.008 0.523 . . . . 5.05 110.373 -179.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -60.08 -48.4 81.89 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.856 0.753 . . . . 0.95 110.936 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.7 -51.69 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.865 0.757 . . . . 0.88 110.837 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.95 -55.5 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.119 0.968 . . . . 2.86 109.943 177.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -57.09 -34.95 68.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.751 1.22 . . . . 1.03 111.597 -177.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.67 -58.1 4.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.529 0.604 . . . . 2.37 110.275 172.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 -41.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.826 1.09 . . . . 1.57 115.826 -176.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -117.25 142.69 46.74 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 117.421 0.61 . . . . 1.98 111.65 -135.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.8 150.49 30.71 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.838 -1.542 . . . . 3.69 106.838 173.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.41 164.61 35.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.235 0.471 . . . . 1.09 111.994 -176.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.7 m -158.2 132.04 7.85 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 118.282 -0.866 . . . . 1.4 110.624 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.49 128.68 37.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.893 1.224 . . . . 2.55 108.777 172.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.465 0.284 0 C-N-CA 123.442 0.697 . . . . 3.05 111.967 177.343 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 N-CA-C 111.796 -0.521 . . . . 1.78 111.796 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.42 128.9 74.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.089 0.956 . . . . 3.36 110.727 -175.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.25 120.3 28.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.108 1.363 . . . . 4.37 108.076 173.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.83 107.89 19.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.185 -1.043 . . . . 2.41 108.185 177.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -117.78 148.55 41.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.036 0.534 . . . . 1.94 110.998 -174.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.7 151.2 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.884 0.873 . . . . 1.81 108.971 173.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.72 86.76 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.981 1.312 . . . . 2.19 109.339 174.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 107.48 18.78 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.664 -0.648 . . . . 6.58 110.416 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.62 -20.77 0.39 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.357 0.98 . . . . 1.54 112.133 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.7 mtm -62.5 169.7 2.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.176 0.988 . . . . 1.72 111.79 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 t -158.9 -44.66 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.519 0.727 . . . . 2.35 110.856 -177.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.9 m -138.44 164.3 29.71 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.189 0.449 . . . . 2.62 110.665 -168.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -38.64 3.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.48 1.912 . . . . 1.23 112.464 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.8 p -52.68 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.782 1.233 . . . . 0.88 112.265 170.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.4 m -42.69 -41.97 3.33 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.638 1.175 . . . . 1.23 111.43 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.22 -72.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.024 0.53 . . . . 0.84 111.121 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -17.88 65.08 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.465 -0.772 . . . . 1.0 112.334 -170.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -54.99 -46.4 75.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.859 0.864 . . . . 3.51 109.36 173.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.08 -60.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.895 -1.15 . . . . 0.59 107.895 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -50.84 -58.17 6.62 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.794 0.438 . . . . 2.97 110.654 178.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -56.2 -33.69 65.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.473 0.709 . . . . 1.09 111.908 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -70.62 -64.46 0.89 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.581 0.628 . . . . 0.99 110.609 172.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.12 -32.89 74.82 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.052 -1.03 . . . . 2.15 111.583 -167.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -56.93 -16.45 6.88 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 2.23 112.701 175.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -63.08 -35.8 81.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.398 -0.814 . . . . 4.97 111.126 171.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -72.98 109.7 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.53 -0.915 . . . . 2.58 108.53 177.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -65.87 -3.74 5.62 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.928 -1.107 . . . . 7.23 110.898 167.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.73 -25.37 71.69 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.623 1.106 . . . . 1.02 112.833 166.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 pp -99.84 156.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 119.142 1.471 . . . . 3.31 110.519 175.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.22 -38.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.557 1.543 . . . . 1.48 110.046 -177.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -155.65 157.06 36.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.651 0.659 . . . . 2.55 109.409 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -140.64 131.78 26.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.073 -1.454 . . . . 1.95 107.073 170.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.45 98.31 3.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.344 1.458 . . . . 1.63 107.651 -177.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.33 106.55 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.334 0.654 . . . . 1.71 111.761 -174.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.13 97.67 8.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.545 -0.722 . . . . 0.9 109.223 -174.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -48.98 -40.2 29.62 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.19 0.996 . . . . 1.76 111.597 175.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.55 -32.95 1.02 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.384 1.074 . . . . 0.86 113.226 175.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -125.82 13.76 7.98 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.084 0.953 . . . . 1.36 111.154 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 34.52 49.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.776 . . . . 1.88 112.277 -172.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 139.71 53.59 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.164 0.585 . . . . 2.77 109.856 -179.001 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.96 112.17 24.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.223 1.409 . . . . 0.6 107.738 162.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -79.18 102.16 8.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.281 -2.488 . . . . 1.35 104.281 160.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.0 mt -106.76 124.73 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.336 -1.728 . . . . 0.95 106.336 174.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -97.48 114.74 26.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.219 -2.141 . . . . 3.52 105.219 166.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.66 151.62 29.0 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.76 -1.941 . . . . 2.94 105.76 -178.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.62 129.43 23.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.409 0.443 . . . . 3.83 110.883 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -56.94 -35.31 98.6 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.898 2.399 . . . . 1.73 111.737 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.64 -25.87 65.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.13 0.789 . . . . 3.71 113.13 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.9 pt -106.86 -26.96 3.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 118.965 0.802 . . . . 2.83 112.161 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -152.93 131.97 3.12 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 CA-C-N 119.246 0.93 . . . . 2.78 109.584 172.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.71 166.75 53.4 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.473 -0.651 . . . . 0.85 111.473 -177.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.02 -55.54 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.86 2.374 . . . . 1.18 110.586 177.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -56.97 -32.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 122.391 -0.193 . . . . 7.49 111.03 -174.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -56.88 13.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.659 1.584 . . . . 4.02 109.184 175.049 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.66 -50.33 68.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.059 -0.719 . . . . 1.41 109.059 176.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.2 -46.97 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.007 -0.542 . . . . 1.98 110.524 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -52.71 -51.73 59.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.984 0.811 . . . . 2.79 109.714 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -52.33 -58.39 6.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.466 0.575 . . . . 0.9 110.302 175.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.3 -55.78 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.043 0.537 . . . . 0.78 111.179 -172.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -53.67 -45.6 70.33 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.709 0.804 . . . . 4.19 109.635 176.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -66.98 -9.88 43.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.617 -1.182 . . . . 1.08 113.392 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.96 -100.99 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.276 1.398 . . . . 2.6 107.85 156.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.86 38.92 0.5 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.243 0.929 . . . . 1.64 112.871 177.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -130.81 122.71 27.61 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.311 1.056 . . . . 1.97 109.336 -171.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -79.91 133.61 36.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.971 -1.863 . . . . 3.01 105.971 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.28 161.15 30.88 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 113.791 1.034 . . . . 1.08 113.791 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -158.22 137.71 11.87 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.912 1.285 . . . . 1.48 108.572 177.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -82.43 48.22 1.26 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.747 1.612 . . . . 3.22 111.232 -175.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 117.209 2.3 . . . . 2.67 117.209 -160.65 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.427 -1.207 . . . . 2.13 115.292 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 p -156.63 127.7 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 120.371 2.086 . . . . 1.8 110.29 172.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.48 108.97 6.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.787 -1.19 . . . . 3.38 107.787 172.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.35 119.44 28.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.434 -1.321 . . . . 2.18 107.434 169.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -119.69 140.49 50.58 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.707 1.139 . . . . 2.8 110.494 170.046 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.81 119.87 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.718 -1.216 . . . . 1.59 107.718 173.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.54 94.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.569 1.148 . . . . 2.54 108.37 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -78.45 86.16 4.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.937 -1.505 . . . . 7.09 106.937 176.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.12 -138.25 5.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 103.48 -3.848 . . . . 3.38 103.48 175.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 mtm 65.78 166.97 0.19 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.951 1.3 . . . . 2.18 111.62 -170.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.6 p -147.21 -83.41 0.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.993 0.517 . . . . 3.66 110.134 -176.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t -146.29 103.46 3.71 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.595 0.758 . . . . 2.94 110.389 -166.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 45.33 -129.98 1.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.458 -0.941 . . . . 2.77 108.458 -169.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.1 p 43.53 -87.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.463 1.905 . . . . 0.8 113.962 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -39.83 -43.75 1.51 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.087 1.755 . . . . 1.09 110.391 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -44.42 -67.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 0.95 110.649 172.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HA ' ' HG3' ' A' ' 23' ' ' GLU 0.326 0.4 OUTLIER -71.78 -21.6 61.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 119.797 -0.761 . . . . 0.94 112.512 -177.525 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.56 -45.32 92.17 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.362 -1.347 . . . . 4.19 107.362 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.43 -69.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.62 -0.718 . . . . 0.61 109.085 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 2.1 pp20? -56.6 -48.14 78.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.774 0.261 . . . . 4.77 111.589 -165.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -70.45 -20.77 62.87 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.23 0.612 . . . . 1.2 110.485 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.7 t -66.85 -62.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.33 -1.481 . . . . 0.99 109.036 162.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.66 -50.58 35.18 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 113.62 0.97 . . . . 1.85 113.62 -162.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -44.15 -28.26 0.48 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.015 1.326 . . . . 2.25 113.58 -167.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -63.17 -40.48 97.67 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.192 2.597 . . . . 4.16 112.944 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -62.2 129.06 39.02 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.254 -1.017 . . . . 2.41 108.254 172.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.88 -3.47 3.44 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.795 1.405 . . . . 10.75 114.795 -166.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' HD12 ' A' ' 52' ' ' ILE . . . -92.16 -14.13 56.49 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 119.546 -0.585 . . . . 1.16 112.214 -178.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mm -88.91 104.86 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.037 -1.098 . . . . 2.45 108.037 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.0 mt -78.99 -38.96 35.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.004 -0.739 . . . . 1.62 109.004 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -155.31 145.68 21.95 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.599 -0.889 . . . . 2.31 108.599 176.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.75 105.99 6.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.307 -1.368 . . . . 1.89 107.307 175.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 t -120.94 103.6 9.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.963 -1.125 . . . . 1.52 107.963 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.04 127.78 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.072 0.549 . . . . 1.87 110.481 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.03 108.94 11.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.035 0.934 . . . . 1.2 110.247 -170.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.81 -41.51 5.06 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.933 1.293 . . . . 2.41 111.08 168.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.77 14.36 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 124.109 0.964 . . . . 0.79 112.475 -175.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -130.07 14.28 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.212 1.005 . . . . 1.4 110.006 -177.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 m120 29.97 53.55 0.13 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 126.169 1.788 . . . . 2.29 111.831 -169.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.29 141.17 37.76 Favored 'General case' 0 N--CA 1.461 0.085 0 O-C-N 121.577 -0.702 . . . . 0.99 110.712 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.19 112.61 24.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.753 1.621 . . . . 0.47 108.424 168.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -79.91 104.0 10.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.055 -1.832 . . . . 0.84 106.055 162.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.41 113.0 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.482 -0.933 . . . . 0.9 108.482 175.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -84.1 107.38 16.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 105.699 -1.963 . . . . 3.06 105.699 164.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -147.2 167.48 24.09 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.67 -1.604 . . . . 2.66 106.67 174.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.35 136.65 27.34 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.757 1.021 . . . . 4.37 113.757 174.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.34 48.59 2.93 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.506 3.471 . . . . 2.06 113.023 -165.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -155.85 -47.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.004 1.322 . . . . 3.11 109.464 -173.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.531 HD12 ' HA2' ' A' ' 31' ' ' GLY . 7.6 pt -67.75 -32.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.228 -1.027 . . . . 3.23 108.228 166.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.56 HG23 ' H ' ' A' ' 54' ' ' GLY 0.31 17.6 tt -131.67 -91.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 123.735 0.647 . . . . 2.4 112.579 170.029 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 135.67 152.78 6.49 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.536 -1.426 . . . . 1.15 109.536 -168.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.71 -57.17 0.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.197 1.931 . . . . 1.01 109.033 172.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptt85 -29.28 -55.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.223 2.209 . . . . 10.04 113.22 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.23 -51.06 65.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.552 -0.907 . . . . 2.85 108.552 -171.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.81 -49.95 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.536 -0.542 . . . . 0.81 109.536 177.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.1 mm -50.28 -57.99 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 119.09 -0.481 . . . . 1.53 109.795 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -51.46 -46.31 63.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.055 0.542 . . . . 2.82 110.258 177.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -57.57 -47.9 80.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.388 -0.339 . . . . 0.69 110.986 178.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.0 -50.6 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.278 0.945 . . . . 1.66 110.989 -177.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -50.28 73.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.337 0.517 . . . . 2.95 110.243 176.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -52.0 -42.0 62.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.526 0.73 . . . . 0.9 111.132 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.74 -49.29 48.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.305 -0.872 . . . . 1.84 111.687 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.9 -44.22 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 116.001 1.16 . . . . 1.37 116.001 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.87 156.8 39.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.813 0.672 . . . . 1.88 112.813 -135.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.21 139.71 39.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.651 -1.611 . . . . 5.65 106.651 171.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.85 70.59 1.21 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.401 1.48 . . . . 2.54 110.1 -166.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -84.99 100.32 11.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.425 0.631 . . . . 1.68 109.629 -170.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.33 73.88 0.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.68 1.592 . . . . 2.63 112.651 -178.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 CA--C 1.541 0.6 0 C-N-CA 125.086 1.354 . . . . 2.0 111.682 167.082 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 109.728 -0.471 . . . . 11.74 109.728 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.03 37.73 86.63 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.282 0.468 . . . . 4.79 112.06 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.84 -52.14 9.36 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.165 0.986 . . . . 6.22 110.061 -163.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.45 113.31 0.3 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.862 -1.695 . . . . 1.46 108.862 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.14 147.54 5.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.06 -1.089 . . . . 2.2 108.06 169.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.5 tp -150.64 82.92 1.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.509 -0.552 . . . . 2.26 109.509 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 74' ' ' ILE . 44.8 mp0 -77.92 100.73 6.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 110.035 -0.357 . . . . 3.49 110.035 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.78 118.21 27.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.04 -1.467 . . . . 2.62 107.04 166.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.77 119.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 105.498 -2.038 . . . . 1.82 105.498 167.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.67 93.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 125.513 1.525 . . . . 2.15 107.967 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -78.47 112.36 15.43 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.009 -1.478 . . . . 6.53 107.009 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.64 -136.76 7.82 Favored Glycine 0 N--CA 1.434 -1.479 1 N-CA-C 101.994 -4.442 . . . . 3.54 101.994 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.63 173.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.874 0.87 . . . . 2.21 112.683 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -154.03 -81.03 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.954 1.302 . . . . 3.29 108.674 -167.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -172.13 131.37 0.63 Allowed 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 125.361 1.464 . . . . 5.37 107.957 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 48.45 -146.12 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.558 -0.734 . . . . 2.8 109.21 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.1 p 51.61 -86.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.907 1.447 . . . . 1.39 114.907 161.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.5 p -45.31 -41.7 9.03 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.214 -0.929 . . . . 3.54 111.53 166.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.03 -72.18 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.3 1.44 . . . . 0.82 110.064 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -25.82 66.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.806 -0.616 . . . . 1.17 111.241 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -53.21 -57.52 10.22 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.527 -0.916 . . . . 4.73 108.527 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.69 -60.12 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.908 -0.775 . . . . 0.58 108.908 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -54.16 -57.03 12.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.85 0.357 . . . . 3.27 111.373 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -57.0 -47.58 80.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.433 0.693 . . . . 1.04 110.07 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -60.03 -65.23 0.71 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.931 -0.396 . . . . 0.84 109.931 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.75 -29.43 69.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 119.006 -1.078 . . . . 2.86 111.217 -166.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.0 m -55.82 -20.38 15.0 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.163 -0.961 . . . . 1.58 112.348 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -30.64 69.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.808 -1.183 . . . . 6.64 112.417 172.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -70.07 116.04 9.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.209 -1.034 . . . . 2.36 108.209 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 32.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.418 -0.802 . . . . 7.84 113.082 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.08 -8.53 5.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.037 1.78 . . . . 0.72 111.82 166.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.02 118.64 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 105.974 -1.861 . . . . 2.5 105.974 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.83 -37.75 18.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.222 -0.659 . . . . 1.73 109.222 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.4 162.12 40.86 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.052 0.387 . . . . 2.89 110.866 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.91 96.08 2.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.433 1.893 . . . . 1.91 108.957 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 m -99.73 99.78 10.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.719 1.608 . . . . 1.96 107.545 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.96 92.53 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 122.819 1.295 . . . . 1.9 109.286 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.72 82.22 3.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 107.484 -1.302 . . . . 1.28 107.484 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -37.5 -44.07 0.63 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.248 1.819 . . . . 2.59 110.378 163.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.4 -32.93 28.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.121 . . . . 1.08 113.067 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 p -120.95 20.45 11.57 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.416 1.086 . . . . 2.53 110.296 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.9 m120 34.59 56.66 0.7 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.368 1.867 . . . . 2.23 111.523 -170.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -140.69 125.58 18.23 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.968 0.359 . . . . 1.6 111.968 -167.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.74 98.99 8.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.62 107.245 165.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -77.25 96.29 4.53 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 104.787 -2.301 . . . . 1.09 104.787 159.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.67 150.0 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 114.249 -1.342 . . . . 1.23 107.996 168.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.14 133.74 55.21 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 105.427 -2.064 . . . . 3.06 105.427 166.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -156.26 161.82 40.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.176 -1.416 . . . . 2.42 107.176 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.18 140.99 22.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.088 -1.449 . . . . 4.15 107.088 161.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.45 -22.58 28.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.399 2.066 . . . . 1.71 111.628 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -65.16 -50.85 64.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.648 0.779 . . . . 4.06 111.169 -172.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.98 -11.29 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.647 0.379 . . . . 2.42 111.957 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -150.88 130.99 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.315 -0.624 . . . . 2.39 109.315 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.01 154.08 47.68 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 109.177 -1.569 . . . . 0.76 109.177 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.04 -40.52 26.73 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.585 1.523 . . . . 0.75 109.34 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 11.3 tpt180 -59.09 -38.26 79.09 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.381 -0.342 . . . . 8.24 111.202 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -53.0 47.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.154 1.382 . . . . 3.51 109.745 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.35 -51.87 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.031 -0.986 . . . . 0.85 109.04 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.46 -52.58 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 118.695 -0.669 . . . . 1.28 111.446 -177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 32.5 m170 -48.06 -49.41 31.57 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.935 1.294 . . . . 2.96 109.496 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -63.37 -47.44 82.06 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.98 -0.555 . . . . 1.13 109.642 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.79 -58.81 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 121.471 -0.768 . . . . 1.0 111.29 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.68 -49.04 76.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.692 -0.855 . . . . 2.73 108.692 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.7 t -48.37 -50.32 31.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.238 1.015 . . . . 1.23 111.712 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.13 -42.76 86.53 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 114.168 1.173 . . . . 1.79 114.168 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.89 -2.92 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 N-CA-C 119.127 2.411 . . . . 1.23 119.127 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -142.27 177.64 8.11 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.963 1.881 . . . . 1.86 111.846 -144.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -110.62 140.3 45.09 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 106.184 -1.784 . . . . 5.18 106.184 150.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.0 116.15 16.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.861 0.864 . . . . 2.25 110.827 -170.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -122.55 116.99 24.83 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.394 1.078 . . . . 1.69 111.417 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.88 72.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.93 1.692 . . . . 2.22 112.407 175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m -55.39 -40.76 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.818 0.847 . . . . 1.99 110.443 169.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt 65.34 101.72 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.72 1.208 . . . . 4.83 110.602 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.439 ' H ' ' CD ' ' A' ' 7' ' ' GLU 0.319 4.7 tp 31.55 63.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.936 2.494 . . . . 5.41 113.989 -161.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 . . . . . 0 C--O 1.255 1.394 0 N-CA-C 101.169 -3.641 . . . . 10.45 101.169 133.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 105.726 -1.953 . . . . 7.98 105.726 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.75 -174.48 7.79 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 108.875 -1.69 . . . . 4.63 108.875 138.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.1 t0 50.02 59.61 4.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.331 1.453 . . . . 5.25 110.253 -170.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.79 139.23 22.61 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.255 -1.538 . . . . 1.58 109.255 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.4 151.96 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.229 -0.656 . . . . 2.3 109.229 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 35.8 tp -152.37 111.07 3.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.271 -1.011 . . . . 2.09 108.271 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -106.49 117.53 34.28 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.096 0.474 . . . . 2.86 111.693 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.6 mt -106.78 129.91 54.57 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.81 -1.182 . . . . 2.79 107.81 174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 p -76.74 101.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.18 -1.415 . . . . 1.95 107.18 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 22' ' ' ILE . 49.0 t -79.91 78.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.578 -1.638 . . . . 1.85 106.578 175.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -77.68 116.06 17.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 5.62 107.458 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.39 -11.71 3.25 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.504 1.049 . . . . 1.45 112.631 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.407 ' CE ' HG22 ' A' ' 19' ' ' VAL . 31.0 mtp -63.76 149.55 46.55 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.053 0.926 . . . . 1.47 109.922 176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.4 17.72 0.34 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.795 0.665 . . . . 2.35 112.795 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -171.39 152.09 3.22 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.787 1.176 . . . . 2.22 110.786 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.14 -35.97 3.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.295 1.838 . . . . 1.21 112.739 173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -59.18 -69.64 0.19 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.8 111.798 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.2 m -40.35 -45.73 2.21 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.908 1.283 . . . . 1.31 110.414 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG22 ' CE ' ' A' ' 13' ' ' MET . 10.5 t -53.32 -73.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 123.842 0.714 . . . . 0.78 111.108 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -21.51 64.33 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 121.706 -0.621 . . . . 1.07 112.13 -166.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -55.8 -47.31 77.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.364 1.066 . . . . 3.82 109.362 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.401 HD13 HG11 ' A' ' 10' ' ' VAL . 54.8 mt -62.56 -59.5 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.453 -0.943 . . . . 0.57 108.453 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -49.94 -60.6 2.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.539 0.736 . . . . 3.19 110.428 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 t -52.39 -44.49 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.726 0.81 . . . . 1.03 110.989 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -61.51 -62.79 1.57 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.107 0.412 . . . . 0.87 110.494 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.38 -33.35 75.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.241 -0.912 . . . . 1.81 111.434 -166.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.1 p -60.02 -11.99 7.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.449 -0.782 . . . . 2.02 112.649 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -62.65 -39.51 94.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.008 0.822 . . . . 4.81 110.908 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -70.71 125.85 27.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.047 -1.094 . . . . 2.37 108.047 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -75.76 48.86 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.899 0.879 . . . . 7.14 110.334 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.86 -39.67 0.15 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 126.516 2.008 . . . . 0.84 110.566 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.0 mp -79.26 119.75 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.43 -1.693 . . . . 2.91 106.43 176.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.96 -26.11 23.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.456 0.702 . . . . 2.04 110.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -155.3 155.11 33.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.959 -0.756 . . . . 2.46 108.959 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -149.75 131.6 15.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.409 -1.33 . . . . 1.97 107.409 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.2 m -142.28 118.87 11.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.055 -1.091 . . . . 1.71 108.055 158.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p -99.76 97.87 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 122.265 1.031 . . . . 1.84 110.938 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 97.82 11.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.687 -0.856 . . . . 0.72 108.687 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -49.99 -34.12 20.03 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.88 0.872 . . . . 2.65 111.684 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.96 60.64 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.742 0.817 . . . . 1.12 111.66 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -119.37 11.67 12.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.086 1.354 . . . . 1.57 109.763 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 m120 37.71 38.73 0.17 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.722 2.009 . . . . 1.79 111.95 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.58 133.52 54.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 121.681 -0.637 . . . . 1.08 109.594 -168.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 101.46 13.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.335 -1.728 . . . . 0.53 106.335 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -76.67 92.62 3.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.684 -2.339 . . . . 1.03 104.684 166.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.4 mt -85.74 150.54 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 106.822 -1.548 . . . . 1.12 106.822 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -126.17 142.48 51.51 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.794 -1.558 . . . . 3.0 106.794 155.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.42 175.57 13.81 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.196 0.999 . . . . 2.06 108.996 -170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.98 125.78 26.55 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 108.671 -0.863 . . . . 3.53 108.671 171.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.26 61.06 6.53 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.364 3.376 . . . . 2.21 111.509 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -168.07 -43.22 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.894 1.678 . . . . 3.57 110.119 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.3 pt -73.26 -30.18 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.748 -0.834 . . . . 2.69 108.748 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -153.49 149.14 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.515 -0.92 . . . . 2.37 108.515 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 167.25 31.74 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 110.62 -0.992 . . . . 0.77 110.62 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.58 -46.22 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.499 2.133 . . . . 0.72 110.756 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -45.72 -40.8 9.8 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.872 1.269 . . . . 7.86 111.105 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -57.5 12.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.447 1.899 . . . . 3.39 107.969 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mt -63.3 -48.82 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.73 109.575 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.8 -60.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.931 0.893 . . . . 1.53 109.139 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -57.83 -42.44 84.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.701 1.2 . . . . 4.87 109.738 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.2 m -61.3 -47.13 87.37 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.468 -0.493 . . . . 0.83 110.564 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.16 -45.05 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.69 111.065 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -57.27 -52.95 63.25 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.103 0.561 . . . . 3.04 109.728 173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.8 t -54.75 -42.22 71.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.818 1.247 . . . . 0.78 111.146 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.82 -55.49 19.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.0 0.818 . . . . 1.77 111.106 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.28 -42.95 0.02 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.65 1.02 . . . . 1.45 115.65 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.68 140.98 52.26 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 117.754 0.777 . . . . 2.0 112.194 -137.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.82 79.76 4.29 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.247 0.546 . . . . 3.34 110.316 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.91 141.16 44.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.571 -0.706 . . . . 1.55 110.284 -165.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -156.41 128.38 7.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.173 -0.955 . . . . 2.15 111.209 -167.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.9 116.96 2.41 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.174 1.39 . . . . 2.22 110.931 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.21 98.08 5.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 124.565 1.146 . . . . 2.71 109.051 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.06 54.5 0.67 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 5.24 111.014 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.14 52.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.124 0.97 . . . . 6.91 111.804 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 116.265 -1.826 . . . . 8.58 107.362 175.033 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.009 -1.848 . . . . 8.26 106.009 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.98 16.1 63.62 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.387 -0.674 . . . . 3.75 112.979 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -12.35 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.77 2.828 . . . . 4.63 116.967 -170.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 38.65 71.12 0.25 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.419 1.485 . . . . 2.35 111.372 -165.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.74 92.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.321 1.058 . . . . 2.12 108.508 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.8 tp -95.31 101.19 12.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.032 1.733 . . . . 2.15 106.961 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -95.42 120.41 35.61 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.514 -1.291 . . . . 2.81 107.514 156.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -102.88 148.51 25.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 124.73 1.269 . . . . 2.71 108.255 158.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.89 143.54 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.534 -2.025 . . . . 1.91 105.534 160.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -140.21 127.56 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.556 1.542 . . . . 2.47 108.308 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -118.24 155.41 30.6 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.391 0.677 . . . . 6.58 110.021 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.89 -31.88 6.52 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.278 1.418 . . . . 1.54 110.582 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 mtp -51.12 130.52 26.28 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.556 0.742 . . . . 1.54 110.273 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -154.03 17.38 0.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.246 -0.407 . . . . 2.38 112.087 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.2 t -169.36 151.17 4.45 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.143 0.883 . . . . 2.27 109.378 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.46 -37.73 12.27 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.798 1.639 . . . . 1.13 112.013 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.6 p -57.92 -71.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.99 0.916 . . . . 0.85 111.67 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.8 m -40.32 -44.07 1.86 Allowed 'General case' 0 C--N 1.338 0.109 0 C-N-CA 125.096 1.358 . . . . 1.23 111.012 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.84 -73.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 123.703 0.627 . . . . 0.87 111.041 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -20.31 66.08 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.567 -0.708 . . . . 1.15 112.206 -168.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.33 -42.53 82.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.865 0.866 . . . . 3.09 109.729 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.5 mt -62.17 -57.26 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 N-CA-C 108.501 -0.926 . . . . 0.47 108.501 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.32 -57.95 8.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.968 0.907 . . . . 3.4 109.866 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -52.29 -54.36 32.37 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.033 0.933 . . . . 0.9 110.442 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.7 t -59.03 -40.08 83.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 118.888 -0.577 . . . . 0.79 112.092 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -73.67 -36.82 65.37 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.331 0.969 . . . . 1.75 112.512 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 m -70.81 70.39 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.034 0.921 . . . . 2.51 110.357 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -174.0 -23.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.687 2.795 . . . . 5.75 112.394 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.249 1.386 . . . . 2.53 111.189 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? 67.84 -3.85 1.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.603 2.361 . . . . 6.08 113.67 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.83 -28.87 40.6 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.412 -1.075 . . . . 0.82 110.412 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.88 129.48 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 123.259 0.624 . . . . 2.68 109.397 171.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.19 -42.74 12.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.291 1.036 . . . . 1.38 109.294 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 110.337 -0.246 . . . . 1.9 110.337 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -137.67 130.77 30.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.666 1.586 . . . . 1.99 107.006 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -134.4 103.61 5.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.976 -1.49 . . . . 1.74 106.976 167.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.334 2.8 p -89.73 88.25 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 123.461 1.601 . . . . 1.81 110.231 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.1 84.81 4.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.305 -1.316 . . . . 1.27 107.839 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.53 -36.56 4.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.725 1.61 . . . . 2.91 111.147 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.85 -33.45 23.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.394 0.678 . . . . 1.16 111.936 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -113.83 4.51 15.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.043 1.737 . . . . 2.38 110.967 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 44.23 52.63 7.04 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 124.23 1.012 . . . . 1.95 110.3 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -139.81 142.66 36.66 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 122.721 0.408 . . . . 1.6 110.696 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.34 101.19 10.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.698 -1.223 . . . . 0.66 107.698 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -78.27 104.89 9.14 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.115 -2.18 . . . . 0.92 105.115 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -112.67 121.72 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.743 -1.577 . . . . 0.91 106.743 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -102.22 123.8 46.69 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.443 -1.688 . . . . 2.6 106.443 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -152.33 152.62 32.33 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.364 0.666 . . . . 2.41 109.478 -171.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -95.67 108.4 39.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 N-CA-C 107.647 -1.242 . . . . 3.84 107.647 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.97 -46.72 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.213 1.942 . . . . 2.5 112.587 -165.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.2 -32.13 15.62 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.989 1.107 . . . . 3.88 113.989 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 pt -96.05 7.47 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 118.521 0.6 . . . . 2.46 112.467 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.72 -55.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.098 0.863 . . . . 3.23 111.69 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.46 143.3 5.25 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.827 1.68 . . . . 0.91 110.266 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -57.94 -39.58 85.16 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.819 2.346 . . . . 0.86 110.603 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -29.23 -50.88 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.006 2.122 . . . . 10.54 113.218 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -71.62 -49.71 37.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.5 1.12 . . . . 4.17 109.767 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.0 mt -58.71 -54.07 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.703 -0.68 . . . . 0.74 109.362 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mm -53.88 -54.68 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.461 -0.57 . . . . 1.93 109.461 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -53.33 -45.12 68.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 122.882 0.473 . . . . 5.06 110.351 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.2 m -59.8 -52.55 64.98 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.104 0.411 . . . . 0.77 110.415 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.6 mt -51.78 -58.66 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.664 0.786 . . . . 0.86 109.361 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -52.07 -57.67 8.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.627 0.727 . . . . 3.43 109.805 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -58.66 -26.11 63.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.322 1.449 . . . . 0.76 113.371 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.27 -76.9 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.592 1.542 . . . . 1.8 110.968 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.6 31.91 0.43 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.775 -1.014 . . . . 1.42 112.989 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -132.68 173.48 11.3 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.368 1.084 . . . . 1.96 112.571 -165.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.58 155.8 34.27 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 105.65 -1.981 . . . . 3.81 105.65 157.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -154.75 166.36 33.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.01 0.823 . . . . 1.04 112.371 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.88 132.04 10.05 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.561 1.144 . . . . 2.25 110.571 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -54.11 125.98 21.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.721 1.209 . . . . 2.64 110.309 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.98 -47.18 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.825 1.25 . . . . 2.09 111.949 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.5 mttm 55.87 92.9 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.286 1.034 . . . . 5.99 112.289 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.1 mm 75.72 52.97 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.393 1.477 . . . . 6.37 109.711 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--O 1.252 1.23 0 N-CA-C 101.757 -3.423 . . . . 12.22 101.757 151.17 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 105.504 -2.035 . . . . 10.37 105.504 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 -149.18 35.08 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.086 -1.606 . . . . 4.54 109.086 -167.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -141.67 92.59 2.47 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.86 -1.163 . . . . 5.74 107.86 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.18 165.66 12.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.385 0.993 . . . . 1.49 113.003 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.16 145.31 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.328 -1.101 . . . . 2.15 109.059 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.9 tp -147.85 119.94 8.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.35 -2.093 . . . . 2.07 105.35 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.98 113.05 22.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.61 -1.626 . . . . 2.49 106.61 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -110.91 131.85 54.7 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.415 -1.328 . . . . 3.43 107.415 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -75.88 126.32 36.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 105.032 -2.211 . . . . 1.77 105.032 154.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -119.34 108.73 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.334 -1.728 . . . . 2.15 106.334 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -79.84 98.77 7.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.767 . . . . 5.0 108.93 -169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.97 -105.23 0.27 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.23 -2.348 . . . . 3.54 107.23 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.657 ' HE3' HG22 ' A' ' 37' ' ' VAL . 41.5 mtp 57.49 35.25 25.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.629 0.772 . . . . 3.29 112.1 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -74.58 121.22 21.24 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.731 -0.606 . . . . 3.08 110.043 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t 68.46 152.53 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.77 1.628 . . . . 2.32 113.239 169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.25 72.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.158 1.783 . . . . 3.39 110.566 174.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.0 p -178.8 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.672 1.189 . . . . 1.6 109.466 -160.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.7 m -73.15 -51.1 19.15 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.922 -0.77 . . . . 1.1 108.922 159.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -42.7 -73.26 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.476 1.911 . . . . 0.96 111.58 -175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -25.73 68.44 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.089 -0.382 . . . . 1.29 111.903 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -67.41 -49.43 63.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.154 0.981 . . . . 4.48 108.925 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -53.34 -62.3 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 108.207 -1.035 . . . . 0.65 108.207 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -53.42 -57.1 11.82 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.366 0.267 . . . . 3.08 110.713 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -49.71 -50.88 42.18 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 118.854 -0.594 . . . . 1.09 110.331 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.2 t -55.53 -50.59 69.58 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.347 0.521 . . . . 0.83 110.801 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 mt -67.83 -38.22 82.94 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 117.59 -1.644 . . . . 1.78 110.557 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.8 m -59.95 -10.23 3.88 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.667 -0.646 . . . . 1.63 112.591 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -62.77 -40.83 98.52 Favored 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.718 -1.238 . . . . 5.22 109.83 168.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -72.38 135.35 45.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.777 -1.194 . . . . 2.66 107.777 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.48 -0.74 55.82 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.868 -0.52 . . . . 6.37 110.961 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.62 -15.07 64.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.402 0.525 . . . . 0.71 113.306 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.7 tt -88.82 124.46 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.028 -1.101 . . . . 2.91 108.028 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.7 mt -82.23 -40.26 21.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.047 0.939 . . . . 1.54 109.5 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -155.21 148.62 25.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 110.127 -0.323 . . . . 1.97 110.127 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.4 t -132.9 138.98 47.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.963 1.305 . . . . 1.96 107.703 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 m -143.92 102.38 3.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.004 -1.11 . . . . 1.5 108.004 164.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.657 HG22 ' HE3' ' A' ' 13' ' ' MET 0.327 1.2 p -88.76 80.88 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 123.708 1.718 . . . . 1.61 108.809 -177.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.7 90.4 4.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.93 1.692 . . . . 0.86 110.158 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pp -54.53 -29.9 52.1 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.571 1.148 . . . . 3.1 112.427 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.9 26.04 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.156 0.582 . . . . 0.89 111.43 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 p -114.63 9.25 16.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.354 1.462 . . . . 2.07 111.658 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 41.97 45.0 3.18 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.254 1.422 . . . . 1.83 111.247 -171.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -133.26 136.49 45.57 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 122.73 0.412 . . . . 1.08 111.734 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -89.63 109.19 20.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.565 1.146 . . . . 0.6 108.247 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -78.58 114.18 17.26 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.846 -2.279 . . . . 0.89 104.846 160.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.12 107.19 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.337 -1.357 . . . . 1.05 107.337 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -87.31 105.3 17.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.672 -1.603 . . . . 3.38 106.672 163.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.26 175.22 6.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.529 1.932 . . . . 1.99 106.293 175.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.35 130.77 23.53 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.239 -0.652 . . . . 3.71 109.239 166.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -57.52 -35.12 98.89 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.681 2.254 . . . . 1.83 110.938 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -68.2 -6.56 24.12 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.5 0.926 . . . . 4.4 113.5 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 pt -120.97 -31.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.421 0 CA-C-N 119.703 1.138 . . . . 3.08 113.047 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.1 tt -152.04 144.35 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 119.783 1.174 . . . . 2.44 108.781 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.67 159.78 51.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.788 -1.325 . . . . 0.75 109.788 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.8 -48.29 1.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.958 1.772 . . . . 0.72 109.274 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 tpt85 -55.7 -34.8 65.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.821 0.849 . . . . 7.84 111.744 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.99 -61.04 2.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.696 2.399 . . . . 3.45 108.807 174.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -57.05 -43.68 81.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.493 0.717 . . . . 0.94 110.139 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.28 -43.23 76.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 118.749 -0.643 . . . . 1.99 110.749 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -54.51 -45.26 73.26 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.248 0.931 . . . . 2.69 110.409 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.5 m -55.31 -53.39 56.68 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.531 0.605 . . . . 0.9 110.559 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.17 -53.93 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.461 0.704 . . . . 1.72 111.335 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -54.11 -57.48 10.93 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.458 1.103 . . . . 3.19 109.807 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.5 t -52.66 -49.75 64.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.545 1.538 . . . . 1.15 111.071 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 65' ' ' LEU . 4.0 mm? -61.18 -54.56 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.099 0.409 . . . . 3.13 110.96 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.87 -42.44 0.02 OUTLIER Glycine 0 CA--C 1.523 0.554 0 C-N-CA 119.782 -1.199 . . . . 1.59 115.42 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -114.68 141.47 47.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.031 -0.668 . . . . 1.97 111.517 -133.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -78.24 123.43 26.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.225 -1.398 . . . . 3.44 107.225 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.18 159.0 15.22 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 1.37 110.757 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.8 m -151.35 114.51 4.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.272 1.029 . . . . 1.97 108.348 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.73 127.13 29.85 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.654 -0.869 . . . . 2.84 108.654 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.74 131.82 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.398 0.679 . . . . 1.99 110.949 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -72.47 81.99 1.07 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.859 0.464 . . . . 5.52 109.759 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -27.94 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.849 -0.614 . . . . 5.2 110.323 163.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.972 2.109 . . . . 8.27 111.704 177.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 106.078 -1.823 . . . . 14.9 106.078 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.11 -66.66 1.83 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.923 -2.071 . . . . 5.65 107.923 -156.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 7.9 p-10 -70.71 171.37 10.57 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.809 -0.441 . . . . 5.25 109.809 162.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.0 111.93 4.25 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.642 -1.383 . . . . 1.66 109.642 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.62 145.41 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 118.524 1.162 . . . . 2.43 108.864 169.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.43 91.09 2.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.903 -1.517 . . . . 2.51 106.903 175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.32 105.65 17.2 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.109 -0.7 . . . . 2.95 109.109 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.494 HD21 HD12 ' A' ' 62' ' ' ILE . 4.1 pp -110.29 147.88 33.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.806 0.692 . . . . 2.11 109.48 173.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 t -76.45 133.44 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.832 -1.914 . . . . 1.7 105.832 161.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.35 137.1 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 125.123 1.369 . . . . 2.34 107.808 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -140.04 153.28 46.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.776 0.831 . . . . 7.3 109.862 -171.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.8 -43.85 1.67 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.829 -1.308 . . . . 1.69 109.829 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -48.43 114.35 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.318 1.447 . . . . 2.14 114.103 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 p -97.48 115.93 28.73 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.133 1.373 . . . . 3.91 110.397 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.7 m 69.73 176.88 0.27 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.157 0.979 . . . . 3.29 113.31 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.18 -37.96 0.19 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.543 2.337 . . . . 1.19 112.523 172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.8 p -64.51 -56.96 10.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.802 0.667 . . . . 0.88 112.802 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.51 -35.45 79.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 119.966 -1.709 . . . . 1.13 108.542 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.93 -66.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 123.623 0.769 . . . . 0.82 110.776 172.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.258 0.1 OUTLIER -68.89 -26.04 64.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 121.795 -0.565 . . . . 1.1 111.285 -174.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -59.77 -53.76 54.24 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 3.69 109.116 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.29 -60.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.727 -0.842 . . . . 0.6 108.727 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -55.18 -52.95 61.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.012 0.195 . . . . 3.16 110.743 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 t -57.73 -43.05 85.04 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.438 0.695 . . . . 1.01 111.603 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 t -62.22 -48.26 80.78 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.278 0.561 . . . . 0.81 109.919 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.61 ' O ' HG21 ' A' ' 32' ' ' ILE . 8.3 mp -70.06 -37.84 75.6 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.779 -0.629 . . . . 2.39 111.047 -173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.9 m -71.09 61.73 0.29 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 120.643 1.565 . . . . 2.36 111.334 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -148.98 -69.98 0.21 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.556 1.942 . . . . 4.02 109.252 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.547 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -63.51 111.98 2.58 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.403 0.681 . . . . 2.3 111.653 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -77.99 47.08 0.62 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.817 1.784 . . . . 5.59 115.817 -152.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.84 2.87 5.26 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.992 0.815 . . . . 0.91 113.058 164.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.61 HG21 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -94.0 115.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.101 1.761 . . . . 2.81 107.049 178.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.9 mt -85.7 -43.69 13.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.827 0.851 . . . . 1.52 110.555 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -145.32 146.91 31.81 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.839 -0.43 . . . . 2.31 109.839 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.8 p -134.68 134.81 41.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.435 1.494 . . . . 3.21 107.397 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -151.06 104.66 3.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.966 -1.494 . . . . 1.67 106.966 169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.33 3.4 p -92.89 88.7 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.445 1.593 . . . . 1.79 110.562 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.28 80.41 4.69 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.514 -1.221 . . . . 1.14 108.459 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.1 tt -42.38 -38.93 2.01 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 126.68 1.992 . . . . 1.7 111.226 166.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.17 -35.01 47.62 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.666 0.786 . . . . 0.92 112.065 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 p -108.64 8.52 27.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.466 1.506 . . . . 2.2 111.015 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 43.6 45.44 5.73 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.595 1.558 . . . . 2.09 110.392 -171.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -133.24 137.92 46.29 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.045 0.538 . . . . 1.12 110.239 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -98.34 107.85 20.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.469 -1.308 . . . . 0.56 107.469 167.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -84.03 97.4 9.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.966 -2.235 . . . . 0.8 104.966 162.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.416 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -93.84 154.38 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 106.512 -1.662 . . . . 1.76 106.512 162.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 5.2 mtmp? -128.55 145.01 51.25 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.57 -1.27 . . . . 2.98 107.57 159.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -160.18 172.43 17.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.492 0.717 . . . . 2.03 111.448 -165.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -105.93 100.17 26.57 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.155 1.382 . . . . 3.91 109.935 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -72.76 67.56 3.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.989 3.126 . . . . 2.35 112.298 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -166.34 -47.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.813 1.245 . . . . 3.75 110.343 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.2 pt -84.17 -17.28 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.071 0 C-N-CA 123.74 0.816 . . . . 2.52 110.462 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.7 tt -148.56 154.72 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 105.472 -2.048 . . . . 2.35 105.472 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.8 167.8 25.84 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.51 -1.436 . . . . 0.9 109.51 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.09 -39.83 76.1 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.664 1.576 . . . . 0.76 109.064 165.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -44.65 -52.36 8.28 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.261 1.424 . . . . 7.23 112.178 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -52.36 64.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.543 1.065 . . . . 2.82 110.321 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -58.83 -56.14 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 109.068 -0.715 . . . . 1.22 109.068 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.5 mt -49.87 -56.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 122.805 0.442 . . . . 1.57 109.851 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -52.73 -49.53 65.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.165 1.386 . . . . 4.97 110.078 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.1 m -58.69 -45.77 88.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.112 -0.329 . . . . 0.75 110.112 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 8' ' ' LEU . 51.7 mt -56.6 -65.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.777 -0.453 . . . . 0.97 109.777 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.28 -46.87 72.82 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.419 -0.513 . . . . 2.92 110.393 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -60.61 -20.3 60.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.134 -1.412 . . . . 0.87 113.688 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.64 -73.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 121.162 1.801 . . . . 1.8 109.655 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.56 29.21 0.39 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 118.723 -1.043 . . . . 1.12 113.23 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.31 172.42 8.66 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 118.763 1.281 . . . . 1.95 113.362 -164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -103.88 146.39 28.72 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.203 -2.147 . . . . 4.25 105.203 158.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.6 137.94 20.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.833 0.853 . . . . 1.32 111.162 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 m -157.07 111.73 2.75 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.084 -1.01 . . . . 1.97 112.593 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -39.22 128.48 1.75 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.407 1.483 . . . . 3.67 110.583 165.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.8 m -127.72 142.76 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.589 1.156 . . . . 1.98 109.1 169.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -74.86 85.46 2.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.582 -1.266 . . . . 5.71 107.582 158.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.33 151.42 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.422 -1.325 . . . . 6.2 107.422 155.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 C--O 1.255 1.377 0 N-CA-C 105.25 -2.13 . . . . 8.87 105.25 173.052 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 106.752 -1.573 . . . . 8.85 106.752 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.31 -135.23 48.0 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 105.412 -3.075 . . . . 6.23 105.412 -130.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -84.56 -110.12 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.379 1.09 . . . . 9.54 108.812 161.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.15 -12.32 31.98 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 110.876 -0.89 . . . . 2.52 110.876 -162.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.41 141.07 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 126.702 2.001 . . . . 1.84 106.385 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.0 tp -153.87 113.86 3.88 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.407 1.483 . . . . 2.23 107.037 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.87 121.23 37.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.209 -1.034 . . . . 2.07 108.209 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 145.45 50.89 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.343 0.52 . . . . 2.52 111.875 170.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.89 136.73 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.062 -1.459 . . . . 1.84 107.062 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.72 95.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 127.019 2.128 . . . . 1.96 106.006 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -79.57 126.11 30.47 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.51 -0.876 . . . . 5.12 108.848 -176.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.46 8.99 4.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.202 1.382 . . . . 1.58 113.555 170.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.464 ' CE ' HG22 ' A' ' 37' ' ' VAL . 36.0 mtp -78.6 117.21 19.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.437 1.118 . . . . 1.79 108.268 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.2 t -143.73 16.39 1.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.146 0.795 . . . . 2.32 113.146 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -169.26 141.32 2.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.23 0.923 . . . . 2.55 109.453 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.03 -39.67 0.91 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.485 1.914 . . . . 1.22 113.63 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -59.52 -75.56 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.816 0.846 . . . . 1.23 111.847 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -46.97 -36.78 8.12 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 125.636 1.575 . . . . 1.85 111.521 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 t -53.21 -80.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.872 0.869 . . . . 1.16 109.123 167.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.256 0.3 OUTLIER -64.73 -15.96 62.25 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.656 -0.653 . . . . 1.64 112.742 -166.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -57.44 -40.43 78.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.42 1.088 . . . . 3.13 108.698 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.43 -63.78 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.292 -1.003 . . . . 0.56 108.292 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.46 -58.35 6.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.495 0.318 . . . . 3.06 110.648 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.6 t -50.97 -47.32 61.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.127 0.971 . . . . 1.05 111.201 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.2 t -62.23 -57.44 11.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.823 -0.548 . . . . 0.83 109.654 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -55.43 -39.69 70.57 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.406 0.682 . . . . 2.29 111.497 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -48.46 -35.81 13.71 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.345 -0.847 . . . . 1.74 112.136 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 1.29 2.03 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.115 -0.991 . . . . 6.57 113.316 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.632 ' CB ' HD11 ' A' ' 53' ' ' ILE . 10.7 m170 -83.71 -19.85 34.5 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.134 -1.604 . . . . 2.4 110.738 171.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 65.92 -3.02 0.81 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.723 1.609 . . . . 6.93 115.236 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -103.79 15.79 51.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.28 0.945 . . . . 0.85 111.833 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 mt -113.19 142.02 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.955 -1.498 . . . . 2.19 106.955 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.73 -40.57 9.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.581 0.752 . . . . 2.49 109.466 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -155.14 156.3 35.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.369 0.531 . . . . 2.4 110.691 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 m -137.29 116.58 12.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 105.54 -2.022 . . . . 2.6 105.54 171.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.62 99.6 7.65 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.253 -1.388 . . . . 1.41 107.253 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG22 ' CE ' ' A' ' 13' ' ' MET 0.285 0.6 OUTLIER -94.38 91.72 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 123.107 1.432 . . . . 1.41 110.484 -173.015 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.15 91.79 7.77 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.678 1.591 . . . . 0.95 111.23 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -44.55 -42.27 7.13 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.4 1.88 . . . . 1.71 112.521 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.28 -35.16 59.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.585 0.754 . . . . 1.46 111.463 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -107.5 3.67 25.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.397 1.479 . . . . 2.23 110.955 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.35 59.13 1.21 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.487 1.915 . . . . 2.86 109.832 -166.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 140.66 37.01 Favored 'General case' 0 C--O 1.225 -0.184 0 C-N-CA 123.083 0.553 . . . . 1.12 111.013 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.47 113.83 26.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.573 1.149 . . . . 0.52 108.384 165.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.59 99.33 8.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.621 -1.992 . . . . 0.97 105.621 158.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.75 141.8 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.377 -1.342 . . . . 1.26 107.377 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -125.19 116.34 21.86 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.231 -1.766 . . . . 3.47 106.231 165.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.09 165.0 37.71 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.591 1.157 . . . . 1.89 109.401 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -90.23 137.74 27.62 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.844 -1.169 . . . . 4.32 107.844 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.49 -40.44 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.165 1.91 . . . . 2.46 112.262 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.09 -31.69 23.23 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.336 0.516 . . . . 3.58 111.373 -164.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -56.4 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.402 -0.592 . . . . 3.79 109.402 171.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.632 HD11 ' CB ' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -92.73 -41.92 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.673 -0.24 . . . . 3.11 110.944 -163.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.73 115.44 0.09 OUTLIER Glycine 0 CA--C 1.534 1.253 0 N-CA-C 109.423 -1.471 . . . . 1.2 109.423 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.72 -33.19 79.26 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 CA-C-N 120.306 2.053 . . . . 0.91 112.44 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -47.55 -43.14 24.85 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.968 0.729 . . . . 6.88 112.968 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -58.67 -55.19 38.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 122.078 0.942 . . . . 4.1 109.903 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.1 mt -50.96 -52.92 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 CA-C-N 115.822 -0.626 . . . . 0.96 110.671 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.39 -48.24 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-O 118.64 -0.695 . . . . 1.79 110.117 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -51.09 -48.69 61.61 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.619 -0.511 . . . . 2.9 109.619 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -61.37 -48.13 82.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 118.513 -1.275 . . . . 1.2 109.907 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.9 mt -54.35 -57.05 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 119.388 -0.339 . . . . 0.9 111.167 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.25 -46.1 88.43 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.503 0.592 . . . . 4.67 110.414 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 t -66.79 -15.97 63.95 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.718 -1.135 . . . . 0.83 112.517 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.81 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.461 1.482 . . . . 1.78 110.496 162.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.96 36.2 0.5 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.017 -0.88 . . . . 1.47 113.548 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -132.81 175.09 9.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.352 1.076 . . . . 1.83 111.265 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -129.74 121.98 27.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.001 -1.111 . . . . 3.36 108.001 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.13 163.46 13.94 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.454 0.701 . . . . 1.37 111.934 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -155.98 123.99 5.7 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.601 1.56 . . . . 1.56 108.53 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.87 138.27 58.4 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.815 0.734 . . . . 2.49 109.963 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.6 -34.01 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.182 0.593 . . . . 2.08 111.443 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.3 tttm 42.54 61.43 2.05 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.733 2.013 . . . . 6.48 113.332 172.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 pt -73.91 68.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.426 0.691 . . . . 5.56 110.291 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.409 1.884 . . . . 9.21 108.114 178.253 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 105.146 -2.168 . . . . 10.31 105.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 54.84 -150.08 19.08 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 117.28 -2.39 . . . . 6.43 107.851 -129.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.19 178.14 0.21 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.342 1.857 . . . . 5.41 112.345 -176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.22 77.18 0.72 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.392 -1.883 . . . . 1.94 108.392 162.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.72 138.4 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 O-C-N 122.294 -0.533 . . . . 2.05 110.008 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -142.43 88.43 2.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.256 1.822 . . . . 2.1 107.541 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -82.57 121.28 26.6 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.873 -1.528 . . . . 2.25 106.873 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -128.71 137.71 51.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.179 -0.325 . . . . 1.89 110.238 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.45 145.81 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.711 -1.218 . . . . 1.73 107.711 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.26 155.19 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.472 -1.677 . . . . 1.9 106.472 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -126.31 132.68 51.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.393 -1.336 . . . . 4.89 107.393 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.25 23.81 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.288 1.423 . . . . 1.83 112.201 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mtp -72.37 78.0 1.02 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.259 1.029 . . . . 2.14 109.189 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 t -97.26 -3.48 40.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.791 0.836 . . . . 2.26 112.813 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -163.41 144.65 9.35 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.591 1.087 . . . . 2.26 110.795 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.05 -37.43 0.16 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 127.88 2.472 . . . . 1.2 113.37 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.6 p -52.46 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.198 0.999 . . . . 0.87 112.339 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.8 m -43.04 -49.51 6.11 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 126.504 1.921 . . . . 1.3 110.191 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.4 t -45.82 -69.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 125.432 1.493 . . . . 1.03 110.554 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.281 0.3 OUTLIER -70.21 -17.68 63.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.428 -0.509 . . . . 1.55 111.638 -175.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -70.24 -42.32 72.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.301 -1.0 . . . . 4.64 108.301 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -51.2 -61.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.53 108.92 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -58.8 -54.32 48.45 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.809 -0.557 . . . . 2.72 112.103 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.4 t -54.4 -30.99 53.98 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.831 0.852 . . . . 1.01 111.483 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.9 t -71.03 -69.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.497 -0.752 . . . . 0.93 110.275 167.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp -50.85 -47.31 60.36 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.26 1.424 . . . . 2.37 113.462 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.7 p -46.08 -34.19 3.99 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.682 0.793 . . . . 2.15 111.83 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -64.09 -21.79 66.67 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.706 1.203 . . . . 6.1 111.788 -175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.529 ' CB ' HD11 ' A' ' 53' ' ' ILE . 12.5 m170 -64.21 -29.75 70.84 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.472 0.578 . . . . 2.2 110.384 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 67.68 -1.95 1.5 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.137 1.775 . . . . 5.06 114.771 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.01 32.64 5.74 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.885 1.22 . . . . 0.87 110.785 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mt -138.37 126.65 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.099 -1.815 . . . . 2.21 106.099 -169.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.1 mt -90.52 -37.66 13.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 123.64 0.588 . . . . 1.86 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -144.76 148.56 34.25 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.161 -1.051 . . . . 3.13 108.161 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -157.07 68.17 0.55 Allowed 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.132 -1.062 . . . . 2.01 108.132 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 m -84.9 108.69 17.67 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.053 -0.351 . . . . 1.67 110.053 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.21 112.87 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.983 -0.747 . . . . 2.33 108.983 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.41 98.5 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.657 0.783 . . . . 0.96 110.429 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -38.75 -47.48 1.38 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.126 1.77 . . . . 1.92 112.148 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.77 -29.12 66.55 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.493 1.117 . . . . 0.98 111.79 -169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -117.09 10.63 13.96 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.723 1.209 . . . . 1.68 109.943 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.32 59.59 0.27 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.438 2.295 . . . . 2.57 112.305 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.12 152.78 37.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.559 0.744 . . . . 1.09 109.76 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.52 118.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.994 1.318 . . . . 0.56 108.101 164.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -81.1 96.52 7.2 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 105.251 -2.129 . . . . 0.76 105.251 163.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.83 141.21 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.837 -1.542 . . . . 0.96 106.837 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -122.87 121.83 37.15 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.53 -2.396 . . . . 2.54 104.53 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -137.78 169.27 18.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.776 0.716 . . . . 2.31 112.293 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -108.01 99.88 33.21 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.651 0.78 . . . . 4.66 109.237 -171.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.67 48.16 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.114 2.542 . . . . 2.45 112.835 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -137.12 17.96 2.99 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.048 1.339 . . . . 5.04 110.323 170.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.11 -56.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 C-N-CA 124.422 1.089 . . . . 4.66 108.576 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.529 HD11 ' CB ' ' A' ' 29' ' ' HIS . 1.6 mt -95.67 142.65 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.154 -1.425 . . . . 2.18 107.154 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.0 151.24 20.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.657 -1.377 . . . . 1.07 109.657 160.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.79 -38.58 29.79 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.957 1.771 . . . . 0.7 110.605 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -50.02 -44.52 51.3 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.433 0.693 . . . . 7.39 111.303 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.6 -53.47 37.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.5 1.12 . . . . 3.34 108.881 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 mt -62.67 -54.49 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.993 -0.549 . . . . 0.74 109.784 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.9 mt -49.91 -52.69 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.449 -0.575 . . . . 1.33 109.449 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -56.21 -47.2 78.86 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.76 0.824 . . . . 4.78 110.263 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.3 m -58.37 -46.08 87.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.235 0.471 . . . . 0.86 110.437 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 54.6 mt -54.3 -64.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.131 -0.692 . . . . 0.74 109.131 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -55.0 -47.82 74.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.948 0.404 . . . . 4.25 110.197 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -58.47 -20.3 44.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 117.116 -1.421 . . . . 0.98 113.825 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.25 -76.4 0.09 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-N 121.189 1.813 . . . . 1.66 109.439 167.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.72 35.56 0.46 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 118.522 -1.154 . . . . 1.38 113.281 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -129.81 175.15 9.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.929 1.365 . . . . 1.86 112.749 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.33 145.62 44.97 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 104.483 -2.414 . . . . 3.29 104.483 161.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.49 162.62 35.03 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.786 1.176 . . . . 1.11 112.503 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 t -155.84 112.86 3.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.623 0.769 . . . . 1.9 108.949 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -63.82 126.22 26.91 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.411 0.551 . . . . 2.63 109.962 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.94 118.65 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.052 -0.721 . . . . 2.18 109.052 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -76.06 70.75 2.77 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.558 0.743 . . . . 5.54 109.179 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.35 -44.03 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.969 0.908 . . . . 4.92 113.167 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.196 0 C-N-CA 123.583 0.753 . . . . 7.99 110.286 -162.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 110.087 -0.338 . . . . 13.83 110.087 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.92 160.49 52.8 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.113 -1.195 . . . . 6.01 110.113 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -72.57 177.27 4.79 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.162 -1.051 . . . . 4.78 108.162 165.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.03 78.71 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 106.318 -2.713 . . . . 2.16 106.318 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.93 80.44 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.632 -1.247 . . . . 2.21 107.632 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.1 78.58 4.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.772 -1.566 . . . . 2.4 106.772 172.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.28 121.73 24.8 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.385 -2.08 . . . . 2.42 105.385 164.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -131.57 145.46 51.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.248 -0.649 . . . . 2.1 109.248 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.4 t -77.23 136.88 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.154 -1.795 . . . . 1.99 106.154 165.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.17 157.09 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 107.148 -1.427 . . . . 2.29 107.148 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.6 ptt85 -146.37 149.42 33.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.409 -0.589 . . . . 5.89 109.409 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.85 -13.89 31.96 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.144 1.354 . . . . 1.65 111.547 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.8 mtm -66.9 113.79 5.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.496 1.148 . . . . 1.51 110.064 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -82.1 -50.96 8.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.531 1.133 . . . . 3.69 110.471 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -169.67 172.28 6.95 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.395 1.078 . . . . 2.33 110.076 -160.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.85 -47.67 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.089 2.956 . . . . 1.18 114.906 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p -67.89 -47.61 68.38 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.861 -0.525 . . . . 1.23 112.108 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 31.8 m -70.65 -35.35 72.84 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.347 -0.983 . . . . 1.58 108.347 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 t -51.34 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 124.633 1.173 . . . . 1.08 109.729 168.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.275 0.3 OUTLIER -71.02 -16.64 62.63 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.671 0.989 . . . . 1.16 113.671 -165.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -45.34 -47.54 13.31 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 108.858 -0.793 . . . . 3.99 108.858 165.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.38 -65.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.085 -0.709 . . . . 0.5 109.085 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -55.18 -48.14 74.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 123.133 0.27 . . . . 4.38 111.056 -166.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.7 t -54.32 -60.27 3.57 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.486 -0.931 . . . . 1.07 108.486 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 t -51.91 -42.59 62.89 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.904 0.481 . . . . 0.88 111.698 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.5 mt -71.9 -53.82 11.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.635 -0.826 . . . . 1.65 111.94 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.0 m -49.23 -33.36 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.729 -1.232 . . . . 1.77 111.902 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -51.93 -32.79 34.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.222 1.193 . . . . 6.11 114.222 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -55.0 -29.75 57.93 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.756 0.707 . . . . 2.37 111.013 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 73.01 -1.04 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.054 1.742 . . . . 5.35 112.001 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 52' ' ' ILE . . . -88.02 -42.43 5.97 Favored Glycine 0 C--O 1.224 -0.522 0 N-CA-C 110.604 -0.998 . . . . 1.95 110.604 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 53' ' ' ILE . 2.1 mp -74.52 125.9 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.102 -1.444 . . . . 3.04 107.102 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.88 -38.71 32.07 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.771 0.828 . . . . 2.75 109.96 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.74 154.88 37.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.376 -0.601 . . . . 2.08 109.376 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.0 t -155.19 63.64 0.63 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.241 0.543 . . . . 1.83 112.144 -164.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 99.75 7.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.96 0.504 . . . . 1.3 109.845 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.295 0.8 OUTLIER -89.04 93.68 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 122.477 1.132 . . . . 1.55 110.269 172.697 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.8 96.55 9.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.365 1.466 . . . . 0.79 109.9 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.0 tp -51.08 -39.25 55.64 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 126.164 1.786 . . . . 2.33 112.555 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.82 73.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.257 0.551 . . . . 1.13 110.674 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -81.05 -22.81 39.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.482 1.113 . . . . 2.26 111.231 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.53 55.8 4.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.773 1.629 . . . . 2.97 107.991 -168.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.57 144.33 46.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.896 -1.047 . . . . 1.0 108.611 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.588 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -104.63 113.74 27.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.588 1.155 . . . . 0.47 108.778 171.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -87.98 91.41 8.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.947 -1.872 . . . . 0.78 105.947 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.588 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.51 125.69 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.731 -1.211 . . . . 1.45 107.731 170.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -96.76 110.45 22.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.85 -1.537 . . . . 3.61 106.85 162.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -125.64 158.36 34.93 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.919 0.888 . . . . 2.14 108.812 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -97.97 113.21 63.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.841 1.256 . . . . 4.11 108.43 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.44 70.0 4.94 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.999 3.133 . . . . 2.89 110.915 -175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -163.13 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.333 1.453 . . . . 3.78 109.56 -173.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.519 HD11 ' HA3' ' A' ' 31' ' ' GLY . 1.8 pp -92.94 -33.88 5.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 122.749 0.419 . . . . 2.9 111.332 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.439 HD13 HD11 ' A' ' 32' ' ' ILE . 5.9 tt -132.66 149.14 31.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.556 -0.905 . . . . 2.46 108.556 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.69 160.02 23.27 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.427 -1.069 . . . . 0.67 110.427 173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.19 -41.39 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.43 2.087 . . . . 0.82 110.483 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -57.18 -35.44 69.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 119.299 -0.382 . . . . 8.01 111.236 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -56.58 20.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.0 2.52 . . . . 3.87 109.143 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.1 mt -54.98 -50.38 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.931 -0.766 . . . . 0.86 108.931 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.05 -47.24 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 118.772 -0.632 . . . . 1.37 110.538 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -52.77 -48.58 66.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.366 1.067 . . . . 3.08 109.191 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.4 m -60.25 -49.95 75.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.158 -0.682 . . . . 0.88 109.158 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.91 -62.44 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.527 0.731 . . . . 0.81 110.865 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.08 -49.22 72.23 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.315 -0.624 . . . . 2.89 109.315 -174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.1 t -51.14 -44.7 61.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.045 0.938 . . . . 0.99 112.546 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 mt -60.78 -52.41 65.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.904 1.229 . . . . 1.85 113.302 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.61 10.53 0.12 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.281 -1.288 . . . . 1.46 116.056 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -139.04 176.14 8.95 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.346 1.573 . . . . 1.84 112.89 -148.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 151.87 37.57 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.534 -2.025 . . . . 3.18 105.534 154.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 157.04 43.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.967 0.507 . . . . 0.97 111.545 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.1 t -147.54 115.55 6.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.587 1.555 . . . . 2.01 108.69 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -68.31 134.39 50.26 Favored 'General case' 0 N--CA 1.458 -0.034 0 C-N-CA 122.637 0.375 . . . . 2.65 111.801 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.82 -42.56 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.847 0.859 . . . . 2.33 110.08 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.69 64.09 1.65 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.215 -1.402 . . . . 4.56 107.215 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.5 mp 64.48 -74.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.549 1.54 . . . . 5.26 108.087 -164.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 131.685 3.994 . . . . 10.42 105.503 169.176 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 105.803 -1.925 . . . . 8.95 105.803 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.51 115.88 0.96 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.334 -1.506 . . . . 5.23 109.334 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.42 92.11 0.13 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.427 1.091 . . . . 8.71 110.451 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.95 58.6 3.53 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 110.392 -1.083 . . . . 2.05 110.392 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.25 143.46 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.689 1.196 . . . . 2.07 109.179 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 74' ' ' ILE . 3.0 tt -147.76 115.42 6.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.62 1.568 . . . . 3.05 107.204 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.74 124.41 49.52 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.144 -0.688 . . . . 2.26 109.144 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.8 mt -102.82 142.41 34.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.355 -1.72 . . . . 2.42 106.355 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.0 t -75.71 138.99 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.387 -2.079 . . . . 2.14 105.387 148.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 131.39 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.597 1.559 . . . . 1.97 108.015 -176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -126.3 144.56 50.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.776 1.231 . . . . 5.0 108.263 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.09 -31.77 6.32 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.849 1.214 . . . . 1.67 110.186 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtm -58.75 141.96 51.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.518 -0.549 . . . . 1.46 109.518 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -152.62 10.99 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.8 0.667 . . . . 2.36 112.8 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.0 t -171.18 152.1 3.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.341 0.973 . . . . 2.29 109.17 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.31 -43.11 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.301 1.84 . . . . 1.15 112.276 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.5 p -44.3 -66.9 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.479 1.512 . . . . 0.79 113.096 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.8 m -47.51 -48.38 27.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.628 1.171 . . . . 1.07 109.488 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.35 -67.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.158 -0.928 . . . . 0.81 111.101 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -27.13 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.233 -0.917 . . . . 1.2 111.632 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -53.39 -49.1 67.94 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.234 0.614 . . . . 3.24 109.838 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -54.47 -65.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.088 -0.708 . . . . 0.64 109.088 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -47.1 -61.6 1.81 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.404 1.082 . . . . 2.76 110.916 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 t -48.95 -45.99 42.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.057 1.343 . . . . 1.06 110.574 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 t -62.25 -65.91 0.62 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.817 -0.611 . . . . 0.89 110.701 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mt -61.54 -35.09 76.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.503 1.047 . . . . 1.78 111.806 -163.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.4 m -46.65 -31.6 2.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.842 -0.536 . . . . 2.08 112.119 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -34.14 23.26 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.353 0.871 . . . . 4.19 113.353 175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -61.07 -41.4 96.56 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.038 0.381 . . . . 2.54 110.329 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.84 -2.23 2.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.657 2.383 . . . . 5.71 113.329 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.28 -31.96 36.47 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.598 -1.001 . . . . 0.92 110.598 172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.11 106.2 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.204 -2.147 . . . . 3.01 105.204 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.7 mt -79.94 -33.3 39.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.995 0.518 . . . . 2.12 109.92 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -147.35 156.47 42.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.539 -0.541 . . . . 2.46 109.539 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -149.86 134.74 17.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.866 -1.531 . . . . 1.86 106.866 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -144.21 116.16 8.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.389 -1.338 . . . . 2.18 107.389 164.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -111.15 111.4 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.573 0.701 . . . . 1.71 110.376 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.44 104.35 12.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.982 0.913 . . . . 1.29 109.659 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.1 mt -44.88 -37.09 3.65 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.609 1.163 . . . . 2.72 111.346 167.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.08 -30.75 16.86 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.796 0.838 . . . . 1.11 112.056 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -127.92 17.4 6.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.385 1.074 . . . . 1.6 109.77 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 31.51 47.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.778 2.031 . . . . 2.13 112.672 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.76 143.6 47.22 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.854 0.462 . . . . 1.29 111.346 -170.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.28 98.49 8.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.575 1.95 . . . . 0.68 107.786 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -79.15 104.06 9.52 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 105.376 -2.083 . . . . 0.97 105.376 167.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.28 136.63 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.307 -1.738 . . . . 1.12 106.307 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -107.46 114.47 28.5 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.719 -1.586 . . . . 3.33 106.719 160.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -129.2 175.69 8.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.13 -2.544 . . . . 1.98 104.13 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.39 132.28 24.17 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 107.746 -1.205 . . . . 3.69 107.746 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.98 59.87 5.28 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 125.058 3.839 . . . . 2.79 110.883 -173.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -155.64 -54.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 128.428 2.691 . . . . 3.38 107.264 -168.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -88.45 -25.4 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.349 1.059 . . . . 2.98 110.407 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -155.55 153.32 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.425 -0.954 . . . . 2.86 108.425 170.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.35 164.76 30.91 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 111.001 -0.839 . . . . 0.86 111.001 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.67 -45.19 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.916 2.41 . . . . 1.05 110.866 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -54.2 -42.63 69.95 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 122.995 0.518 . . . . 8.28 110.587 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.98 -56.28 9.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.732 1.613 . . . . 3.98 109.37 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.8 mt -59.19 -49.71 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.999 0.519 . . . . 0.99 109.602 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -53.78 -52.63 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.793 -0.447 . . . . 1.44 109.793 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -50.92 -51.29 53.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.973 0.509 . . . . 3.58 109.816 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -57.64 -53.37 58.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.226 -0.59 . . . . 0.94 110.262 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.0 mt -53.73 -59.92 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 124.196 0.999 . . . . 0.93 110.466 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.53 -50.46 73.7 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.224 -0.658 . . . . 4.56 109.224 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -48.69 -46.13 40.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 1.05 112.016 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.66 -56.54 19.15 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.255 0.934 . . . . 1.87 113.425 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 10.98 0.12 Allowed Glycine 0 CA--C 1.531 1.05 0 CA-C-O 117.953 -1.471 . . . . 1.39 116.655 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.46 176.02 9.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.851 1.825 . . . . 1.89 112.655 -153.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -120.12 158.48 26.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.756 -1.572 . . . . 3.69 106.756 156.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.01 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.04 0.936 . . . . 1.81 112.482 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.1 t -157.56 111.45 2.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.072 1.349 . . . . 2.79 109.781 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 84.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.614 1.097 . . . . 2.43 108.809 164.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m -61.4 -20.62 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.439 1.096 . . . . 3.21 113.53 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.45 -118.41 0.12 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.857 -1.164 . . . . 5.78 107.857 164.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 6' ' ' LEU 0.279 21.1 pt 40.45 27.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.012 1.725 . . . . 8.21 114.638 -167.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.252 1.224 1 N-CA-C 99.689 -4.189 . . . . 11.86 99.689 156.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 109.135 -0.691 . . . . 9.76 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.12 -82.46 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 105.036 -3.226 . . . . 3.93 105.036 -171.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 75.85 -50.86 0.62 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.2 1.8 . . . . 5.62 114.254 149.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.84 49.86 67.85 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.332 0.968 . . . . 1.97 111.473 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 t -85.97 91.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.345 -0.983 . . . . 3.07 108.345 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -108.34 111.46 23.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.838 -1.171 . . . . 2.98 107.838 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 25.2 mt-10 -83.41 135.21 34.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.952 -1.129 . . . . 2.77 107.952 164.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.33 130.25 54.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.396 -1.335 . . . . 2.79 107.396 168.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 m -76.83 129.51 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 107.807 -1.183 . . . . 3.17 107.807 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.37 151.55 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 125.083 1.353 . . . . 1.81 109.189 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -129.5 144.23 51.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.437 -0.949 . . . . 6.02 108.437 163.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.58 3.11 35.02 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.5 1.524 . . . . 1.93 112.333 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 82.6 mtp -66.94 158.0 31.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.647 -0.914 . . . . 1.98 110.886 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 t -164.67 128.46 2.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.415 1.086 . . . . 3.32 108.556 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.3 m 62.41 177.21 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.54 1.536 . . . . 2.29 112.949 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.29 -27.67 56.21 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.869 -1.059 . . . . 1.26 111.461 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -56.61 -70.39 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.285 1.434 . . . . 0.78 113.648 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.5 m -49.46 -42.19 42.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.457 -0.777 . . . . 1.22 109.707 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 t -51.53 -71.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.407 0.683 . . . . 0.89 111.625 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.97 -29.29 69.1 Favored 'General case' 0 C--N 1.34 0.163 0 O-C-N 121.513 -0.742 . . . . 1.27 111.007 -173.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -55.03 -56.42 20.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.35 -0.611 . . . . 4.12 109.35 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.8 mt -57.52 -54.2 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.631 -0.507 . . . . 0.84 109.631 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -50.5 -54.81 19.41 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.888 0.375 . . . . 3.11 110.99 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.8 t -52.92 -56.74 13.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.121 0.968 . . . . 1.17 110.381 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -50.25 -56.35 11.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.735 1.214 . . . . 1.92 109.919 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.87 -45.62 64.08 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.41 -0.516 . . . . 2.61 111.599 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.4 m -52.12 -36.16 50.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.097 0.862 . . . . 1.65 111.02 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.87 -26.13 23.23 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.12 1.156 . . . . 4.57 114.12 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.25 -29.26 70.62 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.219 1.372 . . . . 2.23 111.093 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 72.04 -3.59 2.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 6.25 113.03 -175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.59 -30.77 38.92 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.321 -1.112 . . . . 0.88 110.321 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.75 116.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.222 -1.399 . . . . 2.83 107.222 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -79.01 -33.9 44.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.157 0.583 . . . . 1.37 109.452 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.08 146.54 24.02 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.226 -0.657 . . . . 1.9 109.226 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.5 t -139.82 130.89 26.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.294 -1.743 . . . . 1.86 106.294 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m -145.36 116.81 8.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.586 -0.894 . . . . 1.86 108.586 167.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.54 85.41 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.935 -1.135 . . . . 1.97 107.935 -166.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.71 93.46 8.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.66 -0.867 . . . . 0.92 108.66 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.1 tt -44.69 -39.83 5.43 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.715 1.206 . . . . 1.81 111.826 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.93 -30.08 22.92 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.857 0.863 . . . . 1.12 112.438 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 t -123.35 14.8 9.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.275 1.43 . . . . 1.53 110.175 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 m120 30.56 53.32 0.15 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 127.376 2.271 . . . . 2.31 112.829 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -133.83 140.25 46.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.221 0.608 . . . . 1.38 109.437 -173.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.34 101.48 10.67 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 126.169 1.788 . . . . 0.55 107.032 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -77.82 107.08 10.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.287 -1.746 . . . . 0.98 106.287 170.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.1 mt -112.7 118.95 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 107.021 -1.474 . . . . 0.96 107.021 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -96.12 119.15 34.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.9 -1.519 . . . . 3.09 106.9 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -158.57 127.42 5.48 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 122.449 0.3 . . . . 2.72 110.744 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.11 128.11 91.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.382 -0.97 . . . . 3.38 108.382 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.88 -50.5 5.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.251 1.967 . . . . 2.44 111.71 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.15 -21.9 36.23 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.721 1.378 . . . . 3.23 114.721 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 pt -94.35 -1.89 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.041 0.837 . . . . 2.33 112.104 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.82 -47.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.322 0.965 . . . . 2.95 113.594 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.54 148.64 8.46 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.446 1.022 . . . . 0.67 112.1 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.05 -47.52 17.47 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.251 2.634 . . . . 0.94 111.402 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.433 HH21 ' N ' ' A' ' 60' ' ' HIS . 7.8 tpm_? -47.81 -43.87 28.19 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.148 0.979 . . . . 7.62 111.843 -174.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.89 -53.88 51.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.868 0.867 . . . . 3.92 110.987 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -58.26 -52.86 53.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.43 -0.581 . . . . 0.67 109.43 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -57.48 -47.38 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.033 -0.728 . . . . 1.57 109.033 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.433 ' N ' HH21 ' A' ' 56' ' ' ARG . 52.4 t-80 -59.09 -41.91 89.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.693 0.797 . . . . 4.69 110.126 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.9 m -63.0 -45.76 90.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.102 -0.333 . . . . 0.93 110.102 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.6 mt -60.31 -49.94 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.327 0.651 . . . . 0.78 110.824 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -49.95 -59.19 4.11 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.108 0.963 . . . . 2.99 109.749 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -52.92 -48.55 67.19 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.753 1.621 . . . . 0.92 111.189 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.21 -55.42 35.2 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.939 -0.476 . . . . 1.63 110.976 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.84 -40.16 0.02 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 115.663 1.025 . . . . 1.67 115.663 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -122.95 132.53 54.2 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.326 0.563 . . . . 1.97 110.874 -133.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.44 133.12 37.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.02 -1.845 . . . . 4.24 106.02 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.74 145.33 30.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.058 -0.401 . . . . 1.49 110.372 -172.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -135.89 110.7 8.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.424 1.09 . . . . 2.5 109.576 -170.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.95 116.56 1.11 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.215 0.606 . . . . 2.12 109.918 164.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 m -66.92 152.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.796 -1.187 . . . . 2.66 107.796 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -102.26 84.91 2.55 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 108.394 -0.965 . . . . 8.51 108.394 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.3 pt -75.78 -46.78 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.923 -0.769 . . . . 5.49 108.923 162.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 116.422 -1.751 . . . . 9.43 111.057 -177.571 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 106.99 -1.485 . . . . 8.07 106.99 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.98 -166.6 6.25 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 107.51 -2.236 . . . . 4.05 107.51 -140.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.14 98.51 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.593 1.157 . . . . 5.53 113.347 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.82 160.19 34.29 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 109.2 -1.56 . . . . 1.64 109.2 156.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.12 146.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 121.657 -0.908 . . . . 2.19 109.95 -173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.05 116.45 22.13 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.471 2.308 . . . . 2.73 105.497 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.11 107.26 12.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.385 -0.969 . . . . 2.53 108.385 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -119.62 143.79 47.48 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 125.128 1.518 . . . . 2.19 109.423 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.31 136.72 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.891 -1.892 . . . . 2.29 105.891 162.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.38 122.97 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.015 1.726 . . . . 2.26 106.905 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -104.35 150.53 24.41 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.082 0.953 . . . . 5.48 110.912 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 -49.58 4.14 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 107.978 -2.049 . . . . 1.83 107.978 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -27.53 112.44 0.06 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 127.844 2.458 . . . . 2.01 112.312 163.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -157.56 160.52 38.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.443 0.697 . . . . 3.1 109.572 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.3 m 63.68 155.84 0.06 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.356 1.862 . . . . 2.59 113.106 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.98 -36.24 2.39 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.64 1.576 . . . . 1.3 111.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.53 -48.26 79.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.712 2.005 . . . . 1.07 114.127 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -72.2 -43.76 64.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.339 -1.356 . . . . 1.29 107.339 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.59 -64.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.465 1.106 . . . . 1.27 111.785 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.97 -31.05 68.56 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.869 -0.519 . . . . 1.64 111.446 -174.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -55.8 -55.92 26.72 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 108.339 -0.985 . . . . 4.57 108.339 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.18 -61.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 N-CA-C 109.454 -0.573 . . . . 0.75 109.454 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 1.7 pp20? -64.33 -44.24 92.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.905 -0.718 . . . . 4.95 111.168 -165.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -64.21 -47.35 80.08 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.674 -0.862 . . . . 1.2 108.674 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 t -56.88 -42.78 80.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.835 -0.602 . . . . 1.12 110.949 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.05 -64.47 0.93 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 119.373 0.988 . . . . 1.79 112.026 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.9 m -44.01 -34.48 1.74 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.763 1.225 . . . . 1.63 114.014 -162.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.28 -29.76 0.15 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.221 1.563 . . . . 6.12 115.221 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -55.82 -40.65 73.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.314 0.961 . . . . 2.25 111.102 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp-105 70.52 -1.67 2.46 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.717 2.007 . . . . 5.97 112.666 -167.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.09 -32.41 35.81 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 1.01 110.51 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 46' ' ' ILE . 4.2 mp -84.13 118.13 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.286 -1.746 . . . . 2.74 106.286 172.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.4 mt -81.42 -33.39 32.2 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.203 1.001 . . . . 1.37 110.427 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -150.55 133.97 16.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.988 -1.486 . . . . 2.39 106.988 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.0 t -133.74 62.51 1.65 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.776 0.83 . . . . 1.94 110.253 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 95.54 8.02 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.648 -0.706 . . . . 1.81 109.674 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -79.27 85.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.6 1.19 . . . . 2.32 107.823 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 80.22 4.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.05 1.34 . . . . 1.16 108.334 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -38.99 -43.8 1.01 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.67 2.388 . . . . 2.3 111.152 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.54 -33.51 45.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.645 0.778 . . . . 1.25 111.834 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 p -112.33 8.26 19.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.558 1.543 . . . . 2.5 111.513 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 43.26 45.92 5.14 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.274 1.43 . . . . 2.08 110.761 -174.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -134.24 144.77 48.6 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.488 0.715 . . . . 1.03 110.594 -171.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.88 105.47 17.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.144 -1.428 . . . . 0.46 107.144 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -83.96 100.41 11.02 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.901 -1.889 . . . . 0.74 105.901 165.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.435 HG23 HG23 ' A' ' 32' ' ' ILE . 14.5 mt -112.07 108.35 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 124.786 1.234 . . . . 1.23 107.716 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.7 115.23 19.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.033 -1.469 . . . . 2.21 107.033 169.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -144.52 162.58 36.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.46 -2.052 . . . . 1.87 105.46 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.99 139.42 32.49 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 107.004 -1.48 . . . . 4.51 107.004 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.56 69.06 5.26 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.351 3.368 . . . . 2.49 111.481 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -165.28 -46.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.561 1.544 . . . . 4.27 110.216 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -81.68 -25.6 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 3.38 109.668 177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -158.33 157.11 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.4 164.49 26.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.728 -0.949 . . . . 0.75 110.728 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.86 -47.49 1.23 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.996 2.464 . . . . 0.82 110.802 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -61.87 -34.09 75.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.211 -0.306 . . . . 7.18 111.211 -175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -57.31 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.495 1.518 . . . . 3.69 108.586 173.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.49 -51.73 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.263 -0.88 . . . . 0.88 109.451 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.5 mt -52.39 -56.84 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 122.472 0.309 . . . . 1.51 110.206 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -49.39 -48.81 46.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.479 0.712 . . . . 3.16 109.819 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.6 m -60.12 -52.23 66.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 119.9 -0.72 . . . . 0.99 110.121 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -53.68 -57.43 5.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 C-N-CA 124.036 0.934 . . . . 0.78 110.468 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.66 -52.23 66.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.441 -0.577 . . . . 4.74 109.441 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -51.19 -40.91 59.74 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.974 0.909 . . . . 1.24 111.895 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.63 -48.68 80.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.713 1.142 . . . . 1.8 113.367 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.28 -1.47 0.06 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 118.371 2.108 . . . . 1.03 118.371 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -138.57 176.64 8.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.788 1.794 . . . . 2.1 113.432 -145.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.58 139.1 53.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.851 -1.907 . . . . 3.35 105.851 167.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.16 161.0 22.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.202 1.001 . . . . 1.66 112.459 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.7 m -157.05 116.2 3.36 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.493 -1.241 . . . . 1.83 110.059 171.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 mt -49.99 140.8 11.7 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.782 1.174 . . . . 3.1 109.18 164.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.83 40.7 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.827 1.251 . . . . 3.08 110.611 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 -64.7 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.913 0.885 . . . . 6.17 109.165 -173.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 74' ' ' ILE . 3.4 mp -87.15 63.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 105.956 -1.868 . . . . 8.89 105.956 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 117.751 -1.119 . . . . 11.98 108.937 -152.623 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tmm? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 108.883 -0.784 . . . . 7.78 108.883 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.99 41.25 44.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.619 0.628 . . . . 5.41 111.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.09 154.64 37.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.276 0.63 . . . . 5.63 110.657 -162.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.66 76.12 0.84 Allowed Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.209 -0.756 . . . . 1.58 111.209 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 m -81.13 140.4 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.653 -1.24 . . . . 2.32 107.653 159.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.0 tp -137.35 91.68 2.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.428 -1.323 . . . . 2.15 107.428 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.99 116.62 26.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.677 -1.601 . . . . 2.55 106.677 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -124.91 140.7 52.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.2 -0.312 . . . . 2.96 110.518 174.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.68 139.92 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 106.829 -1.545 . . . . 1.66 106.829 167.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.82 150.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 123.898 0.879 . . . . 2.44 108.76 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -146.53 168.0 22.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.021 0.928 . . . . 4.85 108.791 -170.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.4 -55.79 3.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.716 -1.754 . . . . 1.62 108.716 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 ptm -60.48 138.93 57.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.466 -0.431 . . . . 1.65 110.767 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -159.07 19.84 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.444 -0.343 . . . . 2.55 111.863 -166.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.6 p -173.33 159.35 3.75 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.907 0.776 . . . . 3.54 110.219 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.72 -41.07 55.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.975 1.71 . . . . 1.16 113.149 -172.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.2 p -63.22 -67.08 0.45 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.137 0.575 . . . . 1.07 111.342 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -43.73 -42.25 5.32 Favored 'General case' 0 N--CA 1.461 0.075 0 O-C-N 121.389 -0.819 . . . . 1.27 110.759 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 t -54.07 -73.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 123.205 0.602 . . . . 0.8 111.011 173.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -21.04 66.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.521 -0.737 . . . . 0.99 111.921 -169.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -58.12 -47.71 82.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.001 0.92 . . . . 4.04 110.03 173.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.7 mt -59.9 -54.25 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.701 -0.852 . . . . 0.58 108.701 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -54.0 -59.82 4.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.641 0.588 . . . . 2.95 109.57 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.3 t -51.37 -49.15 62.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.086 1.354 . . . . 1.02 111.135 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -58.33 -51.11 71.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.762 0.425 . . . . 0.85 110.386 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -64.01 -36.54 84.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 118.705 -1.198 . . . . 2.05 110.158 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.8 m -63.85 7.32 0.12 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.119 -0.988 . . . . 2.09 113.306 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.81 -46.72 43.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.42 -1.425 . . . . 4.45 110.296 157.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -62.71 162.74 10.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.467 0.707 . . . . 2.63 110.613 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -0.52 11.86 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.507 -0.746 . . . . 7.6 112.292 170.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.72 -15.25 61.85 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 118.031 0.378 . . . . 0.84 112.319 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -94.0 142.8 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.484 -1.302 . . . . 3.17 107.484 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.27 -45.75 4.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.321 1.048 . . . . 3.09 110.025 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.13 153.98 49.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.291 1.036 . . . . 2.33 108.829 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 p -156.02 59.63 0.59 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.435 0.694 . . . . 2.99 111.463 -170.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 m -87.06 104.63 16.51 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.509 -0.758 . . . . 1.94 111.429 -175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.303 2.7 p -92.68 92.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 122.655 1.217 . . . . 1.93 111.654 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.68 90.66 7.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.785 -1.191 . . . . 0.79 107.785 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tt -44.15 -37.35 3.07 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.55 1.14 . . . . 1.71 111.453 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.14 22.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.906 0.882 . . . . 1.02 112.247 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -120.8 15.44 11.78 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.012 1.325 . . . . 1.48 110.41 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.15 50.6 0.72 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.548 1.939 . . . . 2.01 111.733 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.75 143.6 35.04 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.222 0.609 . . . . 1.05 109.372 -173.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.84 118.74 36.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.972 -1.122 . . . . 0.55 107.972 165.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -87.33 95.58 10.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.844 -2.28 . . . . 1.04 104.844 162.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.1 mt -93.48 140.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.848 -1.538 . . . . 1.02 106.848 169.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -118.68 136.86 53.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.94 -1.874 . . . . 3.6 105.94 161.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.62 173.7 15.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.964 1.306 . . . . 1.84 108.126 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -113.29 117.48 45.34 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.62 -1.252 . . . . 3.91 107.62 164.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -54.26 -40.11 83.82 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 121.456 1.437 . . . . 2.2 111.945 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -67.64 -12.62 60.86 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.709 0.686 . . . . 4.97 112.663 -167.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 pt -117.97 6.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 C-N-CA 123.928 0.891 . . . . 2.41 112.946 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.37 -42.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.474 0.916 . . . . 2.69 113.474 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.49 159.29 5.55 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 111.201 -0.76 . . . . 0.94 111.201 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.31 -34.54 66.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.526 2.151 . . . . 0.71 110.837 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.11 -46.13 65.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.534 0.938 . . . . 6.82 113.534 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.45 -35.29 70.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.2 0.909 . . . . 4.11 112.182 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 mt -58.19 -47.11 88.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.834 -0.802 . . . . 0.92 108.834 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -57.83 -48.5 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 118.147 -0.93 . . . . 1.71 109.985 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -47.07 -49.46 21.58 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.957 0.799 . . . . 3.44 109.523 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.0 m -59.21 -55.78 30.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.338 -0.545 . . . . 1.36 110.017 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -63.52 -45.5 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 122.537 0.335 . . . . 0.84 110.702 -170.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.92 -54.64 39.06 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.974 0.509 . . . . 3.12 110.315 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -64.88 -20.7 66.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.829 -1.081 . . . . 0.88 112.416 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.16 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 119.849 1.204 . . . . 1.81 109.05 160.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 18.0 0.24 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.152 -1.36 . . . . 1.14 115.111 169.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.15 122.9 40.26 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.95 1.875 . . . . 1.93 112.683 -157.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.76 86.84 4.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.889 -0.782 . . . . 3.41 108.889 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.11 163.11 26.92 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.13 -0.981 . . . . 1.04 110.709 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 72.0 m -154.68 104.53 2.54 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.738 -0.838 . . . . 1.89 108.738 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 126.42 27.3 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 122.86 0.464 . . . . 2.17 111.443 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 m -101.8 113.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.541 0.686 . . . . 1.96 110.853 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -69.97 75.98 0.48 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.573 0.749 . . . . 5.64 109.526 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.2 mt -72.95 90.71 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.665 -1.235 . . . . 5.16 107.665 171.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 126.986 2.114 . . . . 8.7 105.324 173.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 110.807 -0.072 . . . . 12.89 110.807 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.1 -75.75 0.47 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.988 0.804 . . . . 6.24 111.114 175.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 66.83 -62.18 0.3 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.108 2.163 . . . . 7.96 112.283 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.11 44.09 55.01 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 123.946 0.784 . . . . 2.74 111.35 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.83 117.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.58 -1.267 . . . . 3.12 107.58 171.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -154.12 135.63 14.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.909 0.861 . . . . 3.15 111.026 164.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.39 117.36 33.64 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.75 1.22 . . . . 2.43 109.766 -170.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.95 126.43 46.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.966 -1.494 . . . . 2.82 106.966 172.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.46 137.97 21.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.001 -2.222 . . . . 2.45 105.001 160.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.25 107.47 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.306 -1.368 . . . . 1.87 107.306 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -102.25 115.1 29.85 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.965 -1.124 . . . . 5.83 107.965 -174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.65 -45.18 0.99 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.978 -1.649 . . . . 1.51 108.978 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -55.69 137.2 49.94 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.909 0.483 . . . . 1.81 110.224 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -165.97 12.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 2.91 112.766 -163.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -170.74 144.41 2.29 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 117.908 -1.044 . . . . 2.07 108.355 -170.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.81 -50.49 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.621 2.369 . . . . 1.25 113.437 174.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.5 p -57.12 -47.7 80.47 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.797 1.239 . . . . 1.13 114.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.38 -49.63 32.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.388 1.075 . . . . 1.07 108.171 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -43.23 -64.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.335 1.854 . . . . 0.86 110.487 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -9.54 55.09 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 120.348 -0.541 . . . . 1.36 111.554 -174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 -47.49 59.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.48 -1.387 . . . . 4.82 107.96 -172.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.28 -57.28 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.836 -1.074 . . . . 0.76 108.345 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -70.32 0.09 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.234 0.614 . . . . 4.3 111.968 174.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -47.85 -47.13 31.68 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.611 0.641 . . . . 2.37 111.881 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -59.56 -65.68 0.63 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.853 -0.425 . . . . 0.9 109.853 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -58.04 -34.66 70.33 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 118.436 0.562 . . . . 1.77 111.318 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -55.3 -25.32 33.54 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.298 0.481 . . . . 1.58 112.298 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -18.94 64.35 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.663 1.119 . . . . 5.76 112.654 176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -84.88 119.97 25.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.54 -1.282 . . . . 2.37 107.54 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -69.07 -0.82 6.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.088 -1.008 . . . . 6.55 113.704 -172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.48 -20.98 61.0 Favored Glycine 0 CA--C 1.528 0.895 0 O-C-N 121.523 -0.736 . . . . 0.85 113.595 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.99 138.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 117.818 0.809 . . . . 3.64 110.486 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.9 mt -100.62 -42.61 6.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.836 1.655 . . . . 1.55 110.196 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -148.36 149.99 32.77 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.445 -0.576 . . . . 2.31 109.445 -175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 t -141.75 74.22 1.44 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.857 0.837 . . . . 1.92 110.332 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -85.4 82.92 8.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.216 0.606 . . . . 2.32 109.957 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.07 126.34 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 112.594 0.591 . . . . 1.89 112.594 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.35 104.22 7.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.337 1.455 . . . . 0.91 108.684 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.48 -30.02 38.89 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.314 0.645 . . . . 2.77 111.321 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.16 -30.68 50.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.923 0.889 . . . . 1.16 111.61 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -122.08 14.2 10.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 1.69 110.027 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 34.19 55.14 0.62 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 126.457 1.903 . . . . 1.79 111.713 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.59 143.34 25.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.088 -0.383 . . . . 1.45 110.241 -172.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.87 112.31 24.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.608 1.963 . . . . 0.59 108.747 165.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.55 95.6 5.24 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 104.627 -2.36 . . . . 1.1 104.627 160.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 mt -91.27 142.31 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 106.288 -1.745 . . . . 1.12 106.288 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -119.26 111.51 18.31 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.868 -2.271 . . . . 2.87 104.868 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -152.5 155.62 37.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.246 1.019 . . . . 3.29 108.674 -173.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -97.21 100.17 7.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 O-C-N 123.873 0.733 . . . . 3.22 109.458 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.58 -42.05 71.76 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.826 2.351 . . . . 2.37 111.427 -172.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -20.34 -50.59 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.871 2.468 . . . . 4.49 114.385 166.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 pt -112.56 16.1 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.074 0.95 . . . . 2.34 113.112 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.5 tt -160.53 -46.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.961 0.801 . . . . 2.95 112.203 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.27 157.27 8.42 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.551 1.072 . . . . 0.73 111.43 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.59 -45.32 26.37 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.622 2.214 . . . . 1.04 110.474 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.99 -55.49 6.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.75 1.22 . . . . 8.39 112.762 -172.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -56.53 -48.36 77.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.004 0.907 . . . . 3.97 111.056 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.51 -51.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.642 -0.708 . . . . 0.65 109.317 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -49.43 -60.89 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 C-N-CA 123.16 0.584 . . . . 1.66 109.428 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -45.51 -49.0 14.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.538 0.735 . . . . 2.72 109.707 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.1 m -63.15 -48.52 78.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.021 -0.672 . . . . 0.86 110.741 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 93.6 mt -52.19 -64.81 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 C-N-CA 123.322 0.649 . . . . 0.88 109.841 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.1 -47.67 84.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.135 -0.626 . . . . 2.81 109.718 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -61.44 -19.56 62.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.128 -1.415 . . . . 1.05 113.583 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.08 -70.04 0.26 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 121.296 1.862 . . . . 1.77 109.654 166.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.55 24.82 0.27 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.862 -1.521 . . . . 1.34 115.877 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -128.71 173.79 10.01 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.089 1.944 . . . . 1.88 113.431 -164.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.74 152.61 20.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 105.234 -2.135 . . . . 3.61 105.234 154.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.8 162.47 41.24 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.202 0.91 . . . . 1.12 111.449 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.19 141.8 17.78 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.253 0.221 . . . . 2.46 111.571 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.81 70.32 3.26 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.368 1.067 . . . . 2.91 111.211 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 m -68.05 -161.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.976 0.91 . . . . 3.02 110.807 171.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 156.11 45.14 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.372 -2.084 . . . . 5.92 105.372 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.8 tt -118.45 133.79 64.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 103.28 -2.859 . . . . 5.67 103.28 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 13.1 pt-20 . . . . . 0 C--O 1.25 1.1 0 O-C-N 125.049 1.468 . . . . 10.81 111.868 -163.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 105.452 -2.055 . . . . 12.05 105.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.58 49.82 63.38 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 109.03 -1.628 . . . . 5.19 109.03 -167.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.419 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 1.7 p30 -148.99 172.05 15.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.38 1.472 . . . . 4.75 107.8 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.63 160.87 13.22 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.103 -1.599 . . . . 1.61 109.103 164.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.8 152.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 125.407 1.483 . . . . 2.11 107.621 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -141.77 109.92 5.9 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.979 -1.489 . . . . 2.59 106.979 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -122.03 112.33 18.12 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.433 0.693 . . . . 2.52 110.745 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.44 142.38 51.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.856 1.347 . . . . 2.29 110.031 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.33 138.1 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.369 -1.715 . . . . 1.94 106.369 166.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.9 152.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.144 -1.058 . . . . 1.92 108.144 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -138.01 131.16 30.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.798 0.839 . . . . 6.31 109.031 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.18 9.49 85.04 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.813 -0.915 . . . . 1.84 110.813 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -102.25 126.37 49.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.149 1.779 . . . . 2.17 106.798 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.8 t -158.7 155.61 28.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.483 0.583 . . . . 3.13 109.884 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m 66.0 164.1 0.17 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.962 1.705 . . . . 2.71 112.763 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -43.92 49.02 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.924 -1.035 . . . . 1.24 110.891 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 p -43.33 -74.23 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.173 1.789 . . . . 0.92 114.12 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -49.92 -44.24 50.19 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.486 0.714 . . . . 1.18 109.528 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.35 -66.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.16 0.584 . . . . 1.2 111.952 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -68.08 -28.48 67.4 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.263 -0.898 . . . . 1.96 110.688 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -57.65 -52.86 63.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.612 0.642 . . . . 4.02 109.782 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -54.45 -61.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 108.783 -0.821 . . . . 0.69 108.783 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.77 -55.09 33.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.302 0.241 . . . . 2.81 111.077 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.0 t -54.11 -34.74 61.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.317 1.047 . . . . 1.36 111.313 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -69.37 -65.86 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.048 0.84 . . . . 1.07 109.894 173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.98 -44.74 71.05 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.253 1.021 . . . . 2.32 112.091 -170.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.6 p -54.55 -25.42 25.8 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.92 -0.487 . . . . 2.31 112.097 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.85 -20.29 63.42 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.604 0.762 . . . . 5.19 111.698 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -64.25 -38.37 90.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.901 -0.778 . . . . 2.28 108.901 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 70.25 -2.33 2.16 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.282 2.233 . . . . 5.48 113.127 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.91 37.87 3.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.291 -1.123 . . . . 0.84 110.291 167.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.54 139.11 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.524 -2.028 . . . . 2.16 105.524 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.88 -40.17 9.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.006 0.523 . . . . 2.75 110.379 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -155.02 164.13 39.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.369 0.531 . . . . 2.42 111.344 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.9 p -153.56 125.09 7.62 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.753 2.421 . . . . 3.26 106.669 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -132.11 106.67 8.14 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.278 -1.749 . . . . 1.57 106.278 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 t -88.18 81.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.453 -1.314 . . . . 2.05 107.453 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.88 89.44 5.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.244 -1.021 . . . . 0.78 108.244 -171.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.32 -42.99 0.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.588 1.955 . . . . 1.86 111.012 165.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.07 62.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.646 1.178 . . . . 1.08 112.39 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -116.43 17.97 15.3 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.614 1.565 . . . . 1.55 109.246 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 19.42 59.59 0.02 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.489 2.716 . . . . 3.06 113.422 -164.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.9 144.89 39.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.034 0.534 . . . . 0.97 109.748 -174.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.2 106.85 18.9 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.796 -1.187 . . . . 0.42 107.796 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -86.37 100.72 12.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.712 -1.958 . . . . 0.83 105.712 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.72 146.09 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.791 -1.559 . . . . 1.95 106.791 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' NZ ' ' OD1' ' A' ' 3' ' ' ASP . 19.2 mmmt -122.17 133.74 54.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.239 -2.134 . . . . 2.7 105.239 165.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.15 169.16 19.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.615 0.366 . . . . 3.1 110.299 -160.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.21 139.46 24.2 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.052 -1.832 . . . . 4.12 106.052 159.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.35 -34.75 1.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.146 1.898 . . . . 2.57 113.138 -175.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.65 -28.46 15.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.357 0.981 . . . . 3.41 112.348 -163.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.54 -24.62 29.47 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 CA-C-N 118.998 0.817 . . . . 2.25 110.638 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 tt -121.61 -44.18 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.517 0.562 . . . . 2.64 112.517 -169.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.27 120.08 0.24 Allowed Glycine 0 CA--C 1.534 1.224 0 N-CA-C 109.16 -1.576 . . . . 0.91 109.16 -168.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -55.7 -38.05 94.75 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 120.673 2.237 . . . . 1.56 111.138 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.24 -23.26 63.92 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.157 1.169 . . . . 8.89 114.157 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.57 -51.93 67.71 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.91 1.232 . . . . 3.53 109.451 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 mp -56.47 -49.31 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.538 -0.744 . . . . 0.8 110.071 174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.6 -59.44 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.232 0.924 . . . . 1.57 110.164 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -49.14 -50.04 39.33 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.837 0.855 . . . . 3.59 109.344 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.8 m -57.51 -52.06 66.95 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.84 110.231 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.4 mt -56.29 -57.25 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 119.23 -0.414 . . . . 0.88 110.574 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.83 -51.02 71.52 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.725 -0.79 . . . . 3.38 110.019 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -57.81 -35.99 71.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.226 1.01 . . . . 1.58 111.241 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.0 mp -52.12 -68.61 0.16 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.518 0.599 . . . . 2.27 111.518 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.75 14.99 0.18 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.187 -1.341 . . . . 1.1 115.571 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -133.82 175.04 9.81 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.413 1.607 . . . . 1.96 113.869 -156.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.23 152.61 22.65 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 105.367 -2.086 . . . . 4.01 105.367 155.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.09 139.91 23.91 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.023 1.329 . . . . 0.99 109.567 -169.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 m -155.41 110.44 2.99 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.25 -0.906 . . . . 1.5 111.101 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.23 139.98 7.91 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.139 -1.059 . . . . 2.9 108.139 166.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.73 35.2 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.128 0.571 . . . . 2.64 109.961 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt 157.14 146.32 0.01 OUTLIER 'General case' 0 CA--C 1.526 0.05 0 C-N-CA 128.288 2.635 . . . . 6.99 106.545 -169.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.0 mt 78.01 -54.55 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.078 1.351 . . . . 9.16 108.506 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 . . . . . 0 C--O 1.259 1.562 0 N-CA-C 105.672 -1.973 . . . . 13.21 105.672 157.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttm . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 108.328 -0.99 . . . . 8.78 108.328 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -56.29 128.19 45.43 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 104.264 -3.535 . . . . 4.49 104.264 135.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.17 150.65 33.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.748 0.774 . . . . 5.18 111.47 -162.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.78 109.14 2.74 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.294 -1.922 . . . . 1.89 108.294 160.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.56 129.84 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.5 -1.296 . . . . 3.07 107.5 170.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tp -113.26 128.23 56.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.628 -1.99 . . . . 2.13 105.628 166.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 73' ' ' LYS . 24.8 mt-10 -121.17 104.08 9.49 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.287 -0.634 . . . . 2.42 109.287 165.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 mt -90.35 129.76 36.53 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 106.757 -1.571 . . . . 2.7 106.757 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.4 131.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.423 -2.066 . . . . 1.85 105.423 155.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.3 t -108.1 150.44 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.161 -1.792 . . . . 1.83 106.161 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -135.38 125.27 25.67 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.05 -0.722 . . . . 4.81 109.05 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.47 -13.97 5.87 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.294 1.426 . . . . 1.73 112.517 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.1 ptp -65.74 149.4 50.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.54 1.17 . . . . 2.16 110.26 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -163.17 139.6 7.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.659 -1.608 . . . . 3.1 106.659 168.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.8 t 73.46 142.01 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.681 1.592 . . . . 2.9 112.582 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.12 -36.2 0.29 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.911 2.085 . . . . 1.3 113.166 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 p -56.55 -77.08 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.192 0.997 . . . . 1.2 112.805 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -55.11 -33.68 63.05 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 124.076 0.95 . . . . 2.03 110.531 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -52.69 -75.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 O-C-N 123.662 0.601 . . . . 1.23 109.497 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.302 0.3 OUTLIER -66.98 -16.51 64.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.855 -0.528 . . . . 1.51 112.01 -168.177 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -55.94 -44.14 78.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.957 -1.127 . . . . 4.43 107.957 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 mt -58.6 -63.86 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.246 -1.02 . . . . 0.72 108.246 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 2.8 pt-20 -60.18 -50.88 71.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.313 0.486 . . . . 2.9 112.313 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.3 t -50.24 -52.22 37.89 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.888 0.875 . . . . 1.04 109.548 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -56.77 -54.73 42.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.942 0.337 . . . . 0.81 110.897 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.17 -34.4 77.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 118.871 -1.132 . . . . 1.72 111.211 -172.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 m -61.25 -10.73 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.977 -1.077 . . . . 1.49 112.28 173.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -75.86 -20.52 58.03 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 120.924 -1.11 . . . . 4.82 112.197 172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -71.56 -169.12 0.39 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.987 -1.116 . . . . 2.76 107.987 167.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -126.87 -0.84 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.411 -0.806 . . . . 6.15 112.347 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.03 -19.96 22.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.214 0.461 . . . . 0.85 113.023 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.5 mp -79.9 113.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.984 -1.487 . . . . 2.94 106.984 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -79.73 -36.51 37.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.817 1.247 . . . . 1.5 110.202 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -154.91 150.6 27.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.44 -1.319 . . . . 2.48 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -155.65 86.92 1.07 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.983 -0.376 . . . . 1.85 109.983 -164.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.7 m -112.77 107.14 15.67 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.472 0.709 . . . . 1.82 109.933 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.19 90.2 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 122.813 1.292 . . . . 1.74 110.232 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 92.6 8.22 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.414 -0.958 . . . . 0.82 108.414 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -40.58 -39.87 1.14 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.552 1.541 . . . . 1.97 112.395 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.87 -33.1 61.51 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.628 0.771 . . . . 0.79 111.872 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -116.1 11.09 15.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.588 1.555 . . . . 1.49 110.047 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.32 39.33 0.09 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.812 2.445 . . . . 2.14 112.917 -173.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.65 141.09 52.35 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.49 0.716 . . . . 1.11 110.251 -169.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.72 96.57 7.18 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.784 1.634 . . . . 0.64 108.415 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -77.17 101.29 6.1 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.762 -1.94 . . . . 0.8 105.762 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.6 mt -109.92 112.49 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 125.215 1.406 . . . . 0.98 107.512 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -87.74 124.85 34.02 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.694 -1.595 . . . . 2.37 106.694 169.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.21 177.5 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.925 -1.509 . . . . 2.23 106.925 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.98 137.02 28.65 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.342 0.974 . . . . 3.94 109.277 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.24 67.74 5.17 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.012 3.808 . . . . 2.64 110.703 -173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -172.97 -45.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.013 1.725 . . . . 3.63 109.298 -171.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -85.3 -28.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.617 0.767 . . . . 3.26 109.676 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.8 tt -158.08 156.22 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.09 -1.078 . . . . 2.63 108.09 169.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.43 163.01 27.25 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.624 -0.991 . . . . 0.64 110.624 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.09 -45.52 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.699 2.266 . . . . 0.77 110.819 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -61.19 -30.75 70.61 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.952 -0.468 . . . . 7.81 110.896 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -57.47 11.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.838 1.655 . . . . 3.67 109.072 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -56.61 -49.86 76.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.09 -0.707 . . . . 0.76 109.09 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.15 -48.33 84.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.994 -0.527 . . . . 1.39 110.782 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -53.11 -43.99 67.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.689 0.796 . . . . 3.07 109.069 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 m -62.59 -42.98 99.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.838 -0.745 . . . . 0.91 110.158 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.47 -46.35 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.224 -0.922 . . . . 0.85 111.787 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -52.05 -55.13 22.59 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.019 0.928 . . . . 3.16 108.918 172.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 t -53.25 -51.19 63.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.145 1.378 . . . . 0.86 111.276 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.55 -44.42 96.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.51 -0.744 . . . . 1.98 112.263 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.29 -46.63 0.02 OUTLIER Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.844 -0.693 . . . . 1.86 114.751 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -125.75 142.8 51.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 119.432 -0.907 . . . . 2.0 113.031 -126.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -78.47 80.67 4.85 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.315 -0.624 . . . . 3.75 109.315 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.92 158.61 30.59 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.424 -0.797 . . . . 0.98 110.764 -171.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -155.21 117.45 4.19 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.866 -1.146 . . . . 1.98 111.235 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.26 121.04 11.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.465 1.106 . . . . 2.62 111.006 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.32 43.58 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.131 1.372 . . . . 3.24 109.855 173.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HB3' ' H ' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -98.28 -148.13 0.33 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.871 -0.788 . . . . 5.04 108.871 -171.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.585 ' H ' HD12 ' A' ' 74' ' ' ILE . 3.6 mp -77.64 66.85 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.489 -1.671 . . . . 6.36 106.489 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.975 -1.488 . . . . 8.63 108.041 165.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 107.101 -1.444 . . . . 11.16 107.101 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.58 -178.9 41.01 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.834 -2.106 . . . . 4.8 107.834 140.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.12 121.34 0.38 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.014 2.525 . . . . 4.97 113.113 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.16 166.94 50.47 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.078 -2.009 . . . . 1.49 108.078 151.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -135.2 79.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-O 123.019 1.39 . . . . 2.49 108.122 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 tp -80.16 79.74 6.68 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 123.113 1.435 . . . . 2.51 107.175 172.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -77.9 122.68 25.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 112.579 -2.1 . . . . 2.59 105.784 164.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -136.01 139.72 43.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.428 -0.582 . . . . 1.83 109.428 172.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.07 111.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.116 -1.809 . . . . 1.97 106.116 169.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.9 t -77.49 164.51 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 105.527 -2.027 . . . . 1.73 105.527 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -138.22 130.99 29.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.118 -0.989 . . . . 5.44 108.805 164.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.82 5.65 17.79 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.852 1.215 . . . . 1.6 112.377 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.479 ' CE ' HG22 ' A' ' 37' ' ' VAL . 25.0 mtp -75.2 87.37 2.46 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.834 1.317 . . . . 2.01 108.07 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -83.27 -30.13 27.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.859 0.864 . . . . 2.51 111.995 -173.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.3 t -153.76 152.41 30.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.521 -0.737 . . . . 2.04 110.451 -168.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.09 -46.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.976 2.51 . . . . 1.18 113.732 171.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.0 p -39.95 -60.87 0.94 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.53 1.532 . . . . 0.95 113.712 170.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.8 m -59.61 -43.49 93.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.774 1.23 . . . . 1.24 108.06 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -52.92 -70.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.185 -0.916 . . . . 1.11 110.418 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -28.94 68.69 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.501 -0.75 . . . . 1.06 110.706 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -55.02 -54.77 38.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.388 -0.815 . . . . 4.38 109.926 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mt -56.06 -54.08 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 119.475 1.034 . . . . 0.6 110.625 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -54.86 -51.22 66.62 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.311 -0.556 . . . . 3.26 109.773 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 t -56.35 -44.62 80.27 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.481 0.712 . . . . 0.95 111.757 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.9 m -64.96 -39.91 94.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.561 1.144 . . . . 2.45 111.809 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.71 -45.67 50.78 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.969 -0.693 . . . . 2.28 111.45 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -68.25 72.47 0.2 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.303 1.041 . . . . 2.6 110.75 -174.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -34.96 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.74 2.416 . . . . 6.17 110.639 -169.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -53.72 -70.09 0.1 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 119.684 1.129 . . . . 2.95 112.536 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 131.97 -4.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.01 3.724 . . . . 5.57 113.611 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -108.34 18.39 33.11 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 119.643 1.11 . . . . 0.9 112.466 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.18 121.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.799 1.639 . . . . 4.04 107.932 -175.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.8 mt -95.09 -38.04 10.81 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.089 0.555 . . . . 1.4 110.113 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -156.07 157.51 36.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.397 -1.335 . . . . 2.11 107.397 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.23 58.93 0.65 Allowed 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 123.218 0.607 . . . . 2.78 110.24 -163.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -79.19 104.1 9.58 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.361 -0.607 . . . . 1.55 109.361 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' CE ' ' A' ' 13' ' ' MET . 0.9 OUTLIER -95.58 95.43 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.381 1.086 . . . . 1.51 110.165 -177.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.17 95.11 10.05 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 120.902 -1.124 . . . . 0.78 109.331 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 tt -42.79 -38.93 2.29 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.778 1.631 . . . . 1.63 112.36 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.34 -34.55 61.31 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 124.59 1.156 . . . . 1.07 111.529 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.8 t -116.48 14.74 15.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.227 1.411 . . . . 1.72 109.545 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.27 52.02 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.716 2.406 . . . . 2.88 111.41 -169.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.455 -0.778 . . . . 1.49 110.503 -171.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 109.79 22.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.53 1.532 . . . . 0.63 107.872 171.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -82.82 93.07 7.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.574 -1.639 . . . . 0.77 106.574 163.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.7 mt -103.97 110.42 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.344 1.068 . . . . 1.2 109.754 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -78.06 71.93 4.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.521 -1.659 . . . . 2.92 106.521 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.46 162.36 27.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.992 -0.549 . . . . 2.04 109.606 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -116.27 105.32 50.85 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.833 -0.803 . . . . 3.08 108.833 167.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.51 -32.73 83.74 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.67 2.247 . . . . 1.75 113.365 -168.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -55.18 -30.24 59.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.38 0.536 . . . . 3.86 112.26 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.9 pt -118.89 -3.0 9.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 113.503 0.927 . . . . 2.48 113.503 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 tt -157.57 131.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.246 -1.39 . . . . 2.3 107.246 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.44 155.0 46.57 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.347 -1.901 . . . . 0.88 108.347 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -59.29 -40.17 70.97 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.795 -1.271 . . . . 0.73 108.795 171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -44.92 26.79 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.507 1.123 . . . . 9.52 112.526 174.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -57.57 -54.89 41.77 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.275 0.943 . . . . 2.96 109.597 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.32 -47.65 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.357 -0.838 . . . . 0.71 110.006 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.77 -52.26 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.239 -0.652 . . . . 1.42 109.239 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -54.73 -47.38 73.86 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 119.374 -0.346 . . . . 2.73 110.517 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -51.21 -54.62 23.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.137 0.88 . . . . 1.31 110.401 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -57.69 -58.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 119.213 -0.422 . . . . 1.68 110.222 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -63.94 -44.39 93.0 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 119.158 -1.017 . . . . 4.2 111.18 -176.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.9 t -62.84 -20.29 64.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 117.768 -1.111 . . . . 0.71 112.609 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.86 -84.13 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.212 1.369 . . . . 1.98 109.89 165.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.36 25.05 0.32 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-O 118.606 -1.108 . . . . 1.1 114.126 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.23 172.56 7.5 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.85 1.325 . . . . 1.86 113.235 -165.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -95.55 161.4 14.07 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.33 -1.73 . . . . 4.95 106.33 156.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.26 94.9 2.38 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.861 0.864 . . . . 1.64 112.297 174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.5 m -87.69 119.67 28.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.602 0.761 . . . . 1.73 109.788 173.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -63.66 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.125 0.875 . . . . 3.04 110.702 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.83 -166.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.485 1.114 . . . . 3.06 109.515 173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.92 66.95 0.8 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.316 -1.49 . . . . 5.53 110.372 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 74' ' ' ILE 0.263 3.0 mp 71.7 59.11 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 126.012 1.725 . . . . 5.71 108.243 -175.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 . . . . . 0 C--O 1.253 1.281 0 N-CA-C 101.805 -3.406 . . . . 9.49 101.805 156.167 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.807 -1.183 . . . . 11.6 107.807 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.71 49.27 3.43 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 107.889 -2.084 . . . . 5.14 107.889 -170.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.35 173.63 7.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.914 1.685 . . . . 6.31 109.7 -156.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.63 144.76 33.49 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 122.361 0.978 . . . . 2.02 112.509 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.26 147.86 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 106.447 -1.686 . . . . 2.03 106.447 172.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.0 tp -142.36 136.4 29.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.516 -2.031 . . . . 2.06 105.516 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -115.07 145.32 42.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.407 -0.96 . . . . 2.34 108.407 156.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -133.15 146.03 51.2 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 124.668 1.23 . . . . 2.22 107.837 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.18 131.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.535 -1.654 . . . . 2.1 106.535 160.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.0 t -96.54 157.27 3.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 106.153 -1.795 . . . . 2.0 106.153 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -139.07 132.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.273 -1.01 . . . . 4.96 108.273 163.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.35 10.06 12.25 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.663 1.601 . . . . 1.92 112.761 -173.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.5 mtt -62.69 150.46 40.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.034 1.417 . . . . 2.08 109.48 167.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -154.41 86.92 1.16 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.469 0.652 . . . . 3.18 109.937 175.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.5 t 73.62 90.32 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 125.086 1.354 . . . . 2.85 112.916 165.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 47.11 -124.3 1.51 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 117.786 -1.102 . . . . 2.86 108.174 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.5 p 49.47 -81.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.779 2.032 . . . . 1.14 114.165 163.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -46.35 -43.75 16.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.608 0.763 . . . . 1.27 109.747 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.0 t -48.46 -74.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.52 1.128 . . . . 0.88 111.197 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.55 -30.13 69.7 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 122.069 -0.395 . . . . 1.35 111.475 -172.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -51.54 -56.04 15.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.248 -0.649 . . . . 4.24 109.248 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -58.09 -60.19 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.325 -0.62 . . . . 0.52 109.325 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -49.88 -55.73 13.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.236 0.614 . . . . 3.04 111.142 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.2 t -54.26 -59.77 4.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.456 1.102 . . . . 1.13 109.45 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -52.08 -49.97 62.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.687 0.279 . . . . 0.94 110.939 -174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.9 -49.7 69.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.111 0.411 . . . . 1.77 112.111 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.261 4.5 t -60.6 -25.09 65.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 118.549 -1.26 . . . . 2.97 111.541 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -55.35 -25.65 36.28 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.189 0.811 . . . . 4.19 113.189 173.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -54.92 -31.44 60.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.018 0.827 . . . . 2.33 111.286 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.8 -3.66 1.91 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.088 1.755 . . . . 8.45 111.811 -162.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.8 -35.81 15.2 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.553 -1.019 . . . . 1.14 110.553 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 46' ' ' ILE . 4.4 mp -92.36 97.89 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.694 -1.595 . . . . 2.9 106.694 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.11 -24.22 43.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.357 -0.838 . . . . 2.13 110.124 -172.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -155.78 153.74 30.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.971 -0.752 . . . . 2.64 108.971 169.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.7 113.49 5.4 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.783 2.033 . . . . 3.19 107.311 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -119.4 104.77 10.65 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.425 -1.324 . . . . 1.5 107.425 165.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.34 78.38 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.754 1.264 . . . . 2.04 107.657 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.93 88.84 5.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.954 -1.021 . . . . 0.88 108.502 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.7 tt -38.67 -39.66 0.52 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 126.06 1.744 . . . . 1.77 112.413 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -36.41 63.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.454 1.102 . . . . 0.95 112.084 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 t -111.72 11.61 21.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.642 1.577 . . . . 1.56 109.934 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 32.35 41.28 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.234 2.614 . . . . 2.43 113.399 -170.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.95 45.76 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.8 0.84 . . . . 1.15 109.422 -175.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.12 111.45 24.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.854 -1.906 . . . . 0.54 105.854 170.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -82.34 114.28 20.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.408 -2.071 . . . . 0.78 105.408 163.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 32' ' ' ILE . 9.8 mt -121.87 109.08 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 125.002 1.321 . . . . 0.93 107.483 -173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -79.45 72.38 6.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.856 -1.535 . . . . 2.86 106.856 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.89 176.36 9.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.298 1.039 . . . . 2.88 108.618 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -145.86 130.16 8.75 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 118.387 0.54 . . . . 3.66 110.196 160.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -51.88 -34.98 57.99 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.283 2.656 . . . . 1.72 113.589 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.95 -22.6 66.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.075 0.852 . . . . 4.69 112.999 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 pt -110.89 -22.52 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 119.122 0.873 . . . . 2.9 110.486 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -162.53 130.17 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.978 -1.119 . . . . 3.01 107.978 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.76 170.51 48.08 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.974 -0.851 . . . . 1.19 110.974 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.26 -57.06 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.104 1.869 . . . . 1.23 110.689 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.33 -26.79 68.63 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.847 -0.533 . . . . 8.73 111.743 -173.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -51.55 63.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.981 1.312 . . . . 4.56 110.159 173.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.9 -53.0 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 121.23 -0.919 . . . . 0.95 109.694 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -55.46 -50.73 63.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.405 -0.591 . . . . 1.76 109.405 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -49.47 -46.12 47.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.79 0.836 . . . . 3.79 110.396 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -58.23 -50.2 74.4 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.586 -0.524 . . . . 1.21 109.586 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.8 -54.82 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.971 0.509 . . . . 0.75 110.838 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -55.39 -53.42 56.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.243 -0.651 . . . . 4.57 109.243 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -48.4 -47.71 37.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.97 1.308 . . . . 0.89 111.676 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 mt -57.66 -48.57 79.12 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.372 0.987 . . . . 1.92 113.478 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 0.11 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 118.293 2.077 . . . . 1.19 118.293 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -138.97 177.47 7.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.814 1.807 . . . . 1.91 112.617 -144.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -104.0 158.68 16.25 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.093 -1.447 . . . . 2.94 107.093 145.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.88 154.13 37.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.559 0.695 . . . . 1.01 110.905 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.0 m -156.13 103.79 2.22 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.419 -0.8 . . . . 1.94 110.438 -164.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -48.94 134.41 16.92 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.474 1.109 . . . . 2.85 111.94 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m -130.47 144.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.976 1.311 . . . . 2.5 109.099 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 48.52 55.41 9.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.566 1.146 . . . . 8.34 111.32 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.8 tp -154.35 148.21 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.11 -1.811 . . . . 7.97 106.11 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.825 2.05 . . . . 11.65 113.634 -172.012 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 106.941 -1.503 . . . . 11.4 106.941 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.93 152.9 9.06 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.15 -1.18 . . . . 5.93 110.15 -172.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 57.99 -178.02 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.416 1.886 . . . . 5.44 112.028 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.14 132.32 11.06 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 105.564 -3.014 . . . . 1.67 105.564 158.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 m -136.51 146.32 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.211 1.006 . . . . 2.78 110.131 -170.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 tp -155.23 153.37 30.55 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.041 -1.466 . . . . 2.64 107.041 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -115.4 148.52 39.26 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.858 -0.793 . . . . 2.93 108.858 165.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.0 mt -121.85 128.82 52.06 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.063 -1.829 . . . . 2.78 106.063 165.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -75.6 142.1 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.465 -2.42 . . . . 1.75 104.465 161.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.38 120.0 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 124.616 1.166 . . . . 2.12 108.575 -171.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 131.53 53.88 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.085 0.954 . . . . 7.45 110.986 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.22 -19.28 5.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.965 1.745 . . . . 1.86 109.938 -170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.6 mtm -63.32 163.75 10.08 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.204 -0.586 . . . . 1.89 110.531 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -150.47 -44.1 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.618 0.367 . . . . 2.55 111.455 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.3 m -139.36 169.44 17.75 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.78 -0.575 . . . . 2.56 109.697 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.31 -36.86 1.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.938 2.095 . . . . 1.45 113.272 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -48.26 -44.09 33.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.268 1.827 . . . . 0.92 113.786 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.8 m -70.56 -46.92 62.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.166 -1.42 . . . . 1.22 107.166 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.07 -63.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.336 . . . . 1.61 111.001 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.68 -26.53 64.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.496 -0.752 . . . . 1.2 111.703 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -54.78 -54.68 39.0 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.727 -0.842 . . . . 4.43 108.727 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -53.88 -60.34 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.591 -0.522 . . . . 0.75 109.591 175.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -53.22 -52.94 57.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.529 0.331 . . . . 3.28 111.31 -171.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -58.76 -54.6 45.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.94 0.496 . . . . 1.44 110.217 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.4 t -55.31 -38.92 69.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.37 0.668 . . . . 1.11 111.864 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.1 mt -75.21 -54.65 6.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 113.595 0.961 . . . . 1.77 113.595 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 57.1 m -54.58 -35.96 63.87 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.349 -0.844 . . . . 2.03 110.931 -172.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -25.16 9.98 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.338 1.236 . . . . 3.84 114.338 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.752 ' HB3' HD11 ' A' ' 53' ' ' ILE . 12.1 m170 -62.34 -27.78 69.29 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.673 1.124 . . . . 2.22 111.095 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 77.85 -3.73 2.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.698 2.399 . . . . 6.38 113.898 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.582 ' HA3' HD12 ' A' ' 53' ' ' ILE . . . -96.12 -23.84 16.3 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.848 -0.901 . . . . 1.1 110.848 172.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.623 HD12 HD13 ' A' ' 53' ' ' ILE . 3.1 mp -78.41 105.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.728 -1.953 . . . . 2.9 105.728 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.66 -30.51 41.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.227 1.011 . . . . 1.38 109.434 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.08 139.99 18.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.473 -0.936 . . . . 2.26 108.473 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.2 t -133.06 119.19 19.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.579 -2.008 . . . . 2.22 105.579 172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -125.74 106.96 10.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.784 -1.561 . . . . 1.74 106.784 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.24 87.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 122.297 1.046 . . . . 2.02 108.878 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.2 86.23 5.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.017 -1.475 . . . . 0.89 107.017 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -40.91 -38.71 1.0 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.826 1.651 . . . . 2.42 111.201 171.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.53 -36.17 43.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.592 1.157 . . . . 0.83 112.726 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -113.95 13.22 18.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.353 1.461 . . . . 1.62 110.049 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 40.52 41.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.39 1.876 . . . . 1.94 112.057 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.66 143.45 50.83 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.143 0.577 . . . . 1.18 110.368 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.71 108.28 19.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.447 -2.057 . . . . 0.43 105.447 170.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -78.59 115.8 18.54 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.651 -1.981 . . . . 1.22 105.651 165.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.7 mt -120.07 114.7 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.083 -1.08 . . . . 1.06 108.083 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -100.07 115.4 29.69 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.633 -1.617 . . . . 3.28 106.633 169.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.13 145.98 22.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.797 1.239 . . . . 1.96 108.503 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -85.91 137.03 35.78 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 119.054 0.843 . . . . 4.4 109.577 171.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.34 -31.69 13.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.186 1.924 . . . . 2.55 111.765 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.52 46.86 0.99 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.774 1.23 . . . . 5.03 112.538 -169.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 -50.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 128.295 2.638 . . . . 4.46 106.028 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 29' ' ' HIS . 1.2 mt -104.4 -89.0 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 124.887 1.275 . . . . 2.81 107.61 -176.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' N ' HG22 ' A' ' 53' ' ' ILE . . . 95.5 139.01 9.97 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.492 -1.443 . . . . 0.91 109.492 -165.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.7 -37.27 94.99 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.421 2.747 . . . . 0.74 112.812 -164.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -35.98 -49.18 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.002 1.321 . . . . 9.6 112.825 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -68.22 -46.15 71.37 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.018 -0.734 . . . . 3.02 109.018 -171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 mt -60.47 -47.35 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.72 109.219 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.8 mt -54.38 -57.4 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.306 0.642 . . . . 1.79 109.494 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -52.81 -45.82 67.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.655 0.382 . . . . 2.76 110.09 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 79.8 m -59.48 -54.75 43.01 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.1 mt -51.76 -55.45 9.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.593 1.157 . . . . 0.8 110.754 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.35 -57.84 10.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.407 -0.59 . . . . 3.07 109.407 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.3 t -52.94 -37.48 61.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.1 1.36 . . . . 0.8 111.598 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.35 -54.71 28.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.51 0.724 . . . . 2.27 112.632 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.27 -8.36 0.04 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 117.539 1.776 . . . . 1.13 117.539 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.76 176.2 8.67 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.41 1.605 . . . . 1.85 112.475 -142.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -124.54 152.61 43.25 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.922 -2.251 . . . . 3.15 104.922 161.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.61 164.84 30.47 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.015 0.746 . . . . 1.29 113.015 -168.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -153.81 138.88 17.32 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 122.978 0.511 . . . . 2.07 111.379 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.58 66.74 1.45 Allowed 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.547 1.539 . . . . 2.88 110.71 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.2 147.73 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.392 -0.595 . . . . 2.48 109.392 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -128.33 89.22 2.87 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.078 -1.823 . . . . 6.82 106.078 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.77 -178.72 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 127.145 2.178 . . . . 6.53 105.892 -173.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 108.387 -0.968 . . . . 10.68 108.387 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 106.242 -1.762 . . . . 8.55 106.242 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.96 177.85 51.76 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.364 -1.494 . . . . 4.2 109.364 157.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.08 146.74 30.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.266 1.426 . . . . 5.02 109.154 169.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.24 89.73 0.7 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.378 -1.489 . . . . 1.89 109.378 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.08 142.28 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 117.608 0.704 . . . . 2.79 109.782 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -142.2 83.63 1.84 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.768 -1.567 . . . . 2.77 106.768 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.4 116.54 27.67 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.891 -1.504 . . . . 2.31 107.148 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 3.2 pp -128.34 142.22 51.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.746 0.248 . . . . 2.06 110.677 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.88 145.21 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.36 -1.348 . . . . 1.86 107.36 166.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.7 161.62 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.6 1.56 . . . . 1.87 107.441 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.09 140.1 30.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.874 -0.787 . . . . 7.99 108.874 160.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.67 -34.15 3.54 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.0 -1.24 . . . . 1.53 110.0 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.1 mtp -56.18 115.46 2.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.41 -0.464 . . . . 1.52 109.832 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -125.65 -20.49 4.68 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.946 0.899 . . . . 2.4 111.98 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.5 t -153.92 151.59 29.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.052 -1.03 . . . . 2.13 109.707 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -30.99 -45.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.562 2.345 . . . . 1.14 113.526 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 p -39.96 -58.62 1.37 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.508 1.523 . . . . 0.86 113.733 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -60.3 -46.99 87.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.241 -1.392 . . . . 1.24 107.241 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -51.16 -66.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.473 -1.24 . . . . 0.94 110.404 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -27.33 64.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 119.887 -0.725 . . . . 1.1 111.193 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.74 -53.49 57.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.624 0.647 . . . . 4.51 110.259 172.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.6 mt -54.14 -60.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.861 -0.792 . . . . 0.45 108.861 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -54.63 -51.02 66.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.543 -0.299 . . . . 3.25 110.939 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.5 t -60.23 -42.82 96.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.522 0.729 . . . . 0.95 111.237 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 t -65.88 -36.78 84.35 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.827 -0.546 . . . . 0.81 111.102 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.18 -52.64 13.39 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.266 -0.574 . . . . 2.01 111.85 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 m -67.09 76.46 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.228 1.011 . . . . 2.51 110.683 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.45 -34.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.458 2.703 . . . . 3.91 110.518 -171.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -56.33 -30.26 62.35 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.576 1.08 . . . . 2.77 113.296 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 37.97 2.63 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.245 1.018 . . . . 7.61 110.251 -175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.33 -2.01 0.73 Allowed Glycine 0 CA--C 1.531 1.052 0 O-C-N 121.573 -0.705 . . . . 0.99 112.897 165.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -99.05 127.4 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.776 -1.564 . . . . 2.66 106.776 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.78 -43.35 18.47 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.981 1.312 . . . . 1.85 109.417 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -152.11 155.25 37.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 110.203 -0.295 . . . . 2.1 110.203 -175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.47 136.85 35.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.731 1.612 . . . . 3.03 107.004 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 t -151.52 87.92 1.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.229 -1.397 . . . . 2.29 107.229 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 44' ' ' ALA 0.27 0.3 OUTLIER -92.52 92.08 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 122.714 1.245 . . . . 1.66 109.958 -176.894 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.64 92.98 9.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.177 -0.952 . . . . 0.69 108.986 -170.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.05 -42.37 2.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.302 1.441 . . . . 1.87 111.701 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.25 -33.54 42.02 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.435 1.094 . . . . 0.83 112.46 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -117.78 14.43 14.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.887 1.275 . . . . 1.5 110.364 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 30.26 53.97 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.686 2.394 . . . . 3.0 112.363 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.93 150.22 46.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.733 0.813 . . . . 1.11 109.175 -174.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -101.84 113.67 27.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.572 1.149 . . . . 0.63 107.965 168.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -81.22 99.18 8.45 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 104.337 -2.468 . . . . 0.76 104.337 154.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.54 147.01 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.49 -1.67 . . . . 0.95 106.49 169.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -124.58 130.93 53.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.352 -2.092 . . . . 3.11 105.352 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -146.41 173.13 12.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 119.095 0.861 . . . . 2.17 111.365 -171.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -107.77 94.12 11.73 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.112 0.965 . . . . 4.33 109.587 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 63.25 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.659 3.573 . . . . 2.58 111.851 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -155.09 -54.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 128.702 2.801 . . . . 3.74 106.692 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.4 pt -99.82 -13.41 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 124.843 1.257 . . . . 2.45 111.849 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -151.55 142.34 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.638 -1.616 . . . . 2.25 106.638 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.39 168.48 40.36 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.977 -0.849 . . . . 0.91 110.977 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.83 -47.49 1.88 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.563 2.176 . . . . 0.7 110.779 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -24.73 66.81 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.992 -0.442 . . . . 8.24 110.534 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -56.15 25.28 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.893 -1.754 . . . . 3.34 109.27 172.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.49 -55.12 21.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 108.869 -0.789 . . . . 1.22 108.869 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mt -58.05 -44.7 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.43 -0.35 . . . . 1.33 110.105 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.5 -37.26 83.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.906 1.282 . . . . 4.73 109.999 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -58.53 -51.83 68.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.751 -0.833 . . . . 0.77 108.751 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 72.0 mt -54.98 -52.61 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 119.206 -0.426 . . . . 0.78 111.006 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -47.07 -52.2 15.73 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.156 0.983 . . . . 3.12 109.911 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.4 t -70.43 -9.71 57.17 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.754 1.622 . . . . 1.3 113.683 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.48 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.197 -1.409 . . . . 2.65 107.197 159.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.59 37.43 0.51 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.909 -0.94 . . . . 1.24 112.343 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -136.29 124.69 23.39 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 118.222 1.011 . . . . 1.92 110.266 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.75 -1.204 . . . . 4.63 107.75 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.31 163.1 40.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.918 -0.488 . . . . 1.05 111.462 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -145.62 126.69 14.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.607 1.163 . . . . 2.06 108.983 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.85 119.78 11.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.649 1.179 . . . . 3.55 108.314 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.44 13.41 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.83 0.741 . . . . 2.03 111.782 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 67.89 -71.84 0.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.82 1.648 . . . . 5.57 110.564 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 74' ' ' ILE . 4.4 tp -164.94 173.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.723 -1.214 . . . . 4.93 107.723 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.253 1.252 0 N-CA-C 104.843 -2.28 . . . . 11.23 104.843 172.57 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 107.031 -1.47 . . . . 9.05 107.031 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.74 169.81 45.63 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.669 0.668 . . . . 5.23 111.869 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.67 64.12 2.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.408 1.083 . . . . 4.93 109.807 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.92 130.73 12.67 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.187 0.898 . . . . 1.57 111.04 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 m -103.97 126.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-N 117.634 0.717 . . . . 2.73 109.573 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 95.51 3.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.476 1.132 . . . . 4.02 108.873 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 43' ' ' LYS . 5.0 tp10 -78.51 122.64 26.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.612 -1.255 . . . . 2.44 107.612 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 pp -122.43 145.54 48.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.994 -0.373 . . . . 1.77 109.994 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.98 142.48 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.069 -1.826 . . . . 1.93 106.069 164.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.06 95.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 125.246 1.418 . . . . 2.22 108.618 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -97.47 143.5 28.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.523 0.729 . . . . 5.92 111.149 -173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.81 -36.38 3.0 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.627 1.108 . . . . 1.64 110.806 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -64.51 153.43 39.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.133 0.492 . . . . 1.61 112.171 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -153.58 149.5 27.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 170.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m 70.43 151.39 0.1 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.468 1.507 . . . . 2.34 112.486 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.5 -35.37 1.63 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 126.515 1.926 . . . . 1.49 112.559 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 -65.48 0.57 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.251 1.42 . . . . 1.36 112.649 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -68.91 -40.42 79.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.462 -1.31 . . . . 1.26 107.462 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.7 t -42.92 -68.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 113.98 -1.464 . . . . 1.08 110.238 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.304 0.4 OUTLIER -69.62 -20.06 63.62 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.704 -0.798 . . . . 1.86 110.995 -175.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -66.53 -42.21 87.58 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.113 -0.992 . . . . 3.08 108.992 -174.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -53.54 -66.53 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.816 -0.809 . . . . 0.77 108.816 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -54.24 -56.17 20.98 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.035 0.534 . . . . 3.14 111.962 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.0 t -53.43 -36.49 61.6 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.512 1.125 . . . . 1.34 111.174 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -70.22 -62.08 1.53 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.502 -0.749 . . . . 0.83 110.357 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -46.29 66.5 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.699 0.8 . . . . 2.26 111.961 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.7 p -50.85 -33.43 23.78 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.779 0.432 . . . . 2.47 111.129 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -64.26 -18.5 64.62 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.847 0.684 . . . . 4.45 112.847 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -60.48 -28.63 68.5 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 2.46 110.456 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 74.83 -1.85 2.98 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 126.311 1.844 . . . . 6.74 112.285 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.95 24.96 25.35 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.377 -0.689 . . . . 1.2 111.377 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.8 mm -121.04 144.92 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.171 -1.789 . . . . 2.57 106.171 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.13 -45.86 7.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.832 -0.803 . . . . 2.83 108.832 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -155.55 153.4 30.13 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 118.375 0.534 . . . . 2.25 109.939 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.0 m -135.02 113.1 11.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 104.986 -2.227 . . . . 2.57 104.986 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.41 96.09 5.81 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.162 -1.051 . . . . 1.56 108.162 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.03 95.12 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.445 0.64 . . . . 1.88 109.667 -174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.71 91.72 6.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.372 -0.83 . . . . 0.73 110.185 -168.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -37.3 -50.87 1.04 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 1.97 112.819 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.52 31.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 1.27 112.528 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.7 t -105.93 -15.54 14.89 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.829 1.252 . . . . 1.6 110.729 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.72 41.52 14.86 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.837 0.855 . . . . 2.46 109.425 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -120.53 147.57 44.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.66 1.184 . . . . 1.13 108.794 176.007 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.1 114.18 27.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.859 -1.534 . . . . 0.41 106.859 162.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -78.2 94.37 4.75 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.144 -2.169 . . . . 0.74 105.144 167.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 mt -98.74 111.92 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.708 -0.849 . . . . 1.21 108.708 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.15 115.59 26.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.323 -1.732 . . . . 2.87 106.323 159.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -144.62 140.19 28.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.979 1.312 . . . . 2.62 107.792 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -87.37 114.16 57.41 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.381 -0.97 . . . . 3.72 108.381 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.12 -48.78 15.61 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.17 1.913 . . . . 2.16 113.194 -172.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.59 -21.42 60.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.804 1.039 . . . . 3.31 113.804 -173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -97.18 -4.54 9.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 119.728 1.149 . . . . 2.53 112.7 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.1 tt -152.05 -46.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 114.454 1.279 . . . . 2.69 114.454 -175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.84 155.65 2.36 Favored Glycine 0 CA--C 1.541 1.674 0 O-C-N 121.609 -0.682 . . . . 0.83 112.889 -171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.56 -51.58 1.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.25 2.634 . . . . 1.27 112.252 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -47.9 -44.6 29.77 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.679 0.791 . . . . 7.08 112.187 -170.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -52.35 -56.13 16.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.023 0.929 . . . . 3.96 110.859 178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.17 -48.87 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 O-C-N 121.814 -0.554 . . . . 0.76 110.547 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.4 mm -51.81 -51.34 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 119.014 -0.517 . . . . 1.84 110.27 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -50.51 -54.45 22.28 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 122.968 0.507 . . . . 2.74 109.896 176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.0 m -56.41 -47.29 79.32 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.255 -0.978 . . . . 1.1 110.733 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 -54.8 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 118.534 0.606 . . . . 1.06 111.949 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -67.01 -43.63 82.4 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 120.582 -0.447 . . . . 4.99 110.678 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 t -57.9 -40.7 80.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.51 0.724 . . . . 1.0 110.978 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.13 -59.97 4.5 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.389 0.995 . . . . 1.66 110.736 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.57 -40.45 0.02 OUTLIER Glycine 0 CA--C 1.527 0.806 0 N-CA-C 115.762 1.065 . . . . 1.46 115.762 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -112.33 139.72 47.65 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.948 -0.737 . . . . 1.86 111.549 -135.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.02 133.0 36.11 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 106.48 -1.674 . . . . 3.18 106.48 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -121.92 157.18 31.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.044 0.384 . . . . 1.07 111.477 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.48 145.55 25.28 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 109.447 -0.575 . . . . 1.89 109.447 172.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -80.15 130.3 35.13 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.927 -0.768 . . . . 2.32 108.927 -174.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.94 -37.34 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.257 0.623 . . . . 2.06 112.19 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? 54.82 79.71 0.14 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.8 1.24 . . . . 4.82 112.02 175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.3 155.14 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.151 -2.166 . . . . 6.17 105.151 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.552 -1.213 . . . . 12.47 109.428 -159.242 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 106.399 -1.704 . . . . 8.65 106.399 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.64 158.27 26.33 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 109.601 -1.4 . . . . 4.91 109.601 -167.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -83.78 159.28 21.46 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.392 1.877 . . . . 5.46 109.072 174.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.87 100.62 0.34 Allowed Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.679 -0.568 . . . . 1.62 111.679 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.21 138.31 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.208 -1.172 . . . . 1.97 109.302 172.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.23 88.1 2.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.601 -1.629 . . . . 2.23 106.601 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -79.65 123.3 27.52 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.372 -1.714 . . . . 2.25 106.372 171.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.12 133.41 46.63 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.84 0.291 . . . . 2.15 110.336 177.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.3 145.71 9.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 172.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 t -142.4 122.0 9.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.211 1.004 . . . . 1.63 110.117 -169.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.48 132.96 51.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.139 -0.689 . . . . 4.95 109.139 170.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.61 -25.67 5.87 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.995 2.236 . . . . 1.86 109.149 178.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 mtp -57.2 107.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.53 0.732 . . . . 1.75 109.889 164.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -139.99 9.36 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.913 1.285 . . . . 2.34 112.588 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -172.53 147.58 1.88 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.521 1.055 . . . . 2.23 109.92 -173.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.73 -38.02 1.94 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.339 1.856 . . . . 1.23 113.176 178.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.3 p -60.58 -77.75 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.863 0.865 . . . . 0.82 112.04 177.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.2 p -48.59 -29.88 4.75 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.071 1.348 . . . . 2.09 112.122 174.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.98 -72.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 0.92 109.867 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 0.3 OUTLIER -68.62 -12.74 61.73 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.015 -1.053 . . . . 1.17 112.942 -171.367 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -52.7 -42.86 65.2 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.237 -1.023 . . . . 4.3 108.237 172.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.92 -60.83 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 125.478 1.511 . . . . 0.55 109.666 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.23 -48.32 82.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.944 -0.391 . . . . 4.78 109.944 -176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -59.31 -48.69 80.68 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.458 -0.942 . . . . 1.18 108.458 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -51.01 -57.29 9.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 119.667 1.122 . . . . 1.34 111.01 176.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.25 -38.83 75.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 119.006 -1.078 . . . . 1.8 111.451 -169.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -55.07 -15.65 2.29 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.985 -1.072 . . . . 2.33 113.078 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -66.42 -37.24 84.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.369 -0.832 . . . . 5.38 110.766 173.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -69.56 124.94 25.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.716 -1.216 . . . . 2.15 107.716 174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.61 47.32 0.83 Allowed 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.161 -0.962 . . . . 7.56 109.943 172.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.88 -17.21 0.83 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.305 1.907 . . . . 0.89 111.998 -175.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.1 tt -105.54 138.19 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.114 -1.069 . . . . 2.56 108.114 176.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -86.06 -49.38 7.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.531 1.133 . . . . 1.62 109.803 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -152.79 162.54 41.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.717 0.407 . . . . 3.01 110.304 -176.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.58 89.5 1.56 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.219 1.008 . . . . 2.07 109.973 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.94 90.05 8.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.071 -0.714 . . . . 1.39 109.071 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.4 t -85.94 98.42 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.559 1.144 . . . . 2.43 109.304 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.73 92.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.377 0.671 . . . . 0.82 109.849 -174.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -36.89 -44.19 0.49 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.707 2.003 . . . . 1.76 110.869 165.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.94 -29.17 41.28 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.008 0.923 . . . . 0.94 112.461 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.46 14.97 10.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.077 1.351 . . . . 1.53 109.983 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 34.92 55.39 0.74 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.763 2.025 . . . . 2.17 111.876 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.01 153.54 36.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.63 -0.878 . . . . 1.07 108.63 -173.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.01 127.49 54.96 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.637 0.586 . . . . 1.1 109.977 163.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -86.01 91.4 8.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.706 -1.961 . . . . 0.86 105.706 170.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.23 137.84 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.124 -1.436 . . . . 1.55 107.124 172.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -115.31 119.05 34.99 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.365 -2.087 . . . . 2.18 105.365 163.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 178.85 7.39 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 127.213 2.205 . . . . 1.87 106.096 -176.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -132.23 132.63 23.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.95 . . . . 3.67 110.386 168.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.71 64.09 7.46 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.918 3.745 . . . . 2.35 112.161 -167.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -166.74 -45.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.738 1.215 . . . . 3.75 110.239 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.77 -27.11 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.184 -0.673 . . . . 2.72 109.184 174.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -154.89 150.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.771 -1.196 . . . . 2.62 107.771 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.86 166.06 33.73 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.338 -1.105 . . . . 0.75 110.338 173.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.47 -48.57 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.373 2.049 . . . . 0.93 110.479 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.404 HH21 ' CD2' ' A' ' 60' ' ' HIS . 25.4 tpt180 -56.96 -27.42 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.924 0.489 . . . . 7.87 111.274 -177.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -55.59 31.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.299 1.839 . . . . 3.7 109.078 175.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.6 mt -56.23 -47.21 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.62 -0.882 . . . . 0.69 108.62 174.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mm -55.84 -50.97 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 119.28 -0.391 . . . . 1.99 111.0 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CD2' HH21 ' A' ' 56' ' ' ARG . 17.2 m170 -54.36 -46.51 73.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.162 0.985 . . . . 3.06 109.302 178.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.7 m -58.05 -50.08 74.68 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.609 -0.515 . . . . 0.8 109.609 178.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.3 mt -57.93 -51.9 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.15 -0.969 . . . . 0.79 111.782 178.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -50.86 -56.68 11.08 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.438 1.095 . . . . 3.13 109.241 175.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.3 t -52.34 -51.46 58.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.741 1.616 . . . . 0.8 111.365 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.49 -41.21 89.25 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.45 -0.781 . . . . 2.96 111.85 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.27 -50.52 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.328 -0.939 . . . . 1.5 114.624 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.58 144.99 38.61 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 118.973 -1.091 . . . . 1.92 113.806 -128.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.1 59.4 3.85 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.345 -0.613 . . . . 4.28 109.345 -176.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.82 168.47 19.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.689 0.626 . . . . 1.25 112.689 -166.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.06 132.01 10.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.819 -0.808 . . . . 1.88 108.819 173.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.97 130.73 47.88 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.864 -0.791 . . . . 2.31 108.864 167.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.67 173.67 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.322 -0.992 . . . . 2.82 108.322 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 75' ' ' GLU . 3.8 mmmp? -134.71 77.7 1.7 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.895 -0.78 . . . . 6.36 108.895 172.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mt -63.62 -47.85 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.485 -0.932 . . . . 5.84 108.485 171.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 7.8 pt-20 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 103.875 -2.639 . . . . 9.38 103.875 158.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttm . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 105.515 -2.032 . . . . 8.41 105.515 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.76 157.04 2.13 Favored Glycine 0 CA--C 1.536 1.372 0 N-CA-C 108.06 -2.016 . . . . 5.16 108.06 -132.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -96.7 159.89 14.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.151 1.781 . . . . 5.53 108.932 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.71 162.69 50.74 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 121.803 0.669 . . . . 1.82 111.794 -171.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.24 149.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 O-C-N 121.987 -0.713 . . . . 2.02 110.071 -179.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 tp -149.88 158.39 44.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.433 1.893 . . . . 2.76 106.346 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -128.81 157.37 41.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.05 -1.092 . . . . 2.62 108.05 163.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.69 142.92 49.94 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.358 1.036 . . . . 2.98 108.997 162.407 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.8 t -76.84 128.92 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.797 -1.927 . . . . 1.86 105.797 165.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.93 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.375 -1.343 . . . . 1.99 107.375 177.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.97 142.72 45.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.09 -1.448 . . . . 5.01 107.09 166.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.2 -47.63 1.34 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.726 -0.95 . . . . 1.49 110.726 167.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.82 143.57 54.42 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.229 -0.656 . . . . 2.05 109.229 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.62 -66.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.289 -0.257 . . . . 3.33 110.969 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -64.14 148.06 50.83 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.642 -0.661 . . . . 2.29 110.983 -171.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.35 -47.11 0.29 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.278 1.831 . . . . 1.17 112.507 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.2 p -60.08 -37.59 80.38 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.556 1.543 . . . . 1.29 113.64 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -75.65 -46.98 28.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.612 -1.305 . . . . 1.49 109.756 172.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -44.87 -67.66 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.292 1.037 . . . . 0.88 111.157 177.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.09 -27.1 64.33 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.792 -0.568 . . . . 1.01 111.161 -173.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.06 -53.2 60.04 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.18 -0.914 . . . . 4.56 108.994 175.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.0 mt -50.82 -55.68 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 119.423 1.01 . . . . 0.71 109.862 174.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -51.67 -59.26 4.49 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.275 -0.269 . . . . 3.16 110.275 -177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -53.82 -43.37 69.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 1.07 111.812 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -60.07 -50.42 73.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.28 1.032 . . . . 2.24 109.181 -176.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.42 -37.27 71.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.078 -0.649 . . . . 2.24 112.097 179.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -53.57 -23.99 12.4 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.029 -1.044 . . . . 1.49 113.458 177.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -60.21 -31.35 70.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.759 1.163 . . . . 6.52 112.18 174.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -70.52 148.52 48.14 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.867 0.758 . . . . 2.25 109.05 -175.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -105.25 37.77 2.11 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.788 -0.57 . . . . 6.73 111.905 -171.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.03 24.56 0.61 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.12 -0.392 . . . . 1.04 112.12 170.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -114.01 134.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.107 -1.812 . . . . 2.63 106.107 168.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.25 -40.11 10.62 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 1.62 109.069 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -155.53 136.89 14.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 110.201 -0.296 . . . . 2.19 110.201 178.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.1 t -114.91 132.61 56.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.962 -2.607 . . . . 2.21 103.962 164.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.6 t -138.22 138.17 38.26 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 117.977 -1.489 . . . . 2.84 109.096 146.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.286 6.7 p -106.03 94.32 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 122.638 1.209 . . . . 2.08 110.512 -174.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.23 88.62 6.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.495 -0.928 . . . . 0.68 108.495 -168.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tt -30.67 -50.02 0.13 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.048 2.139 . . . . 1.95 111.996 172.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.74 -32.56 52.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.19 0.996 . . . . 0.84 112.754 -175.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -118.93 15.24 13.37 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.7 1.6 . . . . 1.4 110.212 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 16.89 58.95 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.968 2.907 . . . . 3.31 114.597 -167.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 148.65 52.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.523 -0.917 . . . . 0.99 108.523 178.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.88 111.59 23.94 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.167 -2.16 . . . . 0.43 105.167 169.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -79.6 120.58 24.14 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.577 -1.638 . . . . 0.78 106.577 167.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mt -125.6 97.28 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 O-C-N 124.592 1.183 . . . . 1.05 107.882 -171.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -80.53 120.89 25.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.779 -1.563 . . . . 2.54 106.779 166.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.18 164.29 15.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.819 -1.549 . . . . 2.59 106.819 -165.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.06 132.54 24.4 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 108.245 -1.02 . . . . 4.03 108.245 172.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.65 -52.74 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.992 2.462 . . . . 2.42 112.466 -160.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.83 -32.84 46.56 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.252 0.834 . . . . 3.13 113.252 -172.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 pt -88.49 5.51 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 113.322 0.86 . . . . 2.89 113.322 -177.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.39 -52.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.531 1.06 . . . . 3.04 111.584 -172.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.48 114.0 0.37 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 108.97 -1.652 . . . . 0.99 108.97 -171.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -56.9 -31.77 90.27 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 CA-C-N 119.991 1.896 . . . . 0.89 111.204 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -54.16 -36.79 63.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.956 -0.545 . . . . 6.61 112.034 175.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -67.16 -47.0 72.33 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.396 0.998 . . . . 4.2 110.352 -179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.5 mt -54.92 -51.83 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.653 -0.654 . . . . 0.83 110.601 170.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.35 -52.87 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 119.007 -0.52 . . . . 1.42 110.125 -178.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -46.32 -47.95 18.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.305 1.042 . . . . 2.74 109.25 174.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.0 m -62.86 -49.53 74.49 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.107 -0.637 . . . . 0.86 110.663 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.58 -51.12 69.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.414 0.686 . . . . 0.69 111.162 -178.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -69.65 -40.18 76.63 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.867 0.303 . . . . 2.82 111.634 179.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -65.35 -23.17 66.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 117.507 -1.235 . . . . 0.85 112.524 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -66.84 -86.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.52 1.509 . . . . 1.66 109.407 165.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.99 19.04 0.28 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.319 -1.267 . . . . 1.07 114.943 174.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -136.1 116.35 13.52 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.367 1.584 . . . . 2.06 110.251 -163.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 154.46 37.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 117.109 -1.836 . . . . 4.26 107.568 177.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.11 164.43 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.797 0.839 . . . . 1.17 110.53 -173.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.9 m -148.63 92.91 2.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.472 -0.936 . . . . 1.89 108.472 171.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -55.11 126.47 24.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.855 0.862 . . . . 2.83 110.963 174.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.46 146.32 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.393 1.077 . . . . 2.55 109.088 -172.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -66.19 -52.94 43.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.44 -0.578 . . . . 5.32 109.44 175.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 75' ' ' GLU 0.313 12.6 tt 43.66 -135.67 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.535 1.134 . . . . 5.11 110.443 -169.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' H ' HG12 ' A' ' 74' ' ' ILE . 43.2 mt-10 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 104.589 -2.375 . . . . 10.34 104.589 177.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtm . . . . . 0 N--CA 1.475 0.818 0 CA-C-O 121.161 0.505 . . . . 8.02 110.424 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.49 52.9 0.12 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 104.591 -3.404 . . . . 6.06 104.591 176.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 169.45 143.83 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.6 2.36 . . . . 4.93 106.619 -156.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.6 139.48 9.14 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 107.165 -2.374 . . . . 1.74 107.165 169.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.4 139.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.708 -0.849 . . . . 3.07 108.708 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 tp -132.32 87.67 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.333 -1.728 . . . . 2.18 106.333 167.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.1 134.06 36.74 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 118.156 -1.417 . . . . 2.57 108.27 167.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -121.65 146.88 46.56 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 124.23 0.956 . . . . 2.87 108.716 164.159 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.14 135.51 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.662 -1.977 . . . . 1.7 105.662 169.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.8 135.38 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.541 1.536 . . . . 2.78 108.258 -177.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -145.64 136.03 24.05 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.861 -2.274 . . . . 5.18 104.861 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.75 -53.82 0.65 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 108.74 -1.744 . . . . 1.64 108.74 -171.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 ptm -65.5 149.71 49.58 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.395 -0.474 . . . . 1.53 110.623 173.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -156.13 -1.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.633 0.975 . . . . 2.52 113.633 -168.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -169.21 157.53 7.71 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.021 1.282 . . . . 3.18 109.848 -166.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.55 -50.46 1.13 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.183 2.193 . . . . 1.21 113.267 -174.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -65.69 -33.45 75.91 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.063 1.345 . . . . 1.59 113.056 -176.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.9 m -72.56 -53.92 10.61 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.377 -1.342 . . . . 1.14 107.377 168.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -43.99 -64.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.637 1.575 . . . . 0.84 111.689 -173.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.31 -16.21 64.14 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.038 -0.414 . . . . 1.48 111.749 -173.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.5 98.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.668 -0.864 . . . . 4.8 108.668 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -60.49 -58.63 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.169 -1.049 . . . . 0.62 108.169 -178.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -53.73 -56.28 18.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.092 0.557 . . . . 3.15 110.803 178.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -49.52 -45.03 46.79 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.569 0.748 . . . . 1.16 111.235 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.7 t -63.14 -61.04 2.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.445 0.698 . . . . 1.22 110.774 175.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.96 -39.49 94.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.009 -1.076 . . . . 1.9 111.405 -168.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 m -53.4 -16.92 1.57 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.202 0.815 . . . . 1.68 113.202 176.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -61.72 -42.82 99.46 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.036 -1.04 . . . . 4.83 111.212 171.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -76.46 135.63 39.39 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.285 -0.635 . . . . 2.45 109.285 -176.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -78.97 -1.53 35.81 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.718 -0.613 . . . . 6.41 112.639 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.94 -19.21 56.55 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.381 0.537 . . . . 0.84 112.664 -178.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 12.1 tt -93.81 137.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.913 -0.773 . . . . 2.63 108.913 175.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -107.27 -38.36 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.428 1.491 . . . . 1.36 110.087 -174.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -140.16 149.78 43.4 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.919 -0.771 . . . . 2.74 108.919 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 t -153.99 119.12 5.06 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 106.593 -1.632 . . . . 1.72 106.593 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -145.85 111.21 5.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.062 -0.718 . . . . 1.89 109.062 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 44' ' ' ALA . 3.5 p -105.88 108.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.586 0.708 . . . . 1.92 111.321 -175.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.33 101.7 10.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.004 0.922 . . . . 0.74 109.472 -170.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -43.08 -38.92 2.53 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.706 1.202 . . . . 2.31 111.222 168.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.53 -29.18 23.92 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.914 0.886 . . . . 1.53 112.065 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 t -128.06 16.03 6.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.49 1.116 . . . . 1.59 109.9 -179.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m120 35.06 47.23 0.26 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.309 1.843 . . . . 2.57 112.569 -174.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.27 145.71 41.63 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.75 -0.594 . . . . 1.14 110.457 -171.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -108.96 106.88 17.03 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.711 -1.589 . . . . 0.47 106.711 172.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -79.44 98.63 6.86 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.43 -1.693 . . . . 0.89 106.43 168.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.45 140.74 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 105.897 -1.89 . . . . 1.44 105.897 164.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.13 132.21 55.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.452 -1.314 . . . . 2.61 107.452 156.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -148.92 169.12 21.27 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.943 0.897 . . . . 2.17 109.5 -172.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.68 111.33 55.34 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.666 -0.683 . . . . 3.7 109.34 174.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.12 52.05 3.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.048 3.165 . . . . 2.3 112.362 -176.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -139.78 -64.57 0.48 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.467 1.507 . . . . 4.13 107.294 178.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.28 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.118 0.967 . . . . 4.01 111.364 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 142.84 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.851 -1.537 . . . . 2.33 106.851 176.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.05 159.29 35.66 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.045 -1.222 . . . . 0.94 110.045 171.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.69 -47.31 11.49 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.825 1.683 . . . . 0.85 110.054 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -48.43 -42.33 31.93 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 122.999 0.52 . . . . 6.54 111.952 178.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -51.71 54.56 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.414 1.486 . . . . 3.47 109.723 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mt -60.88 -52.23 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.76 109.364 175.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.77 -54.13 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 118.602 0.637 . . . . 1.91 110.411 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -47.67 -53.2 15.64 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.581 1.553 . . . . 3.06 109.789 175.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.1 m -56.35 -51.33 68.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.56 -0.456 . . . . 0.73 109.855 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.5 -53.72 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 O-C-N 121.993 -0.442 . . . . 0.9 110.742 -178.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.9 -47.63 84.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.963 0.802 . . . . 3.89 110.195 -178.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.5 t -68.94 -9.86 54.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.928 -1.035 . . . . 1.01 113.023 -175.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.01 -78.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 120.253 1.388 . . . . 2.52 108.396 158.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.19 26.89 0.32 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.61 -1.106 . . . . 1.05 114.55 171.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -125.36 172.76 9.35 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.061 1.43 . . . . 1.82 113.36 -160.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 70.38 0.82 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.342 1.068 . . . . 3.81 108.666 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.41 144.51 35.8 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.329 -0.857 . . . . 1.22 111.274 -165.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -151.29 110.09 3.85 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.166 -0.959 . . . . 1.92 113.089 -172.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.14 76.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.475 2.31 . . . . 2.45 115.189 -175.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.8 m -60.25 -45.94 95.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 124.241 1.016 . . . . 1.86 112.331 168.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm 59.34 47.45 11.33 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.548 -1.345 . . . . 5.95 111.042 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 mp 57.47 67.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 109.049 -0.723 . . . . 5.15 109.049 -167.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 N-CA-C 103.861 -2.644 . . . . 9.33 103.861 162.189 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 107.329 -1.36 . . . . 9.29 107.329 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.89 178.46 6.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 108.232 -1.947 . . . . 4.35 108.232 -142.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.91 114.98 1.94 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.748 1.219 . . . . 5.51 110.657 -179.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.59 111.07 3.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.148 -2.781 . . . . 1.74 106.148 159.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.43 137.34 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.655 1.228 . . . . 2.31 109.598 177.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.6 tp -144.36 79.47 1.61 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.88 1.324 . . . . 2.07 107.935 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.37 102.06 8.46 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.012 -1.477 . . . . 2.79 107.012 168.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.31 141.28 47.21 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.698 0.399 . . . . 1.94 109.951 176.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.4 t -76.38 140.86 16.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.986 -1.486 . . . . 1.76 106.986 172.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -117.46 107.46 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.433 -1.321 . . . . 1.73 107.433 174.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -78.19 137.91 38.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.114 -1.439 . . . . 5.32 107.114 170.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.08 -41.44 2.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 123.965 0.793 . . . . 1.57 111.415 161.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -58.61 143.05 47.57 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.574 -0.368 . . . . 1.57 111.632 -178.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -145.85 142.0 28.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.44 1.096 . . . . 2.97 110.543 177.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 71.9 m 69.68 164.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.096 1.758 . . . . 3.04 114.186 167.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.61 -35.51 2.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.67 1.988 . . . . 1.34 112.194 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -55.63 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.169 0.988 . . . . 0.97 112.268 173.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -54.37 -37.62 65.19 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 120.831 -1.168 . . . . 1.09 109.623 -177.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 t -49.21 -65.63 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.893 0.477 . . . . 1.02 111.157 172.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.274 0.2 OUTLIER -68.12 -22.42 64.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.759 -0.588 . . . . 1.28 111.486 -175.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -60.28 -56.24 23.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.095 -1.076 . . . . 3.49 108.095 174.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.8 mt -57.62 -58.61 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.693 -0.854 . . . . 0.56 108.693 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.86 -56.47 21.25 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.369 0.531 . . . . 3.12 111.643 -175.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -59.28 -38.86 81.18 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.742 -0.598 . . . . 1.16 111.243 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -65.28 -61.39 2.15 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.829 -0.545 . . . . 0.86 110.543 175.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.27 -31.61 72.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.429 -0.794 . . . . 2.64 111.963 -169.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.4 -10.49 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.666 1.121 . . . . 2.25 113.514 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -69.13 -21.2 64.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.435 1.016 . . . . 5.64 112.212 170.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -69.53 115.59 8.96 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.613 0.765 . . . . 2.34 109.362 -177.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -78.57 46.26 0.64 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.41 -0.806 . . . . 6.86 112.659 -174.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.05 24.6 0.1 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.271 1.415 . . . . 0.93 110.785 170.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -107.14 122.11 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.416 -1.698 . . . . 2.44 106.416 170.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.9 mt -85.18 -38.54 18.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.735 0.814 . . . . 1.89 109.204 -175.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -155.17 156.33 35.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.377 -1.342 . . . . 2.68 107.377 -176.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.2 t -146.67 59.75 1.2 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.03 -1.1 . . . . 2.51 108.03 178.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.38 94.28 3.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.356 -0.979 . . . . 2.28 108.356 -163.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . 0.346 2.6 p -90.06 83.95 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 123.579 1.657 . . . . 1.62 111.242 -169.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.94 87.06 4.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.68 -1.145 . . . . 0.69 108.772 -178.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -40.34 -44.02 1.87 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.297 1.439 . . . . 2.29 110.632 162.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.03 -37.03 0.23 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.815 1.646 . . . . 1.04 113.556 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 p -132.43 26.0 4.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.114 1.366 . . . . 2.62 109.688 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 29.92 52.8 0.11 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.36 2.664 . . . . 1.99 112.571 -175.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 154.53 42.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.602 0.593 . . . . 2.93 112.602 -178.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.1 106.72 17.37 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.232 1.813 . . . . 0.38 109.508 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -78.78 83.09 4.95 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.517 -1.661 . . . . 1.42 106.517 167.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.452 HD13 HG21 ' A' ' 58' ' ' ILE . 11.6 mt -79.06 145.48 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.522 -1.288 . . . . 1.37 107.522 173.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -126.4 134.85 50.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.299 -2.482 . . . . 2.73 104.299 161.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.88 172.28 17.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.773 0.715 . . . . 1.85 109.803 -168.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -107.74 81.78 1.23 Allowed Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.24 1.416 . . . . 4.48 107.952 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.72 -35.48 47.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.302 2.668 . . . . 1.67 112.733 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.95 -20.47 6.19 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.125 1.157 . . . . 4.35 114.125 176.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.9 pt -120.43 -57.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 119.621 1.101 . . . . 2.45 111.702 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tp -87.46 -36.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 110.007 -0.368 . . . . 2.64 110.007 -161.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.53 149.94 3.18 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -177.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.52 -41.16 3.5 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.242 1.961 . . . . 0.77 110.33 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -54.61 -37.65 65.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.965 0.906 . . . . 6.47 111.148 -176.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.5 -57.81 11.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.79 0.436 . . . . 3.68 110.821 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 46' ' ' ILE . 3.4 mp -54.42 -45.32 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 1.31 110.02 176.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -56.32 -51.59 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.626 -0.671 . . . . 1.29 111.322 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -49.39 -47.12 47.98 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.512 0.725 . . . . 2.85 109.279 177.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -49.68 76.23 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 119.681 -0.807 . . . . 1.21 109.645 -177.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.12 -50.32 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.545 0.338 . . . . 0.73 111.561 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.9 -46.63 83.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.405 -0.518 . . . . 4.13 111.042 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.6 t -57.55 -44.63 85.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.557 0.743 . . . . 0.88 111.232 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.8 -54.4 46.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.376 -0.828 . . . . 1.6 110.738 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.55 -42.13 0.02 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.859 1.104 . . . . 1.52 115.859 -178.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.79 134.47 55.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.376 -0.821 . . . . 1.87 111.138 -131.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.24 104.31 6.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.6 1.546 . . . . 4.6 108.715 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.98 154.34 29.62 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.921 0.889 . . . . 1.0 110.331 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 m -152.87 103.93 2.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 1.71 109.52 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 71' ' ' LEU . 1.9 pt? -66.62 71.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.14 1.376 . . . . 2.63 112.643 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.78 -49.93 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 123.996 0.918 . . . . 2.45 111.082 176.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 75' ' ' GLU . 3.7 mtpm? 67.24 152.97 0.08 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.243 1.017 . . . . 4.84 109.324 -166.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 mp -66.97 -51.99 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.654 -1.239 . . . . 5.22 107.654 167.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 74.4 tt0 . . . . . 0 C--O 1.259 1.57 0 N-CA-C 102.034 -3.321 . . . . 9.8 102.034 164.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mtm . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 108.905 -0.776 . . . . 8.24 108.905 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.81 -112.62 4.97 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 106.021 -2.832 . . . . 5.2 106.021 -165.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.91 142.33 18.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.565 -1.272 . . . . 5.06 107.565 153.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.47 84.43 0.44 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.46 -1.456 . . . . 2.05 109.46 174.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.33 129.35 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.236 -0.653 . . . . 1.85 109.236 -174.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -140.51 101.04 4.01 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.918 0.866 . . . . 3.04 109.105 -169.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.41 106.15 18.14 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.019 -1.104 . . . . 2.11 108.019 178.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.93 139.49 48.53 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.303 0.501 . . . . 1.96 110.343 170.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.15 143.77 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.125 -1.435 . . . . 1.62 107.125 167.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.75 156.02 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 107.33 -1.359 . . . . 1.72 107.33 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -138.34 122.23 17.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.405 1.082 . . . . 7.74 108.218 175.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.5 -45.79 1.13 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.925 -1.27 . . . . 1.54 109.925 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -56.0 140.4 43.43 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.851 -0.426 . . . . 2.19 109.851 170.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -166.32 22.79 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.83 0.308 . . . . 2.73 111.83 -172.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -169.33 147.2 3.64 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.11 0.868 . . . . 2.04 109.377 -174.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.0 0.38 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.017 2.127 . . . . 1.18 113.167 175.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 p -54.5 -79.39 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.846 0.858 . . . . 0.92 111.659 172.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -41.32 -47.37 3.47 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 125.5 1.52 . . . . 1.12 110.834 176.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 t -46.63 -66.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.603 1.161 . . . . 0.82 110.933 173.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.318 0.3 OUTLIER -69.82 -17.61 63.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 119.692 -0.803 . . . . 1.33 111.302 -176.087 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -69.11 -45.02 71.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.31 -0.996 . . . . 3.34 108.31 -176.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.4 mt -53.7 -69.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.702 -0.851 . . . . 0.52 108.702 175.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.54 -59.08 3.5 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.522 0.729 . . . . 3.7 112.548 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.1 t -54.88 -41.76 71.26 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.232 0.613 . . . . 1.06 110.37 -177.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.8 t -61.4 -61.07 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.095 -0.378 . . . . 0.81 110.96 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.538 HD13 HG23 ' A' ' 58' ' ' ILE . 14.5 mt -62.35 -35.63 79.72 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 118.627 -1.229 . . . . 1.72 111.406 -169.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -57.89 -13.98 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.109 0.411 . . . . 1.37 112.109 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -61.99 -40.68 96.46 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.093 -1.005 . . . . 4.49 111.15 169.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -67.78 122.44 18.11 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.454 -0.573 . . . . 2.17 109.454 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.68 48.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.173 -0.954 . . . . 6.37 111.095 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.94 0.1 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.08 1.324 . . . . 0.89 111.524 -178.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.3 tt -78.37 142.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 109.052 -0.721 . . . . 2.65 109.052 173.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.96 -34.14 9.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.814 1.246 . . . . 1.63 110.461 -176.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -154.65 155.26 34.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.154 -0.684 . . . . 2.8 109.154 -175.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.7 t -155.76 80.08 1.01 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.73 0.812 . . . . 2.23 110.569 178.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 m -86.21 97.18 10.22 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.466 -0.771 . . . . 1.45 110.321 172.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -85.08 80.23 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.77 1.628 . . . . 2.08 108.651 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.18 93.92 9.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.856 -0.794 . . . . 0.75 108.856 -174.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.8 tt -46.8 -35.49 6.32 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.448 1.099 . . . . 1.89 111.862 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.53 -30.39 41.41 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.567 0.747 . . . . 0.97 111.878 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -121.1 13.35 11.25 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.524 1.53 . . . . 1.44 109.782 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.04 33.19 6.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.167 2.187 . . . . 1.88 112.979 176.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.01 147.47 46.27 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.353 0.661 . . . . 1.03 111.57 -161.397 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.88 108.69 20.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.818 1.647 . . . . 0.43 108.657 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.96 87.41 4.78 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 104.804 -2.295 . . . . 0.84 104.804 162.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 58' ' ' ILE . 18.8 mt -79.67 150.28 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.896 -1.52 . . . . 1.51 106.896 169.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -126.65 122.55 35.31 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 104.824 -2.287 . . . . 2.59 104.824 156.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -145.6 128.87 16.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 107.341 -1.355 . . . . 2.53 107.341 -178.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.3 121.61 75.31 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 106.942 -1.503 . . . . 3.59 106.942 178.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.93 -46.63 18.59 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.378 2.052 . . . . 2.08 112.799 -165.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -56.94 -8.86 0.69 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.964 1.706 . . . . 3.61 115.249 -166.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 pt -115.17 -10.18 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.415 1.086 . . . . 2.32 113.65 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.2 tt -148.89 -42.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.736 1.153 . . . . 2.92 113.097 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.91 153.44 5.33 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.6 -1.0 . . . . 0.86 110.6 -174.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.59 -35.48 17.03 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.261 1.974 . . . . 0.94 110.652 -174.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 -53.07 -37.28 61.51 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.358 0.663 . . . . 6.77 112.291 -172.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.11 -58.09 9.72 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.227 0.467 . . . . 4.36 110.024 175.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 26' ' ' LEU . 2.6 mp -51.29 -49.71 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 109.287 -0.635 . . . . 1.39 109.287 177.056 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.83 -54.16 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.971 -0.537 . . . . 1.75 110.783 179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -48.84 -52.07 26.18 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.498 0.719 . . . . 3.03 109.844 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -56.07 -51.57 67.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 122.123 -0.361 . . . . 0.94 110.487 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.0 mt -55.74 -47.73 78.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 121.748 -0.595 . . . . 0.79 111.877 -176.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -68.52 -44.06 75.42 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.343 0.519 . . . . 4.9 111.477 176.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.6 t -66.85 -15.62 63.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.243 -0.884 . . . . 1.43 112.466 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.33 -89.33 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.602 -1.258 . . . . 2.99 107.602 155.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.49 20.23 0.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.898 -1.501 . . . . 1.01 114.8 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -123.76 139.05 54.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.957 1.878 . . . . 1.91 113.121 -160.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -77.33 139.59 39.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.049 -1.463 . . . . 4.28 107.049 171.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.02 146.58 43.95 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.509 1.124 . . . . 1.12 109.357 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -153.06 112.25 3.81 Favored 'General case' 0 C--O 1.226 -0.157 0 O-C-N 121.673 -0.642 . . . . 1.57 110.575 176.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.06 121.36 7.92 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.847 0.859 . . . . 2.55 109.347 173.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 m -104.01 -42.56 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.293 0.637 . . . . 2.24 110.287 172.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.3 83.44 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.436 . . . . 4.88 111.331 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.11 150.02 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.282 0.633 . . . . 5.76 110.733 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.256 1.417 0 C-N-CA 129.087 2.955 . . . . 9.3 103.512 167.586 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ptp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 106.976 -1.49 . . . . 9.0 106.976 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.25 -61.71 2.66 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.87 -2.092 . . . . 5.1 107.87 -169.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.29 -179.89 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.497 0.665 . . . . 10.01 109.838 151.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.57 -41.26 1.05 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.609 -1.396 . . . . 1.77 109.609 -159.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.18 147.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.134 1.373 . . . . 2.56 109.994 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 7.0 tt -145.31 103.77 3.87 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 2.98 108.6 175.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -96.97 117.8 31.97 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.025 -0.989 . . . . 2.22 108.47 178.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.58 142.12 50.46 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.515 0.598 . . . . 1.94 110.851 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.71 134.84 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 107.033 -1.469 . . . . 1.92 107.033 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -111.61 119.87 60.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.839 1.256 . . . . 1.78 107.687 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -87.14 62.8 7.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.125 0.57 . . . . 5.92 110.484 -164.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.54 -104.63 0.2 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.69 -0.964 . . . . 3.57 110.69 174.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mtm 57.66 65.53 1.31 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.419 1.087 . . . . 2.16 111.873 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 p -65.97 -23.81 66.67 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 114.356 1.243 . . . . 3.81 114.356 -168.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.3 t -166.66 155.48 10.61 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.786 0.721 . . . . 2.21 109.143 -165.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.64 -39.88 0.1 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.659 2.384 . . . . 1.12 113.301 172.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.3 p -52.98 -76.08 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.603 1.161 . . . . 0.81 112.726 169.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.2 m -46.97 -41.03 15.55 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.165 1.786 . . . . 1.39 111.124 178.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.1 t -51.72 -73.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.931 0.893 . . . . 1.0 110.01 168.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.301 0.3 OUTLIER -67.31 -14.86 63.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.388 0.613 . . . . 1.3 112.275 -167.89 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -60.05 -42.15 93.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.032 -1.042 . . . . 4.52 108.494 176.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.46 -65.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.712 -0.847 . . . . 0.5 108.712 -175.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.21 -66.16 0.45 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.107 0.963 . . . . 3.82 112.234 175.723 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -47.55 -45.28 26.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.591 0.756 . . . . 1.1 111.068 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 t -60.95 -62.56 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.224 0.466 . . . . 0.96 111.12 175.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.59 -31.5 69.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.122 0.874 . . . . 1.74 111.163 -171.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 m -54.31 -19.54 5.56 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.116 -0.99 . . . . 1.78 112.646 176.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -37.97 77.4 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.711 -1.243 . . . . 6.0 112.59 170.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -66.86 165.09 16.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 2.76 109.992 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.92 42.13 3.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.758 0.823 . . . . 7.47 110.032 169.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.84 18.4 3.18 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.222 -1.151 . . . . 1.13 110.222 164.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -115.71 148.93 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.807 -2.294 . . . . 3.62 104.807 167.154 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.34 -37.12 5.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.784 1.233 . . . . 1.76 110.276 -174.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -157.63 162.4 38.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.675 -0.861 . . . . 2.58 108.675 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.4 m -143.37 73.85 1.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.194 0.997 . . . . 2.49 110.779 -177.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.85 83.6 5.75 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.161 -0.681 . . . . 1.55 109.161 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.4 103.43 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.522 0.677 . . . . 1.55 110.503 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.71 100.16 9.69 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.383 1.073 . . . . 0.76 108.906 -172.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -38.18 4.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.254 1.422 . . . . 2.03 110.575 170.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.85 39.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.394 1.078 . . . . 0.76 112.262 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -122.24 16.0 10.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.641 1.177 . . . . 1.36 109.688 179.056 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.08 43.51 1.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.212 2.205 . . . . 1.88 112.512 -178.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.17 144.34 34.74 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 122.149 -0.345 . . . . 1.08 110.826 -166.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HB1' HG13 ' A' ' 46' ' ' ILE . . . -98.65 108.13 20.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.443 1.497 . . . . 0.41 108.556 168.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.79 83.44 7.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.354 -2.091 . . . . 0.73 105.354 157.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.421 HG13 ' HB1' ' A' ' 44' ' ' ALA . 59.8 mt -83.06 153.29 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.32 -1.733 . . . . 1.07 106.32 170.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -121.76 141.98 50.65 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.876 -1.898 . . . . 3.88 105.876 166.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -163.09 165.5 24.6 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 118.742 0.701 . . . . 1.99 112.186 -163.758 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -122.74 97.46 44.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 123.986 0.804 . . . . 4.2 110.736 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.72 -21.05 72.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.839 2.359 . . . . 1.73 114.641 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.44 -31.18 14.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.973 0.806 . . . . 4.11 111.875 168.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.99 -66.86 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 123.229 0.611 . . . . 4.73 110.208 175.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.29 116.02 41.41 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.333 -0.988 . . . . 2.69 108.333 -166.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.16 161.91 38.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.378 -1.489 . . . . 0.87 109.378 -176.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -54.03 -37.88 86.68 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.856 1.704 . . . . 1.01 109.485 171.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 57' ' ' ASP . 12.8 ptt180 -35.96 -53.39 0.76 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 10.26 112.05 168.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 56' ' ' ARG . 64.6 m-20 -71.52 -52.02 20.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.709 -1.589 . . . . 2.96 106.709 -164.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -56.08 -52.37 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.384 -1.28 . . . . 0.96 109.406 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -53.38 -56.59 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.042 0.537 . . . . 1.56 109.683 179.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -56.93 -38.1 72.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.206 0.457 . . . . 3.13 110.247 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.7 m -65.08 -46.89 79.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.259 0.481 . . . . 0.74 110.609 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.78 -46.43 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.294 1.038 . . . . 0.68 110.431 -179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.28 -55.65 28.96 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 123.575 0.75 . . . . 2.94 109.672 173.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -51.85 -46.6 64.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.636 1.174 . . . . 1.24 111.357 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.8 mt -66.79 -45.24 79.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.219 -0.926 . . . . 1.92 112.107 177.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.86 -46.46 0.02 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 114.999 0.76 . . . . 1.49 114.999 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -129.13 134.78 48.2 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 120.482 -0.487 . . . . 1.81 112.011 -135.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.46 154.94 32.08 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.731 -1.211 . . . . 3.27 107.731 168.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.29 165.08 28.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.907 0.483 . . . . 1.28 110.962 -166.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 m -132.58 112.09 11.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.571 1.549 . . . . 2.19 107.949 177.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 tp -73.1 78.59 1.23 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.796 1.238 . . . . 2.95 108.698 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.69 -36.61 77.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.583 -0.735 . . . . 2.01 111.377 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 36.88 68.68 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.365 1.866 . . . . 4.73 112.332 -179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.1 pt -46.27 147.26 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.388 1.075 . . . . 4.91 111.014 176.021 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 128.013 2.525 . . . . 10.62 113.074 -165.682 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 106.058 -1.83 . . . . 10.16 106.058 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.75 171.17 40.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 107.735 -2.146 . . . . 4.43 107.735 177.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.55 162.96 1.43 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.13 1.372 . . . . 5.27 112.785 -174.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.9 171.89 39.7 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.385 -1.086 . . . . 2.14 110.385 152.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.89 132.0 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.188 -1.412 . . . . 2.18 107.188 163.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.85 124.42 44.09 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 103.771 -2.677 . . . . 3.36 103.771 169.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -129.4 127.03 40.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.096 -1.816 . . . . 2.46 106.096 -179.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -140.94 144.97 35.45 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.283 -0.266 . . . . 1.94 110.283 -172.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -78.84 139.29 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.212 -1.403 . . . . 1.79 107.212 168.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.98 99.49 6.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 126.235 1.814 . . . . 1.95 108.031 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -84.86 140.9 30.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.464 1.106 . . . . 5.53 108.061 175.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.92 -11.63 34.65 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.328 0.966 . . . . 1.65 112.818 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.6 mtm -67.72 146.89 53.33 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.292 1.046 . . . . 1.49 111.295 177.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -162.04 143.47 10.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.875 -1.898 . . . . 2.97 105.875 166.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.4 t 69.64 145.58 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.351 1.46 . . . . 2.47 113.147 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.19 -32.32 0.47 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.248 1.819 . . . . 1.2 113.176 175.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 p -51.66 -81.75 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.724 1.209 . . . . 1.01 112.936 173.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.5 m -45.7 -43.67 12.93 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.835 1.254 . . . . 1.21 110.68 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.7 t -49.1 -65.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.444 1.098 . . . . 1.14 110.976 174.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.293 0.3 OUTLIER -68.91 -20.21 64.23 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.549 0.69 . . . . 1.43 111.003 -176.559 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.03 -40.46 97.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 120.92 -1.113 . . . . 4.16 109.023 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.7 -67.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.933 0.893 . . . . 0.74 109.096 176.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.99 -64.17 0.87 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.942 0.497 . . . . 3.48 111.64 178.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -48.48 -47.56 38.47 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.933 0.893 . . . . 2.83 111.935 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 t -67.82 -39.94 83.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 O-C-N 121.336 -0.852 . . . . 0.84 112.285 -178.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.97 -37.57 69.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.672 1.124 . . . . 1.77 110.937 178.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -68.87 73.13 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.17 1.388 . . . . 2.55 110.091 -176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.21 -35.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 129.36 3.064 . . . . 5.53 109.648 -172.396 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -54.17 -40.79 67.82 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 119.114 0.87 . . . . 2.59 112.282 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 77.91 -5.17 2.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.674 2.389 . . . . 7.57 111.338 -163.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.53 47.09 Favored Glycine 0 CA--C 1.525 0.674 0 O-C-N 121.304 -0.873 . . . . 1.27 111.456 176.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.28 133.93 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.114 1.366 . . . . 3.74 107.894 173.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -102.16 -31.89 10.37 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.413 1.085 . . . . 1.59 110.731 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -155.1 153.61 31.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.821 -0.609 . . . . 2.09 109.715 174.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -150.02 96.17 2.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.272 1.029 . . . . 2.03 110.846 -171.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.9 104.39 16.28 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.141 -0.689 . . . . 1.46 109.141 171.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.6 82.45 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.996 0.918 . . . . 2.16 108.85 177.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 90.21 6.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.071 -1.085 . . . . 0.91 108.071 -176.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -47.56 -32.68 5.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.773 0.829 . . . . 1.81 111.304 169.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.75 -32.57 31.18 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.941 0.896 . . . . 0.98 111.876 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -122.53 18.05 10.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.405 1.482 . . . . 1.67 109.68 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.9 m120 36.83 45.16 0.4 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.965 2.106 . . . . 2.65 112.916 -175.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.28 143.99 42.45 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.493 0.588 . . . . 1.61 111.82 -174.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.11 112.91 24.5 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.427 1.491 . . . . 0.42 108.131 168.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -86.23 105.68 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.475 -1.676 . . . . 0.89 106.475 164.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.72 103.62 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.586 1.554 . . . . 1.24 108.338 -172.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -78.34 83.66 4.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.57 -1.641 . . . . 3.39 106.57 172.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.55 165.0 14.01 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.287 1.035 . . . . 2.0 112.3 177.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -107.97 101.12 39.59 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.394 1.078 . . . . 3.78 110.195 174.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.93 60.62 6.88 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.489 3.46 . . . . 2.31 113.796 -166.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -157.23 -40.07 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.657 0.783 . . . . 4.17 111.42 167.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.0 pt -76.06 -13.43 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.208 0.603 . . . . 2.26 110.249 174.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -149.48 144.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 108.071 -1.085 . . . . 2.2 108.071 175.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.4 148.75 20.8 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 108.317 -1.913 . . . . 1.06 108.317 170.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.46 -42.93 56.19 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.466 1.444 . . . . 0.72 109.702 178.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.59 -42.28 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.173 1.389 . . . . 7.31 113.218 168.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.26 -41.6 76.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.262 0.937 . . . . 3.32 109.597 -175.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.8 mt -63.59 -49.27 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.422 -0.955 . . . . 0.68 108.422 176.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -50.0 -56.85 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.879 -0.415 . . . . 1.56 109.879 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -51.49 -51.66 53.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.073 0.549 . . . . 3.04 110.114 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.6 m -58.97 -52.57 65.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.625 -0.43 . . . . 0.81 110.056 -176.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.83 -60.55 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.862 0.865 . . . . 0.75 110.024 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.4 -45.06 80.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.802 -0.444 . . . . 3.87 109.802 -176.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -62.97 -9.17 8.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 117.227 -1.368 . . . . 1.11 114.278 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.76 -87.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 121.359 1.89 . . . . 2.54 107.808 155.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.13 42.49 0.47 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.833 -0.982 . . . . 1.22 112.307 174.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -126.4 170.83 11.54 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.327 1.064 . . . . 1.93 112.912 -171.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -117.42 122.47 43.89 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 104.684 -2.339 . . . . 3.45 104.684 167.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.79 154.82 26.74 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.732 0.813 . . . . 1.04 111.073 -171.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.4 m -156.24 121.46 4.76 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 121.455 -0.778 . . . . 1.55 110.363 172.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.44 128.62 38.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.462 1.105 . . . . 3.73 110.149 173.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.32 158.24 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.547 1.539 . . . . 2.37 109.528 178.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -87.4 72.72 9.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.155 -0.966 . . . . 5.0 108.987 -176.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.7 mm 74.41 -70.23 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 125.862 1.665 . . . . 6.53 108.795 -172.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.735 2.014 . . . . 10.03 112.156 176.539 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptp . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.327 -0.62 . . . . 11.62 109.327 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.06 -66.82 1.45 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.114 -1.594 . . . . 7.85 109.114 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -104.86 -168.78 1.52 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.786 1.235 . . . . 5.53 109.562 172.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.27 -19.67 10.07 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 118.327 -1.263 . . . . 2.88 115.069 148.357 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.67 100.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 120.169 1.985 . . . . 2.3 110.975 176.101 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -104.17 101.45 11.19 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.825 2.05 . . . . 2.62 107.288 174.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -97.51 107.15 19.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.97 -0.752 . . . . 2.44 108.97 172.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -99.94 148.25 24.69 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 124.14 0.9 . . . . 2.33 108.952 166.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -79.15 145.73 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 106.161 -1.792 . . . . 1.72 106.161 158.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.05 139.23 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.746 1.218 . . . . 2.29 108.766 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -133.56 153.58 51.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.766 0.826 . . . . 6.85 111.023 -178.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.03 -21.0 28.0 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.862 1.22 . . . . 1.95 110.965 -174.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.5 mtm -66.75 150.55 48.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.156 -0.614 . . . . 1.8 109.681 174.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t -151.35 10.81 0.59 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.105 0.78 . . . . 2.44 113.105 177.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.5 t -171.87 151.56 2.82 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.544 1.066 . . . . 2.29 109.528 -174.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.28 -31.94 0.71 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.696 1.998 . . . . 1.2 113.012 175.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.9 p -53.3 -67.5 0.25 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.377 1.071 . . . . 0.72 113.145 170.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.5 m -43.15 -50.96 6.17 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.217 1.407 . . . . 1.07 108.346 176.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 t -50.02 -66.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.743 -1.117 . . . . 0.84 111.551 177.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' GLU 0.327 0.1 OUTLIER -65.83 -28.98 69.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.98 111.112 -171.404 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -65.07 -52.29 56.57 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.32 1.448 . . . . 3.06 108.281 -178.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -51.76 -65.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.092 -1.077 . . . . 0.76 108.092 171.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 20' ' ' HIS . 11.4 pt-20 -66.44 -42.07 88.19 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.91 -0.586 . . . . 2.96 110.759 -158.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -59.54 -45.66 91.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.739 0.815 . . . . 1.55 110.39 173.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -59.5 -49.67 76.87 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.761 -0.459 . . . . 0.97 109.761 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.07 -45.23 75.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.751 -0.593 . . . . 2.49 110.985 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -61.55 -7.03 2.81 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.395 1.257 . . . . 2.27 114.395 179.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -66.63 -31.94 72.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.492 1.042 . . . . 4.35 110.654 169.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -64.74 121.5 14.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.627 0.771 . . . . 2.26 109.168 -176.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.06 46.05 0.78 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.445 0.906 . . . . 5.6 113.445 -165.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.62 20.38 0.13 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.469 1.033 . . . . 1.41 111.335 166.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.68 140.18 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.093 -1.077 . . . . 2.38 108.093 174.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.3 mt -109.28 -35.9 6.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.366 1.066 . . . . 1.6 111.433 -173.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -155.46 158.42 38.54 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.462 1.028 . . . . 2.24 109.854 -177.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 p -155.91 140.35 16.77 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 127.742 2.417 . . . . 3.13 105.467 -177.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -156.45 90.59 1.18 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.362 -1.718 . . . . 1.55 106.362 170.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.48 76.14 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.603 -1.258 . . . . 1.92 107.603 -172.14 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.86 93.24 4.98 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 121.572 -0.705 . . . . 1.0 109.133 -171.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tt -42.98 -37.17 1.79 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.252 1.421 . . . . 2.17 111.566 168.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.23 -32.91 39.01 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 1.11 112.452 178.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -116.05 12.23 15.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.255 1.422 . . . . 1.6 110.125 178.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 40.44 37.74 0.49 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.823 2.049 . . . . 2.14 112.141 -175.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 154.89 45.54 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.489 0.716 . . . . 1.44 109.762 -169.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.68 112.12 11.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.413 -1.328 . . . . 0.61 107.413 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -92.08 96.94 10.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.899 2.479 . . . . 1.29 104.602 170.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.2 mp -92.79 135.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 104.707 -2.331 . . . . 1.57 104.707 172.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -108.1 127.88 54.19 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.501 -1.666 . . . . 3.2 106.501 168.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -165.35 168.47 16.78 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.111 0.965 . . . . 2.98 109.74 -173.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -92.13 119.05 68.41 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.412 1.07 . . . . 4.0 108.905 171.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.62 -32.51 93.43 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.543 1.495 . . . . 2.15 113.039 176.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -84.88 49.88 1.81 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.901 1.228 . . . . 5.55 111.843 -165.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.97 -47.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 127.395 2.278 . . . . 4.15 107.83 178.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.49 -53.62 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 124.308 1.043 . . . . 2.84 109.595 -173.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.06 145.3 0.08 OUTLIER Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.717 -0.614 . . . . 0.92 111.7 -166.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -52.5 -39.63 74.03 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.514 2.143 . . . . 0.94 111.354 178.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -37.95 -48.76 1.2 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.435 1.494 . . . . 7.66 112.697 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.57 -50.24 59.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.864 0.84 . . . . 3.69 109.506 -172.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.3 -52.58 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.598 -0.689 . . . . 1.04 110.896 175.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mp -51.86 -50.8 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.946 -0.761 . . . . 1.71 108.946 177.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -55.37 -47.04 76.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.008 0.523 . . . . 5.05 110.373 -179.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -60.08 -48.4 81.89 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.856 0.753 . . . . 0.95 110.936 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.7 -51.69 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.865 0.757 . . . . 0.88 110.837 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.95 -55.5 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.119 0.968 . . . . 2.86 109.943 177.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -57.09 -34.95 68.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.751 1.22 . . . . 1.03 111.597 -177.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.67 -58.1 4.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.529 0.604 . . . . 2.37 110.275 172.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 -41.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.826 1.09 . . . . 1.57 115.826 -176.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -117.25 142.69 46.74 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 117.421 0.61 . . . . 1.98 111.65 -135.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.8 150.49 30.71 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.838 -1.542 . . . . 3.69 106.838 173.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.41 164.61 35.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.235 0.471 . . . . 1.09 111.994 -176.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.7 m -158.2 132.04 7.85 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 118.282 -0.866 . . . . 1.4 110.624 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.49 128.68 37.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.893 1.224 . . . . 2.55 108.777 172.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.58 22.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 123.442 0.697 . . . . 3.05 111.967 177.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -161.65 -68.32 0.06 Allowed 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.703 -0.48 . . . . 8.55 109.703 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.273 5.0 tp 21.64 68.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.963 2.105 . . . . 8.48 113.712 -165.171 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-N 114.51 -1.223 . . . . 10.44 109.526 167.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 106.076 -1.824 . . . . 7.79 106.076 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.24 -167.37 12.62 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 107.229 -2.348 . . . . 4.49 107.229 -133.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.8 95.74 7.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.542 1.171 . . . . 6.01 109.017 172.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.34 140.9 31.73 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.796 -0.521 . . . . 1.78 111.796 178.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.42 128.9 74.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 124.089 0.956 . . . . 3.36 110.727 -175.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.25 120.3 28.37 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.108 1.363 . . . . 4.37 108.076 173.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.83 107.89 19.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.185 -1.043 . . . . 2.41 108.185 177.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 pp -117.78 148.55 41.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.036 0.534 . . . . 1.94 110.998 -174.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.7 151.2 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.884 0.873 . . . . 1.81 108.971 173.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.72 86.76 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.981 1.312 . . . . 2.19 109.339 174.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 107.48 18.78 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.664 -0.648 . . . . 6.58 110.416 179.622 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.62 -20.77 0.39 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.357 0.98 . . . . 1.54 112.133 -178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.7 mtm -62.5 169.7 2.84 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.176 0.988 . . . . 1.72 111.79 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 t -158.9 -44.66 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.519 0.727 . . . . 2.35 110.856 -177.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.9 m -138.44 164.3 29.71 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.189 0.449 . . . . 2.62 110.665 -168.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -38.64 3.92 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.48 1.912 . . . . 1.23 112.464 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.8 p -52.68 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.782 1.233 . . . . 0.88 112.265 170.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.4 m -42.69 -41.97 3.33 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.638 1.175 . . . . 1.23 111.43 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.22 -72.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.024 0.53 . . . . 0.84 111.121 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.73 -17.88 65.08 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.465 -0.772 . . . . 1.0 112.334 -170.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -54.99 -46.4 75.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.859 0.864 . . . . 3.51 109.36 173.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.08 -60.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.895 -1.15 . . . . 0.59 107.895 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -50.84 -58.17 6.62 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.794 0.438 . . . . 2.97 110.654 178.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 t -56.2 -33.69 65.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.473 0.709 . . . . 1.09 111.908 -178.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -70.62 -64.46 0.89 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.581 0.628 . . . . 0.99 110.609 172.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.12 -32.89 74.82 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 121.052 -1.03 . . . . 2.15 111.583 -167.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -56.93 -16.45 6.88 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 2.23 112.701 175.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -63.08 -35.8 81.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.398 -0.814 . . . . 4.97 111.126 171.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -72.98 109.7 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.53 -0.915 . . . . 2.58 108.53 177.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -65.87 -3.74 5.62 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.928 -1.107 . . . . 7.23 110.898 167.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.73 -25.37 71.69 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.623 1.106 . . . . 1.02 112.833 166.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 pp -99.84 156.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 CA-C-N 119.142 1.471 . . . . 3.31 110.519 175.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.22 -38.23 6.32 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.557 1.543 . . . . 1.48 110.046 -177.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -155.65 157.06 36.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 118.651 0.659 . . . . 2.55 109.409 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -140.64 131.78 26.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.073 -1.454 . . . . 1.95 107.073 170.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.45 98.31 3.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.344 1.458 . . . . 1.63 107.651 -177.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.33 106.55 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.334 0.654 . . . . 1.71 111.761 -174.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.13 97.67 8.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.545 -0.722 . . . . 0.9 109.223 -174.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.1 tt -48.98 -40.2 29.62 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.19 0.996 . . . . 1.76 111.597 175.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.55 -32.95 1.02 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.384 1.074 . . . . 0.86 113.226 175.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -125.82 13.76 7.98 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.084 0.953 . . . . 1.36 111.154 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 34.52 49.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.141 1.776 . . . . 1.88 112.277 -172.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 139.71 53.59 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.164 0.585 . . . . 2.77 109.856 -179.001 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.96 112.17 24.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.223 1.409 . . . . 0.6 107.738 162.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -79.18 102.16 8.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.281 -2.488 . . . . 1.35 104.281 160.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.0 mt -106.76 124.73 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 106.336 -1.728 . . . . 0.95 106.336 174.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -97.48 114.74 26.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.219 -2.141 . . . . 3.52 105.219 166.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.66 151.62 29.0 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.76 -1.941 . . . . 2.94 105.76 -178.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.62 129.43 23.99 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.409 0.443 . . . . 3.83 110.883 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -56.94 -35.31 98.6 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.898 2.399 . . . . 1.73 111.737 -174.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.64 -25.87 65.05 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.13 0.789 . . . . 3.71 113.13 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.9 pt -106.86 -26.96 3.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 118.965 0.802 . . . . 2.83 112.161 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -152.93 131.97 3.12 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 CA-C-N 119.246 0.93 . . . . 2.78 109.584 172.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.71 166.75 53.4 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.473 -0.651 . . . . 0.85 111.473 -177.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.02 -55.54 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.86 2.374 . . . . 1.18 110.586 177.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -56.97 -32.95 66.58 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 122.391 -0.193 . . . . 7.49 111.03 -174.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -56.88 13.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.659 1.584 . . . . 4.02 109.184 175.049 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.66 -50.33 68.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.059 -0.719 . . . . 1.41 109.059 176.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.2 -46.97 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.007 -0.542 . . . . 1.98 110.524 -179.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -52.71 -51.73 59.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.984 0.811 . . . . 2.79 109.714 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -52.33 -58.39 6.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.466 0.575 . . . . 0.9 110.302 175.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.3 -55.78 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.043 0.537 . . . . 0.78 111.179 -172.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -53.67 -45.6 70.33 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.709 0.804 . . . . 4.19 109.635 176.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -66.98 -9.88 43.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.617 -1.182 . . . . 1.08 113.392 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.96 -100.99 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.276 1.398 . . . . 2.6 107.85 156.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.86 38.92 0.5 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.243 0.929 . . . . 1.64 112.871 177.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -130.81 122.71 27.61 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.311 1.056 . . . . 1.97 109.336 -171.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -79.91 133.61 36.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.971 -1.863 . . . . 3.01 105.971 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.28 161.15 30.88 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 113.791 1.034 . . . . 1.08 113.791 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 m -158.22 137.71 11.87 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.912 1.285 . . . . 1.48 108.572 177.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -82.43 48.22 1.26 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.747 1.612 . . . . 3.22 111.232 -175.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -41.25 -32.79 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 117.209 2.3 . . . . 2.67 117.209 -160.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.11 -30.95 61.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.135 1.334 . . . . 10.1 112.283 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.03 84.44 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.647 1.579 . . . . 7.95 108.279 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 . . . . . 0 C--O 1.251 1.137 0 N-CA-C 105.684 -1.969 . . . . 11.72 105.684 169.637 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 104.501 -2.407 . . . . 9.0 104.501 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.36 178.48 3.97 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 109.27 -1.532 . . . . 6.76 109.27 138.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -118.9 -44.16 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.98 2.112 . . . . 9.13 109.591 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.9 2.55 38.74 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.427 -1.207 . . . . 2.13 115.292 168.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 p -156.63 127.7 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 120.371 2.086 . . . . 1.8 110.29 172.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.48 108.97 6.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.787 -1.19 . . . . 3.38 107.787 172.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.35 119.44 28.78 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.434 -1.321 . . . . 2.18 107.434 169.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -119.69 140.49 50.58 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.707 1.139 . . . . 2.8 110.494 170.046 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.81 119.87 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.718 -1.216 . . . . 1.59 107.718 173.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 m -86.54 94.23 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.569 1.148 . . . . 2.54 108.37 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -78.45 86.16 4.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.937 -1.505 . . . . 7.09 106.937 176.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.12 -138.25 5.15 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 103.48 -3.848 . . . . 3.38 103.48 175.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.5 mtm 65.78 166.97 0.19 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.951 1.3 . . . . 2.18 111.62 -170.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.6 p -147.21 -83.41 0.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.993 0.517 . . . . 3.66 110.134 -176.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t -146.29 103.46 3.71 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.595 0.758 . . . . 2.94 110.389 -166.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 45.33 -129.98 1.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.458 -0.941 . . . . 2.77 108.458 -169.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.1 p 43.53 -87.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.463 1.905 . . . . 0.8 113.962 166.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -39.83 -43.75 1.51 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.087 1.755 . . . . 1.09 110.391 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -44.42 -67.9 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 0.95 110.649 172.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HA ' ' HG3' ' A' ' 23' ' ' GLU 0.326 0.4 OUTLIER -71.78 -21.6 61.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 119.797 -0.761 . . . . 0.94 112.512 -177.525 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.56 -45.32 92.17 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.362 -1.347 . . . . 4.19 107.362 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -55.43 -69.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.62 -0.718 . . . . 0.61 109.085 172.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 20' ' ' HIS . 2.1 pp20? -56.6 -48.14 78.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.774 0.261 . . . . 4.77 111.589 -165.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -70.45 -20.77 62.87 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.23 0.612 . . . . 1.2 110.485 -178.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.7 t -66.85 -62.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.33 -1.481 . . . . 0.99 109.036 162.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.66 -50.58 35.18 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 113.62 0.97 . . . . 1.85 113.62 -162.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -44.15 -28.26 0.48 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.015 1.326 . . . . 2.25 113.58 -167.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -63.17 -40.48 97.67 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 128.192 2.597 . . . . 4.16 112.944 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -62.2 129.06 39.02 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.254 -1.017 . . . . 2.41 108.254 172.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -64.88 -3.47 3.44 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.795 1.405 . . . . 10.75 114.795 -166.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' HD12 ' A' ' 52' ' ' ILE . . . -92.16 -14.13 56.49 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 119.546 -0.585 . . . . 1.16 112.214 -178.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 mm -88.91 104.86 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.037 -1.098 . . . . 2.45 108.037 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.0 mt -78.99 -38.96 35.46 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.004 -0.739 . . . . 1.62 109.004 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -155.31 145.68 21.95 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.599 -0.889 . . . . 2.31 108.599 176.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.75 105.99 6.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.307 -1.368 . . . . 1.89 107.307 175.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 t -120.94 103.6 9.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.963 -1.125 . . . . 1.52 107.963 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.1 p -108.04 127.78 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.072 0.549 . . . . 1.87 110.481 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.03 108.94 11.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.035 0.934 . . . . 1.2 110.247 -170.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.81 -41.51 5.06 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.933 1.293 . . . . 2.41 111.08 168.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.96 -27.77 14.36 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 124.109 0.964 . . . . 0.79 112.475 -175.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -130.07 14.28 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.212 1.005 . . . . 1.4 110.006 -177.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 m120 29.97 53.55 0.13 Allowed 'General case' 0 C--N 1.345 0.385 0 C-N-CA 126.169 1.788 . . . . 2.29 111.831 -169.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.29 141.17 37.76 Favored 'General case' 0 N--CA 1.461 0.085 0 O-C-N 121.577 -0.702 . . . . 0.99 110.712 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.19 112.61 24.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.753 1.621 . . . . 0.47 108.424 168.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -79.91 104.0 10.19 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.055 -1.832 . . . . 0.84 106.055 162.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.0 mt -110.41 113.0 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.482 -0.933 . . . . 0.9 108.482 175.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -84.1 107.38 16.41 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 105.699 -1.963 . . . . 3.06 105.699 164.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -147.2 167.48 24.09 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.67 -1.604 . . . . 2.66 106.67 174.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.35 136.65 27.34 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.757 1.021 . . . . 4.37 113.757 174.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.34 48.59 2.93 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.506 3.471 . . . . 2.06 113.023 -165.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -155.85 -47.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.004 1.322 . . . . 3.11 109.464 -173.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.531 HD12 ' HA2' ' A' ' 31' ' ' GLY . 7.6 pt -67.75 -32.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.228 -1.027 . . . . 3.23 108.228 166.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.56 HG23 ' H ' ' A' ' 54' ' ' GLY 0.31 17.6 tt -131.67 -91.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 123.735 0.647 . . . . 2.4 112.579 170.029 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 135.67 152.78 6.49 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.536 -1.426 . . . . 1.15 109.536 -168.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.71 -57.17 0.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.197 1.931 . . . . 1.01 109.033 172.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 ptt85 -29.28 -55.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.223 2.209 . . . . 10.04 113.22 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.23 -51.06 65.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.552 -0.907 . . . . 2.85 108.552 -171.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.2 mt -60.81 -49.95 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.536 -0.542 . . . . 0.81 109.536 177.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.1 mm -50.28 -57.99 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 119.09 -0.481 . . . . 1.53 109.795 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -51.46 -46.31 63.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.055 0.542 . . . . 2.82 110.258 177.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.2 m -57.57 -47.9 80.82 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 119.388 -0.339 . . . . 0.69 110.986 178.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mm -60.0 -50.6 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.278 0.945 . . . . 1.66 110.989 -177.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -50.28 73.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.337 0.517 . . . . 2.95 110.243 176.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -52.0 -42.0 62.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.526 0.73 . . . . 0.9 111.132 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.74 -49.29 48.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.305 -0.872 . . . . 1.84 111.687 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.9 -44.22 0.02 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 116.001 1.16 . . . . 1.37 116.001 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.87 156.8 39.06 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.813 0.672 . . . . 1.88 112.813 -135.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.21 139.71 39.95 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.651 -1.611 . . . . 5.65 106.651 171.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.85 70.59 1.21 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.401 1.48 . . . . 2.54 110.1 -166.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 m -84.99 100.32 11.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.425 0.631 . . . . 1.68 109.629 -170.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.33 73.88 0.23 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.68 1.592 . . . . 2.63 112.651 -178.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -52.66 -33.28 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.086 1.354 . . . . 2.0 111.682 167.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 tttp 66.49 -62.17 0.29 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.218 2.607 . . . . 6.27 112.67 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.8 mt 71.35 -61.3 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.719 1.607 . . . . 5.1 111.162 -177.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.12 1.368 . . . . 10.92 107.833 174.571 . . . . . . . . 0 0 . 1 stop_ save_